<SEC-DOCUMENT>0001513162-22-000008.txt : 20220112
<SEC-HEADER>0001513162-22-000008.hdr.sgml : 20220112
<ACCEPTANCE-DATETIME>20220112161330
ACCESSION NUMBER:		0001513162-22-000008
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		47
CONFORMED PERIOD OF REPORT:	20211130
FILED AS OF DATE:		20220112
DATE AS OF CHANGE:		20220112

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BIOMERICA INC
		CENTRAL INDEX KEY:			0000073290
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				952645573
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0531

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37863
		FILM NUMBER:		22526724

	BUSINESS ADDRESS:	
		STREET 1:		17571 VON KARMAN AVENUE
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92614
		BUSINESS PHONE:		9496452111

	MAIL ADDRESS:	
		STREET 1:		17571 VON KARMAN AVENUE
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92614

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NMS PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	19871130

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NUCLEAR MEDICAL SYSTEMS INC
		DATE OF NAME CHANGE:	19830216

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NUCLEAR INSTRUMENTS INC
		DATE OF NAME CHANGE:	19720508
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>bmra-20211130.htm
<DESCRIPTION>FORM 10-Q
<TEXT>
<XBRL>
<?xml version="1.0" encoding="ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Wed Jan 12 20:33:19 UTC 2022 -->
<html xmlns:bmra="http://www.biomerica.com/20211130" xmlns:compsci="http://compsciresources.com" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:dtr="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.w3.org/1999/xhtml" xmlns:xml="http://www.w3.org/XML/1998/namespace"><head><title>Form 10-Q</title>
<meta content="text/html" http-equiv="Content-Type" />
</head> <body><div> </div><div style="page:WordSection1"> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 0cm 0pt">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">UNITED STATES</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">SECURITIES AND EXCHANGE COMMISSION</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">WASHINGTON, D.C. 20549</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 0cm 0pt">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">FORM <ix:nonNumeric contextRef="c0" name="dei:DocumentType">10-Q</ix:nonNumeric></span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 0cm 0pt">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;"> (Mark One)</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">[<ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="dei:DocumentQuarterlyReport">X</ix:nonNumeric>] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">FOR THE QUARTERLY PERIOD ENDED <ix:nonNumeric contextRef="c0" format="ixt:date-monthname-day-year-en" name="dei:DocumentPeriodEndDate">NOVEMBER 30, 2021</ix:nonNumeric></span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">OR</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;"><ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:DocumentTransitionReport">[ ]</ix:nonNumeric> TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">Commission File Number:&#160; <ix:nonNumeric contextRef="c0" name="dei:EntityFileNumber">001-37863</ix:nonNumeric></span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><ix:nonNumeric contextRef="c0" name="dei:EntityRegistrantName"><b><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">BIOMERICA, INC.</span></b></ix:nonNumeric></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">--------------------------------------------------------------------------------------------------------------------------------------------------------------------</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">(Exact name of registrant as specified in its charter)</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;"><ix:nonNumeric contextRef="c0" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c0" name="dei:EntityTaxIdentificationNumber">95-2645573</ix:nonNumeric></span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">--------------------------------------------------------------------------------------------------------------------------------------------------------------------</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">(State or other jurisdiction of&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;(I.R.S. Employer</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">incorporation or organization)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;Identification No.)</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;"><ix:nonNumeric contextRef="c0" name="dei:EntityAddressAddressLine1">17571 Von Karman Avenue</ix:nonNumeric>, <ix:nonNumeric contextRef="c0" name="dei:EntityAddressCityOrTown">Irvine</ix:nonNumeric>, <ix:nonNumeric contextRef="c0" name="dei:EntityAddressStateOrProvince">CA</ix:nonNumeric>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c0" name="dei:EntityAddressPostalZipCode">92614</ix:nonNumeric></span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">-------------------------------------------------------------------------------------------------------------------------------------------------------------------</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">(Address of principal executive offices)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(Zip Code)</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">Registrant's telephone number including area code:&#160; (<ix:nonNumeric contextRef="c0" name="dei:CityAreaCode">949</ix:nonNumeric>) <ix:nonNumeric contextRef="c0" name="dei:LocalPhoneNumber">645-2111</ix:nonNumeric></span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">--------------------------------------------------------------------------------------------------------------------------------------------------------------------</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">--------------------------------------------------------------------------------------------------------------------------------------------------------------------</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; TEXT-INDENT:36pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">(Former name, former address and former fiscal year, if changed since last report.)</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; TEXT-INDENT:36pt; text-align: center;">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">Securities registered pursuant to Section 12(b) of the Act:</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; TEXT-INDENT:36pt; text-align: center;">&#160;</p><table cellpadding="0" cellspacing="0" style="WIDTH:550.1pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;" width="733"> <tr style="HEIGHT:16.8pt"> <td style="HEIGHT:16.8pt; WIDTH:177.85pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">(TITLE OF EACH CLASS)</span></p></td> <td style="HEIGHT:16.8pt; WIDTH:24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 24%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">&#160;(TICKER SYMBOL) </span></p></td> <td style="HEIGHT:16.8pt; WIDTH:48.02%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">(NAME OF EACH EXCHANGE ON WHICH REGISTERED)</span></p></td></tr> <tr style="HEIGHT:8.1pt"> <td style="HEIGHT:8.1pt; WIDTH:177.85pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">&#160;----------------------------------- </span></p></td> <td style="HEIGHT:8.1pt; WIDTH:24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 24%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">&#160;-----------------------------------&#160; </span></p></td> <td style="HEIGHT:8.1pt; WIDTH:48.02%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">&#160;------------------------------------------------------------------------------- </span></p></td></tr> <tr style="HEIGHT:16.8pt"> <td style="HEIGHT:16.8pt; WIDTH:177.85pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"><ix:nonNumeric contextRef="c0" name="dei:Security12bTitle"><span style="FONT-SIZE:10pt; COLOR:black">Common, par value $.08</span></ix:nonNumeric></p></td> <td style="HEIGHT:16.8pt; WIDTH:24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 24%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"><ix:nonNumeric contextRef="c0" name="dei:TradingSymbol"><span style="FONT-SIZE:10pt; COLOR:black">BMRA</span></ix:nonNumeric></p></td> <td style="HEIGHT:16.8pt; WIDTH:48.02%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonNumeric contextRef="c0" name="dei:SecurityExchangeName">NASDAQ</ix:nonNumeric> Capital Market</span></p></td></tr></table> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 0cm 0pt">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:justify; MARGIN:0cm 69.65pt 0pt 0cm"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">Indicate by check whether the registrant (1) filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:justify; MARGIN:0cm 69.65pt 0pt 0cm">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 69.65pt 0pt 0cm"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Yes [<span style="-sec-ix-hidden: hidden-fact-0">X</span>]&#160; &#160;No [_]</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 69.65pt 0pt 0cm">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:justify; MARGIN:0cm 69.65pt 0pt 0cm"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">Indicate by check mark whether the registrant has submitted electronically, every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (paragraph 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 69.65pt 0pt 0cm">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 69.65pt 0pt 0cm"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Yes [<span style="-sec-ix-hidden: hidden-fact-1">X</span>] &#160;&#160;No [_]</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 69.65pt 0pt 0cm">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:justify; MARGIN:0cm 69.65pt 0pt 0cm">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:justify; MARGIN:0cm 69.65pt 0pt 0cm">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:justify; MARGIN:0cm 69.65pt 0pt 0cm"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">Indicate by check mark whether the registrant is a large accelerated, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of "large accelerated filer,", "accelerated filer,", "smaller reporting company", and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 69.65pt 0pt 0cm">&#160;</p> <table cellpadding="0" cellspacing="0" style="width: 6.25in; border-collapse: collapse;" width="600">
<tr style="height: 15pt;">
<td style="height: 15pt; width: 122.9pt; padding: 0in;">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt;">Large Accelerated Filer <span style="text-decoration: underline;">[ &#160;]</span></span></p>
</td>
<td style="height: 15pt; width: 189.6pt; padding: 0in;">&#160;</td>
<td style="height: 15pt; width: 137.5pt; padding: 0in;">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt;">Accelerated Filer&#160;&#160;&#160;[<span style="text-decoration: underline;">&#160; </span>]</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; padding: 0in;">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt;"><ix:nonNumeric contextRef="c0" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory">Non-Accelerated Filer</ix:nonNumeric> &#160;&#160;<span style="color: black;">[X]</span></span></p>
</td>
<td style="height: 15pt; padding: 0in;">&#160;</td>
<td style="height: 15pt; padding: 0in;">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt;">Smaller Reporting Company [<ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="dei:EntitySmallBusiness">X</ix:nonNumeric>]</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; padding: 0in;">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; padding: 0in;">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; padding: 0in;">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt;">Emerging Growth Company <ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:EntityEmergingGrowthCompany">[<span style="text-decoration: underline;">&#160; </span>]</ix:nonNumeric></span></p>
</td>
</tr>
</table>
 <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 69.65pt 0pt 0cm">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:justify; MARGIN:0cm 69.65pt 0pt 0cm"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; BACKGROUND:white; COLOR:black">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;</span><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">[_]</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 69.65pt 0pt 0cm">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:justify; MARGIN:0cm 69.65pt 0pt 0cm"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Act).</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 69.65pt 0pt 0cm">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 69.65pt 0pt 0cm"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;Yes [_]&#160; &#160;No [<ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:EntityShellCompany">X</ix:nonNumeric>]</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 69.65pt 0pt 0cm">&#160;</p> <p style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify; margin: 0cm 69.65pt 0pt 0cm;"><span style="font-family: 'Times New Roman','serif';">The number of shares of the registrant's common stock outstanding as of January 12, 2022 was <ix:nonFraction contextRef="c1" decimals="INF" format="ixt:num-dot-decimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" unitRef="shares">12,851,924</ix:nonFraction>.</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 0cm 0pt">&#160;</p> <div style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><div style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;"> <hr/> <div style="PAGE-BREAK-BEFORE: always"></div> </div></div> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></div><div> </div><div style="page:WordSection2"> <div style="text-align: left;"> <a id="TOC"></a><table cellpadding="0" cellspacing="0" style="WIDTH:635.05pt; BORDER-COLLAPSE:collapse; margin-left: auto; margin-right: auto;" width="847"> <tr style="HEIGHT:15pt"> <td colspan="3" style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 10%; white-space: nowrap; text-align: center;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">BIOMERICA, INC.</span></p></td></tr> <tr> <td></td> <td></td> <td></td></tr> <tr style="HEIGHT:15pt"> <td colspan="3" style="HEIGHT:15pt; WIDTH:100%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 100%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">INDEX</span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 10%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:80%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 80%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 10%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 10%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black"><a href="#P1">PART I</a> </span></p></td> <td style="HEIGHT:15pt; WIDTH:80%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 80%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black"><a href="#P1">Financial Information</a> </span></p></td> <td style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 10%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 10%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:80%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 80%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 10%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 10%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black"><a href="#I1">Item 1.</a> </span></p></td> <td style="HEIGHT:15pt; WIDTH:80%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 80%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black"><a href="#I1">Financial Statements:</a> </span></p></td> <td style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 10%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 10%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:80%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 80%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 10%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td></tr> <tr style="HEIGHT:12.8pt"> <td style="HEIGHT:12.8pt; WIDTH:10%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 10%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:12.8pt; WIDTH:80%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 80%;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black"><a href="#BS">Condensed Consolidated Balance Sheets (unaudited) &#8211; November 30, 2021 and May 31, 2021</a></span></p></td> <td style="HEIGHT:12.8pt; WIDTH:10%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 10%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">1</span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 10%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:80%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 80%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 10%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 10%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:80%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 80%;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black"><a href="#IS">Condensed Consolidated Statements of Operations and Comprehensive Loss (unaudited) &#8211; Three and Six Months Ended November 30, 2021 and 2020 (restated)</a></span></p></td> <td style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 10%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">2</span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 10%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:80%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 80%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 10%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td></tr> <tr style="HEIGHT:26.25pt"> <td style="HEIGHT:26.25pt; WIDTH:10%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 10%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:26.25pt; WIDTH:80%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 80%;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black"><a href="#SHEQ">Condensed Consolidated Statements of Shareholders&#8217; Equity (unaudited) &#8211; Six Months Ended November 30, 2021 and 2020 (restated)</a></span></p></td> <td style="HEIGHT:26.25pt; WIDTH:10%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 10%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">3</span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 10%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:80%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 80%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 10%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td></tr> <tr style="HEIGHT:14.85pt"> <td style="HEIGHT:14.85pt; WIDTH:10%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 10%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:14.85pt; WIDTH:80%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 80%;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black"><a href="#CFS">Condensed Consolidated Statements of Cash Flows (unaudited) &#8211; Six Months Ended November 30, 2021 and 2020 (restated)</a></span></p></td> <td style="HEIGHT:14.85pt; WIDTH:10%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 10%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">4</span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 10%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:80%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 80%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 10%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 10%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:80%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 80%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black"><a href="#Notes">Notes to Condensed Consolidated Financial Statements (unaudited)</a> </span></p></td> <td style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 10%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">5 - 14 </span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 10%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:80%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 80%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 10%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 10%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black"><a href="#MDNA">Item 2.</a> </span></p></td> <td style="HEIGHT:15pt; WIDTH:80%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 80%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black"><a href="#MDNA">Management's Discussion and Analysis of Financial Condition and Results of Operations</a> </span></p></td> <td style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 10%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">14 - 18</span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 10%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:80%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 80%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 10%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 10%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black"><a href="#QQD">Item 3.</a> </span></p></td> <td style="HEIGHT:15pt; WIDTH:80%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 80%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black"><a href="#QQD">Quantitative and Qualitative Disclosures about Market Risk</a> </span></p></td> <td style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 10%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">18</span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 10%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:80%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 80%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 10%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 10%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black"><a href="#CP">Item 4.</a>&#160; </span></p></td> <td style="HEIGHT:15pt; WIDTH:80%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 80%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black"><a href="#CP">Controls and Procedures</a> </span></p></td> <td style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 10%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">18</span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 10%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:80%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 80%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 10%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 10%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black"><a href="#P2">PART II</a> </span></p></td> <td style="HEIGHT:15pt; WIDTH:80%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 80%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black"><a href="#P2">Other Information</a>&#160; </span></p></td> <td style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 10%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 10%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:80%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 80%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 10%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 10%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black"><a href="#LP">Item 1.</a> </span></p></td> <td style="HEIGHT:15pt; WIDTH:80%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 80%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black"><a href="#LP">Legal Proceedings</a> </span></p></td> <td style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 10%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">18 - 19</span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 10%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:80%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 80%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 10%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 10%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black"><a href="#R&amp;U">Item 1A.</a> </span></p></td> <td style="HEIGHT:15pt; WIDTH:80%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 80%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black"><a href="#R&amp;U">Risk and Uncertainties</a> </span></p></td> <td style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 10%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">19</span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 10%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:80%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 80%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 10%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 10%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black"><a href="#OI-1">Item 5.</a> </span></p></td> <td style="HEIGHT:15pt; WIDTH:80%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 80%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black"><a href="#OI-1">Other Information</a> &#160;</span></p></td> <td style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 10%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">19</span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 10%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:80%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 80%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 10%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 10%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black"><a href="#Ex-1">Item 6.</a></span></p></td> <td style="HEIGHT:15pt; WIDTH:80%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 80%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black"><a href="#Ex-1">Exhibits</a> </span></p></td> <td style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 10%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">20</span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 10%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:80%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 80%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 10%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 10%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:80%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 80%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black"><a href="#Signatures-1">Signatures</a> </span></p></td> <td style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 10%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">21</span></p></td></tr></table></div><span style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;"><span style="PAGE-BREAK-BEFORE:none; clear: both;"><br/></span></span> <div style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><div style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;"> <hr/> <div style="PAGE-BREAK-BEFORE: always"></div> </div></div> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;"><a href="#TOC">Table of Contents</a></span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;">&#160;</p> <div style="text-align: left;"> <a id="P1"></a><a id="I1"></a><a id="BS"></a><table cellpadding="0" cellspacing="0" style="width: 750pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="1000">

<tr style="height: 47.25pt;">
<td colspan="6" style="height: 47.25pt; width: 100%; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">PART I - FINANCIAL INFORMATION</span></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">SUMMARIZED FINANCIAL INFORMATION</span></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">ITEM 1. FINANCIAL STATEMENTS</span></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td colspan="6" style="height: 15.75pt; width: 100%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 31.5pt;">
<td colspan="6" style="height: 31.5pt; width: 100%; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">BIOMERICA, INC. AND SUBSIDIARIES</span></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">CONDENSED CONSOLIDATED BALANCE SHEETS</span></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td colspan="6" style="height: 15.75pt; width: 100%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td colspan="2" rowspan="3" style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 14%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">November 30, </span></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">2021</span></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">(Unaudited)</span></p>
</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 12%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td colspan="2" rowspan="2" style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 14%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">May 31,</span></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">2021</span></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><strong><span style="font-size: 10pt; color: black;">Assets</span></strong></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 12%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 12%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><strong><span style="font-size: 10pt; color: black;">Current Assets:</span></strong></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; white-space: nowrap; padding: 0cm 0cm 0cm 10pt;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Cash and cash equivalents</span></p>
</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15.75pt; width: 12%; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="0" unitRef="usd">7,199,172</ix:nonFraction></span></p>
</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15.75pt; width: 12%; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="0" unitRef="usd">4,199,311</ix:nonFraction></span></p>
</td>
</tr>
<tr style="height: 26.25pt;">
<td style="height: 26.25pt; width: 70%; background: #b8cce4; padding: 0cm 0cm 0cm 10pt;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Accounts receivable, less allowance for doubtful accounts <br/>&#160;&#160;&#160; of $<ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="0" unitRef="usd">27,777</ix:nonFraction> and $<ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="0" unitRef="usd">837,415</ix:nonFraction> as of November 30, 2021 and May 31, 2021, respectively</span></p>
</td>
<td style="height: 26.25pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 26.25pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:AccountsReceivableNetCurrent" scale="0" unitRef="usd">1,125,239</ix:nonFraction></span></p>
</td>
<td style="height: 26.25pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 26.25pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 26.25pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:AccountsReceivableNetCurrent" scale="0" unitRef="usd">1,455,051</ix:nonFraction></span></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; white-space: nowrap; padding: 0cm 0cm 0cm 10pt;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Inventories, net</span></p>
</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 12%; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:InventoryNet" scale="0" unitRef="usd">2,982,201</ix:nonFraction></span></p>
</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 12%; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:InventoryNet" scale="0" unitRef="usd">3,206,255</ix:nonFraction></span></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; background: #b8cce4; white-space: nowrap; padding: 0cm 0cm 0cm 10pt;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Prepaid expenses and other</span></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="0" unitRef="usd">1,096,750</ix:nonFraction></span></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="0" unitRef="usd">370,290</ix:nonFraction></span></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Total current assets</span></p>
</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 12%; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:AssetsCurrent" scale="0" unitRef="usd">12,403,362</ix:nonFraction></span></p>
</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 12%; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:AssetsCurrent" scale="0" unitRef="usd">9,230,907</ix:nonFraction></span></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
</tr>
<tr style="height: 26.25pt;">
<td style="height: 26.25pt; width: 70%; padding: 0cm 0cm 0cm 10pt;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Property and equipment, net of accumulated depreciation and amortization <br/>&#160;&#160;&#160; of $<ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="0" unitRef="usd">2,026,764</ix:nonFraction> and $<ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="0" unitRef="usd">1,972,357</ix:nonFraction> as of November 30, 2021 and May 31, 2021, respectively</span></p>
</td>
<td style="height: 26.25pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 26.25pt; width: 12%; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="0" unitRef="usd">274,325</ix:nonFraction></span></p>
</td>
<td style="height: 26.25pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 26.25pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 26.25pt; width: 12%; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="0" unitRef="usd">310,520</ix:nonFraction></span></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; background: #b8cce4; white-space: nowrap; padding: 0cm 0cm 0cm 10pt;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
</tr>
<tr style="height: 26.25pt;">
<td style="height: 26.25pt; width: 70%; padding: 0cm 0cm 0cm 10pt;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Right of use assets, net of accumulated amortization of $<ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="bmra:OperatingLeaseRightOfUseAssetAccumulatedAmortization" scale="0" unitRef="usd">595,116</ix:nonFraction> and $<ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="bmra:OperatingLeaseRightOfUseAssetAccumulatedAmortization" scale="0" unitRef="usd">469,077</ix:nonFraction> <br/>&#160;&#160;&#160; as of November 30, 2021 and May 31, 2021, respectively</span></p>
</td>
<td style="height: 26.25pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 26.25pt; width: 12%; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="0" unitRef="usd">1,427,042</ix:nonFraction></span></p>
</td>
<td style="height: 26.25pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 26.25pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 26.25pt; width: 12%; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="0" unitRef="usd">1,553,081</ix:nonFraction></span></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; background: #b8cce4; white-space: nowrap; padding: 0cm 0cm 0cm 10pt;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; white-space: nowrap; padding: 0cm 0cm 0cm 10pt;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Investments</span></p>
</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 12%; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:Investments" scale="0" unitRef="usd">165,324</ix:nonFraction></span></p>
</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 12%; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:Investments" scale="0" unitRef="usd">165,324</ix:nonFraction></span></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; background: #b8cce4; white-space: nowrap; padding: 0cm 0cm 0cm 10pt;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
</tr>
<tr style="height: 26.25pt;">
<td style="height: 26.25pt; width: 70%; padding: 0cm 0cm 0cm 10pt;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Intangible assets, net of accumulated amortization of $<ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="0" unitRef="usd">91,030</ix:nonFraction> and $<ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="0" unitRef="usd">126,769</ix:nonFraction> as<br/>&#160;&#160;&#160; of November 30, 2021 and May 31, 2021, respectively</span></p>
</td>
<td style="height: 26.25pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 26.25pt; width: 12%; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="0" unitRef="usd">389,486</ix:nonFraction></span></p>
</td>
<td style="height: 26.25pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 26.25pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 26.25pt; width: 12%; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="0" unitRef="usd">294,830</ix:nonFraction></span></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; white-space: nowrap; padding: 0cm 0cm 0cm 10pt;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Other assets</span></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:OtherAssetsNoncurrent" scale="0" unitRef="usd">149,581</ix:nonFraction></span></p>
</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:OtherAssetsNoncurrent" scale="0" unitRef="usd">264,151</ix:nonFraction></span></p>
</td>
</tr>
<tr style="height: 16.5pt;">
<td style="height: 16.5pt; width: 70%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Total Assets</span></p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="0" unitRef="usd">14,809,120</ix:nonFraction></span></p>
</td>
<td style="height: 16.5pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="0" unitRef="usd">11,818,813</ix:nonFraction></span></p>
</td>
</tr>
<tr style="height: 16.5pt;">
<td style="height: 16.5pt; width: 70%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 16.5pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 16.5pt; width: 12%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 16.5pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 16.5pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 16.5pt; width: 12%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><strong><span style="font-size: 10pt; color: black;">Liabilities and Shareholders' Equity</span></strong></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 12%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 12%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><strong><span style="font-size: 10pt; color: black;">Current Liabilities:</span></strong></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; white-space: nowrap; padding: 0cm 0cm 0cm 10pt;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Accounts payable and accrued expenses</span></p>
</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15.75pt; width: 12%; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" scale="0" unitRef="usd">1,580,707</ix:nonFraction></span></p>
</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15.75pt; width: 12%; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" scale="0" unitRef="usd">583,380</ix:nonFraction></span></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; background: #b8cce4; white-space: nowrap; padding: 0cm 0cm 0cm 10pt;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Accrued compensation</span></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="0" unitRef="usd">674,327</ix:nonFraction></span></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="0" unitRef="usd">388,896</ix:nonFraction></span></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; white-space: nowrap; padding: 0cm 0cm 0cm 10pt;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Advance from customers</span></p>
</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 12%; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ContractWithCustomerLiability" scale="0" unitRef="usd">2,150,466</ix:nonFraction></span></p>
</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 12%; text-align: right; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom"><div style="-sec-ix-hidden: hidden-fact-2">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">-</span></p>
</div></td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; background: #b8cce4; white-space: nowrap; padding: 0cm 0cm 0cm 10pt;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Lease liability, current portion</span></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="0" unitRef="usd">335,385</ix:nonFraction></span></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="0" unitRef="usd">327,944</ix:nonFraction></span></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Total current liabilities</span></p>
</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 12%; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesCurrent" scale="0" unitRef="usd">4,740,885</ix:nonFraction></span></p>
</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 12%; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesCurrent" scale="0" unitRef="usd">1,300,220</ix:nonFraction></span></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; background: #b8cce4; white-space: nowrap; padding: 0cm 0cm 0cm 10pt;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Lease liability, net of current portion</span></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="0" unitRef="usd">1,166,808</ix:nonFraction></span></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="0" unitRef="usd">1,291,570</ix:nonFraction></span></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Total Liabilities</span></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:Liabilities" scale="0" unitRef="usd">5,907,693</ix:nonFraction></span></p>
</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:Liabilities" scale="0" unitRef="usd">2,591,790</ix:nonFraction></span></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; white-space: nowrap; padding: 0cm 0cm 0cm 10pt;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Commitments and contingencies (Notes 1 and 6)</span></p>
</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 12%; white-space: nowrap; padding: 0cm;" valign="bottom"><div style="-sec-ix-hidden: hidden-fact-3">&#160;</div></td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 12%; white-space: nowrap; padding: 0cm;" valign="bottom"><div style="-sec-ix-hidden: hidden-fact-4">&#160;</div></td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><strong><span style="font-size: 10pt; color: black;">Shareholders' Equity:</span></strong></p>
</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 12%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 12%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
</tr>
<tr style="height: 26.25pt;">
<td style="height: 26.25pt; width: 70%; padding: 0cm 0cm 0cm 10pt;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Preferred stock, Series A 5% convertible, $<ix:nonFraction contextRef="c4" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares"><ix:nonFraction contextRef="c5" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares">0.08</ix:nonFraction></ix:nonFraction> par value, <br/><ix:nonFraction contextRef="c4" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" unitRef="shares"><ix:nonFraction contextRef="c5" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" unitRef="shares">571,429</ix:nonFraction></ix:nonFraction> shares authorized, <ix:nonFraction contextRef="c4" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesIssued" scale="0" unitRef="shares"><ix:nonFraction contextRef="c5" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesIssued" scale="0" unitRef="shares"><ix:nonFraction contextRef="c4" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesOutstanding" scale="0" unitRef="shares"><ix:nonFraction contextRef="c5" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesOutstanding" scale="0" unitRef="shares">none</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> issued and outstanding as of November 30, 2021 and <br/>May 31, 2021</span></p>
</td>
<td style="height: 26.25pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 26.25pt; width: 12%; text-align: right; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom"><div style="-sec-ix-hidden: hidden-fact-5">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">-</span></p>
</div></td>
<td style="height: 26.25pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 26.25pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 26.25pt; width: 12%; text-align: right; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom"><div style="-sec-ix-hidden: hidden-fact-6">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">-</span></p>
</div></td>
</tr>
<tr style="height: 26.25pt;">
<td style="height: 26.25pt; width: 70%; background: #b8cce4; padding: 0cm 0cm 0cm 10pt;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Preferred stock, undesignated, <ix:nonFraction contextRef="c2" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockNoParValue" scale="0" unitRef="usdPershares"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockNoParValue" scale="0" unitRef="usdPershares">no</ix:nonFraction></ix:nonFraction> par value, <br/><ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="bmra:PreferredStockUndesignatedShares" scale="0" unitRef="shares"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="bmra:PreferredStockUndesignatedShares" scale="0" unitRef="shares">4,428,571</ix:nonFraction></ix:nonFraction> shares authorized, <ix:nonFraction contextRef="c2" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesIssued" scale="0" unitRef="shares"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesIssued" scale="0" unitRef="shares"><ix:nonFraction contextRef="c2" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesOutstanding" scale="0" unitRef="shares"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesOutstanding" scale="0" unitRef="shares">none</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> issued and outstanding as of November 30, 2021 and <br/>May 31, 2021</span></p>
</td>
<td style="height: 26.25pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 26.25pt; width: 12%; background: #b8cce4; text-align: right; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom"><div style="-sec-ix-hidden: hidden-fact-7">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">-</span></p>
</div></td>
<td style="height: 26.25pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 26.25pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 26.25pt; width: 12%; background: #b8cce4; text-align: right; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom"><div style="-sec-ix-hidden: hidden-fact-8">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">-</span></p>
</div></td>
</tr>
<tr style="height: 26.25pt;">
<td style="height: 26.25pt; width: 70%; padding: 0cm 0cm 0cm 10pt;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Common stock, $<ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares">0.08</ix:nonFraction></ix:nonFraction> par value, <br/><ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" unitRef="shares"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" unitRef="shares">25,000,000</ix:nonFraction></ix:nonFraction> shares authorized, <ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" unitRef="shares"><ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" unitRef="shares">12,692,327</ix:nonFraction></ix:nonFraction> and <ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" unitRef="shares"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" unitRef="shares">12,307,157</ix:nonFraction></ix:nonFraction> issued and outstanding at <br/>November 30, 2021 and May 31, 2021, respectively</span></p>
</td>
<td style="height: 26.25pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 26.25pt; width: 12%; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockValue" scale="0" unitRef="usd">1,015,385</ix:nonFraction></span></p>
</td>
<td style="height: 26.25pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 26.25pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 26.25pt; width: 12%; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockValue" scale="0" unitRef="usd">984,571</ix:nonFraction></span></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; background: #b8cce4; white-space: nowrap; padding: 0cm 0cm 0cm 10pt;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Additional paid-in-capital</span></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:AdditionalPaidInCapital" scale="0" unitRef="usd">41,158,551</ix:nonFraction></span></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:AdditionalPaidInCapital" scale="0" unitRef="usd">38,836,743</ix:nonFraction></span></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; white-space: nowrap; padding: 0cm 0cm 0cm 10pt;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Accumulated other comprehensive loss</span></p>
</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 12%; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="0" sign="-" unitRef="usd">58,319</ix:nonFraction>)</span></p>
</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 12%; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="0" sign="-" unitRef="usd">47,956</ix:nonFraction>)</span></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; background: #b8cce4; white-space: nowrap; padding: 0cm 0cm 0cm 10pt;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Accumulated deficit</span></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="0" sign="-" unitRef="usd">33,214,190</ix:nonFraction>)</span></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="0" sign="-" unitRef="usd">30,546,335</ix:nonFraction>)</span></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Total Shareholders' Equity</span></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd">8,901,427</ix:nonFraction></span></p>
</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd">9,227,023</ix:nonFraction></span></p>
</td>
</tr>
<tr style="height: 16.5pt;">
<td style="height: 16.5pt; width: 70%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Total Liabilities and Shareholders' Equity</span></p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="0" unitRef="usd">14,809,120</ix:nonFraction></span></p>
</td>
<td style="height: 16.5pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="0" unitRef="usd">11,818,813</ix:nonFraction></span></p>
</td>
</tr>
<tr style="height: 16.5pt;">
<td colspan="6" style="height: 16.5pt; width: 100%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td colspan="6" style="height: 15.75pt; width: 100%; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">The accompanying notes are an integral part of these statements.</span></p>
</td>
</tr>

</table></div> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">1</span></p> <div style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><div style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;"> <hr/> <div style="PAGE-BREAK-BEFORE: always"></div> </div></div> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; color: #0066cc;"><a href="#TOC">Table of Contents</a></span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 0cm 0pt">&#160;</p> <div style="text-align: left;"> <a id="IS"></a><table cellpadding="0" cellspacing="0" style="width: 753.2pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="1004">

<tr style="height: 33pt;">
<td colspan="13" style="height: 33pt; width: 100%; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center; margin: 0cm 0cm 0pt;"><span style="font-family: 'Times New Roman','serif';">BIOMERICA, INC. AND SUBSIDIARIES</span></p>
<p style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center; margin: 0cm 0cm 0pt;"><span style="font-family: 'Times New Roman','serif';">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</span></p>
<p style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center; margin: 0cm 0cm 0pt;"><span style="font-family: 'Times New Roman','serif';">AND COMPREHENSIVE LOSS (UNAUDITED)</span></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
</tr>
<tr style="height: 33pt;">
<td style="height: 33pt; width: 44%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 33pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td colspan="5" style="border-top: 0px; height: 33pt; border-right: 0px; width: 26%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Three Months Ended <br/>November 30,</span></p>
</td>
<td style="height: 33pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td colspan="5" style="border-top: 0px; height: 33pt; border-right: 0px; width: 25.98%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Six Months Ended <br/>November 30,</span></p>
</td>
</tr>
<tr style="height: 15.05pt;">
<td style="height: 15.05pt; width: 44%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td colspan="2" rowspan="2" style="border-top: 0px; height: 15.05pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">2021</span></p>
</td>
<td style="border-top: windowtext 1pt solid; height: 15.05pt; border-right: 0px; width: 2%; border-bottom: 0px; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td colspan="2" rowspan="2" style="border-top: windowtext 1pt solid; height: 15.05pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">2020</span></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">&#160;(As Restated)</span></p>
</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td colspan="2" rowspan="2" style="border-top: 0px; height: 15.05pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">2021</span></p>
</td>
<td style="border-top: windowtext 1pt solid; height: 15.05pt; border-right: 0px; width: 2%; border-bottom: 0px; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td colspan="2" rowspan="2" style="border-top: windowtext 1pt solid; height: 15.05pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">2020</span></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">&#160;(As Restated)</span></p>
</td>
</tr>
<tr style="height: 15.05pt;">
<td style="height: 15.05pt; width: 44%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.05pt;">
<td style="height: 15.05pt; width: 44%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Net sales</span></p>
</td>
<td style="height: 15.05pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.05pt; width: 2%; background: #b8cce4; white-space: nowrap; border: 0px; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="border-top: windowtext 1pt solid; height: 15.05pt; border-right: 0px; width: 10%; background: #b8cce4; border-bottom: 0px; border-left: 0px; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c6" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="0" unitRef="usd">4,646,900</ix:nonFraction> </span></p>
</td>
<td style="height: 15.05pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.05pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15.05pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c7" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="0" unitRef="usd">1,372,526</ix:nonFraction> </span></p>
</td>
<td style="height: 15.05pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.05pt; width: 2%; background: #b8cce4; white-space: nowrap; border: 0px; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="border-top: windowtext 1pt solid; height: 15.05pt; border-right: 0px; width: 10%; background: #b8cce4; border-bottom: 0px; border-left: 0px; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="0" unitRef="usd">5,908,687</ix:nonFraction> </span></p>
</td>
<td style="height: 15.05pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.05pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15.05pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c8" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="0" unitRef="usd">2,516,332</ix:nonFraction> </span></p>
</td>
</tr>
<tr style="height: 15.05pt;">
<td style="height: 15.05pt; width: 44%; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Cost of sales</span></p>
</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.05pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.05pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c6" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CostOfRevenue" scale="0" unitRef="usd">3,875,141</ix:nonFraction>)</span></p>
</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.05pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.05pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c7" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CostOfRevenue" scale="0" unitRef="usd">1,063,807</ix:nonFraction>)</span></p>
</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.05pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.05pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CostOfRevenue" scale="0" unitRef="usd">5,225,898</ix:nonFraction>)</span></p>
</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.05pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.05pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c8" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CostOfRevenue" scale="0" unitRef="usd">2,089,524</ix:nonFraction>)</span></p>
</td>
</tr>
<tr style="height: 15.05pt;">
<td style="height: 15.05pt; width: 44%; background: #b8cce4; white-space: nowrap; padding: 0cm 0cm 0cm 14.4pt;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Gross profit</span></p>
</td>
<td style="height: 15.05pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.05pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.05pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c6" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:GrossProfit" scale="0" unitRef="usd">771,759</ix:nonFraction> </span></p>
</td>
<td style="height: 15.05pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.05pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.05pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c7" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:GrossProfit" scale="0" unitRef="usd">308,719</ix:nonFraction> </span></p>
</td>
<td style="height: 15.05pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.05pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.05pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:GrossProfit" scale="0" unitRef="usd">682,789</ix:nonFraction> </span></p>
</td>
<td style="height: 15.05pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.05pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.05pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c8" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:GrossProfit" scale="0" unitRef="usd">426,808</ix:nonFraction> </span></p>
</td>
</tr>
<tr style="height: 15.05pt;">
<td style="height: 15.05pt; width: 44%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 10%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 10%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 10%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 10%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.05pt;">
<td style="height: 15.05pt; width: 44%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Operating expenses:</span></p>
</td>
<td style="height: 15.05pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.05pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.05pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.05pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.05pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.05pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.05pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.05pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.05pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.05pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.05pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.05pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
</tr>
<tr style="height: 15.05pt;">
<td style="height: 15.05pt; width: 44%; white-space: nowrap; padding: 0cm 0cm 0cm 14.4pt;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Selling, general and administrative</span></p>
</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 10%; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c6" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="0" unitRef="usd">1,282,998</ix:nonFraction> </span></p>
</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 10%; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c7" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="0" unitRef="usd">1,404,846</ix:nonFraction> </span></p>
</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 10%; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="0" unitRef="usd">2,294,533</ix:nonFraction> </span></p>
</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 10%; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c8" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="0" unitRef="usd">2,710,790</ix:nonFraction> </span></p>
</td>
</tr>
<tr style="height: 15.05pt;">
<td style="height: 15.05pt; width: 44%; background: #b8cce4; white-space: nowrap; padding: 0cm 0cm 0cm 14.4pt;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Research and development</span></p>
</td>
<td style="height: 15.05pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.05pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.05pt; border-right: 0px; width: 10%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c6" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="0" unitRef="usd">618,522</ix:nonFraction> </span></p>
</td>
<td style="height: 15.05pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.05pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.05pt; border-right: 0px; width: 10%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c7" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="0" unitRef="usd">616,561</ix:nonFraction> </span></p>
</td>
<td style="height: 15.05pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.05pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.05pt; border-right: 0px; width: 10%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="0" unitRef="usd">1,058,386</ix:nonFraction> </span></p>
</td>
<td style="height: 15.05pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.05pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.05pt; border-right: 0px; width: 10%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c8" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="0" unitRef="usd">1,328,066</ix:nonFraction> </span></p>
</td>
</tr>
<tr style="height: 15.05pt;">
<td style="height: 15.05pt; width: 44%; white-space: nowrap; padding: 0cm 0cm 0cm 25.2pt;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Total operating expense</span></p>
</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.05pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.05pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c6" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:OperatingExpenses" scale="0" unitRef="usd">1,901,520</ix:nonFraction> </span></p>
</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.05pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.05pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c7" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:OperatingExpenses" scale="0" unitRef="usd">2,021,407</ix:nonFraction> </span></p>
</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.05pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.05pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:OperatingExpenses" scale="0" unitRef="usd">3,352,919</ix:nonFraction> </span></p>
</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.05pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.05pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c8" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:OperatingExpenses" scale="0" unitRef="usd">4,038,856</ix:nonFraction> </span></p>
</td>
</tr>
<tr style="height: 15.05pt;">
<td style="height: 15.05pt; width: 44%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.05pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.05pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.05pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.05pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.05pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.05pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.05pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.05pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.05pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.05pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.05pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.05pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
</tr>
<tr style="height: 15.05pt;">
<td style="height: 15.05pt; width: 44%; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Loss from operations</span></p>
</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.05pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.05pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c6" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="0" sign="-" unitRef="usd">1,129,761</ix:nonFraction>)</span></p>
</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.05pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.05pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c7" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="0" sign="-" unitRef="usd">1,712,688</ix:nonFraction>)</span></p>
</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.05pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.05pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="0" sign="-" unitRef="usd">2,670,130</ix:nonFraction>)</span></p>
</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.05pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.05pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c8" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="0" sign="-" unitRef="usd">3,612,048</ix:nonFraction>)</span></p>
</td>
</tr>
<tr style="height: 15.05pt;">
<td style="height: 15.05pt; width: 44%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.05pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.05pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.05pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.05pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.05pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.05pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.05pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.05pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.05pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.05pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.05pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.05pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
</tr>
<tr style="height: 15.05pt;">
<td style="height: 15.05pt; width: 44%; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Other income:</span></p>
</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 10%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 10%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 10%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 10%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.05pt;">
<td style="height: 15.05pt; width: 44%; background: #b8cce4; white-space: nowrap; padding: 0cm 0cm 0cm 14.4pt;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Dividend and interest income</span></p>
</td>
<td style="height: 15.05pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.05pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.05pt; border-right: 0px; width: 10%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c6" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="0" unitRef="usd">6,916</ix:nonFraction> </span></p>
</td>
<td style="height: 15.05pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.05pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.05pt; border-right: 0px; width: 10%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c7" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="0" unitRef="usd">7,983</ix:nonFraction> </span></p>
</td>
<td style="height: 15.05pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.05pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.05pt; border-right: 0px; width: 10%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="0" unitRef="usd">13,721</ix:nonFraction> </span></p>
</td>
<td style="height: 15.05pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.05pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.05pt; border-right: 0px; width: 10%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c8" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="0" unitRef="usd">16,074</ix:nonFraction> </span></p>
</td>
</tr>
<tr style="height: 15.05pt;">
<td style="height: 15.05pt; width: 44%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 10%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 10%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 10%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 10%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.05pt;">
<td style="height: 15.05pt; width: 44%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Loss before income taxes</span></p>
</td>
<td style="height: 15.05pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.05pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.05pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c6" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="0" sign="-" unitRef="usd">1,122,845</ix:nonFraction>)</span></p>
</td>
<td style="height: 15.05pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.05pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.05pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c7" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="0" sign="-" unitRef="usd">1,704,705</ix:nonFraction>)</span></p>
</td>
<td style="height: 15.05pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.05pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.05pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="0" sign="-" unitRef="usd">2,656,409</ix:nonFraction>)</span></p>
</td>
<td style="height: 15.05pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.05pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.05pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c8" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="0" sign="-" unitRef="usd">3,595,974</ix:nonFraction>)</span></p>
</td>
</tr>
<tr style="height: 15.05pt;">
<td style="height: 15.05pt; width: 44%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 10%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 10%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 10%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 10%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.05pt;">
<td style="height: 15.05pt; width: 44%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Provision for income taxes</span></p>
</td>
<td style="height: 15.05pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.05pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.05pt; border-right: 0px; width: 10%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c6" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="0" unitRef="usd">2,429</ix:nonFraction>)</span></p>
</td>
<td style="height: 15.05pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.05pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.05pt; border-right: 0px; width: 10%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c7" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="0" unitRef="usd">13,393</ix:nonFraction>)</span></p>
</td>
<td style="height: 15.05pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.05pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.05pt; border-right: 0px; width: 10%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="0" unitRef="usd">11,446</ix:nonFraction>)</span></p>
</td>
<td style="height: 15.05pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.05pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.05pt; border-right: 0px; width: 10%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c8" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="0" unitRef="usd">14,518</ix:nonFraction>)</span></p>
</td>
</tr>
<tr style="height: 15.05pt;">
<td style="height: 15.05pt; width: 44%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 10%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 10%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 10%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 10%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.8pt;">
<td style="height: 15.8pt; width: 44%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Net loss</span></p>
</td>
<td style="height: 15.8pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.8pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="border-top: 0px; height: 15.8pt; border-right: 0px; width: 10%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c6" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" sign="-" unitRef="usd">1,125,274</ix:nonFraction>)</span></p>
</td>
<td style="height: 15.8pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.8pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="border-top: 0px; height: 15.8pt; border-right: 0px; width: 10%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c7" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" sign="-" unitRef="usd">1,718,098</ix:nonFraction>)</span></p>
</td>
<td style="height: 15.8pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.8pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="border-top: 0px; height: 15.8pt; border-right: 0px; width: 10%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" sign="-" unitRef="usd">2,667,855</ix:nonFraction>)</span></p>
</td>
<td style="height: 15.8pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.8pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="border-top: 0px; height: 15.8pt; border-right: 0px; width: 10%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c8" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" sign="-" unitRef="usd">3,610,492</ix:nonFraction>)</span></p>
</td>
</tr>
<tr style="height: 15.8pt;">
<td style="height: 15.8pt; width: 44%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.8pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.8pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.8pt; width: 10%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.8pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.8pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.8pt; width: 10%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.8pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.8pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.8pt; width: 10%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.8pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.8pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.8pt; width: 10%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.8pt;">
<td style="height: 15.8pt; width: 44%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Basic net loss per common share</span></p>
</td>
<td style="height: 15.8pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.8pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="border-top: 0px; height: 15.8pt; border-right: 0px; width: 10%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c6" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares">0.09</ix:nonFraction>)</span></p>
</td>
<td style="height: 15.8pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.8pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="border-top: 0px; height: 15.8pt; border-right: 0px; width: 10%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c7" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares">0.15</ix:nonFraction>)</span></p>
</td>
<td style="height: 15.8pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.8pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="border-top: 0px; height: 15.8pt; border-right: 0px; width: 10%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares">0.21</ix:nonFraction>)</span></p>
</td>
<td style="height: 15.8pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.8pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="border-top: 0px; height: 15.8pt; border-right: 0px; width: 10%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c8" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares">0.31</ix:nonFraction>)</span></p>
</td>
</tr>
<tr style="height: 15.8pt;">
<td style="height: 15.8pt; width: 44%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.8pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.8pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.8pt; width: 10%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.8pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.8pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.8pt; width: 10%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.8pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.8pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.8pt; width: 10%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.8pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.8pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.8pt; width: 10%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.8pt;">
<td style="height: 15.8pt; width: 44%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Diluted net loss per common share</span></p>
</td>
<td style="height: 15.8pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.8pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="border-top: 0px; height: 15.8pt; border-right: 0px; width: 10%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c6" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareDiluted" scale="0" sign="-" unitRef="usdPershares">0.09</ix:nonFraction>)</span></p>
</td>
<td style="height: 15.8pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.8pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="border-top: 0px; height: 15.8pt; border-right: 0px; width: 10%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c7" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareDiluted" scale="0" sign="-" unitRef="usdPershares">0.15</ix:nonFraction>)</span></p>
</td>
<td style="height: 15.8pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.8pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="border-top: 0px; height: 15.8pt; border-right: 0px; width: 10%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareDiluted" scale="0" sign="-" unitRef="usdPershares">0.21</ix:nonFraction>)</span></p>
</td>
<td style="height: 15.8pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.8pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="border-top: 0px; height: 15.8pt; border-right: 0px; width: 10%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c8" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareDiluted" scale="0" sign="-" unitRef="usdPershares">0.31</ix:nonFraction>)</span></p>
</td>
</tr>
<tr style="height: 15.8pt;">
<td style="height: 15.8pt; width: 44%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.8pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.8pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.8pt; width: 10%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.8pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.8pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.8pt; width: 10%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.8pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.8pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.8pt; width: 10%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.8pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.8pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.8pt; width: 10%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.05pt;">
<td style="height: 15.05pt; width: 44%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Weighted average number of common and <br/>common equivalent shares:</span></p>
</td>
<td style="height: 15.05pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.05pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.05pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.05pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.05pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.05pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.05pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.05pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.05pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.05pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.05pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.05pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
</tr>
<tr style="height: 15.8pt;">
<td style="height: 15.8pt; width: 44%; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Basic</span></p>
</td>
<td style="height: 15.8pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.8pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.8pt; border-right: 0px; width: 10%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c6" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares">12,592,341</ix:nonFraction> </span></p>
</td>
<td style="height: 15.8pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.8pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.8pt; border-right: 0px; width: 10%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c7" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares">11,756,265</ix:nonFraction> </span></p>
</td>
<td style="height: 15.8pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.8pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.8pt; border-right: 0px; width: 10%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares">12,509,110</ix:nonFraction> </span></p>
</td>
<td style="height: 15.8pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.8pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.8pt; border-right: 0px; width: 10%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c8" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares">11,752,299</ix:nonFraction> </span></p>
</td>
</tr>
<tr style="height: 12.5pt;">
<td style="height: 12.5pt; width: 44%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 12.5pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 12.5pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 12.5pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 12.5pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 12.5pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 12.5pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 12.5pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 12.5pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 12.5pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 12.5pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 12.5pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 12.5pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
</tr>
<tr style="height: 15.8pt;">
<td style="height: 15.8pt; width: 44%; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Diluted</span></p>
</td>
<td style="height: 15.8pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.8pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.8pt; border-right: 0px; width: 10%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c6" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" unitRef="shares">12,592,341</ix:nonFraction> </span></p>
</td>
<td style="height: 15.8pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.8pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.8pt; border-right: 0px; width: 10%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c7" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" unitRef="shares">11,756,265</ix:nonFraction> </span></p>
</td>
<td style="height: 15.8pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.8pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.8pt; border-right: 0px; width: 10%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" unitRef="shares">12,509,110</ix:nonFraction> </span></p>
</td>
<td style="height: 15.8pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.8pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.8pt; border-right: 0px; width: 10%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c8" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" unitRef="shares">11,752,299</ix:nonFraction> </span></p>
</td>
</tr>
<tr style="height: 15.8pt;">
<td style="height: 15.8pt; width: 44%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.8pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.8pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.8pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.8pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.8pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.8pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.8pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.8pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.8pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.8pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.8pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.8pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
</tr>
<tr style="height: 15.05pt;">
<td style="height: 15.05pt; width: 44%; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Net loss</span></p>
</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15.05pt; width: 10%; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c6" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" sign="-" unitRef="usd">1,125,274</ix:nonFraction>)</span></p>
</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15.05pt; width: 10%; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c7" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" sign="-" unitRef="usd">1,718,098</ix:nonFraction>)</span></p>
</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15.05pt; width: 10%; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" sign="-" unitRef="usd">2,667,855</ix:nonFraction>)</span></p>
</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15.05pt; width: 10%; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c8" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" sign="-" unitRef="usd">3,610,492</ix:nonFraction>)</span></p>
</td>
</tr>
<tr style="height: 15.05pt;">
<td style="height: 15.05pt; width: 44%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.05pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.05pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.05pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.05pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.05pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.05pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.05pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.05pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.05pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.05pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.05pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.05pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
</tr>
<tr style="height: 15.05pt;">
<td style="height: 15.05pt; width: 44%; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Other comprehensive loss, net of tax:</span></p>
</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 10%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 10%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 10%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 10%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.05pt;">
<td style="height: 15.05pt; width: 44%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Foreign currency translation</span></p>
</td>
<td style="height: 15.05pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.05pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.05pt; border-right: 0px; width: 10%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c6" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="0" sign="-" unitRef="usd">4,750</ix:nonFraction>)</span></p>
</td>
<td style="height: 15.05pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.05pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.05pt; border-right: 0px; width: 10%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c7" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="0" sign="-" unitRef="usd">1,530</ix:nonFraction>)</span></p>
</td>
<td style="height: 15.05pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.05pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.05pt; border-right: 0px; width: 10%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="0" sign="-" unitRef="usd">10,363</ix:nonFraction>)</span></p>
</td>
<td style="height: 15.05pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.05pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.05pt; border-right: 0px; width: 10%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c8" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="0" sign="-" unitRef="usd">3,250</ix:nonFraction>)</span></p>
</td>
</tr>
<tr style="height: 15.05pt;">
<td style="height: 15.05pt; width: 44%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 10%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 10%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 10%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.05pt; width: 10%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.8pt;">
<td style="height: 15.8pt; width: 44%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Comprehensive loss</span></p>
</td>
<td style="height: 15.8pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.8pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 2.5pt double; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="border-top: 0px; height: 15.8pt; border-right: 0px; width: 10%; background: #b8cce4; border-bottom: windowtext 2.5pt double; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c6" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="0" sign="-" unitRef="usd">1,130,024</ix:nonFraction>)</span></p>
</td>
<td style="height: 15.8pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.8pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 2.5pt double; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="border-top: 0px; height: 15.8pt; border-right: 0px; width: 10%; background: #b8cce4; border-bottom: windowtext 2.5pt double; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c7" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="0" sign="-" unitRef="usd">1,719,628</ix:nonFraction>)</span></p>
</td>
<td style="height: 15.8pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.8pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 2.5pt double; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="border-top: 0px; height: 15.8pt; border-right: 0px; width: 10%; background: #b8cce4; border-bottom: windowtext 2.5pt double; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="0" sign="-" unitRef="usd">2,678,218</ix:nonFraction>)</span></p>
</td>
<td style="height: 15.8pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.8pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 2.5pt double; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="border-top: 0px; height: 15.8pt; border-right: 0px; width: 10%; background: #b8cce4; border-bottom: windowtext 2.5pt double; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c8" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="0" sign="-" unitRef="usd">3,613,742</ix:nonFraction>)</span></p>
</td>
</tr>
<tr style="height: 15.8pt;">
<td colspan="13" style="height: 15.8pt; width: 100%; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
</tr>
<tr style="height: 16.55pt;">
<td colspan="13" style="height: 16.55pt; width: 100%; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 10pt; font-family: 'Times New Roman'; margin: 0cm 0cm 0pt;"><span style="font-family: 'Times New Roman','serif';">The accompanying notes are an integral part of these statements.</span></p>
</td>
</tr>

</table></div> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 0cm 0pt">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">2</span></p> <div style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><div style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;"> <hr/> <div style="PAGE-BREAK-BEFORE: always"></div> </div></div> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; color: #0066cc;"><a href="#TOC">Table of Contents</a></span></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p> <div style="text-align: left;"> <a id="SHEQ"></a><table cellpadding="0" cellspacing="0" style="WIDTH:750pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;" width="1000"> <tr style="HEIGHT:30pt"> <td colspan="22" style="HEIGHT:30pt; WIDTH:6%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 6%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">BIOMERICA, INC. AND SUBSIDIARIES</span></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (Unaudited)</span></p></td></tr> <tr style="HEIGHT:15pt"> <td colspan="22" style="HEIGHT:15pt; WIDTH:6%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 6%; white-space: nowrap;" valign="bottom"></td> </tr><tr style="HEIGHT:15pt"> <td colspan="22" style="HEIGHT:15pt; WIDTH:6%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 6%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">For the Six Months Ended November 30, 2020 (As Restated)</span></p></td></tr> <tr style="HEIGHT:15pt"> <td colspan="22" style="HEIGHT:15pt; WIDTH:6%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 6%; white-space: nowrap;" valign="bottom"></td> </tr><tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:26%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 26%; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:6%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 6%; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:6%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 6%; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:6%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 6%; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:6%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 6%; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:6%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 6%; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> </td><td colspan="2" rowspan="4" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:6%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; width: 6%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">Accumulated</span></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">Other</span></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">Comprehensive</span></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">Loss</span></p></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:6%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 6%; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:6%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 6%; white-space: nowrap;" valign="bottom"></td> </tr><tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:26%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 26%; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:6%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 6%; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:6%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 6%; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> </td><td colspan="4" rowspan="2" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:6%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; width: 6%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">Series A 5% Convertible</span></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">Preferred Stock</span></p></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:6%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 6%; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:6%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 6%; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:6%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 6%; white-space: nowrap;" valign="bottom"></td> </tr><tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:26%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 26%; white-space: nowrap;" valign="bottom"> </td><td colspan="4" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:6%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; width: 6%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">Common Stock</span></p></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> </td><td colspan="2" rowspan="2" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:6%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; width: 6%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">Additional</span></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">Paid-in Capital</span></p></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> </td><td colspan="2" rowspan="2" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:6%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; width: 6%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">Accumulated</span></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">Deficit</span></p></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:6%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 6%; white-space: nowrap;" valign="bottom"></td> </tr><tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:26%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 26%; white-space: nowrap;" valign="bottom"> </td><td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:6%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; width: 6%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">Shares</span></p></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> </td><td colspan="2" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:6%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; width: 6%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">Amount</span></p></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> </td><td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:6%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; width: 6%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">Share</span></p></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> </td><td colspan="2" style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:6%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; width: 6%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">Amount</span></p></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> </td><td colspan="2" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:6%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; width: 6%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">Total</span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:26%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 26%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Balances, May 31, 2020, restated</span></p></td> <td style="HEIGHT:15pt; WIDTH:6%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 6%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c9" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesIssued" scale="0" unitRef="shares">11,740,089</ix:nonFraction> </span></p></td> <td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="HEIGHT:15pt; WIDTH:6%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 6%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c9" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd">939,205</ix:nonFraction> </span></p></td> <td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:6%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 6%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c10" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesIssued" scale="0" unitRef="shares">321,429</ix:nonFraction> </span></p></td> <td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="HEIGHT:15pt; WIDTH:6%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 6%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c10" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd">25,714</ix:nonFraction> </span></p></td> <td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="HEIGHT:15pt; WIDTH:6%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 6%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c11" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd">36,388,056</ix:nonFraction> </span></p></td> <td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="HEIGHT:15pt; WIDTH:6%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 6%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(<ix:nonFraction contextRef="c12" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" sign="-" unitRef="usd">39,841</ix:nonFraction>)</span></p></td> <td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="HEIGHT:15pt; WIDTH:6%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 6%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(<ix:nonFraction contextRef="c13" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" sign="-" unitRef="usd">23,100,081</ix:nonFraction>)</span></p></td> <td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="HEIGHT:15pt; WIDTH:6%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; width: 6%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c14" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd">14,213,053</ix:nonFraction> </span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:26%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 26%; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:6%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 6%; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:6%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 6%; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:6%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 6%; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:6%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 6%; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:6%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 6%; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:6%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 6%; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:6%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 6%; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:6%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; width: 6%; white-space: nowrap;" valign="bottom"></td> </tr><tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:26%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 26%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Exercise of stock options</span></p></td> <td style="HEIGHT:15pt; WIDTH:6%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 6%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c15" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" unitRef="shares">30,000</ix:nonFraction> </span></p></td> <td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:6%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 6%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c15" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="0" unitRef="usd">2,400</ix:nonFraction> </span></p></td> <td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:6%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 6%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">&#160;- </span></p></td> <td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:6%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 6%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">&#160;- </span></p></td> <td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:6%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 6%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c16" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="0" unitRef="usd">46,930</ix:nonFraction> </span></p></td> <td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:6%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; width: 6%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">&#160;- </span></p></td> <td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:6%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; width: 6%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">&#160;- </span></p></td> <td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:6%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; width: 6%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c8" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="0" unitRef="usd">49,330</ix:nonFraction> </span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:26%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 26%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Foreign currency translation</span></p></td> <td style="HEIGHT:15pt; WIDTH:6%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 6%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">&#160;- </span></p></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:6%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 6%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">&#160;- </span></p></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:6%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 6%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">&#160;- </span></p></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:6%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 6%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">&#160;- </span></p></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:6%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 6%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">&#160;- </span></p></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:6%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 6%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(<ix:nonFraction contextRef="c17" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="0" sign="-" unitRef="usd">3,250</ix:nonFraction>)</span></p></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:6%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; width: 6%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">&#160;- </span></p></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:6%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 6%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(<ix:nonFraction contextRef="c8" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="0" sign="-" unitRef="usd">3,250</ix:nonFraction>)</span></p></td></tr> <tr style="HEIGHT:26.25pt"> <td style="HEIGHT:26.25pt; WIDTH:26%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 26%;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Compensation expense in connection with options granted</span></p></td> <td style="HEIGHT:26.25pt; WIDTH:6%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 6%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">&#160;- </span></p></td> <td style="HEIGHT:26.25pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:26.25pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:26.25pt; WIDTH:6%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 6%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">&#160;- </span></p></td> <td style="HEIGHT:26.25pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:26.25pt; WIDTH:6%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 6%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">&#160;- </span></p></td> <td style="HEIGHT:26.25pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:26.25pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:26.25pt; WIDTH:6%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 6%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">&#160;- </span></p></td> <td style="HEIGHT:26.25pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:26.25pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:26.25pt; WIDTH:6%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 6%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c16" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" scale="0" unitRef="usd">500,140</ix:nonFraction> </span></p></td> <td style="HEIGHT:26.25pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:26.25pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:26.25pt; WIDTH:6%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; width: 6%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">&#160;- </span></p></td> <td style="HEIGHT:26.25pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:26.25pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:26.25pt; WIDTH:6%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; width: 6%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">&#160;- </span></p></td> <td style="HEIGHT:26.25pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:26.25pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:26.25pt; WIDTH:6%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; width: 6%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c8" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" scale="0" unitRef="usd">500,140</ix:nonFraction> </span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:26%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 26%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Net loss</span></p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:6%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; width: 6%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">&#160;- </span></p></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> </td><td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:6%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; width: 6%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">&#160;- </span></p></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> </td><td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:6%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; width: 6%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">&#160;- </span></p></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> </td><td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:6%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; width: 6%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">&#160;- </span></p></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> </td><td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:6%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; width: 6%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">&#160;- </span></p></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> </td><td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:6%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 6%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">&#160;- </span></p></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> </td><td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:6%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; width: 6%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(<ix:nonFraction contextRef="c18" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" sign="-" unitRef="usd">3,610,492</ix:nonFraction>)</span></p></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> </td><td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:6%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; width: 6%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(<ix:nonFraction contextRef="c8" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" sign="-" unitRef="usd">3,610,492</ix:nonFraction>)</span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:26%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 26%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:6%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 6%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:6%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 6%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:6%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 6%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:6%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 6%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:6%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 6%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:6%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 6%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:6%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 6%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:6%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 6%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:26%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 26%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><b><span style="FONT-SIZE:10pt; COLOR:black">Balances, November 30, 2020, restated</span></b></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:6%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; width: 6%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><b><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c19" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesIssued" scale="0" unitRef="shares">11,770,089</ix:nonFraction> </span></b></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> </td><td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><b><span style="FONT-SIZE:10pt; COLOR:black">$</span></b></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:6%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; width: 6%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><b><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c19" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd">941,605</ix:nonFraction> </span></b></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> </td><td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:6%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; width: 6%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><b><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c20" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesIssued" scale="0" unitRef="shares">321,429</ix:nonFraction> </span></b></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> </td><td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><b><span style="FONT-SIZE:10pt; COLOR:black">$</span></b></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:6%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; width: 6%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><b><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c20" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd">25,714</ix:nonFraction> </span></b></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> </td><td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><b><span style="FONT-SIZE:10pt; COLOR:black">$</span></b></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:6%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; width: 6%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><b><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c21" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd">36,935,126</ix:nonFraction> </span></b></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> </td><td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><b><span style="FONT-SIZE:10pt; COLOR:black">$</span></b></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:6%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; width: 6%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><b><span style="FONT-SIZE:10pt; COLOR:black">(<ix:nonFraction contextRef="c22" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" sign="-" unitRef="usd">43,091</ix:nonFraction>)</span></b></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> </td><td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><b><span style="FONT-SIZE:10pt; COLOR:black">$</span></b></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:6%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; width: 6%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><b><span style="FONT-SIZE:10pt; COLOR:black">(<ix:nonFraction contextRef="c23" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" sign="-" unitRef="usd">26,710,573</ix:nonFraction>)</span></b></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> </td><td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><b><span style="FONT-SIZE:10pt; COLOR:black">$</span></b></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:6%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 6%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><b><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c24" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd">11,148,781</ix:nonFraction> </span></b></p></td></tr></table></div> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p> <div style="text-align: left;"> <table cellpadding="0" cellspacing="0" style="WIDTH:750pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;" width="1000"> <tr style="HEIGHT:15pt"> <td colspan="22" style="HEIGHT:15pt; WIDTH:100%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 100%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">For the Six Months Ended November 30, 2021</span></p></td></tr> <tr style="HEIGHT:15pt"> <td colspan="22" style="HEIGHT:15pt; WIDTH:100%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 100%; white-space: nowrap;" valign="bottom"></td> </tr><tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:25.84%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:6.2%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:1.84%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:1.84%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:5.84%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:1.84%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:5.84%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:1.84%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:1.84%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:5.84%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:1.84%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:2.1%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:6.3%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:1.84%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td colspan="2" rowspan="4" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:8.5%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">Accumulated</span></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">Other</span></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">Comprehensive</span></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">Loss</span></p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:1.84%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 7%; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:1.84%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:1.84%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:6.3%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"></td> </tr><tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:25.84%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:6.2%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:1.84%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:1.84%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:5.84%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:1.84%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td colspan="4" rowspan="2" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:15.36%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">Series A 5% Convertible</span></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">&#160;Preferred Stock</span></p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:2.1%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:6.3%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:1.84%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:1.84%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:1.84%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 7%; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:1.84%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:1.84%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:6.3%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"></td> </tr><tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:25.84%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;">&#160;</p></td> <td colspan="4" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:15.72%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">Common Stock</span></p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;">&#160;</p></td> <td colspan="2" rowspan="2" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:8.4%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">Additional </span></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">&#160;Paid-in Capital</span></p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;">&#160;</p></td> <td colspan="2" rowspan="2" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:8.84%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">Accumulated</span></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">Deficit</span></p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:6.3%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;">&#160;</p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:25.84%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:6.2%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">Shares</span></p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;">&#160;</p></td> <td colspan="2" style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:7.68%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">Amount</span></p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:5.84%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">Shares</span></p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;">&#160;</p></td> <td colspan="2" style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:7.68%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">Amount </span></p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;">&#160;</p></td> <td colspan="2" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:8.14%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">Total</span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:25.84%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Balances, May 31, 2021</span></p></td> <td style="HEIGHT:15pt; WIDTH:6.2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c25" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesIssued" scale="0" unitRef="shares">12,307,157</ix:nonFraction> </span></p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="HEIGHT:15pt; WIDTH:5.84%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c25" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd">984,571</ix:nonFraction> </span></p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:5.84%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">-</span></p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="HEIGHT:15pt; WIDTH:5.84%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">-</span></p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:2.1%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="HEIGHT:15pt; WIDTH:6.3%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c26" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd">38,836,743</ix:nonFraction> </span></p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:2.12%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="HEIGHT:15pt; WIDTH:6.38%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(<ix:nonFraction contextRef="c27" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" sign="-" unitRef="usd">47,956</ix:nonFraction>)</span></p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="HEIGHT:15pt; WIDTH:7%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 7%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(<ix:nonFraction contextRef="c28" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" sign="-" unitRef="usd">30,546,335</ix:nonFraction>)</span></p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="HEIGHT:15pt; WIDTH:6.3%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd">9,227,023</ix:nonFraction> </span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:25.84%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:6.2%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:5.84%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:5.84%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:5.84%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:2.1%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:6.3%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:2.12%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:6.38%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:7%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 7%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:6.3%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:25.84%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Exercise of stock options</span></p></td> <td style="HEIGHT:15pt; WIDTH:6.2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c29" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" unitRef="shares">21,500</ix:nonFraction> </span></p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:5.84%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c29" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="0" unitRef="usd">1,720</ix:nonFraction> </span></p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:5.84%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">-</span></p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:5.84%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">-</span></p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:2.1%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:6.3%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c30" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="0" unitRef="usd">32,760</ix:nonFraction> </span></p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:2.12%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:6.38%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">-</span></p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:7%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; width: 7%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">-</span></p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:6.3%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="0" unitRef="usd">34,480</ix:nonFraction> </span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:25.84%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Net proceeds from ATM</span></p></td> <td style="HEIGHT:15pt; WIDTH:6.2%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c29" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" unitRef="shares">363,670</ix:nonFraction> </span></p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:5.84%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c29" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" unitRef="usd">29,094</ix:nonFraction> </span></p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:5.84%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">-</span></p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:5.84%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">-</span></p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:2.1%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:6.3%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c30" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" unitRef="usd">1,655,029</ix:nonFraction> </span></p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:2.12%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:6.38%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">-</span></p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:7%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; width: 7%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">-</span></p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:6.3%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" unitRef="usd">1,684,123</ix:nonFraction> </span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:25.84%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Foreign currency translation</span></p></td> <td style="HEIGHT:15pt; WIDTH:6.2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">-</span></p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:5.84%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">-</span></p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:5.84%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">-</span></p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:5.84%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">-</span></p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:2.1%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:6.3%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">-</span></p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:2.12%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:6.38%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(<ix:nonFraction contextRef="c31" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="0" sign="-" unitRef="usd">10,363</ix:nonFraction>)</span></p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:7%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; width: 7%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">-</span></p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:6.3%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(<ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="0" sign="-" unitRef="usd">10,363</ix:nonFraction>)</span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:25.84%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Compensation expense in connection with <br/>options granted</span></p></td> <td style="HEIGHT:15pt; WIDTH:6.2%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">-</span></p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:5.84%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">-</span></p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:5.84%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">-</span></p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:5.84%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">-</span></p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:2.1%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:6.3%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c30" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" scale="0" unitRef="usd">634,019</ix:nonFraction> </span></p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:2.12%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:6.38%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">-</span></p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:7%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; width: 7%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">-</span></p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:6.3%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" scale="0" unitRef="usd">634,019</ix:nonFraction> </span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:25.84%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Net loss</span></p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:6.2%; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">-</span></p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:1.84%; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:5.84%; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">-</span></p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:5.84%; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">-</span></p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:1.84%; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:5.84%; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">-</span></p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2.1%; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:6.3%; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">-</span></p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2.12%; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:6.38%; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">-</span></p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:1.84%; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:7%; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; width: 7%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(<ix:nonFraction contextRef="c32" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" sign="-" unitRef="usd">2,667,855</ix:nonFraction>)</span></p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:1.84%; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:6.3%; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(<ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" sign="-" unitRef="usd">2,667,855</ix:nonFraction>)</span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:25.84%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:6.2%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:5.84%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:5.84%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:5.84%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:2.1%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:6.3%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:2.12%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:6.38%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:7%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 7%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:1.84%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:6.3%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:25.84%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><b><span style="FONT-SIZE:10pt; COLOR:black">Balances, November 30, 2021</span></b></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:6.2%; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><b><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c33" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesIssued" scale="0" unitRef="shares">12,692,327</ix:nonFraction> </span></b></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.84%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.84%; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><b><span style="FONT-SIZE:10pt; COLOR:black">$</span></b></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:5.84%; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><b><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c33" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd">1,015,385</ix:nonFraction> </span></b></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.84%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:5.84%; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><b><span style="FONT-SIZE:10pt; COLOR:black">-</span></b></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.84%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.84%; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><b><span style="FONT-SIZE:10pt; COLOR:black">$</span></b></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:5.84%; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><b><span style="FONT-SIZE:10pt; COLOR:black">-</span></b></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.84%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2.1%; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><b><span style="FONT-SIZE:10pt; COLOR:black">$</span></b></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:6.3%; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><b><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c34" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd">41,158,551</ix:nonFraction> </span></b></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.84%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2.12%; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><b><span style="FONT-SIZE:10pt; COLOR:black">$</span></b></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:6.38%; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><b><span style="FONT-SIZE:10pt; COLOR:black">(<ix:nonFraction contextRef="c35" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" sign="-" unitRef="usd">58,319</ix:nonFraction>)</span></b></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.84%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.84%; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><b><span style="FONT-SIZE:10pt; COLOR:black">$</span></b></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:7%; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; width: 7%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><b><span style="FONT-SIZE:10pt; COLOR:black">(<ix:nonFraction contextRef="c36" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" sign="-" unitRef="usd">33,214,190</ix:nonFraction>)</span></b></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.84%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.84%; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><b><span style="FONT-SIZE:10pt; COLOR:black">$</span></b></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:6.3%; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><b><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd">8,901,427</ix:nonFraction> </span></b></p></td></tr> <tr style="HEIGHT:15.75pt"> <td colspan="22" style="HEIGHT:15.75pt; WIDTH:100%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 100%; white-space: nowrap;" valign="bottom"></td> </tr><tr style="HEIGHT:15pt"> <td colspan="22" style="HEIGHT:15pt; WIDTH:100%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 100%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">The accompanying notes are an integral part of these statements.</span></p></td></tr></table></div> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">3</span></p> <div style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><div style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;"> <hr/> <div style="PAGE-BREAK-BEFORE: always"></div> </div></div> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; color: #0066cc;"><a href="#TOC">Table of Contents</a></span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 0cm 0pt">&#160;</p> <div style="text-align: left;"> <a id="CFS"></a><table cellpadding="0" cellspacing="0" style="width: 750pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="1000">

<tr style="height: 47.25pt;">
<td colspan="6" style="height: 47.25pt; width: 100%; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">BIOMERICA, INC. AND SUBSIDIARIES</span></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS </span></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">(UNAUDITED)</span></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td colspan="6" style="height: 15.75pt; width: 100%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td colspan="5" rowspan="2" style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 30%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Six Months Ended </span></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">November 30,</span></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 12%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td colspan="2" rowspan="2" style="border-top: windowtext 1pt solid; height: 15.75pt; border-right: 0px; width: 14%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">2020</span></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">(As Restated)</span></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td colspan="2" style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 14%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">2021</span></p>
</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><strong><span style="font-size: 10pt; color: black;">Cash flows from operating activities:</span></strong></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 12%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 12%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Net loss</span></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15.75pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" sign="-" unitRef="usd">2,667,855</ix:nonFraction>)</span></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15.75pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c8" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" sign="-" unitRef="usd">3,610,492</ix:nonFraction>)</span></p>
</td>
</tr>
<tr style="height: 14.85pt;">
<td style="height: 14.85pt; width: 70%; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><strong><span style="font-size: 10pt; color: black;">Adjustments to reconcile net loss to net cash provided by (used in) operating activities:</span></strong></p>
</td>
<td style="height: 14.85pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 14.85pt; width: 12%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 14.85pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 14.85pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 14.85pt; width: 12%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Depreciation and amortization</span></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:DepreciationAndAmortization" scale="0" unitRef="usd">68,668</ix:nonFraction></span></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c8" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:DepreciationAndAmortization" scale="0" unitRef="usd">64,435</ix:nonFraction></span></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Change in allowance on accounts receivable</span></p>
</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 12%; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ProvisionForDoubtfulAccounts" scale="0" sign="-" unitRef="usd">809,638</ix:nonFraction>)</span></p>
</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 12%; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c8" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ProvisionForDoubtfulAccounts" scale="0" unitRef="usd">410,161</ix:nonFraction></span></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Inventory reserve</span></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:InventoryLIFOReservePeriodCharge" scale="0" unitRef="usd">181,825</ix:nonFraction></span></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c8" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:InventoryLIFOReservePeriodCharge" scale="0" unitRef="usd">11,943</ix:nonFraction></span></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Stock option expense</span></p>
</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 12%; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockOptionPlanExpense" scale="0" unitRef="usd">634,019</ix:nonFraction></span></p>
</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 12%; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c8" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockOptionPlanExpense" scale="0" unitRef="usd">500,140</ix:nonFraction></span></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Amortization of right-of-use asset</span></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="0" unitRef="usd">126,039</ix:nonFraction></span></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c8" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="0" unitRef="usd">115,025</ix:nonFraction></span></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><strong><span style="font-size: 10pt; color: black;">Changes in assets and liabilities:</span></strong></p>
</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 12%; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 12%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Accounts receivable</span></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="0" sign="-" unitRef="usd">1,139,450</ix:nonFraction></span></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c8" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="0" unitRef="usd">256,059</ix:nonFraction>)</span></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Inventories</span></p>
</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 12%; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInInventories" scale="0" sign="-" unitRef="usd">42,229</ix:nonFraction></span></p>
</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 12%; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c8" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInInventories" scale="0" unitRef="usd">1,359,320</ix:nonFraction>)</span></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Prepaid expenses and other</span></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="0" unitRef="usd">726,460</ix:nonFraction>)</span></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c8" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="0" sign="-" unitRef="usd">1,055,946</ix:nonFraction></span></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Reduction in lease liability</span></p>
</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 12%; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="bmra:IncreaseDecreaseInLeaseLiability" scale="0" sign="-" unitRef="usd">117,321</ix:nonFraction>)</span></p>
</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 12%; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c8" decimals="INF" format="ixt:num-dot-decimal" name="bmra:IncreaseDecreaseInLeaseLiability" scale="0" sign="-" unitRef="usd">102,677</ix:nonFraction>)</span></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Other assets</span></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="0" sign="-" unitRef="usd">114,570</ix:nonFraction></span></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c8" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="0" unitRef="usd">94,085</ix:nonFraction>)</span></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Accounts payable and accrued expenses</span></p>
</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 12%; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="0" unitRef="usd">997,327</ix:nonFraction></span></p>
</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 12%; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c8" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="0" unitRef="usd">271,386</ix:nonFraction></span></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Accrued compensation</span></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" scale="0" unitRef="usd">285,431</ix:nonFraction></span></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c8" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" scale="0" unitRef="usd">113,379</ix:nonFraction></span></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Advance from customers</span></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="0" unitRef="usd">2,150,466</ix:nonFraction></span></p>
</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; text-align: right; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom"><div style="-sec-ix-hidden: hidden-fact-9">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">-</span></p>
</div></td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Net cash provided by (used in) operating activities</span></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="0" unitRef="usd">1,418,750</ix:nonFraction></span></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c8" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="0" sign="-" unitRef="usd">2,880,218</ix:nonFraction>)</span></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 12%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 12%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><strong><span style="font-size: 10pt; color: black;">Cash flows from investing activities:</span></strong></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Increase in intangibles</span></p>
</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 12%; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireIntangibleAssets" scale="0" unitRef="usd">108,917</ix:nonFraction>)</span></p>
</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 12%; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c8" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireIntangibleAssets" scale="0" unitRef="usd">61,536</ix:nonFraction>)</span></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Purchases of property and equipment</span></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="0" unitRef="usd">18,212</ix:nonFraction>)</span></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c8" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="0" unitRef="usd">61,566</ix:nonFraction>)</span></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Net cash used in investing activities</span></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="0" sign="-" unitRef="usd">127,129</ix:nonFraction>)</span></p>
</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c8" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="0" sign="-" unitRef="usd">123,102</ix:nonFraction>)</span></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><strong><span style="font-size: 10pt; color: black;">Cash flows from financing activities:</span></strong></p>
</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 12%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 12%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Proceeds from sale of common stock, net</span></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="0" unitRef="usd">1,684,123</ix:nonFraction></span></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 12%; background: #b8cce4; text-align: right; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom"><div style="-sec-ix-hidden: hidden-fact-10">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">-</span></p>
</div></td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Proceeds from exercise of stock options</span></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromStockOptionsExercised" scale="0" unitRef="usd">34,480</ix:nonFraction></span></p>
</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c8" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromStockOptionsExercised" scale="0" unitRef="usd">49,330</ix:nonFraction></span></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Net cash provided by financing activities</span></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="0" unitRef="usd">1,718,603</ix:nonFraction></span></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c8" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="0" unitRef="usd">49,330</ix:nonFraction></span></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 12%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 12%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Effect of exchange rate changes in cash</span></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents" scale="0" sign="-" unitRef="usd">10,363</ix:nonFraction>)</span></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c8" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents" scale="0" sign="-" unitRef="usd">3,250</ix:nonFraction>)</span></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Net increase (decrease) in cash and cash equivalents</span></p>
</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 12%; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="0" unitRef="usd">2,999,861</ix:nonFraction></span></p>
</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 12%; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c8" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="0" sign="-" unitRef="usd">2,957,240</ix:nonFraction>)</span></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Cash and cash equivalents at beginning of period</span></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="0" unitRef="usd">4,199,311</ix:nonFraction></span></p>
</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c14" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="0" unitRef="usd">8,641,027</ix:nonFraction></span></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
</tr>
<tr style="height: 16.5pt;">
<td style="height: 16.5pt; width: 70%; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Cash and cash equivalents at end of period</span></p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 12%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="0" unitRef="usd">7,199,172</ix:nonFraction> </span></p>
</td>
<td style="height: 16.5pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 12%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c24" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="0" unitRef="usd">5,683,787</ix:nonFraction> </span></p>
</td>
</tr>
<tr style="height: 16.5pt;">
<td style="height: 16.5pt; width: 70%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 16.5pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 16.5pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 16.5pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 16.5pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 16.5pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Supplemental Disclosure of Cash-Flow Information:</span></p>
</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 12%; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 12%; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><strong><span style="font-size: 10pt; color: black;">Cash paid during the period for: </span></strong></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
</tr>
<tr style="height: 16.5pt;">
<td style="height: 16.5pt; width: 70%; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Income taxes</span></p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 12%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxesPaid" scale="0" unitRef="usd">10,646</ix:nonFraction> </span></p>
</td>
<td style="height: 16.5pt; width: 2%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 12%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c8" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxesPaid" scale="0" unitRef="usd">11,735</ix:nonFraction> </span></p>
</td>
</tr>
<tr style="height: 16.5pt;">
<td colspan="6" style="height: 16.5pt; width: 100%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td colspan="6" style="height: 15.75pt; width: 100%; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">The accompanying notes are an integral part of these statements</span></p>
</td>
</tr>

</table></div> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">4</span></p> <div style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><div style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;"> <hr/> <div style="PAGE-BREAK-BEFORE: always"></div> </div></div> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; color: #0066cc;"><a href="#TOC">Table of Contents</a></span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 0cm 0pt">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">BIOMERICA, INC. AND SUBSIDIARIES</span></p> <a id="Notes"></a><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 16.2pt 0pt 0cm">&#160;</p> <ix:nonNumeric contextRef="c0" continuedAt="_BasisOfAccounting-c0_cont_1" escape="true" name="us-gaap:BasisOfAccounting"><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 2.7pt 0pt 0cm"><b><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">NOTE 1: &#160;BASIS OF PRESENTATION</span></b></p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p></ix:nonNumeric>  <ix:continuation continuedAt="_BasisOfAccounting-c0_cont_2" id="_BasisOfAccounting-c0_cont_1"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt">Biomerica Inc. and subsidiaries (collectively the &#8220;Company&#8221;, &#8220;Biomerica&#8221;, &#8220;we&#8221;, &#8220;us&#8221;, or &#8220;our&#8221;) develops, patents, manufactures and markets advanced diagnostic and therapeutic products used at the point-of-care <span style="COLOR:black">(in home and physicians' offices) </span>and in hospital/clinical laboratories for detection and/or treatment of medical conditions and diseases. <span style="COLOR:black">The</span> Company's products are designed to enhance the health and well-being of people, while reducing total healthcare costs. </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p></ix:continuation>  <ix:continuation continuedAt="_BasisOfAccounting-c0_cont_3" id="_BasisOfAccounting-c0_cont_2"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Our primary focus is the research and development of patented, diagnostic-guided therapy (&#8220;DGT&#8221;) products to treat gastrointestinal diseases, such as irritable bowel syndrome, and other inflammatory diseases. These products are directed at chronic inflammatory illnesses that are widespread and common, and as such address very large markets. </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p></ix:continuation>  <ix:continuation continuedAt="_BasisOfAccounting-c0_cont_4" id="_BasisOfAccounting-c0_cont_3"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Our existing medical diagnostic products that are in the market are sold worldwide primarily in two markets: 1) clinical laboratories and 2) point-of-care (physicians' offices and over-the-counter drugstores like Walmart and Walgreens). Our diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances and other medical complications, by measuring or detecting the existence and/or level of specific bacteria, hormones, antibodies, antigens or other substances, which may exist in a patient&#8217;s body, stools, or blood, often in extremely small concentrations.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p></ix:continuation>  <ix:continuation continuedAt="_BasisOfAccounting-c0_cont_5" id="_BasisOfAccounting-c0_cont_4"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt">Due to the global 2019 SARS-CoV-2 novel coronavirus pandemic, in March 2020 we began developing COVID-19 products to indicate if a person has been infected by COVID-19. While the Company does offer a COVID-19 antibody diagnostic test, all of our COVID-19 revenues in fiscal 2022 have come from international sales of our antigen tests that use a patient&#8217;s nasal fluid sample to detect if the patient is currently infected with the virus. </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p></ix:continuation>  <ix:continuation continuedAt="_BasisOfAccounting-c0_cont_6" id="_BasisOfAccounting-c0_cont_5"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt; COLOR:black">The other products we sell are primarily focused on gastrointestinal diseases, food intolerances, and certain esoteric tests. These diagnostic test products utilize immunoassay technology. Most of our commercial products are CE marked and/or sold for diagnostic use where they are registered by each country&#8217;s regulatory agency.&#160; In addition, some products are cleared for sale in the U.S. by the FDA.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p></ix:continuation>  <ix:continuation continuedAt="_BasisOfAccounting-c0_cont_7" id="_BasisOfAccounting-c0_cont_6"><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">The information set forth in these condensed consolidated financial statements is unaudited and reflects all adjustments which, in the opinion of management, are necessary to present a fair statement of the consolidated results of operations of Biomerica, Inc. and subsidiaries, for the periods indicated. It does not include all information and footnotes necessary for a fair presentation of financial position, results of operations, and cash flows in conformity with accounting principles generally accepted in the United States of America. All adjustments that were made are of a normal recurring nature.</span></p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p></ix:continuation>  <ix:continuation continuedAt="_BasisOfAccounting-c0_cont_8" id="_BasisOfAccounting-c0_cont_7"><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">The unaudited, condensed consolidated financial statements and notes are presented as permitted by the requirements for Form 10-Q and do not contain certain information included in the annual financial statements and notes. The condensed consolidated balance sheet data as of May 31, 2021 was derived from restated, audited financial statements. The accompanying interim condensed consolidated financial statements should be read in conjunction with the financial statements and related notes included in the Annual Report on Form 10-K filed with the Securities and Exchange Commission (&#8220;SEC&#8221;) on August 27, 2021 for the fiscal year ended May 31, 2021, which have been restated as described in our Form 10-K/A as filed on October 14, 2021. The results of operations for the interim periods are not necessarily indicative of results to be achieved for the full fiscal year.</span></p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p></ix:continuation>  <ix:continuation continuedAt="_BasisOfAccounting-c0_cont_9" id="_BasisOfAccounting-c0_cont_8"><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><b><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; BACKGROUND:white; COLOR:black">CORRECTION OF AN ERROR</span></b></p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p></ix:continuation>  <ix:continuation id="_BasisOfAccounting-c0_cont_9"><p style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify; margin: 0cm 2.7pt 0pt 0cm;"><span style="font-family: 'Times New Roman','serif'; background: white; color: black;">As disclosed in our Form 10-K/A for the year ended May 31, 2021, filed on October 14, 2021, during the process of preparing our financial statements for the quarter ended August 31, 2021, we determined that our calculation of non-cash stock-based compensation expense related to issued stock options in previously issued financial statements was incorrect. Our calculation applied forfeiture adjustments to both vested and unvested outstanding options, including those for which the employee had provided the requisite service, which resulted in an understatement of stock compensation expense. Additionally, our calculation expensed the option at vesting dates versus pro-rata over the period the requisite service was provided. As a result of these errors, certain previously reported amounts in the condensed consolidated statement of operations, condensed consolidated statement of stockholders&#8217; equity and condensed consolidated statement of cash flows for the periods ended November 30, 2020, were materially misstated; accordingly, we have restated the prior period financial statements. See Note 8 to these Financial Statements. </span></p></ix:continuation> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">5</span></p> <div style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><div style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;"> <hr/> <div style="PAGE-BREAK-BEFORE: always"></div> </div></div> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; color: #0066cc;"><a href="#TOC">Table of Contents</a></span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p> <ix:nonNumeric contextRef="c0" continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_1" escape="true" name="us-gaap:SignificantAccountingPoliciesTextBlock"><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 2.7pt 0pt 0cm"><b><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">NOTE 2: &#160;SIGNIFICANT ACCOUNTING POLICIES</span></b></p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p></ix:nonNumeric>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_2" id="_SignificantAccountingPoliciesTextBlock-c0_cont_1"><ix:nonNumeric contextRef="c6" continuedAt="_ConsolidationPolicyTextBlock-c6_cont_1" escape="true" name="us-gaap:ConsolidationPolicyTextBlock"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><b><span style="FONT-SIZE:10pt">PRINCIPLES OF CONSOLIDATION</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p></ix:nonNumeric></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_3" id="_SignificantAccountingPoliciesTextBlock-c0_cont_2"><ix:continuation id="_ConsolidationPolicyTextBlock-c6_cont_1"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt">The condensed consolidated financial statements include the accounts of Biomerica, Inc. as well as its German subsidiary (BioEurope GmbH) and Mexican subsidiary (Biomerica de Mexico). All significant intercompany accounts and transactions have been eliminated in consolidation. </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p></ix:continuation></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_4" id="_SignificantAccountingPoliciesTextBlock-c0_cont_3"><ix:nonNumeric contextRef="c6" continuedAt="_UseOfEstimates-c6_cont_1" escape="true" name="us-gaap:UseOfEstimates"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><b><span style="FONT-SIZE:10pt">ACCOUNTING ESTIMATES</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p></ix:nonNumeric></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_5" id="_SignificantAccountingPoliciesTextBlock-c0_cont_4"><ix:continuation id="_UseOfEstimates-c6_cont_1"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt; COLOR:black">The preparation of the condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of revenues and expenses during the reported period. Estimates that are made include the allowance for doubtful accounts, which is estimated based on current as well as historical past practices with a customer; stock option forfeiture rates, which are calculated based on historical data; inventory obsolescence, which is based on projected and historical usage of materials; and lease liability and right-of-use assets, which are calculated based on certain assumptions such as borrowing rate, the likelihood of lease extensions to occur, asset valuation, among other things; and other items that may be necessary to estimate using current, historical and judgment based information. Actual results could materially differ from those estimates. </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p></ix:continuation></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_6" id="_SignificantAccountingPoliciesTextBlock-c0_cont_5"><ix:nonNumeric contextRef="c6" continuedAt="_MarketsAndMethodsOfDistributionPolicyTextBlock-c6_cont_1" escape="true" name="bmra:MarketsAndMethodsOfDistributionPolicyTextBlock"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><b><span style="FONT-SIZE:10pt; COLOR:black">MARKETS AND METHODS OF DISTRIBUTION</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p></ix:nonNumeric></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_7" id="_SignificantAccountingPoliciesTextBlock-c0_cont_6"><ix:continuation id="_MarketsAndMethodsOfDistributionPolicyTextBlock-c6_cont_1"><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt;">Due to the Coronavirus global pandemic, the Company&#8217;s operations have been negatively impacted. <span style="color: black;">The Company has faced disruptions in certain of the following areas, and may face further challenges from supply chain disruptions, loss of contracts and/or customers, closure of the Company&#8217;s manufacturing or distribution facilities or of the facilities of the Company&#8217;s suppliers, partners and customers, travel, shipping and logistical disruptions, government responses of all types, international business risks in countries where the Company makes and/or sells its products, loss of human capital or personnel at the Company, its partners and its customers, interruptions of production, customer credit risk, and general economic calamities. These ongoing pandemic related disruptions have materially negatively impacted the Company&#8217;s operations and financial performance and may continue to have significant material negative impacts on the Company.&#160;&#160; </span></span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p></ix:continuation></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_8" id="_SignificantAccountingPoliciesTextBlock-c0_cont_7"><ix:nonNumeric contextRef="c6" continuedAt="_LiquidityPolicyTextBlock-c6_cont_1" escape="true" name="bmra:LiquidityPolicyTextBlock"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><b><span style="FONT-SIZE:10pt; COLOR:black">LIQUIDITY</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p></ix:nonNumeric></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_9" id="_SignificantAccountingPoliciesTextBlock-c0_cont_8"><ix:continuation continuedAt="_LiquidityPolicyTextBlock-c6_cont_2" id="_LiquidityPolicyTextBlock-c6_cont_1"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt; COLOR:black">The Company has incurred net losses and negative cash flows from operations and has an accumulated deficit of approximately $<ix:nonFraction contextRef="c2" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" sign="-" unitRef="usd">33.2</ix:nonFraction> million as of November 30, 2021.&#160; Management expects to continue to incur significant costs as it advances its clinical trials and product development activities.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p></ix:continuation></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_10" id="_SignificantAccountingPoliciesTextBlock-c0_cont_9"><ix:continuation continuedAt="_LiquidityPolicyTextBlock-c6_cont_3" id="_LiquidityPolicyTextBlock-c6_cont_2"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">On January 22, 2021, the Company filed a prospectus supplement for purposes of raising up to $<ix:nonFraction contextRef="c37" decimals="0" format="ixt:num-dot-decimal" name="bmra:ShelfRegistrationStatementMaximumAuthorizedCommonStockIssuanceValue" scale="0" unitRef="usd">15,000,000</ix:nonFraction> to the base prospectus filed with the SEC on July 21, 2020 and included in the registration statement on Form S-3 </span><span style="FONT-SIZE:10pt">(<span style="COLOR:black">File No. 333-239980) that was declared effective by the SEC on September 30, 2020. The shares included in the prospectus supplement may be sold pursuant to the terms of an At-The- Market Issuance Sales Agreement between the Company and B. Riley Securities, Inc., as sales agent, the ATM Agreement.</span></span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p></ix:continuation></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_11" id="_SignificantAccountingPoliciesTextBlock-c0_cont_10"><ix:continuation continuedAt="_LiquidityPolicyTextBlock-c6_cont_4" id="_LiquidityPolicyTextBlock-c6_cont_3"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt">The Company intends to use the net proceeds from such offering for general corporate purposes, including, without limitation, sales and marketing activities, clinical studies and product development, making acquisitions of assets, businesses, companies or securities, capital expenditures, and for working capital needs.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p></ix:continuation></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_12" id="_SignificantAccountingPoliciesTextBlock-c0_cont_11"><ix:continuation continuedAt="_LiquidityPolicyTextBlock-c6_cont_5" id="_LiquidityPolicyTextBlock-c6_cont_4"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Under an ATM Agreement, sales of shares are deemed to be &#8220;at the market offerings&#8221; as defined in Rule 415 promulgated under the Securities Act.&#160; The sales agent under the ATM Agreement agrees to use commercially reasonable efforts to sell on the Company&#8217;s behalf all of the shares requested to be sold from time to time by the Company, consistent with its normal trading and sales practices, on mutually agreed terms between the sales agent and the Company. The Company has no obligation to sell any of the shares under the ATM Agreement, and may at any time suspend offers under, or terminate the ATM Agreement.&#160; </span></p></ix:continuation></ix:continuation> <a id="_Hlk80862558"></a><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_13" id="_SignificantAccountingPoliciesTextBlock-c0_cont_12"><ix:continuation id="_LiquidityPolicyTextBlock-c6_cont_5"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0cm 0pt"><span style="FONT-SIZE:10pt">As a result of cash and cash equivalents on hand at November 30, 2021, management believes the Company has sufficient funds to operate through February 2023 and the ability to raise additional funds through the ATM Agreement noted above.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p></ix:continuation></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_14" id="_SignificantAccountingPoliciesTextBlock-c0_cont_13"><ix:nonNumeric contextRef="c6" continuedAt="_ConcentrationRiskCreditRisk-c6_cont_1" escape="true" name="us-gaap:ConcentrationRiskCreditRisk"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><b><span style="FONT-SIZE:10pt">CONCENTRATION OF CREDIT RISK</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p></ix:nonNumeric></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_15" id="_SignificantAccountingPoliciesTextBlock-c0_cont_14"><ix:continuation continuedAt="_ConcentrationRiskCreditRisk-c6_cont_2" id="_ConcentrationRiskCreditRisk-c6_cont_1"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt">The Company maintains cash balances at certain financial institutions in excess of amounts insured by federal agencies. As of November 30, 2021, the Company had approximately $<ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CashUninsuredAmount" scale="0" unitRef="usd">6,950,000</ix:nonFraction> of uninsured cash.&#160; <span style="COLOR:black">The Company does not believe it is exposed to any significant credit risks.</span></span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p></ix:continuation></ix:continuation>  <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">6</span></p> <div style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><div style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;"> <hr/> <div style="PAGE-BREAK-BEFORE: always"></div> </div></div> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; color: #0066cc;"><a href="#TOC">Table of Contents</a></span></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p> <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_16" id="_SignificantAccountingPoliciesTextBlock-c0_cont_15"><ix:continuation continuedAt="_ConcentrationRiskCreditRisk-c6_cont_3" id="_ConcentrationRiskCreditRisk-c6_cont_2"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt">For the six months ended November 30, 2021 and 2020, the Company had two and one key customers which accounted for <ix:nonFraction contextRef="c38" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" unitRef="pure">66</ix:nonFraction>% and <ix:nonFraction contextRef="c39" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" unitRef="pure">35</ix:nonFraction>% of net consolidated sales, respectively.&#160; At November 30, 2021 and May 31, 2021, the Company had three and two key distributors which accounted for a total of <ix:nonFraction contextRef="c40" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" unitRef="pure">73</ix:nonFraction>% and <ix:nonFraction contextRef="c41" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" unitRef="pure">73</ix:nonFraction>%, respectively, of gross accounts receivable. </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p></ix:continuation></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_17" id="_SignificantAccountingPoliciesTextBlock-c0_cont_16"><ix:continuation id="_ConcentrationRiskCreditRisk-c6_cont_3"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt">For the six months ended November 30, 2021 and 2020, the Company had one and two key vendors which accounted for <ix:nonFraction contextRef="c42" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" unitRef="pure">77</ix:nonFraction>% and <ix:nonFraction contextRef="c43" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" unitRef="pure">56</ix:nonFraction>% of the purchases of raw materials, respectively. As of November 30, 2021 and May 31, 2021, the Company had one key vendor which accounted for <ix:nonFraction contextRef="c44" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" unitRef="pure">47</ix:nonFraction>% and <ix:nonFraction contextRef="c45" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" unitRef="pure">17</ix:nonFraction>%, respectively, of accounts payable.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p></ix:continuation></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_18" id="_SignificantAccountingPoliciesTextBlock-c0_cont_17"><ix:nonNumeric contextRef="c6" continuedAt="_CashAndCashEquivalentsPolicyTextBlock-c6_cont_1" escape="true" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><b><span style="FONT-SIZE:10pt">CASH AND CASH EQUIVALENTS </span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p></ix:nonNumeric></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_19" id="_SignificantAccountingPoliciesTextBlock-c0_cont_18"><ix:continuation id="_CashAndCashEquivalentsPolicyTextBlock-c6_cont_1"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt">Cash and cash equivalents consist of demand deposits and money market accounts with original maturities of less than six months.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p></ix:continuation></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_20" id="_SignificantAccountingPoliciesTextBlock-c0_cont_19"><ix:nonNumeric contextRef="c6" continuedAt="_TradeAndOtherAccountsReceivablePolicy-c6_cont_1" escape="true" name="us-gaap:TradeAndOtherAccountsReceivablePolicy"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><b><span style="FONT-SIZE:10pt">ACCOUNTS RECEIVABLE</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p></ix:nonNumeric></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_21" id="_SignificantAccountingPoliciesTextBlock-c0_cont_20"><ix:continuation continuedAt="_TradeAndOtherAccountsReceivablePolicy-c6_cont_2" id="_TradeAndOtherAccountsReceivablePolicy-c6_cont_1"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">The Company extends unsecured credit to its customers on a regular basis. &#160;International accounts are usually required to prepay until they establish a history with the Company and at that time, they are extended credit at levels based on a number of criteria. &#160;Based on various criteria,&#160;initial credit levels for individual distributors are approved by designated officers and managers of the Company. All increases in credit limits are also approved by designated upper-level management. &#160;Management evaluates receivables on a quarterly basis and adjusts the allowance for doubtful accounts accordingly. &#160;Balances over <ix:nonNumeric contextRef="c6" format="ixt-sec:durwordsen" name="us-gaap:ThresholdPeriodPastDueForWriteoffOfTradeAccountsReceivable">ninety days</ix:nonNumeric> old are usually reserved for unless collection is reasonably assured. &#160; </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p></ix:continuation></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_22" id="_SignificantAccountingPoliciesTextBlock-c0_cont_21"><ix:continuation continuedAt="_TradeAndOtherAccountsReceivablePolicy-c6_cont_3" id="_TradeAndOtherAccountsReceivablePolicy-c6_cont_2"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Occasionally certain long-standing customers, who routinely place large orders, will have unusually large receivables balances relative to the total gross receivables. Management monitors the payments for these large balances closely and very often requires payment of existing invoices before shipping new sales orders.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p></ix:continuation></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_23" id="_SignificantAccountingPoliciesTextBlock-c0_cont_22"><ix:continuation id="_TradeAndOtherAccountsReceivablePolicy-c6_cont_3"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt">The Company has established a reserve of approximately $<ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AllowanceForDoubtfulOtherReceivablesCurrent" scale="0" unitRef="usd">28,000</ix:nonFraction> for doubtful accounts as of November 30, 2021. </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p></ix:continuation></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_24" id="_SignificantAccountingPoliciesTextBlock-c0_cont_23"><ix:nonNumeric contextRef="c6" continuedAt="_PrepaidsPolicyPolicyTextBlock-c6_cont_1" escape="true" name="bmra:PrepaidsPolicyPolicyTextBlock"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><b><span style="FONT-SIZE:10pt">PREPAID EXPENSES AND OTHER</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p></ix:nonNumeric></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_25" id="_SignificantAccountingPoliciesTextBlock-c0_cont_24"><ix:continuation continuedAt="_PrepaidsPolicyPolicyTextBlock-c6_cont_2" id="_PrepaidsPolicyPolicyTextBlock-c6_cont_1"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt">The Company occasionally prepays for items such as inventory, insurance and other items.&#160; These items are reported as prepaid expenses and other, until either the inventory is physically received or the insurance and other items are expensed.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p></ix:continuation></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_26" id="_SignificantAccountingPoliciesTextBlock-c0_cont_25"><ix:continuation id="_PrepaidsPolicyPolicyTextBlock-c6_cont_2"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt">As of November 30, 2021 and May 31, 2021, the prepaid expenses and other were approximately $<ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssets" scale="0" unitRef="usd">1,097,000</ix:nonFraction> and $<ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssets" scale="0" unitRef="usd">370,000</ix:nonFraction>, respectively. The prepaid expenses and other balance were composed of prepayments to raw materials suppliers, insurance and various other suppliers. &#160;&#160;</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p></ix:continuation></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_27" id="_SignificantAccountingPoliciesTextBlock-c0_cont_26"><ix:nonNumeric contextRef="c6" continuedAt="_InventoryPolicyTextBlock-c6_cont_1" escape="true" name="us-gaap:InventoryPolicyTextBlock"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><b><span style="FONT-SIZE:10pt">INVENTORIES, NET </span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p></ix:nonNumeric></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_28" id="_SignificantAccountingPoliciesTextBlock-c0_cont_27"><ix:continuation continuedAt="_InventoryPolicyTextBlock-c6_cont_2" id="_InventoryPolicyTextBlock-c6_cont_1"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt">The Company values inventory at the lower of cost (determined using a combination of specific lot identification and the first-in, first-out methods) or net realizable value. Management periodically reviews inventory for excess quantities and obsolescence. Management evaluates quantities on hand, physical condition, and technical functionality as these characteristics may be impacted by anticipated customer demand for current products and new product introductions. The reserve is adjusted based on such evaluation, with a corresponding provision included in cost of sales. Abnormal amounts of idle facility expenses, freight, handling costs and wasted material are recognized as current period charges and the allocation of fixed production overhead is based on the normal capacity of the production facilities.</span></p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p></ix:continuation></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_29" id="_SignificantAccountingPoliciesTextBlock-c0_cont_28"><ix:continuation continuedAt="_InventoryPolicyTextBlock-c6_cont_3" id="_InventoryPolicyTextBlock-c6_cont_2"><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">Inventories approximate the following at:</span></p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p></ix:continuation></ix:continuation>  <div style="text-align: left;"> <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_30" id="_SignificantAccountingPoliciesTextBlock-c0_cont_29"><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock"><ix:continuation continuedAt="_InventoryPolicyTextBlock-c6_cont_4" id="_InventoryPolicyTextBlock-c6_cont_3"><table cellpadding="0" cellspacing="0" style="WIDTH:555.6pt; BORDER-COLLAPSE:collapse; margin-left: auto; margin-right: auto;" width="741"> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:374.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td colspan="2" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:78.6pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">November 30,<br/>2021</span></p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td colspan="2" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:78.6pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">May 31, <br/>2021</span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:374.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Raw materials</span></p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="HEIGHT:15pt; WIDTH:66.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="0" unitRef="usd">1,416,000</ix:nonFraction> </span></p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="HEIGHT:15pt; WIDTH:66.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="0" unitRef="usd">1,583,000</ix:nonFraction> </span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:374.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Work in progress</span></p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:66.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="0" unitRef="usd">708,000</ix:nonFraction> </span></p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:66.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="0" unitRef="usd">1,006,000</ix:nonFraction> </span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:374.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Finished products</span></p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:11.8pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:66.8pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="0" unitRef="usd">858,000</ix:nonFraction> </span></p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:11.8pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:66.8pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="0" unitRef="usd">617,000</ix:nonFraction> </span></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:374.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Total</span></p></td> <td style="HEIGHT:15.75pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:11.8pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:66.8pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryNet" scale="0" unitRef="usd">2,982,000</ix:nonFraction> </span></p></td> <td style="HEIGHT:15.75pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:11.8pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:66.8pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryNet" scale="0" unitRef="usd">3,206,000</ix:nonFraction> </span></p></td></tr></table></ix:continuation></ix:nonNumeric></ix:continuation></div> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 2.7pt 0pt 0cm; text-align: center;">&#160;</p> <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_31" id="_SignificantAccountingPoliciesTextBlock-c0_cont_30"><ix:continuation id="_InventoryPolicyTextBlock-c6_cont_4"><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">Reserves for inventory obsolescence are recorded as necessary to reduce obsolete inventory carrying value to estimated realizable value or to specifically reserve for obsolete inventory that the Company intends to dispose of. As of November 30, 2021 and May 31, 2021, inventory reserves were approximately $<ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InventoryValuationReserves" scale="0" unitRef="usd">1,799,000</ix:nonFraction> and $<ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InventoryValuationReserves" scale="0" unitRef="usd">1,617,000</ix:nonFraction>, respectively. Of the inventory reserve, approximately $<ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InventoryLIFOReserve" scale="0" unitRef="usd">1,686,000</ix:nonFraction> was related to a market downturn in our COVID-19 antibody test and materials, as the market shifted to COVID-19 PCR viral tests and antigen tests.</span></p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p></ix:continuation></ix:continuation>  <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">7</span></p> <div style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><div style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;"> <hr/> <div style="PAGE-BREAK-BEFORE: always"></div> </div></div> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; color: #0066cc;"><a href="#TOC">Table of Contents</a></span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p> <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_32" id="_SignificantAccountingPoliciesTextBlock-c0_cont_31"><ix:nonNumeric contextRef="c6" continuedAt="_PropertyPlantAndEquipmentPolicyTextBlock-c6_cont_1" escape="true" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><b><span style="FONT-SIZE:10pt">PROPERTY AND EQUIPMENT, NET</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p></ix:nonNumeric></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_33" id="_SignificantAccountingPoliciesTextBlock-c0_cont_32"><ix:continuation continuedAt="_PropertyPlantAndEquipmentPolicyTextBlock-c6_cont_2" id="_PropertyPlantAndEquipmentPolicyTextBlock-c6_cont_1"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt">Property and equipment are stated at cost. Expenditures for additions and major improvements are capitalized. Repairs and maintenance costs are charged to operations as incurred. When property and equipment are sold, retired or otherwise disposed of, the related cost and accumulated depreciation or amortization are removed from the accounts, and gains or losses from sales, retirements and dispositions are credited or charged to income. </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm; TEXT-INDENT:36pt">&#160;</p></ix:continuation></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_34" id="_SignificantAccountingPoliciesTextBlock-c0_cont_33"><ix:continuation id="_PropertyPlantAndEquipmentPolicyTextBlock-c6_cont_2"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt">Depreciation and amortization are provided over the estimated useful lives of the related assets, ranging from <ix:nonNumeric contextRef="c46" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">5</ix:nonNumeric> to <ix:nonNumeric contextRef="c47" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">10</ix:nonNumeric> years, using the straight-line method. Leasehold improvements are amortized over the lesser of the estimated useful life of the asset or the term of the lease. Depreciation and amortization expense on property and equipment were approximately $<ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="0" unitRef="usd">26,000</ix:nonFraction> and $<ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="0" unitRef="usd">26,000</ix:nonFraction> for the three months ended November 30, 2021 and 2020, and approximately $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="0" unitRef="usd">54,000</ix:nonFraction> and $<ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="0" unitRef="usd">53,000</ix:nonFraction> for the six months ended November 30, 2021 and 2020, respectively. </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt">&#160; </span></p></ix:continuation></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_35" id="_SignificantAccountingPoliciesTextBlock-c0_cont_34"><ix:nonNumeric contextRef="c6" continuedAt="_GoodwillAndIntangibleAssetsPolicyTextBlock-c6_cont_1" escape="true" name="us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><b><span style="FONT-SIZE:10pt">INTANGIBLE ASSETS, NET</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p></ix:nonNumeric></ix:continuation>  <a id="OLE_LINK9"></a><a id="OLE_LINK8"></a><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_36" id="_SignificantAccountingPoliciesTextBlock-c0_cont_35"><ix:continuation continuedAt="_GoodwillAndIntangibleAssetsPolicyTextBlock-c6_cont_2" id="_GoodwillAndIntangibleAssetsPolicyTextBlock-c6_cont_1"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Intangible assets include trademarks, product rights, technology rights and patents, and are accounted for based on Accounting Standards Codification, ASC 350 Intangibles &#8211; Goodwill and Other. In that regard, intangible assets that have indefinite useful lives are not amortized but are tested at least annually for impairment or more frequently if events or changes in circumstances indicate that the asset might be impaired. </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p></ix:continuation></ix:continuation>  <a id="OLE_LINK6"></a><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_37" id="_SignificantAccountingPoliciesTextBlock-c0_cont_36"><ix:continuation continuedAt="_GoodwillAndIntangibleAssetsPolicyTextBlock-c6_cont_3" id="_GoodwillAndIntangibleAssetsPolicyTextBlock-c6_cont_2"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Intangible assets are being amortized using the straight-line method over the useful life, not to exceed <ix:nonNumeric contextRef="c48" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">18</ix:nonNumeric> years for marketing and distribution rights, <ix:nonNumeric contextRef="c49" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">10</ix:nonNumeric> years for purchased technology use rights, and <ix:nonNumeric contextRef="c50" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">20</ix:nonNumeric> years for patents. Amortization was approximately $<ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="0" unitRef="usd">7,000</ix:nonFraction> and $<ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="0" unitRef="usd">6,000</ix:nonFraction> for the three months ended November 30, 2021 and 2020 and approximately $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="0" unitRef="usd">14,000</ix:nonFraction> and $<ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="0" unitRef="usd">12,000</ix:nonFraction> for the six months ended November 30, 2021 and 2020, respectively.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p></ix:continuation></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_38" id="_SignificantAccountingPoliciesTextBlock-c0_cont_37"><ix:continuation id="_GoodwillAndIntangibleAssetsPolicyTextBlock-c6_cont_3"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">The Company assesses the recoverability of these intangible assets by determining whether the amortization of the asset&#8217;s balance over its remaining life can be recovered through projected undiscounted future cash flows. The Company uses a qualitative assessment to determine whether there was any impairment. No impairment adjustment was required as of </span><span style="FONT-SIZE:10pt">November 30<span style="COLOR:black">, 2021 or 2020.</span></span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p></ix:continuation></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_39" id="_SignificantAccountingPoliciesTextBlock-c0_cont_38"><ix:nonNumeric contextRef="c6" continuedAt="_InvestmentPolicyTextBlock-c6_cont_1" escape="true" name="us-gaap:InvestmentPolicyTextBlock"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><b><span style="FONT-SIZE:10pt; COLOR:black">INVESTMENTS</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p></ix:nonNumeric></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_40" id="_SignificantAccountingPoliciesTextBlock-c0_cont_39"><ix:continuation id="_InvestmentPolicyTextBlock-c6_cont_1"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt; COLOR:black">From time-to-time, the Company makes investments in privately-held companies. &#160;The Company determines whether the fair values of any investments in privately-held entities have declined below their carrying value whenever adverse events or changes in circumstances indicate that recorded values may not be recoverable. &#160;If the Company considers any such decline to be other than temporary (based on various factors, including historical financial results, and the overall health of the investee&#8217;s industry), a write-down to estimated fair value is recorded. Investments represent the Company&#8217;s equity investment in a Polish based distribution company which is primarily engaged in distributing medical products and devices, including those manufactured by the Company, and in certain cases, manufacturing the products they sell. &#160;The Company currently has not written down the investment and has no information that would indicate the carrying value is greater than the fair value.&#160; The Company owns approximately <ix:nonFraction contextRef="c2" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" unitRef="pure">6</ix:nonFraction>% of the Polish distribution company, and accordingly, applies the cost method to account for the investment. &#160;Under the cost method, investments are recorded at cost, with gains and losses recognized as of the sale date, and income recorded when received.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p></ix:continuation></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_41" id="_SignificantAccountingPoliciesTextBlock-c0_cont_40"><ix:nonNumeric contextRef="c6" continuedAt="_ShareBasedCompensationOptionAndIncentivePlansPolicy-c6_cont_1" escape="true" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><b><span style="FONT-SIZE:10pt">SHARE-BASED COMPENSATION</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p></ix:nonNumeric></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_42" id="_SignificantAccountingPoliciesTextBlock-c0_cont_41"><ix:continuation continuedAt="_ShareBasedCompensationOptionAndIncentivePlansPolicy-c6_cont_2" id="_ShareBasedCompensationOptionAndIncentivePlansPolicy-c6_cont_1"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt">The Company follows the guidance of the accounting provisions of Accounting Standards Codification 718, Share-based Compensation, which requires the use of the fair-value based method to determine compensation expense for all arrangements under which employees, directors and others are granted shares of the Company&#8217;s common stock or equity instruments (stock options). The fair value of each option award is estimated on the date of grant using the Black-Scholes option pricing model that uses assumptions for expected volatility, expected dividends, expected forfeiture rate, expected term, and the risk-free interest rate. The Company has not paid dividends historically and does not expect to pay them in the future. Expected volatilities are based on weighted averages of the historical volatility of the Company&#8217;s common stock estimated over the expected term of the options. The expected forfeiture rate is based on historical forfeitures experienced. The expected term of options granted is derived using the &#8220;simplified method&#8221; which computes expected term as the average of the sum of the vesting term plus the contract term as historically the Company had limited activity surrounding its options. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for the period of<b> </b>the expected term.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p></ix:continuation></ix:continuation>  <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">8</span></p> <div style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><div style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;"> <hr/> <div style="PAGE-BREAK-BEFORE: always"></div> </div></div> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; color: #0066cc;"><a href="#TOC">Table of Contents</a></span></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p> <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_43" id="_SignificantAccountingPoliciesTextBlock-c0_cont_42"><ix:continuation continuedAt="_ShareBasedCompensationOptionAndIncentivePlansPolicy-c6_cont_3" id="_ShareBasedCompensationOptionAndIncentivePlansPolicy-c6_cont_2"><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">The following summary presents the options and warrants granted, exercised, expired, canceled and outstanding for the six months ended November 30, 2021:</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p></ix:continuation></ix:continuation>  <div style="text-align: left;"> <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_44" id="_SignificantAccountingPoliciesTextBlock-c0_cont_43"><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"><ix:continuation continuedAt="_ShareBasedCompensationOptionAndIncentivePlansPolicy-c6_cont_4" id="_ShareBasedCompensationOptionAndIncentivePlansPolicy-c6_cont_3"><table cellpadding="0" cellspacing="0" style="WIDTH:554.4pt; BORDER-COLLAPSE:collapse; margin-left: auto; margin-right: auto;" width="739"> <tr style="HEIGHT:48pt"> <td style="HEIGHT:48pt; WIDTH:385.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:48pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:48pt; BORDER-RIGHT:0px; WIDTH:66.8pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">Option Shares</span></p></td> <td style="HEIGHT:48pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td colspan="2" style="BORDER-TOP:0px; HEIGHT:48pt; BORDER-RIGHT:0px; WIDTH:78.2pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">Exercise Price Weighted Average</span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:385.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Outstanding May 31, 2021</span></p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:66.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c55" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" unitRef="shares">2,081,366</ix:nonFraction></span></p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="HEIGHT:15pt; WIDTH:66.4pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c55" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" unitRef="usdPershares">3.59</ix:nonFraction></span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:385.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Granted </span></p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:66.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c56" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" unitRef="shares">24,000</ix:nonFraction></span></p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:66.4pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c56" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" unitRef="usdPershares">4.25</ix:nonFraction></span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:385.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Exercised </span></p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:66.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(<ix:nonFraction contextRef="c56" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" unitRef="shares">21,500</ix:nonFraction>)</span></p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:66.4pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c56" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" unitRef="usdPershares">1.64</ix:nonFraction></span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:385.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Cancelled or expired </span></p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:66.8pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(<ix:nonFraction contextRef="c56" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" scale="0" unitRef="shares">24,750</ix:nonFraction>)</span></p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:11.8pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:66.4pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c56" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" scale="0" unitRef="usdPershares">3.24</ix:nonFraction></span></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:385.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Outstanding November 30, 2021</span></p></td> <td style="HEIGHT:15.75pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:66.8pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><b><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c57" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" unitRef="shares">2,059,116</ix:nonFraction></span></b></p></td> <td style="HEIGHT:15.75pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:11.8pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><strong><span style="FONT-SIZE:10pt; COLOR:black">$</span></strong></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:66.4pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><b><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c57" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" unitRef="usdPershares">3.62</ix:nonFraction></span></b></p></td></tr></table></ix:continuation></ix:nonNumeric></ix:continuation></div> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p> <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_45" id="_SignificantAccountingPoliciesTextBlock-c0_cont_44"><ix:continuation continuedAt="_ShareBasedCompensationOptionAndIncentivePlansPolicy-c6_cont_5" id="_ShareBasedCompensationOptionAndIncentivePlansPolicy-c6_cont_4"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt">During the six months ended November 30, 2021, options to purchase <ix:nonFraction contextRef="c51" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" unitRef="shares">21,500</ix:nonFraction> shares of common stock were exercised at prices ranging from $<ix:nonFraction contextRef="c52" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" scale="0" unitRef="usdPershares">1.20</ix:nonFraction> to $<ix:nonFraction contextRef="c53" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" scale="0" unitRef="usdPershares">3.62</ix:nonFraction>. Total net proceeds to the Company were $<ix:nonFraction contextRef="c51" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromStockOptionsExercised" scale="0" unitRef="usd">34,480</ix:nonFraction>.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p></ix:continuation></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_46" id="_SignificantAccountingPoliciesTextBlock-c0_cont_45"><ix:continuation id="_ShareBasedCompensationOptionAndIncentivePlansPolicy-c6_cont_5"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt">During the six months ended November 30, 2021, the Company granted <ix:nonFraction contextRef="c54" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" unitRef="shares">24,000</ix:nonFraction> options to purchase common stock at an average purchase price of $<ix:nonFraction contextRef="c54" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" unitRef="usdPershares">4.25</ix:nonFraction>. </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p></ix:continuation></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_47" id="_SignificantAccountingPoliciesTextBlock-c0_cont_46"><ix:nonNumeric contextRef="c6" continuedAt="_RevenueRecognitionPolicyTextBlock-c6_cont_1" escape="true" name="us-gaap:RevenueRecognitionPolicyTextBlock"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 2.7pt 0pt 0cm"><b><span style="FONT-SIZE:10pt">REVENUE RECOGNITION</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p></ix:nonNumeric></ix:continuation>  <a id="_Hlk49511094"></a><a id="_Hlk49511094-0"></a><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_48" id="_SignificantAccountingPoliciesTextBlock-c0_cont_47"><ix:continuation continuedAt="_RevenueRecognitionPolicyTextBlock-c6_cont_2" id="_RevenueRecognitionPolicyTextBlock-c6_cont_1"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">The Company has various contracts with customers.&#160; All of the contracts specify that revenues from product sales are recognized at the time the product is shipped, customarily FOB shipping point, which is when the transfer of control of goods has occurred and at which point title passes. The Company does not typically allow for returns except in the event of defective merchandise and therefore does not establish an allowance for returns. In addition, the Company has contracts with customers wherein they receive purchase discounts for achieving specified sales volumes. The Company evaluated the status of these contracts as of </span><span style="FONT-SIZE:10pt">November 30<span style="COLOR:black">, 2021 and 2020, and does not believe that any additional discounts will be given through the end of the contract periods. </span>Services for contract works performed by the Company for others are invoiced and recognized as work that has been performed as the project progresses. <span style="COLOR:black">The Company sells clinical lab products to domestic and international distributors, including hospitals and clinical laboratories, medical research institutions, medical schools and pharmaceutical companies. OTC products are sold directly to drug stores and e-commerce customers as well as to distributors.&#160; Physicians&#8217; office products are sold to physicians and distributors, all of whom are categorized below according to the type of products sold to them. We also manufacture certain components on a contract basis for domestic and international manufacturers. </span></span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p></ix:continuation></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_49" id="_SignificantAccountingPoliciesTextBlock-c0_cont_48"><ix:continuation continuedAt="_RevenueRecognitionPolicyTextBlock-c6_cont_3" id="_RevenueRecognitionPolicyTextBlock-c6_cont_2"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Disaggregation of revenue:</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p></ix:continuation></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_50" id="_SignificantAccountingPoliciesTextBlock-c0_cont_49"><ix:continuation continuedAt="_RevenueRecognitionPolicyTextBlock-c6_cont_4" id="_RevenueRecognitionPolicyTextBlock-c6_cont_3"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">The following is a breakdown of revenues according to markets to which the products are sold:</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt; COLOR:black">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </span></p></ix:continuation></ix:continuation>  <div style="text-align: left;"> <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_51" id="_SignificantAccountingPoliciesTextBlock-c0_cont_50"><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:DisaggregationOfRevenueTableTextBlock"><ix:continuation continuedAt="_RevenueRecognitionPolicyTextBlock-c6_cont_5" id="_RevenueRecognitionPolicyTextBlock-c6_cont_4"><table cellpadding="0" cellspacing="0" style="WIDTH:602.1pt; BORDER-COLLAPSE:collapse; margin-left: auto; margin-right: auto;" width="803"> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:231.05pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:8.05pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td colspan="5" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:178.55pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">Three Months Ended<br/></span><span style="FONT-SIZE:10pt">November 30,</span></p></td> <td style="HEIGHT:15pt; WIDTH:8.1pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td colspan="5" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:176.35pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">Six Months Ended<br/></span><span style="FONT-SIZE:10pt">November 30,</span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:231.05pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:8.05pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td colspan="2" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:85.25pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">2021&#160; </span></p></td> <td style="HEIGHT:15pt; WIDTH:8.05pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td colspan="2" style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:85.25pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">2020&#160; </span></p></td> <td style="HEIGHT:15pt; WIDTH:8.1pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td colspan="2" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:85.25pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">2021&#160; </span></p></td> <td style="HEIGHT:15pt; WIDTH:8.1pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td colspan="2" style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:83pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">2020</span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:231.05pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Physician's office</span></p></td> <td style="HEIGHT:15pt; WIDTH:8.05pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:16.9pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="HEIGHT:15pt; WIDTH:68.35pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c58" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" unitRef="usd">3,359,000</ix:nonFraction> </span></p></td> <td style="HEIGHT:15pt; WIDTH:8.05pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:16.9pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="HEIGHT:15pt; WIDTH:68.35pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c59" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" unitRef="usd">153,000</ix:nonFraction> </span></p></td> <td style="HEIGHT:15pt; WIDTH:8.1pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:16.9pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="HEIGHT:15pt; WIDTH:68.35pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c60" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" unitRef="usd">3,616,000</ix:nonFraction> </span></p></td> <td style="HEIGHT:15pt; WIDTH:8.1pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:16.5pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="HEIGHT:15pt; WIDTH:66.5pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c61" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" unitRef="usd">351,000</ix:nonFraction> </span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:231.05pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Clinical lab</span></p></td> <td style="HEIGHT:15pt; WIDTH:8.05pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:16.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:68.35pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c62" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" unitRef="usd">642,000</ix:nonFraction> </span></p></td> <td style="HEIGHT:15pt; WIDTH:8.05pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:16.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:68.35pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c63" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" unitRef="usd">893,000</ix:nonFraction> </span></p></td> <td style="HEIGHT:15pt; WIDTH:8.1pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:16.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:68.35pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c64" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" unitRef="usd">1,528,000</ix:nonFraction> </span></p></td> <td style="HEIGHT:15pt; WIDTH:8.1pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:16.5pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:66.5pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c65" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" unitRef="usd">1,475,000</ix:nonFraction> </span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:231.05pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Over-the-counter</span></p></td> <td style="HEIGHT:15pt; WIDTH:8.05pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:16.9pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:68.35pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c66" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" unitRef="usd">534,000</ix:nonFraction> </span></p></td> <td style="HEIGHT:15pt; WIDTH:8.05pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:16.9pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:68.35pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c67" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" unitRef="usd">272,000</ix:nonFraction> </span></p></td> <td style="HEIGHT:15pt; WIDTH:8.1pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:16.9pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:68.35pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c68" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" unitRef="usd">613,000</ix:nonFraction> </span></p></td> <td style="HEIGHT:15pt; WIDTH:8.1pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:16.5pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:66.5pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c69" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" unitRef="usd">457,000</ix:nonFraction> </span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:231.05pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Contract manufacturing</span></p></td> <td style="HEIGHT:15pt; WIDTH:8.05pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:16.9pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:68.35pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c70" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" unitRef="usd">112,000</ix:nonFraction> </span></p></td> <td style="HEIGHT:15pt; WIDTH:8.05pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:16.9pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:68.35pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c71" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" unitRef="usd">55,000</ix:nonFraction> </span></p></td> <td style="HEIGHT:15pt; WIDTH:8.1pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:16.9pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:68.35pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c72" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" unitRef="usd">152,000</ix:nonFraction> </span></p></td> <td style="HEIGHT:15pt; WIDTH:8.1pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:16.5pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:66.5pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c73" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" unitRef="usd">233,000</ix:nonFraction> </span></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:231.05pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Total</span></p></td> <td style="HEIGHT:15.75pt; WIDTH:8.05pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:16.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:68.35pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c6" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" unitRef="usd">4,647,000</ix:nonFraction> </span></p></td> <td style="HEIGHT:15.75pt; WIDTH:8.05pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:16.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:68.35pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c7" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" unitRef="usd">1,373,000</ix:nonFraction> </span></p></td> <td style="HEIGHT:15.75pt; WIDTH:8.1pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:16.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:68.35pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" unitRef="usd">5,909,000</ix:nonFraction> </span></p></td> <td style="HEIGHT:15.75pt; WIDTH:8.1pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:16.5pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:66.5pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c8" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" unitRef="usd">2,516,000</ix:nonFraction> </span></p></td></tr></table></ix:continuation></ix:nonNumeric></ix:continuation></div> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 2.7pt 0pt 0cm; text-align: center;">&#160;</p> <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_52" id="_SignificantAccountingPoliciesTextBlock-c0_cont_51"><ix:continuation id="_RevenueRecognitionPolicyTextBlock-c6_cont_5"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 16.2pt 0pt 0cm"><span style="FONT-SIZE:10pt; COLOR:black">See Note 4 for additional information regarding revenue concentrations.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 16.2pt 0pt 0cm">&#160;</p></ix:continuation></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_53" id="_SignificantAccountingPoliciesTextBlock-c0_cont_52"><ix:nonNumeric contextRef="c6" continuedAt="_CostOfSalesPolicyTextBlock-c6_cont_1" escape="true" name="us-gaap:CostOfSalesPolicyTextBlock"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><b><span style="FONT-SIZE:10pt">SHIPPING AND HANDLING FEES</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p></ix:nonNumeric></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_54" id="_SignificantAccountingPoliciesTextBlock-c0_cont_53"><ix:continuation id="_CostOfSalesPolicyTextBlock-c6_cont_1"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt; COLOR:black">The Company includes shipping and handling fees billed to customers in net sales.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p></ix:continuation></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_55" id="_SignificantAccountingPoliciesTextBlock-c0_cont_54"><ix:nonNumeric contextRef="c6" continuedAt="_ResearchAndDevelopmentExpensePolicy-c6_cont_1" escape="true" name="us-gaap:ResearchAndDevelopmentExpensePolicy"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><b><span style="FONT-SIZE:10pt">RESEARCH AND DEVELOPMENT</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p></ix:nonNumeric></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_56" id="_SignificantAccountingPoliciesTextBlock-c0_cont_55"><ix:continuation id="_ResearchAndDevelopmentExpensePolicy-c6_cont_1"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt">Research and development costs are expensed as incurred. The Company expensed approximately $<ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherResearchAndDevelopmentExpense" scale="0" unitRef="usd">619,000</ix:nonFraction> and $<ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherResearchAndDevelopmentExpense" scale="0" unitRef="usd">617,000</ix:nonFraction> of research and development costs during the <span style="COLOR:black">three months ended November 30, 2021 and 2020 and approximately $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherResearchAndDevelopmentExpense" scale="0" unitRef="usd">1,058,000</ix:nonFraction> and $<ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherResearchAndDevelopmentExpense" scale="0" unitRef="usd">1,328,000</ix:nonFraction> during the six months ended November 30, 2021 and 2020, respectively.</span></span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p></ix:continuation></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_57" id="_SignificantAccountingPoliciesTextBlock-c0_cont_56"><ix:nonNumeric contextRef="c6" continuedAt="_IncomeTaxPolicyTextBlock-c6_cont_1" escape="true" name="us-gaap:IncomeTaxPolicyTextBlock"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><b><span style="FONT-SIZE:10pt">INCOME TAXES</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p></ix:nonNumeric></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_58" id="_SignificantAccountingPoliciesTextBlock-c0_cont_57"><ix:continuation id="_IncomeTaxPolicyTextBlock-c6_cont_1"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt; COLOR:black">The Company has provided a valuation allowance on deferred income tax assets of approximately $<ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="0" unitRef="usd">6,462,000</ix:nonFraction> and $<ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="0" unitRef="usd">5,904,000</ix:nonFraction> as of November 30, 2021 and May 31, 2021, respectively. &#160; </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p></ix:continuation></ix:continuation>  <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">9</span></p> <div style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><div style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;"> <hr/> <div style="PAGE-BREAK-BEFORE: always"></div> </div></div> <a id="_Hlk49511094-1"></a><a id="_Hlk49511094-2"></a><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; color: #0066cc;"><a href="#TOC">Table of Contents</a></span></p> <a id="_Hlk49511094-3"></a><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p> <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_59" id="_SignificantAccountingPoliciesTextBlock-c0_cont_58"><ix:nonNumeric contextRef="c6" continuedAt="_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock-c6_cont_1" escape="true" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><b><span style="FONT-SIZE:10pt">FOREIGN CURRENCY TRANSLATION</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p></ix:nonNumeric></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_60" id="_SignificantAccountingPoliciesTextBlock-c0_cont_59"><ix:continuation id="_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock-c6_cont_1"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt; COLOR:black">The subsidiary located in Mexico operates primarily using the Mexican peso. The subsidiary located in Germany operates primarily using the U.S. dollar, with an immaterial amount of transactions occurring using the Euro. Accordingly, assets and liabilities of these subsidiaries are translated using exchange rates in effect at the end of the period, and revenues and costs are translated using average exchange rates for the period. The resulting adjustments to assets and liabilities are presented as a separate component of accumulated other comprehensive loss. There are no adjustments to foreign currency loss that are included in the consolidated statements of operations for the three and six months ended November 30, 2021 and 2020.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p></ix:continuation></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_61" id="_SignificantAccountingPoliciesTextBlock-c0_cont_60"><ix:nonNumeric contextRef="c6" continuedAt="_LesseeLeasesPolicyTextBlock-c6_cont_1" escape="true" name="us-gaap:LesseeLeasesPolicyTextBlock"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><b><span style="FONT-SIZE:10pt; COLOR:black">RIGHT-OF-USE ASSETS AND LEASE LIABILITY</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p></ix:nonNumeric></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_62" id="_SignificantAccountingPoliciesTextBlock-c0_cont_61"><ix:continuation id="_LesseeLeasesPolicyTextBlock-c6_cont_1"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt">The Company follows the guidance of ASC 842, Leases, which requires lessees to recognize most leases on the balance sheet with a corresponding right-of-use asset. Right-of-use assets represent the Company&#8217;s right to use an underlying asset for the lease term and lease liabilities represent the obligation to make lease payments arising from the lease. The Company leases office space and copy machines, all of which are operating leases. The Company has elected to exclude short-term leases. Most leases include the option to renew and the exercise of the renewal options is at the Company&#8217;s sole discretion. Options to extend or terminate a lease are considered in the lease term to the extent that the option is reasonably certain of exercise.&#160; The leases do not include the options to purchase the leased property.&#160; The depreciable life of assets and leasehold improvements are limited by the expected lease term.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p></ix:continuation></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_63" id="_SignificantAccountingPoliciesTextBlock-c0_cont_62"><ix:nonNumeric contextRef="c6" continuedAt="_EarningsPerSharePolicyTextBlock-c6_cont_1" escape="true" name="us-gaap:EarningsPerSharePolicyTextBlock"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><b><span style="FONT-SIZE:10pt">NET LOSS PER SHARE</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 16.2pt 0pt 0cm">&#160;</p></ix:nonNumeric></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_64" id="_SignificantAccountingPoliciesTextBlock-c0_cont_63"><ix:continuation id="_EarningsPerSharePolicyTextBlock-c6_cont_1"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt">Basic loss per share is computed as net loss divided by the weighted average number of common shares outstanding for the period. Diluted loss per share reflects the potential dilution that could occur from common shares issuable through stock options, warrants and other convertible securities using the treasury stock method. The total amount of anti-dilutive stock options not included in the loss per share calculation at November 30, 2021 and 2020 was <ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" unitRef="shares">2,059,116</ix:nonFraction> and <ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" unitRef="shares">1,399,763</ix:nonFraction>, respectively. </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p></ix:continuation></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_65" id="_SignificantAccountingPoliciesTextBlock-c0_cont_64"><ix:nonNumeric contextRef="c6" continuedAt="_NewAccountingPronouncementsPolicyPolicyTextBlock-c6_cont_1" escape="true" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 2.7pt 0pt 0cm"><b><span style="FONT-SIZE:10pt">RECENT ACCOUNTING PRONOUNCEMENTS</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p></ix:nonNumeric></ix:continuation>  <ix:continuation id="_SignificantAccountingPoliciesTextBlock-c0_cont_65"><ix:continuation id="_NewAccountingPronouncementsPolicyPolicyTextBlock-c6_cont_1"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt; COLOR:black">Recent ASUs issued by the Financial Accounting Standards Board and guidance issued by the Securities and Exchange Commission (&#8220;SEC&#8221;) did not, or are not believed by management to, have a material effect on the Company&#8217;s present or future consolidated financial statements. </span></p></ix:continuation></ix:continuation> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 18.7pt">&#160;</p> <ix:nonNumeric contextRef="c0" continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_1" escape="true" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock"><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 2.7pt 0pt 0cm"><b><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">NOTE 3:&#160; SHAREHOLDERS&#8217; EQUITY</span></b></p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p></ix:nonNumeric>  <ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_2" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_1"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt">Stock option expense during the six months ended November 30, 2021 and 2020 was approximately $<ix:nonFraction contextRef="c51" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="0" unitRef="usd">634,000</ix:nonFraction> and $<ix:nonFraction contextRef="c54" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="0" unitRef="usd">500,000</ix:nonFraction> (as restated, see Note 8 to these Financial Statements), respectively.</span></p></ix:continuation> <a id="_Hlk49511094-4"></a><a id="_Hlk49188299"></a><ix:continuation id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_2"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0cm 0pt"><span style="FONT-SIZE:10pt">During the six months ended November 30, 2021, the Company sold <ix:nonFraction contextRef="c74" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" unitRef="shares">363,670</ix:nonFraction> shares of its common stock at prices ranging from $<ix:nonFraction contextRef="c75" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockPricePerShare" scale="0" unitRef="usdPershares">4.02</ix:nonFraction> to $<ix:nonFraction contextRef="c76" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockPricePerShare" scale="0" unitRef="usdPershares">5.63</ix:nonFraction> under its January 22, 2021 prospectus supplement and the ATM Agreement (see Note 2 to these Financial Statements) which resulted in gross proceeds of approximately $<ix:nonFraction contextRef="c74" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="0" unitRef="usd">1,751,000</ix:nonFraction> and net proceeds to the Company of approximately $<ix:nonFraction contextRef="c74" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="0" unitRef="usd">1,684,000</ix:nonFraction> after deducting commissions for each sale and legal, accounting and other fees related to the filing of the Form S-3.</span></p></ix:continuation> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 16.2pt 0pt 0cm">&#160;</p> <ix:nonNumeric contextRef="c0" continuedAt="_GeographicInformationDisclosureTextBlock-c0_cont_1" escape="true" name="bmra:GeographicInformationDisclosureTextBlock"><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 16.2pt 0pt 0cm"><b><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">NOTE 4: &#160;GEOGRAPHIC INFORMATION</span></b></p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 16.2pt 0pt 0cm">&#160;</p></ix:nonNumeric>  <ix:continuation continuedAt="_GeographicInformationDisclosureTextBlock-c0_cont_2" id="_GeographicInformationDisclosureTextBlock-c0_cont_1"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">The Company operates as <ix:nonFraction contextRef="c77" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:NumberOfReportableSegments" scale="0" unitRef="pure">one</ix:nonFraction> segment. Geographic information regarding net sales is approximately as follows: </span></p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p></ix:continuation>  <div style="text-align: left;"> <ix:continuation continuedAt="_GeographicInformationDisclosureTextBlock-c0_cont_3" id="_GeographicInformationDisclosureTextBlock-c0_cont_2"><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock"><table cellpadding="0" cellspacing="0" style="WIDTH:602.1pt; BORDER-COLLAPSE:collapse; margin-left: auto; margin-right: auto;" width="803"> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:294.95pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:13.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td colspan="5" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:140.35pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">Three Months Ended<br/></span><span style="FONT-SIZE:10pt">November 30,</span></p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td colspan="5" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:140.35pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">Six Months Ended<br/></span><span style="FONT-SIZE:10pt">November 30,</span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:294.95pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:13.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td colspan="2" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:63.55pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">2021</span></p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td colspan="2" style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:63.55pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">2020</span></p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td colspan="2" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:63.55pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">2021</span></p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td colspan="2" style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:63.55pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">2020</span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:294.95pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Revenues from sales to unaffiliated customers:</span></p></td> <td style="HEIGHT:15pt; WIDTH:13.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:50.3pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:50.3pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:50.3pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:50.3pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"></td> </tr><tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:294.95pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:10pt; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Asia</span></p></td> <td style="HEIGHT:15pt; WIDTH:13.2pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="HEIGHT:15pt; WIDTH:50.3pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c80" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="0" unitRef="usd">3,373,000</ix:nonFraction> </span></p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="HEIGHT:15pt; WIDTH:50.3pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c81" decimals="-4" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="0" unitRef="usd">550,000</ix:nonFraction> </span></p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="HEIGHT:15pt; WIDTH:50.3pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c82" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="0" unitRef="usd">4,048,000</ix:nonFraction> </span></p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="HEIGHT:15pt; WIDTH:50.3pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c83" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="0" unitRef="usd">897,000</ix:nonFraction> </span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:294.95pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:10pt; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Europe</span></p></td> <td style="HEIGHT:15pt; WIDTH:13.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:50.3pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c84" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="0" unitRef="usd">796,000</ix:nonFraction> </span></p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:50.3pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c85" decimals="-4" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="0" unitRef="usd">580,000</ix:nonFraction> </span></p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:50.3pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c86" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="0" unitRef="usd">1,267,000</ix:nonFraction> </span></p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:50.3pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c87" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="0" unitRef="usd">1,171,000</ix:nonFraction> </span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:294.95pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:10pt; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">North America</span></p></td> <td style="HEIGHT:15pt; WIDTH:13.2pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:50.3pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c88" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="0" unitRef="usd">429,000</ix:nonFraction> </span></p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:50.3pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c89" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="0" unitRef="usd">107,000</ix:nonFraction> </span></p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:50.3pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c90" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="0" unitRef="usd">534,000</ix:nonFraction> </span></p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:50.3pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c91" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="0" unitRef="usd">241,000</ix:nonFraction> </span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:294.95pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:10pt; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Middle East</span></p></td> <td style="HEIGHT:15pt; WIDTH:13.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:50.3pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c92" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="0" unitRef="usd">46,000</ix:nonFraction> </span></p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:50.3pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c93" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="0" unitRef="usd">96,000</ix:nonFraction> </span></p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:50.3pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c94" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="0" unitRef="usd">54,000</ix:nonFraction> </span></p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:50.3pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c95" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="0" unitRef="usd">125,000</ix:nonFraction> </span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:294.95pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:10pt; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">South America</span></p></td> <td style="HEIGHT:15pt; WIDTH:13.2pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:13.25pt; BACKGROUND:#bdd7ee; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:50.3pt; BACKGROUND:#bdd7ee; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c96" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="0" unitRef="usd">3,000</ix:nonFraction> </span></p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:13.25pt; BACKGROUND:#bdd7ee; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:50.3pt; BACKGROUND:#bdd7ee; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c97" decimals="-4" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="0" unitRef="usd">40,000</ix:nonFraction> </span></p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:13.25pt; BACKGROUND:#bdd7ee; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:50.3pt; BACKGROUND:#bdd7ee; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c98" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="0" unitRef="usd">6,000</ix:nonFraction> </span></p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:13.25pt; BACKGROUND:#bdd7ee; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:50.3pt; BACKGROUND:#bdd7ee; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c99" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="0" unitRef="usd">82,000</ix:nonFraction> </span></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:294.95pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15.75pt; WIDTH:13.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:13.25pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:50.3pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="0" unitRef="usd">4,647,000</ix:nonFraction> </span></p></td> <td style="HEIGHT:15.75pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:13.25pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:50.3pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="0" unitRef="usd">1,373,000</ix:nonFraction> </span></p></td> <td style="HEIGHT:15.75pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:13.25pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:50.3pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="0" unitRef="usd">5,909,000</ix:nonFraction> </span></p></td> <td style="HEIGHT:15.75pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:13.25pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:50.3pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="0" unitRef="usd">2,516,000</ix:nonFraction> </span></p></td></tr></table></ix:nonNumeric></ix:continuation></div> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p> <ix:continuation id="_GeographicInformationDisclosureTextBlock-c0_cont_3"><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">As of November 30, 2021 and May 31, 2021, approximately $<ix:nonFraction contextRef="c78" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InventoryGross" scale="0" unitRef="usd">574,000</ix:nonFraction> and $<ix:nonFraction contextRef="c79" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InventoryGross" scale="0" unitRef="usd">803,000</ix:nonFraction> of Biomerica&#8217;s gross inventory was located in Mexicali, Mexico, respectively. As of November 30, 2021 and May 31, 2021, approximately $<ix:nonFraction contextRef="c78" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="0" unitRef="usd">22,000</ix:nonFraction> and $<ix:nonFraction contextRef="c79" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="0" unitRef="usd">25,000</ix:nonFraction> of Biomerica&#8217;s property and equipment, net of accumulated depreciation and amortization, was located in Mexicali, Mexico, respectively.</span></p></ix:continuation> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">10</span></p> <div style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><div style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;"> <hr/> <div style="PAGE-BREAK-BEFORE: always"></div> </div></div> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; color: #0066cc;"><a href="#TOC">Table of Contents</a></span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p> <ix:nonNumeric contextRef="c0" continuedAt="_LesseeOperatingLeasesTextBlock-c0_cont_1" escape="true" name="us-gaap:LesseeOperatingLeasesTextBlock"><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 2.7pt 0pt 0cm"><b><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">NOTE 5:&#160; LEASES</span></b></p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p></ix:nonNumeric>  <ix:continuation continuedAt="_LesseeOperatingLeasesTextBlock-c0_cont_2" id="_LesseeOperatingLeasesTextBlock-c0_cont_1"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">On June 18, 2009, the Company entered into an agreement to lease a building in Irvine, California. The lease commenced <ix:nonNumeric contextRef="c100" format="ixt:date-monthname-day-year-en" name="bmra:OperatingLeaseInitiationDate">September 1, 2009</ix:nonNumeric> and ended <ix:nonNumeric contextRef="c100" format="ixt:date-monthname-day-year-en" name="us-gaap:LeaseExpirationDate1">August 31, 2016</ix:nonNumeric>. </span><span style="FONT-SIZE:10pt">&#160;On November 30, 2015, the Company entered into the First Amendment to Lease wherein it exercised its option to extend its lease until <ix:nonNumeric contextRef="c101" format="ixt:date-monthname-day-year-en" name="us-gaap:LeaseExpirationDate1">August 31, 2021</ix:nonNumeric>. The initial base rent for the lease extension was $<ix:nonFraction contextRef="c100" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PaymentsForRent" scale="0" unitRef="usd">21,000</ix:nonFraction> per month, increasing to $<ix:nonFraction contextRef="c102" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:LeaseAndRentalExpense" scale="0" unitRef="usd">23,637</ix:nonFraction> through August 31, 2021. On April 9, 2021, the Company exercised its second option to extend its lease for an additional five years through August 2026.&#160; The Company was also granted an additional five years lease extension option through August 2031. The rent is currently $<ix:nonFraction contextRef="c103" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseExpense" scale="0" unitRef="usd">25,970</ix:nonFraction> per month and will increase by <ix:nonFraction contextRef="c103" decimals="2" format="ixt:num-dot-decimal" name="bmra:RentPercentage" scale="-2" unitRef="pure">3</ix:nonFraction>% each year at the beginning of September. The security deposit of $<ix:nonFraction contextRef="c104" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SecurityDeposit" scale="0" unitRef="usd">22,080</ix:nonFraction> remains the same.<span style="COLOR:black">&#160;</span></span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p></ix:continuation>  <ix:continuation continuedAt="_LesseeOperatingLeasesTextBlock-c0_cont_3" id="_LesseeOperatingLeasesTextBlock-c0_cont_2"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt">In November 2016, the Company&#8217;s subsidiary, Biomerica de Mexico, entered into a ten-year lease for approximately 8,104 square feet at a monthly rent of $<ix:nonFraction contextRef="c105" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeasesRentExpenseMinimumRentals" scale="0" unitRef="usd">2,926</ix:nonFraction>. The Company has one 10-year option to renew at the end of the initial lease period. The yearly rate is subject to an annual adjustment for inflation according to the United States Bureau of Labor Statistics Consumer Price Index for All Urban Consumers. The monthly rate is currently $<ix:nonFraction contextRef="c106" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:LeaseAndRentalExpense" scale="0" unitRef="usd">3,262</ix:nonFraction>.&#160; Biomerica, Inc. is not a guarantor of such lease.&#160; Biomerica de Mexico also leases a smaller unit on a month-to-month basis for use in one manufacturing process.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p></ix:continuation>  <ix:continuation continuedAt="_LesseeOperatingLeasesTextBlock-c0_cont_4" id="_LesseeOperatingLeasesTextBlock-c0_cont_3"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt">In addition, the Company leases a small office in Lindau, Germany on a month-to-month basis, as headquarters for BioEurope GmbH, its Germany subsidiary.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p></ix:continuation>  <ix:continuation continuedAt="_LesseeOperatingLeasesTextBlock-c0_cont_5" id="_LesseeOperatingLeasesTextBlock-c0_cont_4"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Rent expense in the U.S. for the six months ended November 30, 2021 and 2020 was approximately $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PaymentsForRent" scale="0" unitRef="usd">155,000</ix:nonFraction> and $<ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PaymentsForRent" scale="0" unitRef="usd">152,000</ix:nonFraction>, respectively.&#160; Rent expense for the Mexico facility for the six months ended November 30, 2021 and 2020 was approximately $<ix:nonFraction contextRef="c77" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PaymentsForRent" scale="0" unitRef="usd">21,000</ix:nonFraction> and $<ix:nonFraction contextRef="c107" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PaymentsForRent" scale="0" unitRef="usd">22,000</ix:nonFraction>, respectively. </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p></ix:continuation>  <ix:continuation continuedAt="_LesseeOperatingLeasesTextBlock-c0_cont_6" id="_LesseeOperatingLeasesTextBlock-c0_cont_5"><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">For purposes of determining straight-line rent expense, the lease term is calculated from the date the Company first takes possession of the facility, including any periods of free rent and any renewal option periods that the Company is reasonably certain of exercising. The Company&#8217;s office and equipment leases generally have contractually specified minimum rent and annual rent increases are included in the measurement of the right-of-use asset and related lease liability.&#160; Additionally, under these lease arrangements, the Company may be required to pay directly, or reimburse the lessors, for some maintenance and operating costs. Such amounts are generally variable and therefore not included in the measurement of the right-of-use asset and related lease liability but are instead recognized as variable lease expense in the Consolidated Statements of Operations and Comprehensive Loss when they are incurred.</span></p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p></ix:continuation>  <ix:continuation continuedAt="_LesseeOperatingLeasesTextBlock-c0_cont_7" id="_LesseeOperatingLeasesTextBlock-c0_cont_6"><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 16.2pt 0pt 0cm"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;"> Supplemental cash flow information related to leases for the six months ended November 30, 2021: </span></p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 16.2pt 0pt 0cm">&#160;</p></ix:continuation>  <div style="text-align: left;"> <ix:continuation continuedAt="_LesseeOperatingLeasesTextBlock-c0_cont_8" id="_LesseeOperatingLeasesTextBlock-c0_cont_7"><ix:nonNumeric contextRef="c0" escape="true" name="bmra:ScheduleOfCashFlowSupplementalDisclosuresRelatedToLeaseTableTextBlock"><table cellpadding="0" cellspacing="0" style="width: 550.1pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" width="733">

<tr style="height: 15pt;">
<td style="height: 15pt; width: 462.1pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Operating cash flows from operating leases&#160;&#160;&#160;&#160;&#160; </span></p>
</td>
<td style="height: 15pt; width: 11pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 11pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15pt; width: 66pt; background: #b8cce4; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeasePayments" scale="0" unitRef="usd">166,216</ix:nonFraction></span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 462.1pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Right-of-use assets obtained in exchange for</span></p>
</td>
<td style="height: 15pt; width: 11pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 11pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 66pt; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 462.1pt; white-space: nowrap; padding: 0cm 0cm 0cm 10.8pt;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">new operating lease liabilities</span></p>
</td>
<td style="height: 15pt; width: 11pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 11pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15pt; width: 66pt; text-align: right; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom"><div style="-sec-ix-hidden: hidden-fact-11">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">-</span></p>
</div></td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 462.1pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Weighted average remaining lease term (in years)</span></p>
</td>
<td style="height: 15pt; width: 11pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 11pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 66pt; background: #b8cce4; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><ix:nonNumeric contextRef="c2" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1"><span style="font-size: 10pt; color: black;">4.77</span></ix:nonNumeric></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 462.1pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Weighted average discount rate</span></p>
</td>
<td style="height: 15pt; width: 11pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 11pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 66pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c2" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" unitRef="pure">6.50</ix:nonFraction>%</span></p>
</td>
</tr>

</table></ix:nonNumeric></ix:continuation></div> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 16.2pt 0pt 0cm">&#160;</p> <ix:continuation continuedAt="_LesseeOperatingLeasesTextBlock-c0_cont_9" id="_LesseeOperatingLeasesTextBlock-c0_cont_8"><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 16.2pt 0pt 0cm"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">The approximate maturity of lease liabilities as of November 30, 2021 are as follows:</span></p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 16.2pt 0pt 0cm">&#160;</p></ix:continuation>  <div style="text-align: left;"> <ix:continuation continuedAt="_LesseeOperatingLeasesTextBlock-c0_cont_10" id="_LesseeOperatingLeasesTextBlock-c0_cont_9"><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock"><table cellpadding="0" cellspacing="0" style="WIDTH:554.4pt; BORDER-COLLAPSE:collapse; margin-left: auto; margin-right: auto;" width="739"> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:463.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Less than 1 year</span></p></td> <td style="HEIGHT:15pt; WIDTH:12.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:12.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="HEIGHT:15pt; WIDTH:66.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" scale="0" unitRef="usd">345,000</ix:nonFraction> </span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:463.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">1 to 2 years</span></p></td> <td style="HEIGHT:15pt; WIDTH:12.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:12.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:66.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="0" unitRef="usd">355,000</ix:nonFraction> </span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:463.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">2 to 3 years</span></p></td> <td style="HEIGHT:15pt; WIDTH:12.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:12.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:66.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="0" unitRef="usd">366,000</ix:nonFraction> </span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:463.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">3 to 4 years</span></p></td> <td style="HEIGHT:15pt; WIDTH:12.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:12.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:66.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" scale="0" unitRef="usd">377,000</ix:nonFraction> </span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:463.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">4 to 5 years</span></p></td> <td style="HEIGHT:15pt; WIDTH:12.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12.2pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:66.8pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" scale="0" unitRef="usd">298,000</ix:nonFraction> </span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:463.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Total undiscounted lease payments</span></p></td> <td style="HEIGHT:15pt; WIDTH:12.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12.2pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:66.8pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" scale="0" unitRef="usd">1,741,000</ix:nonFraction> </span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:463.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Less imputed interest</span></p></td> <td style="HEIGHT:15pt; WIDTH:12.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12.2pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:66.8pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="0" unitRef="usd">239,000</ix:nonFraction> </span></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:463.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Total operating lease liabilities</span></p></td> <td style="HEIGHT:15.75pt; WIDTH:12.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12.2pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:66.8pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiability" scale="0" unitRef="usd">1,502,000</ix:nonFraction> </span></p></td></tr></table></ix:nonNumeric></ix:continuation></div> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 16.2pt 0pt 0cm">&#160;</p> <ix:continuation continuedAt="_LesseeOperatingLeasesTextBlock-c0_cont_11" id="_LesseeOperatingLeasesTextBlock-c0_cont_10"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">According to the terms of the lease in Irvine, the Company is also responsible for routine repairs of the building and for certain increases in property tax. </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p></ix:continuation>  <ix:continuation id="_LesseeOperatingLeasesTextBlock-c0_cont_11"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">The Company also has various insignificant leases for office equipment.</span></p></ix:continuation> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">11</span></p> <div style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><div style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;"> <hr/> <div style="PAGE-BREAK-BEFORE: always"></div> </div></div> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; color: #0066cc;"><a href="#TOC">Table of Contents</a></span></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p> <ix:nonNumeric contextRef="c0" continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_1" escape="true" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock"><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 16.2pt 0pt 0cm"><b><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">NOTE 6: &#160;COMMITMENTS AND CONTINGENCIES</span></b></p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 16.2pt 0pt 0cm">&#160;</p></ix:nonNumeric>  <ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_2" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_1"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><b><span style="FONT-SIZE:10pt; COLOR:black">LITIGATION</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p></ix:continuation>  <ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_3" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_2"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">The Company is, from time to time, involved in legal proceedings, claims and litigation arising in the ordinary course of business. While the amounts claimed may be substantial, the ultimate liability cannot presently be determined because of considerable uncertainties that exist. Therefore, it is possible the outcome of such legal proceedings, claims and litigation could have a material effect on quarterly or annual operating results or cash flows when resolved in a future period. However, based on facts currently available, management believes such matters will not have a material adverse effect on the Company's consolidated financial position, results of operations or cash flows. There were no legal proceedings pending as of November 30, 2021.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p></ix:continuation>  <ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_4" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_3"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt">On July 2, 2020, we received a notice of investigation and subpoena from the Division of Enforcement of the SEC. The subpoena requested information and documents related to events leading up to our March 17, 2020 announcement that, among other things, we had commenced shipping samples of our COVID-19 IgG/IgM Rapid Test to countries outside of the United States. In addition, on December 15, 2020, the SEC sent a second subpoena related to this same investigation to Zack Irani, the Company&#8217;s CEO, requesting personal and Company documents and information held by Mr. Irani. The Company and Mr. Irani cooperated fully with the SEC&#8217;s investigation and provided information as requested.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p></ix:continuation>  <ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_5" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_4"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt">On December 2, 2021, the Company was notified by the SEC that they had concluded their investigations with no enforcement action recommendations. The notices of investigation conclusion pertain to the Subpoena for information sent to the Company in July 2020, as well as the Subpoena for information sent to the Company&#8217;s CEO in December 2020. </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p></ix:continuation>  <ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_6" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_5"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 16.2pt 0pt 0cm"><b><span style="FONT-SIZE:10pt">CONTRACTS AND LICENSING AGREEMENTS </span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 16.2pt 0pt 0cm">&#160;</p></ix:continuation>  <ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_7" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_6"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt">On April 15, 2021, the Company signed a general merchandise agreement with Walmart for the Company&#8217;s EZ Detect product. </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p></ix:continuation>  <ix:continuation id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_7"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt">On June 21, 2021, the Company signed an exclusive distribution and marketing agreement in Canada for its Helicobacter Pylori (H. Pylori) test.</span></p></ix:continuation> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 16.2pt 0pt 0cm">&#160;</p> <a id="Form_8_K"></a><ix:nonNumeric contextRef="c0" continuedAt="_SubsequentEventsTextBlock-c0_cont_1" escape="true" name="us-gaap:SubsequentEventsTextBlock"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><b><span style="FONT-SIZE:10pt">NOTE 7:&#160; SUBSEQUENT EVENTS</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p></ix:nonNumeric>  <ix:continuation continuedAt="_SubsequentEventsTextBlock-c0_cont_2" id="_SubsequentEventsTextBlock-c0_cont_1"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt">Subsequent to November 30, 2021, the Company sold <ix:nonFraction contextRef="c108" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" unitRef="shares">157,597</ix:nonFraction> shares of its common stock under its S-3 &#8220;shelf&#8221; Registration statement.&#160; The average sale price was $<ix:nonFraction contextRef="c109" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SharePrice" scale="0" unitRef="usdPershares">4.13</ix:nonFraction> per share. Net proceeds to the Company were approximately $<ix:nonFraction contextRef="c108" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="0" unitRef="usd">634,000</ix:nonFraction>.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p></ix:continuation>  <ix:continuation continuedAt="_SubsequentEventsTextBlock-c0_cont_3" id="_SubsequentEventsTextBlock-c0_cont_2"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt">At the December 9, 2021 board meeting, the Board of Directors approved the grant of <ix:nonFraction contextRef="c110" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" unitRef="shares">283,000</ix:nonFraction> options to purchase shares of the Company&#8217;s common stock to officers, directors and certain employees.&#160; The options are exercisable by outside board members one year from date of grant and for officers and employees one-quarter per year with the first quarter vesting one year from date of grant. The options will be at the exercise price of $<ix:nonFraction contextRef="c110" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" unitRef="usdPershares">4.46</ix:nonFraction> per share and expire <ix:nonNumeric contextRef="c110" format="ixt-sec:durwordsen" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">ten years</ix:nonNumeric> from date of grant.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p></ix:continuation>  <ix:continuation id="_SubsequentEventsTextBlock-c0_cont_3"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt">We held our Annual Meeting of Stockholders on December 9, 2021, to consider and vote on the proposals set forth in our proxy statement filed with the Securities and Exchange Commission on September 28, 2021. Please refer to the Form 8-K filed on December 10, 2021 for a description of the results of the meeting.</span></p></ix:continuation> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p> <ix:nonNumeric contextRef="c0" continuedAt="_ErrorCorrectionTextBlock-c0_cont_1" escape="true" name="us-gaap:ErrorCorrectionTextBlock"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><b><span style="FONT-SIZE:10pt">NOTE 8:&#160; <span style="COLOR:black">RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS</span></span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p></ix:nonNumeric>  <ix:continuation continuedAt="_ErrorCorrectionTextBlock-c0_cont_2" id="_ErrorCorrectionTextBlock-c0_cont_1"><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0cm 16.2pt 0pt 0cm;"><span style="font-size: 10pt; color: black;">During September 2021, the Company determined that errors were included in the previously issued financial statements as described below. As a result, we restated our financial statements for the periods ended November 30, 2020.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 16.2pt 0pt 0cm">&#160;</p></ix:continuation>  <ix:continuation continuedAt="_ErrorCorrectionTextBlock-c0_cont_3" id="_ErrorCorrectionTextBlock-c0_cont_2"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 16.2pt 0pt 0cm"><span style="FONT-SIZE:10pt; COLOR:black">The Company discovered the errors listed below. The restatement corrects these errors.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 16.2pt 0pt 0cm">&#160;</p></ix:continuation>  <ix:continuation continuedAt="_ErrorCorrectionTextBlock-c0_cont_4" id="_ErrorCorrectionTextBlock-c0_cont_3"><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; BACKGROUND:white; COLOR:black">Our non-cash stock-based compensation expenses calculation applied forfeiture adjustments to both vested and unvested outstanding options, including those for which the employee had provided the requisite service and vesting had occurred, which resulted in an understatement of stock compensation expense. Additionally, our calculation expensed all issued options at vesting dates versus pro- rata over the period the requisite service was provided. </span></p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p></ix:continuation>  <ix:continuation continuedAt="_ErrorCorrectionTextBlock-c0_cont_5" id="_ErrorCorrectionTextBlock-c0_cont_4"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt">Stock-based compensation expense shown on the statement of operations is a non-cash expense, and impacts accumulated deficit and additional paid-in capital on the balance sheet. However, this does not impact the Company&#8217;s cash, revenues or other aspects of ongoing operations.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 16.2pt 0pt 0cm">&#160;</p></ix:continuation>  <ix:continuation continuedAt="_ErrorCorrectionTextBlock-c0_cont_6" id="_ErrorCorrectionTextBlock-c0_cont_5"><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0cm 16.2pt 0pt 0cm;"><span style="font-size: 10pt;">The<span style="color: black;"> restatement for the quarter ended November 30, 2020 resulted in no changes in the provision for income taxes. </span></span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 16.2pt 0pt 0cm">&#160;</p></ix:continuation>  <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">12</span></p> <div style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><div style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;"> <hr/> <div style="PAGE-BREAK-BEFORE: always"></div> </div></div> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; color: #0066cc;"><a href="#TOC">Table of Contents</a></span></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 16.2pt 0pt 0cm">&#160;</p> <ix:continuation continuedAt="_ErrorCorrectionTextBlock-c0_cont_7" id="_ErrorCorrectionTextBlock-c0_cont_6"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 16.2pt 0pt 0cm"><span style="FONT-SIZE:10pt; BACKGROUND:white; COLOR:black">The effect of the restatement on the consolidated statement of operations for the three months ended November 30, 2020 is as follows:</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 16.2pt 0pt 0cm">&#160;</p></ix:continuation>  <div style="text-align: left;"> <ix:continuation continuedAt="_ErrorCorrectionTextBlock-c0_cont_8" id="_ErrorCorrectionTextBlock-c0_cont_7"><table cellpadding="0" cellspacing="0" style="WIDTH:575.6pt; BORDER-COLLAPSE:collapse; margin-left: auto; margin-right: auto;" width="767"> <tr> <td style="WIDTH:363.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td colspan="2" style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:68.2pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">As Previously Reported</span></p></td> <td style="WIDTH:9.15pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td colspan="2" style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:64.05pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">Adjustments</span></p></td> <td style="WIDTH:8.45pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td colspan="2" style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:62.55pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">As Restated</span></p></td></tr> <tr style="HEIGHT:12.15pt"> <td style="HEIGHT:12.15pt; WIDTH:363.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"><span style="FONT-SIZE:10pt; COLOR:black">Cost of sales </span></p></td> <td style="HEIGHT:12.15pt; WIDTH:11.9pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="HEIGHT:12.15pt; WIDTH:56.3pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c111" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="0" unitRef="usd">1,011,030</ix:nonFraction> </span></p></td> <td style="HEIGHT:12.15pt; WIDTH:9.15pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:12.15pt; WIDTH:11.5pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="HEIGHT:12.15pt; WIDTH:52.55pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c112" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="0" unitRef="usd">52,777</ix:nonFraction> </span></p></td> <td style="HEIGHT:12.15pt; WIDTH:8.45pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:12.15pt; WIDTH:9.9pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="HEIGHT:12.15pt; WIDTH:52.65pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c113" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="0" unitRef="usd">1,063,807</ix:nonFraction> </span></p></td></tr> <tr style="HEIGHT:14.75pt"> <td style="HEIGHT:14.75pt; WIDTH:363.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:10.8pt; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"><span style="FONT-SIZE:10pt; COLOR:black">Gross Profit </span></p></td> <td style="HEIGHT:14.75pt; WIDTH:11.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:14.75pt; WIDTH:56.3pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c111" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:GrossProfit" scale="0" unitRef="usd">361,496</ix:nonFraction> </span></p></td> <td style="HEIGHT:14.75pt; WIDTH:9.15pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:14.75pt; WIDTH:11.5pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:14.75pt; WIDTH:52.55pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(<ix:nonFraction contextRef="c112" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:GrossProfit" scale="0" sign="-" unitRef="usd">52,777</ix:nonFraction>)</span></p></td> <td style="HEIGHT:14.75pt; WIDTH:8.45pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:14.75pt; WIDTH:9.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:14.75pt; WIDTH:52.65pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c113" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:GrossProfit" scale="0" unitRef="usd">308,719</ix:nonFraction> </span></p></td></tr> <tr style="HEIGHT:13.55pt"> <td style="HEIGHT:13.55pt; WIDTH:363.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:13.55pt; WIDTH:11.9pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:13.55pt; WIDTH:56.3pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:13.55pt; WIDTH:9.15pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:13.55pt; WIDTH:11.5pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:13.55pt; WIDTH:52.55pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:13.55pt; WIDTH:8.45pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:13.55pt; WIDTH:9.9pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:13.55pt; WIDTH:52.65pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"></td> </tr><tr style="HEIGHT:14.45pt"> <td style="HEIGHT:14.45pt; WIDTH:363.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"><span style="FONT-SIZE:10pt; COLOR:black">Operating Expenses: </span></p></td> <td style="HEIGHT:14.45pt; WIDTH:11.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:14.45pt; WIDTH:56.3pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:14.45pt; WIDTH:9.15pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:14.45pt; WIDTH:11.5pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:14.45pt; WIDTH:52.55pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:14.45pt; WIDTH:8.45pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:14.45pt; WIDTH:9.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:14.45pt; WIDTH:52.65pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"></td> </tr><tr style="HEIGHT:14.65pt"> <td style="HEIGHT:14.65pt; WIDTH:363.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:10.8pt; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"><span style="FONT-SIZE:10pt; COLOR:black">Selling, general and administrative </span></p></td> <td style="HEIGHT:14.65pt; WIDTH:11.9pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:14.65pt; WIDTH:56.3pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c111" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="0" unitRef="usd">1,254,847</ix:nonFraction> </span></p></td> <td style="HEIGHT:14.65pt; WIDTH:9.15pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:14.65pt; WIDTH:11.5pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:14.65pt; WIDTH:52.55pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c112" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="0" unitRef="usd">149,999</ix:nonFraction> </span></p></td> <td style="HEIGHT:14.65pt; WIDTH:8.45pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:14.65pt; WIDTH:9.9pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:14.65pt; WIDTH:52.65pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c113" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="0" unitRef="usd">1,404,846</ix:nonFraction> </span></p></td></tr> <tr style="HEIGHT:13.5pt"> <td style="HEIGHT:13.5pt; WIDTH:363.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:10.8pt; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"><span style="FONT-SIZE:10pt; COLOR:black">Research and development </span></p></td> <td style="BORDER-TOP:0px; HEIGHT:13.5pt; BORDER-RIGHT:0px; WIDTH:11.9pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:13.5pt; BORDER-RIGHT:0px; WIDTH:56.3pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c111" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="0" unitRef="usd">586,403</ix:nonFraction> </span></p></td> <td style="HEIGHT:13.5pt; WIDTH:9.15pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:13.5pt; BORDER-RIGHT:0px; WIDTH:11.5pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:13.5pt; BORDER-RIGHT:0px; WIDTH:52.55pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c112" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="0" unitRef="usd">30,158</ix:nonFraction> </span></p></td> <td style="HEIGHT:13.5pt; WIDTH:8.45pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:13.5pt; BORDER-RIGHT:0px; WIDTH:9.9pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:13.5pt; BORDER-RIGHT:0px; WIDTH:52.65pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c113" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="0" unitRef="usd">616,561</ix:nonFraction> </span></p></td></tr> <tr style="HEIGHT:13.35pt"> <td style="HEIGHT:13.35pt; WIDTH:363.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:21.6pt; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"><span style="FONT-SIZE:10pt; COLOR:black">Total operating expense </span></p></td> <td style="BORDER-TOP:0px; HEIGHT:13.35pt; BORDER-RIGHT:0px; WIDTH:11.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:13.35pt; BORDER-RIGHT:0px; WIDTH:56.3pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c111" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:OperatingExpenses" scale="0" unitRef="usd">1,841,250</ix:nonFraction> </span></p></td> <td style="HEIGHT:13.35pt; WIDTH:9.15pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:13.35pt; BORDER-RIGHT:0px; WIDTH:11.5pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:13.35pt; BORDER-RIGHT:0px; WIDTH:52.55pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c112" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:OperatingExpenses" scale="0" unitRef="usd">180,157</ix:nonFraction> </span></p></td> <td style="HEIGHT:13.35pt; WIDTH:8.45pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:13.35pt; BORDER-RIGHT:0px; WIDTH:9.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:13.35pt; BORDER-RIGHT:0px; WIDTH:52.65pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c113" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:OperatingExpenses" scale="0" unitRef="usd">2,021,407</ix:nonFraction> </span></p></td></tr> <tr style="HEIGHT:11.25pt"> <td style="HEIGHT:11.25pt; WIDTH:363.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:11.25pt; WIDTH:11.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:11.25pt; WIDTH:56.3pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:11.25pt; WIDTH:9.15pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:11.25pt; WIDTH:11.5pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:11.25pt; WIDTH:52.55pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:11.25pt; WIDTH:8.45pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:11.25pt; WIDTH:9.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:11.25pt; WIDTH:52.65pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"></td> </tr><tr style="HEIGHT:11.25pt"> <td style="HEIGHT:11.25pt; WIDTH:363.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"><span style="FONT-SIZE:10pt; COLOR:black">Loss from operations</span></p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:11.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:56.3pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(<ix:nonFraction contextRef="c111" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="0" sign="-" unitRef="usd">1,479,754</ix:nonFraction>)</span></p></td> <td style="HEIGHT:11.25pt; WIDTH:9.15pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:11.5pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:52.55pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(<ix:nonFraction contextRef="c112" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="0" sign="-" unitRef="usd">232,934</ix:nonFraction>)</span></p></td> <td style="HEIGHT:11.25pt; WIDTH:8.45pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:9.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:52.65pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(<ix:nonFraction contextRef="c113" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="0" sign="-" unitRef="usd">1,712,688</ix:nonFraction>)</span></p></td></tr> <tr style="HEIGHT:13.5pt"> <td style="HEIGHT:13.5pt; WIDTH:363.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:13.5pt; BORDER-RIGHT:0px; WIDTH:11.9pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:13.5pt; BORDER-RIGHT:0px; WIDTH:56.3pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:13.5pt; WIDTH:9.15pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:13.5pt; BORDER-RIGHT:0px; WIDTH:11.5pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:13.5pt; BORDER-RIGHT:0px; WIDTH:52.55pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:13.5pt; WIDTH:8.45pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:13.5pt; BORDER-RIGHT:0px; WIDTH:9.9pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:13.5pt; BORDER-RIGHT:0px; WIDTH:52.65pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"></td> </tr><tr style="HEIGHT:11.25pt"> <td style="HEIGHT:11.25pt; WIDTH:363.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"><span style="FONT-SIZE:10pt">Loss before income taxes</span></p></td> <td style="HEIGHT:11.25pt; WIDTH:11.9pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:11.25pt; WIDTH:56.3pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(<ix:nonFraction contextRef="c111" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="0" sign="-" unitRef="usd">1,471,771</ix:nonFraction>)</span></p></td> <td style="HEIGHT:11.25pt; WIDTH:9.15pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:11.25pt; WIDTH:11.5pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:11.25pt; WIDTH:52.55pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(<ix:nonFraction contextRef="c112" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="0" sign="-" unitRef="usd">232,934</ix:nonFraction>)</span></p></td> <td style="HEIGHT:11.25pt; WIDTH:8.45pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:11.25pt; WIDTH:9.9pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:11.25pt; WIDTH:52.65pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(<ix:nonFraction contextRef="c113" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="0" sign="-" unitRef="usd">1,704,705</ix:nonFraction>)</span></p></td></tr> <tr style="HEIGHT:13.5pt"> <td style="HEIGHT:13.5pt; WIDTH:363.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:13.5pt; WIDTH:11.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:13.5pt; WIDTH:56.3pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:13.5pt; WIDTH:9.15pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:13.5pt; WIDTH:11.5pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:13.5pt; WIDTH:52.55pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:13.5pt; WIDTH:8.45pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:13.5pt; WIDTH:9.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:13.5pt; WIDTH:52.65pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"></td> </tr><tr style="HEIGHT:11.25pt"> <td style="HEIGHT:11.25pt; WIDTH:363.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"><span style="FONT-SIZE:10pt; COLOR:black">Net loss </span></p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:11.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1.5pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"><span style="FONT-SIZE:10pt; COLOR:black">$ </span></p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:56.3pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1.5pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(<ix:nonFraction contextRef="c111" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" sign="-" unitRef="usd">1,485,164</ix:nonFraction>)</span></p></td> <td style="HEIGHT:11.25pt; WIDTH:9.15pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:11.5pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1.5pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:52.55pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1.5pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(<ix:nonFraction contextRef="c112" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" sign="-" unitRef="usd">232,934</ix:nonFraction>)</span></p></td> <td style="HEIGHT:11.25pt; WIDTH:8.45pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:9.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1.5pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"><span style="FONT-SIZE:10pt; COLOR:black">$ </span></p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:52.65pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1.5pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(<ix:nonFraction contextRef="c113" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" sign="-" unitRef="usd">1,718,098</ix:nonFraction>)</span></p></td></tr> <tr style="HEIGHT:12pt"> <td style="HEIGHT:12pt; WIDTH:363.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:12pt; BORDER-RIGHT:0px; WIDTH:11.9pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:12pt; BORDER-RIGHT:0px; WIDTH:56.3pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:12pt; WIDTH:9.15pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:12pt; BORDER-RIGHT:0px; WIDTH:11.5pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:12pt; BORDER-RIGHT:0px; WIDTH:52.55pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:12pt; WIDTH:8.45pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:12pt; BORDER-RIGHT:0px; WIDTH:9.9pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:12pt; BORDER-RIGHT:0px; WIDTH:52.65pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"></td> </tr><tr style="HEIGHT:12pt"> <td style="HEIGHT:12pt; WIDTH:363.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Basic net loss per common share </span></p></td> <td style="BORDER-TOP:0px; HEIGHT:12pt; BORDER-RIGHT:0px; WIDTH:11.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$ </span></p></td> <td style="BORDER-TOP:0px; HEIGHT:12pt; BORDER-RIGHT:0px; WIDTH:56.3pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(<ix:nonFraction contextRef="c111" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares">0.13</ix:nonFraction>)</span></p></td> <td style="HEIGHT:12pt; WIDTH:9.15pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:12pt; BORDER-RIGHT:0px; WIDTH:11.5pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$ </span></p></td> <td style="BORDER-TOP:0px; HEIGHT:12pt; BORDER-RIGHT:0px; WIDTH:52.55pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(<ix:nonFraction contextRef="c112" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares">0.02</ix:nonFraction>)</span></p></td> <td style="HEIGHT:12pt; WIDTH:8.45pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:12pt; BORDER-RIGHT:0px; WIDTH:9.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$ </span></p></td> <td style="BORDER-TOP:0px; HEIGHT:12pt; BORDER-RIGHT:0px; WIDTH:52.65pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(<ix:nonFraction contextRef="c113" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares">0.15</ix:nonFraction>)</span></p></td></tr> <tr style="HEIGHT:11.25pt"> <td style="HEIGHT:11.25pt; WIDTH:363.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:11.25pt; WIDTH:11.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:11.25pt; WIDTH:56.3pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:11.25pt; WIDTH:9.15pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:11.25pt; WIDTH:11.5pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:11.25pt; WIDTH:52.55pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:11.25pt; WIDTH:8.45pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:11.25pt; WIDTH:9.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:11.25pt; WIDTH:52.65pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"></td> </tr><tr style="HEIGHT:11.25pt"> <td style="HEIGHT:11.25pt; WIDTH:363.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"><span style="FONT-SIZE:10pt; COLOR:black">Diluted net loss per common share </span></p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:11.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"><span style="FONT-SIZE:10pt; COLOR:black">$ </span></p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:56.3pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(<ix:nonFraction contextRef="c111" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareDiluted" scale="0" sign="-" unitRef="usdPershares">0.13</ix:nonFraction>)</span></p></td> <td style="HEIGHT:11.25pt; WIDTH:9.15pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:11.5pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"><span style="FONT-SIZE:10pt; COLOR:black">$ </span></p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:52.55pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(<ix:nonFraction contextRef="c112" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareDiluted" scale="0" sign="-" unitRef="usdPershares">0.02</ix:nonFraction>)</span></p></td> <td style="HEIGHT:11.25pt; WIDTH:8.45pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:9.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"><span style="FONT-SIZE:10pt; COLOR:black">$ </span></p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:52.65pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(<ix:nonFraction contextRef="c113" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareDiluted" scale="0" sign="-" unitRef="usdPershares">0.15</ix:nonFraction>)</span></p></td></tr></table></ix:continuation></div> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 16.2pt 0pt 0cm">&#160;</p> <ix:continuation continuedAt="_ErrorCorrectionTextBlock-c0_cont_9" id="_ErrorCorrectionTextBlock-c0_cont_8"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 16.2pt 0pt 0cm"><span style="FONT-SIZE:10pt; BACKGROUND:white; COLOR:black">The effect of the restatement on the consolidated statement of operations for the six months ended November 30, 2020 is as follows:</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></ix:continuation>  <div style="text-align: left;"> <ix:continuation continuedAt="_ErrorCorrectionTextBlock-c0_cont_10" id="_ErrorCorrectionTextBlock-c0_cont_9"><table cellpadding="0" cellspacing="0" style="WIDTH:579.3pt; BORDER-COLLAPSE:collapse; margin-left: auto; margin-right: auto;" width="772"> <tr> <td style="WIDTH:363.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td colspan="2" style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:71.9pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">As Previously Reported</span></p></td> <td style="WIDTH:9.15pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td colspan="2" style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:64.05pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">Adjustments</span></p></td> <td style="WIDTH:8.45pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td colspan="2" style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:62.55pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">As Restated</span></p></td></tr> <tr style="HEIGHT:14.75pt"> <td style="HEIGHT:14.75pt; WIDTH:363.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"><span style="FONT-SIZE:10pt; COLOR:black">Cost of sales </span></p></td> <td style="HEIGHT:14.75pt; WIDTH:11.9pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="HEIGHT:14.75pt; WIDTH:60pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c114" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="0" unitRef="usd">1,971,960</ix:nonFraction> </span></p></td> <td style="HEIGHT:14.75pt; WIDTH:9.15pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:14.75pt; WIDTH:11.5pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="HEIGHT:14.75pt; WIDTH:52.55pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c115" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="0" unitRef="usd">117,564</ix:nonFraction> </span></p></td> <td style="HEIGHT:14.75pt; WIDTH:8.45pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:14.75pt; WIDTH:9.9pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="HEIGHT:14.75pt; WIDTH:52.65pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c116" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="0" unitRef="usd">2,089,524</ix:nonFraction> </span></p></td></tr> <tr style="HEIGHT:14.55pt"> <td style="HEIGHT:14.55pt; WIDTH:363.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:10.8pt; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"><span style="FONT-SIZE:10pt; COLOR:black">Gross Profit </span></p></td> <td style="HEIGHT:14.55pt; WIDTH:11.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:14.55pt; WIDTH:60pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c114" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:GrossProfit" scale="0" unitRef="usd">544,372</ix:nonFraction> </span></p></td> <td style="HEIGHT:14.55pt; WIDTH:9.15pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:14.55pt; WIDTH:11.5pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:14.55pt; WIDTH:52.55pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(<ix:nonFraction contextRef="c115" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:GrossProfit" scale="0" sign="-" unitRef="usd">117,564</ix:nonFraction>)</span></p></td> <td style="HEIGHT:14.55pt; WIDTH:8.45pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:14.55pt; WIDTH:9.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:14.55pt; WIDTH:52.65pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c116" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:GrossProfit" scale="0" unitRef="usd">426,808</ix:nonFraction> </span></p></td></tr> <tr style="HEIGHT:14.05pt"> <td style="HEIGHT:14.05pt; WIDTH:363.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:14.05pt; WIDTH:11.9pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:14.05pt; WIDTH:60pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:14.05pt; WIDTH:9.15pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:14.05pt; WIDTH:11.5pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:14.05pt; WIDTH:52.55pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:14.05pt; WIDTH:8.45pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:14.05pt; WIDTH:9.9pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:14.05pt; WIDTH:52.65pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"></td> </tr><tr style="HEIGHT:17pt"> <td style="HEIGHT:17pt; WIDTH:363.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"><span style="FONT-SIZE:10pt; COLOR:black">Operating Expenses: </span></p></td> <td style="HEIGHT:17pt; WIDTH:11.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:17pt; WIDTH:60pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:17pt; WIDTH:9.15pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:17pt; WIDTH:11.5pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:17pt; WIDTH:52.55pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:17pt; WIDTH:8.45pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:17pt; WIDTH:9.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:17pt; WIDTH:52.65pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"></td> </tr><tr style="HEIGHT:13.65pt"> <td style="HEIGHT:13.65pt; WIDTH:363.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:10.8pt; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"><span style="FONT-SIZE:10pt; COLOR:black">Selling, general and administrative </span></p></td> <td style="HEIGHT:13.65pt; WIDTH:11.9pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:13.65pt; WIDTH:60pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c114" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="0" unitRef="usd">2,419,411</ix:nonFraction> </span></p></td> <td style="HEIGHT:13.65pt; WIDTH:9.15pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:13.65pt; WIDTH:11.5pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:13.65pt; WIDTH:52.55pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c115" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="0" unitRef="usd">291,379</ix:nonFraction> </span></p></td> <td style="HEIGHT:13.65pt; WIDTH:8.45pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:13.65pt; WIDTH:9.9pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:13.65pt; WIDTH:52.65pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c116" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="0" unitRef="usd">2,710,790</ix:nonFraction> </span></p></td></tr> <tr style="HEIGHT:14.6pt"> <td style="HEIGHT:14.6pt; WIDTH:363.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:10.8pt; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"><span style="FONT-SIZE:10pt; COLOR:black">Research and development </span></p></td> <td style="BORDER-TOP:0px; HEIGHT:14.6pt; BORDER-RIGHT:0px; WIDTH:11.9pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:14.6pt; BORDER-RIGHT:0px; WIDTH:60pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c114" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="0" unitRef="usd">1,261,096</ix:nonFraction> </span></p></td> <td style="HEIGHT:14.6pt; WIDTH:9.15pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:14.6pt; BORDER-RIGHT:0px; WIDTH:11.5pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:14.6pt; BORDER-RIGHT:0px; WIDTH:52.55pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c115" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="0" unitRef="usd">66,970</ix:nonFraction> </span></p></td> <td style="HEIGHT:14.6pt; WIDTH:8.45pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:14.6pt; BORDER-RIGHT:0px; WIDTH:9.9pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:14.6pt; BORDER-RIGHT:0px; WIDTH:52.65pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c116" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="0" unitRef="usd">1,328,066</ix:nonFraction> </span></p></td></tr> <tr style="HEIGHT:11.25pt"> <td style="HEIGHT:11.25pt; WIDTH:363.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:21.6pt; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"><span style="FONT-SIZE:10pt; COLOR:black">Total operating expense </span></p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:11.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:60pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c114" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:OperatingExpenses" scale="0" unitRef="usd">3,680,507</ix:nonFraction> </span></p></td> <td style="HEIGHT:11.25pt; WIDTH:9.15pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:11.5pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:52.55pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c115" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:OperatingExpenses" scale="0" unitRef="usd">358,349</ix:nonFraction> </span></p></td> <td style="HEIGHT:11.25pt; WIDTH:8.45pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:9.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:52.65pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c116" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:OperatingExpenses" scale="0" unitRef="usd">4,038,856</ix:nonFraction> </span></p></td></tr> <tr style="HEIGHT:11.25pt"> <td style="HEIGHT:11.25pt; WIDTH:363.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:11.25pt; WIDTH:11.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:11.25pt; WIDTH:60pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:11.25pt; WIDTH:9.15pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:11.25pt; WIDTH:11.5pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:11.25pt; WIDTH:52.55pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:11.25pt; WIDTH:8.45pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:11.25pt; WIDTH:9.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:11.25pt; WIDTH:52.65pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"></td> </tr><tr style="HEIGHT:11.25pt"> <td style="HEIGHT:11.25pt; WIDTH:363.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"><span style="FONT-SIZE:10pt; COLOR:black">Loss from operations</span></p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:11.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:60pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(<ix:nonFraction contextRef="c114" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="0" sign="-" unitRef="usd">3,136,135</ix:nonFraction>)</span></p></td> <td style="HEIGHT:11.25pt; WIDTH:9.15pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:11.5pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:52.55pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(<ix:nonFraction contextRef="c115" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="0" sign="-" unitRef="usd">475,913</ix:nonFraction>)</span></p></td> <td style="HEIGHT:11.25pt; WIDTH:8.45pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:9.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:52.65pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(<ix:nonFraction contextRef="c116" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="0" sign="-" unitRef="usd">3,612,048</ix:nonFraction>)</span></p></td></tr> <tr style="HEIGHT:13.5pt"> <td style="HEIGHT:13.5pt; WIDTH:363.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:13.5pt; BORDER-RIGHT:0px; WIDTH:11.9pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:13.5pt; BORDER-RIGHT:0px; WIDTH:60pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:13.5pt; WIDTH:9.15pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:13.5pt; BORDER-RIGHT:0px; WIDTH:11.5pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:13.5pt; BORDER-RIGHT:0px; WIDTH:52.55pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:13.5pt; WIDTH:8.45pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:13.5pt; BORDER-RIGHT:0px; WIDTH:9.9pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:13.5pt; BORDER-RIGHT:0px; WIDTH:52.65pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"></td> </tr><tr style="HEIGHT:11.25pt"> <td style="HEIGHT:11.25pt; WIDTH:363.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"><span style="FONT-SIZE:10pt">Loss before income taxes</span></p></td> <td style="HEIGHT:11.25pt; WIDTH:11.9pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:11.25pt; WIDTH:60pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(<ix:nonFraction contextRef="c114" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="0" sign="-" unitRef="usd">3,120,061</ix:nonFraction>)</span></p></td> <td style="HEIGHT:11.25pt; WIDTH:9.15pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:11.25pt; WIDTH:11.5pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:11.25pt; WIDTH:52.55pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(<ix:nonFraction contextRef="c115" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="0" sign="-" unitRef="usd">475,913</ix:nonFraction>)</span></p></td> <td style="HEIGHT:11.25pt; WIDTH:8.45pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:11.25pt; WIDTH:9.9pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:11.25pt; WIDTH:52.65pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(<ix:nonFraction contextRef="c116" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="0" sign="-" unitRef="usd">3,595,974</ix:nonFraction>)</span></p></td></tr> <tr style="HEIGHT:13.5pt"> <td style="HEIGHT:13.5pt; WIDTH:363.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:13.5pt; WIDTH:11.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:13.5pt; WIDTH:60pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:13.5pt; WIDTH:9.15pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:13.5pt; WIDTH:11.5pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:13.5pt; WIDTH:52.55pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:13.5pt; WIDTH:8.45pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:13.5pt; WIDTH:9.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:13.5pt; WIDTH:52.65pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"></td> </tr><tr style="HEIGHT:11.25pt"> <td style="HEIGHT:11.25pt; WIDTH:363.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"><span style="FONT-SIZE:10pt; COLOR:black">Net loss </span></p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:11.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"><span style="FONT-SIZE:10pt; COLOR:black">$ </span></p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:60pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(<ix:nonFraction contextRef="c114" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" sign="-" unitRef="usd">3,134,579</ix:nonFraction>)</span></p></td> <td style="HEIGHT:11.25pt; WIDTH:9.15pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:11.5pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:52.55pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(<ix:nonFraction contextRef="c115" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" sign="-" unitRef="usd">475,913</ix:nonFraction>)</span></p></td> <td style="HEIGHT:11.25pt; WIDTH:8.45pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:9.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"><span style="FONT-SIZE:10pt; COLOR:black">$ </span></p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:52.65pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(<ix:nonFraction contextRef="c116" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" sign="-" unitRef="usd">3,610,492</ix:nonFraction>)</span></p></td></tr> <tr style="HEIGHT:12pt"> <td style="HEIGHT:12pt; WIDTH:363.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:12pt; WIDTH:11.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:12pt; WIDTH:60pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:12pt; WIDTH:9.15pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:12pt; WIDTH:11.5pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:12pt; WIDTH:52.55pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:12pt; WIDTH:8.45pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:12pt; WIDTH:9.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:12pt; WIDTH:52.65pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td></tr> <tr style="HEIGHT:12pt"> <td style="HEIGHT:12pt; WIDTH:363.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Basic net loss per common share </span></p></td> <td style="BORDER-TOP:0px; HEIGHT:12pt; BORDER-RIGHT:0px; WIDTH:11.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$ </span></p></td> <td style="BORDER-TOP:0px; HEIGHT:12pt; BORDER-RIGHT:0px; WIDTH:60pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(<ix:nonFraction contextRef="c114" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares">0.27</ix:nonFraction>)</span></p></td> <td style="HEIGHT:12pt; WIDTH:9.15pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:12pt; BORDER-RIGHT:0px; WIDTH:11.5pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$ </span></p></td> <td style="BORDER-TOP:0px; HEIGHT:12pt; BORDER-RIGHT:0px; WIDTH:52.55pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(<ix:nonFraction contextRef="c115" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares">0.04</ix:nonFraction>)</span></p></td> <td style="HEIGHT:12pt; WIDTH:8.45pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:12pt; BORDER-RIGHT:0px; WIDTH:9.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$ </span></p></td> <td style="BORDER-TOP:0px; HEIGHT:12pt; BORDER-RIGHT:0px; WIDTH:52.65pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(<ix:nonFraction contextRef="c116" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares">0.31</ix:nonFraction>)</span></p></td></tr> <tr style="HEIGHT:11.25pt"> <td style="HEIGHT:11.25pt; WIDTH:363.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:11.25pt; WIDTH:11.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:11.25pt; WIDTH:60pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:11.25pt; WIDTH:9.15pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:11.25pt; WIDTH:11.5pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:11.25pt; WIDTH:52.55pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:11.25pt; WIDTH:8.45pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:11.25pt; WIDTH:9.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:11.25pt; WIDTH:52.65pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"></td> </tr><tr style="HEIGHT:11.25pt"> <td style="HEIGHT:11.25pt; WIDTH:363.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"><span style="FONT-SIZE:10pt; COLOR:black">Diluted net loss per common share </span></p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:11.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"><span style="FONT-SIZE:10pt; COLOR:black">$ </span></p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:60pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(<ix:nonFraction contextRef="c114" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareDiluted" scale="0" sign="-" unitRef="usdPershares">0.27</ix:nonFraction>)</span></p></td> <td style="HEIGHT:11.25pt; WIDTH:9.15pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:11.5pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"><span style="FONT-SIZE:10pt; COLOR:black">$ </span></p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:52.55pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(<ix:nonFraction contextRef="c115" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareDiluted" scale="0" sign="-" unitRef="usdPershares">0.04</ix:nonFraction>)</span></p></td> <td style="HEIGHT:11.25pt; WIDTH:8.45pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:9.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"><span style="FONT-SIZE:10pt; COLOR:black">$ </span></p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:52.65pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(<ix:nonFraction contextRef="c116" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareDiluted" scale="0" sign="-" unitRef="usdPershares">0.31</ix:nonFraction>)</span></p></td></tr> <tr style="HEIGHT:11.25pt"> <td style="HEIGHT:11.25pt; WIDTH:363.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:11.25pt; WIDTH:11.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:11.25pt; WIDTH:60pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:11.25pt; WIDTH:9.15pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:11.25pt; WIDTH:11.5pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:11.25pt; WIDTH:52.55pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:11.25pt; WIDTH:8.45pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:11.25pt; WIDTH:9.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:11.25pt; WIDTH:52.65pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"></td> </tr><tr style="HEIGHT:11.25pt"> <td style="HEIGHT:11.25pt; WIDTH:363.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"><span style="FONT-SIZE:10pt; COLOR:black">Comprehensive loss </span></p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:11.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"><span style="FONT-SIZE:10pt; COLOR:black">$ </span></p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:60pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(<ix:nonFraction contextRef="c114" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="0" sign="-" unitRef="usd">3,137,829</ix:nonFraction>)</span></p></td> <td style="HEIGHT:11.25pt; WIDTH:9.15pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:11.5pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"><span style="FONT-SIZE:10pt; COLOR:black">$ </span></p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:52.55pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(<ix:nonFraction contextRef="c115" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="0" sign="-" unitRef="usd">475,913</ix:nonFraction>)</span></p></td> <td style="HEIGHT:11.25pt; WIDTH:8.45pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:9.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"><span style="FONT-SIZE:10pt; COLOR:black">$ </span></p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:52.65pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(<ix:nonFraction contextRef="c116" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="0" sign="-" unitRef="usd">3,613,742</ix:nonFraction>)</span></p></td></tr></table></ix:continuation></div> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">13</span></p> <div style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><div style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;"> <hr/> <div style="PAGE-BREAK-BEFORE: always"></div> </div></div> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; color: #0066cc;"><a href="#TOC">Table of Contents</a></span></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p> <ix:continuation continuedAt="_ErrorCorrectionTextBlock-c0_cont_11" id="_ErrorCorrectionTextBlock-c0_cont_10"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; BACKGROUND:white; COLOR:black">The effect of the restatement on the consolidated statement of cash flows for the period ended November 30, 2020 is as follows:</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p></ix:continuation>  <div style="text-align: left;"> <ix:continuation id="_ErrorCorrectionTextBlock-c0_cont_11"><table cellpadding="0" cellspacing="0" style="width: 573.3pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" width="764">

<tr style="height: 22.65pt;">
<td style="height: 22.65pt; width: 372.5pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td colspan="2" style="border-top: 0px; height: 22.65pt; border-right: 0px; width: 66pt; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">As Previously Reported</span></p>
</td>
<td style="height: 22.65pt; width: 9.7pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td colspan="2" style="border-top: 0px; height: 22.65pt; border-right: 0px; width: 56.75pt; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Adjustments</span></p>
</td>
<td style="height: 22.65pt; width: 9.75pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td colspan="2" style="border-top: 0px; height: 22.65pt; border-right: 0px; width: 58.6pt; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">As Restated</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 372.5pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><strong><span style="font-size: 10pt; color: black;">Cash flows from operating activities:</span></strong></p>
</td>
<td style="height: 15pt; width: 9.7pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 56.3pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 9.7pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 10.25pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 46.5pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 9.75pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 9.75pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 48.85pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 372.5pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 9.7pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 56.3pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 9.7pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 10.25pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 46.5pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 9.75pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 9.75pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 48.85pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 372.5pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Net loss</span></p>
</td>
<td style="height: 15pt; width: 9.7pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15pt; width: 56.3pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c117" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" sign="-" unitRef="usd">3,134,579</ix:nonFraction>)</span></p>
</td>
<td style="height: 15pt; width: 9.7pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 10.25pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15pt; width: 46.5pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c118" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" sign="-" unitRef="usd">475,913</ix:nonFraction>)</span></p>
</td>
<td style="height: 15pt; width: 9.75pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 9.75pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15pt; width: 48.85pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c119" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" sign="-" unitRef="usd">3,610,492</ix:nonFraction>)</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 372.5pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><strong><span style="font-size: 10pt; color: black;">Adjustments to reconcile net loss to net cash used in operating activities: </span></strong></p>
</td>
<td style="height: 15pt; width: 9.7pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 56.3pt; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 9.7pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 10.25pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 46.5pt; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 9.75pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 9.75pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 48.85pt; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 372.5pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Stock option expense</span></p>
</td>
<td style="height: 15pt; width: 9.7pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 56.3pt; background: #b8cce4; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c117" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockOptionPlanExpense" scale="0" unitRef="usd">24,227</ix:nonFraction> </span></p>
</td>
<td style="height: 15pt; width: 9.7pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 10.25pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 46.5pt; background: #b8cce4; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c118" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockOptionPlanExpense" scale="0" unitRef="usd">475,913</ix:nonFraction> </span></p>
</td>
<td style="height: 15pt; width: 9.75pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 9.75pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 48.85pt; background: #b8cce4; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c119" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockOptionPlanExpense" scale="0" unitRef="usd">500,140</ix:nonFraction> </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 372.5pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Net cash used in operating activities </span></p>
</td>
<td style="height: 15pt; width: 9.7pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 56.3pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c117" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="0" sign="-" unitRef="usd">2,880,218</ix:nonFraction>)</span></p>
</td>
<td style="height: 15pt; width: 9.7pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 10.25pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 46.5pt; text-align: right; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom"><div style="-sec-ix-hidden: hidden-fact-12">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">-</span></p>
</div></td>
<td style="height: 15pt; width: 9.75pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 9.75pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 48.85pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c119" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="0" sign="-" unitRef="usd">2,880,218</ix:nonFraction>)</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 372.5pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 9.7pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 56.3pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 9.7pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 10.25pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 46.5pt; background: #b8cce4; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 9.75pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 9.75pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 48.85pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 372.5pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Cash and cash equivalents at end of period</span></p>
</td>
<td style="height: 15pt; width: 9.7pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15pt; width: 56.3pt; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c120" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="0" unitRef="usd">5,683,787</ix:nonFraction> </span></p>
</td>
<td style="height: 15pt; width: 9.7pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 10.25pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15pt; width: 46.5pt; text-align: right; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom"><div style="-sec-ix-hidden: hidden-fact-13">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">-</span></p>
</div></td>
<td style="height: 15pt; width: 9.75pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 9.75pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15pt; width: 48.85pt; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c122" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="0" unitRef="usd">5,683,787</ix:nonFraction> </span></p>
</td>
</tr>

</table></ix:continuation></div> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p> <p style="font-size: 10pt; font-family: 'Times New Roman'; margin: 0cm 2.7pt 0pt 0cm;"><strong><span style="font-family: 'Times New Roman','serif';">&#160;</span></strong></p>
<a id="MDNA"></a><a id="OLE_LINK4"></a><a id="OLE_LINK3"></a><p style="font-size: 10pt; font-family: 'Times New Roman'; margin: 0cm 2.7pt 0pt 0cm;"><strong><span style="font-family: 'Times New Roman','serif';">ITEM 2. &#160;MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></strong></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><i><span style="FONT-SIZE:10pt; COLOR:black">You should read the following discussion and analysis in conjunction with our consolidated financial statements and the accompanying notes thereto included in Part II, Item 8 of this Report. This discussion and analysis contains forward-looking statements that are based on our management&#8217;s current beliefs and assumptions, which statements are subject to substantial risks and uncertainties. Our actual results may differ materially from those expressed or implied by these forward-looking statements as a result of many factors, including those discussed in &#8220;Risk Factors&#8221; included in Part I, Item 1A of this Report.&#160;</span></i></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><b><span style="FONT-SIZE:10pt; COLOR:black">OVERVIEW</span></b></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p> <a id="_Hlk53571612"></a><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Biomerica, Inc. and its subsidiaries (which includes wholly-owned subsidiaries, Biomerica de Mexico and BioEurope GmbH), is </span><span style="font-size: 10pt;">a biomedical technology company that develops, patents, manufactures and markets advanced diagnostic and therapeutic products used at the point-of-care <span style="color: black;">(in home and physicians' offices)</span> and in hospital/clinical laboratories for detection and/or treatment of medical conditions and diseases<span style="color: black;">. The</span> Company's products are designed to enhance the health and well-being of people, while reducing total healthcare costs. </span></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Our primary focus is the research and development of revolutionary, patented, diagnostic-guided therapy, or DGT, products to treat gastrointestinal diseases, such as irritable bowel syndrome, and other inflammatory diseases. These products are directed at chronic inflammatory illnesses that are widespread and common, and as such address very large markets. If these DGT products prove effective in their clinical trials, and are ultimately cleared for sale by the U.S. Food and Drug Administration, we believe the revenues potential to the Company is significant.&#160; </span></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p> <p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">We are currently finalizing an endpoint determination clinical trial on our InFoods</span><span style="font-size: 10pt;">&#174; <span style="color: black;">IBS product. This trial is and has been conducted at </span>Mayo Clinics in Florida and Arizona, Beth Israel Deaconess Medical Center Inc., a Harvard Medical School Teaching Hospital, University of Texas Health Science Center at Houston, Houston Methodist, the University of Michigan and other institutions<span style="color: black;">. This trial monitors IBS patients over an 8-week period to determine the efficacy of our InFoods&#174; IBS product to improve the patients&#8217; IBS symptoms. We have completed the trial, and we expect top-line trial results to be reported at or around the end of January 2022</span>. During the next six months, we also expect to be entertaining partnership/licensing discussions with pharmaceutical and technology companies that could help us commercialize the product, including assisting with obtaining final FDA clearance. </span></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Our medical diagnostic products are sold worldwide primarily in two markets: 1) clinical laboratories and 2) point-of-care (physicians' offices and over-the-counter drugstores like Walmart and Walgreens). The diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances and other medical complications, by measuring or detecting the existence and/or level of specific bacteria, hormones, antibodies, antigens or other substances, which may exist in a patient&#8217;s body, stools, or blood, often in extremely small concentrations.</span></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt">Due to the global 2019 SARS-CoV-2 novel coronavirus pandemic, in March 2020 we began developing COVID-19 products to indicate if a person has been infected by COVID-19. While the Company does offer a COVID-19 antibody diagnostic test, all of our COVID-19 revenues in fiscal 2022 have come from international sales of our antigen tests that use a patient&#8217;s nasal fluid sample to detect if the patient is currently infected with the virus. These COVID-19 antigen tests have accounted for approximately 60% of our revenues during the first six months of fiscal 2022.</span></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">The other products we sell are primarily focused on gastrointestinal diseases, food intolerances, and certain esoteric tests. These diagnostic test products utilize immunoassay technology. Most of our products are CE marked and/or sold for diagnostic use where they are registered by each country&#8217;s regulatory agency.&#160; In addition, some products are cleared for sale in the U.S. by the FDA.</span></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">14</span></p> <div style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><div style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;"> <hr/> <div style="PAGE-BREAK-BEFORE: always"></div> </div></div> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; color: #0066cc;"><a href="#TOC">Table of Contents</a></span></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">While sales continue to occur in our COVID-19 products, </span><span style="FONT-SIZE:10pt">the majority of our research and development efforts are focused on development and commercialization of non-COVID related products such as our H. Pylori product, and our InFoods&#174; IBS product. </span></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt">We also recently added several new employees in our sales and marketing department in order to increase sales of existing products during fiscal 2022. Through these efforts, our EZ Detect colon disease home screening test is seeing a significant increased interest from retailers such as Walmart, distributors, and screening programs in other countries. </span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 7.2pt 0pt 0cm">&#160;</p> <a id="_Hlk53149431"></a><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 2.7pt 0pt 0cm"><b><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">RESULTS OF OPERATIONS</span></b></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; BACKGROUND:white">As disclosed in Note 8 of Item 1 to these unaudited condensed consolidated financial statements, during the fiscal quarter ended November 30, 2021, we determined that our calculation of non-cash stock-based compensation expense related to issued stock options in previously issued financial statements was incorrect. <span style="COLOR:black">Our calculation applied forfeiture adjustments to both vested and unvested outstanding options, including those for which the employee had provided the requisite service, which resulted in an understatement of stock compensation expense. Additionally, our calculation expensed the option at vesting dates versus pro rata over the period the requisite service was provided. </span>These errors resulted in an understatement of stock compensation expense during the six months ended November 30, 2020, and periods prior to May 31, 2020, resulting in a cumulative adjustment to equity accounts. As a result, our previously issued financial statements for the six months ended November 30, 2020 have been restated.</span></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; BACKGROUND:white; MARGIN:0cm 0cm 0pt">&#160;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; BACKGROUND:white; MARGIN:0cm 0cm 0pt"><b><span style="FONT-SIZE:10pt; COLOR:black">Three months ended November&#160;30, 2021</span></b></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><i><span style="FONT-SIZE:10pt; COLOR:black">Net Sales and Cost of Sales</span></i></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">The following is a breakdown of revenues according to markets to which the products are sold:</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p> <div style="text-align: left;"> <table cellpadding="0" cellspacing="0" style="WIDTH:622.9pt; BORDER-COLLAPSE:collapse; margin-left: auto; margin-right: auto;" width="831"> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:232.65pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:9.65pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td colspan="5" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:186.55pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">Three Months Ended<br/></span><span style="FONT-SIZE:10pt">November 30,</span></p></td> <td style="HEIGHT:15pt; WIDTH:9.7pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td colspan="5" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:184.35pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">Increase (Decrease)</span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:232.65pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:9.65pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td colspan="2" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:88.45pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">2021&#160; </span></p></td> <td style="HEIGHT:15pt; WIDTH:9.65pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td colspan="2" style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:88.45pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">2020&#160; </span></p></td> <td style="HEIGHT:15pt; WIDTH:9.7pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td colspan="2" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:88.45pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">$&#160; </span></p></td> <td style="HEIGHT:15pt; WIDTH:9.7pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td colspan="2" style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:86.2pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">%</span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:232.65pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Physician's office</span></p></td> <td style="HEIGHT:15pt; WIDTH:9.65pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:18.5pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="HEIGHT:15pt; WIDTH:69.95pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">3,359,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:9.65pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:18.5pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="HEIGHT:15pt; WIDTH:69.95pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">153,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:9.7pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:18.5pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="HEIGHT:15pt; WIDTH:69.95pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">3,206,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:9.7pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:18.1pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:68.1pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">2095%</span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:232.65pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Clinical lab</span></p></td> <td style="HEIGHT:15pt; WIDTH:9.65pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:18.5pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:69.95pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">642,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:9.65pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:18.5pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:69.95pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">893,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:9.7pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:18.5pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:69.95pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(251,000)</span></p></td> <td style="HEIGHT:15pt; WIDTH:9.7pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:18.1pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:68.1pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">-28%</span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:232.65pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Over-the-counter</span></p></td> <td style="HEIGHT:15pt; WIDTH:9.65pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:18.5pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:69.95pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">534,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:9.65pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:18.5pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:69.95pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">272,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:9.7pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:18.5pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:69.95pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">262,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:9.7pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:18.1pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:68.1pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">96%</span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:232.65pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Contract manufacturing</span></p></td> <td style="HEIGHT:15pt; WIDTH:9.65pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:18.5pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:69.95pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">112,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:9.65pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:18.5pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:69.95pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">55,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:9.7pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:18.5pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:69.95pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">57,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:9.7pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:18.1pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:68.1pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">104%</span></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:232.65pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Total</span></p></td> <td style="HEIGHT:15.75pt; WIDTH:9.65pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:18.5pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:69.95pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">4,647,000 </span></p></td> <td style="HEIGHT:15.75pt; WIDTH:9.65pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:18.5pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:69.95pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">1,373,000 </span></p></td> <td style="HEIGHT:15.75pt; WIDTH:9.7pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:18.5pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:69.95pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">3,274,000 </span></p></td> <td style="HEIGHT:15.75pt; WIDTH:9.7pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:18.1pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:68.1pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">238%</span></p></td></tr></table></div> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">Consolidated net sales were approximately $4,647,000 for the three months ended November 30, 2021, as compared to $1,373,000 for the three months ended November 30, 2020. This represents an increase of approximately $3,274,000 or 238%. The increase for the three months ended November 30, 2021, as compared to the three months ended November 30, 2020, was primarily due to the sale of our COVID-19 product to distributors in Asia and Europe. </span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </span></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt">Consolidated cost of sales was approximately $3,875,000 or 83% of net sales, for the three months ended November 30, 2021, as compared to $1,064,000 or 78% of net sales, for the three months ended November 30, 2020. This represents an increase of approximately $2,811,000 or 264%. The increase for the three months ended November 30, 2021, as compared to the three months ended November 30, 2020, was primarily due to the sale of our COVID-19 product to distributors in Asia and Europe.</span></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><i><span style="FONT-SIZE:10pt; COLOR:black">Operating Expenses</span></i></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">The following is a summary of operating expenses:</span></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p> <div style="text-align: left;"> <table cellpadding="0" cellspacing="0" style="WIDTH:700pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;" width="933"> <tr style="HEIGHT:12.75pt"> <td style="HEIGHT:12.75pt; WIDTH:25.86%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:12.75pt; WIDTH:1.6%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td colspan="8" rowspan="2" style="BORDER-TOP:0px; HEIGHT:12.75pt; BORDER-RIGHT:0px; WIDTH:49.06%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">Three Months Ended</span></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">November 30,</span></p></td> <td style="HEIGHT:12.75pt; WIDTH:1.86%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:12.75pt; WIDTH:1.6%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:12.75pt; WIDTH:9.86%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:12.75pt; WIDTH:1.86%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:12.75pt; WIDTH:8.3%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"></td> </tr><tr style="HEIGHT:12.75pt"> <td style="HEIGHT:12.75pt; WIDTH:25.86%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:12.75pt; BORDER-RIGHT:0px; WIDTH:1.6%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:12.75pt; WIDTH:1.86%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:12.75pt; WIDTH:1.6%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:12.75pt; WIDTH:9.86%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:12.75pt; WIDTH:1.86%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:12.75pt; WIDTH:8.3%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"></td> </tr><tr style="HEIGHT:12.75pt"> <td style="HEIGHT:12.75pt; WIDTH:25.86%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;">&#160;</p></td> <td colspan="4" style="BORDER-TOP:0px; HEIGHT:12.75pt; BORDER-RIGHT:0px; WIDTH:24.32%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><b><span style="FONT-SIZE:10pt; COLOR:black">&#160;</span></b><span style="FONT-SIZE:10pt; COLOR:black">2021</span></p></td> <td style="HEIGHT:12.75pt; WIDTH:1.86%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td colspan="4" style="BORDER-TOP:0px; HEIGHT:12.75pt; BORDER-RIGHT:0px; WIDTH:24.5%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">2020</span></p></td> <td style="HEIGHT:12.75pt; WIDTH:1.86%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td colspan="4" style="BORDER-TOP:0px; HEIGHT:12.75pt; BORDER-RIGHT:0px; WIDTH:21.62%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">Increase (Decrease)</span></p></td></tr> <tr style="HEIGHT:12.75pt"> <td style="HEIGHT:12.75pt; WIDTH:25.86%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;">&#160;</p></td> <td colspan="2" style="BORDER-TOP:0px; HEIGHT:12.75pt; BORDER-RIGHT:0px; WIDTH:12.58%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;">&#160;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">Operating Expense</span></p></td> <td style="HEIGHT:12.75pt; WIDTH:1.86%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:12.75pt; BORDER-RIGHT:0px; WIDTH:9.88%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">As a % of <br/>Total Revenues</span></p></td> <td style="HEIGHT:12.75pt; WIDTH:1.86%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;">&#160;</p></td> <td colspan="2" style="BORDER-TOP:0px; HEIGHT:12.75pt; BORDER-RIGHT:0px; WIDTH:12.78%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;">&#160;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">Operating Expense</span></p></td> <td style="BORDER-TOP:windowtext 1pt solid; HEIGHT:12.75pt; BORDER-RIGHT:0px; WIDTH:1.86%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="BORDER-TOP:windowtext 1pt solid; HEIGHT:12.75pt; BORDER-RIGHT:0px; WIDTH:9.86%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">As a % of <br/>Total Revenues</span></p></td> <td style="HEIGHT:12.75pt; WIDTH:1.86%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td colspan="2" style="BORDER-TOP:0px; HEIGHT:12.75pt; BORDER-RIGHT:0px; WIDTH:11.46%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="HEIGHT:12.75pt; WIDTH:1.86%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="BORDER-TOP:0px; HEIGHT:12.75pt; BORDER-RIGHT:0px; WIDTH:8.3%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">%</span></p></td></tr> <tr style="HEIGHT:12.75pt"> <td style="HEIGHT:12.75pt; WIDTH:25.86%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Selling, General and <br/>Administrative Expenses</span></p></td> <td style="BORDER-TOP:0px; HEIGHT:12.75pt; BORDER-RIGHT:0px; WIDTH:1.6%; BACKGROUND:#b8cce4; BORDER-BOTTOM:0px; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="HEIGHT:12.75pt; WIDTH:10.96%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">1,282,998 </span></p></td> <td style="HEIGHT:12.75pt; WIDTH:1.86%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:12.75pt; BORDER-RIGHT:0px; WIDTH:9.88%; BACKGROUND:#b8cce4; BORDER-BOTTOM:0px; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">28%</span></p></td> <td style="HEIGHT:12.75pt; WIDTH:1.86%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:12.75pt; BORDER-RIGHT:0px; WIDTH:1.86%; BACKGROUND:#b8cce4; BORDER-BOTTOM:0px; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$ </span></p></td> <td style="BORDER-TOP:windowtext 1pt solid; HEIGHT:12.75pt; BORDER-RIGHT:0px; WIDTH:10.92%; BACKGROUND:#b8cce4; BORDER-BOTTOM:0px; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">1,404,846 </span></p></td> <td style="HEIGHT:12.75pt; WIDTH:1.86%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:12.75pt; BORDER-RIGHT:0px; WIDTH:9.86%; BACKGROUND:#b8cce4; BORDER-BOTTOM:0px; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">102%</span></p></td> <td style="HEIGHT:12.75pt; WIDTH:1.86%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:12.75pt; BORDER-RIGHT:0px; WIDTH:1.6%; BACKGROUND:#b8cce4; BORDER-BOTTOM:0px; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$ </span></p></td> <td style="HEIGHT:12.75pt; WIDTH:9.86%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">&#160;(121,848)</span></p></td> <td style="HEIGHT:12.75pt; WIDTH:1.86%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:12.75pt; WIDTH:8.3%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">-9%</span></p></td></tr> <tr style="HEIGHT:12.75pt"> <td style="HEIGHT:12.75pt; WIDTH:25.86%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Research and Development</span></p></td> <td style="HEIGHT:12.75pt; WIDTH:1.6%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="HEIGHT:12.75pt; WIDTH:10.96%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">618,522 </span></p></td> <td style="HEIGHT:12.75pt; WIDTH:1.86%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:12.75pt; WIDTH:9.88%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">13%</span></p></td> <td style="HEIGHT:12.75pt; WIDTH:1.86%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:12.75pt; WIDTH:1.86%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$ </span></p></td> <td style="HEIGHT:12.75pt; WIDTH:10.92%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">616,561 </span></p></td> <td style="HEIGHT:12.75pt; WIDTH:1.86%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:12.75pt; WIDTH:9.86%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">45%</span></p></td> <td style="HEIGHT:12.75pt; WIDTH:1.86%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:12.75pt; WIDTH:1.6%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$ </span></p></td> <td style="HEIGHT:12.75pt; WIDTH:9.86%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.85pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">1,961 </span></p></td> <td style="HEIGHT:12.75pt; WIDTH:1.86%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:12.75pt; WIDTH:8.3%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">0%</span></p></td></tr></table></div> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><i><span style="FONT-SIZE:10pt; COLOR:black">Selling, General and Administrative Expenses</span></i></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p> <a id="_Hlk53409686"></a><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0cm 2.7pt 0pt 0cm;"><span style="font-size: 10pt; color: black;">Consolidated selling, general and administrative expenses were approximately $1,283,000 for the three months ended November 30, 2021, as compared to $1,405,000 for the three months ended November 30, 2020. This represents a decrease of approximately $122,000 or 9%. </span><span style="font-size: 10pt;"><span style="color: black;">The decrease in the </span>three months <span style="color: black;">ended November 30, 2021, was primarily due to a reduction of legal expense and bad debt expense.</span></span></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">15</span></p> <div style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><div style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;"> <hr/> <div style="PAGE-BREAK-BEFORE: always"></div> </div></div> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; color: #0066cc;"><a href="#TOC">Table of Contents</a></span></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><i><span style="FONT-SIZE:10pt; COLOR:black">Research and Development</span></i></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt">Consolidated research and development expenses were <span style="COLOR:black">approximately</span> $619,000 for the three months ended November 30, 2021, as compared to $617,000 for the three months ended November 30, 2020. This represents an increase of <span style="COLOR:black">approximately </span>$2,000 or 0%. </span></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><i><span style="FONT-SIZE:10pt; COLOR:black">Interest Income</span></i></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">Interest and dividend income were $6,916 for the three months ended November 30, 2021, as compared to $7,983 for the three months ended November 30, 2020. This represents a decrease of $1,067 or 13%.</span></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; BACKGROUND:white; MARGIN:0cm 0cm 0pt">&#160;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; BACKGROUND:white; MARGIN:0cm 0cm 0pt"><b><span style="FONT-SIZE:10pt; COLOR:black">Six months ended November&#160;30, 2021 </span></b></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><i><span style="FONT-SIZE:10pt; COLOR:black">Net Sales and Cost of Sales</span></i></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">The following is a breakdown of revenues according to markets to which the products are sold:</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p> <div style="text-align: left;"> <table cellpadding="0" cellspacing="0" style="WIDTH:664.5pt; BORDER-COLLAPSE:collapse; margin-left: auto; margin-right: auto;" width="886"> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:235.85pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:12.85pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td colspan="5" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:202.55pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">Six Months Ended<br/></span><span style="FONT-SIZE:10pt">November 30,</span></p></td> <td style="HEIGHT:15pt; WIDTH:12.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td colspan="5" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:200.35pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">Increase (Decrease)</span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:235.85pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:12.85pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td colspan="2" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:94.85pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">2021&#160; </span></p></td> <td style="HEIGHT:15pt; WIDTH:12.85pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td colspan="2" style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:94.85pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">2020&#160; </span></p></td> <td style="HEIGHT:15pt; WIDTH:12.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td colspan="2" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:94.85pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">$&#160; </span></p></td> <td style="HEIGHT:15pt; WIDTH:12.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td colspan="2" style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:92.6pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">%</span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:235.85pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Physician's office</span></p></td> <td style="HEIGHT:15pt; WIDTH:12.85pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:21.7pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="HEIGHT:15pt; WIDTH:73.15pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">3,616,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:12.85pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:21.7pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="HEIGHT:15pt; WIDTH:73.15pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">351,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:12.9pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:21.7pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="HEIGHT:15pt; WIDTH:73.15pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">3,265,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:12.9pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:21.3pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:71.3pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">930%</span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:235.85pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Clinical lab</span></p></td> <td style="HEIGHT:15pt; WIDTH:12.85pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:21.7pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:73.15pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">1,528,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:12.85pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:21.7pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:73.15pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">1,475,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:12.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:21.7pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:73.15pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.85pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">53,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:12.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:21.3pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:71.3pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">4%</span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:235.85pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Over-the-counter</span></p></td> <td style="HEIGHT:15pt; WIDTH:12.85pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:21.7pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:73.15pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">613,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:12.85pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:21.7pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:73.15pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">457,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:12.9pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:21.7pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:73.15pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">156,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:12.9pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:21.3pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:71.3pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">34%</span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:235.85pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Contract manufacturing</span></p></td> <td style="HEIGHT:15pt; WIDTH:12.85pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:21.7pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:73.15pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">152,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:12.85pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:21.7pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:73.15pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">233,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:12.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:21.7pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:73.15pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(81,000)</span></p></td> <td style="HEIGHT:15pt; WIDTH:12.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:21.3pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:71.3pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">-35%</span></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:235.85pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Total</span></p></td> <td style="HEIGHT:15.75pt; WIDTH:12.85pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:21.7pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:73.15pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">5,909,000 </span></p></td> <td style="HEIGHT:15.75pt; WIDTH:12.85pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:21.7pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:73.15pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">2,516,000 </span></p></td> <td style="HEIGHT:15.75pt; WIDTH:12.9pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:21.7pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:73.15pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">3,393,000 </span></p></td> <td style="HEIGHT:15.75pt; WIDTH:12.9pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:21.3pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:71.3pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">135%</span></p></td></tr></table></div> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p> <a id="_Hlk91777417"></a><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">Consolidated net sales were approximately $5,909,000 for the six months ended November 30, 2021, as compared to $2,516,000 for the six months ended November 30, 2020. This represents an increase of approximately $3,393,000 or 135%. The increase for the six months ended November 30, 2021, as compared to the six months ended November 30, 2020, was primarily due to the sale of our COVID-19 product to distributors in Asia and Europe. </span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </span></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt">Consolidated cost of sales was approximately $5,226,000 or 88% of net sales, for the six months ended November 30, 2021, as compared to $2,090,000 or 83% of net sales, for the six months ended November 30, 2020. This represents an increase of approximately $3,136,000 or 150%. The increase for the six months ended November 30, 2021, as compared to the six months ended November 30, 2020, was primarily due to the sale of our COVID-19 product to distributors in Asia and Europe.</span></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><i><span style="FONT-SIZE:10pt; COLOR:black">Operating Expenses</span></i></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">The following is a summary of operating expenses:</span></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p> <div style="text-align: left;"> <table cellpadding="0" cellspacing="0" style="width: 700pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="933">

<tr style="height: 12.75pt;">
<td style="height: 12.75pt; width: 25.86%; background: white; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 12.75pt; width: 1.6%; background: white; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td colspan="8" rowspan="2" style="border-top: 0px; height: 12.75pt; border-right: 0px; width: 49.04%; background: white; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Six Months Ended</span></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">November 30,</span></p>
</td>
<td style="height: 12.75pt; width: 1.86%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 12.75pt; width: 1.6%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 12.75pt; width: 9.86%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 12.75pt; width: 1.86%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 12.75pt; width: 8.32%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 12.75pt;">
<td style="height: 12.75pt; width: 25.86%; background: white; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 12.75pt; border-right: 0px; width: 1.6%; background: white; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 12.75pt; width: 1.86%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 12.75pt; width: 1.6%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 12.75pt; width: 9.86%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 12.75pt; width: 1.86%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 12.75pt; width: 8.32%; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 12.75pt;">
<td style="height: 12.75pt; width: 25.86%; background: white; white-space: nowrap; padding: 0cm;">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td colspan="4" style="border-top: 0px; height: 12.75pt; border-right: 0px; width: 24.3%; background: white; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0cm 0cm 0pt;"><strong><span style="font-size: 10pt; color: black;">&#160;</span></strong><span style="font-size: 10pt; color: black;">2021</span></p>
</td>
<td style="height: 12.75pt; width: 1.86%; background: white; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td colspan="4" style="border-top: 0px; height: 12.75pt; border-right: 0px; width: 24.5%; background: white; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">2020</span></p>
</td>
<td style="height: 12.75pt; width: 1.86%; background: white; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td colspan="4" style="border-top: 0px; height: 12.75pt; border-right: 0px; width: 21.64%; background: white; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Increase (Decrease)</span></p>
</td>
</tr>
<tr style="height: 12.75pt;">
<td style="height: 12.75pt; width: 25.86%; background: white; white-space: nowrap; padding: 0cm;">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td colspan="2" style="border-top: 0px; height: 12.75pt; border-right: 0px; width: 12.58%; background: white; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0cm 0cm 0pt;">&#160;</p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Operating Expense</span></p>
</td>
<td style="height: 12.75pt; width: 1.86%; background: white; white-space: nowrap; padding: 0cm;">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 12.75pt; border-right: 0px; width: 9.86%; background: white; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">As a % of <br/>Total Revenues</span></p>
</td>
<td style="height: 12.75pt; width: 1.86%; background: white; white-space: nowrap; padding: 0cm;">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td colspan="2" style="border-top: 0px; height: 12.75pt; border-right: 0px; width: 12.78%; background: white; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0cm 0cm 0pt;">&#160;</p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Operating Expense</span></p>
</td>
<td style="border-top: windowtext 1pt solid; height: 12.75pt; border-right: 0px; width: 1.86%; background: white; border-bottom: 0px; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="border-top: windowtext 1pt solid; height: 12.75pt; border-right: 0px; width: 9.86%; background: white; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">As a % of <br/>Total Revenues</span></p>
</td>
<td style="height: 12.75pt; width: 1.86%; background: white; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td colspan="2" style="border-top: 0px; height: 12.75pt; border-right: 0px; width: 11.46%; background: white; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="border-top: windowtext 1pt solid; height: 12.75pt; border-right: 0px; width: 1.86%; background: white; border-bottom: 0px; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="border-top: windowtext 1pt solid; height: 12.75pt; border-right: 0px; width: 8.32%; background: white; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">%</span></p>
</td>
</tr>
<tr style="height: 12.75pt;">
<td style="height: 12.75pt; width: 25.86%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Selling, General and <br/>Administrative Expenses</span></p>
</td>
<td style="height: 12.75pt; width: 1.6%; background: #b8cce4; white-space: nowrap; border: 0px; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 12.75pt; width: 10.96%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">2,294,533 </span></p>
</td>
<td style="height: 12.75pt; width: 1.86%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 12.75pt; width: 9.86%; background: #b8cce4; white-space: nowrap; border: 0px; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">39%</span></p>
</td>
<td style="height: 12.75pt; width: 1.86%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 12.75pt; width: 1.86%; background: #b8cce4; white-space: nowrap; border: 0px; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">$ </span></p>
</td>
<td style="border-top: windowtext 1pt solid; height: 12.75pt; border-right: 0px; width: 10.92%; background: #b8cce4; border-bottom: 0px; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">2,710,790 </span></p>
</td>
<td style="height: 12.75pt; width: 1.86%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 12.75pt; width: 9.86%; background: #b8cce4; white-space: nowrap; border: 0px; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">108%</span></p>
</td>
<td style="height: 12.75pt; width: 1.86%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 12.75pt; width: 1.6%; background: #b8cce4; white-space: nowrap; border: 0px; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">$ </span></p>
</td>
<td style="height: 12.75pt; width: 9.86%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">&#160;(416,257)</span></p>
</td>
<td style="height: 12.75pt; width: 1.86%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 12.75pt; width: 8.32%; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">-15%</span></p>
</td>
</tr>
<tr style="height: 12.75pt;">
<td style="height: 12.75pt; width: 25.86%; background: white; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Research and Development</span></p>
</td>
<td style="height: 12.75pt; width: 1.6%; background: white; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 12.75pt; width: 10.96%; background: white; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">1,058,386 </span></p>
</td>
<td style="height: 12.75pt; width: 1.86%; background: white; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 12.75pt; width: 9.86%; background: white; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">18%</span></p>
</td>
<td style="height: 12.75pt; width: 1.86%; background: white; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 12.75pt; width: 1.86%; background: white; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">$ </span></p>
</td>
<td style="height: 12.75pt; width: 10.92%; background: white; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">1,328,066 </span></p>
</td>
<td style="height: 12.75pt; width: 1.86%; background: white; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 12.75pt; width: 9.86%; background: white; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">53%</span></p>
</td>
<td style="height: 12.75pt; width: 1.86%; background: white; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 12.75pt; width: 1.6%; background: white; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">$ </span></p>
</td>
<td style="height: 12.75pt; width: 9.86%; background: white; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">(269,680)</span></p>
</td>
<td style="height: 12.75pt; width: 1.86%; background: white; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 12.75pt; width: 8.32%; background: white; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">-20%</span></p>
</td>
</tr>

</table></div> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><i><span style="FONT-SIZE:10pt; COLOR:black">Selling, General and Administrative Expenses</span></i></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt; COLOR:black">Consolidated selling, general and administrative expenses were approximately $2,295,000 for the </span><span style="FONT-SIZE:10pt">six <span style="COLOR:black">months ended November 30, 2021, as compared to $2,711,000 for the </span>six <span style="COLOR:black">months ended November 30, 2020. This represents a decrease of approximately $416,000 or 15%. The decrease in the </span>six months <span style="COLOR:black">ended November 30, 2021, was primarily due to a reduction of legal expense and bad debt expense.</span></span></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><i><span style="FONT-SIZE:10pt; COLOR:black">Research and Development</span></i></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt">Consolidated research and development expenses were <span style="COLOR:black">approximately</span> $1,058,000 for the six months ended November 30, 2021, as compared to $1,328,000 for the six months ended November 30, 2020. This represents a decrease of <span style="COLOR:black">approximately </span>$270,000 or 20%. <span style="COLOR:black">The decrease in the </span>six months <span style="COLOR:black">ended November 30, 2021, was primarily a result of decreases in costs related to the research, development, and validation of COVID-19 tests.</span></span></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">16</span></p> <div style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><div style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;"> <hr/> <div style="PAGE-BREAK-BEFORE: always"></div> </div></div> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; color: #0066cc;"><a href="#TOC">Table of Contents</a></span></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><i><span style="FONT-SIZE:10pt; COLOR:black">Interest Income</span></i></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">Interest and dividend income were $13,721 for the six months ended November 30, 2021, as compared to $16,074 for the six months ended November 30, 2020. This represents a decrease of $2,353 or 15%.</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 2.7pt 0pt 0cm"><b><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">LIQUIDITY AND CAPITAL RESOURCES</span></b></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">The following are the principal sources of liquidity:</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p> <div style="text-align: left;"> <table cellpadding="0" cellspacing="0" style="WIDTH:500pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;" width="667"> <tr style="HEIGHT:12.75pt"> <td style="HEIGHT:12.75pt; WIDTH:72%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 72%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:12.75pt; WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td colspan="2" rowspan="2" style="HEIGHT:12.75pt; WIDTH:10%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 10%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">November 30,</span></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">2021</span></p></td> <td style="HEIGHT:12.75pt; WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> </td><td colspan="2" rowspan="2" style="HEIGHT:12.75pt; WIDTH:10%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 10%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;">&#160;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">May 31,</span></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">2021</span></p></td></tr> <tr style="HEIGHT:12.75pt"> <td style="HEIGHT:12.75pt; WIDTH:72%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 72%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:12.75pt; WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:12.75pt; WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;">&#160;</p></td></tr> <tr style="HEIGHT:16.5pt"> <td style="HEIGHT:16.5pt; WIDTH:72%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 72%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Cash and cash equivalents</span></p></td> <td style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:10%; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; width: 10%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">7,199,172 </span></p></td> <td style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">&#160;$ </span></p></td> <td style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:10%; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; width: 10%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">4,199,311 </span></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:72%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 72%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Working capital including cash and cash equivalents</span></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:white; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:10%; BACKGROUND:white; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; width: 10%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">7,662,477 </span></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:white; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">&#160;$ </span></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:10%; BACKGROUND:white; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; width: 10%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">7,930,687 </span></p></td></tr></table></div> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">As of November 30, 2021 and May 31, 2021, we had cash and cash equivalents of approximately $7,199,000 and $4,199,000, respectively, and working capital of approximately $7,662,000 and $7,931,000, respectively. As a result of cash and cash equivalents on hand at November 30, 2021, and our ability to raise additional funds through our ATM Agreement, management believes we have sufficient funds to operate through the next twelve months or more. </span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><i><span style="FONT-SIZE:10pt; COLOR:black">Operating Activities</span></i></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">Cash provided by operating activities of approximately $1,419,000 during the six months ended November 30, 2021, reflects a net loss of approximately $2,668,000 and non-cash adjustments of $201,000 primarily associated with depreciation, amortization, stock-based compensation, adjustments to allowance for doubtful accounts, and inventory reserves. In addition, we realized an increase in net working capital of approximately $3,886,000 primarily driven by an increase in advance from customers, and decrease in accounts receivable. For the six months ended November 30, 2020, cash used by operating activities of approximately $2,880,000 reflects a net loss of $3,610,000 and non-cash adjustments of $1,102,000 primarily associated with depreciation, amortization, stock-based compensation, and inventory reserves. The non-cash adjustments were partially offset by a decline in net working capital of approximately $371,000 driven by an increase in inventory, which was partially offset by a decrease in prepaid expenses.</span></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><i><span style="FONT-SIZE:10pt; COLOR:black">Investing Activities</span></i></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">Cash used in investing activities for the six months ended November 30, 2021, was approximately $18,000 for purchases of property and equipment and $109,000 for increased intangibles. Cash used in investing activities for the six months ended November 30, 2020, was approximately $62,000 for purchases of property and equipment and $62,000 for increased intangibles. </span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><i><span style="FONT-SIZE:10pt; COLOR:black">Financing Activities</span></i></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">Cash provided by financing activities for the six months ended November 30, 2021, was approximately $1,719,000 which was a result of stock option exercises of $35,000 and net proceeds from the sale of common stock of $1,684,000. Cash provided by financing activities for the six months ended November 30, 2020, was approximately $49,000 which was a result of stock option exercises of $49,000.</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 16.2pt 0pt 0cm"><b><span style="FONT-SIZE:10pt; COLOR:black">OFF BALANCE SHEET ARRANGEMENTS</span></b></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 16.2pt 0pt 0cm">&#160;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 16.2pt 0pt 0cm"><span style="FONT-SIZE:10pt; COLOR:black">There were no off-balance sheet arrangements as of November 30, 2021.</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 16.2pt 0pt 0cm">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 16.2pt 0pt 0cm"><b><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">CRITICAL ACCOUNTING POLICIES</span></b></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 16.2pt 0pt 0cm">&#160;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt">The preparation of condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires us to make a number of estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. Such estimates and assumptions affect the reported amounts of revenues and expenses during the reporting period. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances. Actual results may differ materially from these estimates under different assumptions or conditions. We continue to monitor significant estimates made during the preparation of our financial statements. On an ongoing basis, we evaluate estimates and assumptions based upon historical experience and various other factors and circumstances. We believe our estimates and assumptions are reasonable under the current conditions; however, actual results may differ from these estimates under different future conditions.</span></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">17</span></p> <div style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><div style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;"> <hr/> <div style="PAGE-BREAK-BEFORE: always"></div> </div></div> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; color: #0066cc;"><a href="#TOC">Table of Contents</a></span></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt">We believe that the estimates and assumptions that are most important to the portrayal of our financial condition and results of operations, in that they require subjective or complex judgments, form the basis for the accounting policies deemed to be most critical to us. These relate to revenue recognition, accounts receivable reserves, inventory valuation, lease liabilities, right-of-use assets, and stock- based compensation. We believe estimates and assumptions related to these critical accounting policies are appropriate under the circumstances; however, should future events or occurrences result in unanticipated consequences, there could be a material impact on our future financial conditions or results of operations. We suggest that our significant accounting policies be read in conjunction with this Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations. See Note 2 to these Financial Statements for information on Significant Accounting Policies.</span></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p> <a id="QQD"></a><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 2.7pt 0pt 0cm"><b><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">ITEM 3. &#160;QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></b></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt">We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p> <a id="CP"></a><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><b><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">ITEM 4.&#160; CONTROLS AND PROCEDURES</span></b></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; COLOR:black">Our management, including our principal executive officer and principal financial officer, conducted an evaluation of the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) promulgated under the Securities and Exchange Act of 1934 as of </span><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">November 30<span style="COLOR:black">, 2021. Our evaluation tested controls and other procedures designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Securities and Exchange Act of 1934, as amended, or the Exchange Act, is recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Act is accumulated and communicated to the issuer&#8217;s management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. Based on our evaluation, as of </span>November 30<span style="COLOR:black">, 2021, our management, including our principal executive officer and principal financial officer, concluded that our disclosure controls and procedures were not effective due to a material weakness in our internal control over financial reporting related to the financial reporting described below in the area of accounting for non-cash stock-based compensation.</span></span></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:13.5pt 0cm 0pt"><b><span style="FONT-SIZE:10pt; COLOR:black">Changes in Internal Control over Financial Reporting<br/><br/></span></b><span style="FONT-SIZE:10pt; COLOR:black">Other than as described below, there were no changes to internal controls in the first quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:9pt 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">During the second quarter ending November&#160;30, 2021 and prior to filing this Quarterly Report, we completed the following steps to address the non-cash stock-based compensation deficiency identified in our Form 10-K/A filed on October 14, 2021:</span></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p> <table cellpadding="0" cellspacing="0" style="WIDTH:80%; BACKGROUND:white; BORDER-COLLAPSE:collapse" width="80%"> <tr> <td style="WIDTH:5%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 5%;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="WIDTH:2%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%;" valign="top"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt">&#8226;</span></p></td> <td style="WIDTH:1%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 1%;" valign="top"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm" valign="top"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt">implemented a leading industry standard equity and disclosure management software system to calculate non-cash stock-based compensation expense;</span></p></td></tr></table> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p> <table cellpadding="0" cellspacing="0" style="WIDTH:80%; BACKGROUND:white; BORDER-COLLAPSE:collapse" width="80%"> <tr> <td style="WIDTH:5%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 5%;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="WIDTH:2%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%;" valign="top"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt">&#8226;</span></p></td> <td style="WIDTH:1%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 1%;" valign="top"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm" valign="top"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt">engaged an outside accounting advisory firm to review our revised stock-based compensation amounts and our methods for calculating non-cash stock-based compensation expenses going forward; </span></p></td></tr></table> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p> <table cellpadding="0" cellspacing="0" style="WIDTH:80%; BACKGROUND:white; BORDER-COLLAPSE:collapse" width="80%"> <tr> <td style="WIDTH:5%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 5%;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="WIDTH:2%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%;" valign="top"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt">&#8226;</span></p></td> <td style="WIDTH:1%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 1%;" valign="top"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm" valign="top"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt">developed and implemented additional procedures to increase the level of review, evaluation and validation of the Company&#8217;s stock-based compensation expense;</span></p></td></tr></table> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </span><span style="FONT-SIZE:4.5pt; COLOR:black">&#160;</span></p> <table cellpadding="0" cellspacing="0" style="WIDTH:80%; BACKGROUND:white; BORDER-COLLAPSE:collapse" width="80%"> <tr> <td style="WIDTH:5%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 5%;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="WIDTH:2%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%;" valign="top"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt">&#8226;</span></p></td> <td style="WIDTH:1%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 1%;" valign="top"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm" valign="top"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt">increased the level of knowledge among our executives and accounting staff in the area of stock-based compensation; and </span></p></td></tr></table> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </span><span style="FONT-SIZE:4.5pt; COLOR:black">&#160;</span></p> <table cellpadding="0" cellspacing="0" style="WIDTH:80%; BACKGROUND:white; BORDER-COLLAPSE:collapse" width="80%"> <tr> <td style="WIDTH:5%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 5%;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="WIDTH:2%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%;" valign="top"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt">&#8226;</span></p></td> <td style="WIDTH:1%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 1%;" valign="top"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm" valign="top"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt">independently tested the calculations produced by our new equity and disclosure management software system </span></p></td></tr></table> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </span><span style="FONT-SIZE:4.5pt; COLOR:black">&#160;</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p> <a id="P2"></a><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 2.7pt 0pt 0cm"><b><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">PART II. &#160;OTHER INFORMATION</span></b></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p> <a id="LP"></a><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 2.7pt 0pt 0cm"><b><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">ITEM 1.&#160; LEGAL PROCEEDINGS</span></b></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">The Company is, from time to time, involved in legal proceedings, claims and litigation arising in the ordinary course of business. While the amounts claimed may be substantial, the ultimate liability cannot presently be determined because of considerable uncertainties that exist. Therefore, it is possible the outcome of such legal proceedings, claims and litigation could have a material effect on quarterly or annual operating results or cash flows when resolved in a future period. However, based on facts currently available, management believes such matters will not have a material adverse effect on the Company's consolidated financial position, results of operations or cash flows. There were no legal proceedings pending as of November 30, 2021.</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">18</span></p> <div style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><div style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;"> <hr/> <div style="PAGE-BREAK-BEFORE: always"></div> </div></div> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; color: #0066cc;"><a href="#TOC">Table of Contents</a></span></p> <p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin-left: 0cm; margin-right: 0cm;"><span style="font-size: 10pt;">&#160;</span></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin-left: 0cm; margin-right: 0cm;"><span style="font-size: 10pt;">On July 2, 2020, we received a notice of investigation and subpoena from the Division of Enforcement of the SEC. The subpoena requested information and documents related to events leading up to our March 17, 2020 announcement that, among other things, we had commenced shipping samples of our COVID-19 IgG/IgM Rapid Test to countries outside of the United States. In addition, on December 15, 2020, the SEC sent a second subpoena related to this same investigation to Zack Irani, the Company&#8217;s CEO, requesting personal and Company documents and information held by Mr. Irani. The Company and Mr. Irani cooperated fully with the SEC&#8217;s investigation and provided information as requested.</span></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN-LEFT:0cm; MARGIN-RIGHT:0cm"><span style="FONT-SIZE:10pt">On December 2, 2021, the Company was notified by the SEC that they had concluded their investigations with no enforcement action recommendations. The notices of investigation conclusion pertain to the Subpoena for information sent to the Company in July 2020, as well as the Subpoena for information sent to the Company&#8217;s CEO in December 2020.</span></p> <a id="new_id"></a><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 2.7pt 0pt 0cm"><b><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">ITEM 1A. &#160;RISKS AND UNCERTAINTIES.</span></b></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt">An investment in our common stock involves risks. Before making an investment decision, you should carefully consider all the information within this Quarterly Report, including the information contained in Part I, Item 2, "Management's Discussion and Analysis of Financial Condition and Results of Operations," as well as in our condensed consolidated financial statements and the related notes contained in Part I, Item 1 within this Quarterly Report. In addition, you should carefully consider the risks and uncertainties described in Part I, Item 1A, &#8220;Risk Factors,&#8221; of our 2021 Annual Report on Form 10-K/A, as well as in our other public filings with the SEC. If any of the identified risks are realized, our business, results of operations, financial condition, liquidity, and prospects could be materially and adversely affected. In that case, the trading price of our common stock may decline, and you could lose all or part of your investment. In addition, other risks of which we are currently unaware, or which we do not currently view as material, could have a material adverse effect on our business, results of operations, financial condition, and prospects.</span></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt">During the six months ended November 30, 2021, there were no material changes to the risks and uncertainties described in Part I, Item 1A, &#8220;Risk Factors,&#8221; of our 2021 Annual Report on Form 10-K/A.</span></p> <a id="OI"></a><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 16.2pt 0pt 0cm">&#160;</p> <a id="OI-0"></a><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 16.2pt 0pt 0cm"><b><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">ITEM 5.&#160; OTHER INFORMATION</span></b></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 16.2pt 0pt 0cm">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 16.2pt 0pt 0cm"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">See Note 8 to the Financial Statements for discussion of our prior period financial restatements. </span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 16.2pt 0pt 0cm">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">19</span></p> <div style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><div style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;"> <hr/> <div style="PAGE-BREAK-BEFORE: always"></div> </div></div> <a id="OI-1"></a><a id="Ex"></a><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; color: #0066cc;"><a href="#TOC">Table of Contents</a></span></p> <a id="Ex-0"></a><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 16.2pt 0pt 0cm">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 16.2pt 0pt 0cm"><b><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">ITEM 6.&#160; EXHIBITS. </span></b></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 16.2pt 0pt 0cm">&#160;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 16.2pt 0pt 0cm"><span style="FONT-SIZE:10pt">The following exhibits are filed or furnished as part of this quarterly report on Form 10-Q: </span></p> <table cellpadding="0" cellspacing="0" style="WIDTH:80%" width="80%"> <tr> <td colspan="2" style="WIDTH:3.68%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 16.2pt 0pt 0cm">&#160;</p></td> <td colspan="2" style="WIDTH:3.84%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 16.2pt 0pt 0cm">&#160;</p></td> <td style="WIDTH:3.68%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 16.2pt 0pt 0cm">&#160;</p></td> <td style="WIDTH:2.88%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 16.2pt 0pt 0cm">&#160;</p></td> <td colspan="2" style="WIDTH:85.9%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 16.2pt 0pt 0cm">&#160;</p></td></tr> <tr> <td colspan="5" style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.2%; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 16.2pt 0pt 0cm; text-align: center;"><span style="FONT-SIZE:10pt">Exhibit No.</span></p></td> <td style="WIDTH:2.88%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 16.2pt 0pt 0cm">&#160;</p></td> <td colspan="2" style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:85.9%; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 16.2pt 0pt 0cm"><span style="FONT-SIZE:10pt">Description</span></p></td></tr> <tr> <td colspan="2" style="WIDTH:3.68%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm" valign="top"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 16.2pt 0pt 0cm; text-align: right;">&#160;</p></td> <td colspan="2" style="WIDTH:3.84%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm" valign="top"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 16.2pt 0pt 0cm; text-align: right;">&#160;</p></td> <td style="WIDTH:3.68%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm" valign="top"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 16.2pt 0pt 0cm">&#160;</p></td> <td style="WIDTH:2.88%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 16.2pt 0pt 0cm">&#160;</p></td> <td colspan="2" style="WIDTH:85.9%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 16.2pt 0pt 0cm">&#160;</p></td></tr> <tr> <td colspan="2" style="WIDTH:3.68%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 16.2pt 0pt 0cm; text-align: right;">&#160;</p></td> <td colspan="2" style="WIDTH:3.84%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 16.2pt 0pt 0cm; text-align: right;"><span style="FONT-SIZE:10pt"><a href="exhibit31_1.htm">31.1</a></span></p></td> <td style="WIDTH:3.68%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 16.2pt 0pt 0cm"><span style="FONT-SIZE:10pt">*</span></p></td> <td style="WIDTH:2.88%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 16.2pt 0pt 0cm">&#160;</p></td> <td colspan="2" style="WIDTH:85.9%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 16.2pt 0pt 0cm"><span style="FONT-SIZE:10pt"><a href="exhibit31_1.htm">Certification Pursuant to Section&#160;302 of the Sarbanes-Oxley Act &#8212; Zackary S. Irani</a></span></p></td></tr> <tr> <td colspan="2" style="WIDTH:3.68%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm" valign="top"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 16.2pt 0pt 0cm; text-align: right;">&#160;</p></td> <td colspan="2" style="WIDTH:3.84%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm" valign="top"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 16.2pt 0pt 0cm; text-align: right;">&#160;</p></td> <td style="WIDTH:3.68%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm" valign="top"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 16.2pt 0pt 0cm">&#160;</p></td> <td style="WIDTH:2.88%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 16.2pt 0pt 0cm">&#160;</p></td> <td colspan="2" style="WIDTH:85.9%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 16.2pt 0pt 0cm">&#160;</p></td></tr> <tr> <td colspan="2" style="WIDTH:3.68%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 16.2pt 0pt 0cm; text-align: right;">&#160;</p></td> <td colspan="2" style="WIDTH:3.84%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 16.2pt 0pt 0cm; text-align: right;"><span style="FONT-SIZE:10pt"><a href="exhibit31_2.htm">31.2</a></span></p></td> <td style="WIDTH:3.68%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 16.2pt 0pt 0cm"><span style="FONT-SIZE:10pt">*</span></p></td> <td style="WIDTH:2.88%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 16.2pt 0pt 0cm">&#160;</p></td> <td colspan="2" style="WIDTH:85.9%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 16.2pt 0pt 0cm"><span style="FONT-SIZE:10pt"><a href="exhibit31_2.htm">Certification Pursuant to Section&#160;302 of the Sarbanes-Oxley Act &#8212; Steve Sloan</a></span></p></td></tr> <tr> <td colspan="2" style="WIDTH:3.68%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm" valign="top"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 16.2pt 0pt 0cm; text-align: right;">&#160;</p></td> <td colspan="2" style="WIDTH:3.84%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm" valign="top"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 16.2pt 0pt 0cm; text-align: right;">&#160;</p></td> <td style="WIDTH:3.68%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm" valign="top"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 16.2pt 0pt 0cm">&#160;</p></td> <td style="WIDTH:2.88%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 16.2pt 0pt 0cm">&#160;</p></td> <td colspan="2" style="WIDTH:85.9%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 16.2pt 0pt 0cm">&#160;</p></td></tr> <tr> <td colspan="2" style="WIDTH:3.68%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 16.2pt 0pt 0cm; text-align: right;">&#160;</p></td> <td colspan="2" style="WIDTH:3.84%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 16.2pt 0pt 0cm; text-align: right;"><span style="FONT-SIZE:10pt"><a href="exhibit32_1.htm">32.1</a></span></p></td> <td style="WIDTH:3.68%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 16.2pt 0pt 0cm"><span style="FONT-SIZE:10pt">*</span></p></td> <td style="WIDTH:2.88%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 16.2pt 0pt 0cm">&#160;</p></td> <td colspan="2" style="WIDTH:85.9%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 16.2pt 0pt 0cm"><span style="FONT-SIZE:10pt"><a href="exhibit32_1.htm">Certification Pursuant to Section&#160;906 of the Sarbanes-Oxley Act &#8212; Zackary S. Irani</a></span></p></td></tr> <tr> <td colspan="2" style="WIDTH:3.68%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm" valign="top"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 16.2pt 0pt 0cm; text-align: right;">&#160;</p></td> <td colspan="2" style="WIDTH:3.84%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm" valign="top"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 16.2pt 0pt 0cm; text-align: right;">&#160;</p></td> <td style="WIDTH:3.68%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm" valign="top"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 16.2pt 0pt 0cm">&#160;</p></td> <td style="WIDTH:2.88%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 16.2pt 0pt 0cm">&#160;</p></td> <td colspan="2" style="WIDTH:85.9%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 16.2pt 0pt 0cm">&#160;</p></td></tr> <tr> <td colspan="2" style="WIDTH:3.68%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 16.2pt 0pt 0cm; text-align: right;">&#160;</p></td> <td colspan="2" style="WIDTH:3.84%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 16.2pt 0pt 0cm; text-align: right;"><span style="FONT-SIZE:10pt"><a href="exhibit32_2.htm">32.2</a></span></p></td> <td style="WIDTH:3.68%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 16.2pt 0pt 0cm"><span style="FONT-SIZE:10pt">*</span></p></td> <td style="WIDTH:2.88%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 16.2pt 0pt 0cm">&#160;</p></td> <td colspan="2" style="WIDTH:85.9%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 16.2pt 0pt 0cm"><span style="FONT-SIZE:10pt"><a href="exhibit32_2.htm">Certification Pursuant to Section&#160;906 of the Sarbanes-Oxley Act &#8212; Steve Sloan</a></span></p></td></tr> <tr> <td style="WIDTH:3.16%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 16.2pt 0pt 0cm">&#160;</p></td> <td colspan="2" style="WIDTH:1.18%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 16.2pt 0pt 0cm">&#160;</p></td> <td colspan="5" style="WIDTH:95.66%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 16.2pt 0pt 0cm">&#160;</p></td></tr> <tr> <td style="WIDTH:3.16%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 16.2pt 0pt 0cm">&#160;</p></td> <td colspan="2" style="WIDTH:1.18%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 16.2pt 0pt 0cm">&#160;</p></td> <td colspan="5" style="WIDTH:95.66%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 16.2pt 0pt 0cm">&#160;</p></td></tr> <tr> <td style="WIDTH:3.16%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="top"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 16.2pt 0pt 0cm">&#160;</p></td> <td colspan="2" style="WIDTH:1.18%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm" valign="top"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 16.2pt 0pt 0cm">&#160;</p></td> <td colspan="5" style="WIDTH:95.66%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm" valign="top"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 16.2pt 0pt 0cm"><span style="FONT-SIZE:10pt">101&#160;&#160;&#160;&#160;&#160;&#160; Interactive data files pursuant to Rule 405 Regulation S-T, as follows:</span></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 16.2pt 0pt 0cm">&#160;</p></td></tr> <tr> <td colspan="7" style="WIDTH:95.66%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 16.2pt 0pt 0cm"><span style="FONT-SIZE:10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 101.INS-XBRL Instance Document</span></p></td> <td style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; width: 4%;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td></tr> <tr> <td colspan="7" style="WIDTH:95.66%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 16.2pt 0pt 0cm"><span style="FONT-SIZE:10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 101.SCH-XBRL Taxonomy Extension Schema Document</span></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 16.2pt 0pt 0cm"><span style="FONT-SIZE:10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 101.CAL-XBRL Taxonomy Extension Calculation Linkbase Document</span></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 16.2pt 0pt 0cm"><span style="FONT-SIZE:10pt">&#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;101.DEF&#8211;XBRL Taxonomy Extension Definition Linkbase Document</span></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 16.2pt 0pt 0cm"><span style="FONT-SIZE:10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 101.LAB-XBRL Taxonomy Extension Label Linkbase Document</span></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 16.2pt 0pt 0cm"><span style="FONT-SIZE:10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 101.PRE-XBRL Taxonomy Extension Presentation Linkbase Document </span></p></td> <td style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; width: 4%;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td></tr> <tr> <td style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px; width: 25px;"> </td><td style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px; width: 11px;"> </td><td style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px; width: 14px;"> </td><td style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px; width: 38px;"> </td><td style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px; width: 29px;"> </td><td style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px; width: 25px;"> </td><td style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px; width: 454px;"> </td><td style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px; width: 4px;"></td></tr></table> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 16.2pt 0pt 0cm; TEXT-INDENT:36pt"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">&#160;&#160; *Filed herewith.</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 16.2pt 0pt 0cm">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">20</span></p> <div style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><div style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;"> <hr/> <div style="PAGE-BREAK-BEFORE: always"></div> </div></div> <a id="Ex-1"></a><a id="Signatures"></a><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; color: #0066cc;"><a href="#TOC">Table of Contents</a></span></p> <a id="Signatures-0"></a><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 16.2pt 0pt 0cm">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 16.2pt 0pt 0cm"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">SIGNATURES</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 16.2pt 0pt 0cm">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 16.2pt 0pt 0cm"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has fully caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 16.2pt 0pt 0cm">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 16.2pt 0pt 0cm">&#160;</p></div><div><a id="Signatures-1"></a><span style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;"><span style="PAGE-BREAK-BEFORE:none; clear: both;"><br/></span></span></div><div> </div><div style="page:WordSection3"> <table cellpadding="0" cellspacing="0" style="WIDTH:450pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" width="600"> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:49.58%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td colspan="2" style="HEIGHT:15pt; WIDTH:50.42%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">BIOMERICA, INC.</span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:49.58%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:3.84%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:46.58%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:49.58%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Date:&#160; </span><span style="FONT-SIZE:10pt">January 12, 2022</span></p></td> <td style="HEIGHT:15pt; WIDTH:3.84%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:46.58%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:49.58%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></p></td> <td style="HEIGHT:15pt; WIDTH:3.84%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">By:&#160; </span></p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:46.58%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">/S/ Zackary S. Irani</span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:49.58%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:3.84%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:46.58%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:2.9pt; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Zackary S. Irani</span></p></td></tr> <tr style="HEIGHT:15pt"> <td colspan="2" style="HEIGHT:15pt; WIDTH:53.42%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </span></p></td> <td style="HEIGHT:15pt; WIDTH:46.58%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:2.9pt; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Chief Executive Officer</span></p></td></tr> <tr style="HEIGHT:15pt"> <td colspan="2" style="HEIGHT:15pt; WIDTH:53.42%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </span></p></td> <td style="HEIGHT:15pt; WIDTH:46.58%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">(Principal Executive Officer)</span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:49.58%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:3.84%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:46.58%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:49.58%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Date:&#160; </span><span style="FONT-SIZE:10pt">January 12, 2022</span></p></td> <td style="HEIGHT:15pt; WIDTH:3.84%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:46.58%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:49.58%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:3.84%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">By:&#160;</span></p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:46.58%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt">/S/ Steve Sloan</span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:49.58%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:3.84%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:46.58%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt">Steve Sloan</span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:49.58%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:3.84%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:46.58%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt">Chief Financial Officer</span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:49.58%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:3.84%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:46.58%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt">(Principal Financial Officer)</span></p></td></tr> </table> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:justify; MARGIN:0cm 16.2pt 0pt 0cm">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:center; MARGIN:0cm 16.2pt 0pt 0cm; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">21</span></p></div><div>
</div><!-- EDGAR Validation Code: 19310E6D --><div>

</div><div style="display: none"><ix:header>
<ix:hidden>
<ix:nonNumeric contextRef="c0" id="hidden-fact-0" name="dei:EntityCurrentReportingStatus">Yes</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" id="hidden-fact-1" name="dei:EntityInteractiveDataCurrent">Yes</ix:nonNumeric>
<ix:nonFraction contextRef="c3" id="hidden-fact-2" name="us-gaap:ContractWithCustomerLiability" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c2" id="hidden-fact-3" name="us-gaap:CommitmentsAndContingencies" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-4" name="us-gaap:CommitmentsAndContingencies" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-5" name="us-gaap:PreferredStockValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-6" name="us-gaap:PreferredStockValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c2" id="hidden-fact-7" name="us-gaap:PreferredStockValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-8" name="us-gaap:PreferredStockValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c8" id="hidden-fact-9" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c8" id="hidden-fact-10" name="us-gaap:ProceedsFromIssuanceOfCommonStock" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-11" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c118" id="hidden-fact-12" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c121" id="hidden-fact-13" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonNumeric contextRef="c0" name="dei:AmendmentFlag">false</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:CurrentFiscalYearEndDate">--05-31</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:DocumentFiscalPeriodFocus">Q2</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:DocumentFiscalYearFocus">2022</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:EntityCentralIndexKey">0000073290</ix:nonNumeric>
</ix:hidden>
<ix:references><link:schemaRef xlink:href="bmra-20211130.xsd" xlink:type="simple"></link:schemaRef></ix:references>
<ix:resources xmlns="http://www.xbrl.org/2003/instance"><xbrli:context id="c0">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-06-01</xbrli:startDate>
    <xbrli:endDate>2021-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c1">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-01-12</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c2">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-11-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c3">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-05-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c4">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">bmra:A5ConvertiblePreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-11-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c5">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">bmra:A5ConvertiblePreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-05-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c6">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-09-01</xbrli:startDate>
    <xbrli:endDate>2021-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c7">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-09-01</xbrli:startDate>
    <xbrli:endDate>2020-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c8">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-06-01</xbrli:startDate>
    <xbrli:endDate>2020-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c9">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-05-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c10">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bmra:A5ConvertiblePreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-05-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c11">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-05-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c12">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-05-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c13">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-05-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c14">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-05-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c15">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-06-01</xbrli:startDate>
    <xbrli:endDate>2020-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c16">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-06-01</xbrli:startDate>
    <xbrli:endDate>2020-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c17">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-06-01</xbrli:startDate>
    <xbrli:endDate>2020-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c18">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-06-01</xbrli:startDate>
    <xbrli:endDate>2020-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c19">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-11-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c20">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bmra:A5ConvertiblePreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-11-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c21">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-11-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c22">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-11-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c23">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-11-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c24">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-11-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c25">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-05-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c26">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-05-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c27">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-05-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c28">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-05-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c29">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-06-01</xbrli:startDate>
    <xbrli:endDate>2021-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c30">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-06-01</xbrli:startDate>
    <xbrli:endDate>2021-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c31">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-06-01</xbrli:startDate>
    <xbrli:endDate>2021-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c32">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-06-01</xbrli:startDate>
    <xbrli:endDate>2021-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c33">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-11-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c34">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-11-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c35">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-11-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c36">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-11-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c37">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-01-22</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c38">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">bmra:TwoDistributorsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-06-01</xbrli:startDate>
    <xbrli:endDate>2021-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c39">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">bmra:TwoDistributorsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-06-01</xbrli:startDate>
    <xbrli:endDate>2020-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c40">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">bmra:TwoDistributorsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-09-01</xbrli:startDate>
    <xbrli:endDate>2021-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c41">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">bmra:TwoDistributorsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-06-01</xbrli:startDate>
    <xbrli:endDate>2021-05-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c42">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:CostOfGoodsProductLineMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">bmra:TwoVendorsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-06-01</xbrli:startDate>
    <xbrli:endDate>2021-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c43">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:CostOfGoodsProductLineMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">bmra:TwoVendorsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-06-01</xbrli:startDate>
    <xbrli:endDate>2020-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c44">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsPayableMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">bmra:TwoVendorsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-06-01</xbrli:startDate>
    <xbrli:endDate>2021-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c45">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsPayableMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">bmra:TwoVendorsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-06-01</xbrli:startDate>
    <xbrli:endDate>2021-05-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c46">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-09-01</xbrli:startDate>
    <xbrli:endDate>2021-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c47">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-09-01</xbrli:startDate>
    <xbrli:endDate>2021-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c48">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DistributionRightsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-09-01</xbrli:startDate>
    <xbrli:endDate>2021-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c49">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">bmra:PurchasedTechnologyRightsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-09-01</xbrli:startDate>
    <xbrli:endDate>2021-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c50">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-09-01</xbrli:startDate>
    <xbrli:endDate>2021-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c51">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-06-01</xbrli:startDate>
    <xbrli:endDate>2021-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c52">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-11-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c53">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-11-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c54">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-06-01</xbrli:startDate>
    <xbrli:endDate>2020-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c55">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-05-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c56">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-06-01</xbrli:startDate>
    <xbrli:endDate>2021-11-29</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c57">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-11-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c58">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bmra:PhysiciansOfficeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-09-01</xbrli:startDate>
    <xbrli:endDate>2021-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c59">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bmra:PhysiciansOfficeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-09-01</xbrli:startDate>
    <xbrli:endDate>2020-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c60">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bmra:PhysiciansOfficeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-06-01</xbrli:startDate>
    <xbrli:endDate>2021-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c61">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bmra:PhysiciansOfficeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-06-01</xbrli:startDate>
    <xbrli:endDate>2020-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c62">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bmra:ClinicalLabMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt+1Vq3zhhUlfDeP/RQUzUZihDO8dLtQrMZMNe4t6pAivP0axfdFZpsLdRcC6V+fMavDgd7cFnpNNH6/9LXkBbSc8G8uA9huUzxoSaIHwz4vVYlYkDywCEAeWuqQU5kjj/9if9ldPlDmKw//pZSBlTR0cJe8RogwaRvBh/Si8BbEEglMEr+7LaiGaTFjjPvg7ek=] CSR-->
  <xbrli:period>
    <xbrli:startDate>2021-09-01</xbrli:startDate>
    <xbrli:endDate>2021-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c63">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bmra:ClinicalLabMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-09-01</xbrli:startDate>
    <xbrli:endDate>2020-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c64">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bmra:ClinicalLabMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-06-01</xbrli:startDate>
    <xbrli:endDate>2021-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c65">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bmra:ClinicalLabMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-06-01</xbrli:startDate>
    <xbrli:endDate>2020-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c66">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bmra:OverthecounterMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-09-01</xbrli:startDate>
    <xbrli:endDate>2021-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c67">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bmra:OverthecounterMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-09-01</xbrli:startDate>
    <xbrli:endDate>2020-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c68">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bmra:OverthecounterMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-06-01</xbrli:startDate>
    <xbrli:endDate>2021-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c69">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bmra:OverthecounterMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-06-01</xbrli:startDate>
    <xbrli:endDate>2020-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c70">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bmra:ContractManufacturingMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-09-01</xbrli:startDate>
    <xbrli:endDate>2021-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c71">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bmra:ContractManufacturingMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-09-01</xbrli:startDate>
    <xbrli:endDate>2020-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c72">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bmra:ContractManufacturingMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-06-01</xbrli:startDate>
    <xbrli:endDate>2021-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c73">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bmra:ContractManufacturingMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-06-01</xbrli:startDate>
    <xbrli:endDate>2020-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c74">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-06-01</xbrli:startDate>
    <xbrli:endDate>2021-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c75">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-11-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c76">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-11-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c77">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:MX</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-06-01</xbrli:startDate>
    <xbrli:endDate>2021-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c78">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:MX</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-11-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c79">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:MX</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-05-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c80">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-09-01</xbrli:startDate>
    <xbrli:endDate>2021-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c81">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-09-01</xbrli:startDate>
    <xbrli:endDate>2020-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c82">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-06-01</xbrli:startDate>
    <xbrli:endDate>2021-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c83">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-06-01</xbrli:startDate>
    <xbrli:endDate>2020-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c84">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-09-01</xbrli:startDate>
    <xbrli:endDate>2021-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c85">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-09-01</xbrli:startDate>
    <xbrli:endDate>2020-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c86">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-06-01</xbrli:startDate>
    <xbrli:endDate>2021-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c87">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-06-01</xbrli:startDate>
    <xbrli:endDate>2020-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c88">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-09-01</xbrli:startDate>
    <xbrli:endDate>2021-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c89">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-09-01</xbrli:startDate>
    <xbrli:endDate>2020-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c90">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-06-01</xbrli:startDate>
    <xbrli:endDate>2021-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c91">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-06-01</xbrli:startDate>
    <xbrli:endDate>2020-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c92">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:MiddleEastMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-09-01</xbrli:startDate>
    <xbrli:endDate>2021-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c93">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:MiddleEastMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-09-01</xbrli:startDate>
    <xbrli:endDate>2020-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c94">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:MiddleEastMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-06-01</xbrli:startDate>
    <xbrli:endDate>2021-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c95">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:MiddleEastMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-06-01</xbrli:startDate>
    <xbrli:endDate>2020-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c96">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:SouthAmericaMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-09-01</xbrli:startDate>
    <xbrli:endDate>2021-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c97">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:SouthAmericaMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-09-01</xbrli:startDate>
    <xbrli:endDate>2020-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c98">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:SouthAmericaMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-06-01</xbrli:startDate>
    <xbrli:endDate>2021-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c99">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:SouthAmericaMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-06-01</xbrli:startDate>
    <xbrli:endDate>2020-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c100">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">bmra:BuildingInIrvineCaliforniaMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2009-06-18</xbrli:startDate>
    <xbrli:endDate>2009-06-18</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c101">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="bmra:LeaseAmendmentAxis">bmra:FirstAmendmentToLeaseMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">bmra:BuildingInIrvineCaliforniaMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2009-06-18</xbrli:startDate>
    <xbrli:endDate>2009-06-18</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c102">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">us-gaap:PropertyAvailableForOperatingLeaseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2009-06-18</xbrli:startDate>
    <xbrli:endDate>2009-06-18</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c103">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">bmra:BuildingInIrvineCaliforniaMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-09-01</xbrli:startDate>
    <xbrli:endDate>2021-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c104">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">bmra:BuildingInIrvineCaliforniaMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2009-06-18</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c105">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:MX</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">us-gaap:PropertyAvailableForOperatingLeaseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2009-06-18</xbrli:startDate>
    <xbrli:endDate>2009-06-18</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c106">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:MX</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">us-gaap:PropertyAvailableForOperatingLeaseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2016-11-01</xbrli:startDate>
    <xbrli:endDate>2016-11-01</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c107">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:MX</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-06-01</xbrli:startDate>
    <xbrli:endDate>2020-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c108">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-12-01</xbrli:startDate>
    <xbrli:endDate>2022-02-28</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c109">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-02-28</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c110">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-12-09</xbrli:startDate>
    <xbrli:endDate>2021-12-09</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c111">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-09-01</xbrli:startDate>
    <xbrli:endDate>2020-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c112">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-09-01</xbrli:startDate>
    <xbrli:endDate>2020-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c113">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">bmra:RestatementOfCompanysFinancialStatementsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-09-01</xbrli:startDate>
    <xbrli:endDate>2020-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c114">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-06-01</xbrli:startDate>
    <xbrli:endDate>2020-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c115">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-06-01</xbrli:startDate>
    <xbrli:endDate>2020-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c116">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">bmra:RestatementOfCompanysFinancialStatementsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-06-01</xbrli:startDate>
    <xbrli:endDate>2020-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c117">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-09-01</xbrli:startDate>
    <xbrli:endDate>2021-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c118">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-09-01</xbrli:startDate>
    <xbrli:endDate>2021-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c119">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">bmra:RestatementOfCompanysFinancialStatementsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-09-01</xbrli:startDate>
    <xbrli:endDate>2021-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c120">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-11-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c121">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-11-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c122">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">bmra:RestatementOfCompanysFinancialStatementsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-11-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:unit id="shares">
  <xbrli:measure>xbrli:shares</xbrli:measure>
</xbrli:unit><xbrli:unit id="usd">
  <xbrli:measure>iso4217:USD</xbrli:measure>
</xbrli:unit><xbrli:unit id="usdPershares">
  <xbrli:divide>
    <xbrli:unitNumerator>
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unitNumerator>
    <xbrli:unitDenominator>
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unitDenominator>
  </xbrli:divide>
</xbrli:unit><xbrli:unit id="pure">
  <xbrli:measure>xbrli:pure</xbrli:measure>
</xbrli:unit></ix:resources></ix:header>

</div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>exhibit31_1.htm
<DESCRIPTION>EXHIBIT 31.1
<TEXT>
<HTML>
<head><title>Exhibit 31.1</title></head> <body> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; MARGIN:0px" align="left"><b>Exhibit 31.1</b></p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; MARGIN:0px" align="center"><b>CERTIFICATION PURSUANT TO</b></p><b> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; MARGIN:0px" align="center">18 U.S.C. SECTION 1350,</p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; MARGIN:0px" align="center">AS ADOPTED PURSUANT TO</p> </b><p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; MARGIN:0px" align="center"><b>SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</b><br></p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; MARGIN:0px" align="justify">&nbsp;</p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; MARGIN:0px" align="justify">I, Zackary S. Irani, certify that:</p> <p style="MARGIN:0px" align="justify"><br></p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; MARGIN:0px" align="justify">1. I have reviewed this Quarterly Report on Form 10-Q of Biomerica, Inc.;</p> <p style="MARGIN:0px" align="justify"><br></p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; MARGIN:0px" align="justify">2.
 Based on my knowledge, this report does not contain any untrue
statement of a material fact or omit to state a material fact necessary
to make the statements made, in light of the circumstances under which
such statements were made, not misleading with respect to the period
covered by this report;</p> <p style="MARGIN:0px" align="justify"><br></p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; MARGIN:0px" align="justify">3.
 Based on my knowledge, the financial statements, and other financial
information included in this report, fairly present in all material
respects, the financial condition, results of operations and cash flows
of the registrant as of, and for, the periods presented in this report;</p> <p style="MARGIN:0px" align="justify"><br></p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; MARGIN:0px" align="justify">4.
 The registrant's other certifying officer and I are responsible for
establishing and maintaining disclosure controls and procedures (as
defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal
control over financial reporting (as defined in Exchange Act Rules
13a-15(f) and 15d-15(f)) for the registrant and have:</p> <p style="MARGIN:0px" align="justify"><br></p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; TEXT-ALIGN:justify; MARGIN:0px; TEXT-INDENT:48px">a)
 designed such disclosure controls and procedures, or caused such
disclosure controls and procedures to be designed under our supervision,
 to ensure that material information relating to the registrant,
including its consolidated subsidiaries is made known to us by others
within those entities, particularly during the period in which this
report is being prepared;</p> <p style="MARGIN:0px"><br></p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; TEXT-ALIGN:justify; MARGIN:0px; TEXT-INDENT:48px">b)

 designed such internal control over financial reporting, or caused such
 internal control over financial reporting to be designed under our
supervision, to provide reasonable assurance regarding the reliability
of financial reporting and the preparation of financial statements for
external purposes in accordance with accounting principles generally
accepted in the United States of America;</p> <p style="MARGIN:0px"><br></p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; TEXT-ALIGN:justify; MARGIN:0px; TEXT-INDENT:48px">c)
 evaluated the effectiveness of the registrant's disclosure controls and
 procedures and presented in this report our conclusions about the
effectiveness of the disclosure controls and procedures, as of the end
of the period covered by this report based on such evaluation; and</p> <p style="MARGIN:0px"><br></p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; TEXT-ALIGN:justify; MARGIN:0px; TEXT-INDENT:48px">d)
 disclosed in this report any change in the registrant's internal
control over financial reporting that occurred during the registrant's
most recent fiscal quarter (the registrant's fourth quarter in the case
of an annual report) that has materially affected, or is reasonably
likely to materially affect, the registrant's internal control over
financial reporting; and</p> <p style="MARGIN:0px"><br></p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; TEXT-ALIGN:justify; MARGIN:0px">5.
 The registrant's other certifying officer and I have disclosed, based
on our most recent evaluation of our internal control over financial
reporting, to the registrant's auditors and the audit committee of the
registrant's board of directors (or other persons performing the
equivalent functions):</p> <p style="MARGIN:0px"><br></p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; TEXT-ALIGN:justify; MARGIN:0px; TEXT-INDENT:48px">a)
 all significant deficiencies and material weaknesses in the design or
operation of internal control over financial reporting which are
reasonably likely to adversely affect the registrant's ability to
record, process, summarize and report financial information; and</p> <p style="MARGIN:0px"><br></p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; TEXT-ALIGN:justify; MARGIN:0px; TEXT-INDENT:48px">b)
 any fraud, whether or not material, that involves management or other
employees who have a significant role in the registrant's internal
control over financial reporting.</p> <p style="MARGIN:0px">&nbsp;</p> <table style="WIDTH:210.75pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" width="281" cellspacing="0" cellpadding="0" bordercolor="transparent"> <tr style="HEIGHT:22pt"> <td style="HEIGHT:14.75pt; WIDTH:210.75pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0pt; PADDING-RIGHT:5.4pt" width="281" nowrap="nowrap"> <p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;sans-serif&quot;; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal"><font style="FONT-SIZE:9pt; FONT-FAMILY:&quot;Times New Roman&quot;; COLOR:black">Date: January 12, 2022</font></p></td></tr> <tr style="HEIGHT:14.75pt"> <td style="BORDER-TOP:0px; HEIGHT:14.75pt; BORDER-RIGHT:0px; WIDTH:210.75pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" width="281" nowrap="nowrap"> <p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;sans-serif&quot;; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal"><font style="FONT-SIZE:9pt; FONT-FAMILY:&quot;Times New Roman&quot;; COLOR:black">/s/ Zackary S. Irani</font></p></td></tr> <tr style="HEIGHT:14.75pt"> <td style="HEIGHT:14.75pt; WIDTH:210.75pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0pt; PADDING-RIGHT:5.4pt" width="281" nowrap="nowrap"> <p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;sans-serif&quot;; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal"><font style="FONT-SIZE:9pt; FONT-FAMILY:&quot;Times New Roman&quot;; COLOR:black">Zackary S. Irani</font></p></td></tr> <tr style="HEIGHT:14.75pt"> <td style="HEIGHT:14.75pt; WIDTH:210.75pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0pt; PADDING-RIGHT:5.4pt" width="281" nowrap="nowrap"> <p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;sans-serif&quot;; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal"><font style="FONT-SIZE:9pt; FONT-FAMILY:&quot;Times New Roman&quot;; COLOR:black">Chief Executive Officer</font></p></td></tr> <tr style="HEIGHT:14.75pt"> <td style="HEIGHT:14.75pt; WIDTH:210.75pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0pt; PADDING-RIGHT:5.4pt" width="281" nowrap="nowrap"> <p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;sans-serif&quot;; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal"><font style="FONT-SIZE:9pt; FONT-FAMILY:&quot;Times New Roman&quot;; COLOR:black">(Principal Executive Officer)</font></p></td></tr></table> <p style="MARGIN-BOTTOM:9px; MARGIN-TOP:0px">&nbsp;</p></body>
<!-- EDGAR Validation Code: 237E9F32 -->
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>exhibit31_2.htm
<DESCRIPTION>EXHIBIT 31.2
<TEXT>
<HTML>
<head><title>Exhibit 31.2</title></head> <body> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; MARGIN:0px" align="left"><font style="FONT-SIZE:9pt"><b>EXHIBIT 31.2</b></font></p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; MARGIN:0px" align="center"><font style="FONT-SIZE:9pt"><b>CERTIFICATION PURSUANT TO</b></font></p><b> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; MARGIN:0px" align="center"><font style="FONT-SIZE:9pt">18 U.S.C. SECTION 1350,</font></p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; MARGIN:0px" align="center"><font style="FONT-SIZE:9pt">AS ADOPTED PURSUANT TO</font></p> </b><p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; MARGIN:0px" align="center"><b><font style="FONT-SIZE:9pt">SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></b><font style="FONT-SIZE:9pt"><br></font></p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; MARGIN:0px" align="center">&nbsp;</p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; MARGIN:0px"><font style="FONT-SIZE:9pt">I, Steve Sloan, certify that:</font></p> <p style="MARGIN:0px"><font style="FONT-SIZE:9pt"><br></font></p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; MARGIN:0px"><font style="FONT-SIZE:9pt">1. I have reviewed this Quarterly Report on Form 10-Q of Biomerica, Inc.;</font></p> <p style="MARGIN:0px"><font style="FONT-SIZE:9pt"><br></font></p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; TEXT-ALIGN:justify; MARGIN:0px"><font style="FONT-SIZE:9pt">2.
 Based on my knowledge, this report does not contain any untrue
statement of a material fact or omit to state a material fact necessary
to make the statements made, in light of the circumstances under which
such statements were made, not misleading with respect to the period
covered by this report;</font></p> <p style="MARGIN:0px"><font style="FONT-SIZE:9pt"><br></font></p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; TEXT-ALIGN:justify; MARGIN:0px"><font style="FONT-SIZE:9pt">3.
 Based on my knowledge, the financial statements, and other financial
information included in this report, fairly present in all material
respects, the financial condition, results of operations and cash flows
of the registrant as of, and for, the periods presented in this report;</font></p> <p style="MARGIN:0px"><font style="FONT-SIZE:9pt"><br></font></p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; TEXT-ALIGN:justify; MARGIN:0px"><font style="FONT-SIZE:9pt">4.
 The registrant's other certifying officer and I are responsible for
establishing and maintaining disclosure controls and procedures (as
defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal
control over financial reporting (as defined in Exchange Act Rules
13a-15(f) and 15d-15(f)) for the registrant and have:</font></p> <p style="MARGIN:0px"><font style="FONT-SIZE:9pt"><br></font></p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; TEXT-ALIGN:justify; MARGIN:0px"><font style="FONT-SIZE:9pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a)
 designed such disclosure controls and procedures, or caused such
disclosure controls and procedures to be designed under our supervision,
 to ensure that material information relating to the registrant,
including its consolidated subsidiaries, is made known to us by others
within those entities, particularly during the period in which this
report is being prepared;</font></p> <p style="MARGIN:0px"><font style="FONT-SIZE:9pt"><br></font></p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; TEXT-ALIGN:justify; MARGIN:0px"><font style="FONT-SIZE:9pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b)

 designed such internal control over financial reporting, or caused such
 internal control over financial reporting to be designed under our
supervision, to provide reasonable assurance regarding the reliability
of financial reporting and the preparation of financial statements for
external purposes in accordance with accounting principles generally
accepted in the United States of America;</font></p> <p style="MARGIN:0px"><font style="FONT-SIZE:9pt"><br></font></p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; TEXT-ALIGN:justify; MARGIN:0px"><font style="FONT-SIZE:9pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c)
 evaluated the effectiveness of the registrant's disclosure controls and
 procedures and presented in this report our conclusions about the
effectiveness of the disclosure controls and procedures, as of the end
of the period covered by this report based on such evaluation; and</font></p> <p style="MARGIN:0px"><font style="FONT-SIZE:9pt"><br></font></p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; TEXT-ALIGN:justify; MARGIN:0px"><font style="FONT-SIZE:9pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d)
 disclosed in this report any change in the registrant's internal
control over financial reporting that occurred during the registrant's
most recent fiscal quarter (the registrant's fourth quarter in the case
of an annual report) that has materially affected, or is reasonably
likely to materially affect, the registrant's internal control over
financial reporting; and</font></p> <p style="MARGIN:0px"><font style="FONT-SIZE:9pt"><br></font></p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; TEXT-ALIGN:justify; MARGIN:0px"><font style="FONT-SIZE:9pt">5.
 The registrant's other certifying officer and I have disclosed, based
on our most recent evaluation of our internal control over financial
reporting, to the registrant's auditors and the audit committee of the
registrant's board of directors (or other persons performing the
equivalent functions):</font></p> <p style="MARGIN:0px"><font style="FONT-SIZE:9pt"><br></font></p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; TEXT-ALIGN:justify; MARGIN:0px"><font style="FONT-SIZE:9pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a)
 all significant deficiencies and material weaknesses in the design or
operation of internal control over financial reporting which are
reasonably likely to adversely affect the registrant's ability to
record, process, summarize and report financial information; and</font></p> <p style="MARGIN:0px"><font style="FONT-SIZE:9pt"><br></font></p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; TEXT-ALIGN:justify; MARGIN:0px"><font style="FONT-SIZE:9pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b)
 any fraud, whether or not material, that involves management or other
employees who have a significant role in the registrant's internal
control over financial reporting.</font></p> <p style="MARGIN:0px">&nbsp;</p> <table style="WIDTH:179pt; BORDER-COLLAPSE:collapse" width="239" cellspacing="0" cellpadding="0" bordercolor="transparent"><tr style="HEIGHT:15pt"> <td style="HEIGHT:22pt; WIDTH:179pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" width="239"> <p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;sans-serif&quot;; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal"><font style="FONT-SIZE:9pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">Date: January 12, 2022</font></p></td></tr> <tr style="HEIGHT:15pt"> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;sans-serif&quot;; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal"><font style="FONT-SIZE:9pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">/s/ Steve Sloan</font></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;sans-serif&quot;; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal"><font style="FONT-SIZE:9pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">Steve Sloan</font></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;sans-serif&quot;; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal"><font style="FONT-SIZE:9pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">Chief Financial Officer</font></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0pt; PADDING-RIGHT:0in"> <p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;sans-serif&quot;; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal"><font style="FONT-SIZE:9pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">(Principal Financial Officer)</font></p></td></tr></table> <p style="MARGIN:0px"><br><br></p></body>
<!-- EDGAR Validation Code: 237E9F32 -->
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>exhibit32_1.htm
<DESCRIPTION>EXHIBIT 32.1
<TEXT>
<HTML>
<head><title>Exhibit 32.1</title></head> <body> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; MARGIN:0px">&nbsp;</p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; MARGIN:0px"><b>EXHIBIT 32.1</b></p> <p style="MARGIN:0px"><br></p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; MARGIN:0px" align="center"><b>CERTIFICATION PURSUANT TO</b></p><b> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; MARGIN:0px" align="center">18 U.S.C. SECTION 1350,</p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; MARGIN:0px" align="center">AS ADOPTED PURSUANT TO</p> </b><p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; MARGIN:0px" align="center"><b>SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</b></p> <p style="MARGIN:0px"><br></p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; TEXT-ALIGN:justify;MARGIN:0px">In
 connection with the Quarterly Report of Biomerica, Inc. (the "Company")
 on Form 10-Q for the period ending November 30, 2021, as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), I,
 Zackary Irani, Chief Executive Officer of the Company, certify, to the
best of my knowledge, Pursuant to Exchange Act Rule 15d-14(b) and 18
U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes
Oxley Act of 2002,</p> <p style="MARGIN:0px"><br></p> <p style="FONT-SIZE:9pt; MARGIN-BOTTOM:-2px; FONT-FAMILY:'Times New Roman'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left">i. &nbsp;&nbsp;</p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; MARGIN:0px; TEXT-INDENT:-2px">The Report fully complies with the requirements of Sections 13(a) or 15(d) of the Securities Exchange Act of 1934, and</p> <p style="CLEAR:left; MARGIN:0px"><br></p> <p style="FONT-SIZE:9pt; MARGIN-BOTTOM:-2px; FONT-FAMILY:'Times New Roman'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left">ii. &nbsp;</p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; MARGIN:0px; TEXT-INDENT:-2px">The
 information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the
Company.</p> <p style="CLEAR:left; MARGIN:0px"><br></p> <p style="MARGIN:0px"><br></p> <p style="MARGIN:0px"><br></p> <table style="WIDTH:167pt; BORDER-COLLAPSE:collapse" width="223" cellspacing="0" cellpadding="0" bordercolor="transparent"><tr style="HEIGHT:15pt"> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:167pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" width="223"> <p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;sans-serif&quot;; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal"><font style="FONT-SIZE:9pt; FONT-FAMILY:&quot;Times New Roman&quot;">/s/ Zackary S. Irani</font></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;sans-serif&quot;; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal"><font style="FONT-SIZE:9pt; FONT-FAMILY:&quot;Times New Roman&quot;">Zackary S. Irani</font></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;sans-serif&quot;; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal"><font style="FONT-SIZE:9pt; FONT-FAMILY:&quot;Times New Roman&quot;">Chief Executive Officer</font></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;sans-serif&quot;; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal"><font style="FONT-SIZE:9pt; FONT-FAMILY:&quot;Times New Roman&quot;">Date: January 12, 2022</font></p></td></tr></table> <p style="MARGIN:0px"><br></p> <p style="MARGIN:0px"><br></p> <p style="MARGIN:0px"><br><br></p></body>
<!-- EDGAR Validation Code: 237E9F32 -->
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>5
<FILENAME>exhibit32_2.htm
<DESCRIPTION>EXHIBIT 32.2
<TEXT>
<HTML>
<head><title>Exhibit 32.2</title></head> <body> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; MARGIN:0px">&nbsp;</p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; MARGIN:0px"><b>EXHIBIT 32.2</b></p> <p style="MARGIN:0px"><br></p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; MARGIN:0px" align="center"><b>CERTIFICATION PURSUANT TO</b></p><b> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; MARGIN:0px" align="center">18 U.S.C. SECTION 1350,</p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; MARGIN:0px" align="center">AS ADOPTED PURSUANT TO</p> </b><p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; MARGIN:0px" align="center"><b>SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</b></p> <p style="MARGIN:0px"><br></p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; TEXT-ALIGN:justify;MARGIN:0px">In
 connection with the Quarterly Report of Biomerica, Inc. (the "Company")
 on Form 10-Q for the period ending November 30, 2021, as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), I,
 Steve Sloan, Chief Financial Officer of the Company, certify, to the
best of my knowledge, Pursuant to Exchange Act Rule 15d-14(b) and 18
U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes
Oxley Act of 2002,</p> <p style="MARGIN:0px"><br></p> <p style="FONT-SIZE:9pt; MARGIN-BOTTOM:-2px; FONT-FAMILY:'Times New Roman'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left">i. &nbsp;&nbsp;</p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; MARGIN:0px; TEXT-INDENT:-2px">The Report fully complies with the requirements of Sections 13(a) or 15(d) of the Securities Exchange Act of 1934, and</p> <p style="CLEAR:left; MARGIN:0px"><br></p> <p style="FONT-SIZE:9pt; MARGIN-BOTTOM:-2px; FONT-FAMILY:'Times New Roman'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left">ii. &nbsp;</p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; MARGIN:0px; TEXT-INDENT:-2px">The
 information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the
Company.</p> <p style="CLEAR:left; MARGIN:0px"><br></p> <p style="MARGIN:0px"><br></p>  <table style="WIDTH:179pt; BORDER-COLLAPSE:collapse" width="239" cellspacing="0" cellpadding="0" bordercolor="transparent"><tr style="HEIGHT:15pt"> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:179pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" width="239" valign="bottom"> <p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;sans-serif&quot;; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal"><font style="FONT-SIZE:9pt; FONT-FAMILY:&quot;Times New Roman&quot;">/s/ Steve Sloan</font></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign="bottom"> <p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;sans-serif&quot;; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal"><font style="FONT-SIZE:9pt; FONT-FAMILY:&quot;Times New Roman&quot;">Steve Sloan</font></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign="bottom"> <p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;sans-serif&quot;; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal"><font style="FONT-SIZE:9pt; FONT-FAMILY:&quot;Times New Roman&quot;">Chief Financial Officer</font></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign="bottom"></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign="bottom"> <p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;sans-serif&quot;; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal"><font style="FONT-SIZE:9pt; FONT-FAMILY:&quot;Times New Roman&quot;">Date: January 12, 2022</font></p></td></tr></table><p style="MARGIN:0px"><br></p> <p style="MARGIN-BOTTOM:9px; MARGIN-TOP:0px"><br></p> <p style="MARGIN-BOTTOM:9px; MARGIN-TOP:0px"><br><br></p></body>
<!-- EDGAR Validation Code: 237E9F32 -->
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>bmra-20211130.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Wed Jan 12 20:33:18 UTC 2022 -->
<xs:schema xmlns:bmra="http://www.biomerica.com/20211130" elementFormDefault="qualified" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" targetNamespace="http://www.biomerica.com/20211130" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dtr="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="bmra-20211130_lab.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="bmra-20211130_pre.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="bmra-20211130_def.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="bmra-20211130_cal.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef"/>
      <link:roleType roleURI="http://www.biomerica.com/role/ConsolidatedBalanceSheet" id="bmra_r_ConsolidatedBalanceSheet">
        <link:definition>001 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.biomerica.com/role/ConsolidatedBalanceSheet_Parentheticals" id="bmra_r_ConsolidatedBalanceSheet_Parentheticals">
        <link:definition>002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.biomerica.com/role/ConsolidatedIncomeStatement" id="bmra_r_ConsolidatedIncomeStatement">
        <link:definition>003 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.biomerica.com/role/ConsolidatedIncomeStatementAlt0" id="bmra_r_ConsolidatedIncomeStatementAlt0">
        <link:definition>003 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED) Alternate 0</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.biomerica.com/role/ShareholdersEquityType2or3" id="bmra_r_ShareholdersEquityType2or3">
        <link:definition>004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.biomerica.com/role/ConsolidatedCashFlow" id="bmra_r_ConsolidatedCashFlow">
        <link:definition>005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.biomerica.com/role/BASISOFPRESENTATION" id="bmra_r_BASISOFPRESENTATION">
        <link:definition>006 - Disclosure - BASIS OF PRESENTATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIES" id="bmra_r_SIGNIFICANTACCOUNTINGPOLICIES">
        <link:definition>007 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.biomerica.com/role/SHAREHOLDERSEQUITY" id="bmra_r_SHAREHOLDERSEQUITY">
        <link:definition>008 - Disclosure - SHAREHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.biomerica.com/role/GEOGRAPHICINFORMATION" id="bmra_r_GEOGRAPHICINFORMATION">
        <link:definition>009 - Disclosure - GEOGRAPHIC INFORMATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.biomerica.com/role/LEASES" id="bmra_r_LEASES">
        <link:definition>010 - Disclosure - LEASES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.biomerica.com/role/COMMITMENTSANDCONTINGENCIES" id="bmra_r_COMMITMENTSANDCONTINGENCIES">
        <link:definition>011 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.biomerica.com/role/SUBSEQUENTEVENTS" id="bmra_r_SUBSEQUENTEVENTS">
        <link:definition>012 - Disclosure - SUBSEQUENT EVENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.biomerica.com/role/RESTATEMENTOFPREVIOUSLYISSUEDFINANCIALSTATEMENTS" id="bmra_r_RESTATEMENTOFPREVIOUSLYISSUEDFINANCIALSTATEMENTS">
        <link:definition>013 - Disclosure - RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.biomerica.com/role/AccountingPoliciesByPolicy" id="bmra_r_AccountingPoliciesByPolicy">
        <link:definition>014 - Disclosure - Accounting Policies, by Policy (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables" id="bmra_r_SIGNIFICANTACCOUNTINGPOLICIESTables">
        <link:definition>015 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.biomerica.com/role/GEOGRAPHICINFORMATIONTables" id="bmra_r_GEOGRAPHICINFORMATIONTables">
        <link:definition>016 - Disclosure - GEOGRAPHIC INFORMATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.biomerica.com/role/LEASESTables" id="bmra_r_LEASESTables">
        <link:definition>017 - Disclosure - LEASES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails" id="bmra_r_SIGNIFICANTACCOUNTINGPOLICIESDetails">
        <link:definition>018 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.biomerica.com/role/InventoriesTable" id="bmra_r_InventoriesTable">
        <link:definition>019 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details) - Inventories</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt+1Vq3zhhUlfDeP/RQUzUZihDO8dLtQrMZMNe4t6pAivP0axfdFZpsLdRcC6V+fMavDgd7cFnpNNH6/9LXkBbSc8G8uA9huUzxoSaIHwz4vVYlYkDywCEAeWuqQU5kjj/9if9ldPlDmKw//pZSBlTR0cJe8RogwaRs02nUMeYMwE483+biVhn5MQ5bch+ZobYI=] CSR-->
      <link:roleType roleURI="http://www.biomerica.com/role/OptionsActivityTable" id="bmra_r_OptionsActivityTable">
        <link:definition>020 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details) - Options Activity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.biomerica.com/role/RevenuefromcontractswithcustomersTable" id="bmra_r_RevenuefromcontractswithcustomersTable">
        <link:definition>021 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details) - Revenue from contracts with customers</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.biomerica.com/role/SHAREHOLDERSEQUITYDetails" id="bmra_r_SHAREHOLDERSEQUITYDetails">
        <link:definition>022 - Disclosure - SHAREHOLDERS' EQUITY (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.biomerica.com/role/GEOGRAPHICINFORMATIONDetails" id="bmra_r_GEOGRAPHICINFORMATIONDetails">
        <link:definition>023 - Disclosure - GEOGRAPHIC INFORMATION (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.biomerica.com/role/GeographicinformationregardingnetsalesTable" id="bmra_r_GeographicinformationregardingnetsalesTable">
        <link:definition>024 - Disclosure - GEOGRAPHIC INFORMATION (Details) - Geographic information regarding net sales</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.biomerica.com/role/LEASESDetails" id="bmra_r_LEASESDetails">
        <link:definition>025 - Disclosure - LEASES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.biomerica.com/role/SupplementalcashflowinformationrelatedtoleasesTable" id="bmra_r_SupplementalcashflowinformationrelatedtoleasesTable">
        <link:definition>026 - Disclosure - LEASES (Details) - Supplemental cash flow information related to leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.biomerica.com/role/ThematurityofleaseliabilitiesTable" id="bmra_r_ThematurityofleaseliabilitiesTable">
        <link:definition>027 - Disclosure - LEASES (Details) - The maturity of lease liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.biomerica.com/role/SUBSEQUENTEVENTSDetails" id="bmra_r_SUBSEQUENTEVENTSDetails">
        <link:definition>028 - Disclosure - SUBSEQUENT EVENTS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.biomerica.com/role/RestatementontheconsolidatedstatementofoperationsandtheconsolidatedstatementofcashflowsTable" id="bmra_r_RestatementontheconsolidatedstatementofoperationsandtheconsolidatedstatementofcashflowsTable">
        <link:definition>029 - Disclosure - RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Details) - Restatement on the consolidated statement of operations and the consolidated statement of cash flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.biomerica.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000 - Document - Document And Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://fasb.org/srt-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/sic/2021" schemaLocation="https://xbrl.sec.gov/sic/2021/sic-2021.xsd"/>
  <xs:element name="InventoriesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_InventoriesAbstract"/>
  <xs:element name="OptionsActivityAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_OptionsActivityAbstract"/>
  <xs:element name="RevenueFromContractsWithCustomersAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_RevenueFromContractsWithCustomersAbstract"/>
  <xs:element name="GeographicInformationDisclosureAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_GeographicInformationDisclosureAbstract"/>
  <xs:element name="GeographicInformationRegardingNetSalesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_GeographicInformationRegardingNetSalesAbstract"/>
  <xs:element name="SupplementalCashFlowInformationRelatedToLeasesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_SupplementalCashFlowInformationRelatedToLeasesAbstract"/>
  <xs:element name="TheMaturityOfLeaseLiabilitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_TheMaturityOfLeaseLiabilitiesAbstract"/>
  <xs:element name="RestatementOnTheConsolidatedStatementOfOperationsAndTheConsolidatedStatementOfCashFlowsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_RestatementOnTheConsolidatedStatementOfOperationsAndTheConsolidatedStatementOfCashFlowsAbstract"/>
  <xs:element name="TheAccompanyingNotesAreAnIntegralPartOfTheseStatementsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_TheAccompanyingNotesAreAnIntegralPartOfTheseStatementsAbstract"/>
  <xs:element name="TheAccompanyingNotesAreAnIntegralPartOfTheseStatementsAbstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_TheAccompanyingNotesAreAnIntegralPartOfTheseStatementsAbstract0"/>
  <xs:element name="TheAccompanyingNotesAreAnIntegralPartOfTheseStatementsAbstract00" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_TheAccompanyingNotesAreAnIntegralPartOfTheseStatementsAbstract00"/>
  <xs:element name="SupplementalDisclosureOfCashFlowInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_SupplementalDisclosureOfCashFlowInformationAbstract"/>
  <xs:element name="CashPaidDuringThePeriodForAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_CashPaidDuringThePeriodForAbstract"/>
  <xs:element name="TheAccompanyingNotesAreAnIntegralPartOfTheseStatementsAbstract000" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_TheAccompanyingNotesAreAnIntegralPartOfTheseStatementsAbstract000"/>
  <xs:element name="RevenuesFromSalesToUnaffiliatedCustomersAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_RevenuesFromSalesToUnaffiliatedCustomersAbstract"/>
  <xs:element name="RightOfUseAssetsObtainedInExchangeForAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_RightOfUseAssetsObtainedInExchangeForAbstract"/>
  <xs:element name="OperatingExpensesAbstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_OperatingExpensesAbstract0"/>
  <xs:element name="AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract"/>
  <xs:element name="OperatingLeaseRightOfUseAssetAccumulatedAmortization" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="bmra_OperatingLeaseRightOfUseAssetAccumulatedAmortization"/>
  <xs:element name="PreferredStockUndesignatedShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="bmra_PreferredStockUndesignatedShares"/>
  <xs:element name="IncreaseDecreaseInLeaseLiability" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="bmra_IncreaseDecreaseInLeaseLiability"/>
  <xs:element name="GeographicInformationDisclosureTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_GeographicInformationDisclosureTextBlock"/>
  <xs:element name="MarketsAndMethodsOfDistributionPolicyTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_MarketsAndMethodsOfDistributionPolicyTextBlock"/>
  <xs:element name="LiquidityPolicyTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_LiquidityPolicyTextBlock"/>
  <xs:element name="PrepaidsPolicyPolicyTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_PrepaidsPolicyPolicyTextBlock"/>
  <xs:element name="ScheduleOfCashFlowSupplementalDisclosuresRelatedToLeaseTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_ScheduleOfCashFlowSupplementalDisclosuresRelatedToLeaseTableTextBlock"/>
  <xs:element name="SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityTable"/>
  <xs:element name="SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityLineItems"/>
  <xs:element name="GEOGRAPHICINFORMATIONDetailsGeographicinformationregardingnetsalesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="bmra_GEOGRAPHICINFORMATIONDetailsGeographicinformationregardingnetsalesTable"/>
  <xs:element name="GEOGRAPHICINFORMATIONDetailsGeographicinformationregardingnetsalesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_GEOGRAPHICINFORMATIONDetailsGeographicinformationregardingnetsalesLineItems"/>
  <xs:element name="SIGNIFICANTACCOUNTINGPOLICIESDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsTable"/>
  <xs:element name="SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems"/>
  <xs:element name="ShelfRegistrationStatementMaximumAuthorizedCommonStockIssuanceValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="bmra_ShelfRegistrationStatementMaximumAuthorizedCommonStockIssuanceValue"/>
  <xs:element name="SHAREHOLDERSEQUITYDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="bmra_SHAREHOLDERSEQUITYDetailsTable"/>
  <xs:element name="SHAREHOLDERSEQUITYDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_SHAREHOLDERSEQUITYDetailsLineItems"/>
  <xs:element name="GEOGRAPHICINFORMATIONDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="bmra_GEOGRAPHICINFORMATIONDetailsTable"/>
  <xs:element name="GEOGRAPHICINFORMATIONDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_GEOGRAPHICINFORMATIONDetailsLineItems"/>
  <xs:element name="LeaseAmendmentDomain" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_LeaseAmendmentDomain"/>
  <xs:element name="PropertySubjectToOrAvailableForOperatingLease_Domain" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_PropertySubjectToOrAvailableForOperatingLease_Domain"/>
  <xs:element name="LEASESDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="bmra_LEASESDetailsTable"/>
  <xs:element name="LEASESDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_LEASESDetailsLineItems"/>
  <xs:element name="OperatingLeaseInitiationDate" type="xbrli:dateItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_OperatingLeaseInitiationDate"/>
  <xs:element name="RentPercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_RentPercentage"/>
  <xs:element name="SUBSEQUENTEVENTSDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="bmra_SUBSEQUENTEVENTSDetailsTable"/>
  <xs:element name="SUBSEQUENTEVENTSDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_SUBSEQUENTEVENTSDetailsLineItems"/>
  <xs:element name="LeaseAmendmentAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:dimensionItem" id="bmra_LeaseAmendmentAxis"/>
  <xs:element name="A5ConvertiblePreferredStockMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_A5ConvertiblePreferredStockMember"/>
  <xs:element name="BuildingInIrvineCaliforniaMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_BuildingInIrvineCaliforniaMember"/>
  <xs:element name="ClinicalLabMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_ClinicalLabMember"/>
  <xs:element name="ContractManufacturingMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_ContractManufacturingMember"/>
  <xs:element name="FirstAmendmentToLeaseMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_FirstAmendmentToLeaseMember"/>
  <xs:element name="OverthecounterMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_OverthecounterMember"/>
  <xs:element name="PhysiciansOfficeMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_PhysiciansOfficeMember"/>
  <xs:element name="PurchasedTechnologyRightsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_PurchasedTechnologyRightsMember"/>
  <xs:element name="RestatementOfCompanysFinancialStatementsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_RestatementOfCompanysFinancialStatementsMember"/>
  <xs:element name="TwoDistributorsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_TwoDistributorsMember"/>
  <xs:element name="TwoVendorsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_TwoVendorsMember"/>
  <xs:element name="DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_DocumentAndEntityInformationAbstract"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>bmra-20211130_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Wed Jan 12 20:33:18 UTC 2022 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="bmra-20211130.xsd#bmra_r_ConsolidatedBalanceSheet" roleURI="http://www.biomerica.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20211130.xsd#bmra_r_ConsolidatedIncomeStatement" roleURI="http://www.biomerica.com/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20211130.xsd#bmra_r_ConsolidatedCashFlow" roleURI="http://www.biomerica.com/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20211130.xsd#bmra_r_InventoriesTable" roleURI="http://www.biomerica.com/role/InventoriesTable"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20211130.xsd#bmra_r_ThematurityofleaseliabilitiesTable" roleURI="http://www.biomerica.com/role/ThematurityofleaseliabilitiesTable"/>
  <calculationLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/ConsolidatedBalanceSheet">
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_InventoryNet" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsCurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Investments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Investments"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Investments" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_OtherAssetsNoncurrent" order="6" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_ContractWithCustomerLiability" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_LiabilitiesCurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_CommitmentsAndContingencies" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_PreferredStockValue" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_CommonStockValue" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AdditionalPaidInCapital" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="6" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_Liabilities" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_StockholdersEquity" order="2" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/ConsolidatedIncomeStatement">
    <loc xlink:type="locator" xlink:label="us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_Revenues" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_CostOfRevenue" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_GrossProfit" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingExpenses" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_OperatingIncomeLoss" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeInterestAndDividend" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterestAndDividend"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_InvestmentIncomeInterestAndDividend" order="2" weight="1"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt+1Vq3zhhUlfDeP/RQUzUZihDO8dLtQrMZMNe4t6pAivP0axfdFZpsLdRcC6V+fMavDgd7cFnpNNH6/9LXkBbSc8G8uA9huUzxoSaIHwz4vVYlYkDywCEAeWuqQU5kjj/9if9ldPlDmKw//pZSBlTR0cJe8RogwaRtrh0VYY6eVHjx/9VlB1OlJsc56xRX9JbA=] CSR-->
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_NetIncomeLoss" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" order="2" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/ConsolidatedCashFlow">
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetIncomeLoss" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_DepreciationAndAmortization" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProvisionForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ProvisionForDoubtfulAccounts" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryLIFOReservePeriodCharge" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryLIFOReservePeriodCharge"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_InventoryLIFOReservePeriodCharge" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockOptionPlanExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockOptionPlanExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_StockOptionPlanExpense" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" order="6" weight="1"/>
    <loc xlink:type="locator" xlink:label="bmra_IncreaseDecreaseInLeaseLiability" xlink:href="bmra-20211130.xsd#bmra_IncreaseDecreaseInLeaseLiability"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="bmra_IncreaseDecreaseInLeaseLiability" order="7" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" order="8" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" order="9" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" order="10" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable" order="11" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInInventories" order="12" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="13" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets" order="14" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets" order="1" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="2" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" order="4" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/InventoriesTable">
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryRawMaterialsNetOfReserves" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryWorkInProcessNetOfReserves" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryFinishedGoodsNetOfReserves" order="3" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/ThematurityofleaseliabilitiesTable">
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" order="5" weight="1"/>
  </calculationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>bmra-20211130_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Wed Jan 12 20:33:18 UTC 2022 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <roleRef xlink:type="simple" xlink:href="bmra-20211130.xsd#bmra_r_ConsolidatedBalanceSheet" roleURI="http://www.biomerica.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20211130.xsd#bmra_r_ConsolidatedBalanceSheet_Parentheticals" roleURI="http://www.biomerica.com/role/ConsolidatedBalanceSheet_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20211130.xsd#bmra_r_ConsolidatedIncomeStatement" roleURI="http://www.biomerica.com/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20211130.xsd#bmra_r_ShareholdersEquityType2or3" roleURI="http://www.biomerica.com/role/ShareholdersEquityType2or3"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20211130.xsd#bmra_r_ConsolidatedCashFlow" roleURI="http://www.biomerica.com/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20211130.xsd#bmra_r_BASISOFPRESENTATION" roleURI="http://www.biomerica.com/role/BASISOFPRESENTATION"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20211130.xsd#bmra_r_SIGNIFICANTACCOUNTINGPOLICIES" roleURI="http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIES"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20211130.xsd#bmra_r_SHAREHOLDERSEQUITY" roleURI="http://www.biomerica.com/role/SHAREHOLDERSEQUITY"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20211130.xsd#bmra_r_GEOGRAPHICINFORMATION" roleURI="http://www.biomerica.com/role/GEOGRAPHICINFORMATION"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20211130.xsd#bmra_r_LEASES" roleURI="http://www.biomerica.com/role/LEASES"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20211130.xsd#bmra_r_COMMITMENTSANDCONTINGENCIES" roleURI="http://www.biomerica.com/role/COMMITMENTSANDCONTINGENCIES"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20211130.xsd#bmra_r_SUBSEQUENTEVENTS" roleURI="http://www.biomerica.com/role/SUBSEQUENTEVENTS"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20211130.xsd#bmra_r_RESTATEMENTOFPREVIOUSLYISSUEDFINANCIALSTATEMENTS" roleURI="http://www.biomerica.com/role/RESTATEMENTOFPREVIOUSLYISSUEDFINANCIALSTATEMENTS"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20211130.xsd#bmra_r_AccountingPoliciesByPolicy" roleURI="http://www.biomerica.com/role/AccountingPoliciesByPolicy"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20211130.xsd#bmra_r_SIGNIFICANTACCOUNTINGPOLICIESTables" roleURI="http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20211130.xsd#bmra_r_GEOGRAPHICINFORMATIONTables" roleURI="http://www.biomerica.com/role/GEOGRAPHICINFORMATIONTables"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20211130.xsd#bmra_r_LEASESTables" roleURI="http://www.biomerica.com/role/LEASESTables"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20211130.xsd#bmra_r_InventoriesTable" roleURI="http://www.biomerica.com/role/InventoriesTable"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20211130.xsd#bmra_r_OptionsActivityTable" roleURI="http://www.biomerica.com/role/OptionsActivityTable"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20211130.xsd#bmra_r_RevenuefromcontractswithcustomersTable" roleURI="http://www.biomerica.com/role/RevenuefromcontractswithcustomersTable"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20211130.xsd#bmra_r_GeographicinformationregardingnetsalesTable" roleURI="http://www.biomerica.com/role/GeographicinformationregardingnetsalesTable"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20211130.xsd#bmra_r_SupplementalcashflowinformationrelatedtoleasesTable" roleURI="http://www.biomerica.com/role/SupplementalcashflowinformationrelatedtoleasesTable"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20211130.xsd#bmra_r_ThematurityofleaseliabilitiesTable" roleURI="http://www.biomerica.com/role/ThematurityofleaseliabilitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20211130.xsd#bmra_r_RestatementontheconsolidatedstatementofoperationsandtheconsolidatedstatementofcashflowsTable" roleURI="http://www.biomerica.com/role/RestatementontheconsolidatedstatementofoperationsandtheconsolidatedstatementofcashflowsTable"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20211130.xsd#bmra_r_SIGNIFICANTACCOUNTINGPOLICIESDetails" roleURI="http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20211130.xsd#bmra_r_SHAREHOLDERSEQUITYDetails" roleURI="http://www.biomerica.com/role/SHAREHOLDERSEQUITYDetails"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20211130.xsd#bmra_r_GEOGRAPHICINFORMATIONDetails" roleURI="http://www.biomerica.com/role/GEOGRAPHICINFORMATIONDetails"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20211130.xsd#bmra_r_LEASESDetails" roleURI="http://www.biomerica.com/role/LEASESDetails"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20211130.xsd#bmra_r_SUBSEQUENTEVENTSDetails" roleURI="http://www.biomerica.com/role/SUBSEQUENTEVENTSDetails"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20211130.xsd#DocumentAndEntityInformation" roleURI="http://www.biomerica.com/role/DocumentAndEntityInformation"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all"/>
  <definitionLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/ConsolidatedBalanceSheet">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableByTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableTypeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="us-gaap_EquityInterestIssuedOrIssuableTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmra_A5ConvertiblePreferredStockMember" xlink:href="bmra-20211130.xsd#bmra_A5ConvertiblePreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:to="bmra_A5ConvertiblePreferredStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesAPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesAPreferredStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsCurrentAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AccountsReceivableNetCurrent" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_InventoryNet" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Investments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Investments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_Investments" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_OtherAssetsNoncurrent" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_Assets" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesCurrentAbstract" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_ContractWithCustomerLiability" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_Liabilities" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_CommitmentsAndContingencies" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquityAbstract" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_PreferredStockValue" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapital" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="6" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/ConsolidatedBalanceSheet_Parentheticals">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableByTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableTypeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="us-gaap_EquityInterestIssuedOrIssuableTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmra_A5ConvertiblePreferredStockMember" xlink:href="bmra-20211130.xsd#bmra_A5ConvertiblePreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:to="bmra_A5ConvertiblePreferredStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesAPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesAPreferredStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmra_OperatingLeaseRightOfUseAssetAccumulatedAmortization" xlink:href="bmra-20211130.xsd#bmra_OperatingLeaseRightOfUseAssetAccumulatedAmortization"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="bmra_OperatingLeaseRightOfUseAssetAccumulatedAmortization" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockNoParValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockNoParValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockNoParValue" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmra_PreferredStockUndesignatedShares" xlink:href="bmra-20211130.xsd#bmra_PreferredStockUndesignatedShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="bmra_PreferredStockUndesignatedShares" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="14" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/ConsolidatedIncomeStatement">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_Revenues" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_CostOfRevenue" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CostOfRevenue" xlink:to="us-gaap_GrossProfit" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingExpensesAbstract" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_OperatingExpenses" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingIncomeLoss" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherIncomeAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OtherIncomeAndExpensesAbstract" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeInterestAndDividend" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterestAndDividend"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="us-gaap_InvestmentIncomeInterestAndDividend" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_NetIncomeLoss" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareBasic" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareDiluted" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax" order="12" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/ShareholdersEquityType2or3">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmra_A5ConvertiblePreferredStockMember" xlink:href="bmra-20211130.xsd#bmra_A5ConvertiblePreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="bmra_A5ConvertiblePreferredStockMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesIssued" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="9" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/ConsolidatedCashFlow">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetIncomeLoss" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_DepreciationAndAmortization" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProvisionForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ProvisionForDoubtfulAccounts" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryLIFOReservePeriodCharge" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryLIFOReservePeriodCharge"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_InventoryLIFOReservePeriodCharge" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockOptionPlanExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockOptionPlanExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_StockOptionPlanExpense" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInInventories" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmra_IncreaseDecreaseInLeaseLiability" xlink:href="bmra-20211130.xsd#bmra_IncreaseDecreaseInLeaseLiability"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="bmra_IncreaseDecreaseInLeaseLiability" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmra_CashPaidDuringThePeriodForAbstract" xlink:href="bmra-20211130.xsd#bmra_CashPaidDuringThePeriodForAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="bmra_CashPaidDuringThePeriodForAbstract" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxesPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_CashPaidDuringThePeriodForAbstract" xlink:to="us-gaap_IncomeTaxesPaid" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/BASISOFPRESENTATION">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BasisOfAccounting" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccounting"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_BasisOfAccounting" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIES">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/SHAREHOLDERSEQUITY">
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/GEOGRAPHICINFORMATION">
    <loc xlink:type="locator" xlink:label="bmra_GeographicInformationDisclosureAbstract" xlink:href="bmra-20211130.xsd#bmra_GeographicInformationDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="bmra_GeographicInformationDisclosureTextBlock" xlink:href="bmra-20211130.xsd#bmra_GeographicInformationDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_GeographicInformationDisclosureAbstract" xlink:to="bmra_GeographicInformationDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/LEASES">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/COMMITMENTSANDCONTINGENCIES">
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/SUBSEQUENTEVENTS">
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/RESTATEMENTOFPREVIOUSLYISSUEDFINANCIALSTATEMENTS">
    <loc xlink:type="locator" xlink:label="us-gaap_PriorPeriodAdjustmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PriorPeriodAdjustmentAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ErrorCorrectionTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ErrorCorrectionTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PriorPeriodAdjustmentAbstract" xlink:to="us-gaap_ErrorCorrectionTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/AccountingPoliciesByPolicy">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConsolidationPolicyTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmra_MarketsAndMethodsOfDistributionPolicyTextBlock" xlink:href="bmra-20211130.xsd#bmra_MarketsAndMethodsOfDistributionPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="bmra_MarketsAndMethodsOfDistributionPolicyTextBlock" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmra_LiquidityPolicyTextBlock" xlink:href="bmra-20211130.xsd#bmra_LiquidityPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="bmra_LiquidityPolicyTextBlock" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConcentrationRiskCreditRisk" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_TradeAndOtherAccountsReceivablePolicy" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmra_PrepaidsPolicyPolicyTextBlock" xlink:href="bmra-20211130.xsd#bmra_PrepaidsPolicyPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="bmra_PrepaidsPolicyPolicyTextBlock" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_InventoryPolicyTextBlock" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_InvestmentPolicyTextBlock" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfSalesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CostOfSalesPolicyTextBlock" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_IncomeTaxPolicyTextBlock" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" order="20" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_DisaggregationOfRevenueTableTextBlock" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/GEOGRAPHICINFORMATIONTables">
    <loc xlink:type="locator" xlink:label="bmra_GeographicInformationDisclosureAbstract" xlink:href="bmra-20211130.xsd#bmra_GeographicInformationDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_GeographicInformationDisclosureAbstract" xlink:to="us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/LEASESTables">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="bmra_ScheduleOfCashFlowSupplementalDisclosuresRelatedToLeaseTableTextBlock" xlink:href="bmra-20211130.xsd#bmra_ScheduleOfCashFlowSupplementalDisclosuresRelatedToLeaseTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="bmra_ScheduleOfCashFlowSupplementalDisclosuresRelatedToLeaseTableTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/InventoriesTable">
    <loc xlink:type="locator" xlink:label="bmra_InventoriesAbstract" xlink:href="bmra-20211130.xsd#bmra_InventoriesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_InventoriesAbstract" xlink:to="us-gaap_InventoryRawMaterialsNetOfReserves" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_InventoriesAbstract" xlink:to="us-gaap_InventoryWorkInProcessNetOfReserves" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_InventoriesAbstract" xlink:to="us-gaap_InventoryFinishedGoodsNetOfReserves" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_InventoriesAbstract" xlink:to="us-gaap_InventoryNet" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/OptionsActivityTable">
    <loc xlink:type="locator" xlink:label="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityLineItems" xlink:href="bmra-20211130.xsd#bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityLineItems"/>
    <loc xlink:type="locator" xlink:label="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityTable" xlink:href="bmra-20211130.xsd#bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityLineItems" xlink:to="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityTable" xlink:to="us-gaap_AwardTypeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt+1Vq3zhhUlfDeP/RQUzUZihDO8dLtQrMZMNe4t6pAivP0axfdFZpsLdRcC6V+fMavDgd7cFnpNNH6/9LXkBbSc8G8uA9huUzxoSaIHwz4vVYlYkDywCEAeWuqQU5kjj/9if9ldPlDmKw//pZSBlTR0cJe8RogwaRuOrAH9JsEdsECx4heVq3+Admibh074nzU=] CSR-->
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" order="8" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/RevenuefromcontractswithcustomersTable">
    <loc xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_DisaggregationOfRevenueTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_StatementBusinessSegmentsAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmra_PhysiciansOfficeMember" xlink:href="bmra-20211130.xsd#bmra_PhysiciansOfficeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentDomain" xlink:to="bmra_PhysiciansOfficeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmra_ClinicalLabMember" xlink:href="bmra-20211130.xsd#bmra_ClinicalLabMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentDomain" xlink:to="bmra_ClinicalLabMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmra_OverthecounterMember" xlink:href="bmra-20211130.xsd#bmra_OverthecounterMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentDomain" xlink:to="bmra_OverthecounterMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmra_ContractManufacturingMember" xlink:href="bmra-20211130.xsd#bmra_ContractManufacturingMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentDomain" xlink:to="bmra_ContractManufacturingMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/GeographicinformationregardingnetsalesTable">
    <loc xlink:type="locator" xlink:label="bmra_GEOGRAPHICINFORMATIONDetailsGeographicinformationregardingnetsalesLineItems" xlink:href="bmra-20211130.xsd#bmra_GEOGRAPHICINFORMATIONDetailsGeographicinformationregardingnetsalesLineItems"/>
    <loc xlink:type="locator" xlink:label="bmra_GEOGRAPHICINFORMATIONDetailsGeographicinformationregardingnetsalesTable" xlink:href="bmra-20211130.xsd#bmra_GEOGRAPHICINFORMATIONDetailsGeographicinformationregardingnetsalesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="bmra_GEOGRAPHICINFORMATIONDetailsGeographicinformationregardingnetsalesLineItems" xlink:to="bmra_GEOGRAPHICINFORMATIONDetailsGeographicinformationregardingnetsalesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="bmra_GEOGRAPHICINFORMATIONDetailsGeographicinformationregardingnetsalesTable" xlink:to="srt_StatementGeographicalAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain_0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_AsiaMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AsiaMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="srt_AsiaMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_EuropeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EuropeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="srt_EuropeMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_NorthAmericaMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NorthAmericaMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="srt_NorthAmericaMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MiddleEastMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MiddleEastMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="us-gaap_MiddleEastMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_SouthAmericaMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SouthAmericaMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="srt_SouthAmericaMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmra_RevenuesFromSalesToUnaffiliatedCustomersAbstract" xlink:href="bmra-20211130.xsd#bmra_RevenuesFromSalesToUnaffiliatedCustomersAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_GEOGRAPHICINFORMATIONDetailsGeographicinformationregardingnetsalesLineItems" xlink:to="bmra_RevenuesFromSalesToUnaffiliatedCustomersAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_RevenuesFromSalesToUnaffiliatedCustomersAbstract" xlink:to="us-gaap_Revenues" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/SupplementalcashflowinformationrelatedtoleasesTable">
    <loc xlink:type="locator" xlink:label="bmra_SupplementalCashFlowInformationRelatedToLeasesAbstract" xlink:href="bmra-20211130.xsd#bmra_SupplementalCashFlowInformationRelatedToLeasesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SupplementalCashFlowInformationRelatedToLeasesAbstract" xlink:to="us-gaap_OperatingLeasePayments" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmra_RightOfUseAssetsObtainedInExchangeForAbstract" xlink:href="bmra-20211130.xsd#bmra_RightOfUseAssetsObtainedInExchangeForAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SupplementalCashFlowInformationRelatedToLeasesAbstract" xlink:to="bmra_RightOfUseAssetsObtainedInExchangeForAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_RightOfUseAssetsObtainedInExchangeForAbstract" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SupplementalCashFlowInformationRelatedToLeasesAbstract" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SupplementalCashFlowInformationRelatedToLeasesAbstract" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/ThematurityofleaseliabilitiesTable">
    <loc xlink:type="locator" xlink:label="bmra_TheMaturityOfLeaseLiabilitiesAbstract" xlink:href="bmra-20211130.xsd#bmra_TheMaturityOfLeaseLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_TheMaturityOfLeaseLiabilitiesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_TheMaturityOfLeaseLiabilitiesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_TheMaturityOfLeaseLiabilitiesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_TheMaturityOfLeaseLiabilitiesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_TheMaturityOfLeaseLiabilitiesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_TheMaturityOfLeaseLiabilitiesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_TheMaturityOfLeaseLiabilitiesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_TheMaturityOfLeaseLiabilitiesAbstract" xlink:to="us-gaap_OperatingLeaseLiability" order="7" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/RestatementontheconsolidatedstatementofoperationsandtheconsolidatedstatementofcashflowsTable">
    <loc xlink:type="locator" xlink:label="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:to="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsForErrorCorrectionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForErrorCorrectionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis" xlink:to="us-gaap_AdjustmentsForErrorCorrectionDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsForErrorCorrectionDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForErrorCorrectionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis" xlink:to="us-gaap_AdjustmentsForErrorCorrectionDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioPreviouslyReportedMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsForErrorCorrectionDomain" xlink:to="srt_ScenarioPreviouslyReportedMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsForErrorCorrectionDomain" xlink:to="srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmra_RestatementOfCompanysFinancialStatementsMember" xlink:href="bmra-20211130.xsd#bmra_RestatementOfCompanysFinancialStatementsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsForErrorCorrectionDomain" xlink:to="bmra_RestatementOfCompanysFinancialStatementsMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_CostOfGoodsAndServicesSold" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_GrossProfit" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_OperatingExpensesAbstract" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpenses" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_OperatingIncomeLoss" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_EarningsPerShareBasic" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_EarningsPerShareDiluted" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmra_AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" xlink:href="bmra-20211130.xsd#bmra_AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="bmra_AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockOptionPlanExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockOptionPlanExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_StockOptionPlanExpense" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails">
    <loc xlink:type="locator" xlink:label="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:href="bmra-20211130.xsd#bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsTable" xlink:href="bmra-20211130.xsd#bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsTable" xlink:to="us-gaap_ConcentrationRiskByTypeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskTypeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsTable" xlink:to="srt_RangeAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember_0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsTable" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsTable" xlink:to="us-gaap_AwardTypeAxis" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmra_TwoDistributorsMember" xlink:href="bmra-20211130.xsd#bmra_TwoDistributorsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="bmra_TwoDistributorsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmra_TwoVendorsMember" xlink:href="bmra-20211130.xsd#bmra_TwoVendorsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="bmra_TwoVendorsMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DistributionRightsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DistributionRightsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_DistributionRightsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmra_PurchasedTechnologyRightsMember" xlink:href="bmra-20211130.xsd#bmra_PurchasedTechnologyRightsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="bmra_PurchasedTechnologyRightsMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PatentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PatentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_PatentsMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SalesRevenueNetMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_SalesRevenueNetMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsReceivableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_AccountsReceivableMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfGoodsProductLineMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsProductLineMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_CostOfGoodsProductLineMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_AccountsPayableMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CustomerConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConcentrationRiskTypeDomain" xlink:to="us-gaap_CustomerConcentrationRiskMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SupplierConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplierConcentrationRiskMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConcentrationRiskTypeDomain" xlink:to="us-gaap_SupplierConcentrationRiskMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmra_ShelfRegistrationStatementMaximumAuthorizedCommonStockIssuanceValue" xlink:href="bmra-20211130.xsd#bmra_ShelfRegistrationStatementMaximumAuthorizedCommonStockIssuanceValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="bmra_ShelfRegistrationStatementMaximumAuthorizedCommonStockIssuanceValue" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashUninsuredAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashUninsuredAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_CashUninsuredAmount" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_ConcentrationRiskPercentage1" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ThresholdPeriodPastDueForWriteoffOfTradeAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ThresholdPeriodPastDueForWriteoffOfTradeAccountsReceivable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_ThresholdPeriodPastDueForWriteoffOfTradeAccountsReceivable" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_PrepaidExpenseAndOtherAssets" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryValuationReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryValuationReserves"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_InventoryValuationReserves" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryLIFOReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryLIFOReserve"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_InventoryLIFOReserve" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_DepreciationDepletionAndAmortization" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_AmortizationOfIntangibleAssets" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherResearchAndDevelopmentExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_OtherResearchAndDevelopmentExpense" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="22" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/SHAREHOLDERSEQUITYDetails">
    <loc xlink:type="locator" xlink:label="bmra_SHAREHOLDERSEQUITYDetailsLineItems" xlink:href="bmra-20211130.xsd#bmra_SHAREHOLDERSEQUITYDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="bmra_SHAREHOLDERSEQUITYDetailsTable" xlink:href="bmra-20211130.xsd#bmra_SHAREHOLDERSEQUITYDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="bmra_SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="bmra_SHAREHOLDERSEQUITYDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableByTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="bmra_SHAREHOLDERSEQUITYDetailsTable" xlink:to="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableTypeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="us-gaap_EquityInterestIssuedOrIssuableTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="bmra_SHAREHOLDERSEQUITYDetailsTable" xlink:to="srt_RangeAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember_0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="bmra_SHAREHOLDERSEQUITYDetailsTable" xlink:to="us-gaap_AwardTypeAxis" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:to="us-gaap_CommonStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/GEOGRAPHICINFORMATIONDetails">
    <loc xlink:type="locator" xlink:label="bmra_GEOGRAPHICINFORMATIONDetailsLineItems" xlink:href="bmra-20211130.xsd#bmra_GEOGRAPHICINFORMATIONDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="bmra_GEOGRAPHICINFORMATIONDetailsTable" xlink:href="bmra-20211130.xsd#bmra_GEOGRAPHICINFORMATIONDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="bmra_GEOGRAPHICINFORMATIONDetailsLineItems" xlink:to="bmra_GEOGRAPHICINFORMATIONDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="bmra_GEOGRAPHICINFORMATIONDetailsTable" xlink:to="srt_StatementGeographicalAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain_0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="country_MX" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_MX"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_MX" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_GEOGRAPHICINFORMATIONDetailsLineItems" xlink:to="us-gaap_NumberOfReportableSegments" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryGross"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_GEOGRAPHICINFORMATIONDetailsLineItems" xlink:to="us-gaap_InventoryGross" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_GEOGRAPHICINFORMATIONDetailsLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/LEASESDetails">
    <loc xlink:type="locator" xlink:label="bmra_LEASESDetailsLineItems" xlink:href="bmra-20211130.xsd#bmra_LEASESDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="bmra_LEASESDetailsTable" xlink:href="bmra-20211130.xsd#bmra_LEASESDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="bmra_LEASESDetailsLineItems" xlink:to="bmra_LEASESDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="bmra_LEASESDetailsTable" xlink:to="srt_StatementGeographicalAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain_0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmra_LeaseAmendmentAxis" xlink:href="bmra-20211130.xsd#bmra_LeaseAmendmentAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="bmra_LEASESDetailsTable" xlink:to="bmra_LeaseAmendmentAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmra_LeaseAmendmentDomain" xlink:href="bmra-20211130.xsd#bmra_LeaseAmendmentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="bmra_LeaseAmendmentAxis" xlink:to="bmra_LeaseAmendmentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmra_LeaseAmendmentDomain_0" xlink:href="bmra-20211130.xsd#bmra_LeaseAmendmentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="bmra_LeaseAmendmentAxis" xlink:to="bmra_LeaseAmendmentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="bmra_LEASESDetailsTable" xlink:to="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmra_PropertySubjectToOrAvailableForOperatingLease_Domain" xlink:href="bmra-20211130.xsd#bmra_PropertySubjectToOrAvailableForOperatingLease_Domain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:to="bmra_PropertySubjectToOrAvailableForOperatingLease_Domain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmra_PropertySubjectToOrAvailableForOperatingLease_Domain_0" xlink:href="bmra-20211130.xsd#bmra_PropertySubjectToOrAvailableForOperatingLease_Domain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:to="bmra_PropertySubjectToOrAvailableForOperatingLease_Domain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmra_FirstAmendmentToLeaseMember" xlink:href="bmra-20211130.xsd#bmra_FirstAmendmentToLeaseMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_LeaseAmendmentDomain" xlink:to="bmra_FirstAmendmentToLeaseMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmra_BuildingInIrvineCaliforniaMember" xlink:href="bmra-20211130.xsd#bmra_BuildingInIrvineCaliforniaMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_PropertySubjectToOrAvailableForOperatingLease_Domain" xlink:to="bmra_BuildingInIrvineCaliforniaMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyAvailableForOperatingLeaseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyAvailableForOperatingLeaseMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_PropertySubjectToOrAvailableForOperatingLease_Domain" xlink:to="us-gaap_PropertyAvailableForOperatingLeaseMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="country_MX" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_MX"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_MX" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmra_OperatingLeaseInitiationDate" xlink:href="bmra-20211130.xsd#bmra_OperatingLeaseInitiationDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_LEASESDetailsLineItems" xlink:to="bmra_OperatingLeaseInitiationDate" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseExpirationDate1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseExpirationDate1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_LEASESDetailsLineItems" xlink:to="us-gaap_LeaseExpirationDate1" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsForRent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_LEASESDetailsLineItems" xlink:to="us-gaap_PaymentsForRent" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseAndRentalExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseAndRentalExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_LEASESDetailsLineItems" xlink:to="us-gaap_LeaseAndRentalExpense" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_LEASESDetailsLineItems" xlink:to="us-gaap_OperatingLeaseExpense" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmra_RentPercentage" xlink:href="bmra-20211130.xsd#bmra_RentPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_LEASESDetailsLineItems" xlink:to="bmra_RentPercentage" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SecurityDeposit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecurityDeposit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_LEASESDetailsLineItems" xlink:to="us-gaap_SecurityDeposit" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasesRentExpenseMinimumRentals" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesRentExpenseMinimumRentals"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_LEASESDetailsLineItems" xlink:to="us-gaap_OperatingLeasesRentExpenseMinimumRentals" order="8" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/SUBSEQUENTEVENTSDetails">
    <loc xlink:type="locator" xlink:label="bmra_SUBSEQUENTEVENTSDetailsLineItems" xlink:href="bmra-20211130.xsd#bmra_SUBSEQUENTEVENTSDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="bmra_SUBSEQUENTEVENTSDetailsTable" xlink:href="bmra-20211130.xsd#bmra_SUBSEQUENTEVENTSDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="bmra_SUBSEQUENTEVENTSDetailsLineItems" xlink:to="bmra_SUBSEQUENTEVENTSDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="bmra_SUBSEQUENTEVENTSDetailsTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SUBSEQUENTEVENTSDetailsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SUBSEQUENTEVENTSDetailsLineItems" xlink:to="us-gaap_SharePrice" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SUBSEQUENTEVENTSDetailsLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SUBSEQUENTEVENTSDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SUBSEQUENTEVENTSDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SUBSEQUENTEVENTSDetailsLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" order="6" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentInformationLineItems"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentInformationTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCommonStockSharesOutstanding" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCurrentReportingStatus" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFilerCategory" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalYearFocus" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalPeriodFocus" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntitySmallBusiness" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityShellCompany" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentQuarterlyReport" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentTransitionReport" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="22" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" order="23" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="24" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" order="25" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="26" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" order="27" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" order="28" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityInteractiveDataCurrent" order="29" xbrldt:closed="true"/>
  </definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>bmra-20211130_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Wed Jan 12 20:33:18 UTC 2022 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
  <labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of Financial Position [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl0" xml:lang="en-US">Cash and cash equivalents at beginning of period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl1" xml:lang="en-US">Cash and cash equivalents at end of period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl2" xml:lang="en-US">Cash and cash equivalents at end of period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl2"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xml:lang="en-US">Accounts receivable, less allowance for doubtful accounts of $27,777 and $837,415 as of November 30, 2021 and May 31, 2021, respectively</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl" xml:lang="en-US">Allowance for doubtful accounts (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryNet_lbl" xml:lang="en-US">Inventories, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_InventoryNet_lbl0" xml:lang="en-US">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xml:lang="en-US">Prepaid expenses and other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">Property and equipment, net of accumulated depreciation and amortization of $2,026,764 and $1,972,357 as of November 30, 2021 and May 31, 2021, respectively</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl0" xml:lang="en-US">Property, Plant and Equipment, Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xml:lang="en-US">Accumulated depreciation and amortization (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xml:lang="en-US">Right of use assets, net of accumulated amortization of $595,116 and $469,077 as of November 30, 2021 and May 31, 2021, respectively</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_OperatingLeaseRightOfUseAssetAccumulatedAmortization" xlink:href="bmra-20211130.xsd#bmra_OperatingLeaseRightOfUseAssetAccumulatedAmortization"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_OperatingLeaseRightOfUseAssetAccumulatedAmortization_lbl" xml:lang="en-US">Accumulated amortization, Right of Use Assets (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_OperatingLeaseRightOfUseAssetAccumulatedAmortization" xlink:to="bmra_OperatingLeaseRightOfUseAssetAccumulatedAmortization_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Investments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Investments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Investments_lbl" xml:lang="en-US">Investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Investments" xlink:to="us-gaap_Investments_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xml:lang="en-US">Intangible assets, net of accumulated amortization of $91,030 and $126,769 as of November 30, 2021 and May 31, 2021, respectively</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xml:lang="en-US">Accumulated amortization, Intangible Assets (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xml:lang="en-US">Other assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">Total Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accounts payable and accrued expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xml:lang="en-US">Accrued compensation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ContractWithCustomerLiability_lbl" xml:lang="en-US">Advance from customers</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiability" xlink:to="us-gaap_ContractWithCustomerLiability_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xml:lang="en-US">Lease liability, current portion</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xml:lang="en-US">Lease liability, net of current portion</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">Total Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US">Commitments and contingencies (Notes 1 and 6)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableByTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis_lbl" xml:lang="en-US">Equity Interest Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US">Preferred stock, Series A 5% convertible, $0.08 par value, 571,429 shares authorized, none issued and outstanding as of November 30, 2021 and May 31, 2021</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockValue_lbl0" xml:lang="en-US">Preferred stock, undesignated, no par value, 4,428,571 shares authorized, none issued and outstanding as of November 30, 2021 and May 31, 2021</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Preferred Stock, Par Value (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Preferred Stock, shares authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US">Preferred Stock, shares issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US">Preferred Stock, shares outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockNoParValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockNoParValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockNoParValue_lbl" xml:lang="en-US">Preferred Stock, No Par Value (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockNoParValue" xlink:to="us-gaap_PreferredStockNoParValue_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_PreferredStockUndesignatedShares" xlink:href="bmra-20211130.xsd#bmra_PreferredStockUndesignatedShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_PreferredStockUndesignatedShares_lbl" xml:lang="en-US">Preferred Stock, undesignated shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_PreferredStockUndesignatedShares" xlink:to="bmra_PreferredStockUndesignatedShares_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common stock, $0.08 par value, 25,000,000 shares authorized, 12,692,327 and 12,307,157 issued and outstanding at November 30, 2021 and May 31, 2021, respectively</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common stock par value (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common stock, shares authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common stock, shares issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common stock, shares outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">Additional paid-in-capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xml:lang="en-US">Accumulated other comprehensive loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl0" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total Shareholders&apos; Equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquity_lbl0" xml:lang="en-US">Balances</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquity_lbl1" xml:lang="en-US">Balances</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">Total Liabilities and Shareholders&apos; Equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Income Statement [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Revenues_lbl" xml:lang="en-US">Net sales</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_Revenues_lbl0" xml:lang="en-US">Net Sales</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_CostOfRevenue_lbl" xml:lang="en-US">Cost of sales</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfRevenue" xlink:to="us-gaap_CostOfRevenue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_GrossProfit_lbl" xml:lang="en-US">Gross profit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GrossProfit_lbl0" xml:lang="en-US">Gross Profit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xml:lang="en-US">Selling, general and administrative</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US">Research and development</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingExpenses_lbl" xml:lang="en-US">Total operating expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpenses_lbl0" xml:lang="en-US">Total operating expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">Loss from operations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_lbl0" xml:lang="en-US">Loss from operations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeInterestAndDividend" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterestAndDividend"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentIncomeInterestAndDividend_lbl" xml:lang="en-US">Dividend and interest income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeInterestAndDividend" xlink:to="us-gaap_InvestmentIncomeInterestAndDividend_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US">Loss before income taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl0" xml:lang="en-US">Loss before income taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Provision for income taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_lbl0" xml:lang="en-US">Net loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US">Basic net loss per common share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xml:lang="en-US">Diluted net loss per common share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US">Basic (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xml:lang="en-US">Diluted (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_lbl" xml:lang="en-US">Foreign currency translation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xml:lang="en-US">Comprehensive loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl0" xml:lang="en-US">Comprehensive loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xml:lang="en-US">Statement of Stockholders&apos; Equity [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesIssued_lbl" xml:lang="en-US">Balances (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssued" xlink:to="us-gaap_SharesIssued_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesIssued_lbl0" xml:lang="en-US">Balances (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssued" xlink:to="us-gaap_SharesIssued_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xml:lang="en-US">Exercise of stock options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US">Exercise of stock options (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl0" xml:lang="en-US">Option Exercised, Shares | shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl1" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_lbl" xml:lang="en-US">Compensation expense in connection with options granted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xml:lang="en-US">Net proceeds from ATM</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US">Net proceeds from ATM (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl0" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationAndAmortization_lbl" xml:lang="en-US">Depreciation and amortization</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationAndAmortization" xlink:to="us-gaap_DepreciationAndAmortization_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProvisionForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProvisionForDoubtfulAccounts_lbl" xml:lang="en-US">Change in allowance on accounts receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProvisionForDoubtfulAccounts" xlink:to="us-gaap_ProvisionForDoubtfulAccounts_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryLIFOReservePeriodCharge" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryLIFOReservePeriodCharge"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryLIFOReservePeriodCharge_lbl" xml:lang="en-US">Inventory reserve</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryLIFOReservePeriodCharge" xlink:to="us-gaap_InventoryLIFOReservePeriodCharge_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockOptionPlanExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockOptionPlanExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockOptionPlanExpense_lbl" xml:lang="en-US">Stock option expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockOptionPlanExpense" xlink:to="us-gaap_StockOptionPlanExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl" xml:lang="en-US">Amortization of right-of-use asset</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xml:lang="en-US">Accounts receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xml:lang="en-US">Inventories</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xml:lang="en-US">Prepaid expenses and other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_IncreaseDecreaseInLeaseLiability" xlink:href="bmra-20211130.xsd#bmra_IncreaseDecreaseInLeaseLiability"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_IncreaseDecreaseInLeaseLiability_lbl" xml:lang="en-US">Reduction in lease liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_IncreaseDecreaseInLeaseLiability" xlink:to="bmra_IncreaseDecreaseInLeaseLiability_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl" xml:lang="en-US">Other assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US">Accounts payable and accrued expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_lbl" xml:lang="en-US">Accrued compensation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_lbl" xml:lang="en-US">Advance from customers</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash provided by (used in) operating activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl0" xml:lang="en-US">Net cash used in operating activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_lbl" xml:lang="en-US">Increase in intangibles</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US">Purchases of property and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash used in investing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US">Proceeds from sale of common stock, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl0" xml:lang="en-US">Proceeds from Issuance of Common Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xml:lang="en-US">Proceeds from exercise of stock options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl0" xml:lang="en-US">Proceeds from Stock Options Exercised</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash provided by financing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_lbl" xml:lang="en-US">Effect of exchange rate changes in cash</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:to="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xml:lang="en-US">Net increase (decrease) in cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxesPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxesPaid_lbl" xml:lang="en-US">Income taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaid" xlink:to="us-gaap_IncomeTaxesPaid_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_InventoriesAbstract" xlink:href="bmra-20211130.xsd#bmra_InventoriesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_InventoriesAbstract_lbl" xml:lang="en-US">Inventories [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_InventoriesAbstract" xlink:to="bmra_InventoriesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryRawMaterialsNetOfReserves_lbl" xml:lang="en-US">Raw materials</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="us-gaap_InventoryRawMaterialsNetOfReserves_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryWorkInProcessNetOfReserves_lbl" xml:lang="en-US">Work in progress</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="us-gaap_InventoryWorkInProcessNetOfReserves_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryFinishedGoodsNetOfReserves_lbl" xml:lang="en-US">Finished products</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="us-gaap_InventoryFinishedGoodsNetOfReserves_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_OptionsActivityAbstract" xlink:href="bmra-20211130.xsd#bmra_OptionsActivityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_OptionsActivityAbstract_lbl" xml:lang="en-US">Options Activity [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_OptionsActivityAbstract" xlink:to="bmra_OptionsActivityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US">Options Outstanding, Shares | shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl0" xml:lang="en-US">Options Outstanding, Shares | shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Option Outstanding, Exercise Price Weighted Average | $ / shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Option Outstanding, Exercise Price Weighted Average | $ / shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xml:lang="en-US">Option Granted, Shares | shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl0" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl1" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Option Granted, Exercise Price Weighted Average | $ / shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl1" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Option Exercised, Exercise Price Weighted Average | $ / shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl" xml:lang="en-US">Option Cancelled or expired, Shares | shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Option Cancelled or expired, Exercise Price Weighted Average | $ / shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US">Award Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_RevenueFromContractsWithCustomersAbstract" xlink:href="bmra-20211130.xsd#bmra_RevenueFromContractsWithCustomersAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_RevenueFromContractsWithCustomersAbstract_lbl" xml:lang="en-US">Revenue from contracts with customers [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_RevenueFromContractsWithCustomersAbstract" xlink:to="bmra_RevenueFromContractsWithCustomersAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementBusinessSegmentsAxis_lbl" xml:lang="en-US">Segments [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_StatementBusinessSegmentsAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xml:lang="en-US">Revenue From Customers</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteAbstract_lbl" xml:lang="en-US">Stockholders&apos; Equity Note [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_StockholdersEquityNoteAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_GeographicInformationDisclosureAbstract" xlink:href="bmra-20211130.xsd#bmra_GeographicInformationDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_GeographicInformationDisclosureAbstract_lbl" xml:lang="en-US">Geographic Information Disclosure [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_GeographicInformationDisclosureAbstract" xlink:to="bmra_GeographicInformationDisclosureAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_GeographicInformationRegardingNetSalesAbstract" xlink:href="bmra-20211130.xsd#bmra_GeographicInformationRegardingNetSalesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_GeographicInformationRegardingNetSalesAbstract_lbl" xml:lang="en-US">Geographic information regarding net sales [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_GeographicInformationRegardingNetSalesAbstract" xlink:to="bmra_GeographicInformationRegardingNetSalesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementGeographicalAxis_lbl" xml:lang="en-US">Geographical [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_StatementGeographicalAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureTextBlockAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureTextBlockAbstract_lbl" xml:lang="en-US">Disclosure Text Block [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_DisclosureTextBlockAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_SupplementalCashFlowInformationRelatedToLeasesAbstract" xlink:href="bmra-20211130.xsd#bmra_SupplementalCashFlowInformationRelatedToLeasesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_SupplementalCashFlowInformationRelatedToLeasesAbstract_lbl" xml:lang="en-US">Supplemental cash flow information related to leases [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_SupplementalCashFlowInformationRelatedToLeasesAbstract" xlink:to="bmra_SupplementalCashFlowInformationRelatedToLeasesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasePayments_lbl" xml:lang="en-US">Operating cash flows from operating leases</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasePayments" xlink:to="us-gaap_OperatingLeasePayments_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl" xml:lang="en-US">Right-of-use assets obtained in exchange for new operating lease liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xml:lang="en-US">Weighted average remaining lease term (in years)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xml:lang="en-US">Weighted average discount rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_TheMaturityOfLeaseLiabilitiesAbstract" xlink:href="bmra-20211130.xsd#bmra_TheMaturityOfLeaseLiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_TheMaturityOfLeaseLiabilitiesAbstract_lbl" xml:lang="en-US">The maturity of lease liabilities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_TheMaturityOfLeaseLiabilitiesAbstract" xlink:to="bmra_TheMaturityOfLeaseLiabilitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_lbl" xml:lang="en-US">Less than 1 year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xml:lang="en-US">1 to 2 years</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xml:lang="en-US">2 to 3 years</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xml:lang="en-US">3 to 4 years</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xml:lang="en-US">4 to 5 years</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xml:lang="en-US">Total undiscounted lease payments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xml:lang="en-US">Less imputed interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xml:lang="en-US">Total operating lease liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PriorPeriodAdjustmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PriorPeriodAdjustmentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PriorPeriodAdjustmentAbstract_lbl" xml:lang="en-US">Prior Period Adjustment [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PriorPeriodAdjustmentAbstract" xlink:to="us-gaap_PriorPeriodAdjustmentAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_RestatementOnTheConsolidatedStatementOfOperationsAndTheConsolidatedStatementOfCashFlowsAbstract" xlink:href="bmra-20211130.xsd#bmra_RestatementOnTheConsolidatedStatementOfOperationsAndTheConsolidatedStatementOfCashFlowsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_RestatementOnTheConsolidatedStatementOfOperationsAndTheConsolidatedStatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Restatement on the consolidated statement of operations and the consolidated statement of cash flows [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_RestatementOnTheConsolidatedStatementOfOperationsAndTheConsolidatedStatementOfCashFlowsAbstract" xlink:to="bmra_RestatementOnTheConsolidatedStatementOfOperationsAndTheConsolidatedStatementOfCashFlowsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfGoodsAndServicesSold_lbl" xml:lang="en-US">Cost of sales</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfGoodsAndServicesSold" xlink:to="us-gaap_CostOfGoodsAndServicesSold_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_lbl" xml:lang="en-US">Error Correction, Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis" xlink:to="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current Assets:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">Liabilities and Shareholders&apos; Equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Current Liabilities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">Shareholders&apos; Equity:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_TheAccompanyingNotesAreAnIntegralPartOfTheseStatementsAbstract" xlink:href="bmra-20211130.xsd#bmra_TheAccompanyingNotesAreAnIntegralPartOfTheseStatementsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmra_TheAccompanyingNotesAreAnIntegralPartOfTheseStatementsAbstract_lbl" xml:lang="en-US">The accompanying notes are an integral part of these statements.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_TheAccompanyingNotesAreAnIntegralPartOfTheseStatementsAbstract" xlink:to="bmra_TheAccompanyingNotesAreAnIntegralPartOfTheseStatementsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xml:lang="en-US">Operating expenses:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingExpensesAbstract_lbl0" xml:lang="en-US">Operating Expenses:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherIncomeAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherIncomeAndExpensesAbstract_lbl" xml:lang="en-US">Other income:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="us-gaap_OtherIncomeAndExpensesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl" xml:lang="en-US">Weighted average number of common and common equivalent shares:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_lbl" xml:lang="en-US">Other comprehensive loss, net of tax:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_TheAccompanyingNotesAreAnIntegralPartOfTheseStatementsAbstract0" xlink:href="bmra-20211130.xsd#bmra_TheAccompanyingNotesAreAnIntegralPartOfTheseStatementsAbstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmra_TheAccompanyingNotesAreAnIntegralPartOfTheseStatementsAbstract0_lbl" xml:lang="en-US">The accompanying notes are an integral part of these statements.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_TheAccompanyingNotesAreAnIntegralPartOfTheseStatementsAbstract0" xlink:to="bmra_TheAccompanyingNotesAreAnIntegralPartOfTheseStatementsAbstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_TheAccompanyingNotesAreAnIntegralPartOfTheseStatementsAbstract00" xlink:href="bmra-20211130.xsd#bmra_TheAccompanyingNotesAreAnIntegralPartOfTheseStatementsAbstract00"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmra_TheAccompanyingNotesAreAnIntegralPartOfTheseStatementsAbstract00_lbl" xml:lang="en-US">The accompanying notes are an integral part of these statements.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_TheAccompanyingNotesAreAnIntegralPartOfTheseStatementsAbstract00" xlink:to="bmra_TheAccompanyingNotesAreAnIntegralPartOfTheseStatementsAbstract00_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from operating activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to reconcile net loss to net cash provided by (used in) operating activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US">Changes in assets and liabilities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from investing activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from financing activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_SupplementalDisclosureOfCashFlowInformationAbstract" xlink:href="bmra-20211130.xsd#bmra_SupplementalDisclosureOfCashFlowInformationAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmra_SupplementalDisclosureOfCashFlowInformationAbstract_lbl" xml:lang="en-US">Supplemental Disclosure of Cash-Flow Information:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_SupplementalDisclosureOfCashFlowInformationAbstract" xlink:to="bmra_SupplementalDisclosureOfCashFlowInformationAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_CashPaidDuringThePeriodForAbstract" xlink:href="bmra-20211130.xsd#bmra_CashPaidDuringThePeriodForAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmra_CashPaidDuringThePeriodForAbstract_lbl" xml:lang="en-US">Cash paid during the period for:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_CashPaidDuringThePeriodForAbstract" xlink:to="bmra_CashPaidDuringThePeriodForAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_TheAccompanyingNotesAreAnIntegralPartOfTheseStatementsAbstract000" xlink:href="bmra-20211130.xsd#bmra_TheAccompanyingNotesAreAnIntegralPartOfTheseStatementsAbstract000"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmra_TheAccompanyingNotesAreAnIntegralPartOfTheseStatementsAbstract000_lbl" xml:lang="en-US">The accompanying notes are an integral part of these statements</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_TheAccompanyingNotesAreAnIntegralPartOfTheseStatementsAbstract000" xlink:to="bmra_TheAccompanyingNotesAreAnIntegralPartOfTheseStatementsAbstract000_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_A5ConvertiblePreferredStockMember" xlink:href="bmra-20211130.xsd#bmra_A5ConvertiblePreferredStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmra_A5ConvertiblePreferredStockMember_lbl" xml:lang="en-US">5% Convertible Preferred Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_A5ConvertiblePreferredStockMember" xlink:to="bmra_A5ConvertiblePreferredStockMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesAPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SeriesAPreferredStockMember_lbl" xml:lang="en-US">Series A Preferred Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesAPreferredStockMember" xlink:to="us-gaap_SeriesAPreferredStockMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional Paid-in Capital [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xml:lang="en-US">AOCI Attributable to Parent [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Retained Earnings [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BasisOfAccounting" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccounting"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BasisOfAccounting_lbl" xml:lang="en-US">Basis of Accounting [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccounting" xlink:to="us-gaap_BasisOfAccounting_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">Significant Accounting Policies [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xml:lang="en-US">Share-based Payment Arrangement, Option, Activity [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US">Stockholders&apos; Equity Note Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_GeographicInformationDisclosureTextBlock" xlink:href="bmra-20211130.xsd#bmra_GeographicInformationDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmra_GeographicInformationDisclosureTextBlock_lbl" xml:lang="en-US">Geographic Information Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_GeographicInformationDisclosureTextBlock" xlink:to="bmra_GeographicInformationDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_lbl" xml:lang="en-US">Revenue from External Customers by Geographic Areas [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:to="us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_RevenuesFromSalesToUnaffiliatedCustomersAbstract" xlink:href="bmra-20211130.xsd#bmra_RevenuesFromSalesToUnaffiliatedCustomersAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmra_RevenuesFromSalesToUnaffiliatedCustomersAbstract_lbl" xml:lang="en-US">Revenues from sales to unaffiliated customers:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_RevenuesFromSalesToUnaffiliatedCustomersAbstract" xlink:to="bmra_RevenuesFromSalesToUnaffiliatedCustomersAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xml:lang="en-US">Lessee, Operating Leases [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_ScheduleOfCashFlowSupplementalDisclosuresRelatedToLeaseTableTextBlock" xlink:href="bmra-20211130.xsd#bmra_ScheduleOfCashFlowSupplementalDisclosuresRelatedToLeaseTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmra_ScheduleOfCashFlowSupplementalDisclosuresRelatedToLeaseTableTextBlock_lbl" xml:lang="en-US">Schedule Of Cash Flow Supplemental Disclosures Related To Lease [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_ScheduleOfCashFlowSupplementalDisclosuresRelatedToLeaseTableTextBlock" xlink:to="bmra_ScheduleOfCashFlowSupplementalDisclosuresRelatedToLeaseTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_RightOfUseAssetsObtainedInExchangeForAbstract" xlink:href="bmra-20211130.xsd#bmra_RightOfUseAssetsObtainedInExchangeForAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmra_RightOfUseAssetsObtainedInExchangeForAbstract_lbl" xml:lang="en-US">Right-of-use assets obtained in exchange for</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_RightOfUseAssetsObtainedInExchangeForAbstract" xlink:to="bmra_RightOfUseAssetsObtainedInExchangeForAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">Subsequent Events [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ErrorCorrectionTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ErrorCorrectionTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ErrorCorrectionTextBlock_lbl" xml:lang="en-US">Error Correction [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ErrorCorrectionTextBlock" xlink:to="us-gaap_ErrorCorrectionTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_OperatingExpensesAbstract0" xlink:href="bmra-20211130.xsd#bmra_OperatingExpensesAbstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmra_OperatingExpensesAbstract0_lbl" xml:lang="en-US">Operating Expenses:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_OperatingExpensesAbstract0" xlink:to="bmra_OperatingExpensesAbstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" xlink:href="bmra-20211130.xsd#bmra_AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmra_AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" xlink:to="bmra_AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOptionMember" xlink:to="us-gaap_EmployeeStockOptionMember_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_PhysiciansOfficeMember" xlink:href="bmra-20211130.xsd#bmra_PhysiciansOfficeMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmra_PhysiciansOfficeMember_lbl" xml:lang="en-US">Physicians Office [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_PhysiciansOfficeMember" xlink:to="bmra_PhysiciansOfficeMember_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_ClinicalLabMember" xlink:href="bmra-20211130.xsd#bmra_ClinicalLabMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmra_ClinicalLabMember_lbl" xml:lang="en-US">Clinical Lab [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_ClinicalLabMember" xlink:to="bmra_ClinicalLabMember_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_OverthecounterMember" xlink:href="bmra-20211130.xsd#bmra_OverthecounterMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmra_OverthecounterMember_lbl" xml:lang="en-US">Over-the-counter [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_OverthecounterMember" xlink:to="bmra_OverthecounterMember_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_ContractManufacturingMember" xlink:href="bmra-20211130.xsd#bmra_ContractManufacturingMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmra_ContractManufacturingMember_lbl" xml:lang="en-US">Contract Manufacturing [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_ContractManufacturingMember" xlink:to="bmra_ContractManufacturingMember_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_AsiaMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AsiaMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_AsiaMember_lbl" xml:lang="en-US">Asia [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_AsiaMember" xlink:to="srt_AsiaMember_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_EuropeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EuropeMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_EuropeMember_lbl" xml:lang="en-US">Europe [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_EuropeMember" xlink:to="srt_EuropeMember_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_NorthAmericaMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NorthAmericaMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_NorthAmericaMember_lbl" xml:lang="en-US">North America [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_NorthAmericaMember" xlink:to="srt_NorthAmericaMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MiddleEastMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MiddleEastMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_MiddleEastMember_lbl" xml:lang="en-US">Middle East [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MiddleEastMember" xlink:to="us-gaap_MiddleEastMember_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_SouthAmericaMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SouthAmericaMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_SouthAmericaMember_lbl" xml:lang="en-US">South America [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_SouthAmericaMember" xlink:to="srt_SouthAmericaMember_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioPreviouslyReportedMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_ScenarioPreviouslyReportedMember_lbl" xml:lang="en-US">Previously Reported [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioPreviouslyReportedMember" xlink:to="srt_ScenarioPreviouslyReportedMember_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember_lbl" xml:lang="en-US">Revision of Prior Period, Error Correction, Adjustment [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember" xlink:to="srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_RestatementOfCompanysFinancialStatementsMember" xlink:href="bmra-20211130.xsd#bmra_RestatementOfCompanysFinancialStatementsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmra_RestatementOfCompanysFinancialStatementsMember_lbl" xml:lang="en-US">Restatement Of Companys Financial Statements [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_RestatementOfCompanysFinancialStatementsMember" xlink:to="bmra_RestatementOfCompanysFinancialStatementsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xml:lang="en-US">Concentration Risk Benchmark [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByTypeAxis_lbl" xml:lang="en-US">Concentration Risk Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskByTypeAxis_lbl"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt+1Vq3zhhUlfDeP/RQUzUZihDO8dLtQrMZMNe4t6pAivP0axfdFZpsLdRcC6V+fMavDgd7cFnpNNH6/9LXkBbSc8G8uA9huUzxoSaIHwz4vVYlYkDywCEAeWuqQU5kjj/9if9ldPlDmKw//pZSBlTR0cJe8RogwaRsLqhbw+5nWfnS3zpr+4LoPV9Ho7IbBLJQ=] CSR-->
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xml:lang="en-US">Related Party [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeAxis_lbl" xml:lang="en-US">Statistical Measurement [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis_lbl" xml:lang="en-US">Property Subject to or Available for Operating Lease [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:to="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_LeaseAmendmentAxis" xlink:href="bmra-20211130.xsd#bmra_LeaseAmendmentAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmra_LeaseAmendmentAxis_lbl" xml:lang="en-US">Lease Amendment [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_LeaseAmendmentAxis" xlink:to="bmra_LeaseAmendmentAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xml:lang="en-US">Subsequent Event Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_ShelfRegistrationStatementMaximumAuthorizedCommonStockIssuanceValue" xlink:href="bmra-20211130.xsd#bmra_ShelfRegistrationStatementMaximumAuthorizedCommonStockIssuanceValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmra_ShelfRegistrationStatementMaximumAuthorizedCommonStockIssuanceValue_lbl" xml:lang="en-US">Shelf Registration Statement, Maximum Authorized Common Stock Issuance, Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_ShelfRegistrationStatementMaximumAuthorizedCommonStockIssuanceValue" xlink:to="bmra_ShelfRegistrationStatementMaximumAuthorizedCommonStockIssuanceValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashUninsuredAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashUninsuredAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashUninsuredAmount_lbl" xml:lang="en-US">Cash, Uninsured Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashUninsuredAmount" xlink:to="us-gaap_CashUninsuredAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConcentrationRiskPercentage1_lbl" xml:lang="en-US">Concentration Risk, Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskPercentage1" xlink:to="us-gaap_ConcentrationRiskPercentage1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ThresholdPeriodPastDueForWriteoffOfTradeAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ThresholdPeriodPastDueForWriteoffOfTradeAccountsReceivable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ThresholdPeriodPastDueForWriteoffOfTradeAccountsReceivable_lbl" xml:lang="en-US">Threshold Period Past Due for Write-off of Trade Accounts Receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ThresholdPeriodPastDueForWriteoffOfTradeAccountsReceivable" xlink:to="us-gaap_ThresholdPeriodPastDueForWriteoffOfTradeAccountsReceivable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent_lbl" xml:lang="en-US">Allowance for Credit Loss, Receivable, Other, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent" xlink:to="us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PrepaidExpenseAndOtherAssets_lbl" xml:lang="en-US">Prepaid Expense and Other Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssets" xlink:to="us-gaap_PrepaidExpenseAndOtherAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryValuationReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryValuationReserves"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InventoryValuationReserves_lbl" xml:lang="en-US">Inventory Valuation Reserves</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryValuationReserves" xlink:to="us-gaap_InventoryValuationReserves_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryLIFOReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryLIFOReserve"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InventoryLIFOReserve_lbl" xml:lang="en-US">Inventory, LIFO Reserve</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryLIFOReserve" xlink:to="us-gaap_InventoryLIFOReserve_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xml:lang="en-US">Property, Plant and Equipment, Useful Life</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xml:lang="en-US">Depreciation, Depletion and Amortization</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl" xml:lang="en-US">Amortization of Intangible Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xml:lang="en-US">Equity Method Investment, Ownership Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_lbl" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherResearchAndDevelopmentExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherResearchAndDevelopmentExpense_lbl" xml:lang="en-US">Other Research and Development Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherResearchAndDevelopmentExpense" xlink:to="us-gaap_OtherResearchAndDevelopmentExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xml:lang="en-US">Share-based Payment Arrangement, Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xml:lang="en-US">Sale of Stock, Number of Shares Issued in Transaction (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl" xml:lang="en-US">Sale of Stock, Price Per Share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl" xml:lang="en-US">Sale of Stock, Consideration Received on Transaction</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NumberOfReportableSegments_lbl" xml:lang="en-US">Number of Reportable Segments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NumberOfReportableSegments" xlink:to="us-gaap_NumberOfReportableSegments_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryGross"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InventoryGross_lbl" xml:lang="en-US">Inventory, Gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryGross" xlink:to="us-gaap_InventoryGross_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_OperatingLeaseInitiationDate" xlink:href="bmra-20211130.xsd#bmra_OperatingLeaseInitiationDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmra_OperatingLeaseInitiationDate_lbl" xml:lang="en-US">Operating Lease Initiation Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_OperatingLeaseInitiationDate" xlink:to="bmra_OperatingLeaseInitiationDate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseExpirationDate1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseExpirationDate1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LeaseExpirationDate1_lbl" xml:lang="en-US">Lease Expiration Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseExpirationDate1" xlink:to="us-gaap_LeaseExpirationDate1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsForRent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PaymentsForRent_lbl" xml:lang="en-US">Payments for Rent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRent" xlink:to="us-gaap_PaymentsForRent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseAndRentalExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseAndRentalExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LeaseAndRentalExpense_lbl" xml:lang="en-US">Operating Leases, Rent Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseAndRentalExpense" xlink:to="us-gaap_LeaseAndRentalExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeaseExpense_lbl" xml:lang="en-US">Operating Lease, Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseExpense" xlink:to="us-gaap_OperatingLeaseExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_RentPercentage" xlink:href="bmra-20211130.xsd#bmra_RentPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmra_RentPercentage_lbl" xml:lang="en-US">Rent Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_RentPercentage" xlink:to="bmra_RentPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SecurityDeposit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecurityDeposit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SecurityDeposit_lbl" xml:lang="en-US">Security Deposit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SecurityDeposit" xlink:to="us-gaap_SecurityDeposit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasesRentExpenseMinimumRentals" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesRentExpenseMinimumRentals"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeasesRentExpenseMinimumRentals_lbl" xml:lang="en-US">Operating Leases, Rent Expense, Minimum Rentals</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesRentExpenseMinimumRentals" xlink:to="us-gaap_OperatingLeasesRentExpenseMinimumRentals_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharePrice_lbl" xml:lang="en-US">Share Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_MarketsAndMethodsOfDistributionPolicyTextBlock" xlink:href="bmra-20211130.xsd#bmra_MarketsAndMethodsOfDistributionPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmra_MarketsAndMethodsOfDistributionPolicyTextBlock_lbl" xml:lang="en-US">Markets And Methods Of Distribution [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_MarketsAndMethodsOfDistributionPolicyTextBlock" xlink:to="bmra_MarketsAndMethodsOfDistributionPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_LiquidityPolicyTextBlock" xlink:href="bmra-20211130.xsd#bmra_LiquidityPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmra_LiquidityPolicyTextBlock_lbl" xml:lang="en-US">Liquidity [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_LiquidityPolicyTextBlock" xlink:to="bmra_LiquidityPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy_lbl" xml:lang="en-US">Accounts Receivable [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:to="us-gaap_TradeAndOtherAccountsReceivablePolicy_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_PrepaidsPolicyPolicyTextBlock" xlink:href="bmra-20211130.xsd#bmra_PrepaidsPolicyPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmra_PrepaidsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Prepaids Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_PrepaidsPolicyPolicyTextBlock" xlink:to="bmra_PrepaidsPolicyPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InventoryPolicyTextBlock_lbl" xml:lang="en-US">Inventory, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryPolicyTextBlock" xlink:to="us-gaap_InventoryPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl" xml:lang="en-US">Goodwill and Intangible Assets, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:to="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InvestmentPolicyTextBlock_lbl" xml:lang="en-US">Investment, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentPolicyTextBlock" xlink:to="us-gaap_InvestmentPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xml:lang="en-US">Share-based Payment Arrangement [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xml:lang="en-US">Revenue [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfSalesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CostOfSalesPolicyTextBlock_lbl" xml:lang="en-US">Cost of Goods and Service [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfSalesPolicyTextBlock" xlink:to="us-gaap_CostOfSalesPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xml:lang="en-US">Lessee, Leases [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SalesRevenueNetMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SalesRevenueNetMember_lbl" xml:lang="en-US">Revenue Benchmark [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesRevenueNetMember" xlink:to="us-gaap_SalesRevenueNetMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CustomerConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CustomerConcentrationRiskMember_lbl" xml:lang="en-US">Customer Concentration Risk [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerConcentrationRiskMember" xlink:to="us-gaap_CustomerConcentrationRiskMember_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_TwoDistributorsMember" xlink:href="bmra-20211130.xsd#bmra_TwoDistributorsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmra_TwoDistributorsMember_lbl" xml:lang="en-US">Two Distributors [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_TwoDistributorsMember" xlink:to="bmra_TwoDistributorsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsReceivableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccountsReceivableMember_lbl" xml:lang="en-US">Accounts Receivable [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableMember" xlink:to="us-gaap_AccountsReceivableMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfGoodsProductLineMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsProductLineMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CostOfGoodsProductLineMember_lbl" xml:lang="en-US">Cost of Goods and Service, Product and Service Benchmark [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfGoodsProductLineMember" xlink:to="us-gaap_CostOfGoodsProductLineMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SupplierConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplierConcentrationRiskMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SupplierConcentrationRiskMember_lbl" xml:lang="en-US">Supplier Concentration Risk [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplierConcentrationRiskMember" xlink:to="us-gaap_SupplierConcentrationRiskMember_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_TwoVendorsMember" xlink:href="bmra-20211130.xsd#bmra_TwoVendorsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmra_TwoVendorsMember_lbl" xml:lang="en-US">Two Vendors [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_TwoVendorsMember" xlink:to="bmra_TwoVendorsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccountsPayableMember_lbl" xml:lang="en-US">Accounts Payable [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableMember" xlink:to="us-gaap_AccountsPayableMember_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_MinimumMember_lbl" xml:lang="en-US">Minimum [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_MaximumMember_lbl" xml:lang="en-US">Maximum [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DistributionRightsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DistributionRightsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DistributionRightsMember_lbl" xml:lang="en-US">Distribution Rights [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DistributionRightsMember" xlink:to="us-gaap_DistributionRightsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_PurchasedTechnologyRightsMember" xlink:href="bmra-20211130.xsd#bmra_PurchasedTechnologyRightsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmra_PurchasedTechnologyRightsMember_lbl" xml:lang="en-US">Purchased Technology Rights [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_PurchasedTechnologyRightsMember" xlink:to="bmra_PurchasedTechnologyRightsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PatentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PatentsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PatentsMember_lbl" xml:lang="en-US">Patents [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PatentsMember" xlink:to="us-gaap_PatentsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="country_MX" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_MX"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="country_MX_lbl" xml:lang="en-US">MEXICO</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_MX" xlink:to="country_MX_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_BuildingInIrvineCaliforniaMember" xlink:href="bmra-20211130.xsd#bmra_BuildingInIrvineCaliforniaMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmra_BuildingInIrvineCaliforniaMember_lbl" xml:lang="en-US">Building In Irvine California [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_BuildingInIrvineCaliforniaMember" xlink:to="bmra_BuildingInIrvineCaliforniaMember_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_FirstAmendmentToLeaseMember" xlink:href="bmra-20211130.xsd#bmra_FirstAmendmentToLeaseMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmra_FirstAmendmentToLeaseMember_lbl" xml:lang="en-US">First Amendment To Lease [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_FirstAmendmentToLeaseMember" xlink:to="bmra_FirstAmendmentToLeaseMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyAvailableForOperatingLeaseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyAvailableForOperatingLeaseMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyAvailableForOperatingLeaseMember_lbl" xml:lang="en-US">Property Available for Operating Lease [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyAvailableForOperatingLeaseMember" xlink:to="us-gaap_PropertyAvailableForOperatingLeaseMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SubsequentEventMember_lbl" xml:lang="en-US">Subsequent Event [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityInterestIssuedOrIssuableTypeDomain_lbl" xml:lang="en-US">Equity Interest Issued or Issuable, Type [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:to="us-gaap_EquityInterestIssuedOrIssuableTypeDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfStockDomain_lbl" xml:lang="en-US">Class of Stock [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityComponentDomain_lbl" xml:lang="en-US">Equity Component [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_EquityComponentDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xml:lang="en-US">Award Type [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityTable" xlink:href="bmra-20211130.xsd#bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityTable_lbl" xml:lang="en-US">SIGNIFICANT ACCOUNTING POLICIES (Details) - Options Activity [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityTable" xlink:to="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityTable_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityLineItems" xlink:href="bmra-20211130.xsd#bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityLineItems_lbl" xml:lang="en-US">SIGNIFICANT ACCOUNTING POLICIES (Details) - Options Activity [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityLineItems" xlink:to="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentDomain_lbl" xml:lang="en-US">Segments [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentDomain" xlink:to="us-gaap_SegmentDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisaggregationOfRevenueTable_lbl" xml:lang="en-US">Disaggregation of Revenue [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_DisaggregationOfRevenueTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisaggregationOfRevenueLineItems_lbl" xml:lang="en-US">Disaggregation of Revenue [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_DisaggregationOfRevenueLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_SegmentGeographicalDomain_lbl" xml:lang="en-US">Geographical [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_SegmentGeographicalDomain" xlink:to="srt_SegmentGeographicalDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_GEOGRAPHICINFORMATIONDetailsGeographicinformationregardingnetsalesTable" xlink:href="bmra-20211130.xsd#bmra_GEOGRAPHICINFORMATIONDetailsGeographicinformationregardingnetsalesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_GEOGRAPHICINFORMATIONDetailsGeographicinformationregardingnetsalesTable_lbl" xml:lang="en-US">GEOGRAPHIC INFORMATION (Details) - Geographic information regarding net sales [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_GEOGRAPHICINFORMATIONDetailsGeographicinformationregardingnetsalesTable" xlink:to="bmra_GEOGRAPHICINFORMATIONDetailsGeographicinformationregardingnetsalesTable_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_GEOGRAPHICINFORMATIONDetailsGeographicinformationregardingnetsalesLineItems" xlink:href="bmra-20211130.xsd#bmra_GEOGRAPHICINFORMATIONDetailsGeographicinformationregardingnetsalesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_GEOGRAPHICINFORMATIONDetailsGeographicinformationregardingnetsalesLineItems_lbl" xml:lang="en-US">GEOGRAPHIC INFORMATION (Details) - Geographic information regarding net sales [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_GEOGRAPHICINFORMATIONDetailsGeographicinformationregardingnetsalesLineItems" xlink:to="bmra_GEOGRAPHICINFORMATIONDetailsGeographicinformationregardingnetsalesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsForErrorCorrectionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForErrorCorrectionDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsForErrorCorrectionDomain_lbl" xml:lang="en-US">Error Correction, Type [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsForErrorCorrectionDomain" xlink:to="us-gaap_AdjustmentsForErrorCorrectionDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_lbl" xml:lang="en-US">Schedule of Error Corrections and Prior Period Adjustment Restatement [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:to="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_lbl" xml:lang="en-US">Error Corrections and Prior Period Adjustments Restatement [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskTypeDomain_lbl" xml:lang="en-US">Concentration Risk Type [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskTypeDomain" xlink:to="us-gaap_ConcentrationRiskTypeDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeMember_lbl" xml:lang="en-US">Statistical Measurement [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeMember" xlink:to="srt_RangeMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain_lbl" xml:lang="en-US">Concentration Risk Benchmark [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyDomain_lbl" xml:lang="en-US">Related Party [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_RelatedPartyDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsTable" xlink:href="bmra-20211130.xsd#bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsTable_lbl" xml:lang="en-US">SIGNIFICANT ACCOUNTING POLICIES (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsTable" xlink:to="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:href="bmra-20211130.xsd#bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems_lbl" xml:lang="en-US">SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_SHAREHOLDERSEQUITYDetailsTable" xlink:href="bmra-20211130.xsd#bmra_SHAREHOLDERSEQUITYDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_SHAREHOLDERSEQUITYDetailsTable_lbl" xml:lang="en-US">SHAREHOLDERS&apos; EQUITY (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_SHAREHOLDERSEQUITYDetailsTable" xlink:to="bmra_SHAREHOLDERSEQUITYDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_SHAREHOLDERSEQUITYDetailsLineItems" xlink:href="bmra-20211130.xsd#bmra_SHAREHOLDERSEQUITYDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_SHAREHOLDERSEQUITYDetailsLineItems_lbl" xml:lang="en-US">SHAREHOLDERS&apos; EQUITY (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="bmra_SHAREHOLDERSEQUITYDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_GEOGRAPHICINFORMATIONDetailsTable" xlink:href="bmra-20211130.xsd#bmra_GEOGRAPHICINFORMATIONDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_GEOGRAPHICINFORMATIONDetailsTable_lbl" xml:lang="en-US">GEOGRAPHIC INFORMATION (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_GEOGRAPHICINFORMATIONDetailsTable" xlink:to="bmra_GEOGRAPHICINFORMATIONDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_GEOGRAPHICINFORMATIONDetailsLineItems" xlink:href="bmra-20211130.xsd#bmra_GEOGRAPHICINFORMATIONDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_GEOGRAPHICINFORMATIONDetailsLineItems_lbl" xml:lang="en-US">GEOGRAPHIC INFORMATION (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_GEOGRAPHICINFORMATIONDetailsLineItems" xlink:to="bmra_GEOGRAPHICINFORMATIONDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_LeaseAmendmentDomain" xlink:href="bmra-20211130.xsd#bmra_LeaseAmendmentDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_LeaseAmendmentDomain_lbl" xml:lang="en-US">LeaseAmendment [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_LeaseAmendmentDomain" xlink:to="bmra_LeaseAmendmentDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_PropertySubjectToOrAvailableForOperatingLease_Domain" xlink:href="bmra-20211130.xsd#bmra_PropertySubjectToOrAvailableForOperatingLease_Domain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_PropertySubjectToOrAvailableForOperatingLease_Domain_lbl" xml:lang="en-US">PropertySubjectToOrAvailableForOperatingLease_ [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_PropertySubjectToOrAvailableForOperatingLease_Domain" xlink:to="bmra_PropertySubjectToOrAvailableForOperatingLease_Domain_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_LEASESDetailsTable" xlink:href="bmra-20211130.xsd#bmra_LEASESDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_LEASESDetailsTable_lbl" xml:lang="en-US">LEASES (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_LEASESDetailsTable" xlink:to="bmra_LEASESDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_LEASESDetailsLineItems" xlink:href="bmra-20211130.xsd#bmra_LEASESDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_LEASESDetailsLineItems_lbl" xml:lang="en-US">LEASES (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_LEASESDetailsLineItems" xlink:to="bmra_LEASESDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeDomain_lbl" xml:lang="en-US">Subsequent Event Type [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventTypeDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_SUBSEQUENTEVENTSDetailsTable" xlink:href="bmra-20211130.xsd#bmra_SUBSEQUENTEVENTSDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_SUBSEQUENTEVENTSDetailsTable_lbl" xml:lang="en-US">SUBSEQUENT EVENTS (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_SUBSEQUENTEVENTSDetailsTable" xlink:to="bmra_SUBSEQUENTEVENTSDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_SUBSEQUENTEVENTSDetailsLineItems" xlink:href="bmra-20211130.xsd#bmra_SUBSEQUENTEVENTSDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_SUBSEQUENTEVENTSDetailsLineItems_lbl" xml:lang="en-US">SUBSEQUENT EVENTS (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_SUBSEQUENTEVENTSDetailsLineItems" xlink:to="bmra_SUBSEQUENTEVENTSDetailsLineItems_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="bmra_GeographicInformationDisclosureTextBlock_lbl0" xml:lang="en-US">The entire disclosure for reporting segments according to the geographic areas.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_GeographicInformationDisclosureTextBlock" xlink:to="bmra_GeographicInformationDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="bmra_IncreaseDecreaseInLeaseLiability_lbl0" xml:lang="en-US">The increase (decrease) during the reporting period in LeaseLiability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_IncreaseDecreaseInLeaseLiability" xlink:to="bmra_IncreaseDecreaseInLeaseLiability_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="bmra_LiquidityPolicyTextBlock_lbl0" xml:lang="en-US">Disclosure of accounting policy for liquidity position during the period.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_LiquidityPolicyTextBlock" xlink:to="bmra_LiquidityPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="bmra_MarketsAndMethodsOfDistributionPolicyTextBlock_lbl0" xml:lang="en-US">Disclosure of accounting policy for Markets And Methods Of Distribution during the period.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_MarketsAndMethodsOfDistributionPolicyTextBlock" xlink:to="bmra_MarketsAndMethodsOfDistributionPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="bmra_OperatingLeaseInitiationDate_lbl0" xml:lang="en-US">Date the operating lease was initiated, in CCYY-MM-DD format.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_OperatingLeaseInitiationDate" xlink:to="bmra_OperatingLeaseInitiationDate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="bmra_OperatingLeaseRightOfUseAssetAccumulatedAmortization_lbl0" xml:lang="en-US">Amount of accumulated amortization of right-of-use asset from operating lease</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_OperatingLeaseRightOfUseAssetAccumulatedAmortization" xlink:to="bmra_OperatingLeaseRightOfUseAssetAccumulatedAmortization_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="bmra_PreferredStockUndesignatedShares_lbl0" xml:lang="en-US">Number of preferred shares undesignated during the period.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_PreferredStockUndesignatedShares" xlink:to="bmra_PreferredStockUndesignatedShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="bmra_PrepaidsPolicyPolicyTextBlock_lbl0" xml:lang="en-US">Disclosure of accounting policy for prepaids.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_PrepaidsPolicyPolicyTextBlock" xlink:to="bmra_PrepaidsPolicyPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="bmra_RentPercentage_lbl0" xml:lang="en-US">Rent percentage.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_RentPercentage" xlink:to="bmra_RentPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="bmra_ScheduleOfCashFlowSupplementalDisclosuresRelatedToLeaseTableTextBlock_lbl0" xml:lang="en-US">Tabular disclosure of supplemental cash flow information related to lease for the periods.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_ScheduleOfCashFlowSupplementalDisclosuresRelatedToLeaseTableTextBlock" xlink:to="bmra_ScheduleOfCashFlowSupplementalDisclosuresRelatedToLeaseTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="bmra_ShelfRegistrationStatementMaximumAuthorizedCommonStockIssuanceValue_lbl0" xml:lang="en-US">Amount related with Maximum Authorized Common Stock Issuance of Shelf Registration Statement.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_ShelfRegistrationStatementMaximumAuthorizedCommonStockIssuanceValue" xlink:to="bmra_ShelfRegistrationStatementMaximumAuthorizedCommonStockIssuanceValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_RestatementOfCompanysFinancialStatementsMember_lbl0" xml:lang="en-US">RestatementOfCompanysFinancialStatementsMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_RestatementOfCompanysFinancialStatementsMember" xlink:to="bmra_RestatementOfCompanysFinancialStatementsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_A5ConvertiblePreferredStockMember_lbl0" xml:lang="en-US">A5ConvertiblePreferredStockMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_A5ConvertiblePreferredStockMember" xlink:to="bmra_A5ConvertiblePreferredStockMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_TheAccompanyingNotesAreAnIntegralPartOfTheseStatementsAbstract00_lbl0" xml:lang="en-US">TheAccompanyingNotesAreAnIntegralPartOfTheseStatementsAbstract00</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_TheAccompanyingNotesAreAnIntegralPartOfTheseStatementsAbstract00" xlink:to="bmra_TheAccompanyingNotesAreAnIntegralPartOfTheseStatementsAbstract00_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_ContractManufacturingMember_lbl0" xml:lang="en-US">ContractManufacturingMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_ContractManufacturingMember" xlink:to="bmra_ContractManufacturingMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_LiquidityPolicyTextBlock_lbl1" xml:lang="en-US">LiquidityPolicyTextBlock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_LiquidityPolicyTextBlock" xlink:to="bmra_LiquidityPolicyTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_OverthecounterMember_lbl0" xml:lang="en-US">OverthecounterMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_OverthecounterMember" xlink:to="bmra_OverthecounterMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_PurchasedTechnologyRightsMember_lbl0" xml:lang="en-US">PurchasedTechnologyRightsMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_PurchasedTechnologyRightsMember" xlink:to="bmra_PurchasedTechnologyRightsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_SupplementalDisclosureOfCashFlowInformationAbstract_lbl0" xml:lang="en-US">SupplementalDisclosureOfCashFlowInformationAbstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_SupplementalDisclosureOfCashFlowInformationAbstract" xlink:to="bmra_SupplementalDisclosureOfCashFlowInformationAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_TheAccompanyingNotesAreAnIntegralPartOfTheseStatementsAbstract_lbl0" xml:lang="en-US">TheAccompanyingNotesAreAnIntegralPartOfTheseStatementsAbstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_TheAccompanyingNotesAreAnIntegralPartOfTheseStatementsAbstract" xlink:to="bmra_TheAccompanyingNotesAreAnIntegralPartOfTheseStatementsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_LeaseAmendmentAxis_lbl0" xml:lang="en-US">LeaseAmendmentAxis</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_LeaseAmendmentAxis" xlink:to="bmra_LeaseAmendmentAxis_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_CashPaidDuringThePeriodForAbstract_lbl0" xml:lang="en-US">CashPaidDuringThePeriodForAbstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_CashPaidDuringThePeriodForAbstract" xlink:to="bmra_CashPaidDuringThePeriodForAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_ScheduleOfCashFlowSupplementalDisclosuresRelatedToLeaseTableTextBlock_lbl1" xml:lang="en-US">ScheduleOfCashFlowSupplementalDisclosuresRelatedToLeaseTableTextBlock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_ScheduleOfCashFlowSupplementalDisclosuresRelatedToLeaseTableTextBlock" xlink:to="bmra_ScheduleOfCashFlowSupplementalDisclosuresRelatedToLeaseTableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_RightOfUseAssetsObtainedInExchangeForAbstract_lbl0" xml:lang="en-US">RightOfUseAssetsObtainedInExchangeForAbstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_RightOfUseAssetsObtainedInExchangeForAbstract" xlink:to="bmra_RightOfUseAssetsObtainedInExchangeForAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_TwoDistributorsMember_lbl0" xml:lang="en-US">TwoDistributorsMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_TwoDistributorsMember" xlink:to="bmra_TwoDistributorsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_GeographicInformationDisclosureTextBlock_lbl1" xml:lang="en-US">GeographicInformationDisclosureTextBlock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_GeographicInformationDisclosureTextBlock" xlink:to="bmra_GeographicInformationDisclosureTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_BuildingInIrvineCaliforniaMember_lbl0" xml:lang="en-US">BuildingInIrvineCaliforniaMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_BuildingInIrvineCaliforniaMember" xlink:to="bmra_BuildingInIrvineCaliforniaMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_TheAccompanyingNotesAreAnIntegralPartOfTheseStatementsAbstract000_lbl0" xml:lang="en-US">TheAccompanyingNotesAreAnIntegralPartOfTheseStatementsAbstract000</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_TheAccompanyingNotesAreAnIntegralPartOfTheseStatementsAbstract000" xlink:to="bmra_TheAccompanyingNotesAreAnIntegralPartOfTheseStatementsAbstract000_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_MarketsAndMethodsOfDistributionPolicyTextBlock_lbl1" xml:lang="en-US">MarketsAndMethodsOfDistributionPolicyTextBlock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_MarketsAndMethodsOfDistributionPolicyTextBlock" xlink:to="bmra_MarketsAndMethodsOfDistributionPolicyTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_FirstAmendmentToLeaseMember_lbl0" xml:lang="en-US">FirstAmendmentToLeaseMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_FirstAmendmentToLeaseMember" xlink:to="bmra_FirstAmendmentToLeaseMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_RentPercentage_lbl1" xml:lang="en-US">RentPercentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_RentPercentage" xlink:to="bmra_RentPercentage_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_TwoVendorsMember_lbl0" xml:lang="en-US">TwoVendorsMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_TwoVendorsMember" xlink:to="bmra_TwoVendorsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_PhysiciansOfficeMember_lbl0" xml:lang="en-US">PhysiciansOfficeMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_PhysiciansOfficeMember" xlink:to="bmra_PhysiciansOfficeMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract_lbl0" xml:lang="en-US">AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" xlink:to="bmra_AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_PrepaidsPolicyPolicyTextBlock_lbl1" xml:lang="en-US">PrepaidsPolicyPolicyTextBlock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_PrepaidsPolicyPolicyTextBlock" xlink:to="bmra_PrepaidsPolicyPolicyTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_TheAccompanyingNotesAreAnIntegralPartOfTheseStatementsAbstract0_lbl0" xml:lang="en-US">TheAccompanyingNotesAreAnIntegralPartOfTheseStatementsAbstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_TheAccompanyingNotesAreAnIntegralPartOfTheseStatementsAbstract0" xlink:to="bmra_TheAccompanyingNotesAreAnIntegralPartOfTheseStatementsAbstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_OperatingLeaseInitiationDate_lbl1" xml:lang="en-US">OperatingLeaseInitiationDate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_OperatingLeaseInitiationDate" xlink:to="bmra_OperatingLeaseInitiationDate_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_RevenuesFromSalesToUnaffiliatedCustomersAbstract_lbl0" xml:lang="en-US">RevenuesFromSalesToUnaffiliatedCustomersAbstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_RevenuesFromSalesToUnaffiliatedCustomersAbstract" xlink:to="bmra_RevenuesFromSalesToUnaffiliatedCustomersAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_ClinicalLabMember_lbl0" xml:lang="en-US">ClinicalLabMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_ClinicalLabMember" xlink:to="bmra_ClinicalLabMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_OperatingExpensesAbstract0_lbl0" xml:lang="en-US">OperatingExpensesAbstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_OperatingExpensesAbstract0" xlink:to="bmra_OperatingExpensesAbstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_ShelfRegistrationStatementMaximumAuthorizedCommonStockIssuanceValue_lbl1" xml:lang="en-US">ShelfRegistrationStatementMaximumAuthorizedCommonStockIssuanceValue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_ShelfRegistrationStatementMaximumAuthorizedCommonStockIssuanceValue" xlink:to="bmra_ShelfRegistrationStatementMaximumAuthorizedCommonStockIssuanceValue_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl0" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpensesAbstract_lbl1" xml:lang="en-US">Operating Expenses [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl0" xml:lang="en-US">Additional Paid-in Capital [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_lbl0" xml:lang="en-US">Revenue from External Customers by Geographic Areas [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:to="us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent_lbl0" xml:lang="en-US">Allowance for Credit Loss, Receivable, Other, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent" xlink:to="us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryPolicyTextBlock_lbl0" xml:lang="en-US">Inventory, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryPolicyTextBlock" xlink:to="us-gaap_InventoryPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl0" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl0" xml:lang="en-US">Sale of Stock, Consideration Received on Transaction</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfSalesPolicyTextBlock_lbl0" xml:lang="en-US">Cost of Goods and Service [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfSalesPolicyTextBlock" xlink:to="us-gaap_CostOfSalesPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl0" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember_lbl0" xml:lang="en-US">Revision of Prior Period, Error Correction, Adjustment [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember" xlink:to="srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl0" xml:lang="en-US">Entity File Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl0" xml:lang="en-US">Entity Small Business</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_AsiaMember_lbl0" xml:lang="en-US">Asia [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_AsiaMember" xlink:to="srt_AsiaMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl0" xml:lang="en-US">Entity Address, City or Town</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherIncomeAndExpensesAbstract_lbl0" xml:lang="en-US">Other Income and Expenses [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="us-gaap_OtherIncomeAndExpensesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl0" xml:lang="en-US">Common Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl0" xml:lang="en-US">Significant Accounting Policies [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseExpirationDate1_lbl0" xml:lang="en-US">Lease Expiration Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseExpirationDate1" xlink:to="us-gaap_LeaseExpirationDate1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScenarioPreviouslyReportedMember_lbl0" xml:lang="en-US">Previously Reported [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioPreviouslyReportedMember" xlink:to="srt_ScenarioPreviouslyReportedMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl0" xml:lang="en-US">Entity Filer Category</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl0" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl0" xml:lang="en-US">Equity Method Investment, Ownership Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyAvailableForOperatingLeaseMember_lbl0" xml:lang="en-US">Property Available for Operating Lease [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyAvailableForOperatingLeaseMember" xlink:to="us-gaap_PropertyAvailableForOperatingLeaseMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl0" xml:lang="en-US">Entity Address, State or Province</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesIssued_lbl1" xml:lang="en-US">Shares, Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssued" xlink:to="us-gaap_SharesIssued_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl0" xml:lang="en-US">Increase (Decrease) in Inventories</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl0" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForRent_lbl0" xml:lang="en-US">Payments for Rent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRent" xlink:to="us-gaap_PaymentsForRent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy_lbl0" xml:lang="en-US">Accounts Receivable [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:to="us-gaap_TradeAndOtherAccountsReceivablePolicy_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl0" xml:lang="en-US">Employee-related Liabilities, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl0" xml:lang="en-US">Local Phone Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventMember_lbl0" xml:lang="en-US">Subsequent Event [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl0" xml:lang="en-US">Sale of Stock, Price Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl0" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl0" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl0" xml:lang="en-US">Entity Common Stock, Shares Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseAndRentalExpense_lbl0" xml:lang="en-US">Operating Leases, Rent Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseAndRentalExpense" xlink:to="us-gaap_LeaseAndRentalExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl0" xml:lang="en-US">Document Transition Report</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeStockOptionMember_lbl0" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOptionMember" xlink:to="us-gaap_EmployeeStockOptionMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl0" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl1" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractWithCustomerLiability_lbl0" xml:lang="en-US">Contract with Customer, Liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiability" xlink:to="us-gaap_ContractWithCustomerLiability_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl0" xml:lang="en-US">Entity Shell Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ErrorCorrectionTextBlock_lbl0" xml:lang="en-US">Error Correction [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ErrorCorrectionTextBlock" xlink:to="us-gaap_ErrorCorrectionTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl0" xml:lang="en-US">Share-based Payment Arrangement, Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl0" xml:lang="en-US">Entity Incorporation, State or Country Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl0" xml:lang="en-US">Security Exchange Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MiddleEastMember_lbl0" xml:lang="en-US">Middle East [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MiddleEastMember" xlink:to="us-gaap_MiddleEastMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl0" xml:lang="en-US">Entity Address, Address Line One</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl0" xml:lang="en-US">Assets [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SeriesAPreferredStockMember_lbl0" xml:lang="en-US">Series A Preferred Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesAPreferredStockMember" xlink:to="us-gaap_SeriesAPreferredStockMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentPolicyTextBlock_lbl0" xml:lang="en-US">Investment, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentPolicyTextBlock" xlink:to="us-gaap_InvestmentPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_lbl0" xml:lang="en-US">Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl0" xml:lang="en-US">Title of 12(b) Security</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryGross_lbl0" xml:lang="en-US">Inventory, Gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryGross" xlink:to="us-gaap_InventoryGross_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl0" xml:lang="en-US">Retained Earnings [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl1" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_lbl0" xml:lang="en-US">Lessee, Operating Leases [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl0" xml:lang="en-US">Goodwill and Intangible Assets, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:to="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl0" xml:lang="en-US">Income Tax Expense (Benefit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl0" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MaximumMember_lbl0" xml:lang="en-US">Maximum [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl0" xml:lang="en-US">Amortization of Intangible Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl0" xml:lang="en-US">Entity Registrant Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherResearchAndDevelopmentExpense_lbl0" xml:lang="en-US">Other Research and Development Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherResearchAndDevelopmentExpense" xlink:to="us-gaap_OtherResearchAndDevelopmentExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplierConcentrationRiskMember_lbl0" xml:lang="en-US">Supplier Concentration Risk [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplierConcentrationRiskMember" xlink:to="us-gaap_SupplierConcentrationRiskMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl0" xml:lang="en-US">City Area Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableMember_lbl0" xml:lang="en-US">Accounts Receivable [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableMember" xlink:to="us-gaap_AccountsReceivableMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MinimumMember_lbl0" xml:lang="en-US">Minimum [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl0" xml:lang="en-US">Subsequent Events [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl0" xml:lang="en-US">Amendment Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl0" xml:lang="en-US">Stockholders&apos; Equity Attributable to Parent [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_lbl0" xml:lang="en-US">Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl0" xml:lang="en-US">Stockholders&apos; Equity Note Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl0" xml:lang="en-US">Entity Central Index Key</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SecurityDeposit_lbl0" xml:lang="en-US">Security Deposit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SecurityDeposit" xlink:to="us-gaap_SecurityDeposit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl0" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfRevenue_lbl0" xml:lang="en-US">Cost of Revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfRevenue" xlink:to="us-gaap_CostOfRevenue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl0" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalesRevenueNetMember_lbl0" xml:lang="en-US">Revenue Benchmark [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesRevenueNetMember" xlink:to="us-gaap_SalesRevenueNetMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl0" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl0" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl0" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_lbl0" xml:lang="en-US">Assets, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_lbl0" xml:lang="en-US">Liabilities, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesRentExpenseMinimumRentals_lbl0" xml:lang="en-US">Operating Leases, Rent Expense, Minimum Rentals</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesRentExpenseMinimumRentals" xlink:to="us-gaap_OperatingLeasesRentExpenseMinimumRentals_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl0" xml:lang="en-US">Sale of Stock, Number of Shares Issued in Transaction</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl0" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl0" xml:lang="en-US">Share-based Payment Arrangement, Option, Activity [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_SouthAmericaMember_lbl0" xml:lang="en-US">South America [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_SouthAmericaMember" xlink:to="srt_SouthAmericaMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl0" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl0" xml:lang="en-US">Liabilities and Equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl0" xml:lang="en-US">Lessee, Leases [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl0" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl0" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseExpense_lbl0" xml:lang="en-US">Operating Lease, Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseExpense" xlink:to="us-gaap_OperatingLeaseExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_lbl0" xml:lang="en-US">Payments to Acquire Intangible Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl0" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl0" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl0" xml:lang="en-US">Property, Plant and Equipment, Useful Life</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssets_lbl0" xml:lang="en-US">Prepaid Expense and Other Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssets" xlink:to="us-gaap_PrepaidExpenseAndOtherAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl0" xml:lang="en-US">Current Fiscal Year End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CustomerConcentrationRiskMember_lbl0" xml:lang="en-US">Customer Concentration Risk [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerConcentrationRiskMember" xlink:to="us-gaap_CustomerConcentrationRiskMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl0" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl0" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashUninsuredAmount_lbl0" xml:lang="en-US">Cash, Uninsured Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashUninsuredAmount" xlink:to="us-gaap_CashUninsuredAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl1" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryValuationReserves_lbl0" xml:lang="en-US">Inventory Valuation Reserves</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryValuationReserves" xlink:to="us-gaap_InventoryValuationReserves_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_MX_lbl0" xml:lang="en-US">MEXICO</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_MX" xlink:to="country_MX_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfAccounting_lbl0" xml:lang="en-US">Basis of Accounting [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccounting" xlink:to="us-gaap_BasisOfAccounting_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_lbl0" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl0" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl0" xml:lang="en-US">Liabilities and Equity [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl2" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharePrice_lbl0" xml:lang="en-US">Share Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl0" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_EuropeMember_lbl0" xml:lang="en-US">Europe [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_EuropeMember" xlink:to="srt_EuropeMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl0" xml:lang="en-US">Document Fiscal Year Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl0" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl0" xml:lang="en-US">AOCI Attributable to Parent [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl0" xml:lang="en-US">Entity Emerging Growth Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PatentsMember_lbl0" xml:lang="en-US">Patents [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PatentsMember" xlink:to="us-gaap_PatentsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl0" xml:lang="en-US">Entity Tax Identification Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl0" xml:lang="en-US">Entity Address, Postal Zip Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl0" xml:lang="en-US">Document Type</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl0" xml:lang="en-US">Entity Current Reporting Status</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl0" xml:lang="en-US">Document Fiscal Period Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl0" xml:lang="en-US">Depreciation, Depletion and Amortization</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl0" xml:lang="en-US">Entity Interactive Data Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_NorthAmericaMember_lbl0" xml:lang="en-US">North America [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_NorthAmericaMember" xlink:to="srt_NorthAmericaMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NumberOfReportableSegments_lbl0" xml:lang="en-US">Number of Reportable Segments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NumberOfReportableSegments" xlink:to="us-gaap_NumberOfReportableSegments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl0" xml:lang="en-US">Liabilities, Current [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_lbl0" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableMember_lbl0" xml:lang="en-US">Accounts Payable [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableMember" xlink:to="us-gaap_AccountsPayableMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl0" xml:lang="en-US">Share-based Payment Arrangement [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfGoodsProductLineMember_lbl0" xml:lang="en-US">Cost of Goods and Service, Product and Service Benchmark [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfGoodsProductLineMember" xlink:to="us-gaap_CostOfGoodsProductLineMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl0" xml:lang="en-US">Document Quarterly Report</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_lbl2" xml:lang="en-US">Stockholders&apos; Equity Attributable to Parent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl0" xml:lang="en-US">Trading Symbol</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryLIFOReserve_lbl0" xml:lang="en-US">Inventory, LIFO Reserve</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryLIFOReserve" xlink:to="us-gaap_InventoryLIFOReserve_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl0" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskPercentage1_lbl0" xml:lang="en-US">Concentration Risk, Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskPercentage1" xlink:to="us-gaap_ConcentrationRiskPercentage1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl0" xml:lang="en-US">Document Period End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl0" xml:lang="en-US">Revenue [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl0" xml:lang="en-US">Assets, Current [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ThresholdPeriodPastDueForWriteoffOfTradeAccountsReceivable_lbl0" xml:lang="en-US">Threshold Period Past Due for Write-off of Trade Accounts Receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ThresholdPeriodPastDueForWriteoffOfTradeAccountsReceivable" xlink:to="us-gaap_ThresholdPeriodPastDueForWriteoffOfTradeAccountsReceivable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DistributionRightsMember_lbl0" xml:lang="en-US">Distribution Rights [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DistributionRightsMember" xlink:to="us-gaap_DistributionRightsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl0" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl0" xml:lang="en-US">Accounts Payable and Accrued Liabilities, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl0" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementScenarioAxis_lbl" xml:lang="en-US">Scenario [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_StatementScenarioAxis_lbl"/>
  </labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>bmra-20211130_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Wed Jan 12 20:33:18 UTC 2022 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="bmra-20211130.xsd#bmra_r_ConsolidatedBalanceSheet" roleURI="http://www.biomerica.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20211130.xsd#bmra_r_ConsolidatedBalanceSheet_Parentheticals" roleURI="http://www.biomerica.com/role/ConsolidatedBalanceSheet_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20211130.xsd#bmra_r_ConsolidatedIncomeStatement" roleURI="http://www.biomerica.com/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20211130.xsd#bmra_r_ShareholdersEquityType2or3" roleURI="http://www.biomerica.com/role/ShareholdersEquityType2or3"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20211130.xsd#bmra_r_ConsolidatedCashFlow" roleURI="http://www.biomerica.com/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20211130.xsd#bmra_r_BASISOFPRESENTATION" roleURI="http://www.biomerica.com/role/BASISOFPRESENTATION"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20211130.xsd#bmra_r_SIGNIFICANTACCOUNTINGPOLICIES" roleURI="http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIES"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20211130.xsd#bmra_r_SHAREHOLDERSEQUITY" roleURI="http://www.biomerica.com/role/SHAREHOLDERSEQUITY"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20211130.xsd#bmra_r_GEOGRAPHICINFORMATION" roleURI="http://www.biomerica.com/role/GEOGRAPHICINFORMATION"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20211130.xsd#bmra_r_LEASES" roleURI="http://www.biomerica.com/role/LEASES"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20211130.xsd#bmra_r_COMMITMENTSANDCONTINGENCIES" roleURI="http://www.biomerica.com/role/COMMITMENTSANDCONTINGENCIES"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20211130.xsd#bmra_r_SUBSEQUENTEVENTS" roleURI="http://www.biomerica.com/role/SUBSEQUENTEVENTS"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20211130.xsd#bmra_r_RESTATEMENTOFPREVIOUSLYISSUEDFINANCIALSTATEMENTS" roleURI="http://www.biomerica.com/role/RESTATEMENTOFPREVIOUSLYISSUEDFINANCIALSTATEMENTS"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20211130.xsd#bmra_r_AccountingPoliciesByPolicy" roleURI="http://www.biomerica.com/role/AccountingPoliciesByPolicy"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20211130.xsd#bmra_r_SIGNIFICANTACCOUNTINGPOLICIESTables" roleURI="http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20211130.xsd#bmra_r_GEOGRAPHICINFORMATIONTables" roleURI="http://www.biomerica.com/role/GEOGRAPHICINFORMATIONTables"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20211130.xsd#bmra_r_LEASESTables" roleURI="http://www.biomerica.com/role/LEASESTables"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20211130.xsd#bmra_r_InventoriesTable" roleURI="http://www.biomerica.com/role/InventoriesTable"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20211130.xsd#bmra_r_OptionsActivityTable" roleURI="http://www.biomerica.com/role/OptionsActivityTable"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20211130.xsd#bmra_r_RevenuefromcontractswithcustomersTable" roleURI="http://www.biomerica.com/role/RevenuefromcontractswithcustomersTable"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20211130.xsd#bmra_r_GeographicinformationregardingnetsalesTable" roleURI="http://www.biomerica.com/role/GeographicinformationregardingnetsalesTable"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20211130.xsd#bmra_r_SupplementalcashflowinformationrelatedtoleasesTable" roleURI="http://www.biomerica.com/role/SupplementalcashflowinformationrelatedtoleasesTable"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20211130.xsd#bmra_r_ThematurityofleaseliabilitiesTable" roleURI="http://www.biomerica.com/role/ThematurityofleaseliabilitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20211130.xsd#bmra_r_RestatementontheconsolidatedstatementofoperationsandtheconsolidatedstatementofcashflowsTable" roleURI="http://www.biomerica.com/role/RestatementontheconsolidatedstatementofoperationsandtheconsolidatedstatementofcashflowsTable"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20211130.xsd#bmra_r_SIGNIFICANTACCOUNTINGPOLICIESDetails" roleURI="http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20211130.xsd#bmra_r_SHAREHOLDERSEQUITYDetails" roleURI="http://www.biomerica.com/role/SHAREHOLDERSEQUITYDetails"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20211130.xsd#bmra_r_GEOGRAPHICINFORMATIONDetails" roleURI="http://www.biomerica.com/role/GEOGRAPHICINFORMATIONDetails"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20211130.xsd#bmra_r_LEASESDetails" roleURI="http://www.biomerica.com/role/LEASESDetails"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20211130.xsd#bmra_r_SUBSEQUENTEVENTSDetails" roleURI="http://www.biomerica.com/role/SUBSEQUENTEVENTSDetails"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20211130.xsd#DocumentAndEntityInformation" roleURI="http://www.biomerica.com/role/DocumentAndEntityInformation"/>
  <presentationLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/ConsolidatedBalanceSheet">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableByTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="A5ConvertiblePreferredStockMember" xlink:href="bmra-20211130.xsd#bmra_A5ConvertiblePreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="A5ConvertiblePreferredStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesAPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_SeriesAPreferredStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="3.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsCurrentAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AccountsReceivableNetCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_InventoryNet" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Investments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Investments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_Investments" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_OtherAssetsNoncurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_Assets" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesCurrentAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_ContractWithCustomerLiability" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_Liabilities" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_CommitmentsAndContingencies" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquityAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_PreferredStockValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockValue_0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_PreferredStockValue_0" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapital" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/ConsolidatedBalanceSheet_Parentheticals">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableByTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="A5ConvertiblePreferredStockMember" xlink:href="bmra-20211130.xsd#bmra_A5ConvertiblePreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="A5ConvertiblePreferredStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesAPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_SeriesAPreferredStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="3.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="OperatingLeaseRightOfUseAssetAccumulatedAmortization" xlink:href="bmra-20211130.xsd#bmra_OperatingLeaseRightOfUseAssetAccumulatedAmortization"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="OperatingLeaseRightOfUseAssetAccumulatedAmortization" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockNoParValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockNoParValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockNoParValue" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="PreferredStockUndesignatedShares" xlink:href="bmra-20211130.xsd#bmra_PreferredStockUndesignatedShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="PreferredStockUndesignatedShares" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/ConsolidatedIncomeStatement">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_Revenues" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_CostOfRevenue" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CostOfRevenue" xlink:to="us-gaap_GrossProfit" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingExpensesAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_OperatingExpenses" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingIncomeLoss" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherIncomeAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OtherIncomeAndExpensesAbstract" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeInterestAndDividend" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterestAndDividend"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="us-gaap_InvestmentIncomeInterestAndDividend" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_NetIncomeLoss" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareBasic" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareDiluted" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss_0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_NetIncomeLoss_0" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/ShareholdersEquityType2or3">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_CommonStockMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="A5ConvertiblePreferredStockMember" xlink:href="bmra-20211130.xsd#bmra_A5ConvertiblePreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="A5ConvertiblePreferredStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_RetainedEarningsMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="5.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesIssued" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity_0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity_0" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssued_0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesIssued_0" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/ConsolidatedCashFlow">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetIncomeLoss" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_DepreciationAndAmortization" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProvisionForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ProvisionForDoubtfulAccounts" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryLIFOReservePeriodCharge" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryLIFOReservePeriodCharge"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_InventoryLIFOReservePeriodCharge" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockOptionPlanExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockOptionPlanExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_StockOptionPlanExpense" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInInventories" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="IncreaseDecreaseInLeaseLiability" xlink:href="bmra-20211130.xsd#bmra_IncreaseDecreaseInLeaseLiability"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="IncreaseDecreaseInLeaseLiability" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_0" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="CashPaidDuringThePeriodForAbstract" xlink:href="bmra-20211130.xsd#bmra_CashPaidDuringThePeriodForAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="CashPaidDuringThePeriodForAbstract" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxesPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashPaidDuringThePeriodForAbstract" xlink:to="us-gaap_IncomeTaxesPaid" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/BASISOFPRESENTATION">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BasisOfAccounting" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccounting"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_BasisOfAccounting" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIES">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/SHAREHOLDERSEQUITY">
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/GEOGRAPHICINFORMATION">
    <loc xlink:type="locator" xlink:label="GeographicInformationDisclosureAbstract" xlink:href="bmra-20211130.xsd#bmra_GeographicInformationDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="GeographicInformationDisclosureTextBlock" xlink:href="bmra-20211130.xsd#bmra_GeographicInformationDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeographicInformationDisclosureAbstract" xlink:to="GeographicInformationDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/LEASES">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/COMMITMENTSANDCONTINGENCIES">
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/SUBSEQUENTEVENTS">
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/RESTATEMENTOFPREVIOUSLYISSUEDFINANCIALSTATEMENTS">
    <loc xlink:type="locator" xlink:label="us-gaap_PriorPeriodAdjustmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PriorPeriodAdjustmentAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ErrorCorrectionTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ErrorCorrectionTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PriorPeriodAdjustmentAbstract" xlink:to="us-gaap_ErrorCorrectionTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/AccountingPoliciesByPolicy">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConsolidationPolicyTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="MarketsAndMethodsOfDistributionPolicyTextBlock" xlink:href="bmra-20211130.xsd#bmra_MarketsAndMethodsOfDistributionPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="MarketsAndMethodsOfDistributionPolicyTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="LiquidityPolicyTextBlock" xlink:href="bmra-20211130.xsd#bmra_LiquidityPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="LiquidityPolicyTextBlock" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConcentrationRiskCreditRisk" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_TradeAndOtherAccountsReceivablePolicy" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PrepaidsPolicyPolicyTextBlock" xlink:href="bmra-20211130.xsd#bmra_PrepaidsPolicyPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="PrepaidsPolicyPolicyTextBlock" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_InventoryPolicyTextBlock" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_InvestmentPolicyTextBlock" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfSalesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CostOfSalesPolicyTextBlock" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_IncomeTaxPolicyTextBlock" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_DisaggregationOfRevenueTableTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/GEOGRAPHICINFORMATIONTables">
    <loc xlink:type="locator" xlink:label="GeographicInformationDisclosureAbstract" xlink:href="bmra-20211130.xsd#bmra_GeographicInformationDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeographicInformationDisclosureAbstract" xlink:to="us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/LEASESTables">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfCashFlowSupplementalDisclosuresRelatedToLeaseTableTextBlock" xlink:href="bmra-20211130.xsd#bmra_ScheduleOfCashFlowSupplementalDisclosuresRelatedToLeaseTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="ScheduleOfCashFlowSupplementalDisclosuresRelatedToLeaseTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/InventoriesTable">
    <loc xlink:type="locator" xlink:label="InventoriesAbstract" xlink:href="bmra-20211130.xsd#bmra_InventoriesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InventoriesAbstract" xlink:to="us-gaap_InventoryRawMaterialsNetOfReserves" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InventoriesAbstract" xlink:to="us-gaap_InventoryWorkInProcessNetOfReserves" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InventoriesAbstract" xlink:to="us-gaap_InventoryFinishedGoodsNetOfReserves" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InventoriesAbstract" xlink:to="us-gaap_InventoryNet" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/OptionsActivityTable">
    <loc xlink:type="locator" xlink:label="OptionsActivityAbstract" xlink:href="bmra-20211130.xsd#bmra_OptionsActivityAbstract"/>
    <loc xlink:type="locator" xlink:label="SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityTable" xlink:href="bmra-20211130.xsd#bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityTable"/>
    <loc xlink:type="locator" xlink:label="SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityLineItems" xlink:href="bmra-20211130.xsd#bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OptionsActivityAbstract" xlink:to="SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt+1Vq3zhhUlfDeP/RQUzUZihDO8dLtQrMZMNe4t6pAivP0axfdFZpsLdRcC6V+fMavDgd7cFnpNNH6/9LXkBbSc8G8uA9huUzxoSaIHwz4vVYlYkDywCEAeWuqQU5kjj/9if9ldPlDmKw//pZSBlTR0cJe8RogwaRtoaHjgvr01afdt/zZLRXJxDnIxOc9NO2o=] CSR-->
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityTable" xlink:to="us-gaap_AwardTypeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_EmployeeStockOptionMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityTable" xlink:to="SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/RevenuefromcontractswithcustomersTable">
    <loc xlink:type="locator" xlink:label="RevenueFromContractsWithCustomersAbstract" xlink:href="bmra-20211130.xsd#bmra_RevenueFromContractsWithCustomersAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenueFromContractsWithCustomersAbstract" xlink:to="us-gaap_DisaggregationOfRevenueTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_StatementBusinessSegmentsAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="PhysiciansOfficeMember" xlink:href="bmra-20211130.xsd#bmra_PhysiciansOfficeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="PhysiciansOfficeMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ClinicalLabMember" xlink:href="bmra-20211130.xsd#bmra_ClinicalLabMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="ClinicalLabMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OverthecounterMember" xlink:href="bmra-20211130.xsd#bmra_OverthecounterMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="OverthecounterMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ContractManufacturingMember" xlink:href="bmra-20211130.xsd#bmra_ContractManufacturingMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="ContractManufacturingMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_DisaggregationOfRevenueLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/GeographicinformationregardingnetsalesTable">
    <loc xlink:type="locator" xlink:label="GeographicInformationRegardingNetSalesAbstract" xlink:href="bmra-20211130.xsd#bmra_GeographicInformationRegardingNetSalesAbstract"/>
    <loc xlink:type="locator" xlink:label="GEOGRAPHICINFORMATIONDetailsGeographicinformationregardingnetsalesTable" xlink:href="bmra-20211130.xsd#bmra_GEOGRAPHICINFORMATIONDetailsGeographicinformationregardingnetsalesTable"/>
    <loc xlink:type="locator" xlink:label="GEOGRAPHICINFORMATIONDetailsGeographicinformationregardingnetsalesLineItems" xlink:href="bmra-20211130.xsd#bmra_GEOGRAPHICINFORMATIONDetailsGeographicinformationregardingnetsalesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeographicInformationRegardingNetSalesAbstract" xlink:to="GEOGRAPHICINFORMATIONDetailsGeographicinformationregardingnetsalesTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GEOGRAPHICINFORMATIONDetailsGeographicinformationregardingnetsalesTable" xlink:to="srt_StatementGeographicalAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="srt_AsiaMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AsiaMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_AsiaMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_EuropeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EuropeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_EuropeMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_NorthAmericaMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NorthAmericaMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_NorthAmericaMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MiddleEastMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MiddleEastMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="us-gaap_MiddleEastMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_SouthAmericaMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SouthAmericaMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SouthAmericaMember" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GEOGRAPHICINFORMATIONDetailsGeographicinformationregardingnetsalesTable" xlink:to="GEOGRAPHICINFORMATIONDetailsGeographicinformationregardingnetsalesLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="RevenuesFromSalesToUnaffiliatedCustomersAbstract" xlink:href="bmra-20211130.xsd#bmra_RevenuesFromSalesToUnaffiliatedCustomersAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GEOGRAPHICINFORMATIONDetailsGeographicinformationregardingnetsalesLineItems" xlink:to="RevenuesFromSalesToUnaffiliatedCustomersAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenuesFromSalesToUnaffiliatedCustomersAbstract" xlink:to="us-gaap_Revenues" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/SupplementalcashflowinformationrelatedtoleasesTable">
    <loc xlink:type="locator" xlink:label="SupplementalCashFlowInformationRelatedToLeasesAbstract" xlink:href="bmra-20211130.xsd#bmra_SupplementalCashFlowInformationRelatedToLeasesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SupplementalCashFlowInformationRelatedToLeasesAbstract" xlink:to="us-gaap_OperatingLeasePayments" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="RightOfUseAssetsObtainedInExchangeForAbstract" xlink:href="bmra-20211130.xsd#bmra_RightOfUseAssetsObtainedInExchangeForAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SupplementalCashFlowInformationRelatedToLeasesAbstract" xlink:to="RightOfUseAssetsObtainedInExchangeForAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RightOfUseAssetsObtainedInExchangeForAbstract" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SupplementalCashFlowInformationRelatedToLeasesAbstract" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SupplementalCashFlowInformationRelatedToLeasesAbstract" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/ThematurityofleaseliabilitiesTable">
    <loc xlink:type="locator" xlink:label="TheMaturityOfLeaseLiabilitiesAbstract" xlink:href="bmra-20211130.xsd#bmra_TheMaturityOfLeaseLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TheMaturityOfLeaseLiabilitiesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TheMaturityOfLeaseLiabilitiesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TheMaturityOfLeaseLiabilitiesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TheMaturityOfLeaseLiabilitiesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TheMaturityOfLeaseLiabilitiesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TheMaturityOfLeaseLiabilitiesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TheMaturityOfLeaseLiabilitiesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TheMaturityOfLeaseLiabilitiesAbstract" xlink:to="us-gaap_OperatingLeaseLiability" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/RestatementontheconsolidatedstatementofoperationsandtheconsolidatedstatementofcashflowsTable">
    <loc xlink:type="locator" xlink:label="RestatementOnTheConsolidatedStatementOfOperationsAndTheConsolidatedStatementOfCashFlowsAbstract" xlink:href="bmra-20211130.xsd#bmra_RestatementOnTheConsolidatedStatementOfOperationsAndTheConsolidatedStatementOfCashFlowsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RestatementOnTheConsolidatedStatementOfOperationsAndTheConsolidatedStatementOfCashFlowsAbstract" xlink:to="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:to="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioPreviouslyReportedMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis" xlink:to="srt_ScenarioPreviouslyReportedMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis" xlink:to="srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RestatementOfCompanysFinancialStatementsMember" xlink:href="bmra-20211130.xsd#bmra_RestatementOfCompanysFinancialStatementsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis" xlink:to="RestatementOfCompanysFinancialStatementsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:to="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_CostOfGoodsAndServicesSold" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_GrossProfit" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_OperatingExpensesAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpenses" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_OperatingIncomeLoss" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_EarningsPerShareBasic" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_EarningsPerShareDiluted" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" xlink:href="bmra-20211130.xsd#bmra_AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockOptionPlanExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockOptionPlanExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_StockOptionPlanExpense" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="SIGNIFICANTACCOUNTINGPOLICIESDetailsTable" xlink:href="bmra-20211130.xsd#bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsTable"/>
    <loc xlink:type="locator" xlink:label="SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:href="bmra-20211130.xsd#bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="SIGNIFICANTACCOUNTINGPOLICIESDetailsTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsTable" xlink:to="us-gaap_ConcentrationRiskByTypeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CustomerConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_CustomerConcentrationRiskMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SupplierConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplierConcentrationRiskMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_SupplierConcentrationRiskMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsTable" xlink:to="srt_RangeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MinimumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MaximumMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DistributionRightsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DistributionRightsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_DistributionRightsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PurchasedTechnologyRightsMember" xlink:href="bmra-20211130.xsd#bmra_PurchasedTechnologyRightsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="PurchasedTechnologyRightsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PatentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PatentsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_PatentsMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsTable" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SalesRevenueNetMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_SalesRevenueNetMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsReceivableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_AccountsReceivableMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfGoodsProductLineMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsProductLineMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_CostOfGoodsProductLineMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_AccountsPayableMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="TwoDistributorsMember" xlink:href="bmra-20211130.xsd#bmra_TwoDistributorsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="TwoDistributorsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TwoVendorsMember" xlink:href="bmra-20211130.xsd#bmra_TwoVendorsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="TwoVendorsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsTable" xlink:to="us-gaap_AwardTypeAxis" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_EmployeeStockOptionMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsTable" xlink:to="SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" order="7.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ShelfRegistrationStatementMaximumAuthorizedCommonStockIssuanceValue" xlink:href="bmra-20211130.xsd#bmra_ShelfRegistrationStatementMaximumAuthorizedCommonStockIssuanceValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="ShelfRegistrationStatementMaximumAuthorizedCommonStockIssuanceValue" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashUninsuredAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashUninsuredAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_CashUninsuredAmount" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_ConcentrationRiskPercentage1" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ThresholdPeriodPastDueForWriteoffOfTradeAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ThresholdPeriodPastDueForWriteoffOfTradeAccountsReceivable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_ThresholdPeriodPastDueForWriteoffOfTradeAccountsReceivable" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_PrepaidExpenseAndOtherAssets" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryValuationReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryValuationReserves"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_InventoryValuationReserves" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryLIFOReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryLIFOReserve"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_InventoryLIFOReserve" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_DepreciationDepletionAndAmortization" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_AmortizationOfIntangibleAssets" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherResearchAndDevelopmentExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_OtherResearchAndDevelopmentExpense" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/SHAREHOLDERSEQUITYDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:label="SHAREHOLDERSEQUITYDetailsTable" xlink:href="bmra-20211130.xsd#bmra_SHAREHOLDERSEQUITYDetailsTable"/>
    <loc xlink:type="locator" xlink:label="SHAREHOLDERSEQUITYDetailsLineItems" xlink:href="bmra-20211130.xsd#bmra_SHAREHOLDERSEQUITYDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="SHAREHOLDERSEQUITYDetailsTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableByTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsTable" xlink:to="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="us-gaap_CommonStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsTable" xlink:to="srt_RangeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MinimumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MaximumMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsTable" xlink:to="us-gaap_AwardTypeAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_EmployeeStockOptionMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsTable" xlink:to="SHAREHOLDERSEQUITYDetailsLineItems" order="4.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/GEOGRAPHICINFORMATIONDetails">
    <loc xlink:type="locator" xlink:label="GeographicInformationDisclosureAbstract" xlink:href="bmra-20211130.xsd#bmra_GeographicInformationDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="GEOGRAPHICINFORMATIONDetailsTable" xlink:href="bmra-20211130.xsd#bmra_GEOGRAPHICINFORMATIONDetailsTable"/>
    <loc xlink:type="locator" xlink:label="GEOGRAPHICINFORMATIONDetailsLineItems" xlink:href="bmra-20211130.xsd#bmra_GEOGRAPHICINFORMATIONDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeographicInformationDisclosureAbstract" xlink:to="GEOGRAPHICINFORMATIONDetailsTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GEOGRAPHICINFORMATIONDetailsTable" xlink:to="srt_StatementGeographicalAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="country_MX" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_MX"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="country_MX" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GEOGRAPHICINFORMATIONDetailsTable" xlink:to="GEOGRAPHICINFORMATIONDetailsLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GEOGRAPHICINFORMATIONDetailsLineItems" xlink:to="us-gaap_NumberOfReportableSegments" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GEOGRAPHICINFORMATIONDetailsLineItems" xlink:to="us-gaap_InventoryGross" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GEOGRAPHICINFORMATIONDetailsLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/LEASESDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="LEASESDetailsTable" xlink:href="bmra-20211130.xsd#bmra_LEASESDetailsTable"/>
    <loc xlink:type="locator" xlink:label="LEASESDetailsLineItems" xlink:href="bmra-20211130.xsd#bmra_LEASESDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="LEASESDetailsTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LEASESDetailsTable" xlink:to="srt_StatementGeographicalAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="country_MX" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_MX"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="country_MX" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="LeaseAmendmentAxis" xlink:href="bmra-20211130.xsd#bmra_LeaseAmendmentAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LEASESDetailsTable" xlink:to="LeaseAmendmentAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="LeaseAmendmentDomain" xlink:href="bmra-20211130.xsd#bmra_LeaseAmendmentDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeaseAmendmentAxis" xlink:to="LeaseAmendmentDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="FirstAmendmentToLeaseMember" xlink:href="bmra-20211130.xsd#bmra_FirstAmendmentToLeaseMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeaseAmendmentAxis" xlink:to="FirstAmendmentToLeaseMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LEASESDetailsTable" xlink:to="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="PropertySubjectToOrAvailableForOperatingLease_Domain" xlink:href="bmra-20211130.xsd#bmra_PropertySubjectToOrAvailableForOperatingLease_Domain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:to="PropertySubjectToOrAvailableForOperatingLease_Domain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="BuildingInIrvineCaliforniaMember" xlink:href="bmra-20211130.xsd#bmra_BuildingInIrvineCaliforniaMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:to="BuildingInIrvineCaliforniaMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyAvailableForOperatingLeaseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyAvailableForOperatingLeaseMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:to="us-gaap_PropertyAvailableForOperatingLeaseMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LEASESDetailsTable" xlink:to="LEASESDetailsLineItems" order="4.0"/>
    <loc xlink:type="locator" xlink:label="OperatingLeaseInitiationDate" xlink:href="bmra-20211130.xsd#bmra_OperatingLeaseInitiationDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LEASESDetailsLineItems" xlink:to="OperatingLeaseInitiationDate" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseExpirationDate1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseExpirationDate1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LEASESDetailsLineItems" xlink:to="us-gaap_LeaseExpirationDate1" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsForRent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LEASESDetailsLineItems" xlink:to="us-gaap_PaymentsForRent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseAndRentalExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseAndRentalExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LEASESDetailsLineItems" xlink:to="us-gaap_LeaseAndRentalExpense" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LEASESDetailsLineItems" xlink:to="us-gaap_OperatingLeaseExpense" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RentPercentage" xlink:href="bmra-20211130.xsd#bmra_RentPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LEASESDetailsLineItems" xlink:to="RentPercentage" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SecurityDeposit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecurityDeposit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LEASESDetailsLineItems" xlink:to="us-gaap_SecurityDeposit" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasesRentExpenseMinimumRentals" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesRentExpenseMinimumRentals"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LEASESDetailsLineItems" xlink:to="us-gaap_OperatingLeasesRentExpenseMinimumRentals" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/SUBSEQUENTEVENTSDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <loc xlink:type="locator" xlink:label="SUBSEQUENTEVENTSDetailsTable" xlink:href="bmra-20211130.xsd#bmra_SUBSEQUENTEVENTSDetailsTable"/>
    <loc xlink:type="locator" xlink:label="SUBSEQUENTEVENTSDetailsLineItems" xlink:href="bmra-20211130.xsd#bmra_SUBSEQUENTEVENTSDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="SUBSEQUENTEVENTSDetailsTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SUBSEQUENTEVENTSDetailsTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SUBSEQUENTEVENTSDetailsTable" xlink:to="SUBSEQUENTEVENTSDetailsLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SUBSEQUENTEVENTSDetailsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SUBSEQUENTEVENTSDetailsLineItems" xlink:to="us-gaap_SharePrice" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SUBSEQUENTEVENTSDetailsLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SUBSEQUENTEVENTSDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SUBSEQUENTEVENTSDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SUBSEQUENTEVENTSDetailsLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:label="DocumentAndEntityInformationAbstract" xlink:href="bmra-20211130.xsd#bmra_DocumentAndEntityInformationAbstract"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentInformationTable"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentInformationLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentInformationTable" order="1.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationLineItems" order="1.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCommonStockSharesOutstanding" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCurrentReportingStatus" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFilerCategory" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalYearFocus" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalPeriodFocus" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntitySmallBusiness" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityShellCompany" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentQuarterlyReport" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentTransitionReport" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityInteractiveDataCurrent" order="28.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140654046949448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document And Entity Information - shares<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Nov. 30, 2021</div></th>
<th class="th"><div>Jan. 12, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information Line Items</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">BIOMERICA, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BMRA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--05-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,851,924<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000073290<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Nov. 30,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-37863<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">95-2645573<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">17571 Von Karman Avenue<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Irvine<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92614<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">949<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">645-2111<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common, par value $.08<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140654047036440">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)<br></strong></div></th>
<th class="th"><div>Nov. 30, 2021</div></th>
<th class="th"><div>May 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 7,199,172<span></span>
</td>
<td class="nump">$ 4,199,311<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, less allowance for doubtful accounts of $27,777 and $837,415 as of November 30, 2021 and May 31, 2021, respectively</a></td>
<td class="nump">1,125,239<span></span>
</td>
<td class="nump">1,455,051<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories, net</a></td>
<td class="nump">2,982,201<span></span>
</td>
<td class="nump">3,206,255<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other</a></td>
<td class="nump">1,096,750<span></span>
</td>
<td class="nump">370,290<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">12,403,362<span></span>
</td>
<td class="nump">9,230,907<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net of accumulated depreciation and amortization of $2,026,764 and $1,972,357 as of November 30, 2021 and May 31, 2021, respectively</a></td>
<td class="nump">274,325<span></span>
</td>
<td class="nump">310,520<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right of use assets, net of accumulated amortization of $595,116 and $469,077 as of November 30, 2021 and May 31, 2021, respectively</a></td>
<td class="nump">1,427,042<span></span>
</td>
<td class="nump">1,553,081<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Investments', window );">Investments</a></td>
<td class="nump">165,324<span></span>
</td>
<td class="nump">165,324<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net of accumulated amortization of $91,030 and $126,769 as of November 30, 2021 and May 31, 2021, respectively</a></td>
<td class="nump">389,486<span></span>
</td>
<td class="nump">294,830<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">149,581<span></span>
</td>
<td class="nump">264,151<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="nump">14,809,120<span></span>
</td>
<td class="nump">11,818,813<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable and accrued expenses</a></td>
<td class="nump">1,580,707<span></span>
</td>
<td class="nump">583,380<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation</a></td>
<td class="nump">674,327<span></span>
</td>
<td class="nump">388,896<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Advance from customers</a></td>
<td class="nump">2,150,466<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Lease liability, current portion</a></td>
<td class="nump">335,385<span></span>
</td>
<td class="nump">327,944<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">4,740,885<span></span>
</td>
<td class="nump">1,300,220<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Lease liability, net of current portion</a></td>
<td class="nump">1,166,808<span></span>
</td>
<td class="nump">1,291,570<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total Liabilities</a></td>
<td class="nump">5,907,693<span></span>
</td>
<td class="nump">2,591,790<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Notes 1 and 6)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders' Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, Series A 5% convertible, $0.08 par value, 571,429 shares authorized, none issued and outstanding as of November 30, 2021 and May 31, 2021</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, undesignated, no par value, 4,428,571 shares authorized, none issued and outstanding as of November 30, 2021 and May 31, 2021</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.08 par value, 25,000,000 shares authorized, 12,692,327 and 12,307,157 issued and outstanding at November 30, 2021 and May 31, 2021, respectively</a></td>
<td class="nump">1,015,385<span></span>
</td>
<td class="nump">984,571<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in-capital</a></td>
<td class="nump">41,158,551<span></span>
</td>
<td class="nump">38,836,743<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(58,319)<span></span>
</td>
<td class="num">(47,956)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(33,214,190)<span></span>
</td>
<td class="num">(30,546,335)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Shareholders' Equity</a></td>
<td class="nump">8,901,427<span></span>
</td>
<td class="nump">9,227,023<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total Liabilities and Shareholders' Equity</a></td>
<td class="nump">14,809,120<span></span>
</td>
<td class="nump">11,818,813<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=bmra_A5ConvertiblePreferredStockMember', window );">5% Convertible Preferred Stock [Member] | Series A Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders' Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, Series A 5% convertible, $0.08 par value, 571,429 shares authorized, none issued and outstanding as of November 30, 2021 and May 31, 2021</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, undesignated, no par value, 4,428,571 shares authorized, none issued and outstanding as of November 30, 2021 and May 31, 2021</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Investments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Investments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=bmra_A5ConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=bmra_A5ConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140654048303608">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Parentheticals) - USD ($)<br></strong></div></th>
<th class="th"><div>Nov. 30, 2021</div></th>
<th class="th"><div>May 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for doubtful accounts (in Dollars)</a></td>
<td class="nump">$ 27,777<span></span>
</td>
<td class="nump">$ 837,415<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation and amortization (in Dollars)</a></td>
<td class="nump">2,026,764<span></span>
</td>
<td class="nump">1,972,357<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_OperatingLeaseRightOfUseAssetAccumulatedAmortization', window );">Accumulated amortization, Right of Use Assets (in Dollars)</a></td>
<td class="nump">595,116<span></span>
</td>
<td class="nump">469,077<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization, Intangible Assets (in Dollars)</a></td>
<td class="nump">$ 91,030<span></span>
</td>
<td class="nump">$ 126,769<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred Stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred Stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockNoParValue', window );">Preferred Stock, No Par Value (in Dollars per share)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_PreferredStockUndesignatedShares', window );">Preferred Stock, undesignated shares</a></td>
<td class="nump">4,428,571<span></span>
</td>
<td class="nump">4,428,571<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock par value (in Dollars per share)</a></td>
<td class="nump">$ 0.08<span></span>
</td>
<td class="nump">$ 0.08<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">25,000,000<span></span>
</td>
<td class="nump">25,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">12,692,327<span></span>
</td>
<td class="nump">12,307,157<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">12,692,327<span></span>
</td>
<td class="nump">12,307,157<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=bmra_A5ConvertiblePreferredStockMember', window );">5% Convertible Preferred Stock [Member] | Series A Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred Stock, Par Value (in Dollars per share)</a></td>
<td class="nump">$ 0.08<span></span>
</td>
<td class="nump">$ 0.08<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, shares authorized</a></td>
<td class="nump">571,429<span></span>
</td>
<td class="nump">571,429<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred Stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred Stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmra_OperatingLeaseRightOfUseAssetAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated amortization of right-of-use asset from operating lease</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmra_OperatingLeaseRightOfUseAssetAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmra_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmra_PreferredStockUndesignatedShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of preferred shares undesignated during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmra_PreferredStockUndesignatedShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmra_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockNoParValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount per share of no-par value preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockNoParValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=bmra_A5ConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=bmra_A5ConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140654047171112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 30, 2021</div></th>
<th class="th"><div>Nov. 30, 2020</div></th>
<th class="th"><div>Nov. 30, 2021</div></th>
<th class="th"><div>Nov. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="nump">$ 4,646,900<span></span>
</td>
<td class="nump">$ 1,372,526<span></span>
</td>
<td class="nump">$ 5,908,687<span></span>
</td>
<td class="nump">$ 2,516,332<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of sales</a></td>
<td class="num">(3,875,141)<span></span>
</td>
<td class="num">(1,063,807)<span></span>
</td>
<td class="num">(5,225,898)<span></span>
</td>
<td class="num">(2,089,524)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">771,759<span></span>
</td>
<td class="nump">308,719<span></span>
</td>
<td class="nump">682,789<span></span>
</td>
<td class="nump">426,808<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">1,282,998<span></span>
</td>
<td class="nump">1,404,846<span></span>
</td>
<td class="nump">2,294,533<span></span>
</td>
<td class="nump">2,710,790<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">618,522<span></span>
</td>
<td class="nump">616,561<span></span>
</td>
<td class="nump">1,058,386<span></span>
</td>
<td class="nump">1,328,066<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expense</a></td>
<td class="nump">1,901,520<span></span>
</td>
<td class="nump">2,021,407<span></span>
</td>
<td class="nump">3,352,919<span></span>
</td>
<td class="nump">4,038,856<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(1,129,761)<span></span>
</td>
<td class="num">(1,712,688)<span></span>
</td>
<td class="num">(2,670,130)<span></span>
</td>
<td class="num">(3,612,048)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Dividend and interest income</a></td>
<td class="nump">6,916<span></span>
</td>
<td class="nump">7,983<span></span>
</td>
<td class="nump">13,721<span></span>
</td>
<td class="nump">16,074<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before income taxes</a></td>
<td class="num">(1,122,845)<span></span>
</td>
<td class="num">(1,704,705)<span></span>
</td>
<td class="num">(2,656,409)<span></span>
</td>
<td class="num">(3,595,974)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="num">(2,429)<span></span>
</td>
<td class="num">(13,393)<span></span>
</td>
<td class="num">(11,446)<span></span>
</td>
<td class="num">(14,518)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (1,125,274)<span></span>
</td>
<td class="num">$ (1,718,098)<span></span>
</td>
<td class="num">$ (2,667,855)<span></span>
</td>
<td class="num">$ (3,610,492)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net loss per common share (in Dollars per share)</a></td>
<td class="num">$ (0.09)<span></span>
</td>
<td class="num">$ (0.15)<span></span>
</td>
<td class="num">$ (0.21)<span></span>
</td>
<td class="num">$ (0.31)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net loss per common share (in Dollars per share)</a></td>
<td class="num">$ (0.09)<span></span>
</td>
<td class="num">$ (0.15)<span></span>
</td>
<td class="num">$ (0.21)<span></span>
</td>
<td class="num">$ (0.31)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average number of common and common equivalent shares:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in Shares)</a></td>
<td class="nump">12,592,341<span></span>
</td>
<td class="nump">11,756,265<span></span>
</td>
<td class="nump">12,509,110<span></span>
</td>
<td class="nump">11,752,299<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in Shares)</a></td>
<td class="nump">12,592,341<span></span>
</td>
<td class="nump">11,756,265<span></span>
</td>
<td class="nump">12,509,110<span></span>
</td>
<td class="nump">11,752,299<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (1,125,274)<span></span>
</td>
<td class="num">$ (1,718,098)<span></span>
</td>
<td class="num">$ (2,667,855)<span></span>
</td>
<td class="num">$ (3,610,492)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive loss, net of tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax', window );">Foreign currency translation</a></td>
<td class="num">(4,750)<span></span>
</td>
<td class="num">(1,530)<span></span>
</td>
<td class="num">(10,363)<span></span>
</td>
<td class="num">(3,250)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="num">$ (1,130,024)<span></span>
</td>
<td class="num">$ (1,719,628)<span></span>
</td>
<td class="num">$ (2,678,218)<span></span>
</td>
<td class="num">$ (3,613,742)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterestAndDividend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(a),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterestAndDividend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30304-110892<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=120253306&amp;loc=d3e28129-110885<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32022-110900<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a-c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140654046569592">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (Unaudited) - USD ($)<br></strong></div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>5% Convertible Preferred Stock [Member]</div></th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>AOCI Attributable to Parent [Member]</div></th>
<th class="th"><div>Retained Earnings [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balances at May. 31, 2020</a></td>
<td class="nump">$ 939,205<span></span>
</td>
<td class="nump">$ 25,714<span></span>
</td>
<td class="nump">$ 36,388,056<span></span>
</td>
<td class="num">$ (39,841)<span></span>
</td>
<td class="num">$ (23,100,081)<span></span>
</td>
<td class="nump">$ 14,213,053<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balances (in Shares) at May. 31, 2020</a></td>
<td class="nump">11,740,089<span></span>
</td>
<td class="nump">321,429<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">$ 2,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46,930<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,330<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in Shares)</a></td>
<td class="nump">30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax', window );">Foreign currency translation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,250)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,250)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Compensation expense in connection with options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,140<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,140<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,610,492)<span></span>
</td>
<td class="num">(3,610,492)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balances at Nov. 30, 2020</a></td>
<td class="nump">$ 941,605<span></span>
</td>
<td class="nump">$ 25,714<span></span>
</td>
<td class="nump">36,935,126<span></span>
</td>
<td class="num">(43,091)<span></span>
</td>
<td class="num">(26,710,573)<span></span>
</td>
<td class="nump">11,148,781<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balances (in Shares) at Nov. 30, 2020</a></td>
<td class="nump">11,770,089<span></span>
</td>
<td class="nump">321,429<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balances at May. 31, 2021</a></td>
<td class="nump">$ 984,571<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,836,743<span></span>
</td>
<td class="num">(47,956)<span></span>
</td>
<td class="num">(30,546,335)<span></span>
</td>
<td class="nump">9,227,023<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balances (in Shares) at May. 31, 2021</a></td>
<td class="nump">12,307,157<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">$ 1,720<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,760<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,480<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in Shares)</a></td>
<td class="nump">21,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Net proceeds from ATM</a></td>
<td class="nump">$ 29,094<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,655,029<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,684,123<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Net proceeds from ATM (in Shares)</a></td>
<td class="nump">363,670<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax', window );">Foreign currency translation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,363)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,363)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Compensation expense in connection with options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">634,019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">634,019<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,667,855)<span></span>
</td>
<td class="num">(2,667,855)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balances at Nov. 30, 2021</a></td>
<td class="nump">$ 1,015,385<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 41,158,551<span></span>
</td>
<td class="num">$ (58,319)<span></span>
</td>
<td class="num">$ (33,214,190)<span></span>
</td>
<td class="nump">$ 8,901,427<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balances (in Shares) at Nov. 30, 2021</a></td>
<td class="nump">12,692,327<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30304-110892<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=120253306&amp;loc=d3e28129-110885<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32022-110900<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a-c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140654047159144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 30, 2021</div></th>
<th class="th"><div>Nov. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (2,667,855)<span></span>
</td>
<td class="num">$ (3,610,492)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash provided by (used in) operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">68,668<span></span>
</td>
<td class="nump">64,435<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Change in allowance on accounts receivable</a></td>
<td class="num">(809,638)<span></span>
</td>
<td class="nump">410,161<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryLIFOReservePeriodCharge', window );">Inventory reserve</a></td>
<td class="nump">181,825<span></span>
</td>
<td class="nump">11,943<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockOptionPlanExpense', window );">Stock option expense</a></td>
<td class="nump">634,019<span></span>
</td>
<td class="nump">500,140<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Amortization of right-of-use asset</a></td>
<td class="nump">126,039<span></span>
</td>
<td class="nump">115,025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="nump">1,139,450<span></span>
</td>
<td class="num">(256,059)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="nump">42,229<span></span>
</td>
<td class="num">(1,359,320)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other</a></td>
<td class="num">(726,460)<span></span>
</td>
<td class="nump">1,055,946<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_IncreaseDecreaseInLeaseLiability', window );">Reduction in lease liability</a></td>
<td class="num">(117,321)<span></span>
</td>
<td class="num">(102,677)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets</a></td>
<td class="nump">114,570<span></span>
</td>
<td class="num">(94,085)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued expenses</a></td>
<td class="nump">997,327<span></span>
</td>
<td class="nump">271,386<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities', window );">Accrued compensation</a></td>
<td class="nump">285,431<span></span>
</td>
<td class="nump">113,379<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Advance from customers</a></td>
<td class="nump">2,150,466<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by (used in) operating activities</a></td>
<td class="nump">1,418,750<span></span>
</td>
<td class="num">(2,880,218)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Increase in intangibles</a></td>
<td class="num">(108,917)<span></span>
</td>
<td class="num">(61,536)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(18,212)<span></span>
</td>
<td class="num">(61,566)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(127,129)<span></span>
</td>
<td class="num">(123,102)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from sale of common stock, net</a></td>
<td class="nump">1,684,123<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of stock options</a></td>
<td class="nump">34,480<span></span>
</td>
<td class="nump">49,330<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">1,718,603<span></span>
</td>
<td class="nump">49,330<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents', window );">Effect of exchange rate changes in cash</a></td>
<td class="num">(10,363)<span></span>
</td>
<td class="num">(3,250)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase (decrease) in cash and cash equivalents</a></td>
<td class="nump">2,999,861<span></span>
</td>
<td class="num">(2,957,240)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents at beginning of period</a></td>
<td class="nump">4,199,311<span></span>
</td>
<td class="nump">8,641,027<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents at end of period</a></td>
<td class="nump">7,199,172<span></span>
</td>
<td class="nump">5,683,787<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_CashPaidDuringThePeriodForAbstract', window );"><strong>Cash paid during the period for:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Income taxes</a></td>
<td class="nump">$ 10,646<span></span>
</td>
<td class="nump">$ 11,735<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmra_CashPaidDuringThePeriodForAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmra_CashPaidDuringThePeriodForAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmra_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmra_IncreaseDecreaseInLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in LeaseLiability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmra_IncreaseDecreaseInLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmra_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 310<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123371682&amp;loc=d3e55415-109406<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryLIFOReservePeriodCharge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The change in the inventory reserve representing the cumulative difference in cost between the first in, first out and the last in, first out inventory valuation methods, which change has been reflected in the statement of income during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e99989-122729<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryLIFOReservePeriodCharge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockOptionPlanExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockOptionPlanExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140654052440776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BASIS OF PRESENTATION<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Nov. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccounting', window );">Basis of Accounting [Text Block]</a></td>
<td class="text"><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 2.7pt 0pt 0cm"><b><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">NOTE 1: &#160;BASIS OF PRESENTATION</span></b></p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt">Biomerica Inc. and subsidiaries (collectively the &#8220;Company&#8221;, &#8220;Biomerica&#8221;, &#8220;we&#8221;, &#8220;us&#8221;, or &#8220;our&#8221;) develops, patents, manufactures and markets advanced diagnostic and therapeutic products used at the point-of-care <span style="COLOR:black">(in home and physicians' offices) </span>and in hospital/clinical laboratories for detection and/or treatment of medical conditions and diseases. <span style="COLOR:black">The</span> Company's products are designed to enhance the health and well-being of people, while reducing total healthcare costs. </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Our primary focus is the research and development of patented, diagnostic-guided therapy (&#8220;DGT&#8221;) products to treat gastrointestinal diseases, such as irritable bowel syndrome, and other inflammatory diseases. These products are directed at chronic inflammatory illnesses that are widespread and common, and as such address very large markets. </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Our existing medical diagnostic products that are in the market are sold worldwide primarily in two markets: 1) clinical laboratories and 2) point-of-care (physicians' offices and over-the-counter drugstores like Walmart and Walgreens). Our diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances and other medical complications, by measuring or detecting the existence and/or level of specific bacteria, hormones, antibodies, antigens or other substances, which may exist in a patient&#8217;s body, stools, or blood, often in extremely small concentrations.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt">Due to the global 2019 SARS-CoV-2 novel coronavirus pandemic, in March 2020 we began developing COVID-19 products to indicate if a person has been infected by COVID-19. While the Company does offer a COVID-19 antibody diagnostic test, all of our COVID-19 revenues in fiscal 2022 have come from international sales of our antigen tests that use a patient&#8217;s nasal fluid sample to detect if the patient is currently infected with the virus. </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt; COLOR:black">The other products we sell are primarily focused on gastrointestinal diseases, food intolerances, and certain esoteric tests. These diagnostic test products utilize immunoassay technology. Most of our commercial products are CE marked and/or sold for diagnostic use where they are registered by each country&#8217;s regulatory agency.&#160; In addition, some products are cleared for sale in the U.S. by the FDA.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">The information set forth in these condensed consolidated financial statements is unaudited and reflects all adjustments which, in the opinion of management, are necessary to present a fair statement of the consolidated results of operations of Biomerica, Inc. and subsidiaries, for the periods indicated. It does not include all information and footnotes necessary for a fair presentation of financial position, results of operations, and cash flows in conformity with accounting principles generally accepted in the United States of America. All adjustments that were made are of a normal recurring nature.</span></p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">The unaudited, condensed consolidated financial statements and notes are presented as permitted by the requirements for Form 10-Q and do not contain certain information included in the annual financial statements and notes. The condensed consolidated balance sheet data as of May 31, 2021 was derived from restated, audited financial statements. The accompanying interim condensed consolidated financial statements should be read in conjunction with the financial statements and related notes included in the Annual Report on Form 10-K filed with the Securities and Exchange Commission (&#8220;SEC&#8221;) on August 27, 2021 for the fiscal year ended May 31, 2021, which have been restated as described in our Form 10-K/A as filed on October 14, 2021. The results of operations for the interim periods are not necessarily indicative of results to be achieved for the full fiscal year.</span></p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><b><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; BACKGROUND:white; COLOR:black">CORRECTION OF AN ERROR</span></b></p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify; margin: 0cm 2.7pt 0pt 0cm;"><span style="font-family: 'Times New Roman','serif'; background: white; color: black;">As disclosed in our Form 10-K/A for the year ended May 31, 2021, filed on October 14, 2021, during the process of preparing our financial statements for the quarter ended August 31, 2021, we determined that our calculation of non-cash stock-based compensation expense related to issued stock options in previously issued financial statements was incorrect. Our calculation applied forfeiture adjustments to both vested and unvested outstanding options, including those for which the employee had provided the requisite service, which resulted in an understatement of stock compensation expense. Additionally, our calculation expensed the option at vesting dates versus pro-rata over the period the requisite service was provided. As a result of these errors, certain previously reported amounts in the condensed consolidated statement of operations, condensed consolidated statement of stockholders&#8217; equity and condensed consolidated statement of cash flows for the periods ended November 30, 2020, were materially misstated; accordingly, we have restated the prior period financial statements. See Note 8 to these Financial Statements. </span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccounting">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccounting</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140654052439096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Nov. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Significant Accounting Policies [Text Block]</a></td>
<td class="text"><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 2.7pt 0pt 0cm"><b><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">NOTE 2: &#160;SIGNIFICANT ACCOUNTING POLICIES</span></b></p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><b><span style="FONT-SIZE:10pt">PRINCIPLES OF CONSOLIDATION</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt">The condensed consolidated financial statements include the accounts of Biomerica, Inc. as well as its German subsidiary (BioEurope GmbH) and Mexican subsidiary (Biomerica de Mexico). All significant intercompany accounts and transactions have been eliminated in consolidation. </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><b><span style="FONT-SIZE:10pt">ACCOUNTING ESTIMATES</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt; COLOR:black">The preparation of the condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of revenues and expenses during the reported period. Estimates that are made include the allowance for doubtful accounts, which is estimated based on current as well as historical past practices with a customer; stock option forfeiture rates, which are calculated based on historical data; inventory obsolescence, which is based on projected and historical usage of materials; and lease liability and right-of-use assets, which are calculated based on certain assumptions such as borrowing rate, the likelihood of lease extensions to occur, asset valuation, among other things; and other items that may be necessary to estimate using current, historical and judgment based information. Actual results could materially differ from those estimates. </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><b><span style="FONT-SIZE:10pt; COLOR:black">MARKETS AND METHODS OF DISTRIBUTION</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt;">Due to the Coronavirus global pandemic, the Company&#8217;s operations have been negatively impacted. <span style="color: black;">The Company has faced disruptions in certain of the following areas, and may face further challenges from supply chain disruptions, loss of contracts and/or customers, closure of the Company&#8217;s manufacturing or distribution facilities or of the facilities of the Company&#8217;s suppliers, partners and customers, travel, shipping and logistical disruptions, government responses of all types, international business risks in countries where the Company makes and/or sells its products, loss of human capital or personnel at the Company, its partners and its customers, interruptions of production, customer credit risk, and general economic calamities. These ongoing pandemic related disruptions have materially negatively impacted the Company&#8217;s operations and financial performance and may continue to have significant material negative impacts on the Company.&#160;&#160; </span></span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><b><span style="FONT-SIZE:10pt; COLOR:black">LIQUIDITY</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt; COLOR:black">The Company has incurred net losses and negative cash flows from operations and has an accumulated deficit of approximately $33.2 million as of November 30, 2021.&#160; Management expects to continue to incur significant costs as it advances its clinical trials and product development activities.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">On January 22, 2021, the Company filed a prospectus supplement for purposes of raising up to $15,000,000 to the base prospectus filed with the SEC on July 21, 2020 and included in the registration statement on Form S-3 </span><span style="FONT-SIZE:10pt">(<span style="COLOR:black">File No. 333-239980) that was declared effective by the SEC on September 30, 2020. The shares included in the prospectus supplement may be sold pursuant to the terms of an At-The- Market Issuance Sales Agreement between the Company and B. Riley Securities, Inc., as sales agent, the ATM Agreement.</span></span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt">The Company intends to use the net proceeds from such offering for general corporate purposes, including, without limitation, sales and marketing activities, clinical studies and product development, making acquisitions of assets, businesses, companies or securities, capital expenditures, and for working capital needs.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Under an ATM Agreement, sales of shares are deemed to be &#8220;at the market offerings&#8221; as defined in Rule 415 promulgated under the Securities Act.&#160; The sales agent under the ATM Agreement agrees to use commercially reasonable efforts to sell on the Company&#8217;s behalf all of the shares requested to be sold from time to time by the Company, consistent with its normal trading and sales practices, on mutually agreed terms between the sales agent and the Company. The Company has no obligation to sell any of the shares under the ATM Agreement, and may at any time suspend offers under, or terminate the ATM Agreement.&#160; </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0cm 0pt"><span style="FONT-SIZE:10pt">As a result of cash and cash equivalents on hand at November 30, 2021, management believes the Company has sufficient funds to operate through February 2023 and the ability to raise additional funds through the ATM Agreement noted above.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><b><span style="FONT-SIZE:10pt">CONCENTRATION OF CREDIT RISK</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt">The Company maintains cash balances at certain financial institutions in excess of amounts insured by federal agencies. As of November 30, 2021, the Company had approximately $6,950,000 of uninsured cash.&#160; <span style="COLOR:black">The Company does not believe it is exposed to any significant credit risks.</span></span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt">For the six months ended November 30, 2021 and 2020, the Company had two and one key customers which accounted for 66% and 35% of net consolidated sales, respectively.&#160; At November 30, 2021 and May 31, 2021, the Company had three and two key distributors which accounted for a total of 73% and 73%, respectively, of gross accounts receivable. </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt">For the six months ended November 30, 2021 and 2020, the Company had one and two key vendors which accounted for 77% and 56% of the purchases of raw materials, respectively. As of November 30, 2021 and May 31, 2021, the Company had one key vendor which accounted for 47% and 17%, respectively, of accounts payable.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><b><span style="FONT-SIZE:10pt">CASH AND CASH EQUIVALENTS </span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt">Cash and cash equivalents consist of demand deposits and money market accounts with original maturities of less than six months.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><b><span style="FONT-SIZE:10pt">ACCOUNTS RECEIVABLE</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">The Company extends unsecured credit to its customers on a regular basis. &#160;International accounts are usually required to prepay until they establish a history with the Company and at that time, they are extended credit at levels based on a number of criteria. &#160;Based on various criteria,&#160;initial credit levels for individual distributors are approved by designated officers and managers of the Company. All increases in credit limits are also approved by designated upper-level management. &#160;Management evaluates receivables on a quarterly basis and adjusts the allowance for doubtful accounts accordingly. &#160;Balances over ninety days old are usually reserved for unless collection is reasonably assured. &#160; </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Occasionally certain long-standing customers, who routinely place large orders, will have unusually large receivables balances relative to the total gross receivables. Management monitors the payments for these large balances closely and very often requires payment of existing invoices before shipping new sales orders.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt">The Company has established a reserve of approximately $28,000 for doubtful accounts as of November 30, 2021. </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><b><span style="FONT-SIZE:10pt">PREPAID EXPENSES AND OTHER</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt">The Company occasionally prepays for items such as inventory, insurance and other items.&#160; These items are reported as prepaid expenses and other, until either the inventory is physically received or the insurance and other items are expensed.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt">As of November 30, 2021 and May 31, 2021, the prepaid expenses and other were approximately $1,097,000 and $370,000, respectively. The prepaid expenses and other balance were composed of prepayments to raw materials suppliers, insurance and various other suppliers. &#160;&#160;</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><b><span style="FONT-SIZE:10pt">INVENTORIES, NET </span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt">The Company values inventory at the lower of cost (determined using a combination of specific lot identification and the first-in, first-out methods) or net realizable value. Management periodically reviews inventory for excess quantities and obsolescence. Management evaluates quantities on hand, physical condition, and technical functionality as these characteristics may be impacted by anticipated customer demand for current products and new product introductions. The reserve is adjusted based on such evaluation, with a corresponding provision included in cost of sales. Abnormal amounts of idle facility expenses, freight, handling costs and wasted material are recognized as current period charges and the allocation of fixed production overhead is based on the normal capacity of the production facilities.</span></p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">Inventories approximate the following at:</span></p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><table cellpadding="0" cellspacing="0" style="WIDTH:555.6pt; BORDER-COLLAPSE:collapse; margin-left: auto; margin-right: auto;" width="741"> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:374.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td colspan="2" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:78.6pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">November 30,<br/>2021</span></p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td colspan="2" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:78.6pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">May 31, <br/>2021</span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:374.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Raw materials</span></p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="HEIGHT:15pt; WIDTH:66.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">1,416,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="HEIGHT:15pt; WIDTH:66.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">1,583,000 </span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:374.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Work in progress</span></p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:66.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">708,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:66.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">1,006,000 </span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:374.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Finished products</span></p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:11.8pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:66.8pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">858,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:11.8pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:66.8pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">617,000 </span></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:374.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Total</span></p></td> <td style="HEIGHT:15.75pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:11.8pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:66.8pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">2,982,000 </span></p></td> <td style="HEIGHT:15.75pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:11.8pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:66.8pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">3,206,000 </span></p></td></tr></table><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">Reserves for inventory obsolescence are recorded as necessary to reduce obsolete inventory carrying value to estimated realizable value or to specifically reserve for obsolete inventory that the Company intends to dispose of. As of November 30, 2021 and May 31, 2021, inventory reserves were approximately $1,799,000 and $1,617,000, respectively. Of the inventory reserve, approximately $1,686,000 was related to a market downturn in our COVID-19 antibody test and materials, as the market shifted to COVID-19 PCR viral tests and antigen tests.</span></p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><b><span style="FONT-SIZE:10pt">PROPERTY AND EQUIPMENT, NET</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt">Property and equipment are stated at cost. Expenditures for additions and major improvements are capitalized. Repairs and maintenance costs are charged to operations as incurred. When property and equipment are sold, retired or otherwise disposed of, the related cost and accumulated depreciation or amortization are removed from the accounts, and gains or losses from sales, retirements and dispositions are credited or charged to income. </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm; TEXT-INDENT:36pt">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt">Depreciation and amortization are provided over the estimated useful lives of the related assets, ranging from 5 to 10 years, using the straight-line method. Leasehold improvements are amortized over the lesser of the estimated useful life of the asset or the term of the lease. Depreciation and amortization expense on property and equipment were approximately $26,000 and $26,000 for the three months ended November 30, 2021 and 2020, and approximately $54,000 and $53,000 for the six months ended November 30, 2021 and 2020, respectively. </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt">&#160; </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><b><span style="FONT-SIZE:10pt">INTANGIBLE ASSETS, NET</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Intangible assets include trademarks, product rights, technology rights and patents, and are accounted for based on Accounting Standards Codification, ASC 350 Intangibles &#8211; Goodwill and Other. In that regard, intangible assets that have indefinite useful lives are not amortized but are tested at least annually for impairment or more frequently if events or changes in circumstances indicate that the asset might be impaired. </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Intangible assets are being amortized using the straight-line method over the useful life, not to exceed 18 years for marketing and distribution rights, 10 years for purchased technology use rights, and 20 years for patents. Amortization was approximately $7,000 and $6,000 for the three months ended November 30, 2021 and 2020 and approximately $14,000 and $12,000 for the six months ended November 30, 2021 and 2020, respectively.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">The Company assesses the recoverability of these intangible assets by determining whether the amortization of the asset&#8217;s balance over its remaining life can be recovered through projected undiscounted future cash flows. The Company uses a qualitative assessment to determine whether there was any impairment. No impairment adjustment was required as of </span><span style="FONT-SIZE:10pt">November 30<span style="COLOR:black">, 2021 or 2020.</span></span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><b><span style="FONT-SIZE:10pt; COLOR:black">INVESTMENTS</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt; COLOR:black">From time-to-time, the Company makes investments in privately-held companies. &#160;The Company determines whether the fair values of any investments in privately-held entities have declined below their carrying value whenever adverse events or changes in circumstances indicate that recorded values may not be recoverable. &#160;If the Company considers any such decline to be other than temporary (based on various factors, including historical financial results, and the overall health of the investee&#8217;s industry), a write-down to estimated fair value is recorded. Investments represent the Company&#8217;s equity investment in a Polish based distribution company which is primarily engaged in distributing medical products and devices, including those manufactured by the Company, and in certain cases, manufacturing the products they sell. &#160;The Company currently has not written down the investment and has no information that would indicate the carrying value is greater than the fair value.&#160; The Company owns approximately 6% of the Polish distribution company, and accordingly, applies the cost method to account for the investment. &#160;Under the cost method, investments are recorded at cost, with gains and losses recognized as of the sale date, and income recorded when received.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><b><span style="FONT-SIZE:10pt">SHARE-BASED COMPENSATION</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt">The Company follows the guidance of the accounting provisions of Accounting Standards Codification 718, Share-based Compensation, which requires the use of the fair-value based method to determine compensation expense for all arrangements under which employees, directors and others are granted shares of the Company&#8217;s common stock or equity instruments (stock options). The fair value of each option award is estimated on the date of grant using the Black-Scholes option pricing model that uses assumptions for expected volatility, expected dividends, expected forfeiture rate, expected term, and the risk-free interest rate. The Company has not paid dividends historically and does not expect to pay them in the future. Expected volatilities are based on weighted averages of the historical volatility of the Company&#8217;s common stock estimated over the expected term of the options. The expected forfeiture rate is based on historical forfeitures experienced. The expected term of options granted is derived using the &#8220;simplified method&#8221; which computes expected term as the average of the sum of the vesting term plus the contract term as historically the Company had limited activity surrounding its options. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for the period of<b> </b>the expected term.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">The following summary presents the options and warrants granted, exercised, expired, canceled and outstanding for the six months ended November 30, 2021:</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><table cellpadding="0" cellspacing="0" style="WIDTH:554.4pt; BORDER-COLLAPSE:collapse; margin-left: auto; margin-right: auto;" width="739"> <tr style="HEIGHT:48pt"> <td style="HEIGHT:48pt; WIDTH:385.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:48pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:48pt; BORDER-RIGHT:0px; WIDTH:66.8pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">Option Shares</span></p></td> <td style="HEIGHT:48pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td colspan="2" style="BORDER-TOP:0px; HEIGHT:48pt; BORDER-RIGHT:0px; WIDTH:78.2pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">Exercise Price Weighted Average</span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:385.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Outstanding May 31, 2021</span></p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:66.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">2,081,366</span></p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="HEIGHT:15pt; WIDTH:66.4pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">3.59</span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:385.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Granted </span></p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:66.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">24,000</span></p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:66.4pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">4.25</span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:385.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Exercised </span></p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:66.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(21,500)</span></p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:66.4pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">1.64</span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:385.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Cancelled or expired </span></p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:66.8pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(24,750)</span></p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:11.8pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:66.4pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">3.24</span></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:385.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Outstanding November 30, 2021</span></p></td> <td style="HEIGHT:15.75pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:66.8pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><b><span style="FONT-SIZE:10pt; COLOR:black">2,059,116</span></b></p></td> <td style="HEIGHT:15.75pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:11.8pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><strong><span style="FONT-SIZE:10pt; COLOR:black">$</span></strong></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:66.4pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><b><span style="FONT-SIZE:10pt; COLOR:black">3.62</span></b></p></td></tr></table><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt">During the six months ended November 30, 2021, options to purchase 21,500 shares of common stock were exercised at prices ranging from $1.20 to $3.62. Total net proceeds to the Company were $34,480.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt">During the six months ended November 30, 2021, the Company granted 24,000 options to purchase common stock at an average purchase price of $4.25. </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 2.7pt 0pt 0cm"><b><span style="FONT-SIZE:10pt">REVENUE RECOGNITION</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">The Company has various contracts with customers.&#160; All of the contracts specify that revenues from product sales are recognized at the time the product is shipped, customarily FOB shipping point, which is when the transfer of control of goods has occurred and at which point title passes. The Company does not typically allow for returns except in the event of defective merchandise and therefore does not establish an allowance for returns. In addition, the Company has contracts with customers wherein they receive purchase discounts for achieving specified sales volumes. The Company evaluated the status of these contracts as of </span><span style="FONT-SIZE:10pt">November 30<span style="COLOR:black">, 2021 and 2020, and does not believe that any additional discounts will be given through the end of the contract periods. </span>Services for contract works performed by the Company for others are invoiced and recognized as work that has been performed as the project progresses. <span style="COLOR:black">The Company sells clinical lab products to domestic and international distributors, including hospitals and clinical laboratories, medical research institutions, medical schools and pharmaceutical companies. OTC products are sold directly to drug stores and e-commerce customers as well as to distributors.&#160; Physicians&#8217; office products are sold to physicians and distributors, all of whom are categorized below according to the type of products sold to them. We also manufacture certain components on a contract basis for domestic and international manufacturers. </span></span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Disaggregation of revenue:</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">The following is a breakdown of revenues according to markets to which the products are sold:</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt; COLOR:black">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </span></p><table cellpadding="0" cellspacing="0" style="WIDTH:602.1pt; BORDER-COLLAPSE:collapse; margin-left: auto; margin-right: auto;" width="803"> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:231.05pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:8.05pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td colspan="5" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:178.55pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">Three Months Ended<br/></span><span style="FONT-SIZE:10pt">November 30,</span></p></td> <td style="HEIGHT:15pt; WIDTH:8.1pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td colspan="5" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:176.35pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">Six Months Ended<br/></span><span style="FONT-SIZE:10pt">November 30,</span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:231.05pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:8.05pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td colspan="2" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:85.25pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">2021&#160; </span></p></td> <td style="HEIGHT:15pt; WIDTH:8.05pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td colspan="2" style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:85.25pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">2020&#160; </span></p></td> <td style="HEIGHT:15pt; WIDTH:8.1pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td colspan="2" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:85.25pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">2021&#160; </span></p></td> <td style="HEIGHT:15pt; WIDTH:8.1pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td colspan="2" style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:83pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">2020</span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:231.05pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Physician's office</span></p></td> <td style="HEIGHT:15pt; WIDTH:8.05pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:16.9pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="HEIGHT:15pt; WIDTH:68.35pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">3,359,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:8.05pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:16.9pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="HEIGHT:15pt; WIDTH:68.35pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">153,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:8.1pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:16.9pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="HEIGHT:15pt; WIDTH:68.35pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">3,616,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:8.1pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:16.5pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="HEIGHT:15pt; WIDTH:66.5pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">351,000 </span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:231.05pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Clinical lab</span></p></td> <td style="HEIGHT:15pt; WIDTH:8.05pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:16.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:68.35pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">642,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:8.05pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:16.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:68.35pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">893,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:8.1pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:16.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:68.35pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">1,528,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:8.1pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:16.5pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:66.5pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">1,475,000 </span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:231.05pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Over-the-counter</span></p></td> <td style="HEIGHT:15pt; WIDTH:8.05pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:16.9pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:68.35pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">534,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:8.05pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:16.9pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:68.35pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">272,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:8.1pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:16.9pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:68.35pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">613,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:8.1pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:16.5pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:66.5pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">457,000 </span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:231.05pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Contract manufacturing</span></p></td> <td style="HEIGHT:15pt; WIDTH:8.05pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:16.9pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:68.35pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">112,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:8.05pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:16.9pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:68.35pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">55,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:8.1pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:16.9pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:68.35pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">152,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:8.1pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:16.5pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:66.5pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">233,000 </span></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:231.05pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Total</span></p></td> <td style="HEIGHT:15.75pt; WIDTH:8.05pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:16.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:68.35pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">4,647,000 </span></p></td> <td style="HEIGHT:15.75pt; WIDTH:8.05pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:16.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:68.35pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">1,373,000 </span></p></td> <td style="HEIGHT:15.75pt; WIDTH:8.1pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:16.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:68.35pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">5,909,000 </span></p></td> <td style="HEIGHT:15.75pt; WIDTH:8.1pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:16.5pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:66.5pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">2,516,000 </span></p></td></tr></table><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 16.2pt 0pt 0cm"><span style="FONT-SIZE:10pt; COLOR:black">See Note 4 for additional information regarding revenue concentrations.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 16.2pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><b><span style="FONT-SIZE:10pt">SHIPPING AND HANDLING FEES</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt; COLOR:black">The Company includes shipping and handling fees billed to customers in net sales.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><b><span style="FONT-SIZE:10pt">RESEARCH AND DEVELOPMENT</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt">Research and development costs are expensed as incurred. The Company expensed approximately $619,000 and $617,000 of research and development costs during the <span style="COLOR:black">three months ended November 30, 2021 and 2020 and approximately $1,058,000 and $1,328,000 during the six months ended November 30, 2021 and 2020, respectively.</span></span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><b><span style="FONT-SIZE:10pt">INCOME TAXES</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt; COLOR:black">The Company has provided a valuation allowance on deferred income tax assets of approximately $6,462,000 and $5,904,000 as of November 30, 2021 and May 31, 2021, respectively. &#160; </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><b><span style="FONT-SIZE:10pt">FOREIGN CURRENCY TRANSLATION</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt; COLOR:black">The subsidiary located in Mexico operates primarily using the Mexican peso. The subsidiary located in Germany operates primarily using the U.S. dollar, with an immaterial amount of transactions occurring using the Euro. Accordingly, assets and liabilities of these subsidiaries are translated using exchange rates in effect at the end of the period, and revenues and costs are translated using average exchange rates for the period. The resulting adjustments to assets and liabilities are presented as a separate component of accumulated other comprehensive loss. There are no adjustments to foreign currency loss that are included in the consolidated statements of operations for the three and six months ended November 30, 2021 and 2020.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><b><span style="FONT-SIZE:10pt; COLOR:black">RIGHT-OF-USE ASSETS AND LEASE LIABILITY</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt">The Company follows the guidance of ASC 842, Leases, which requires lessees to recognize most leases on the balance sheet with a corresponding right-of-use asset. Right-of-use assets represent the Company&#8217;s right to use an underlying asset for the lease term and lease liabilities represent the obligation to make lease payments arising from the lease. The Company leases office space and copy machines, all of which are operating leases. The Company has elected to exclude short-term leases. Most leases include the option to renew and the exercise of the renewal options is at the Company&#8217;s sole discretion. Options to extend or terminate a lease are considered in the lease term to the extent that the option is reasonably certain of exercise.&#160; The leases do not include the options to purchase the leased property.&#160; The depreciable life of assets and leasehold improvements are limited by the expected lease term.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><b><span style="FONT-SIZE:10pt">NET LOSS PER SHARE</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 16.2pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt">Basic loss per share is computed as net loss divided by the weighted average number of common shares outstanding for the period. Diluted loss per share reflects the potential dilution that could occur from common shares issuable through stock options, warrants and other convertible securities using the treasury stock method. The total amount of anti-dilutive stock options not included in the loss per share calculation at November 30, 2021 and 2020 was 2,059,116 and 1,399,763, respectively. </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 2.7pt 0pt 0cm"><b><span style="FONT-SIZE:10pt">RECENT ACCOUNTING PRONOUNCEMENTS</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt; COLOR:black">Recent ASUs issued by the Financial Accounting Standards Board and guidance issued by the Securities and Exchange Commission (&#8220;SEC&#8221;) did not, or are not believed by management to, have a material effect on the Company&#8217;s present or future consolidated financial statements. </span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140654052510920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHAREHOLDERS' EQUITY<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Nov. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity Note Disclosure [Text Block]</a></td>
<td class="text"><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 2.7pt 0pt 0cm"><b><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">NOTE 3:&#160; SHAREHOLDERS&#8217; EQUITY</span></b></p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt">Stock option expense during the six months ended November 30, 2021 and 2020 was approximately $634,000 and $500,000 (as restated, see Note 8 to these Financial Statements), respectively.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0cm 0pt"><span style="FONT-SIZE:10pt">During the six months ended November 30, 2021, the Company sold 363,670 shares of its common stock at prices ranging from $4.02 to $5.63 under its January 22, 2021 prospectus supplement and the ATM Agreement (see Note 2 to these Financial Statements) which resulted in gross proceeds of approximately $1,751,000 and net proceeds to the Company of approximately $1,684,000 after deducting commissions for each sale and legal, accounting and other fees related to the filing of the Form S-3.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140654052463352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GEOGRAPHIC INFORMATION<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Nov. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_GeographicInformationDisclosureAbstract', window );"><strong>Geographic Information Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_GeographicInformationDisclosureTextBlock', window );">Geographic Information Disclosure [Text Block]</a></td>
<td class="text"><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 16.2pt 0pt 0cm"><b><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">NOTE 4: &#160;GEOGRAPHIC INFORMATION</span></b></p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 16.2pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">The Company operates as one segment. Geographic information regarding net sales is approximately as follows: </span></p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><table cellpadding="0" cellspacing="0" style="WIDTH:602.1pt; BORDER-COLLAPSE:collapse; margin-left: auto; margin-right: auto;" width="803"> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:294.95pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:13.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td colspan="5" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:140.35pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">Three Months Ended<br/></span><span style="FONT-SIZE:10pt">November 30,</span></p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td colspan="5" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:140.35pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">Six Months Ended<br/></span><span style="FONT-SIZE:10pt">November 30,</span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:294.95pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:13.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td colspan="2" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:63.55pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">2021</span></p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td colspan="2" style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:63.55pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">2020</span></p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td colspan="2" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:63.55pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">2021</span></p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td colspan="2" style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:63.55pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">2020</span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:294.95pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Revenues from sales to unaffiliated customers:</span></p></td> <td style="HEIGHT:15pt; WIDTH:13.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:50.3pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:50.3pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:50.3pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:50.3pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"/> </tr><tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:294.95pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:10pt; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Asia</span></p></td> <td style="HEIGHT:15pt; WIDTH:13.2pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="HEIGHT:15pt; WIDTH:50.3pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">3,373,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="HEIGHT:15pt; WIDTH:50.3pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">550,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="HEIGHT:15pt; WIDTH:50.3pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">4,048,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="HEIGHT:15pt; WIDTH:50.3pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">897,000 </span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:294.95pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:10pt; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Europe</span></p></td> <td style="HEIGHT:15pt; WIDTH:13.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:50.3pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">796,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:50.3pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">580,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:50.3pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">1,267,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:50.3pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">1,171,000 </span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:294.95pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:10pt; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">North America</span></p></td> <td style="HEIGHT:15pt; WIDTH:13.2pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:50.3pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">429,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:50.3pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">107,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:50.3pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">534,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:50.3pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">241,000 </span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:294.95pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:10pt; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Middle East</span></p></td> <td style="HEIGHT:15pt; WIDTH:13.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:50.3pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">46,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:50.3pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">96,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:50.3pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">54,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:50.3pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">125,000 </span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:294.95pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:10pt; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">South America</span></p></td> <td style="HEIGHT:15pt; WIDTH:13.2pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:13.25pt; BACKGROUND:#bdd7ee; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:50.3pt; BACKGROUND:#bdd7ee; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">3,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:13.25pt; BACKGROUND:#bdd7ee; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:50.3pt; BACKGROUND:#bdd7ee; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">40,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:13.25pt; BACKGROUND:#bdd7ee; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:50.3pt; BACKGROUND:#bdd7ee; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">6,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:13.25pt; BACKGROUND:#bdd7ee; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:50.3pt; BACKGROUND:#bdd7ee; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">82,000 </span></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:294.95pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15.75pt; WIDTH:13.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:13.25pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:50.3pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">4,647,000 </span></p></td> <td style="HEIGHT:15.75pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:13.25pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:50.3pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">1,373,000 </span></p></td> <td style="HEIGHT:15.75pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:13.25pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:50.3pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">5,909,000 </span></p></td> <td style="HEIGHT:15.75pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:13.25pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:50.3pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">2,516,000 </span></p></td></tr></table><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">As of November 30, 2021 and May 31, 2021, approximately $574,000 and $803,000 of Biomerica&#8217;s gross inventory was located in Mexicali, Mexico, respectively. As of November 30, 2021 and May 31, 2021, approximately $22,000 and $25,000 of Biomerica&#8217;s property and equipment, net of accumulated depreciation and amortization, was located in Mexicali, Mexico, respectively.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmra_GeographicInformationDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmra_GeographicInformationDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmra_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmra_GeographicInformationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments according to the geographic areas.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmra_GeographicInformationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmra_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140654052489432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Nov. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Disclosure Text Block [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Lessee, Operating Leases [Text Block]</a></td>
<td class="text"><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 2.7pt 0pt 0cm"><b><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">NOTE 5:&#160; LEASES</span></b></p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">On June 18, 2009, the Company entered into an agreement to lease a building in Irvine, California. The lease commenced September 1, 2009 and ended August 31, 2016. </span><span style="FONT-SIZE:10pt">&#160;On November 30, 2015, the Company entered into the First Amendment to Lease wherein it exercised its option to extend its lease until August 31, 2021. The initial base rent for the lease extension was $21,000 per month, increasing to $23,637 through August 31, 2021. On April 9, 2021, the Company exercised its second option to extend its lease for an additional five years through August 2026.&#160; The Company was also granted an additional five years lease extension option through August 2031. The rent is currently $25,970 per month and will increase by 3% each year at the beginning of September. The security deposit of $22,080 remains the same.<span style="COLOR:black">&#160;</span></span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt">In November 2016, the Company&#8217;s subsidiary, Biomerica de Mexico, entered into a ten-year lease for approximately 8,104 square feet at a monthly rent of $2,926. The Company has one 10-year option to renew at the end of the initial lease period. The yearly rate is subject to an annual adjustment for inflation according to the United States Bureau of Labor Statistics Consumer Price Index for All Urban Consumers. The monthly rate is currently $3,262.&#160; Biomerica, Inc. is not a guarantor of such lease.&#160; Biomerica de Mexico also leases a smaller unit on a month-to-month basis for use in one manufacturing process.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt">In addition, the Company leases a small office in Lindau, Germany on a month-to-month basis, as headquarters for BioEurope GmbH, its Germany subsidiary.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Rent expense in the U.S. for the six months ended November 30, 2021 and 2020 was approximately $155,000 and $152,000, respectively.&#160; Rent expense for the Mexico facility for the six months ended November 30, 2021 and 2020 was approximately $21,000 and $22,000, respectively. </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">For purposes of determining straight-line rent expense, the lease term is calculated from the date the Company first takes possession of the facility, including any periods of free rent and any renewal option periods that the Company is reasonably certain of exercising. The Company&#8217;s office and equipment leases generally have contractually specified minimum rent and annual rent increases are included in the measurement of the right-of-use asset and related lease liability.&#160; Additionally, under these lease arrangements, the Company may be required to pay directly, or reimburse the lessors, for some maintenance and operating costs. Such amounts are generally variable and therefore not included in the measurement of the right-of-use asset and related lease liability but are instead recognized as variable lease expense in the Consolidated Statements of Operations and Comprehensive Loss when they are incurred.</span></p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 16.2pt 0pt 0cm"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;"> Supplemental cash flow information related to leases for the six months ended November 30, 2021: </span></p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 16.2pt 0pt 0cm">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 550.1pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" width="733">

<tr style="height: 15pt;">
<td style="height: 15pt; width: 462.1pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Operating cash flows from operating leases&#160;&#160;&#160;&#160;&#160; </span></p>
</td>
<td style="height: 15pt; width: 11pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 11pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15pt; width: 66pt; background: #b8cce4; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">166,216</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 462.1pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Right-of-use assets obtained in exchange for</span></p>
</td>
<td style="height: 15pt; width: 11pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 11pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 66pt; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 462.1pt; white-space: nowrap; padding: 0cm 0cm 0cm 10.8pt;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">new operating lease liabilities</span></p>
</td>
<td style="height: 15pt; width: 11pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 11pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15pt; width: 66pt; text-align: right; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom"><div style="-sec-ix-hidden: hidden-fact-11">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">-</span></p>
</div></td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 462.1pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Weighted average remaining lease term (in years)</span></p>
</td>
<td style="height: 15pt; width: 11pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 11pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 66pt; background: #b8cce4; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">4.77</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 462.1pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Weighted average discount rate</span></p>
</td>
<td style="height: 15pt; width: 11pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 11pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 66pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">6.50%</span></p>
</td>
</tr>

</table><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 16.2pt 0pt 0cm"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">The approximate maturity of lease liabilities as of November 30, 2021 are as follows:</span></p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 16.2pt 0pt 0cm">&#160;</p><table cellpadding="0" cellspacing="0" style="WIDTH:554.4pt; BORDER-COLLAPSE:collapse; margin-left: auto; margin-right: auto;" width="739"> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:463.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Less than 1 year</span></p></td> <td style="HEIGHT:15pt; WIDTH:12.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:12.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="HEIGHT:15pt; WIDTH:66.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">345,000 </span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:463.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">1 to 2 years</span></p></td> <td style="HEIGHT:15pt; WIDTH:12.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:12.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:66.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">355,000 </span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:463.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">2 to 3 years</span></p></td> <td style="HEIGHT:15pt; WIDTH:12.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:12.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:66.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">366,000 </span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:463.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">3 to 4 years</span></p></td> <td style="HEIGHT:15pt; WIDTH:12.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:12.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:66.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">377,000 </span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:463.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">4 to 5 years</span></p></td> <td style="HEIGHT:15pt; WIDTH:12.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12.2pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:66.8pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">298,000 </span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:463.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Total undiscounted lease payments</span></p></td> <td style="HEIGHT:15pt; WIDTH:12.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12.2pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:66.8pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">1,741,000 </span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:463.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Less imputed interest</span></p></td> <td style="HEIGHT:15pt; WIDTH:12.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12.2pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:66.8pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">239,000 </span></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:463.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Total operating lease liabilities</span></p></td> <td style="HEIGHT:15.75pt; WIDTH:12.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12.2pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:66.8pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">1,502,000 </span></p></td></tr></table><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">According to the terms of the lease in Irvine, the Company is also responsible for routine repairs of the building and for certain increases in property tax. </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">The Company also has various insignificant leases for office equipment.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140654052447544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Nov. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies Disclosure [Text Block]</a></td>
<td class="text"><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 16.2pt 0pt 0cm"><b><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">NOTE 6: &#160;COMMITMENTS AND CONTINGENCIES</span></b></p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 16.2pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><b><span style="FONT-SIZE:10pt; COLOR:black">LITIGATION</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">The Company is, from time to time, involved in legal proceedings, claims and litigation arising in the ordinary course of business. While the amounts claimed may be substantial, the ultimate liability cannot presently be determined because of considerable uncertainties that exist. Therefore, it is possible the outcome of such legal proceedings, claims and litigation could have a material effect on quarterly or annual operating results or cash flows when resolved in a future period. However, based on facts currently available, management believes such matters will not have a material adverse effect on the Company's consolidated financial position, results of operations or cash flows. There were no legal proceedings pending as of November 30, 2021.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt">On July 2, 2020, we received a notice of investigation and subpoena from the Division of Enforcement of the SEC. The subpoena requested information and documents related to events leading up to our March 17, 2020 announcement that, among other things, we had commenced shipping samples of our COVID-19 IgG/IgM Rapid Test to countries outside of the United States. In addition, on December 15, 2020, the SEC sent a second subpoena related to this same investigation to Zack Irani, the Company&#8217;s CEO, requesting personal and Company documents and information held by Mr. Irani. The Company and Mr. Irani cooperated fully with the SEC&#8217;s investigation and provided information as requested.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt">On December 2, 2021, the Company was notified by the SEC that they had concluded their investigations with no enforcement action recommendations. The notices of investigation conclusion pertain to the Subpoena for information sent to the Company in July 2020, as well as the Subpoena for information sent to the Company&#8217;s CEO in December 2020. </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 16.2pt 0pt 0cm"><b><span style="FONT-SIZE:10pt">CONTRACTS AND LICENSING AGREEMENTS </span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 16.2pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt">On April 15, 2021, the Company signed a general merchandise agreement with Walmart for the Company&#8217;s EZ Detect product. </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt">On June 21, 2021, the Company signed an exclusive distribution and marketing agreement in Canada for its Helicobacter Pylori (H. Pylori) test.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140654052430984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Nov. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events [Text Block]</a></td>
<td class="text"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><b><span style="FONT-SIZE:10pt">NOTE 7:&#160; SUBSEQUENT EVENTS</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt">Subsequent to November 30, 2021, the Company sold 157,597 shares of its common stock under its S-3 &#8220;shelf&#8221; Registration statement.&#160; The average sale price was $4.13 per share. Net proceeds to the Company were approximately $634,000.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt">At the December 9, 2021 board meeting, the Board of Directors approved the grant of 283,000 options to purchase shares of the Company&#8217;s common stock to officers, directors and certain employees.&#160; The options are exercisable by outside board members one year from date of grant and for officers and employees one-quarter per year with the first quarter vesting one year from date of grant. The options will be at the exercise price of $4.46 per share and expire ten years from date of grant.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt">We held our Annual Meeting of Stockholders on December 9, 2021, to consider and vote on the proposals set forth in our proxy statement filed with the Securities and Exchange Commission on September 28, 2021. Please refer to the Form 8-K filed on December 10, 2021 for a description of the results of the meeting.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140654052464184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Nov. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PriorPeriodAdjustmentAbstract', window );"><strong>Prior Period Adjustment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ErrorCorrectionTextBlock', window );">Error Correction [Text Block]</a></td>
<td class="text"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><b><span style="FONT-SIZE:10pt">NOTE 8:&#160; <span style="COLOR:black">RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS</span></span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0cm 16.2pt 0pt 0cm;"><span style="font-size: 10pt; color: black;">During September 2021, the Company determined that errors were included in the previously issued financial statements as described below. As a result, we restated our financial statements for the periods ended November 30, 2020.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 16.2pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 16.2pt 0pt 0cm"><span style="FONT-SIZE:10pt; COLOR:black">The Company discovered the errors listed below. The restatement corrects these errors.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 16.2pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; BACKGROUND:white; COLOR:black">Our non-cash stock-based compensation expenses calculation applied forfeiture adjustments to both vested and unvested outstanding options, including those for which the employee had provided the requisite service and vesting had occurred, which resulted in an understatement of stock compensation expense. Additionally, our calculation expensed all issued options at vesting dates versus pro- rata over the period the requisite service was provided. </span></p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt">Stock-based compensation expense shown on the statement of operations is a non-cash expense, and impacts accumulated deficit and additional paid-in capital on the balance sheet. However, this does not impact the Company&#8217;s cash, revenues or other aspects of ongoing operations.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 16.2pt 0pt 0cm">&#160;</p><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0cm 16.2pt 0pt 0cm;"><span style="font-size: 10pt;">The<span style="color: black;"> restatement for the quarter ended November 30, 2020 resulted in no changes in the provision for income taxes. </span></span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 16.2pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 16.2pt 0pt 0cm"><span style="FONT-SIZE:10pt; BACKGROUND:white; COLOR:black">The effect of the restatement on the consolidated statement of operations for the three months ended November 30, 2020 is as follows:</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 16.2pt 0pt 0cm">&#160;</p><table cellpadding="0" cellspacing="0" style="WIDTH:575.6pt; BORDER-COLLAPSE:collapse; margin-left: auto; margin-right: auto;" width="767"> <tr> <td style="WIDTH:363.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td colspan="2" style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:68.2pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">As Previously Reported</span></p></td> <td style="WIDTH:9.15pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td colspan="2" style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:64.05pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">Adjustments</span></p></td> <td style="WIDTH:8.45pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td colspan="2" style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:62.55pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">As Restated</span></p></td></tr> <tr style="HEIGHT:12.15pt"> <td style="HEIGHT:12.15pt; WIDTH:363.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"><span style="FONT-SIZE:10pt; COLOR:black">Cost of sales </span></p></td> <td style="HEIGHT:12.15pt; WIDTH:11.9pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="HEIGHT:12.15pt; WIDTH:56.3pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">1,011,030 </span></p></td> <td style="HEIGHT:12.15pt; WIDTH:9.15pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:12.15pt; WIDTH:11.5pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="HEIGHT:12.15pt; WIDTH:52.55pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">52,777 </span></p></td> <td style="HEIGHT:12.15pt; WIDTH:8.45pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:12.15pt; WIDTH:9.9pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="HEIGHT:12.15pt; WIDTH:52.65pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">1,063,807 </span></p></td></tr> <tr style="HEIGHT:14.75pt"> <td style="HEIGHT:14.75pt; WIDTH:363.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:10.8pt; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"><span style="FONT-SIZE:10pt; COLOR:black">Gross Profit </span></p></td> <td style="HEIGHT:14.75pt; WIDTH:11.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:14.75pt; WIDTH:56.3pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">361,496 </span></p></td> <td style="HEIGHT:14.75pt; WIDTH:9.15pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:14.75pt; WIDTH:11.5pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:14.75pt; WIDTH:52.55pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(52,777)</span></p></td> <td style="HEIGHT:14.75pt; WIDTH:8.45pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:14.75pt; WIDTH:9.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:14.75pt; WIDTH:52.65pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">308,719 </span></p></td></tr> <tr style="HEIGHT:13.55pt"> <td style="HEIGHT:13.55pt; WIDTH:363.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:13.55pt; WIDTH:11.9pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:13.55pt; WIDTH:56.3pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:13.55pt; WIDTH:9.15pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:13.55pt; WIDTH:11.5pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:13.55pt; WIDTH:52.55pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:13.55pt; WIDTH:8.45pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:13.55pt; WIDTH:9.9pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:13.55pt; WIDTH:52.65pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"/> </tr><tr style="HEIGHT:14.45pt"> <td style="HEIGHT:14.45pt; WIDTH:363.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"><span style="FONT-SIZE:10pt; COLOR:black">Operating Expenses: </span></p></td> <td style="HEIGHT:14.45pt; WIDTH:11.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:14.45pt; WIDTH:56.3pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:14.45pt; WIDTH:9.15pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:14.45pt; WIDTH:11.5pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:14.45pt; WIDTH:52.55pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:14.45pt; WIDTH:8.45pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:14.45pt; WIDTH:9.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:14.45pt; WIDTH:52.65pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"/> </tr><tr style="HEIGHT:14.65pt"> <td style="HEIGHT:14.65pt; WIDTH:363.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:10.8pt; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"><span style="FONT-SIZE:10pt; COLOR:black">Selling, general and administrative </span></p></td> <td style="HEIGHT:14.65pt; WIDTH:11.9pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:14.65pt; WIDTH:56.3pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">1,254,847 </span></p></td> <td style="HEIGHT:14.65pt; WIDTH:9.15pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:14.65pt; WIDTH:11.5pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:14.65pt; WIDTH:52.55pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">149,999 </span></p></td> <td style="HEIGHT:14.65pt; WIDTH:8.45pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:14.65pt; WIDTH:9.9pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:14.65pt; WIDTH:52.65pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">1,404,846 </span></p></td></tr> <tr style="HEIGHT:13.5pt"> <td style="HEIGHT:13.5pt; WIDTH:363.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:10.8pt; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"><span style="FONT-SIZE:10pt; COLOR:black">Research and development </span></p></td> <td style="BORDER-TOP:0px; HEIGHT:13.5pt; BORDER-RIGHT:0px; WIDTH:11.9pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:13.5pt; BORDER-RIGHT:0px; WIDTH:56.3pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">586,403 </span></p></td> <td style="HEIGHT:13.5pt; WIDTH:9.15pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:13.5pt; BORDER-RIGHT:0px; WIDTH:11.5pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:13.5pt; BORDER-RIGHT:0px; WIDTH:52.55pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">30,158 </span></p></td> <td style="HEIGHT:13.5pt; WIDTH:8.45pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:13.5pt; BORDER-RIGHT:0px; WIDTH:9.9pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:13.5pt; BORDER-RIGHT:0px; WIDTH:52.65pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">616,561 </span></p></td></tr> <tr style="HEIGHT:13.35pt"> <td style="HEIGHT:13.35pt; WIDTH:363.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:21.6pt; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"><span style="FONT-SIZE:10pt; COLOR:black">Total operating expense </span></p></td> <td style="BORDER-TOP:0px; HEIGHT:13.35pt; BORDER-RIGHT:0px; WIDTH:11.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:13.35pt; BORDER-RIGHT:0px; WIDTH:56.3pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">1,841,250 </span></p></td> <td style="HEIGHT:13.35pt; WIDTH:9.15pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:13.35pt; BORDER-RIGHT:0px; WIDTH:11.5pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:13.35pt; BORDER-RIGHT:0px; WIDTH:52.55pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">180,157 </span></p></td> <td style="HEIGHT:13.35pt; WIDTH:8.45pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:13.35pt; BORDER-RIGHT:0px; WIDTH:9.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:13.35pt; BORDER-RIGHT:0px; WIDTH:52.65pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">2,021,407 </span></p></td></tr> <tr style="HEIGHT:11.25pt"> <td style="HEIGHT:11.25pt; WIDTH:363.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:11.25pt; WIDTH:11.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:11.25pt; WIDTH:56.3pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:11.25pt; WIDTH:9.15pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:11.25pt; WIDTH:11.5pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:11.25pt; WIDTH:52.55pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:11.25pt; WIDTH:8.45pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:11.25pt; WIDTH:9.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:11.25pt; WIDTH:52.65pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"/> </tr><tr style="HEIGHT:11.25pt"> <td style="HEIGHT:11.25pt; WIDTH:363.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"><span style="FONT-SIZE:10pt; COLOR:black">Loss from operations</span></p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:11.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:56.3pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(1,479,754)</span></p></td> <td style="HEIGHT:11.25pt; WIDTH:9.15pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:11.5pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:52.55pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(232,934)</span></p></td> <td style="HEIGHT:11.25pt; WIDTH:8.45pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:9.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:52.65pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(1,712,688)</span></p></td></tr> <tr style="HEIGHT:13.5pt"> <td style="HEIGHT:13.5pt; WIDTH:363.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:13.5pt; BORDER-RIGHT:0px; WIDTH:11.9pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:13.5pt; BORDER-RIGHT:0px; WIDTH:56.3pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:13.5pt; WIDTH:9.15pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:13.5pt; BORDER-RIGHT:0px; WIDTH:11.5pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:13.5pt; BORDER-RIGHT:0px; WIDTH:52.55pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:13.5pt; WIDTH:8.45pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:13.5pt; BORDER-RIGHT:0px; WIDTH:9.9pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:13.5pt; BORDER-RIGHT:0px; WIDTH:52.65pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"/> </tr><tr style="HEIGHT:11.25pt"> <td style="HEIGHT:11.25pt; WIDTH:363.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"><span style="FONT-SIZE:10pt">Loss before income taxes</span></p></td> <td style="HEIGHT:11.25pt; WIDTH:11.9pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:11.25pt; WIDTH:56.3pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(1,471,771)</span></p></td> <td style="HEIGHT:11.25pt; WIDTH:9.15pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:11.25pt; WIDTH:11.5pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:11.25pt; WIDTH:52.55pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(232,934)</span></p></td> <td style="HEIGHT:11.25pt; WIDTH:8.45pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:11.25pt; WIDTH:9.9pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:11.25pt; WIDTH:52.65pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(1,704,705)</span></p></td></tr> <tr style="HEIGHT:13.5pt"> <td style="HEIGHT:13.5pt; WIDTH:363.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:13.5pt; WIDTH:11.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:13.5pt; WIDTH:56.3pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:13.5pt; WIDTH:9.15pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:13.5pt; WIDTH:11.5pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:13.5pt; WIDTH:52.55pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:13.5pt; WIDTH:8.45pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:13.5pt; WIDTH:9.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:13.5pt; WIDTH:52.65pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"/> </tr><tr style="HEIGHT:11.25pt"> <td style="HEIGHT:11.25pt; WIDTH:363.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"><span style="FONT-SIZE:10pt; COLOR:black">Net loss </span></p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:11.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1.5pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"><span style="FONT-SIZE:10pt; COLOR:black">$ </span></p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:56.3pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1.5pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(1,485,164)</span></p></td> <td style="HEIGHT:11.25pt; WIDTH:9.15pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:11.5pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1.5pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:52.55pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1.5pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(232,934)</span></p></td> <td style="HEIGHT:11.25pt; WIDTH:8.45pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:9.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1.5pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"><span style="FONT-SIZE:10pt; COLOR:black">$ </span></p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:52.65pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1.5pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(1,718,098)</span></p></td></tr> <tr style="HEIGHT:12pt"> <td style="HEIGHT:12pt; WIDTH:363.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:12pt; BORDER-RIGHT:0px; WIDTH:11.9pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:12pt; BORDER-RIGHT:0px; WIDTH:56.3pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:12pt; WIDTH:9.15pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:12pt; BORDER-RIGHT:0px; WIDTH:11.5pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:12pt; BORDER-RIGHT:0px; WIDTH:52.55pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:12pt; WIDTH:8.45pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:12pt; BORDER-RIGHT:0px; WIDTH:9.9pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:12pt; BORDER-RIGHT:0px; WIDTH:52.65pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"/> </tr><tr style="HEIGHT:12pt"> <td style="HEIGHT:12pt; WIDTH:363.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Basic net loss per common share </span></p></td> <td style="BORDER-TOP:0px; HEIGHT:12pt; BORDER-RIGHT:0px; WIDTH:11.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$ </span></p></td> <td style="BORDER-TOP:0px; HEIGHT:12pt; BORDER-RIGHT:0px; WIDTH:56.3pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(0.13)</span></p></td> <td style="HEIGHT:12pt; WIDTH:9.15pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:12pt; BORDER-RIGHT:0px; WIDTH:11.5pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$ </span></p></td> <td style="BORDER-TOP:0px; HEIGHT:12pt; BORDER-RIGHT:0px; WIDTH:52.55pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(0.02)</span></p></td> <td style="HEIGHT:12pt; WIDTH:8.45pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:12pt; BORDER-RIGHT:0px; WIDTH:9.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$ </span></p></td> <td style="BORDER-TOP:0px; HEIGHT:12pt; BORDER-RIGHT:0px; WIDTH:52.65pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(0.15)</span></p></td></tr> <tr style="HEIGHT:11.25pt"> <td style="HEIGHT:11.25pt; WIDTH:363.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:11.25pt; WIDTH:11.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:11.25pt; WIDTH:56.3pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:11.25pt; WIDTH:9.15pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:11.25pt; WIDTH:11.5pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:11.25pt; WIDTH:52.55pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:11.25pt; WIDTH:8.45pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:11.25pt; WIDTH:9.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:11.25pt; WIDTH:52.65pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"/> </tr><tr style="HEIGHT:11.25pt"> <td style="HEIGHT:11.25pt; WIDTH:363.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"><span style="FONT-SIZE:10pt; COLOR:black">Diluted net loss per common share </span></p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:11.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"><span style="FONT-SIZE:10pt; COLOR:black">$ </span></p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:56.3pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(0.13)</span></p></td> <td style="HEIGHT:11.25pt; WIDTH:9.15pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:11.5pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"><span style="FONT-SIZE:10pt; COLOR:black">$ </span></p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:52.55pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(0.02)</span></p></td> <td style="HEIGHT:11.25pt; WIDTH:8.45pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:9.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"><span style="FONT-SIZE:10pt; COLOR:black">$ </span></p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:52.65pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(0.15)</span></p></td></tr></table><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 16.2pt 0pt 0cm"><span style="FONT-SIZE:10pt; BACKGROUND:white; COLOR:black">The effect of the restatement on the consolidated statement of operations for the six months ended November 30, 2020 is as follows:</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p><table cellpadding="0" cellspacing="0" style="WIDTH:579.3pt; BORDER-COLLAPSE:collapse; margin-left: auto; margin-right: auto;" width="772"> <tr> <td style="WIDTH:363.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td colspan="2" style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:71.9pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">As Previously Reported</span></p></td> <td style="WIDTH:9.15pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td colspan="2" style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:64.05pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">Adjustments</span></p></td> <td style="WIDTH:8.45pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td colspan="2" style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:62.55pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">As Restated</span></p></td></tr> <tr style="HEIGHT:14.75pt"> <td style="HEIGHT:14.75pt; WIDTH:363.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"><span style="FONT-SIZE:10pt; COLOR:black">Cost of sales </span></p></td> <td style="HEIGHT:14.75pt; WIDTH:11.9pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="HEIGHT:14.75pt; WIDTH:60pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">1,971,960 </span></p></td> <td style="HEIGHT:14.75pt; WIDTH:9.15pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:14.75pt; WIDTH:11.5pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="HEIGHT:14.75pt; WIDTH:52.55pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">117,564 </span></p></td> <td style="HEIGHT:14.75pt; WIDTH:8.45pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:14.75pt; WIDTH:9.9pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="HEIGHT:14.75pt; WIDTH:52.65pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">2,089,524 </span></p></td></tr> <tr style="HEIGHT:14.55pt"> <td style="HEIGHT:14.55pt; WIDTH:363.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:10.8pt; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"><span style="FONT-SIZE:10pt; COLOR:black">Gross Profit </span></p></td> <td style="HEIGHT:14.55pt; WIDTH:11.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:14.55pt; WIDTH:60pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">544,372 </span></p></td> <td style="HEIGHT:14.55pt; WIDTH:9.15pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:14.55pt; WIDTH:11.5pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:14.55pt; WIDTH:52.55pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(117,564)</span></p></td> <td style="HEIGHT:14.55pt; WIDTH:8.45pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:14.55pt; WIDTH:9.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:14.55pt; WIDTH:52.65pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">426,808 </span></p></td></tr> <tr style="HEIGHT:14.05pt"> <td style="HEIGHT:14.05pt; WIDTH:363.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:14.05pt; WIDTH:11.9pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:14.05pt; WIDTH:60pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:14.05pt; WIDTH:9.15pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:14.05pt; WIDTH:11.5pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:14.05pt; WIDTH:52.55pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:14.05pt; WIDTH:8.45pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:14.05pt; WIDTH:9.9pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:14.05pt; WIDTH:52.65pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"/> </tr><tr style="HEIGHT:17pt"> <td style="HEIGHT:17pt; WIDTH:363.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"><span style="FONT-SIZE:10pt; COLOR:black">Operating Expenses: </span></p></td> <td style="HEIGHT:17pt; WIDTH:11.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:17pt; WIDTH:60pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:17pt; WIDTH:9.15pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:17pt; WIDTH:11.5pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:17pt; WIDTH:52.55pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:17pt; WIDTH:8.45pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:17pt; WIDTH:9.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:17pt; WIDTH:52.65pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"/> </tr><tr style="HEIGHT:13.65pt"> <td style="HEIGHT:13.65pt; WIDTH:363.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:10.8pt; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"><span style="FONT-SIZE:10pt; COLOR:black">Selling, general and administrative </span></p></td> <td style="HEIGHT:13.65pt; WIDTH:11.9pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:13.65pt; WIDTH:60pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">2,419,411 </span></p></td> <td style="HEIGHT:13.65pt; WIDTH:9.15pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:13.65pt; WIDTH:11.5pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:13.65pt; WIDTH:52.55pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">291,379 </span></p></td> <td style="HEIGHT:13.65pt; WIDTH:8.45pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:13.65pt; WIDTH:9.9pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:13.65pt; WIDTH:52.65pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">2,710,790 </span></p></td></tr> <tr style="HEIGHT:14.6pt"> <td style="HEIGHT:14.6pt; WIDTH:363.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:10.8pt; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"><span style="FONT-SIZE:10pt; COLOR:black">Research and development </span></p></td> <td style="BORDER-TOP:0px; HEIGHT:14.6pt; BORDER-RIGHT:0px; WIDTH:11.9pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:14.6pt; BORDER-RIGHT:0px; WIDTH:60pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">1,261,096 </span></p></td> <td style="HEIGHT:14.6pt; WIDTH:9.15pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:14.6pt; BORDER-RIGHT:0px; WIDTH:11.5pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:14.6pt; BORDER-RIGHT:0px; WIDTH:52.55pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">66,970 </span></p></td> <td style="HEIGHT:14.6pt; WIDTH:8.45pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:14.6pt; BORDER-RIGHT:0px; WIDTH:9.9pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:14.6pt; BORDER-RIGHT:0px; WIDTH:52.65pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">1,328,066 </span></p></td></tr> <tr style="HEIGHT:11.25pt"> <td style="HEIGHT:11.25pt; WIDTH:363.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:21.6pt; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"><span style="FONT-SIZE:10pt; COLOR:black">Total operating expense </span></p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:11.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:60pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">3,680,507 </span></p></td> <td style="HEIGHT:11.25pt; WIDTH:9.15pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:11.5pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:52.55pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">358,349 </span></p></td> <td style="HEIGHT:11.25pt; WIDTH:8.45pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:9.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:52.65pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">4,038,856 </span></p></td></tr> <tr style="HEIGHT:11.25pt"> <td style="HEIGHT:11.25pt; WIDTH:363.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:11.25pt; WIDTH:11.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:11.25pt; WIDTH:60pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:11.25pt; WIDTH:9.15pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:11.25pt; WIDTH:11.5pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:11.25pt; WIDTH:52.55pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:11.25pt; WIDTH:8.45pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:11.25pt; WIDTH:9.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:11.25pt; WIDTH:52.65pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"/> </tr><tr style="HEIGHT:11.25pt"> <td style="HEIGHT:11.25pt; WIDTH:363.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"><span style="FONT-SIZE:10pt; COLOR:black">Loss from operations</span></p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:11.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:60pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(3,136,135)</span></p></td> <td style="HEIGHT:11.25pt; WIDTH:9.15pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:11.5pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:52.55pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(475,913)</span></p></td> <td style="HEIGHT:11.25pt; WIDTH:8.45pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:9.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:52.65pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(3,612,048)</span></p></td></tr> <tr style="HEIGHT:13.5pt"> <td style="HEIGHT:13.5pt; WIDTH:363.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:13.5pt; BORDER-RIGHT:0px; WIDTH:11.9pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:13.5pt; BORDER-RIGHT:0px; WIDTH:60pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:13.5pt; WIDTH:9.15pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:13.5pt; BORDER-RIGHT:0px; WIDTH:11.5pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:13.5pt; BORDER-RIGHT:0px; WIDTH:52.55pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:13.5pt; WIDTH:8.45pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:13.5pt; BORDER-RIGHT:0px; WIDTH:9.9pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:13.5pt; BORDER-RIGHT:0px; WIDTH:52.65pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"/> </tr><tr style="HEIGHT:11.25pt"> <td style="HEIGHT:11.25pt; WIDTH:363.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"><span style="FONT-SIZE:10pt">Loss before income taxes</span></p></td> <td style="HEIGHT:11.25pt; WIDTH:11.9pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:11.25pt; WIDTH:60pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(3,120,061)</span></p></td> <td style="HEIGHT:11.25pt; WIDTH:9.15pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:11.25pt; WIDTH:11.5pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:11.25pt; WIDTH:52.55pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(475,913)</span></p></td> <td style="HEIGHT:11.25pt; WIDTH:8.45pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:11.25pt; WIDTH:9.9pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:11.25pt; WIDTH:52.65pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(3,595,974)</span></p></td></tr> <tr style="HEIGHT:13.5pt"> <td style="HEIGHT:13.5pt; WIDTH:363.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:13.5pt; WIDTH:11.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:13.5pt; WIDTH:60pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:13.5pt; WIDTH:9.15pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:13.5pt; WIDTH:11.5pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:13.5pt; WIDTH:52.55pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:13.5pt; WIDTH:8.45pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:13.5pt; WIDTH:9.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:13.5pt; WIDTH:52.65pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"/> </tr><tr style="HEIGHT:11.25pt"> <td style="HEIGHT:11.25pt; WIDTH:363.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"><span style="FONT-SIZE:10pt; COLOR:black">Net loss </span></p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:11.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"><span style="FONT-SIZE:10pt; COLOR:black">$ </span></p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:60pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(3,134,579)</span></p></td> <td style="HEIGHT:11.25pt; WIDTH:9.15pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:11.5pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:52.55pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(475,913)</span></p></td> <td style="HEIGHT:11.25pt; WIDTH:8.45pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:9.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"><span style="FONT-SIZE:10pt; COLOR:black">$ </span></p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:52.65pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(3,610,492)</span></p></td></tr> <tr style="HEIGHT:12pt"> <td style="HEIGHT:12pt; WIDTH:363.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:12pt; WIDTH:11.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:12pt; WIDTH:60pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:12pt; WIDTH:9.15pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:12pt; WIDTH:11.5pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:12pt; WIDTH:52.55pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:12pt; WIDTH:8.45pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:12pt; WIDTH:9.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:12pt; WIDTH:52.65pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td></tr> <tr style="HEIGHT:12pt"> <td style="HEIGHT:12pt; WIDTH:363.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Basic net loss per common share </span></p></td> <td style="BORDER-TOP:0px; HEIGHT:12pt; BORDER-RIGHT:0px; WIDTH:11.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$ </span></p></td> <td style="BORDER-TOP:0px; HEIGHT:12pt; BORDER-RIGHT:0px; WIDTH:60pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(0.27)</span></p></td> <td style="HEIGHT:12pt; WIDTH:9.15pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:12pt; BORDER-RIGHT:0px; WIDTH:11.5pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$ </span></p></td> <td style="BORDER-TOP:0px; HEIGHT:12pt; BORDER-RIGHT:0px; WIDTH:52.55pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(0.04)</span></p></td> <td style="HEIGHT:12pt; WIDTH:8.45pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:12pt; BORDER-RIGHT:0px; WIDTH:9.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$ </span></p></td> <td style="BORDER-TOP:0px; HEIGHT:12pt; BORDER-RIGHT:0px; WIDTH:52.65pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(0.31)</span></p></td></tr> <tr style="HEIGHT:11.25pt"> <td style="HEIGHT:11.25pt; WIDTH:363.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:11.25pt; WIDTH:11.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:11.25pt; WIDTH:60pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:11.25pt; WIDTH:9.15pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:11.25pt; WIDTH:11.5pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:11.25pt; WIDTH:52.55pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:11.25pt; WIDTH:8.45pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:11.25pt; WIDTH:9.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:11.25pt; WIDTH:52.65pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"/> </tr><tr style="HEIGHT:11.25pt"> <td style="HEIGHT:11.25pt; WIDTH:363.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"><span style="FONT-SIZE:10pt; COLOR:black">Diluted net loss per common share </span></p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:11.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"><span style="FONT-SIZE:10pt; COLOR:black">$ </span></p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:60pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(0.27)</span></p></td> <td style="HEIGHT:11.25pt; WIDTH:9.15pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:11.5pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"><span style="FONT-SIZE:10pt; COLOR:black">$ </span></p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:52.55pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(0.04)</span></p></td> <td style="HEIGHT:11.25pt; WIDTH:8.45pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:9.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"><span style="FONT-SIZE:10pt; COLOR:black">$ </span></p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:52.65pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(0.31)</span></p></td></tr> <tr style="HEIGHT:11.25pt"> <td style="HEIGHT:11.25pt; WIDTH:363.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:11.25pt; WIDTH:11.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:11.25pt; WIDTH:60pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:11.25pt; WIDTH:9.15pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:11.25pt; WIDTH:11.5pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:11.25pt; WIDTH:52.55pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:11.25pt; WIDTH:8.45pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:11.25pt; WIDTH:9.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="HEIGHT:11.25pt; WIDTH:52.65pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"/> </tr><tr style="HEIGHT:11.25pt"> <td style="HEIGHT:11.25pt; WIDTH:363.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"><span style="FONT-SIZE:10pt; COLOR:black">Comprehensive loss </span></p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:11.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"><span style="FONT-SIZE:10pt; COLOR:black">$ </span></p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:60pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(3,137,829)</span></p></td> <td style="HEIGHT:11.25pt; WIDTH:9.15pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:11.5pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"><span style="FONT-SIZE:10pt; COLOR:black">$ </span></p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:52.55pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(475,913)</span></p></td> <td style="HEIGHT:11.25pt; WIDTH:8.45pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:9.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"><span style="FONT-SIZE:10pt; COLOR:black">$ </span></p></td> <td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:52.65pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(3,613,742)</span></p></td></tr></table><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; BACKGROUND:white; COLOR:black">The effect of the restatement on the consolidated statement of cash flows for the period ended November 30, 2020 is as follows:</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 573.3pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" width="764">

<tr style="height: 22.65pt;">
<td style="height: 22.65pt; width: 372.5pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td colspan="2" style="border-top: 0px; height: 22.65pt; border-right: 0px; width: 66pt; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">As Previously Reported</span></p>
</td>
<td style="height: 22.65pt; width: 9.7pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td colspan="2" style="border-top: 0px; height: 22.65pt; border-right: 0px; width: 56.75pt; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Adjustments</span></p>
</td>
<td style="height: 22.65pt; width: 9.75pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td colspan="2" style="border-top: 0px; height: 22.65pt; border-right: 0px; width: 58.6pt; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">As Restated</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 372.5pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><strong><span style="font-size: 10pt; color: black;">Cash flows from operating activities:</span></strong></p>
</td>
<td style="height: 15pt; width: 9.7pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 56.3pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 9.7pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 10.25pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 46.5pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 9.75pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 9.75pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 48.85pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 372.5pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 9.7pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 56.3pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 9.7pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 10.25pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 46.5pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 9.75pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 9.75pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 48.85pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 372.5pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Net loss</span></p>
</td>
<td style="height: 15pt; width: 9.7pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15pt; width: 56.3pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">(3,134,579)</span></p>
</td>
<td style="height: 15pt; width: 9.7pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 10.25pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15pt; width: 46.5pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">(475,913)</span></p>
</td>
<td style="height: 15pt; width: 9.75pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 9.75pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15pt; width: 48.85pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">(3,610,492)</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 372.5pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><strong><span style="font-size: 10pt; color: black;">Adjustments to reconcile net loss to net cash used in operating activities: </span></strong></p>
</td>
<td style="height: 15pt; width: 9.7pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 56.3pt; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 9.7pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 10.25pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 46.5pt; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 9.75pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 9.75pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 48.85pt; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 372.5pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Stock option expense</span></p>
</td>
<td style="height: 15pt; width: 9.7pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 56.3pt; background: #b8cce4; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">24,227 </span></p>
</td>
<td style="height: 15pt; width: 9.7pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 10.25pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 46.5pt; background: #b8cce4; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">475,913 </span></p>
</td>
<td style="height: 15pt; width: 9.75pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 9.75pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 48.85pt; background: #b8cce4; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">500,140 </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 372.5pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Net cash used in operating activities </span></p>
</td>
<td style="height: 15pt; width: 9.7pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 56.3pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">(2,880,218)</span></p>
</td>
<td style="height: 15pt; width: 9.7pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 10.25pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 46.5pt; text-align: right; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom"><div style="-sec-ix-hidden: hidden-fact-12">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">-</span></p>
</div></td>
<td style="height: 15pt; width: 9.75pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 9.75pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 48.85pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">(2,880,218)</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 372.5pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 9.7pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 56.3pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 9.7pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 10.25pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 46.5pt; background: #b8cce4; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 9.75pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 9.75pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 48.85pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 372.5pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Cash and cash equivalents at end of period</span></p>
</td>
<td style="height: 15pt; width: 9.7pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15pt; width: 56.3pt; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">5,683,787 </span></p>
</td>
<td style="height: 15pt; width: 9.7pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 10.25pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15pt; width: 46.5pt; text-align: right; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom"><div style="-sec-ix-hidden: hidden-fact-13">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">-</span></p>
</div></td>
<td style="height: 15pt; width: 9.75pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 9.75pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15pt; width: 48.85pt; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">5,683,787 </span></p>
</td>
</tr>

</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ErrorCorrectionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting error correction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ErrorCorrectionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodAdjustmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodAdjustmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140654046673640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounting Policies, by Policy (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Nov. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Consolidation, Policy [Policy Text Block]</a></td>
<td class="text"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><b><span style="FONT-SIZE:10pt">PRINCIPLES OF CONSOLIDATION</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt">The condensed consolidated financial statements include the accounts of Biomerica, Inc. as well as its German subsidiary (BioEurope GmbH) and Mexican subsidiary (Biomerica de Mexico). All significant intercompany accounts and transactions have been eliminated in consolidation. </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates, Policy [Policy Text Block]</a></td>
<td class="text"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><b><span style="FONT-SIZE:10pt">ACCOUNTING ESTIMATES</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt; COLOR:black">The preparation of the condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of revenues and expenses during the reported period. Estimates that are made include the allowance for doubtful accounts, which is estimated based on current as well as historical past practices with a customer; stock option forfeiture rates, which are calculated based on historical data; inventory obsolescence, which is based on projected and historical usage of materials; and lease liability and right-of-use assets, which are calculated based on certain assumptions such as borrowing rate, the likelihood of lease extensions to occur, asset valuation, among other things; and other items that may be necessary to estimate using current, historical and judgment based information. Actual results could materially differ from those estimates. </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_MarketsAndMethodsOfDistributionPolicyTextBlock', window );">Markets And Methods Of Distribution [Policy Text Block]</a></td>
<td class="text"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><b><span style="FONT-SIZE:10pt; COLOR:black">MARKETS AND METHODS OF DISTRIBUTION</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt;">Due to the Coronavirus global pandemic, the Company&#8217;s operations have been negatively impacted. <span style="color: black;">The Company has faced disruptions in certain of the following areas, and may face further challenges from supply chain disruptions, loss of contracts and/or customers, closure of the Company&#8217;s manufacturing or distribution facilities or of the facilities of the Company&#8217;s suppliers, partners and customers, travel, shipping and logistical disruptions, government responses of all types, international business risks in countries where the Company makes and/or sells its products, loss of human capital or personnel at the Company, its partners and its customers, interruptions of production, customer credit risk, and general economic calamities. These ongoing pandemic related disruptions have materially negatively impacted the Company&#8217;s operations and financial performance and may continue to have significant material negative impacts on the Company.&#160;&#160; </span></span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_LiquidityPolicyTextBlock', window );">Liquidity [Policy Text Block]</a></td>
<td class="text"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><b><span style="FONT-SIZE:10pt; COLOR:black">LIQUIDITY</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt; COLOR:black">The Company has incurred net losses and negative cash flows from operations and has an accumulated deficit of approximately $33.2 million as of November 30, 2021.&#160; Management expects to continue to incur significant costs as it advances its clinical trials and product development activities.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">On January 22, 2021, the Company filed a prospectus supplement for purposes of raising up to $15,000,000 to the base prospectus filed with the SEC on July 21, 2020 and included in the registration statement on Form S-3 </span><span style="FONT-SIZE:10pt">(<span style="COLOR:black">File No. 333-239980) that was declared effective by the SEC on September 30, 2020. The shares included in the prospectus supplement may be sold pursuant to the terms of an At-The- Market Issuance Sales Agreement between the Company and B. Riley Securities, Inc., as sales agent, the ATM Agreement.</span></span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt">The Company intends to use the net proceeds from such offering for general corporate purposes, including, without limitation, sales and marketing activities, clinical studies and product development, making acquisitions of assets, businesses, companies or securities, capital expenditures, and for working capital needs.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Under an ATM Agreement, sales of shares are deemed to be &#8220;at the market offerings&#8221; as defined in Rule 415 promulgated under the Securities Act.&#160; The sales agent under the ATM Agreement agrees to use commercially reasonable efforts to sell on the Company&#8217;s behalf all of the shares requested to be sold from time to time by the Company, consistent with its normal trading and sales practices, on mutually agreed terms between the sales agent and the Company. The Company has no obligation to sell any of the shares under the ATM Agreement, and may at any time suspend offers under, or terminate the ATM Agreement.&#160; </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0cm 0pt"><span style="FONT-SIZE:10pt">As a result of cash and cash equivalents on hand at November 30, 2021, management believes the Company has sufficient funds to operate through February 2023 and the ability to raise additional funds through the ATM Agreement noted above.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration Risk, Credit Risk, Policy [Policy Text Block]</a></td>
<td class="text"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><b><span style="FONT-SIZE:10pt">CONCENTRATION OF CREDIT RISK</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt">The Company maintains cash balances at certain financial institutions in excess of amounts insured by federal agencies. As of November 30, 2021, the Company had approximately $6,950,000 of uninsured cash.&#160; <span style="COLOR:black">The Company does not believe it is exposed to any significant credit risks.</span></span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt">For the six months ended November 30, 2021 and 2020, the Company had two and one key customers which accounted for 66% and 35% of net consolidated sales, respectively.&#160; At November 30, 2021 and May 31, 2021, the Company had three and two key distributors which accounted for a total of 73% and 73%, respectively, of gross accounts receivable. </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt">For the six months ended November 30, 2021 and 2020, the Company had one and two key vendors which accounted for 77% and 56% of the purchases of raw materials, respectively. As of November 30, 2021 and May 31, 2021, the Company had one key vendor which accounted for 47% and 17%, respectively, of accounts payable.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents, Policy [Policy Text Block]</a></td>
<td class="text"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><b><span style="FONT-SIZE:10pt">CASH AND CASH EQUIVALENTS </span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt">Cash and cash equivalents consist of demand deposits and money market accounts with original maturities of less than six months.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradeAndOtherAccountsReceivablePolicy', window );">Accounts Receivable [Policy Text Block]</a></td>
<td class="text"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><b><span style="FONT-SIZE:10pt">ACCOUNTS RECEIVABLE</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">The Company extends unsecured credit to its customers on a regular basis. &#160;International accounts are usually required to prepay until they establish a history with the Company and at that time, they are extended credit at levels based on a number of criteria. &#160;Based on various criteria,&#160;initial credit levels for individual distributors are approved by designated officers and managers of the Company. All increases in credit limits are also approved by designated upper-level management. &#160;Management evaluates receivables on a quarterly basis and adjusts the allowance for doubtful accounts accordingly. &#160;Balances over ninety days old are usually reserved for unless collection is reasonably assured. &#160; </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Occasionally certain long-standing customers, who routinely place large orders, will have unusually large receivables balances relative to the total gross receivables. Management monitors the payments for these large balances closely and very often requires payment of existing invoices before shipping new sales orders.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt">The Company has established a reserve of approximately $28,000 for doubtful accounts as of November 30, 2021. </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_PrepaidsPolicyPolicyTextBlock', window );">Prepaids Policy [Policy Text Block]</a></td>
<td class="text"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><b><span style="FONT-SIZE:10pt">PREPAID EXPENSES AND OTHER</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt">The Company occasionally prepays for items such as inventory, insurance and other items.&#160; These items are reported as prepaid expenses and other, until either the inventory is physically received or the insurance and other items are expensed.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt">As of November 30, 2021 and May 31, 2021, the prepaid expenses and other were approximately $1,097,000 and $370,000, respectively. The prepaid expenses and other balance were composed of prepayments to raw materials suppliers, insurance and various other suppliers. &#160;&#160;</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventory, Policy [Policy Text Block]</a></td>
<td class="text"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><b><span style="FONT-SIZE:10pt">INVENTORIES, NET </span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt">The Company values inventory at the lower of cost (determined using a combination of specific lot identification and the first-in, first-out methods) or net realizable value. Management periodically reviews inventory for excess quantities and obsolescence. Management evaluates quantities on hand, physical condition, and technical functionality as these characteristics may be impacted by anticipated customer demand for current products and new product introductions. The reserve is adjusted based on such evaluation, with a corresponding provision included in cost of sales. Abnormal amounts of idle facility expenses, freight, handling costs and wasted material are recognized as current period charges and the allocation of fixed production overhead is based on the normal capacity of the production facilities.</span></p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">Inventories approximate the following at:</span></p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><table cellpadding="0" cellspacing="0" style="WIDTH:555.6pt; BORDER-COLLAPSE:collapse; margin-left: auto; margin-right: auto;" width="741"> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:374.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td colspan="2" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:78.6pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">November 30,<br/>2021</span></p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td colspan="2" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:78.6pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">May 31, <br/>2021</span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:374.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Raw materials</span></p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="HEIGHT:15pt; WIDTH:66.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">1,416,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="HEIGHT:15pt; WIDTH:66.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">1,583,000 </span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:374.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Work in progress</span></p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:66.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">708,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:66.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">1,006,000 </span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:374.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Finished products</span></p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:11.8pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:66.8pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">858,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:11.8pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:66.8pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">617,000 </span></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:374.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Total</span></p></td> <td style="HEIGHT:15.75pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:11.8pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:66.8pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">2,982,000 </span></p></td> <td style="HEIGHT:15.75pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:11.8pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:66.8pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">3,206,000 </span></p></td></tr></table><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">Reserves for inventory obsolescence are recorded as necessary to reduce obsolete inventory carrying value to estimated realizable value or to specifically reserve for obsolete inventory that the Company intends to dispose of. As of November 30, 2021 and May 31, 2021, inventory reserves were approximately $1,799,000 and $1,617,000, respectively. Of the inventory reserve, approximately $1,686,000 was related to a market downturn in our COVID-19 antibody test and materials, as the market shifted to COVID-19 PCR viral tests and antigen tests.</span></p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property, Plant and Equipment, Policy [Policy Text Block]</a></td>
<td class="text"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><b><span style="FONT-SIZE:10pt">PROPERTY AND EQUIPMENT, NET</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt">Property and equipment are stated at cost. Expenditures for additions and major improvements are capitalized. Repairs and maintenance costs are charged to operations as incurred. When property and equipment are sold, retired or otherwise disposed of, the related cost and accumulated depreciation or amortization are removed from the accounts, and gains or losses from sales, retirements and dispositions are credited or charged to income. </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm; TEXT-INDENT:36pt">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt">Depreciation and amortization are provided over the estimated useful lives of the related assets, ranging from 5 to 10 years, using the straight-line method. Leasehold improvements are amortized over the lesser of the estimated useful life of the asset or the term of the lease. Depreciation and amortization expense on property and equipment were approximately $26,000 and $26,000 for the three months ended November 30, 2021 and 2020, and approximately $54,000 and $53,000 for the six months ended November 30, 2021 and 2020, respectively. </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt">&#160; </span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock', window );">Goodwill and Intangible Assets, Policy [Policy Text Block]</a></td>
<td class="text"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><b><span style="FONT-SIZE:10pt">INTANGIBLE ASSETS, NET</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Intangible assets include trademarks, product rights, technology rights and patents, and are accounted for based on Accounting Standards Codification, ASC 350 Intangibles &#8211; Goodwill and Other. In that regard, intangible assets that have indefinite useful lives are not amortized but are tested at least annually for impairment or more frequently if events or changes in circumstances indicate that the asset might be impaired. </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Intangible assets are being amortized using the straight-line method over the useful life, not to exceed 18 years for marketing and distribution rights, 10 years for purchased technology use rights, and 20 years for patents. Amortization was approximately $7,000 and $6,000 for the three months ended November 30, 2021 and 2020 and approximately $14,000 and $12,000 for the six months ended November 30, 2021 and 2020, respectively.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">The Company assesses the recoverability of these intangible assets by determining whether the amortization of the asset&#8217;s balance over its remaining life can be recovered through projected undiscounted future cash flows. The Company uses a qualitative assessment to determine whether there was any impairment. No impairment adjustment was required as of </span><span style="FONT-SIZE:10pt">November 30<span style="COLOR:black">, 2021 or 2020.</span></span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentPolicyTextBlock', window );">Investment, Policy [Policy Text Block]</a></td>
<td class="text"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><b><span style="FONT-SIZE:10pt; COLOR:black">INVESTMENTS</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt; COLOR:black">From time-to-time, the Company makes investments in privately-held companies. &#160;The Company determines whether the fair values of any investments in privately-held entities have declined below their carrying value whenever adverse events or changes in circumstances indicate that recorded values may not be recoverable. &#160;If the Company considers any such decline to be other than temporary (based on various factors, including historical financial results, and the overall health of the investee&#8217;s industry), a write-down to estimated fair value is recorded. Investments represent the Company&#8217;s equity investment in a Polish based distribution company which is primarily engaged in distributing medical products and devices, including those manufactured by the Company, and in certain cases, manufacturing the products they sell. &#160;The Company currently has not written down the investment and has no information that would indicate the carrying value is greater than the fair value.&#160; The Company owns approximately 6% of the Polish distribution company, and accordingly, applies the cost method to account for the investment. &#160;Under the cost method, investments are recorded at cost, with gains and losses recognized as of the sale date, and income recorded when received.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Share-based Payment Arrangement [Policy Text Block]</a></td>
<td class="text"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><b><span style="FONT-SIZE:10pt">SHARE-BASED COMPENSATION</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt">The Company follows the guidance of the accounting provisions of Accounting Standards Codification 718, Share-based Compensation, which requires the use of the fair-value based method to determine compensation expense for all arrangements under which employees, directors and others are granted shares of the Company&#8217;s common stock or equity instruments (stock options). The fair value of each option award is estimated on the date of grant using the Black-Scholes option pricing model that uses assumptions for expected volatility, expected dividends, expected forfeiture rate, expected term, and the risk-free interest rate. The Company has not paid dividends historically and does not expect to pay them in the future. Expected volatilities are based on weighted averages of the historical volatility of the Company&#8217;s common stock estimated over the expected term of the options. The expected forfeiture rate is based on historical forfeitures experienced. The expected term of options granted is derived using the &#8220;simplified method&#8221; which computes expected term as the average of the sum of the vesting term plus the contract term as historically the Company had limited activity surrounding its options. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for the period of<b> </b>the expected term.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">The following summary presents the options and warrants granted, exercised, expired, canceled and outstanding for the six months ended November 30, 2021:</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><table cellpadding="0" cellspacing="0" style="WIDTH:554.4pt; BORDER-COLLAPSE:collapse; margin-left: auto; margin-right: auto;" width="739"> <tr style="HEIGHT:48pt"> <td style="HEIGHT:48pt; WIDTH:385.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:48pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:48pt; BORDER-RIGHT:0px; WIDTH:66.8pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">Option Shares</span></p></td> <td style="HEIGHT:48pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td colspan="2" style="BORDER-TOP:0px; HEIGHT:48pt; BORDER-RIGHT:0px; WIDTH:78.2pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">Exercise Price Weighted Average</span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:385.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Outstanding May 31, 2021</span></p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:66.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">2,081,366</span></p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="HEIGHT:15pt; WIDTH:66.4pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">3.59</span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:385.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Granted </span></p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:66.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">24,000</span></p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:66.4pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">4.25</span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:385.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Exercised </span></p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:66.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(21,500)</span></p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:66.4pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">1.64</span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:385.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Cancelled or expired </span></p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:66.8pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(24,750)</span></p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:11.8pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:66.4pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">3.24</span></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:385.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Outstanding November 30, 2021</span></p></td> <td style="HEIGHT:15.75pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:66.8pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><b><span style="FONT-SIZE:10pt; COLOR:black">2,059,116</span></b></p></td> <td style="HEIGHT:15.75pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:11.8pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><strong><span style="FONT-SIZE:10pt; COLOR:black">$</span></strong></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:66.4pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><b><span style="FONT-SIZE:10pt; COLOR:black">3.62</span></b></p></td></tr></table><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt">During the six months ended November 30, 2021, options to purchase 21,500 shares of common stock were exercised at prices ranging from $1.20 to $3.62. Total net proceeds to the Company were $34,480.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt">During the six months ended November 30, 2021, the Company granted 24,000 options to purchase common stock at an average purchase price of $4.25. </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue [Policy Text Block]</a></td>
<td class="text"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 2.7pt 0pt 0cm"><b><span style="FONT-SIZE:10pt">REVENUE RECOGNITION</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">The Company has various contracts with customers.&#160; All of the contracts specify that revenues from product sales are recognized at the time the product is shipped, customarily FOB shipping point, which is when the transfer of control of goods has occurred and at which point title passes. The Company does not typically allow for returns except in the event of defective merchandise and therefore does not establish an allowance for returns. In addition, the Company has contracts with customers wherein they receive purchase discounts for achieving specified sales volumes. The Company evaluated the status of these contracts as of </span><span style="FONT-SIZE:10pt">November 30<span style="COLOR:black">, 2021 and 2020, and does not believe that any additional discounts will be given through the end of the contract periods. </span>Services for contract works performed by the Company for others are invoiced and recognized as work that has been performed as the project progresses. <span style="COLOR:black">The Company sells clinical lab products to domestic and international distributors, including hospitals and clinical laboratories, medical research institutions, medical schools and pharmaceutical companies. OTC products are sold directly to drug stores and e-commerce customers as well as to distributors.&#160; Physicians&#8217; office products are sold to physicians and distributors, all of whom are categorized below according to the type of products sold to them. We also manufacture certain components on a contract basis for domestic and international manufacturers. </span></span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Disaggregation of revenue:</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">The following is a breakdown of revenues according to markets to which the products are sold:</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt; COLOR:black">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </span></p><table cellpadding="0" cellspacing="0" style="WIDTH:602.1pt; BORDER-COLLAPSE:collapse; margin-left: auto; margin-right: auto;" width="803"> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:231.05pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:8.05pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td colspan="5" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:178.55pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">Three Months Ended<br/></span><span style="FONT-SIZE:10pt">November 30,</span></p></td> <td style="HEIGHT:15pt; WIDTH:8.1pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td colspan="5" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:176.35pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">Six Months Ended<br/></span><span style="FONT-SIZE:10pt">November 30,</span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:231.05pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:8.05pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td colspan="2" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:85.25pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">2021&#160; </span></p></td> <td style="HEIGHT:15pt; WIDTH:8.05pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td colspan="2" style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:85.25pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">2020&#160; </span></p></td> <td style="HEIGHT:15pt; WIDTH:8.1pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td colspan="2" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:85.25pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">2021&#160; </span></p></td> <td style="HEIGHT:15pt; WIDTH:8.1pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td colspan="2" style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:83pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">2020</span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:231.05pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Physician's office</span></p></td> <td style="HEIGHT:15pt; WIDTH:8.05pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:16.9pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="HEIGHT:15pt; WIDTH:68.35pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">3,359,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:8.05pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:16.9pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="HEIGHT:15pt; WIDTH:68.35pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">153,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:8.1pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:16.9pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="HEIGHT:15pt; WIDTH:68.35pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">3,616,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:8.1pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:16.5pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="HEIGHT:15pt; WIDTH:66.5pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">351,000 </span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:231.05pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Clinical lab</span></p></td> <td style="HEIGHT:15pt; WIDTH:8.05pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:16.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:68.35pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">642,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:8.05pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:16.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:68.35pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">893,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:8.1pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:16.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:68.35pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">1,528,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:8.1pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:16.5pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:66.5pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">1,475,000 </span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:231.05pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Over-the-counter</span></p></td> <td style="HEIGHT:15pt; WIDTH:8.05pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:16.9pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:68.35pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">534,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:8.05pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:16.9pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:68.35pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">272,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:8.1pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:16.9pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:68.35pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">613,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:8.1pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:16.5pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:66.5pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">457,000 </span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:231.05pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Contract manufacturing</span></p></td> <td style="HEIGHT:15pt; WIDTH:8.05pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:16.9pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:68.35pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">112,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:8.05pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:16.9pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:68.35pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">55,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:8.1pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:16.9pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:68.35pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">152,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:8.1pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:16.5pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:66.5pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">233,000 </span></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:231.05pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Total</span></p></td> <td style="HEIGHT:15.75pt; WIDTH:8.05pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:16.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:68.35pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">4,647,000 </span></p></td> <td style="HEIGHT:15.75pt; WIDTH:8.05pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:16.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:68.35pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">1,373,000 </span></p></td> <td style="HEIGHT:15.75pt; WIDTH:8.1pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:16.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:68.35pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">5,909,000 </span></p></td> <td style="HEIGHT:15.75pt; WIDTH:8.1pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:16.5pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:66.5pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">2,516,000 </span></p></td></tr></table><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 16.2pt 0pt 0cm"><span style="FONT-SIZE:10pt; COLOR:black">See Note 4 for additional information regarding revenue concentrations.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 16.2pt 0pt 0cm">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfSalesPolicyTextBlock', window );">Cost of Goods and Service [Policy Text Block]</a></td>
<td class="text"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><b><span style="FONT-SIZE:10pt">SHIPPING AND HANDLING FEES</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt; COLOR:black">The Company includes shipping and handling fees billed to customers in net sales.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development Expense, Policy [Policy Text Block]</a></td>
<td class="text"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><b><span style="FONT-SIZE:10pt">RESEARCH AND DEVELOPMENT</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt">Research and development costs are expensed as incurred. The Company expensed approximately $619,000 and $617,000 of research and development costs during the <span style="COLOR:black">three months ended November 30, 2021 and 2020 and approximately $1,058,000 and $1,328,000 during the six months ended November 30, 2021 and 2020, respectively.</span></span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Tax, Policy [Policy Text Block]</a></td>
<td class="text"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><b><span style="FONT-SIZE:10pt">INCOME TAXES</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt; COLOR:black">The Company has provided a valuation allowance on deferred income tax assets of approximately $6,462,000 and $5,904,000 as of November 30, 2021 and May 31, 2021, respectively. &#160; </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency Transactions and Translations Policy [Policy Text Block]</a></td>
<td class="text"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><b><span style="FONT-SIZE:10pt">FOREIGN CURRENCY TRANSLATION</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt; COLOR:black">The subsidiary located in Mexico operates primarily using the Mexican peso. The subsidiary located in Germany operates primarily using the U.S. dollar, with an immaterial amount of transactions occurring using the Euro. Accordingly, assets and liabilities of these subsidiaries are translated using exchange rates in effect at the end of the period, and revenues and costs are translated using average exchange rates for the period. The resulting adjustments to assets and liabilities are presented as a separate component of accumulated other comprehensive loss. There are no adjustments to foreign currency loss that are included in the consolidated statements of operations for the three and six months ended November 30, 2021 and 2020.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Lessee, Leases [Policy Text Block]</a></td>
<td class="text"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><b><span style="FONT-SIZE:10pt; COLOR:black">RIGHT-OF-USE ASSETS AND LEASE LIABILITY</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt">The Company follows the guidance of ASC 842, Leases, which requires lessees to recognize most leases on the balance sheet with a corresponding right-of-use asset. Right-of-use assets represent the Company&#8217;s right to use an underlying asset for the lease term and lease liabilities represent the obligation to make lease payments arising from the lease. The Company leases office space and copy machines, all of which are operating leases. The Company has elected to exclude short-term leases. Most leases include the option to renew and the exercise of the renewal options is at the Company&#8217;s sole discretion. Options to extend or terminate a lease are considered in the lease term to the extent that the option is reasonably certain of exercise.&#160; The leases do not include the options to purchase the leased property.&#160; The depreciable life of assets and leasehold improvements are limited by the expected lease term.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings Per Share, Policy [Policy Text Block]</a></td>
<td class="text"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><b><span style="FONT-SIZE:10pt">NET LOSS PER SHARE</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 16.2pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt">Basic loss per share is computed as net loss divided by the weighted average number of common shares outstanding for the period. Diluted loss per share reflects the potential dilution that could occur from common shares issuable through stock options, warrants and other convertible securities using the treasury stock method. The total amount of anti-dilutive stock options not included in the loss per share calculation at November 30, 2021 and 2020 was 2,059,116 and 1,399,763, respectively. </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">New Accounting Pronouncements, Policy [Policy Text Block]</a></td>
<td class="text"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 2.7pt 0pt 0cm"><b><span style="FONT-SIZE:10pt">RECENT ACCOUNTING PRONOUNCEMENTS</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"><span style="FONT-SIZE:10pt; COLOR:black">Recent ASUs issued by the Financial Accounting Standards Board and guidance issued by the Securities and Exchange Commission (&#8220;SEC&#8221;) did not, or are not believed by management to, have a material effect on the Company&#8217;s present or future consolidated financial statements. </span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmra_LiquidityPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for liquidity position during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmra_LiquidityPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmra_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmra_MarketsAndMethodsOfDistributionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for Markets And Methods Of Distribution during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmra_MarketsAndMethodsOfDistributionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmra_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmra_PrepaidsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for prepaids.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmra_PrepaidsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmra_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123345438&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfSalesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cost of product sold and service rendered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 705<br> -URI http://asc.fasb.org/topic&amp;trid=2122478<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfSalesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI http://asc.fasb.org/topic&amp;trid=2175825<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 330<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6471895&amp;loc=d3e55923-109411<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124437754&amp;loc=d3e543-108305<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment in financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradeAndOtherAccountsReceivablePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e4975-111524<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5212-111524<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=SL6953423-111524<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5093-111524<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5033-111524<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradeAndOtherAccountsReceivablePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140654050882584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Nov. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Inventory, Current [Table Text Block]</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="WIDTH:555.6pt; BORDER-COLLAPSE:collapse; margin-left: auto; margin-right: auto;" width="741"> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:374.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td colspan="2" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:78.6pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">November 30,<br/>2021</span></p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td colspan="2" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:78.6pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">May 31, <br/>2021</span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:374.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Raw materials</span></p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="HEIGHT:15pt; WIDTH:66.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">1,416,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="HEIGHT:15pt; WIDTH:66.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">1,583,000 </span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:374.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Work in progress</span></p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:66.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">708,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:66.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">1,006,000 </span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:374.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Finished products</span></p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:11.8pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:66.8pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">858,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:11.8pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:66.8pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">617,000 </span></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:374.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Total</span></p></td> <td style="HEIGHT:15.75pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:11.8pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:66.8pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">2,982,000 </span></p></td> <td style="HEIGHT:15.75pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:11.8pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:66.8pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">3,206,000 </span></p></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Share-based Payment Arrangement, Option, Activity [Table Text Block]</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="WIDTH:554.4pt; BORDER-COLLAPSE:collapse; margin-left: auto; margin-right: auto;" width="739"> <tr style="HEIGHT:48pt"> <td style="HEIGHT:48pt; WIDTH:385.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:48pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:48pt; BORDER-RIGHT:0px; WIDTH:66.8pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">Option Shares</span></p></td> <td style="HEIGHT:48pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td colspan="2" style="BORDER-TOP:0px; HEIGHT:48pt; BORDER-RIGHT:0px; WIDTH:78.2pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">Exercise Price Weighted Average</span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:385.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Outstanding May 31, 2021</span></p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:66.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">2,081,366</span></p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="HEIGHT:15pt; WIDTH:66.4pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">3.59</span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:385.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Granted </span></p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:66.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">24,000</span></p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:66.4pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">4.25</span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:385.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Exercised </span></p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:66.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(21,500)</span></p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:66.4pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">1.64</span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:385.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Cancelled or expired </span></p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:66.8pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">(24,750)</span></p></td> <td style="HEIGHT:15pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:11.8pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:66.4pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">3.24</span></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:385.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Outstanding November 30, 2021</span></p></td> <td style="HEIGHT:15.75pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:66.8pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><b><span style="FONT-SIZE:10pt; COLOR:black">2,059,116</span></b></p></td> <td style="HEIGHT:15.75pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:11.8pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><strong><span style="FONT-SIZE:10pt; COLOR:black">$</span></strong></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:66.4pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><b><span style="FONT-SIZE:10pt; COLOR:black">3.62</span></b></p></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue [Table Text Block]</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="WIDTH:602.1pt; BORDER-COLLAPSE:collapse; margin-left: auto; margin-right: auto;" width="803"> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:231.05pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:8.05pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td colspan="5" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:178.55pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">Three Months Ended<br/></span><span style="FONT-SIZE:10pt">November 30,</span></p></td> <td style="HEIGHT:15pt; WIDTH:8.1pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td colspan="5" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:176.35pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">Six Months Ended<br/></span><span style="FONT-SIZE:10pt">November 30,</span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:231.05pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:8.05pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td colspan="2" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:85.25pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">2021&#160; </span></p></td> <td style="HEIGHT:15pt; WIDTH:8.05pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td colspan="2" style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:85.25pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">2020&#160; </span></p></td> <td style="HEIGHT:15pt; WIDTH:8.1pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td colspan="2" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:85.25pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">2021&#160; </span></p></td> <td style="HEIGHT:15pt; WIDTH:8.1pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td colspan="2" style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:83pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">2020</span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:231.05pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Physician's office</span></p></td> <td style="HEIGHT:15pt; WIDTH:8.05pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:16.9pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="HEIGHT:15pt; WIDTH:68.35pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">3,359,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:8.05pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:16.9pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="HEIGHT:15pt; WIDTH:68.35pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">153,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:8.1pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:16.9pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="HEIGHT:15pt; WIDTH:68.35pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">3,616,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:8.1pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:16.5pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="HEIGHT:15pt; WIDTH:66.5pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">351,000 </span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:231.05pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Clinical lab</span></p></td> <td style="HEIGHT:15pt; WIDTH:8.05pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:16.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:68.35pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">642,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:8.05pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:16.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:68.35pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">893,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:8.1pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:16.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:68.35pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">1,528,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:8.1pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:16.5pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:66.5pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">1,475,000 </span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:231.05pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Over-the-counter</span></p></td> <td style="HEIGHT:15pt; WIDTH:8.05pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:16.9pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:68.35pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">534,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:8.05pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:16.9pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:68.35pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">272,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:8.1pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:16.9pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:68.35pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">613,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:8.1pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:16.5pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:66.5pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">457,000 </span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:231.05pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Contract manufacturing</span></p></td> <td style="HEIGHT:15pt; WIDTH:8.05pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:16.9pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:68.35pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">112,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:8.05pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:16.9pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:68.35pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">55,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:8.1pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:16.9pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:68.35pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">152,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:8.1pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:16.5pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:66.5pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">233,000 </span></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:231.05pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Total</span></p></td> <td style="HEIGHT:15.75pt; WIDTH:8.05pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:16.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:68.35pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">4,647,000 </span></p></td> <td style="HEIGHT:15.75pt; WIDTH:8.05pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:16.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:68.35pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">1,373,000 </span></p></td> <td style="HEIGHT:15.75pt; WIDTH:8.1pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:16.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:68.35pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">5,909,000 </span></p></td> <td style="HEIGHT:15.75pt; WIDTH:8.1pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:16.5pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:66.5pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">2,516,000 </span></p></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140654052458360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GEOGRAPHIC INFORMATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Nov. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_GeographicInformationDisclosureAbstract', window );"><strong>Geographic Information Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock', window );">Revenue from External Customers by Geographic Areas [Table Text Block]</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="WIDTH:602.1pt; BORDER-COLLAPSE:collapse; margin-left: auto; margin-right: auto;" width="803"> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:294.95pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:13.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td colspan="5" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:140.35pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">Three Months Ended<br/></span><span style="FONT-SIZE:10pt">November 30,</span></p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td colspan="5" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:140.35pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">Six Months Ended<br/></span><span style="FONT-SIZE:10pt">November 30,</span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:294.95pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:13.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td colspan="2" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:63.55pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">2021</span></p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td colspan="2" style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:63.55pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">2020</span></p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td colspan="2" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:63.55pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">2021</span></p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td colspan="2" style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:63.55pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">2020</span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:294.95pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Revenues from sales to unaffiliated customers:</span></p></td> <td style="HEIGHT:15pt; WIDTH:13.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:50.3pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:50.3pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:50.3pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:50.3pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"/> </tr><tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:294.95pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:10pt; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Asia</span></p></td> <td style="HEIGHT:15pt; WIDTH:13.2pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="HEIGHT:15pt; WIDTH:50.3pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">3,373,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="HEIGHT:15pt; WIDTH:50.3pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">550,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="HEIGHT:15pt; WIDTH:50.3pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">4,048,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="HEIGHT:15pt; WIDTH:50.3pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">897,000 </span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:294.95pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:10pt; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Europe</span></p></td> <td style="HEIGHT:15pt; WIDTH:13.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:50.3pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">796,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:50.3pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">580,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:50.3pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">1,267,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:50.3pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">1,171,000 </span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:294.95pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:10pt; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">North America</span></p></td> <td style="HEIGHT:15pt; WIDTH:13.2pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:50.3pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">429,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:50.3pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">107,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:50.3pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">534,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:50.3pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">241,000 </span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:294.95pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:10pt; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Middle East</span></p></td> <td style="HEIGHT:15pt; WIDTH:13.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:50.3pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">46,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:50.3pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">96,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:50.3pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">54,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15pt; WIDTH:50.3pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">125,000 </span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:294.95pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:10pt; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">South America</span></p></td> <td style="HEIGHT:15pt; WIDTH:13.2pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:13.25pt; BACKGROUND:#bdd7ee; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:50.3pt; BACKGROUND:#bdd7ee; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">3,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:13.25pt; BACKGROUND:#bdd7ee; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:50.3pt; BACKGROUND:#bdd7ee; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">40,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:13.25pt; BACKGROUND:#bdd7ee; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:50.3pt; BACKGROUND:#bdd7ee; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">6,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:13.25pt; BACKGROUND:#bdd7ee; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:50.3pt; BACKGROUND:#bdd7ee; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">82,000 </span></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:294.95pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="HEIGHT:15.75pt; WIDTH:13.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:13.25pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:50.3pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">4,647,000 </span></p></td> <td style="HEIGHT:15.75pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:13.25pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:50.3pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">1,373,000 </span></p></td> <td style="HEIGHT:15.75pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:13.25pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:50.3pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">5,909,000 </span></p></td> <td style="HEIGHT:15.75pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> </td><td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:13.25pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:50.3pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">2,516,000 </span></p></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmra_GeographicInformationDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmra_GeographicInformationDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmra_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph a<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140654052391000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Nov. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Disclosure Text Block [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_ScheduleOfCashFlowSupplementalDisclosuresRelatedToLeaseTableTextBlock', window );">Schedule Of Cash Flow Supplemental Disclosures Related To Lease [Table Text Block]</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="width: 550.1pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" width="733">

<tr style="height: 15pt;">
<td style="height: 15pt; width: 462.1pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Operating cash flows from operating leases&#160;&#160;&#160;&#160;&#160; </span></p>
</td>
<td style="height: 15pt; width: 11pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 11pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15pt; width: 66pt; background: #b8cce4; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">166,216</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 462.1pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Right-of-use assets obtained in exchange for</span></p>
</td>
<td style="height: 15pt; width: 11pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 11pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 66pt; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 462.1pt; white-space: nowrap; padding: 0cm 0cm 0cm 10.8pt;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">new operating lease liabilities</span></p>
</td>
<td style="height: 15pt; width: 11pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 11pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15pt; width: 66pt; text-align: right; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom"><div style="-sec-ix-hidden: hidden-fact-11">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">-</span></p>
</div></td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 462.1pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Weighted average remaining lease term (in years)</span></p>
</td>
<td style="height: 15pt; width: 11pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 11pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 66pt; background: #b8cce4; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">4.77</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 462.1pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">Weighted average discount rate</span></p>
</td>
<td style="height: 15pt; width: 11pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 11pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 66pt; white-space: nowrap; padding: 0cm;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"><span style="font-size: 10pt; color: black;">6.50%</span></p>
</td>
</tr>

</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="WIDTH:554.4pt; BORDER-COLLAPSE:collapse; margin-left: auto; margin-right: auto;" width="739"> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:463.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Less than 1 year</span></p></td> <td style="HEIGHT:15pt; WIDTH:12.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:12.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="HEIGHT:15pt; WIDTH:66.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">345,000 </span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:463.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">1 to 2 years</span></p></td> <td style="HEIGHT:15pt; WIDTH:12.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:12.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:66.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">355,000 </span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:463.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">2 to 3 years</span></p></td> <td style="HEIGHT:15pt; WIDTH:12.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:12.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:66.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">366,000 </span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:463.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">3 to 4 years</span></p></td> <td style="HEIGHT:15pt; WIDTH:12.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:12.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:66.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">377,000 </span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:463.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">4 to 5 years</span></p></td> <td style="HEIGHT:15pt; WIDTH:12.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12.2pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:66.8pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">298,000 </span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:463.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Total undiscounted lease payments</span></p></td> <td style="HEIGHT:15pt; WIDTH:12.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12.2pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:66.8pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">1,741,000 </span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:463.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Less imputed interest</span></p></td> <td style="HEIGHT:15pt; WIDTH:12.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12.2pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:66.8pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">239,000 </span></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:463.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Total operating lease liabilities</span></p></td> <td style="HEIGHT:15.75pt; WIDTH:12.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12.2pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:66.8pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">1,502,000 </span></p></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmra_ScheduleOfCashFlowSupplementalDisclosuresRelatedToLeaseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of supplemental cash flow information related to lease for the periods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmra_ScheduleOfCashFlowSupplementalDisclosuresRelatedToLeaseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmra_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140654042808936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="3">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Nov. 30, 2021</div></th>
<th class="th"><div>Nov. 30, 2020</div></th>
<th class="th"><div>Nov. 30, 2021</div></th>
<th class="th"><div>Nov. 29, 2021</div></th>
<th class="th"><div>Nov. 30, 2020</div></th>
<th class="th"><div>May 31, 2021</div></th>
<th class="th"><div>Jan. 22, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems', window );"><strong>SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained Earnings (Accumulated Deficit)</a></td>
<td class="num">$ (33,214,190)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (33,214,190)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (30,546,335)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_ShelfRegistrationStatementMaximumAuthorizedCommonStockIssuanceValue', window );">Shelf Registration Statement, Maximum Authorized Common Stock Issuance, Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashUninsuredAmount', window );">Cash, Uninsured Amount</a></td>
<td class="nump">$ 6,950,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,950,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ThresholdPeriodPastDueForWriteoffOfTradeAccountsReceivable', window );">Threshold Period Past Due for Write-off of Trade Accounts Receivable</a></td>
<td class="text">90 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent', window );">Allowance for Credit Loss, Receivable, Other, Current</a></td>
<td class="nump">$ 28,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssets', window );">Prepaid Expense and Other Assets</a></td>
<td class="nump">1,097,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,097,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">370,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryValuationReserves', window );">Inventory Valuation Reserves</a></td>
<td class="nump">1,799,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,799,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,617,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryLIFOReserve', window );">Inventory, LIFO Reserve</a></td>
<td class="nump">1,686,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,686,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation, Depletion and Amortization</a></td>
<td class="nump">26,000<span></span>
</td>
<td class="nump">$ 26,000<span></span>
</td>
<td class="nump">54,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 53,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of Intangible Assets</a></td>
<td class="nump">$ 7,000<span></span>
</td>
<td class="nump">6,000<span></span>
</td>
<td class="nump">$ 14,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity Method Investment, Ownership Percentage</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from Stock Options Exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34,480<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,330<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherResearchAndDevelopmentExpense', window );">Other Research and Development Expense</a></td>
<td class="nump">$ 619,000<span></span>
</td>
<td class="nump">$ 617,000<span></span>
</td>
<td class="nump">1,058,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,328,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Deferred Tax Assets, Valuation Allowance</a></td>
<td class="nump">$ 6,462,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,462,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,904,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares)</a></td>
<td class="nump">2,059,116<span></span>
</td>
<td class="nump">1,399,763<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Share-based Payment Arrangement, Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems', window );"><strong>SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,500<span></span>
</td>
<td class="nump">21,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from Stock Options Exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34,480<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,000<span></span>
</td>
<td class="nump">24,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.25<span></span>
</td>
<td class="nump">$ 4.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DistributionRightsMember', window );">Distribution Rights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems', window );"><strong>SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life</a></td>
<td class="text">18 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=bmra_PurchasedTechnologyRightsMember', window );">Purchased Technology Rights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems', window );"><strong>SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember', window );">Patents [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems', window );"><strong>SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life</a></td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems', window );"><strong>SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Share-based Payment Arrangement, Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems', window );"><strong>SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price (in Dollars per share)</a></td>
<td class="nump">$ 1.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems', window );"><strong>SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Share-based Payment Arrangement, Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems', window );"><strong>SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price (in Dollars per share)</a></td>
<td class="nump">$ 3.62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Two Distributors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems', window );"><strong>SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk [Member] | Accounts Receivable [Member] | Two Distributors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems', window );"><strong>SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="nump">73.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">73.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk [Member] | Accounts Payable [Member] | Two Vendors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems', window );"><strong>SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_SupplierConcentrationRiskMember', window );">Supplier Concentration Risk [Member] | Cost of Goods and Service, Product and Service Benchmark [Member] | Two Vendors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems', window );"><strong>SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">77.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_SupplierConcentrationRiskMember', window );">Supplier Concentration Risk [Member] | Accounts Payable [Member] | Two Vendors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems', window );"><strong>SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmra_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmra_ShelfRegistrationStatementMaximumAuthorizedCommonStockIssuanceValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount related with Maximum Authorized Common Stock Issuance of Shelf Registration Statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmra_ShelfRegistrationStatementMaximumAuthorizedCommonStockIssuanceValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmra_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on receivable, classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashUninsuredAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash as of the balance sheet date that is not insured by the Federal Deposit Insurance Corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashUninsuredAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryLIFOReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which inventory stated at last-in first-out (LIFO) is less than (in excess of) inventory stated at other inventory cost methods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryLIFOReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryValuationReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation reserve for inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryValuationReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other research and development expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ThresholdPeriodPastDueForWriteoffOfTradeAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Threshold period past due for trade accounts receivable to write off as uncollectible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ThresholdPeriodPastDueForWriteoffOfTradeAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DistributionRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DistributionRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=bmra_PurchasedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=bmra_PurchasedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=bmra_TwoDistributorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=bmra_TwoDistributorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=bmra_TwoVendorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=bmra_TwoVendorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_SupplierConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_SupplierConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_CostOfGoodsProductLineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_CostOfGoodsProductLineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140654048301912">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Details) - Inventories - USD ($)<br></strong></div></th>
<th class="th"><div>Nov. 30, 2021</div></th>
<th class="th"><div>May 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_InventoriesAbstract', window );"><strong>Inventories [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Raw materials</a></td>
<td class="nump">$ 1,416,000<span></span>
</td>
<td class="nump">$ 1,583,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work in progress</a></td>
<td class="nump">708,000<span></span>
</td>
<td class="nump">1,006,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished products</a></td>
<td class="nump">858,000<span></span>
</td>
<td class="nump">617,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total</a></td>
<td class="nump">$ 2,982,201<span></span>
</td>
<td class="nump">$ 3,206,255<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmra_InventoriesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmra_InventoriesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmra_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140654051169864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Details) - Options Activity - Share-based Payment Arrangement, Option [Member] - $ / shares<br></strong></div></th>
<th class="th" colspan="3">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 30, 2021</div></th>
<th class="th"><div>Nov. 29, 2021</div></th>
<th class="th"><div>Nov. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityLineItems', window );"><strong>SIGNIFICANT ACCOUNTING POLICIES (Details) - Options Activity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options Outstanding, Shares | shares</a></td>
<td class="nump">2,081,366<span></span>
</td>
<td class="nump">2,081,366<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Option Outstanding, Exercise Price Weighted Average | $ / shares</a></td>
<td class="nump">$ 3.59<span></span>
</td>
<td class="nump">$ 3.59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Option Granted, Shares | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,000<span></span>
</td>
<td class="nump">24,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Option Granted, Exercise Price Weighted Average | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.25<span></span>
</td>
<td class="nump">$ 4.25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Option Exercised, Shares | shares</a></td>
<td class="num">(21,500)<span></span>
</td>
<td class="num">(21,500)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Option Exercised, Exercise Price Weighted Average | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.64<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Option Cancelled or expired, Shares | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(24,750)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Option Cancelled or expired, Exercise Price Weighted Average | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options Outstanding, Shares | shares</a></td>
<td class="nump">2,059,116<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Option Outstanding, Exercise Price Weighted Average | $ / shares</a></td>
<td class="nump">$ 3.62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmra_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140654046558072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Details) - Revenue from contracts with customers - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 30, 2021</div></th>
<th class="th"><div>Nov. 30, 2020</div></th>
<th class="th"><div>Nov. 30, 2021</div></th>
<th class="th"><div>Nov. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue From Customers</a></td>
<td class="nump">$ 4,647,000<span></span>
</td>
<td class="nump">$ 1,373,000<span></span>
</td>
<td class="nump">$ 5,909,000<span></span>
</td>
<td class="nump">$ 2,516,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bmra_PhysiciansOfficeMember', window );">Physicians Office [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue From Customers</a></td>
<td class="nump">3,359,000<span></span>
</td>
<td class="nump">153,000<span></span>
</td>
<td class="nump">3,616,000<span></span>
</td>
<td class="nump">351,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bmra_ClinicalLabMember', window );">Clinical Lab [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue From Customers</a></td>
<td class="nump">642,000<span></span>
</td>
<td class="nump">893,000<span></span>
</td>
<td class="nump">1,528,000<span></span>
</td>
<td class="nump">1,475,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bmra_OverthecounterMember', window );">Over-the-counter [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue From Customers</a></td>
<td class="nump">534,000<span></span>
</td>
<td class="nump">272,000<span></span>
</td>
<td class="nump">613,000<span></span>
</td>
<td class="nump">457,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bmra_ContractManufacturingMember', window );">Contract Manufacturing [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue From Customers</a></td>
<td class="nump">$ 112,000<span></span>
</td>
<td class="nump">$ 55,000<span></span>
</td>
<td class="nump">$ 152,000<span></span>
</td>
<td class="nump">$ 233,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bmra_PhysiciansOfficeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bmra_PhysiciansOfficeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bmra_ClinicalLabMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bmra_ClinicalLabMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bmra_OverthecounterMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bmra_OverthecounterMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bmra_ContractManufacturingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bmra_ContractManufacturingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140654046953752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHAREHOLDERS' EQUITY (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 30, 2021</div></th>
<th class="th"><div>Nov. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_SHAREHOLDERSEQUITYDetailsLineItems', window );"><strong>SHAREHOLDERS' EQUITY (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from Issuance of Common Stock</a></td>
<td class="nump">$ 1,684,123<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Share-based Payment Arrangement, Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_SHAREHOLDERSEQUITYDetailsLineItems', window );"><strong>SHAREHOLDERS' EQUITY (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based Payment Arrangement, Expense</a></td>
<td class="nump">$ 634,000<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_SHAREHOLDERSEQUITYDetailsLineItems', window );"><strong>SHAREHOLDERS' EQUITY (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of Stock, Number of Shares Issued in Transaction (in Shares)</a></td>
<td class="nump">363,670<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Sale of Stock, Consideration Received on Transaction</a></td>
<td class="nump">$ 1,751,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from Issuance of Common Stock</a></td>
<td class="nump">$ 1,684,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=us-gaap_CommonStockMember', window );">Common Stock [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_SHAREHOLDERSEQUITYDetailsLineItems', window );"><strong>SHAREHOLDERS' EQUITY (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of Stock, Price Per Share (in Dollars per share)</a></td>
<td class="nump">$ 4.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=us-gaap_CommonStockMember', window );">Common Stock [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_SHAREHOLDERSEQUITYDetailsLineItems', window );"><strong>SHAREHOLDERS' EQUITY (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of Stock, Price Per Share (in Dollars per share)</a></td>
<td class="nump">$ 5.63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmra_SHAREHOLDERSEQUITYDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmra_SHAREHOLDERSEQUITYDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmra_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140654052547576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GEOGRAPHIC INFORMATION (Details) - MEXICO<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Nov. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_GEOGRAPHICINFORMATIONDetailsLineItems', window );"><strong>GEOGRAPHIC INFORMATION (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of Reportable Segments</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryGross', window );">Inventory, Gross</a></td>
<td class="nump">$ 574,000<span></span>
</td>
<td class="nump">$ 803,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, Plant and Equipment, Net</a></td>
<td class="nump">$ 22,000<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmra_GEOGRAPHICINFORMATIONDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmra_GEOGRAPHICINFORMATIONDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmra_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross amount, as of the balance sheet date, of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_MX">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_MX</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140654048100200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GEOGRAPHIC INFORMATION (Details) - Geographic information regarding net sales - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 30, 2021</div></th>
<th class="th"><div>Nov. 30, 2020</div></th>
<th class="th"><div>Nov. 30, 2021</div></th>
<th class="th"><div>Nov. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_RevenuesFromSalesToUnaffiliatedCustomersAbstract', window );"><strong>Revenues from sales to unaffiliated customers:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net Sales</a></td>
<td class="nump">$ 4,646,900<span></span>
</td>
<td class="nump">$ 1,372,526<span></span>
</td>
<td class="nump">$ 5,908,687<span></span>
</td>
<td class="nump">$ 2,516,332<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AsiaMember', window );">Asia [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_RevenuesFromSalesToUnaffiliatedCustomersAbstract', window );"><strong>Revenues from sales to unaffiliated customers:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net Sales</a></td>
<td class="nump">3,373,000<span></span>
</td>
<td class="nump">550,000<span></span>
</td>
<td class="nump">4,048,000<span></span>
</td>
<td class="nump">897,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_RevenuesFromSalesToUnaffiliatedCustomersAbstract', window );"><strong>Revenues from sales to unaffiliated customers:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net Sales</a></td>
<td class="nump">796,000<span></span>
</td>
<td class="nump">580,000<span></span>
</td>
<td class="nump">1,267,000<span></span>
</td>
<td class="nump">1,171,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_NorthAmericaMember', window );">North America [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_RevenuesFromSalesToUnaffiliatedCustomersAbstract', window );"><strong>Revenues from sales to unaffiliated customers:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net Sales</a></td>
<td class="nump">429,000<span></span>
</td>
<td class="nump">107,000<span></span>
</td>
<td class="nump">534,000<span></span>
</td>
<td class="nump">241,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_MiddleEastMember', window );">Middle East [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_RevenuesFromSalesToUnaffiliatedCustomersAbstract', window );"><strong>Revenues from sales to unaffiliated customers:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net Sales</a></td>
<td class="nump">46,000<span></span>
</td>
<td class="nump">96,000<span></span>
</td>
<td class="nump">54,000<span></span>
</td>
<td class="nump">125,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_SouthAmericaMember', window );">South America [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_RevenuesFromSalesToUnaffiliatedCustomersAbstract', window );"><strong>Revenues from sales to unaffiliated customers:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net Sales</a></td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="nump">$ 40,000<span></span>
</td>
<td class="nump">$ 6,000<span></span>
</td>
<td class="nump">$ 82,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmra_RevenuesFromSalesToUnaffiliatedCustomersAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmra_RevenuesFromSalesToUnaffiliatedCustomersAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmra_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AsiaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AsiaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_NorthAmericaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_NorthAmericaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_MiddleEastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_MiddleEastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_SouthAmericaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_SouthAmericaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140654048183192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 01, 2016</div></th>
<th class="th"><div>Jun. 18, 2009</div></th>
<th class="th"><div>Nov. 30, 2021</div></th>
<th class="th"><div>Nov. 30, 2021</div></th>
<th class="th"><div>Nov. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_LEASESDetailsLineItems', window );"><strong>LEASES (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRent', window );">Payments for Rent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 155,000<span></span>
</td>
<td class="nump">$ 152,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis=bmra_BuildingInIrvineCaliforniaMember', window );">Building In Irvine California [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_LEASESDetailsLineItems', window );"><strong>LEASES (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_OperatingLeaseInitiationDate', window );">Operating Lease Initiation Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sep.  01,  2009<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseExpirationDate1', window );">Lease Expiration Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Aug. 31,  2016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRent', window );">Payments for Rent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Operating Lease, Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,970<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_RentPercentage', window );">Rent Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecurityDeposit', window );">Security Deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,080<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis=us-gaap_PropertyAvailableForOperatingLeaseMember', window );">Property Available for Operating Lease [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_LEASESDetailsLineItems', window );"><strong>LEASES (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseAndRentalExpense', window );">Operating Leases, Rent Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23,637<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_LeaseAmendmentAxis=bmra_FirstAmendmentToLeaseMember', window );">First Amendment To Lease [Member] | Building In Irvine California [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_LEASESDetailsLineItems', window );"><strong>LEASES (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseExpirationDate1', window );">Lease Expiration Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Aug. 31,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_MX', window );">MEXICO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_LEASESDetailsLineItems', window );"><strong>LEASES (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRent', window );">Payments for Rent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21,000<span></span>
</td>
<td class="nump">$ 22,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_MX', window );">MEXICO | Property Available for Operating Lease [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_LEASESDetailsLineItems', window );"><strong>LEASES (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseAndRentalExpense', window );">Operating Leases, Rent Expense</a></td>
<td class="nump">$ 3,262<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesRentExpenseMinimumRentals', window );">Operating Leases, Rent Expense, Minimum Rentals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,926<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmra_LEASESDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmra_LEASESDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmra_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmra_OperatingLeaseInitiationDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date the operating lease was initiated, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmra_OperatingLeaseInitiationDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmra_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmra_RentPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Rent percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmra_RentPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmra_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseAndRentalExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseAndRentalExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseExpirationDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date which lease or group of leases is set to expire, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseExpirationDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesRentExpenseMinimumRentals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the payments that the lessee is obligated to make or can be required to make in connection with a property under the terms of an agreement classified as an operating lease, excluding contingent rentals and a guarantee by the lessee of the lessor's debt and the lessee's obligation to pay (apart from the rental payments) executory costs such as insurance, maintenance, and taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 25<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123403832&amp;loc=d3e34039-112682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123403562&amp;loc=d3e38371-112697<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123406913&amp;loc=d3e41499-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesRentExpenseMinimumRentals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash payments to lessor's for use of assets under operating leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecurityDeposit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8,17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecurityDeposit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis=bmra_BuildingInIrvineCaliforniaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis=bmra_BuildingInIrvineCaliforniaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis=us-gaap_PropertyAvailableForOperatingLeaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis=us-gaap_PropertyAvailableForOperatingLeaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmra_LeaseAmendmentAxis=bmra_FirstAmendmentToLeaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmra_LeaseAmendmentAxis=bmra_FirstAmendmentToLeaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_MX">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_MX</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140654047111352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES (Details) - Supplemental cash flow information related to leases<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Nov. 30, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_SupplementalCashFlowInformationRelatedToLeasesAbstract', window );"><strong>Supplemental cash flow information related to leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash flows from operating leases</a></td>
<td class="nump">$ 166,216<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_RightOfUseAssetsObtainedInExchangeForAbstract', window );"><strong>Right-of-use assets obtained in exchange for</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-use assets obtained in exchange for new operating lease liabilities</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term (in years)</a></td>
<td class="text">4 years 9 months 7 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate</a></td>
<td class="nump">6.50%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmra_RightOfUseAssetsObtainedInExchangeForAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmra_RightOfUseAssetsObtainedInExchangeForAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmra_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmra_SupplementalCashFlowInformationRelatedToLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmra_SupplementalCashFlowInformationRelatedToLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmra_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140654042714264">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LEASES (Details) - The maturity of lease liabilities<br></strong></div></th>
<th class="th">
<div>Nov. 30, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_TheMaturityOfLeaseLiabilitiesAbstract', window );"><strong>The maturity of lease liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">Less than 1 year</a></td>
<td class="nump">$ 345,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">1 to 2 years</a></td>
<td class="nump">355,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2 to 3 years</a></td>
<td class="nump">366,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">3 to 4 years</a></td>
<td class="nump">377,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">4 to 5 years</a></td>
<td class="nump">298,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total undiscounted lease payments</a></td>
<td class="nump">1,741,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less imputed interest</a></td>
<td class="nump">239,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="nump">$ 1,502,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmra_TheMaturityOfLeaseLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmra_TheMaturityOfLeaseLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmra_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140654048144760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS (Details) - Subsequent Event [Member] - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 09, 2021</div></th>
<th class="th"><div>Feb. 28, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_SUBSEQUENTEVENTSDetailsLineItems', window );"><strong>SUBSEQUENT EVENTS (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">157,597<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from Issuance of Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 634,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</a></td>
<td class="nump">283,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</a></td>
<td class="nump">$ 4.46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmra_SUBSEQUENTEVENTSDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmra_SUBSEQUENTEVENTSDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmra_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140654047980616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Details) - Restatement on the consolidated statement of operations and the consolidated statement of cash flows - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 30, 2021</div></th>
<th class="th"><div>Nov. 30, 2020</div></th>
<th class="th"><div>Nov. 30, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis=srt_ScenarioPreviouslyReportedMember', window );">Previously Reported [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems', window );"><strong>Error Corrections and Prior Period Adjustments Restatement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,011,030<span></span>
</td>
<td class="nump">$ 1,971,960<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross Profit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">361,496<span></span>
</td>
<td class="nump">544,372<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating Expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,254,847<span></span>
</td>
<td class="nump">2,419,411<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">586,403<span></span>
</td>
<td class="nump">1,261,096<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,841,250<span></span>
</td>
<td class="nump">3,680,507<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,479,754)<span></span>
</td>
<td class="num">(3,136,135)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,471,771)<span></span>
</td>
<td class="num">(3,120,061)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (3,134,579)<span></span>
</td>
<td class="num">$ (1,485,164)<span></span>
</td>
<td class="num">$ (3,134,579)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net loss per common share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.13)<span></span>
</td>
<td class="num">$ (0.27)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net loss per common share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.13)<span></span>
</td>
<td class="num">$ (0.27)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (3,137,829)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockOptionPlanExpense', window );">Stock option expense</a></td>
<td class="nump">24,227<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(2,880,218)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents at end of period</a></td>
<td class="nump">5,683,787<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis=srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember', window );">Revision of Prior Period, Error Correction, Adjustment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems', window );"><strong>Error Corrections and Prior Period Adjustments Restatement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 52,777<span></span>
</td>
<td class="nump">117,564<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross Profit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(52,777)<span></span>
</td>
<td class="num">(117,564)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating Expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">149,999<span></span>
</td>
<td class="nump">291,379<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,158<span></span>
</td>
<td class="nump">66,970<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">180,157<span></span>
</td>
<td class="nump">358,349<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(232,934)<span></span>
</td>
<td class="num">(475,913)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(232,934)<span></span>
</td>
<td class="num">(475,913)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(475,913)<span></span>
</td>
<td class="num">$ (232,934)<span></span>
</td>
<td class="num">$ (475,913)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net loss per common share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.02)<span></span>
</td>
<td class="num">$ (0.04)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net loss per common share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.02)<span></span>
</td>
<td class="num">$ (0.04)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (475,913)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockOptionPlanExpense', window );">Stock option expense</a></td>
<td class="nump">475,913<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents at end of period</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis=bmra_RestatementOfCompanysFinancialStatementsMember', window );">Restatement Of Companys Financial Statements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems', window );"><strong>Error Corrections and Prior Period Adjustments Restatement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,063,807<span></span>
</td>
<td class="nump">2,089,524<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross Profit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">308,719<span></span>
</td>
<td class="nump">426,808<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating Expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,404,846<span></span>
</td>
<td class="nump">2,710,790<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">616,561<span></span>
</td>
<td class="nump">1,328,066<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,021,407<span></span>
</td>
<td class="nump">4,038,856<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,712,688)<span></span>
</td>
<td class="num">(3,612,048)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,704,705)<span></span>
</td>
<td class="num">(3,595,974)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(3,610,492)<span></span>
</td>
<td class="num">$ (1,718,098)<span></span>
</td>
<td class="num">$ (3,610,492)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net loss per common share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.15)<span></span>
</td>
<td class="num">$ (0.31)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net loss per common share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.15)<span></span>
</td>
<td class="num">$ (0.31)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (3,613,742)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockOptionPlanExpense', window );">Stock option expense</a></td>
<td class="nump">500,140<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(2,880,218)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents at end of period</a></td>
<td class="nump">$ 5,683,787<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmra_AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmra_AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmra_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockOptionPlanExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockOptionPlanExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis=srt_ScenarioPreviouslyReportedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis=srt_ScenarioPreviouslyReportedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis=srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis=srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis=bmra_RestatementOfCompanysFinancialStatementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis=bmra_RestatementOfCompanysFinancialStatementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>bmra-20211130_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:bmra="http://www.biomerica.com/20211130"
  xmlns:country="http://xbrl.sec.gov/country/2021"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="bmra-20211130.xsd" xlink:type="simple"/>
    <context id="c0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="c1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
        </entity>
        <period>
            <instant>2022-01-12</instant>
        </period>
    </context>
    <context id="c2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
        </entity>
        <period>
            <instant>2021-11-30</instant>
        </period>
    </context>
    <context id="c3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
        </entity>
        <period>
            <instant>2021-05-31</instant>
        </period>
    </context>
    <context id="c4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">bmra:A5ConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-11-30</instant>
        </period>
    </context>
    <context id="c5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">bmra:A5ConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-31</instant>
        </period>
    </context>
    <context id="c6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
        </entity>
        <period>
            <startDate>2021-09-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="c7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
        </entity>
        <period>
            <startDate>2020-09-01</startDate>
            <endDate>2020-11-30</endDate>
        </period>
    </context>
    <context id="c8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-11-30</endDate>
        </period>
    </context>
    <context id="c9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-31</instant>
        </period>
    </context>
    <context id="c10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bmra:A5ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-31</instant>
        </period>
    </context>
    <context id="c11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-31</instant>
        </period>
    </context>
    <context id="c12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-31</instant>
        </period>
    </context>
    <context id="c13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-31</instant>
        </period>
    </context>
    <context id="c14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
        </entity>
        <period>
            <instant>2020-05-31</instant>
        </period>
    </context>
    <context id="c15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-11-30</endDate>
        </period>
    </context>
    <context id="c16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-11-30</endDate>
        </period>
    </context>
    <context id="c17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-11-30</endDate>
        </period>
    </context>
    <context id="c18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-11-30</endDate>
        </period>
    </context>
    <context id="c19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-30</instant>
        </period>
    </context>
    <context id="c20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bmra:A5ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-30</instant>
        </period>
    </context>
    <context id="c21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-30</instant>
        </period>
    </context>
    <context id="c22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-30</instant>
        </period>
    </context>
    <context id="c23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-30</instant>
        </period>
    </context>
    <context id="c24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
        </entity>
        <period>
            <instant>2020-11-30</instant>
        </period>
    </context>
    <context id="c25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-31</instant>
        </period>
    </context>
    <context id="c26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-31</instant>
        </period>
    </context>
    <context id="c27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-31</instant>
        </period>
    </context>
    <context id="c28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-31</instant>
        </period>
    </context>
    <context id="c29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="c30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="c31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="c32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="c33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-11-30</instant>
        </period>
    </context>
    <context id="c34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-11-30</instant>
        </period>
    </context>
    <context id="c35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-11-30</instant>
        </period>
    </context>
    <context id="c36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-11-30</instant>
        </period>
    </context>
    <context id="c37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
        </entity>
        <period>
            <instant>2021-01-22</instant>
        </period>
    </context>
    <context id="c38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">bmra:TwoDistributorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="c39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">bmra:TwoDistributorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-11-30</endDate>
        </period>
    </context>
    <context id="c40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">bmra:TwoDistributorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="c41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">bmra:TwoDistributorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2021-05-31</endDate>
        </period>
    </context>
    <context id="c42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:CostOfGoodsProductLineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">bmra:TwoVendorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="c43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:CostOfGoodsProductLineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">bmra:TwoVendorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-11-30</endDate>
        </period>
    </context>
    <context id="c44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">bmra:TwoVendorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="c45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">bmra:TwoVendorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2021-05-31</endDate>
        </period>
    </context>
    <context id="c46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="c47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="c48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DistributionRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="c49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">bmra:PurchasedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="c50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="c51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="c52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-11-30</instant>
        </period>
    </context>
    <context id="c53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-11-30</instant>
        </period>
    </context>
    <context id="c54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-11-30</endDate>
        </period>
    </context>
    <context id="c55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-31</instant>
        </period>
    </context>
    <context id="c56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-11-29</endDate>
        </period>
    </context>
    <context id="c57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-11-30</instant>
        </period>
    </context>
    <context id="c58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bmra:PhysiciansOfficeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="c59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bmra:PhysiciansOfficeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-01</startDate>
            <endDate>2020-11-30</endDate>
        </period>
    </context>
    <context id="c60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bmra:PhysiciansOfficeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="c61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bmra:PhysiciansOfficeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-11-30</endDate>
        </period>
    </context>
    <context id="c62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bmra:ClinicalLabMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="c63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bmra:ClinicalLabMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-01</startDate>
            <endDate>2020-11-30</endDate>
        </period>
    </context>
    <context id="c64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bmra:ClinicalLabMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="c65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bmra:ClinicalLabMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-11-30</endDate>
        </period>
    </context>
    <context id="c66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bmra:OverthecounterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="c67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bmra:OverthecounterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-01</startDate>
            <endDate>2020-11-30</endDate>
        </period>
    </context>
    <context id="c68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bmra:OverthecounterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="c69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bmra:OverthecounterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-11-30</endDate>
        </period>
    </context>
    <context id="c70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bmra:ContractManufacturingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="c71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bmra:ContractManufacturingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-01</startDate>
            <endDate>2020-11-30</endDate>
        </period>
    </context>
    <context id="c72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bmra:ContractManufacturingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="c73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bmra:ContractManufacturingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-11-30</endDate>
        </period>
    </context>
    <context id="c74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="c75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-11-30</instant>
        </period>
    </context>
    <context id="c76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-11-30</instant>
        </period>
    </context>
    <context id="c77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:MX</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="c78">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:MX</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-11-30</instant>
        </period>
    </context>
    <context id="c79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:MX</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-31</instant>
        </period>
    </context>
    <context id="c80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="c81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-01</startDate>
            <endDate>2020-11-30</endDate>
        </period>
    </context>
    <context id="c82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="c83">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-11-30</endDate>
        </period>
    </context>
    <context id="c84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="c85">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-01</startDate>
            <endDate>2020-11-30</endDate>
        </period>
    </context>
    <context id="c86">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="c87">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-11-30</endDate>
        </period>
    </context>
    <context id="c88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="c89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-01</startDate>
            <endDate>2020-11-30</endDate>
        </period>
    </context>
    <context id="c90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="c91">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-11-30</endDate>
        </period>
    </context>
    <context id="c92">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:MiddleEastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="c93">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:MiddleEastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-01</startDate>
            <endDate>2020-11-30</endDate>
        </period>
    </context>
    <context id="c94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:MiddleEastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="c95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:MiddleEastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-11-30</endDate>
        </period>
    </context>
    <context id="c96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:SouthAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="c97">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:SouthAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-01</startDate>
            <endDate>2020-11-30</endDate>
        </period>
    </context>
    <context id="c98">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:SouthAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="c99">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:SouthAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-11-30</endDate>
        </period>
    </context>
    <context id="c100">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">bmra:BuildingInIrvineCaliforniaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2009-06-18</startDate>
            <endDate>2009-06-18</endDate>
        </period>
    </context>
    <context id="c101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">bmra:BuildingInIrvineCaliforniaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bmra:LeaseAmendmentAxis">bmra:FirstAmendmentToLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2009-06-18</startDate>
            <endDate>2009-06-18</endDate>
        </period>
    </context>
    <context id="c102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">us-gaap:PropertyAvailableForOperatingLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2009-06-18</startDate>
            <endDate>2009-06-18</endDate>
        </period>
    </context>
    <context id="c103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">bmra:BuildingInIrvineCaliforniaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="c104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">bmra:BuildingInIrvineCaliforniaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2009-06-18</instant>
        </period>
    </context>
    <context id="c105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:MX</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">us-gaap:PropertyAvailableForOperatingLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2009-06-18</startDate>
            <endDate>2009-06-18</endDate>
        </period>
    </context>
    <context id="c106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:MX</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">us-gaap:PropertyAvailableForOperatingLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-11-01</startDate>
            <endDate>2016-11-01</endDate>
        </period>
    </context>
    <context id="c107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:MX</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-11-30</endDate>
        </period>
    </context>
    <context id="c108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-01</startDate>
            <endDate>2022-02-28</endDate>
        </period>
    </context>
    <context id="c109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-28</instant>
        </period>
    </context>
    <context id="c110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-09</startDate>
            <endDate>2021-12-09</endDate>
        </period>
    </context>
    <context id="c111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-01</startDate>
            <endDate>2020-11-30</endDate>
        </period>
    </context>
    <context id="c112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-01</startDate>
            <endDate>2020-11-30</endDate>
        </period>
    </context>
    <context id="c113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">bmra:RestatementOfCompanysFinancialStatementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-01</startDate>
            <endDate>2020-11-30</endDate>
        </period>
    </context>
    <context id="c114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-11-30</endDate>
        </period>
    </context>
    <context id="c115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-11-30</endDate>
        </period>
    </context>
    <context id="c116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">bmra:RestatementOfCompanysFinancialStatementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-11-30</endDate>
        </period>
    </context>
    <context id="c117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="c118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="c119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">bmra:RestatementOfCompanysFinancialStatementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="c120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-11-30</instant>
        </period>
    </context>
    <context id="c121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-11-30</instant>
        </period>
    </context>
    <context id="c122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">bmra:RestatementOfCompanysFinancialStatementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-11-30</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPershares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <dei:DocumentType contextRef="c0">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport contextRef="c0">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate contextRef="c0">2021-11-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport contextRef="c0">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="c0">001-37863</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="c0">BIOMERICA, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c0">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="c0">95-2645573</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c0">17571 Von Karman Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c0">Irvine</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c0">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c0">92614</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c0">949</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c0">645-2111</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="c0">Common, par value $.08</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c0">BMRA</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c0">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityFilerCategory contextRef="c0">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="c0">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="c0">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany contextRef="c0">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding contextRef="c1" decimals="INF" unitRef="shares">12851924</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c2" decimals="INF" unitRef="usd">7199172</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c3" decimals="INF" unitRef="usd">4199311</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="c2" decimals="INF" unitRef="usd">27777</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="c3" decimals="INF" unitRef="usd">837415</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c2" decimals="INF" unitRef="usd">1125239</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c3" decimals="INF" unitRef="usd">1455051</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet contextRef="c2" decimals="INF" unitRef="usd">2982201</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="c3" decimals="INF" unitRef="usd">3206255</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c2" decimals="INF" unitRef="usd">1096750</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c3" decimals="INF" unitRef="usd">370290</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c2" decimals="INF" unitRef="usd">12403362</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c3" decimals="INF" unitRef="usd">9230907</us-gaap:AssetsCurrent>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c2" decimals="INF" unitRef="usd">2026764</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c3" decimals="INF" unitRef="usd">1972357</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c2" decimals="INF" unitRef="usd">274325</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c3" decimals="INF" unitRef="usd">310520</us-gaap:PropertyPlantAndEquipmentNet>
    <bmra:OperatingLeaseRightOfUseAssetAccumulatedAmortization contextRef="c2" decimals="INF" unitRef="usd">595116</bmra:OperatingLeaseRightOfUseAssetAccumulatedAmortization>
    <bmra:OperatingLeaseRightOfUseAssetAccumulatedAmortization contextRef="c3" decimals="INF" unitRef="usd">469077</bmra:OperatingLeaseRightOfUseAssetAccumulatedAmortization>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c2" decimals="INF" unitRef="usd">1427042</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c3" decimals="INF" unitRef="usd">1553081</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:Investments contextRef="c2" decimals="INF" unitRef="usd">165324</us-gaap:Investments>
    <us-gaap:Investments contextRef="c3" decimals="INF" unitRef="usd">165324</us-gaap:Investments>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c2" decimals="INF" unitRef="usd">91030</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c3" decimals="INF" unitRef="usd">126769</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c2" decimals="INF" unitRef="usd">389486</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c3" decimals="INF" unitRef="usd">294830</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:OtherAssetsNoncurrent contextRef="c2" decimals="INF" unitRef="usd">149581</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c3" decimals="INF" unitRef="usd">264151</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets contextRef="c2" decimals="INF" unitRef="usd">14809120</us-gaap:Assets>
    <us-gaap:Assets contextRef="c3" decimals="INF" unitRef="usd">11818813</us-gaap:Assets>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="c2" decimals="INF" unitRef="usd">1580707</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="c3" decimals="INF" unitRef="usd">583380</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c2" decimals="INF" unitRef="usd">674327</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c3" decimals="INF" unitRef="usd">388896</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:ContractWithCustomerLiability contextRef="c2" decimals="INF" unitRef="usd">2150466</us-gaap:ContractWithCustomerLiability>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c2" decimals="INF" unitRef="usd">335385</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c3" decimals="INF" unitRef="usd">327944</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c2" decimals="INF" unitRef="usd">4740885</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c3" decimals="INF" unitRef="usd">1300220</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c2" decimals="INF" unitRef="usd">1166808</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c3" decimals="INF" unitRef="usd">1291570</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:Liabilities contextRef="c2" decimals="INF" unitRef="usd">5907693</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c3" decimals="INF" unitRef="usd">2591790</us-gaap:Liabilities>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="c4" decimals="INF" unitRef="usdPershares">0.08</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="c5" decimals="INF" unitRef="usdPershares">0.08</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c4" decimals="INF" unitRef="shares">571429</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c5" decimals="INF" unitRef="shares">571429</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued contextRef="c4" decimals="INF" unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued contextRef="c5" decimals="INF" unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c4" decimals="INF" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c5" decimals="INF" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockNoParValue contextRef="c2" decimals="INF" unitRef="usdPershares">0</us-gaap:PreferredStockNoParValue>
    <us-gaap:PreferredStockNoParValue contextRef="c3" decimals="INF" unitRef="usdPershares">0</us-gaap:PreferredStockNoParValue>
    <bmra:PreferredStockUndesignatedShares contextRef="c2" decimals="INF" unitRef="shares">4428571</bmra:PreferredStockUndesignatedShares>
    <bmra:PreferredStockUndesignatedShares contextRef="c3" decimals="INF" unitRef="shares">4428571</bmra:PreferredStockUndesignatedShares>
    <us-gaap:PreferredStockSharesIssued contextRef="c2" decimals="INF" unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued contextRef="c3" decimals="INF" unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c2" decimals="INF" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c3" decimals="INF" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="c2" decimals="INF" unitRef="usdPershares">0.08</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="c3" decimals="INF" unitRef="usdPershares">0.08</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="c2" decimals="INF" unitRef="shares">25000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="c3" decimals="INF" unitRef="shares">25000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="c2" decimals="INF" unitRef="shares">12692327</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c2" decimals="INF" unitRef="shares">12692327</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="c3" decimals="INF" unitRef="shares">12307157</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c3" decimals="INF" unitRef="shares">12307157</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue contextRef="c2" decimals="INF" unitRef="usd">1015385</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="c3" decimals="INF" unitRef="usd">984571</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital contextRef="c2" decimals="INF" unitRef="usd">41158551</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="c3" decimals="INF" unitRef="usd">38836743</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c2" decimals="INF" unitRef="usd">-58319</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c3" decimals="INF" unitRef="usd">-47956</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c2" decimals="INF" unitRef="usd">-33214190</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c3" decimals="INF" unitRef="usd">-30546335</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity contextRef="c2" decimals="INF" unitRef="usd">8901427</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c3" decimals="INF" unitRef="usd">9227023</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c2" decimals="INF" unitRef="usd">14809120</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c3" decimals="INF" unitRef="usd">11818813</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:Revenues contextRef="c6" decimals="INF" unitRef="usd">4646900</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c7" decimals="INF" unitRef="usd">1372526</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c0" decimals="INF" unitRef="usd">5908687</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c8" decimals="INF" unitRef="usd">2516332</us-gaap:Revenues>
    <us-gaap:CostOfRevenue contextRef="c6" decimals="INF" unitRef="usd">3875141</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="c7" decimals="INF" unitRef="usd">1063807</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="c0" decimals="INF" unitRef="usd">5225898</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="c8" decimals="INF" unitRef="usd">2089524</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit contextRef="c6" decimals="INF" unitRef="usd">771759</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c7" decimals="INF" unitRef="usd">308719</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c0" decimals="INF" unitRef="usd">682789</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c8" decimals="INF" unitRef="usd">426808</us-gaap:GrossProfit>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c6" decimals="INF" unitRef="usd">1282998</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c7" decimals="INF" unitRef="usd">1404846</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c0" decimals="INF" unitRef="usd">2294533</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c8" decimals="INF" unitRef="usd">2710790</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c6" decimals="INF" unitRef="usd">618522</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c7" decimals="INF" unitRef="usd">616561</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c0" decimals="INF" unitRef="usd">1058386</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c8" decimals="INF" unitRef="usd">1328066</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:OperatingExpenses contextRef="c6" decimals="INF" unitRef="usd">1901520</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c7" decimals="INF" unitRef="usd">2021407</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c0" decimals="INF" unitRef="usd">3352919</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c8" decimals="INF" unitRef="usd">4038856</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="c6" decimals="INF" unitRef="usd">-1129761</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c7" decimals="INF" unitRef="usd">-1712688</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c0" decimals="INF" unitRef="usd">-2670130</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c8" decimals="INF" unitRef="usd">-3612048</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeInterestAndDividend contextRef="c6" decimals="INF" unitRef="usd">6916</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend contextRef="c7" decimals="INF" unitRef="usd">7983</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend contextRef="c0" decimals="INF" unitRef="usd">13721</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend contextRef="c8" decimals="INF" unitRef="usd">16074</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c6" decimals="INF" unitRef="usd">-1122845</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c7" decimals="INF" unitRef="usd">-1704705</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c0" decimals="INF" unitRef="usd">-2656409</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c8" decimals="INF" unitRef="usd">-3595974</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c6" decimals="INF" unitRef="usd">2429</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c7" decimals="INF" unitRef="usd">13393</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c0" decimals="INF" unitRef="usd">11446</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c8" decimals="INF" unitRef="usd">14518</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss contextRef="c6" decimals="INF" unitRef="usd">-1125274</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c7" decimals="INF" unitRef="usd">-1718098</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c0" decimals="INF" unitRef="usd">-2667855</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c8" decimals="INF" unitRef="usd">-3610492</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic contextRef="c6" decimals="INF" unitRef="usdPershares">-0.09</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="c7" decimals="INF" unitRef="usdPershares">-0.15</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="c0" decimals="INF" unitRef="usdPershares">-0.21</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="c8" decimals="INF" unitRef="usdPershares">-0.31</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted contextRef="c6" decimals="INF" unitRef="usdPershares">-0.09</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted contextRef="c7" decimals="INF" unitRef="usdPershares">-0.15</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted contextRef="c0" decimals="INF" unitRef="usdPershares">-0.21</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted contextRef="c8" decimals="INF" unitRef="usdPershares">-0.31</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c6" decimals="INF" unitRef="shares">12592341</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c7" decimals="INF" unitRef="shares">11756265</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c0" decimals="INF" unitRef="shares">12509110</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c8" decimals="INF" unitRef="shares">11752299</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c6" decimals="INF" unitRef="shares">12592341</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c7" decimals="INF" unitRef="shares">11756265</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c0" decimals="INF" unitRef="shares">12509110</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c8" decimals="INF" unitRef="shares">11752299</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss contextRef="c6" decimals="INF" unitRef="usd">-1125274</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c7" decimals="INF" unitRef="usd">-1718098</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c0" decimals="INF" unitRef="usd">-2667855</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c8" decimals="INF" unitRef="usd">-3610492</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax contextRef="c6" decimals="INF" unitRef="usd">-4750</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax contextRef="c7" decimals="INF" unitRef="usd">-1530</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax contextRef="c0" decimals="INF" unitRef="usd">-10363</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax contextRef="c8" decimals="INF" unitRef="usd">-3250</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c6" decimals="INF" unitRef="usd">-1130024</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c7" decimals="INF" unitRef="usd">-1719628</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c0" decimals="INF" unitRef="usd">-2678218</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c8" decimals="INF" unitRef="usd">-3613742</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:SharesIssued contextRef="c9" decimals="INF" unitRef="shares">11740089</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity contextRef="c9" decimals="INF" unitRef="usd">939205</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued contextRef="c10" decimals="INF" unitRef="shares">321429</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity contextRef="c10" decimals="INF" unitRef="usd">25714</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c11" decimals="INF" unitRef="usd">36388056</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c12" decimals="INF" unitRef="usd">-39841</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c13" decimals="INF" unitRef="usd">-23100081</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c14" decimals="INF" unitRef="usd">14213053</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="c15" decimals="INF" unitRef="shares">30000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c15" decimals="INF" unitRef="usd">2400</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c16" decimals="INF" unitRef="usd">46930</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c8" decimals="INF" unitRef="usd">49330</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax contextRef="c17" decimals="INF" unitRef="usd">-3250</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax contextRef="c8" decimals="INF" unitRef="usd">-3250</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="c16" decimals="INF" unitRef="usd">500140</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="c8" decimals="INF" unitRef="usd">500140</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:NetIncomeLoss contextRef="c18" decimals="INF" unitRef="usd">-3610492</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c8" decimals="INF" unitRef="usd">-3610492</us-gaap:NetIncomeLoss>
    <us-gaap:SharesIssued contextRef="c19" decimals="INF" unitRef="shares">11770089</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity contextRef="c19" decimals="INF" unitRef="usd">941605</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued contextRef="c20" decimals="INF" unitRef="shares">321429</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity contextRef="c20" decimals="INF" unitRef="usd">25714</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c21" decimals="INF" unitRef="usd">36935126</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c22" decimals="INF" unitRef="usd">-43091</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c23" decimals="INF" unitRef="usd">-26710573</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c24" decimals="INF" unitRef="usd">11148781</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued contextRef="c25" decimals="INF" unitRef="shares">12307157</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity contextRef="c25" decimals="INF" unitRef="usd">984571</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c26" decimals="INF" unitRef="usd">38836743</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c27" decimals="INF" unitRef="usd">-47956</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c28" decimals="INF" unitRef="usd">-30546335</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c3" decimals="INF" unitRef="usd">9227023</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="c29" decimals="INF" unitRef="shares">21500</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c29" decimals="INF" unitRef="usd">1720</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c30" decimals="INF" unitRef="usd">32760</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c0" decimals="INF" unitRef="usd">34480</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="c29" decimals="INF" unitRef="shares">363670</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c29" decimals="INF" unitRef="usd">29094</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c30" decimals="INF" unitRef="usd">1655029</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c0" decimals="INF" unitRef="usd">1684123</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax contextRef="c31" decimals="INF" unitRef="usd">-10363</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax contextRef="c0" decimals="INF" unitRef="usd">-10363</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="c30" decimals="INF" unitRef="usd">634019</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="c0" decimals="INF" unitRef="usd">634019</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:NetIncomeLoss contextRef="c32" decimals="INF" unitRef="usd">-2667855</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c0" decimals="INF" unitRef="usd">-2667855</us-gaap:NetIncomeLoss>
    <us-gaap:SharesIssued contextRef="c33" decimals="INF" unitRef="shares">12692327</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity contextRef="c33" decimals="INF" unitRef="usd">1015385</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c34" decimals="INF" unitRef="usd">41158551</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c35" decimals="INF" unitRef="usd">-58319</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c36" decimals="INF" unitRef="usd">-33214190</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c2" decimals="INF" unitRef="usd">8901427</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c0" decimals="INF" unitRef="usd">-2667855</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c8" decimals="INF" unitRef="usd">-3610492</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationAndAmortization contextRef="c0" decimals="INF" unitRef="usd">68668</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="c8" decimals="INF" unitRef="usd">64435</us-gaap:DepreciationAndAmortization>
    <us-gaap:ProvisionForDoubtfulAccounts contextRef="c0" decimals="INF" unitRef="usd">-809638</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts contextRef="c8" decimals="INF" unitRef="usd">410161</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:InventoryLIFOReservePeriodCharge contextRef="c0" decimals="INF" unitRef="usd">181825</us-gaap:InventoryLIFOReservePeriodCharge>
    <us-gaap:InventoryLIFOReservePeriodCharge contextRef="c8" decimals="INF" unitRef="usd">11943</us-gaap:InventoryLIFOReservePeriodCharge>
    <us-gaap:StockOptionPlanExpense contextRef="c0" decimals="INF" unitRef="usd">634019</us-gaap:StockOptionPlanExpense>
    <us-gaap:StockOptionPlanExpense contextRef="c8" decimals="INF" unitRef="usd">500140</us-gaap:StockOptionPlanExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="c0" decimals="INF" unitRef="usd">126039</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="c8" decimals="INF" unitRef="usd">115025</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c0" decimals="INF" unitRef="usd">-1139450</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c8" decimals="INF" unitRef="usd">256059</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories contextRef="c0" decimals="INF" unitRef="usd">-42229</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories contextRef="c8" decimals="INF" unitRef="usd">1359320</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c0" decimals="INF" unitRef="usd">726460</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c8" decimals="INF" unitRef="usd">-1055946</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <bmra:IncreaseDecreaseInLeaseLiability contextRef="c0" decimals="INF" unitRef="usd">-117321</bmra:IncreaseDecreaseInLeaseLiability>
    <bmra:IncreaseDecreaseInLeaseLiability contextRef="c8" decimals="INF" unitRef="usd">-102677</bmra:IncreaseDecreaseInLeaseLiability>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets contextRef="c0" decimals="INF" unitRef="usd">-114570</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets contextRef="c8" decimals="INF" unitRef="usd">94085</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="c0" decimals="INF" unitRef="usd">997327</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="c8" decimals="INF" unitRef="usd">271386</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities contextRef="c0" decimals="INF" unitRef="usd">285431</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities contextRef="c8" decimals="INF" unitRef="usd">113379</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability contextRef="c0" decimals="INF" unitRef="usd">2150466</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c0" decimals="INF" unitRef="usd">1418750</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c8" decimals="INF" unitRef="usd">-2880218</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireIntangibleAssets contextRef="c0" decimals="INF" unitRef="usd">108917</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets contextRef="c8" decimals="INF" unitRef="usd">61536</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c0" decimals="INF" unitRef="usd">18212</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c8" decimals="INF" unitRef="usd">61566</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c0" decimals="INF" unitRef="usd">-127129</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c8" decimals="INF" unitRef="usd">-123102</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c0" decimals="INF" unitRef="usd">1684123</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="c0" decimals="INF" unitRef="usd">34480</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="c8" decimals="INF" unitRef="usd">49330</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c0" decimals="INF" unitRef="usd">1718603</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c8" decimals="INF" unitRef="usd">49330</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents contextRef="c0" decimals="INF" unitRef="usd">-10363</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents contextRef="c8" decimals="INF" unitRef="usd">-3250</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c0" decimals="INF" unitRef="usd">2999861</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c8" decimals="INF" unitRef="usd">-2957240</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c3" decimals="INF" unitRef="usd">4199311</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c14" decimals="INF" unitRef="usd">8641027</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c2" decimals="INF" unitRef="usd">7199172</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c24" decimals="INF" unitRef="usd">5683787</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:IncomeTaxesPaid contextRef="c0" decimals="INF" unitRef="usd">10646</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid contextRef="c8" decimals="INF" unitRef="usd">11735</us-gaap:IncomeTaxesPaid>
    <us-gaap:BasisOfAccounting contextRef="c0">&lt;p style="FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;b&gt;&lt;span style="FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;"&gt;NOTE 1: &#160;BASIS OF PRESENTATION&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt"&gt;Biomerica Inc. and subsidiaries (collectively the &#x201c;Company&#x201d;, &#x201c;Biomerica&#x201d;, &#x201c;we&#x201d;, &#x201c;us&#x201d;, or &#x201c;our&#x201d;) develops, patents, manufactures and markets advanced diagnostic and therapeutic products used at the point-of-care &lt;span style="COLOR:black"&gt;(in home and physicians' offices) &lt;/span&gt;and in hospital/clinical laboratories for detection and/or treatment of medical conditions and diseases. &lt;span style="COLOR:black"&gt;The&lt;/span&gt; Company's products are designed to enhance the health and well-being of people, while reducing total healthcare costs. &lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Our primary focus is the research and development of patented, diagnostic-guided therapy (&#x201c;DGT&#x201d;) products to treat gastrointestinal diseases, such as irritable bowel syndrome, and other inflammatory diseases. These products are directed at chronic inflammatory illnesses that are widespread and common, and as such address very large markets. &lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Our existing medical diagnostic products that are in the market are sold worldwide primarily in two markets: 1) clinical laboratories and 2) point-of-care (physicians' offices and over-the-counter drugstores like Walmart and Walgreens). Our diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances and other medical complications, by measuring or detecting the existence and/or level of specific bacteria, hormones, antibodies, antigens or other substances, which may exist in a patient&#x2019;s body, stools, or blood, often in extremely small concentrations.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt"&gt;Due to the global 2019 SARS-CoV-2 novel coronavirus pandemic, in March 2020 we began developing COVID-19 products to indicate if a person has been infected by COVID-19. While the Company does offer a COVID-19 antibody diagnostic test, all of our COVID-19 revenues in fiscal 2022 have come from international sales of our antigen tests that use a patient&#x2019;s nasal fluid sample to detect if the patient is currently infected with the virus. &lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;The other products we sell are primarily focused on gastrointestinal diseases, food intolerances, and certain esoteric tests. These diagnostic test products utilize immunoassay technology. Most of our commercial products are CE marked and/or sold for diagnostic use where they are registered by each country&#x2019;s regulatory agency.&#160; In addition, some products are cleared for sale in the U.S. by the FDA.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;span style="FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;"&gt;The information set forth in these condensed consolidated financial statements is unaudited and reflects all adjustments which, in the opinion of management, are necessary to present a fair statement of the consolidated results of operations of Biomerica, Inc. and subsidiaries, for the periods indicated. It does not include all information and footnotes necessary for a fair presentation of financial position, results of operations, and cash flows in conformity with accounting principles generally accepted in the United States of America. All adjustments that were made are of a normal recurring nature.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;span style="FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;"&gt;The unaudited, condensed consolidated financial statements and notes are presented as permitted by the requirements for Form 10-Q and do not contain certain information included in the annual financial statements and notes. The condensed consolidated balance sheet data as of May 31, 2021 was derived from restated, audited financial statements. The accompanying interim condensed consolidated financial statements should be read in conjunction with the financial statements and related notes included in the Annual Report on Form 10-K filed with the Securities and Exchange Commission (&#x201c;SEC&#x201d;) on August 27, 2021 for the fiscal year ended May 31, 2021, which have been restated as described in our Form 10-K/A as filed on October 14, 2021. The results of operations for the interim periods are not necessarily indicative of results to be achieved for the full fiscal year.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;b&gt;&lt;span style="FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; BACKGROUND:white; COLOR:black"&gt;CORRECTION OF AN ERROR&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify; margin: 0cm 2.7pt 0pt 0cm;"&gt;&lt;span style="font-family: 'Times New Roman','serif'; background: white; color: black;"&gt;As disclosed in our Form 10-K/A for the year ended May 31, 2021, filed on October 14, 2021, during the process of preparing our financial statements for the quarter ended August 31, 2021, we determined that our calculation of non-cash stock-based compensation expense related to issued stock options in previously issued financial statements was incorrect. Our calculation applied forfeiture adjustments to both vested and unvested outstanding options, including those for which the employee had provided the requisite service, which resulted in an understatement of stock compensation expense. Additionally, our calculation expensed the option at vesting dates versus pro-rata over the period the requisite service was provided. As a result of these errors, certain previously reported amounts in the condensed consolidated statement of operations, condensed consolidated statement of stockholders&#x2019; equity and condensed consolidated statement of cash flows for the periods ended November 30, 2020, were materially misstated; accordingly, we have restated the prior period financial statements. See Note 8 to these Financial Statements. &lt;/span&gt;&lt;/p&gt;</us-gaap:BasisOfAccounting>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="c0">&lt;p style="FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;b&gt;&lt;span style="FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;"&gt;NOTE 2: &#160;SIGNIFICANT ACCOUNTING POLICIES&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt"&gt;PRINCIPLES OF CONSOLIDATION&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;span style="FONT-SIZE:10pt"&gt;The condensed consolidated financial statements include the accounts of Biomerica, Inc. as well as its German subsidiary (BioEurope GmbH) and Mexican subsidiary (Biomerica de Mexico). All significant intercompany accounts and transactions have been eliminated in consolidation. &lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt"&gt;ACCOUNTING ESTIMATES&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;The preparation of the condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of revenues and expenses during the reported period. Estimates that are made include the allowance for doubtful accounts, which is estimated based on current as well as historical past practices with a customer; stock option forfeiture rates, which are calculated based on historical data; inventory obsolescence, which is based on projected and historical usage of materials; and lease liability and right-of-use assets, which are calculated based on certain assumptions such as borrowing rate, the likelihood of lease extensions to occur, asset valuation, among other things; and other items that may be necessary to estimate using current, historical and judgment based information. Actual results could materially differ from those estimates. &lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;MARKETS AND METHODS OF DISTRIBUTION&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0cm 0cm 0pt;"&gt;&lt;span style="font-size: 10pt;"&gt;Due to the Coronavirus global pandemic, the Company&#x2019;s operations have been negatively impacted. &lt;span style="color: black;"&gt;The Company has faced disruptions in certain of the following areas, and may face further challenges from supply chain disruptions, loss of contracts and/or customers, closure of the Company&#x2019;s manufacturing or distribution facilities or of the facilities of the Company&#x2019;s suppliers, partners and customers, travel, shipping and logistical disruptions, government responses of all types, international business risks in countries where the Company makes and/or sells its products, loss of human capital or personnel at the Company, its partners and its customers, interruptions of production, customer credit risk, and general economic calamities. These ongoing pandemic related disruptions have materially negatively impacted the Company&#x2019;s operations and financial performance and may continue to have significant material negative impacts on the Company.&#160;&#160; &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;LIQUIDITY&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;The Company has incurred net losses and negative cash flows from operations and has an accumulated deficit of approximately $33.2 million as of November 30, 2021.&#160; Management expects to continue to incur significant costs as it advances its clinical trials and product development activities.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;On January 22, 2021, the Company filed a prospectus supplement for purposes of raising up to $15,000,000 to the base prospectus filed with the SEC on July 21, 2020 and included in the registration statement on Form S-3 &lt;/span&gt;&lt;span style="FONT-SIZE:10pt"&gt;(&lt;span style="COLOR:black"&gt;File No. 333-239980) that was declared effective by the SEC on September 30, 2020. The shares included in the prospectus supplement may be sold pursuant to the terms of an At-The- Market Issuance Sales Agreement between the Company and B. Riley Securities, Inc., as sales agent, the ATM Agreement.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt"&gt;The Company intends to use the net proceeds from such offering for general corporate purposes, including, without limitation, sales and marketing activities, clinical studies and product development, making acquisitions of assets, businesses, companies or securities, capital expenditures, and for working capital needs.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Under an ATM Agreement, sales of shares are deemed to be &#x201c;at the market offerings&#x201d; as defined in Rule 415 promulgated under the Securities Act.&#160; The sales agent under the ATM Agreement agrees to use commercially reasonable efforts to sell on the Company&#x2019;s behalf all of the shares requested to be sold from time to time by the Company, consistent with its normal trading and sales practices, on mutually agreed terms between the sales agent and the Company. The Company has no obligation to sell any of the shares under the ATM Agreement, and may at any time suspend offers under, or terminate the ATM Agreement.&#160; &lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt"&gt;As a result of cash and cash equivalents on hand at November 30, 2021, management believes the Company has sufficient funds to operate through February 2023 and the ability to raise additional funds through the ATM Agreement noted above.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt"&gt;CONCENTRATION OF CREDIT RISK&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;span style="FONT-SIZE:10pt"&gt;The Company maintains cash balances at certain financial institutions in excess of amounts insured by federal agencies. As of November 30, 2021, the Company had approximately $6,950,000 of uninsured cash.&#160; &lt;span style="COLOR:black"&gt;The Company does not believe it is exposed to any significant credit risks.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;span style="FONT-SIZE:10pt"&gt;For the six months ended November 30, 2021 and 2020, the Company had two and one key customers which accounted for 66% and 35% of net consolidated sales, respectively.&#160; At November 30, 2021 and May 31, 2021, the Company had three and two key distributors which accounted for a total of 73% and 73%, respectively, of gross accounts receivable. &lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;span style="FONT-SIZE:10pt"&gt;For the six months ended November 30, 2021 and 2020, the Company had one and two key vendors which accounted for 77% and 56% of the purchases of raw materials, respectively. As of November 30, 2021 and May 31, 2021, the Company had one key vendor which accounted for 47% and 17%, respectively, of accounts payable.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt"&gt;CASH AND CASH EQUIVALENTS &lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;span style="FONT-SIZE:10pt"&gt;Cash and cash equivalents consist of demand deposits and money market accounts with original maturities of less than six months.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt"&gt;ACCOUNTS RECEIVABLE&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;The Company extends unsecured credit to its customers on a regular basis. &#160;International accounts are usually required to prepay until they establish a history with the Company and at that time, they are extended credit at levels based on a number of criteria. &#160;Based on various criteria,&#160;initial credit levels for individual distributors are approved by designated officers and managers of the Company. All increases in credit limits are also approved by designated upper-level management. &#160;Management evaluates receivables on a quarterly basis and adjusts the allowance for doubtful accounts accordingly. &#160;Balances over ninety days old are usually reserved for unless collection is reasonably assured. &#160; &lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Occasionally certain long-standing customers, who routinely place large orders, will have unusually large receivables balances relative to the total gross receivables. Management monitors the payments for these large balances closely and very often requires payment of existing invoices before shipping new sales orders.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;span style="FONT-SIZE:10pt"&gt;The Company has established a reserve of approximately $28,000 for doubtful accounts as of November 30, 2021. &lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt"&gt;PREPAID EXPENSES AND OTHER&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;span style="FONT-SIZE:10pt"&gt;The Company occasionally prepays for items such as inventory, insurance and other items.&#160; These items are reported as prepaid expenses and other, until either the inventory is physically received or the insurance and other items are expensed.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;span style="FONT-SIZE:10pt"&gt;As of November 30, 2021 and May 31, 2021, the prepaid expenses and other were approximately $1,097,000 and $370,000, respectively. The prepaid expenses and other balance were composed of prepayments to raw materials suppliers, insurance and various other suppliers. &#160;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt"&gt;INVENTORIES, NET &lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;span style="FONT-SIZE:10pt"&gt;The Company values inventory at the lower of cost (determined using a combination of specific lot identification and the first-in, first-out methods) or net realizable value. Management periodically reviews inventory for excess quantities and obsolescence. Management evaluates quantities on hand, physical condition, and technical functionality as these characteristics may be impacted by anticipated customer demand for current products and new product introductions. The reserve is adjusted based on such evaluation, with a corresponding provision included in cost of sales. Abnormal amounts of idle facility expenses, freight, handling costs and wasted material are recognized as current period charges and the allocation of fixed production overhead is based on the normal capacity of the production facilities.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;span style="FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;"&gt;Inventories approximate the following at:&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="WIDTH:555.6pt; BORDER-COLLAPSE:collapse; margin-left: auto; margin-right: auto;" width="741"&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:374.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td colspan="2" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:78.6pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;November 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td colspan="2" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:78.6pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;May 31, &lt;br/&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:374.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Raw materials&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:66.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;1,416,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:66.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;1,583,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:374.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Work in progress&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:66.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;708,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:66.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;1,006,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:374.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Finished products&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:11.8pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:66.8pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;858,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:11.8pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:66.8pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;617,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15.75pt"&gt; &lt;td style="HEIGHT:15.75pt; WIDTH:374.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15.75pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:11.8pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:66.8pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;2,982,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15.75pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:11.8pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:66.8pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;3,206,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;span style="FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;"&gt;Reserves for inventory obsolescence are recorded as necessary to reduce obsolete inventory carrying value to estimated realizable value or to specifically reserve for obsolete inventory that the Company intends to dispose of. As of November 30, 2021 and May 31, 2021, inventory reserves were approximately $1,799,000 and $1,617,000, respectively. Of the inventory reserve, approximately $1,686,000 was related to a market downturn in our COVID-19 antibody test and materials, as the market shifted to COVID-19 PCR viral tests and antigen tests.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt"&gt;PROPERTY AND EQUIPMENT, NET&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;span style="FONT-SIZE:10pt"&gt;Property and equipment are stated at cost. Expenditures for additions and major improvements are capitalized. Repairs and maintenance costs are charged to operations as incurred. When property and equipment are sold, retired or otherwise disposed of, the related cost and accumulated depreciation or amortization are removed from the accounts, and gains or losses from sales, retirements and dispositions are credited or charged to income. &lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm; TEXT-INDENT:36pt"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;span style="FONT-SIZE:10pt"&gt;Depreciation and amortization are provided over the estimated useful lives of the related assets, ranging from 5 to 10 years, using the straight-line method. Leasehold improvements are amortized over the lesser of the estimated useful life of the asset or the term of the lease. Depreciation and amortization expense on property and equipment were approximately $26,000 and $26,000 for the three months ended November 30, 2021 and 2020, and approximately $54,000 and $53,000 for the six months ended November 30, 2021 and 2020, respectively. &lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;span style="FONT-SIZE:10pt"&gt;&#160; &lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt"&gt;INTANGIBLE ASSETS, NET&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Intangible assets include trademarks, product rights, technology rights and patents, and are accounted for based on Accounting Standards Codification, ASC 350 Intangibles &#x2013; Goodwill and Other. In that regard, intangible assets that have indefinite useful lives are not amortized but are tested at least annually for impairment or more frequently if events or changes in circumstances indicate that the asset might be impaired. &lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Intangible assets are being amortized using the straight-line method over the useful life, not to exceed 18 years for marketing and distribution rights, 10 years for purchased technology use rights, and 20 years for patents. Amortization was approximately $7,000 and $6,000 for the three months ended November 30, 2021 and 2020 and approximately $14,000 and $12,000 for the six months ended November 30, 2021 and 2020, respectively.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;The Company assesses the recoverability of these intangible assets by determining whether the amortization of the asset&#x2019;s balance over its remaining life can be recovered through projected undiscounted future cash flows. The Company uses a qualitative assessment to determine whether there was any impairment. No impairment adjustment was required as of &lt;/span&gt;&lt;span style="FONT-SIZE:10pt"&gt;November 30&lt;span style="COLOR:black"&gt;, 2021 or 2020.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;INVESTMENTS&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;From time-to-time, the Company makes investments in privately-held companies. &#160;The Company determines whether the fair values of any investments in privately-held entities have declined below their carrying value whenever adverse events or changes in circumstances indicate that recorded values may not be recoverable. &#160;If the Company considers any such decline to be other than temporary (based on various factors, including historical financial results, and the overall health of the investee&#x2019;s industry), a write-down to estimated fair value is recorded. Investments represent the Company&#x2019;s equity investment in a Polish based distribution company which is primarily engaged in distributing medical products and devices, including those manufactured by the Company, and in certain cases, manufacturing the products they sell. &#160;The Company currently has not written down the investment and has no information that would indicate the carrying value is greater than the fair value.&#160; The Company owns approximately 6% of the Polish distribution company, and accordingly, applies the cost method to account for the investment. &#160;Under the cost method, investments are recorded at cost, with gains and losses recognized as of the sale date, and income recorded when received.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt"&gt;SHARE-BASED COMPENSATION&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;span style="FONT-SIZE:10pt"&gt;The Company follows the guidance of the accounting provisions of Accounting Standards Codification 718, Share-based Compensation, which requires the use of the fair-value based method to determine compensation expense for all arrangements under which employees, directors and others are granted shares of the Company&#x2019;s common stock or equity instruments (stock options). The fair value of each option award is estimated on the date of grant using the Black-Scholes option pricing model that uses assumptions for expected volatility, expected dividends, expected forfeiture rate, expected term, and the risk-free interest rate. The Company has not paid dividends historically and does not expect to pay them in the future. Expected volatilities are based on weighted averages of the historical volatility of the Company&#x2019;s common stock estimated over the expected term of the options. The expected forfeiture rate is based on historical forfeitures experienced. The expected term of options granted is derived using the &#x201c;simplified method&#x201d; which computes expected term as the average of the sum of the vesting term plus the contract term as historically the Company had limited activity surrounding its options. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for the period of&lt;b&gt; &lt;/b&gt;the expected term.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;span style="FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;"&gt;The following summary presents the options and warrants granted, exercised, expired, canceled and outstanding for the six months ended November 30, 2021:&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="WIDTH:554.4pt; BORDER-COLLAPSE:collapse; margin-left: auto; margin-right: auto;" width="739"&gt; &lt;tr style="HEIGHT:48pt"&gt; &lt;td style="HEIGHT:48pt; WIDTH:385.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:48pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:48pt; BORDER-RIGHT:0px; WIDTH:66.8pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Option Shares&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:48pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td colspan="2" style="BORDER-TOP:0px; HEIGHT:48pt; BORDER-RIGHT:0px; WIDTH:78.2pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Exercise Price Weighted Average&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:385.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Outstanding May 31, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:66.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;2,081,366&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:66.4pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;3.59&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:385.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Granted &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:66.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;24,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:66.4pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;4.25&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:385.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Exercised &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:66.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;(21,500)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:66.4pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;1.64&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:385.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Cancelled or expired &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:66.8pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;(24,750)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:11.8pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:66.4pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;3.24&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15.75pt"&gt; &lt;td style="HEIGHT:15.75pt; WIDTH:385.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Outstanding November 30, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15.75pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:66.8pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;2,059,116&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15.75pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:11.8pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;strong&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:66.4pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;3.62&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;span style="FONT-SIZE:10pt"&gt;During the six months ended November 30, 2021, options to purchase 21,500 shares of common stock were exercised at prices ranging from $1.20 to $3.62. Total net proceeds to the Company were $34,480.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;span style="FONT-SIZE:10pt"&gt;During the six months ended November 30, 2021, the Company granted 24,000 options to purchase common stock at an average purchase price of $4.25. &lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt"&gt;REVENUE RECOGNITION&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;The Company has various contracts with customers.&#160; All of the contracts specify that revenues from product sales are recognized at the time the product is shipped, customarily FOB shipping point, which is when the transfer of control of goods has occurred and at which point title passes. The Company does not typically allow for returns except in the event of defective merchandise and therefore does not establish an allowance for returns. In addition, the Company has contracts with customers wherein they receive purchase discounts for achieving specified sales volumes. The Company evaluated the status of these contracts as of &lt;/span&gt;&lt;span style="FONT-SIZE:10pt"&gt;November 30&lt;span style="COLOR:black"&gt;, 2021 and 2020, and does not believe that any additional discounts will be given through the end of the contract periods. &lt;/span&gt;Services for contract works performed by the Company for others are invoiced and recognized as work that has been performed as the project progresses. &lt;span style="COLOR:black"&gt;The Company sells clinical lab products to domestic and international distributors, including hospitals and clinical laboratories, medical research institutions, medical schools and pharmaceutical companies. OTC products are sold directly to drug stores and e-commerce customers as well as to distributors.&#160; Physicians&#x2019; office products are sold to physicians and distributors, all of whom are categorized below according to the type of products sold to them. We also manufacture certain components on a contract basis for domestic and international manufacturers. &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Disaggregation of revenue:&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;The following is a breakdown of revenues according to markets to which the products are sold:&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="WIDTH:602.1pt; BORDER-COLLAPSE:collapse; margin-left: auto; margin-right: auto;" width="803"&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:231.05pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:15pt; WIDTH:8.05pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td colspan="5" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:178.55pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Three Months Ended&lt;br/&gt;&lt;/span&gt;&lt;span style="FONT-SIZE:10pt"&gt;November 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:8.1pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td colspan="5" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:176.35pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Six Months Ended&lt;br/&gt;&lt;/span&gt;&lt;span style="FONT-SIZE:10pt"&gt;November 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:231.05pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:15pt; WIDTH:8.05pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td colspan="2" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:85.25pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;2021&#160; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:8.05pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td colspan="2" style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:85.25pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;2020&#160; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:8.1pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td colspan="2" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:85.25pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;2021&#160; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:8.1pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td colspan="2" style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:83pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:231.05pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Physician's office&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:8.05pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:16.9pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:68.35pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;3,359,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:8.05pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:16.9pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:68.35pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;153,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:8.1pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:16.9pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:68.35pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;3,616,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:8.1pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:16.5pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:66.5pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;351,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:231.05pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Clinical lab&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:8.05pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:15pt; WIDTH:16.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:15pt; WIDTH:68.35pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;642,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:8.05pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:15pt; WIDTH:16.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:15pt; WIDTH:68.35pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;893,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:8.1pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:15pt; WIDTH:16.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:15pt; WIDTH:68.35pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;1,528,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:8.1pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:15pt; WIDTH:16.5pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:15pt; WIDTH:66.5pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;1,475,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:231.05pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Over-the-counter&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:8.05pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:16.9pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:68.35pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;534,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:8.05pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:16.9pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:68.35pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;272,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:8.1pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:16.9pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:68.35pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;613,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:8.1pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:16.5pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:66.5pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;457,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:231.05pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Contract manufacturing&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:8.05pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:16.9pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:68.35pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;112,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:8.05pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:16.9pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:68.35pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;55,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:8.1pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:16.9pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:68.35pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;152,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:8.1pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:16.5pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:66.5pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;233,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15.75pt"&gt; &lt;td style="HEIGHT:15.75pt; WIDTH:231.05pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15.75pt; WIDTH:8.05pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:16.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:68.35pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;4,647,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15.75pt; WIDTH:8.05pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:16.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:68.35pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;1,373,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15.75pt; WIDTH:8.1pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:16.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:68.35pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;5,909,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15.75pt; WIDTH:8.1pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:16.5pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:66.5pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;2,516,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 16.2pt 0pt 0cm"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;See Note 4 for additional information regarding revenue concentrations.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 16.2pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt"&gt;SHIPPING AND HANDLING FEES&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;The Company includes shipping and handling fees billed to customers in net sales.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt"&gt;RESEARCH AND DEVELOPMENT&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;span style="FONT-SIZE:10pt"&gt;Research and development costs are expensed as incurred. The Company expensed approximately $619,000 and $617,000 of research and development costs during the &lt;span style="COLOR:black"&gt;three months ended November 30, 2021 and 2020 and approximately $1,058,000 and $1,328,000 during the six months ended November 30, 2021 and 2020, respectively.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt"&gt;INCOME TAXES&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;The Company has provided a valuation allowance on deferred income tax assets of approximately $6,462,000 and $5,904,000 as of November 30, 2021 and May 31, 2021, respectively. &#160; &lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt"&gt;FOREIGN CURRENCY TRANSLATION&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;The subsidiary located in Mexico operates primarily using the Mexican peso. The subsidiary located in Germany operates primarily using the U.S. dollar, with an immaterial amount of transactions occurring using the Euro. Accordingly, assets and liabilities of these subsidiaries are translated using exchange rates in effect at the end of the period, and revenues and costs are translated using average exchange rates for the period. The resulting adjustments to assets and liabilities are presented as a separate component of accumulated other comprehensive loss. There are no adjustments to foreign currency loss that are included in the consolidated statements of operations for the three and six months ended November 30, 2021 and 2020.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;RIGHT-OF-USE ASSETS AND LEASE LIABILITY&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;span style="FONT-SIZE:10pt"&gt;The Company follows the guidance of ASC 842, Leases, which requires lessees to recognize most leases on the balance sheet with a corresponding right-of-use asset. Right-of-use assets represent the Company&#x2019;s right to use an underlying asset for the lease term and lease liabilities represent the obligation to make lease payments arising from the lease. The Company leases office space and copy machines, all of which are operating leases. The Company has elected to exclude short-term leases. Most leases include the option to renew and the exercise of the renewal options is at the Company&#x2019;s sole discretion. Options to extend or terminate a lease are considered in the lease term to the extent that the option is reasonably certain of exercise.&#160; The leases do not include the options to purchase the leased property.&#160; The depreciable life of assets and leasehold improvements are limited by the expected lease term.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt"&gt;NET LOSS PER SHARE&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 16.2pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;span style="FONT-SIZE:10pt"&gt;Basic loss per share is computed as net loss divided by the weighted average number of common shares outstanding for the period. Diluted loss per share reflects the potential dilution that could occur from common shares issuable through stock options, warrants and other convertible securities using the treasury stock method. The total amount of anti-dilutive stock options not included in the loss per share calculation at November 30, 2021 and 2020 was 2,059,116 and 1,399,763, respectively. &lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt"&gt;RECENT ACCOUNTING PRONOUNCEMENTS&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Recent ASUs issued by the Financial Accounting Standards Board and guidance issued by the Securities and Exchange Commission (&#x201c;SEC&#x201d;) did not, or are not believed by management to, have a material effect on the Company&#x2019;s present or future consolidated financial statements. &lt;/span&gt;&lt;/p&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="c6">&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt"&gt;PRINCIPLES OF CONSOLIDATION&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;span style="FONT-SIZE:10pt"&gt;The condensed consolidated financial statements include the accounts of Biomerica, Inc. as well as its German subsidiary (BioEurope GmbH) and Mexican subsidiary (Biomerica de Mexico). All significant intercompany accounts and transactions have been eliminated in consolidation. &lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="c6">&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt"&gt;ACCOUNTING ESTIMATES&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;The preparation of the condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of revenues and expenses during the reported period. Estimates that are made include the allowance for doubtful accounts, which is estimated based on current as well as historical past practices with a customer; stock option forfeiture rates, which are calculated based on historical data; inventory obsolescence, which is based on projected and historical usage of materials; and lease liability and right-of-use assets, which are calculated based on certain assumptions such as borrowing rate, the likelihood of lease extensions to occur, asset valuation, among other things; and other items that may be necessary to estimate using current, historical and judgment based information. Actual results could materially differ from those estimates. &lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;</us-gaap:UseOfEstimates>
    <bmra:MarketsAndMethodsOfDistributionPolicyTextBlock contextRef="c6">&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;MARKETS AND METHODS OF DISTRIBUTION&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0cm 0cm 0pt;"&gt;&lt;span style="font-size: 10pt;"&gt;Due to the Coronavirus global pandemic, the Company&#x2019;s operations have been negatively impacted. &lt;span style="color: black;"&gt;The Company has faced disruptions in certain of the following areas, and may face further challenges from supply chain disruptions, loss of contracts and/or customers, closure of the Company&#x2019;s manufacturing or distribution facilities or of the facilities of the Company&#x2019;s suppliers, partners and customers, travel, shipping and logistical disruptions, government responses of all types, international business risks in countries where the Company makes and/or sells its products, loss of human capital or personnel at the Company, its partners and its customers, interruptions of production, customer credit risk, and general economic calamities. These ongoing pandemic related disruptions have materially negatively impacted the Company&#x2019;s operations and financial performance and may continue to have significant material negative impacts on the Company.&#160;&#160; &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;</bmra:MarketsAndMethodsOfDistributionPolicyTextBlock>
    <bmra:LiquidityPolicyTextBlock contextRef="c6">&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;LIQUIDITY&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;The Company has incurred net losses and negative cash flows from operations and has an accumulated deficit of approximately $33.2 million as of November 30, 2021.&#160; Management expects to continue to incur significant costs as it advances its clinical trials and product development activities.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;On January 22, 2021, the Company filed a prospectus supplement for purposes of raising up to $15,000,000 to the base prospectus filed with the SEC on July 21, 2020 and included in the registration statement on Form S-3 &lt;/span&gt;&lt;span style="FONT-SIZE:10pt"&gt;(&lt;span style="COLOR:black"&gt;File No. 333-239980) that was declared effective by the SEC on September 30, 2020. The shares included in the prospectus supplement may be sold pursuant to the terms of an At-The- Market Issuance Sales Agreement between the Company and B. Riley Securities, Inc., as sales agent, the ATM Agreement.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt"&gt;The Company intends to use the net proceeds from such offering for general corporate purposes, including, without limitation, sales and marketing activities, clinical studies and product development, making acquisitions of assets, businesses, companies or securities, capital expenditures, and for working capital needs.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Under an ATM Agreement, sales of shares are deemed to be &#x201c;at the market offerings&#x201d; as defined in Rule 415 promulgated under the Securities Act.&#160; The sales agent under the ATM Agreement agrees to use commercially reasonable efforts to sell on the Company&#x2019;s behalf all of the shares requested to be sold from time to time by the Company, consistent with its normal trading and sales practices, on mutually agreed terms between the sales agent and the Company. The Company has no obligation to sell any of the shares under the ATM Agreement, and may at any time suspend offers under, or terminate the ATM Agreement.&#160; &lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt"&gt;As a result of cash and cash equivalents on hand at November 30, 2021, management believes the Company has sufficient funds to operate through February 2023 and the ability to raise additional funds through the ATM Agreement noted above.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;</bmra:LiquidityPolicyTextBlock>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c2" decimals="-5" unitRef="usd">-33200000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <bmra:ShelfRegistrationStatementMaximumAuthorizedCommonStockIssuanceValue contextRef="c37" decimals="0" unitRef="usd">15000000</bmra:ShelfRegistrationStatementMaximumAuthorizedCommonStockIssuanceValue>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="c6">&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt"&gt;CONCENTRATION OF CREDIT RISK&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;span style="FONT-SIZE:10pt"&gt;The Company maintains cash balances at certain financial institutions in excess of amounts insured by federal agencies. As of November 30, 2021, the Company had approximately $6,950,000 of uninsured cash.&#160; &lt;span style="COLOR:black"&gt;The Company does not believe it is exposed to any significant credit risks.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;span style="FONT-SIZE:10pt"&gt;For the six months ended November 30, 2021 and 2020, the Company had two and one key customers which accounted for 66% and 35% of net consolidated sales, respectively.&#160; At November 30, 2021 and May 31, 2021, the Company had three and two key distributors which accounted for a total of 73% and 73%, respectively, of gross accounts receivable. &lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;span style="FONT-SIZE:10pt"&gt;For the six months ended November 30, 2021 and 2020, the Company had one and two key vendors which accounted for 77% and 56% of the purchases of raw materials, respectively. As of November 30, 2021 and May 31, 2021, the Company had one key vendor which accounted for 47% and 17%, respectively, of accounts payable.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:CashUninsuredAmount contextRef="c2" decimals="0" unitRef="usd">6950000</us-gaap:CashUninsuredAmount>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c38" decimals="2" unitRef="pure">0.66</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c39" decimals="2" unitRef="pure">0.35</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c40" decimals="2" unitRef="pure">0.73</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c41" decimals="2" unitRef="pure">0.73</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c42" decimals="2" unitRef="pure">0.77</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c43" decimals="2" unitRef="pure">0.56</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c44" decimals="2" unitRef="pure">0.47</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c45" decimals="2" unitRef="pure">0.17</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="c6">&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt"&gt;CASH AND CASH EQUIVALENTS &lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;span style="FONT-SIZE:10pt"&gt;Cash and cash equivalents consist of demand deposits and money market accounts with original maturities of less than six months.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:TradeAndOtherAccountsReceivablePolicy contextRef="c6">&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt"&gt;ACCOUNTS RECEIVABLE&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;The Company extends unsecured credit to its customers on a regular basis. &#160;International accounts are usually required to prepay until they establish a history with the Company and at that time, they are extended credit at levels based on a number of criteria. &#160;Based on various criteria,&#160;initial credit levels for individual distributors are approved by designated officers and managers of the Company. All increases in credit limits are also approved by designated upper-level management. &#160;Management evaluates receivables on a quarterly basis and adjusts the allowance for doubtful accounts accordingly. &#160;Balances over ninety days old are usually reserved for unless collection is reasonably assured. &#160; &lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Occasionally certain long-standing customers, who routinely place large orders, will have unusually large receivables balances relative to the total gross receivables. Management monitors the payments for these large balances closely and very often requires payment of existing invoices before shipping new sales orders.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;span style="FONT-SIZE:10pt"&gt;The Company has established a reserve of approximately $28,000 for doubtful accounts as of November 30, 2021. &lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;</us-gaap:TradeAndOtherAccountsReceivablePolicy>
    <us-gaap:ThresholdPeriodPastDueForWriteoffOfTradeAccountsReceivable contextRef="c6">P90D</us-gaap:ThresholdPeriodPastDueForWriteoffOfTradeAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulOtherReceivablesCurrent contextRef="c2" decimals="0" unitRef="usd">28000</us-gaap:AllowanceForDoubtfulOtherReceivablesCurrent>
    <bmra:PrepaidsPolicyPolicyTextBlock contextRef="c6">&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt"&gt;PREPAID EXPENSES AND OTHER&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;span style="FONT-SIZE:10pt"&gt;The Company occasionally prepays for items such as inventory, insurance and other items.&#160; These items are reported as prepaid expenses and other, until either the inventory is physically received or the insurance and other items are expensed.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;span style="FONT-SIZE:10pt"&gt;As of November 30, 2021 and May 31, 2021, the prepaid expenses and other were approximately $1,097,000 and $370,000, respectively. The prepaid expenses and other balance were composed of prepayments to raw materials suppliers, insurance and various other suppliers. &#160;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;</bmra:PrepaidsPolicyPolicyTextBlock>
    <us-gaap:PrepaidExpenseAndOtherAssets contextRef="c2" decimals="0" unitRef="usd">1097000</us-gaap:PrepaidExpenseAndOtherAssets>
    <us-gaap:PrepaidExpenseAndOtherAssets contextRef="c3" decimals="0" unitRef="usd">370000</us-gaap:PrepaidExpenseAndOtherAssets>
    <us-gaap:InventoryPolicyTextBlock contextRef="c6">&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt"&gt;INVENTORIES, NET &lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;span style="FONT-SIZE:10pt"&gt;The Company values inventory at the lower of cost (determined using a combination of specific lot identification and the first-in, first-out methods) or net realizable value. Management periodically reviews inventory for excess quantities and obsolescence. Management evaluates quantities on hand, physical condition, and technical functionality as these characteristics may be impacted by anticipated customer demand for current products and new product introductions. The reserve is adjusted based on such evaluation, with a corresponding provision included in cost of sales. Abnormal amounts of idle facility expenses, freight, handling costs and wasted material are recognized as current period charges and the allocation of fixed production overhead is based on the normal capacity of the production facilities.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;span style="FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;"&gt;Inventories approximate the following at:&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="WIDTH:555.6pt; BORDER-COLLAPSE:collapse; margin-left: auto; margin-right: auto;" width="741"&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:374.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td colspan="2" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:78.6pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;November 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td colspan="2" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:78.6pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;May 31, &lt;br/&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:374.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Raw materials&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:66.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;1,416,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:66.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;1,583,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:374.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Work in progress&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:66.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;708,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:66.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;1,006,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:374.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Finished products&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:11.8pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:66.8pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;858,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:11.8pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:66.8pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;617,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15.75pt"&gt; &lt;td style="HEIGHT:15.75pt; WIDTH:374.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15.75pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:11.8pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:66.8pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;2,982,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15.75pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:11.8pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:66.8pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;3,206,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;span style="FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;"&gt;Reserves for inventory obsolescence are recorded as necessary to reduce obsolete inventory carrying value to estimated realizable value or to specifically reserve for obsolete inventory that the Company intends to dispose of. As of November 30, 2021 and May 31, 2021, inventory reserves were approximately $1,799,000 and $1,617,000, respectively. Of the inventory reserve, approximately $1,686,000 was related to a market downturn in our COVID-19 antibody test and materials, as the market shifted to COVID-19 PCR viral tests and antigen tests.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="WIDTH:555.6pt; BORDER-COLLAPSE:collapse; margin-left: auto; margin-right: auto;" width="741"&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:374.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td colspan="2" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:78.6pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;November 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td colspan="2" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:78.6pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;May 31, &lt;br/&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:374.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Raw materials&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:66.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;1,416,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:66.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;1,583,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:374.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Work in progress&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:66.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;708,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:66.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;1,006,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:374.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Finished products&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:11.8pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:66.8pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;858,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:11.8pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:66.8pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;617,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15.75pt"&gt; &lt;td style="HEIGHT:15.75pt; WIDTH:374.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15.75pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:11.8pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:66.8pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;2,982,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15.75pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:11.8pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:66.8pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;3,206,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsNetOfReserves contextRef="c2" decimals="-3" unitRef="usd">1416000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves contextRef="c3" decimals="-3" unitRef="usd">1583000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves contextRef="c2" decimals="-3" unitRef="usd">708000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves contextRef="c3" decimals="-3" unitRef="usd">1006000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves contextRef="c2" decimals="-3" unitRef="usd">858000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves contextRef="c3" decimals="-3" unitRef="usd">617000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryNet contextRef="c2" decimals="-3" unitRef="usd">2982000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="c3" decimals="-3" unitRef="usd">3206000</us-gaap:InventoryNet>
    <us-gaap:InventoryValuationReserves contextRef="c2" decimals="0" unitRef="usd">1799000</us-gaap:InventoryValuationReserves>
    <us-gaap:InventoryValuationReserves contextRef="c3" decimals="0" unitRef="usd">1617000</us-gaap:InventoryValuationReserves>
    <us-gaap:InventoryLIFOReserve contextRef="c2" decimals="0" unitRef="usd">1686000</us-gaap:InventoryLIFOReserve>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="c6">&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt"&gt;PROPERTY AND EQUIPMENT, NET&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;span style="FONT-SIZE:10pt"&gt;Property and equipment are stated at cost. Expenditures for additions and major improvements are capitalized. Repairs and maintenance costs are charged to operations as incurred. When property and equipment are sold, retired or otherwise disposed of, the related cost and accumulated depreciation or amortization are removed from the accounts, and gains or losses from sales, retirements and dispositions are credited or charged to income. &lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm; TEXT-INDENT:36pt"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;span style="FONT-SIZE:10pt"&gt;Depreciation and amortization are provided over the estimated useful lives of the related assets, ranging from 5 to 10 years, using the straight-line method. Leasehold improvements are amortized over the lesser of the estimated useful life of the asset or the term of the lease. Depreciation and amortization expense on property and equipment were approximately $26,000 and $26,000 for the three months ended November 30, 2021 and 2020, and approximately $54,000 and $53,000 for the six months ended November 30, 2021 and 2020, respectively. &lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;span style="FONT-SIZE:10pt"&gt;&#160; &lt;/span&gt;&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c46">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c47">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c6" decimals="0" unitRef="usd">26000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c7" decimals="0" unitRef="usd">26000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c0" decimals="0" unitRef="usd">54000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c8" decimals="0" unitRef="usd">53000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock contextRef="c6">&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt"&gt;INTANGIBLE ASSETS, NET&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Intangible assets include trademarks, product rights, technology rights and patents, and are accounted for based on Accounting Standards Codification, ASC 350 Intangibles &#x2013; Goodwill and Other. In that regard, intangible assets that have indefinite useful lives are not amortized but are tested at least annually for impairment or more frequently if events or changes in circumstances indicate that the asset might be impaired. &lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Intangible assets are being amortized using the straight-line method over the useful life, not to exceed 18 years for marketing and distribution rights, 10 years for purchased technology use rights, and 20 years for patents. Amortization was approximately $7,000 and $6,000 for the three months ended November 30, 2021 and 2020 and approximately $14,000 and $12,000 for the six months ended November 30, 2021 and 2020, respectively.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;The Company assesses the recoverability of these intangible assets by determining whether the amortization of the asset&#x2019;s balance over its remaining life can be recovered through projected undiscounted future cash flows. The Company uses a qualitative assessment to determine whether there was any impairment. No impairment adjustment was required as of &lt;/span&gt;&lt;span style="FONT-SIZE:10pt"&gt;November 30&lt;span style="COLOR:black"&gt;, 2021 or 2020.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;</us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c48">P18Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c49">P10Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c50">P20Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c6" decimals="0" unitRef="usd">7000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c7" decimals="0" unitRef="usd">6000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c0" decimals="0" unitRef="usd">14000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c8" decimals="0" unitRef="usd">12000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:InvestmentPolicyTextBlock contextRef="c6">&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;INVESTMENTS&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;From time-to-time, the Company makes investments in privately-held companies. &#160;The Company determines whether the fair values of any investments in privately-held entities have declined below their carrying value whenever adverse events or changes in circumstances indicate that recorded values may not be recoverable. &#160;If the Company considers any such decline to be other than temporary (based on various factors, including historical financial results, and the overall health of the investee&#x2019;s industry), a write-down to estimated fair value is recorded. Investments represent the Company&#x2019;s equity investment in a Polish based distribution company which is primarily engaged in distributing medical products and devices, including those manufactured by the Company, and in certain cases, manufacturing the products they sell. &#160;The Company currently has not written down the investment and has no information that would indicate the carrying value is greater than the fair value.&#160; The Company owns approximately 6% of the Polish distribution company, and accordingly, applies the cost method to account for the investment. &#160;Under the cost method, investments are recorded at cost, with gains and losses recognized as of the sale date, and income recorded when received.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;</us-gaap:InvestmentPolicyTextBlock>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="c2" decimals="2" unitRef="pure">0.06</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="c6">&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt"&gt;SHARE-BASED COMPENSATION&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;span style="FONT-SIZE:10pt"&gt;The Company follows the guidance of the accounting provisions of Accounting Standards Codification 718, Share-based Compensation, which requires the use of the fair-value based method to determine compensation expense for all arrangements under which employees, directors and others are granted shares of the Company&#x2019;s common stock or equity instruments (stock options). The fair value of each option award is estimated on the date of grant using the Black-Scholes option pricing model that uses assumptions for expected volatility, expected dividends, expected forfeiture rate, expected term, and the risk-free interest rate. The Company has not paid dividends historically and does not expect to pay them in the future. Expected volatilities are based on weighted averages of the historical volatility of the Company&#x2019;s common stock estimated over the expected term of the options. The expected forfeiture rate is based on historical forfeitures experienced. The expected term of options granted is derived using the &#x201c;simplified method&#x201d; which computes expected term as the average of the sum of the vesting term plus the contract term as historically the Company had limited activity surrounding its options. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for the period of&lt;b&gt; &lt;/b&gt;the expected term.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;span style="FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;"&gt;The following summary presents the options and warrants granted, exercised, expired, canceled and outstanding for the six months ended November 30, 2021:&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="WIDTH:554.4pt; BORDER-COLLAPSE:collapse; margin-left: auto; margin-right: auto;" width="739"&gt; &lt;tr style="HEIGHT:48pt"&gt; &lt;td style="HEIGHT:48pt; WIDTH:385.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:48pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:48pt; BORDER-RIGHT:0px; WIDTH:66.8pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Option Shares&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:48pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td colspan="2" style="BORDER-TOP:0px; HEIGHT:48pt; BORDER-RIGHT:0px; WIDTH:78.2pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Exercise Price Weighted Average&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:385.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Outstanding May 31, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:66.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;2,081,366&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:66.4pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;3.59&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:385.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Granted &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:66.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;24,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:66.4pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;4.25&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:385.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Exercised &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:66.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;(21,500)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:66.4pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;1.64&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:385.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Cancelled or expired &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:66.8pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;(24,750)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:11.8pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:66.4pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;3.24&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15.75pt"&gt; &lt;td style="HEIGHT:15.75pt; WIDTH:385.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Outstanding November 30, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15.75pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:66.8pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;2,059,116&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15.75pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:11.8pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;strong&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:66.4pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;3.62&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;span style="FONT-SIZE:10pt"&gt;During the six months ended November 30, 2021, options to purchase 21,500 shares of common stock were exercised at prices ranging from $1.20 to $3.62. Total net proceeds to the Company were $34,480.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;span style="FONT-SIZE:10pt"&gt;During the six months ended November 30, 2021, the Company granted 24,000 options to purchase common stock at an average purchase price of $4.25. &lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="WIDTH:554.4pt; BORDER-COLLAPSE:collapse; margin-left: auto; margin-right: auto;" width="739"&gt; &lt;tr style="HEIGHT:48pt"&gt; &lt;td style="HEIGHT:48pt; WIDTH:385.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:48pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:48pt; BORDER-RIGHT:0px; WIDTH:66.8pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Option Shares&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:48pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td colspan="2" style="BORDER-TOP:0px; HEIGHT:48pt; BORDER-RIGHT:0px; WIDTH:78.2pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Exercise Price Weighted Average&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:385.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Outstanding May 31, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:66.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;2,081,366&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:66.4pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;3.59&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:385.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Granted &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:66.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;24,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:66.4pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;4.25&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:385.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Exercised &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:66.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;(21,500)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:66.4pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;1.64&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:385.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Cancelled or expired &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:66.8pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;(24,750)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:11.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:11.8pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:66.4pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;3.24&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15.75pt"&gt; &lt;td style="HEIGHT:15.75pt; WIDTH:385.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Outstanding November 30, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15.75pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:66.8pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;2,059,116&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15.75pt; WIDTH:11.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:11.8pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;strong&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:66.4pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;3.62&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="c55" decimals="INF" unitRef="shares">2081366</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="c55" decimals="INF" unitRef="usdPershares">3.59</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="c56" decimals="INF" unitRef="shares">24000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="c56" decimals="INF" unitRef="usdPershares">4.25</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="c56" decimals="INF" unitRef="shares">21500</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice contextRef="c56" decimals="INF" unitRef="usdPershares">1.64</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod contextRef="c56" decimals="INF" unitRef="shares">24750</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice contextRef="c56" decimals="INF" unitRef="usdPershares">3.24</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="c57" decimals="INF" unitRef="shares">2059116</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="c57" decimals="INF" unitRef="usdPershares">3.62</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="c51" decimals="0" unitRef="shares">21500</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 contextRef="c52" decimals="2" unitRef="usdPershares">1.2</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 contextRef="c53" decimals="2" unitRef="usdPershares">3.62</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="c51" decimals="0" unitRef="usd">34480</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="c54" decimals="0" unitRef="shares">24000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="c54" decimals="2" unitRef="usdPershares">4.25</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="c6">&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt"&gt;REVENUE RECOGNITION&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;The Company has various contracts with customers.&#160; All of the contracts specify that revenues from product sales are recognized at the time the product is shipped, customarily FOB shipping point, which is when the transfer of control of goods has occurred and at which point title passes. The Company does not typically allow for returns except in the event of defective merchandise and therefore does not establish an allowance for returns. In addition, the Company has contracts with customers wherein they receive purchase discounts for achieving specified sales volumes. The Company evaluated the status of these contracts as of &lt;/span&gt;&lt;span style="FONT-SIZE:10pt"&gt;November 30&lt;span style="COLOR:black"&gt;, 2021 and 2020, and does not believe that any additional discounts will be given through the end of the contract periods. &lt;/span&gt;Services for contract works performed by the Company for others are invoiced and recognized as work that has been performed as the project progresses. &lt;span style="COLOR:black"&gt;The Company sells clinical lab products to domestic and international distributors, including hospitals and clinical laboratories, medical research institutions, medical schools and pharmaceutical companies. OTC products are sold directly to drug stores and e-commerce customers as well as to distributors.&#160; Physicians&#x2019; office products are sold to physicians and distributors, all of whom are categorized below according to the type of products sold to them. We also manufacture certain components on a contract basis for domestic and international manufacturers. &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Disaggregation of revenue:&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;The following is a breakdown of revenues according to markets to which the products are sold:&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="WIDTH:602.1pt; BORDER-COLLAPSE:collapse; margin-left: auto; margin-right: auto;" width="803"&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:231.05pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:15pt; WIDTH:8.05pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td colspan="5" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:178.55pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Three Months Ended&lt;br/&gt;&lt;/span&gt;&lt;span style="FONT-SIZE:10pt"&gt;November 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:8.1pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td colspan="5" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:176.35pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Six Months Ended&lt;br/&gt;&lt;/span&gt;&lt;span style="FONT-SIZE:10pt"&gt;November 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:231.05pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:15pt; WIDTH:8.05pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td colspan="2" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:85.25pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;2021&#160; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:8.05pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td colspan="2" style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:85.25pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;2020&#160; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:8.1pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td colspan="2" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:85.25pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;2021&#160; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:8.1pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td colspan="2" style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:83pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:231.05pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Physician's office&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:8.05pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:16.9pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:68.35pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;3,359,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:8.05pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:16.9pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:68.35pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;153,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:8.1pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:16.9pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:68.35pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;3,616,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:8.1pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:16.5pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:66.5pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;351,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:231.05pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Clinical lab&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:8.05pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:15pt; WIDTH:16.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:15pt; WIDTH:68.35pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;642,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:8.05pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:15pt; WIDTH:16.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:15pt; WIDTH:68.35pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;893,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:8.1pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:15pt; WIDTH:16.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:15pt; WIDTH:68.35pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;1,528,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:8.1pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:15pt; WIDTH:16.5pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:15pt; WIDTH:66.5pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;1,475,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:231.05pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Over-the-counter&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:8.05pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:16.9pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:68.35pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;534,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:8.05pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:16.9pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:68.35pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;272,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:8.1pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:16.9pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:68.35pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;613,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:8.1pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:16.5pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:66.5pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;457,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:231.05pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Contract manufacturing&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:8.05pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:16.9pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:68.35pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;112,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:8.05pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:16.9pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:68.35pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;55,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:8.1pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:16.9pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:68.35pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;152,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:8.1pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:16.5pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:66.5pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;233,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15.75pt"&gt; &lt;td style="HEIGHT:15.75pt; WIDTH:231.05pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15.75pt; WIDTH:8.05pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:16.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:68.35pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;4,647,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15.75pt; WIDTH:8.05pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:16.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:68.35pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;1,373,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15.75pt; WIDTH:8.1pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:16.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:68.35pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;5,909,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15.75pt; WIDTH:8.1pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:16.5pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:66.5pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;2,516,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 16.2pt 0pt 0cm"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;See Note 4 for additional information regarding revenue concentrations.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 16.2pt 0pt 0cm"&gt;&#160;&lt;/p&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="WIDTH:602.1pt; BORDER-COLLAPSE:collapse; margin-left: auto; margin-right: auto;" width="803"&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:231.05pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:15pt; WIDTH:8.05pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td colspan="5" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:178.55pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Three Months Ended&lt;br/&gt;&lt;/span&gt;&lt;span style="FONT-SIZE:10pt"&gt;November 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:8.1pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td colspan="5" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:176.35pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Six Months Ended&lt;br/&gt;&lt;/span&gt;&lt;span style="FONT-SIZE:10pt"&gt;November 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:231.05pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:15pt; WIDTH:8.05pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td colspan="2" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:85.25pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;2021&#160; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:8.05pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td colspan="2" style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:85.25pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;2020&#160; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:8.1pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td colspan="2" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:85.25pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;2021&#160; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:8.1pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td colspan="2" style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:83pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:231.05pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Physician's office&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:8.05pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:16.9pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:68.35pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;3,359,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:8.05pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:16.9pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:68.35pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;153,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:8.1pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:16.9pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:68.35pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;3,616,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:8.1pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:16.5pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:66.5pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;351,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:231.05pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Clinical lab&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:8.05pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:15pt; WIDTH:16.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:15pt; WIDTH:68.35pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;642,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:8.05pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:15pt; WIDTH:16.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:15pt; WIDTH:68.35pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;893,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:8.1pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:15pt; WIDTH:16.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:15pt; WIDTH:68.35pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;1,528,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:8.1pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:15pt; WIDTH:16.5pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:15pt; WIDTH:66.5pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;1,475,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:231.05pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Over-the-counter&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:8.05pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:16.9pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:68.35pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;534,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:8.05pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:16.9pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:68.35pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;272,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:8.1pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:16.9pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:68.35pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;613,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:8.1pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:16.5pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:66.5pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;457,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:231.05pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Contract manufacturing&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:8.05pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:16.9pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:68.35pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;112,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:8.05pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:16.9pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:68.35pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;55,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:8.1pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:16.9pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:68.35pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;152,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:8.1pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:16.5pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:66.5pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;233,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15.75pt"&gt; &lt;td style="HEIGHT:15.75pt; WIDTH:231.05pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15.75pt; WIDTH:8.05pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:16.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:68.35pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;4,647,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15.75pt; WIDTH:8.05pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:16.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:68.35pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;1,373,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15.75pt; WIDTH:8.1pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:16.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:68.35pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;5,909,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15.75pt; WIDTH:8.1pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:16.5pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:66.5pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;2,516,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c58" decimals="INF" unitRef="usd">3359000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c59" decimals="INF" unitRef="usd">153000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c60" decimals="INF" unitRef="usd">3616000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c61" decimals="INF" unitRef="usd">351000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c62" decimals="INF" unitRef="usd">642000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c63" decimals="INF" unitRef="usd">893000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c64" decimals="INF" unitRef="usd">1528000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c65" decimals="INF" unitRef="usd">1475000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c66" decimals="INF" unitRef="usd">534000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c67" decimals="INF" unitRef="usd">272000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c68" decimals="INF" unitRef="usd">613000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c69" decimals="INF" unitRef="usd">457000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c70" decimals="INF" unitRef="usd">112000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c71" decimals="INF" unitRef="usd">55000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c72" decimals="INF" unitRef="usd">152000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c73" decimals="INF" unitRef="usd">233000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c6" decimals="INF" unitRef="usd">4647000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c7" decimals="INF" unitRef="usd">1373000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c0" decimals="INF" unitRef="usd">5909000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c8" decimals="INF" unitRef="usd">2516000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfSalesPolicyTextBlock contextRef="c6">&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt"&gt;SHIPPING AND HANDLING FEES&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;The Company includes shipping and handling fees billed to customers in net sales.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;</us-gaap:CostOfSalesPolicyTextBlock>
    <us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="c6">&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt"&gt;RESEARCH AND DEVELOPMENT&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;span style="FONT-SIZE:10pt"&gt;Research and development costs are expensed as incurred. The Company expensed approximately $619,000 and $617,000 of research and development costs during the &lt;span style="COLOR:black"&gt;three months ended November 30, 2021 and 2020 and approximately $1,058,000 and $1,328,000 during the six months ended November 30, 2021 and 2020, respectively.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:OtherResearchAndDevelopmentExpense contextRef="c6" decimals="0" unitRef="usd">619000</us-gaap:OtherResearchAndDevelopmentExpense>
    <us-gaap:OtherResearchAndDevelopmentExpense contextRef="c7" decimals="0" unitRef="usd">617000</us-gaap:OtherResearchAndDevelopmentExpense>
    <us-gaap:OtherResearchAndDevelopmentExpense contextRef="c0" decimals="0" unitRef="usd">1058000</us-gaap:OtherResearchAndDevelopmentExpense>
    <us-gaap:OtherResearchAndDevelopmentExpense contextRef="c8" decimals="0" unitRef="usd">1328000</us-gaap:OtherResearchAndDevelopmentExpense>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="c6">&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt"&gt;INCOME TAXES&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;The Company has provided a valuation allowance on deferred income tax assets of approximately $6,462,000 and $5,904,000 as of November 30, 2021 and May 31, 2021, respectively. &#160; &lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c2" decimals="0" unitRef="usd">6462000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c3" decimals="0" unitRef="usd">5904000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock contextRef="c6">&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt"&gt;FOREIGN CURRENCY TRANSLATION&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;The subsidiary located in Mexico operates primarily using the Mexican peso. The subsidiary located in Germany operates primarily using the U.S. dollar, with an immaterial amount of transactions occurring using the Euro. Accordingly, assets and liabilities of these subsidiaries are translated using exchange rates in effect at the end of the period, and revenues and costs are translated using average exchange rates for the period. The resulting adjustments to assets and liabilities are presented as a separate component of accumulated other comprehensive loss. There are no adjustments to foreign currency loss that are included in the consolidated statements of operations for the three and six months ended November 30, 2021 and 2020.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:LesseeLeasesPolicyTextBlock contextRef="c6">&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;RIGHT-OF-USE ASSETS AND LEASE LIABILITY&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;span style="FONT-SIZE:10pt"&gt;The Company follows the guidance of ASC 842, Leases, which requires lessees to recognize most leases on the balance sheet with a corresponding right-of-use asset. Right-of-use assets represent the Company&#x2019;s right to use an underlying asset for the lease term and lease liabilities represent the obligation to make lease payments arising from the lease. The Company leases office space and copy machines, all of which are operating leases. The Company has elected to exclude short-term leases. Most leases include the option to renew and the exercise of the renewal options is at the Company&#x2019;s sole discretion. Options to extend or terminate a lease are considered in the lease term to the extent that the option is reasonably certain of exercise.&#160; The leases do not include the options to purchase the leased property.&#160; The depreciable life of assets and leasehold improvements are limited by the expected lease term.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="c6">&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt"&gt;NET LOSS PER SHARE&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 16.2pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;span style="FONT-SIZE:10pt"&gt;Basic loss per share is computed as net loss divided by the weighted average number of common shares outstanding for the period. Diluted loss per share reflects the potential dilution that could occur from common shares issuable through stock options, warrants and other convertible securities using the treasury stock method. The total amount of anti-dilutive stock options not included in the loss per share calculation at November 30, 2021 and 2020 was 2,059,116 and 1,399,763, respectively. &lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c6" decimals="0" unitRef="shares">2059116</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c7" decimals="0" unitRef="shares">1399763</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="c6">&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt"&gt;RECENT ACCOUNTING PRONOUNCEMENTS&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Recent ASUs issued by the Financial Accounting Standards Board and guidance issued by the Securities and Exchange Commission (&#x201c;SEC&#x201d;) did not, or are not believed by management to, have a material effect on the Company&#x2019;s present or future consolidated financial statements. &lt;/span&gt;&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="c0">&lt;p style="FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;b&gt;&lt;span style="FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;"&gt;NOTE 3:&#160; SHAREHOLDERS&#x2019; EQUITY&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt"&gt;Stock option expense during the six months ended November 30, 2021 and 2020 was approximately $634,000 and $500,000 (as restated, see Note 8 to these Financial Statements), respectively.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt"&gt;During the six months ended November 30, 2021, the Company sold 363,670 shares of its common stock at prices ranging from $4.02 to $5.63 under its January 22, 2021 prospectus supplement and the ATM Agreement (see Note 2 to these Financial Statements) which resulted in gross proceeds of approximately $1,751,000 and net proceeds to the Company of approximately $1,684,000 after deducting commissions for each sale and legal, accounting and other fees related to the filing of the Form S-3.&lt;/span&gt;&lt;/p&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c51" decimals="0" unitRef="usd">634000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c54" decimals="0" unitRef="usd">500000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="c74" decimals="0" unitRef="shares">363670</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare contextRef="c75" decimals="2" unitRef="usdPershares">4.02</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockPricePerShare contextRef="c76" decimals="2" unitRef="usdPershares">5.63</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c74" decimals="0" unitRef="usd">1751000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c74" decimals="0" unitRef="usd">1684000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <bmra:GeographicInformationDisclosureTextBlock contextRef="c0">&lt;p style="FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;; MARGIN:0cm 16.2pt 0pt 0cm"&gt;&lt;b&gt;&lt;span style="FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;"&gt;NOTE 4: &#160;GEOGRAPHIC INFORMATION&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;; MARGIN:0cm 16.2pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;The Company operates as one segment. Geographic information regarding net sales is approximately as follows: &lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="WIDTH:602.1pt; BORDER-COLLAPSE:collapse; margin-left: auto; margin-right: auto;" width="803"&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:294.95pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:15pt; WIDTH:13.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td colspan="5" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:140.35pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Three Months Ended&lt;br/&gt;&lt;/span&gt;&lt;span style="FONT-SIZE:10pt"&gt;November 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td colspan="5" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:140.35pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Six Months Ended&lt;br/&gt;&lt;/span&gt;&lt;span style="FONT-SIZE:10pt"&gt;November 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:294.95pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:15pt; WIDTH:13.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td colspan="2" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:63.55pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td colspan="2" style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:63.55pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td colspan="2" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:63.55pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td colspan="2" style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:63.55pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:294.95pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Revenues from sales to unaffiliated customers:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:13.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:15pt; WIDTH:50.3pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:15pt; WIDTH:50.3pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:15pt; WIDTH:50.3pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:15pt; WIDTH:50.3pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"/&gt; &lt;/tr&gt;&lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:294.95pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:10pt; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Asia&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:13.2pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:50.3pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;3,373,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:50.3pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;550,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:50.3pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;4,048,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:50.3pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;897,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:294.95pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:10pt; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Europe&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:13.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:15pt; WIDTH:50.3pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;796,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:15pt; WIDTH:50.3pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;580,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:15pt; WIDTH:50.3pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;1,267,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:15pt; WIDTH:50.3pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;1,171,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:294.95pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:10pt; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;North America&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:13.2pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:50.3pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;429,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:50.3pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;107,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:50.3pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;534,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:50.3pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;241,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:294.95pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:10pt; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Middle East&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:13.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:15pt; WIDTH:50.3pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;46,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:15pt; WIDTH:50.3pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;96,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:15pt; WIDTH:50.3pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;54,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:15pt; WIDTH:50.3pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;125,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:294.95pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:10pt; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;South America&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:13.2pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:13.25pt; BACKGROUND:#bdd7ee; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:50.3pt; BACKGROUND:#bdd7ee; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;3,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:13.25pt; BACKGROUND:#bdd7ee; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:50.3pt; BACKGROUND:#bdd7ee; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;40,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:13.25pt; BACKGROUND:#bdd7ee; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:50.3pt; BACKGROUND:#bdd7ee; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;6,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:13.25pt; BACKGROUND:#bdd7ee; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:50.3pt; BACKGROUND:#bdd7ee; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;82,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15.75pt"&gt; &lt;td style="HEIGHT:15.75pt; WIDTH:294.95pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:15.75pt; WIDTH:13.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:13.25pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:50.3pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;4,647,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15.75pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:13.25pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:50.3pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;1,373,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15.75pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:13.25pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:50.3pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;5,909,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15.75pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:13.25pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:50.3pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;2,516,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;span style="FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;"&gt;As of November 30, 2021 and May 31, 2021, approximately $574,000 and $803,000 of Biomerica&#x2019;s gross inventory was located in Mexicali, Mexico, respectively. As of November 30, 2021 and May 31, 2021, approximately $22,000 and $25,000 of Biomerica&#x2019;s property and equipment, net of accumulated depreciation and amortization, was located in Mexicali, Mexico, respectively.&lt;/span&gt;&lt;/p&gt;</bmra:GeographicInformationDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments contextRef="c77" decimals="0" unitRef="pure">1</us-gaap:NumberOfReportableSegments>
    <us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="WIDTH:602.1pt; BORDER-COLLAPSE:collapse; margin-left: auto; margin-right: auto;" width="803"&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:294.95pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:15pt; WIDTH:13.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td colspan="5" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:140.35pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Three Months Ended&lt;br/&gt;&lt;/span&gt;&lt;span style="FONT-SIZE:10pt"&gt;November 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td colspan="5" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:140.35pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Six Months Ended&lt;br/&gt;&lt;/span&gt;&lt;span style="FONT-SIZE:10pt"&gt;November 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:294.95pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:15pt; WIDTH:13.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td colspan="2" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:63.55pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td colspan="2" style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:63.55pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td colspan="2" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:63.55pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td colspan="2" style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:63.55pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:294.95pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Revenues from sales to unaffiliated customers:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:13.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:15pt; WIDTH:50.3pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:15pt; WIDTH:50.3pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:15pt; WIDTH:50.3pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:15pt; WIDTH:50.3pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"/&gt; &lt;/tr&gt;&lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:294.95pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:10pt; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Asia&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:13.2pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:50.3pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;3,373,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:50.3pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;550,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:50.3pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;4,048,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:50.3pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;897,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:294.95pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:10pt; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Europe&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:13.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:15pt; WIDTH:50.3pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;796,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:15pt; WIDTH:50.3pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;580,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:15pt; WIDTH:50.3pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;1,267,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:15pt; WIDTH:50.3pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;1,171,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:294.95pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:10pt; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;North America&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:13.2pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:50.3pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;429,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:50.3pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;107,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:50.3pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;534,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:50.3pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;241,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:294.95pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:10pt; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Middle East&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:13.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:15pt; WIDTH:50.3pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;46,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:15pt; WIDTH:50.3pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;96,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:15pt; WIDTH:50.3pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;54,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:15pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:15pt; WIDTH:50.3pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;125,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:294.95pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:10pt; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;South America&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:13.2pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:13.25pt; BACKGROUND:#bdd7ee; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:50.3pt; BACKGROUND:#bdd7ee; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;3,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:13.25pt; BACKGROUND:#bdd7ee; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:50.3pt; BACKGROUND:#bdd7ee; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;40,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:13.25pt; BACKGROUND:#bdd7ee; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:50.3pt; BACKGROUND:#bdd7ee; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;6,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:13.25pt; BACKGROUND:#bdd7ee; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:13.25pt; BACKGROUND:#bdd7ee; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:50.3pt; BACKGROUND:#bdd7ee; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;82,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15.75pt"&gt; &lt;td style="HEIGHT:15.75pt; WIDTH:294.95pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:15.75pt; WIDTH:13.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:13.25pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:50.3pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;4,647,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15.75pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:13.25pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:50.3pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;1,373,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15.75pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:13.25pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:50.3pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;5,909,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15.75pt; WIDTH:13.25pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:13.25pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:50.3pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;2,516,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock>
    <us-gaap:Revenues contextRef="c80" decimals="-3" unitRef="usd">3373000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c81" decimals="-4" unitRef="usd">550000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c82" decimals="-3" unitRef="usd">4048000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c83" decimals="-3" unitRef="usd">897000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c84" decimals="-3" unitRef="usd">796000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c85" decimals="-4" unitRef="usd">580000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c86" decimals="-3" unitRef="usd">1267000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c87" decimals="-3" unitRef="usd">1171000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c88" decimals="-3" unitRef="usd">429000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c89" decimals="-3" unitRef="usd">107000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c90" decimals="-3" unitRef="usd">534000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c91" decimals="-3" unitRef="usd">241000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c92" decimals="-3" unitRef="usd">46000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c93" decimals="-3" unitRef="usd">96000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c94" decimals="-3" unitRef="usd">54000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c95" decimals="-3" unitRef="usd">125000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c96" decimals="-3" unitRef="usd">3000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c97" decimals="-4" unitRef="usd">40000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c98" decimals="-3" unitRef="usd">6000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c99" decimals="-3" unitRef="usd">82000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c6" decimals="-3" unitRef="usd">4647000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c7" decimals="-3" unitRef="usd">1373000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c0" decimals="-3" unitRef="usd">5909000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c8" decimals="-3" unitRef="usd">2516000</us-gaap:Revenues>
    <us-gaap:InventoryGross contextRef="c78" decimals="0" unitRef="usd">574000</us-gaap:InventoryGross>
    <us-gaap:InventoryGross contextRef="c79" decimals="0" unitRef="usd">803000</us-gaap:InventoryGross>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c78" decimals="0" unitRef="usd">22000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c79" decimals="0" unitRef="usd">25000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="c0">&lt;p style="FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;b&gt;&lt;span style="FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;"&gt;NOTE 5:&#160; LEASES&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;On June 18, 2009, the Company entered into an agreement to lease a building in Irvine, California. The lease commenced September 1, 2009 and ended August 31, 2016. &lt;/span&gt;&lt;span style="FONT-SIZE:10pt"&gt;&#160;On November 30, 2015, the Company entered into the First Amendment to Lease wherein it exercised its option to extend its lease until August 31, 2021. The initial base rent for the lease extension was $21,000 per month, increasing to $23,637 through August 31, 2021. On April 9, 2021, the Company exercised its second option to extend its lease for an additional five years through August 2026.&#160; The Company was also granted an additional five years lease extension option through August 2031. The rent is currently $25,970 per month and will increase by 3% each year at the beginning of September. The security deposit of $22,080 remains the same.&lt;span style="COLOR:black"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt"&gt;In November 2016, the Company&#x2019;s subsidiary, Biomerica de Mexico, entered into a ten-year lease for approximately 8,104 square feet at a monthly rent of $2,926. The Company has one 10-year option to renew at the end of the initial lease period. The yearly rate is subject to an annual adjustment for inflation according to the United States Bureau of Labor Statistics Consumer Price Index for All Urban Consumers. The monthly rate is currently $3,262.&#160; Biomerica, Inc. is not a guarantor of such lease.&#160; Biomerica de Mexico also leases a smaller unit on a month-to-month basis for use in one manufacturing process.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt"&gt;In addition, the Company leases a small office in Lindau, Germany on a month-to-month basis, as headquarters for BioEurope GmbH, its Germany subsidiary.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Rent expense in the U.S. for the six months ended November 30, 2021 and 2020 was approximately $155,000 and $152,000, respectively.&#160; Rent expense for the Mexico facility for the six months ended November 30, 2021 and 2020 was approximately $21,000 and $22,000, respectively. &lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;span style="FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;"&gt;For purposes of determining straight-line rent expense, the lease term is calculated from the date the Company first takes possession of the facility, including any periods of free rent and any renewal option periods that the Company is reasonably certain of exercising. The Company&#x2019;s office and equipment leases generally have contractually specified minimum rent and annual rent increases are included in the measurement of the right-of-use asset and related lease liability.&#160; Additionally, under these lease arrangements, the Company may be required to pay directly, or reimburse the lessors, for some maintenance and operating costs. Such amounts are generally variable and therefore not included in the measurement of the right-of-use asset and related lease liability but are instead recognized as variable lease expense in the Consolidated Statements of Operations and Comprehensive Loss when they are incurred.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;; MARGIN:0cm 16.2pt 0pt 0cm"&gt;&lt;span style="FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;"&gt; Supplemental cash flow information related to leases for the six months ended November 30, 2021: &lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;; MARGIN:0cm 16.2pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 550.1pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" width="733"&gt;

&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 462.1pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Operating cash flows from operating leases&#160;&#160;&#160;&#160;&#160; &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 11pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 11pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 66pt; background: #b8cce4; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;166,216&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 462.1pt; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Right-of-use assets obtained in exchange for&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 11pt; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 11pt; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 66pt; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 462.1pt; white-space: nowrap; padding: 0cm 0cm 0cm 10.8pt;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;new operating lease liabilities&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 11pt; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 11pt; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 66pt; text-align: right; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-11"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;-&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 462.1pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Weighted average remaining lease term (in years)&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 11pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 11pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 66pt; background: #b8cce4; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;4.77&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 462.1pt; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Weighted average discount rate&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 11pt; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 11pt; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 66pt; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;6.50%&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;

&lt;/table&gt;&lt;p style="FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;; MARGIN:0cm 16.2pt 0pt 0cm"&gt;&lt;span style="FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;"&gt;The approximate maturity of lease liabilities as of November 30, 2021 are as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;; MARGIN:0cm 16.2pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="WIDTH:554.4pt; BORDER-COLLAPSE:collapse; margin-left: auto; margin-right: auto;" width="739"&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:463.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Less than 1 year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:12.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:12.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:66.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;345,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:463.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;1 to 2 years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:12.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:12.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:66.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;355,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:463.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;2 to 3 years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:12.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:12.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:66.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;366,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:463.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;3 to 4 years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:12.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:12.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:66.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;377,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:463.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;4 to 5 years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:12.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12.2pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:66.8pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;298,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:463.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Total undiscounted lease payments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:12.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12.2pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:66.8pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;1,741,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:463.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Less imputed interest&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:12.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12.2pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:66.8pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;239,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15.75pt"&gt; &lt;td style="HEIGHT:15.75pt; WIDTH:463.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15.75pt; WIDTH:12.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12.2pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:66.8pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;1,502,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;According to the terms of the lease in Irvine, the Company is also responsible for routine repairs of the building and for certain increases in property tax. &lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;The Company also has various insignificant leases for office equipment.&lt;/span&gt;&lt;/p&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <bmra:OperatingLeaseInitiationDate contextRef="c100">2009-09-01</bmra:OperatingLeaseInitiationDate>
    <us-gaap:LeaseExpirationDate1 contextRef="c100">2016-08-31</us-gaap:LeaseExpirationDate1>
    <us-gaap:LeaseExpirationDate1 contextRef="c101">2021-08-31</us-gaap:LeaseExpirationDate1>
    <us-gaap:PaymentsForRent contextRef="c100" decimals="0" unitRef="usd">21000</us-gaap:PaymentsForRent>
    <us-gaap:LeaseAndRentalExpense contextRef="c102" decimals="0" unitRef="usd">23637</us-gaap:LeaseAndRentalExpense>
    <us-gaap:OperatingLeaseExpense contextRef="c103" decimals="0" unitRef="usd">25970</us-gaap:OperatingLeaseExpense>
    <bmra:RentPercentage contextRef="c103" decimals="2" unitRef="pure">0.03</bmra:RentPercentage>
    <us-gaap:SecurityDeposit contextRef="c104" decimals="0" unitRef="usd">22080</us-gaap:SecurityDeposit>
    <us-gaap:OperatingLeasesRentExpenseMinimumRentals contextRef="c105" decimals="0" unitRef="usd">2926</us-gaap:OperatingLeasesRentExpenseMinimumRentals>
    <us-gaap:LeaseAndRentalExpense contextRef="c106" decimals="0" unitRef="usd">3262</us-gaap:LeaseAndRentalExpense>
    <us-gaap:PaymentsForRent contextRef="c0" decimals="0" unitRef="usd">155000</us-gaap:PaymentsForRent>
    <us-gaap:PaymentsForRent contextRef="c8" decimals="0" unitRef="usd">152000</us-gaap:PaymentsForRent>
    <us-gaap:PaymentsForRent contextRef="c77" decimals="0" unitRef="usd">21000</us-gaap:PaymentsForRent>
    <us-gaap:PaymentsForRent contextRef="c107" decimals="0" unitRef="usd">22000</us-gaap:PaymentsForRent>
    <bmra:ScheduleOfCashFlowSupplementalDisclosuresRelatedToLeaseTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="width: 550.1pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" width="733"&gt;

&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 462.1pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Operating cash flows from operating leases&#160;&#160;&#160;&#160;&#160; &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 11pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 11pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 66pt; background: #b8cce4; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;166,216&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 462.1pt; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Right-of-use assets obtained in exchange for&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 11pt; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 11pt; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 66pt; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 462.1pt; white-space: nowrap; padding: 0cm 0cm 0cm 10.8pt;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;new operating lease liabilities&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 11pt; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 11pt; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 66pt; text-align: right; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-11"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;-&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 462.1pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Weighted average remaining lease term (in years)&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 11pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 11pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 66pt; background: #b8cce4; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;4.77&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 462.1pt; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Weighted average discount rate&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 11pt; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 11pt; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 66pt; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;6.50%&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;

&lt;/table&gt;</bmra:ScheduleOfCashFlowSupplementalDisclosuresRelatedToLeaseTableTextBlock>
    <us-gaap:OperatingLeasePayments contextRef="c6" decimals="0" unitRef="usd">166216</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c2">P4Y9M7D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="c2" decimals="4" unitRef="pure">0.065</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="WIDTH:554.4pt; BORDER-COLLAPSE:collapse; margin-left: auto; margin-right: auto;" width="739"&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:463.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Less than 1 year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:12.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:12.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:66.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;345,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:463.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;1 to 2 years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:12.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:12.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:66.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;355,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:463.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;2 to 3 years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:12.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:12.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:66.8pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;366,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:463.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;3 to 4 years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:12.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:12.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:66.8pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;377,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:463.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;4 to 5 years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:12.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12.2pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:66.8pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;298,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:463.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Total undiscounted lease payments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:12.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12.2pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:66.8pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;1,741,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:463.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Less imputed interest&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:12.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12.2pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:66.8pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;239,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15.75pt"&gt; &lt;td style="HEIGHT:15.75pt; WIDTH:463.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15.75pt; WIDTH:12.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12.2pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:66.8pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;1,502,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear contextRef="c2" decimals="INF" unitRef="usd">345000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths contextRef="c2" decimals="INF" unitRef="usd">355000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo contextRef="c2" decimals="INF" unitRef="usd">366000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree contextRef="c2" decimals="INF" unitRef="usd">377000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour contextRef="c2" decimals="INF" unitRef="usd">298000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue contextRef="c2" decimals="INF" unitRef="usd">1741000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount contextRef="c2" decimals="INF" unitRef="usd">239000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability contextRef="c2" decimals="INF" unitRef="usd">1502000</us-gaap:OperatingLeaseLiability>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="c0">&lt;p style="FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;; MARGIN:0cm 16.2pt 0pt 0cm"&gt;&lt;b&gt;&lt;span style="FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;"&gt;NOTE 6: &#160;COMMITMENTS AND CONTINGENCIES&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;; MARGIN:0cm 16.2pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;LITIGATION&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;The Company is, from time to time, involved in legal proceedings, claims and litigation arising in the ordinary course of business. While the amounts claimed may be substantial, the ultimate liability cannot presently be determined because of considerable uncertainties that exist. Therefore, it is possible the outcome of such legal proceedings, claims and litigation could have a material effect on quarterly or annual operating results or cash flows when resolved in a future period. However, based on facts currently available, management believes such matters will not have a material adverse effect on the Company's consolidated financial position, results of operations or cash flows. There were no legal proceedings pending as of November 30, 2021.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;span style="FONT-SIZE:10pt"&gt;On July 2, 2020, we received a notice of investigation and subpoena from the Division of Enforcement of the SEC. The subpoena requested information and documents related to events leading up to our March 17, 2020 announcement that, among other things, we had commenced shipping samples of our COVID-19 IgG/IgM Rapid Test to countries outside of the United States. In addition, on December 15, 2020, the SEC sent a second subpoena related to this same investigation to Zack Irani, the Company&#x2019;s CEO, requesting personal and Company documents and information held by Mr. Irani. The Company and Mr. Irani cooperated fully with the SEC&#x2019;s investigation and provided information as requested.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;span style="FONT-SIZE:10pt"&gt;On December 2, 2021, the Company was notified by the SEC that they had concluded their investigations with no enforcement action recommendations. The notices of investigation conclusion pertain to the Subpoena for information sent to the Company in July 2020, as well as the Subpoena for information sent to the Company&#x2019;s CEO in December 2020. &lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 16.2pt 0pt 0cm"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt"&gt;CONTRACTS AND LICENSING AGREEMENTS &lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 16.2pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt"&gt;On April 15, 2021, the Company signed a general merchandise agreement with Walmart for the Company&#x2019;s EZ Detect product. &lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt"&gt;On June 21, 2021, the Company signed an exclusive distribution and marketing agreement in Canada for its Helicobacter Pylori (H. Pylori) test.&lt;/span&gt;&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:SubsequentEventsTextBlock contextRef="c0">&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt"&gt;NOTE 7:&#160; SUBSEQUENT EVENTS&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;span style="FONT-SIZE:10pt"&gt;Subsequent to November 30, 2021, the Company sold 157,597 shares of its common stock under its S-3 &#x201c;shelf&#x201d; Registration statement.&#160; The average sale price was $4.13 per share. Net proceeds to the Company were approximately $634,000.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;span style="FONT-SIZE:10pt"&gt;At the December 9, 2021 board meeting, the Board of Directors approved the grant of 283,000 options to purchase shares of the Company&#x2019;s common stock to officers, directors and certain employees.&#160; The options are exercisable by outside board members one year from date of grant and for officers and employees one-quarter per year with the first quarter vesting one year from date of grant. The options will be at the exercise price of $4.46 per share and expire ten years from date of grant.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;span style="FONT-SIZE:10pt"&gt;We held our Annual Meeting of Stockholders on December 9, 2021, to consider and vote on the proposals set forth in our proxy statement filed with the Securities and Exchange Commission on September 28, 2021. Please refer to the Form 8-K filed on December 10, 2021 for a description of the results of the meeting.&lt;/span&gt;&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="c108" decimals="0" unitRef="shares">157597</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharePrice contextRef="c109" decimals="2" unitRef="usdPershares">4.13</us-gaap:SharePrice>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c108" decimals="0" unitRef="usd">634000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="c110" decimals="0" unitRef="shares">283000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="c110" decimals="2" unitRef="usdPershares">4.46</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod contextRef="c110">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ErrorCorrectionTextBlock contextRef="c0">&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt"&gt;NOTE 8:&#160; &lt;span style="COLOR:black"&gt;RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0cm 16.2pt 0pt 0cm;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;During September 2021, the Company determined that errors were included in the previously issued financial statements as described below. As a result, we restated our financial statements for the periods ended November 30, 2020.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 16.2pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 16.2pt 0pt 0cm"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;The Company discovered the errors listed below. The restatement corrects these errors.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 16.2pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&lt;span style="FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; BACKGROUND:white; COLOR:black"&gt;Our non-cash stock-based compensation expenses calculation applied forfeiture adjustments to both vested and unvested outstanding options, including those for which the employee had provided the requisite service and vesting had occurred, which resulted in an understatement of stock compensation expense. Additionally, our calculation expensed all issued options at vesting dates versus pro- rata over the period the requisite service was provided. &lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt"&gt;Stock-based compensation expense shown on the statement of operations is a non-cash expense, and impacts accumulated deficit and additional paid-in capital on the balance sheet. However, this does not impact the Company&#x2019;s cash, revenues or other aspects of ongoing operations.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 16.2pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0cm 16.2pt 0pt 0cm;"&gt;&lt;span style="font-size: 10pt;"&gt;The&lt;span style="color: black;"&gt; restatement for the quarter ended November 30, 2020 resulted in no changes in the provision for income taxes. &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 16.2pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 16.2pt 0pt 0cm"&gt;&lt;span style="FONT-SIZE:10pt; BACKGROUND:white; COLOR:black"&gt;The effect of the restatement on the consolidated statement of operations for the three months ended November 30, 2020 is as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 16.2pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="WIDTH:575.6pt; BORDER-COLLAPSE:collapse; margin-left: auto; margin-right: auto;" width="767"&gt; &lt;tr&gt; &lt;td style="WIDTH:363.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td colspan="2" style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:68.2pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;As Previously Reported&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="WIDTH:9.15pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td colspan="2" style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:64.05pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Adjustments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="WIDTH:8.45pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td colspan="2" style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:62.55pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;As Restated&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:12.15pt"&gt; &lt;td style="HEIGHT:12.15pt; WIDTH:363.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Cost of sales &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:12.15pt; WIDTH:11.9pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:12.15pt; WIDTH:56.3pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;1,011,030 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:12.15pt; WIDTH:9.15pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:12.15pt; WIDTH:11.5pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:12.15pt; WIDTH:52.55pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;52,777 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:12.15pt; WIDTH:8.45pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:12.15pt; WIDTH:9.9pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:12.15pt; WIDTH:52.65pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;1,063,807 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:14.75pt"&gt; &lt;td style="HEIGHT:14.75pt; WIDTH:363.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:10.8pt; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Gross Profit &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:14.75pt; WIDTH:11.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:14.75pt; WIDTH:56.3pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;361,496 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:14.75pt; WIDTH:9.15pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:14.75pt; WIDTH:11.5pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:14.75pt; WIDTH:52.55pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;(52,777)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:14.75pt; WIDTH:8.45pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:14.75pt; WIDTH:9.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:14.75pt; WIDTH:52.65pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;308,719 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:13.55pt"&gt; &lt;td style="HEIGHT:13.55pt; WIDTH:363.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:13.55pt; WIDTH:11.9pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:13.55pt; WIDTH:56.3pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:13.55pt; WIDTH:9.15pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:13.55pt; WIDTH:11.5pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:13.55pt; WIDTH:52.55pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:13.55pt; WIDTH:8.45pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:13.55pt; WIDTH:9.9pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:13.55pt; WIDTH:52.65pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"/&gt; &lt;/tr&gt;&lt;tr style="HEIGHT:14.45pt"&gt; &lt;td style="HEIGHT:14.45pt; WIDTH:363.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Operating Expenses: &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:14.45pt; WIDTH:11.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:14.45pt; WIDTH:56.3pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:14.45pt; WIDTH:9.15pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:14.45pt; WIDTH:11.5pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:14.45pt; WIDTH:52.55pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:14.45pt; WIDTH:8.45pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:14.45pt; WIDTH:9.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:14.45pt; WIDTH:52.65pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"/&gt; &lt;/tr&gt;&lt;tr style="HEIGHT:14.65pt"&gt; &lt;td style="HEIGHT:14.65pt; WIDTH:363.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:10.8pt; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Selling, general and administrative &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:14.65pt; WIDTH:11.9pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:14.65pt; WIDTH:56.3pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;1,254,847 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:14.65pt; WIDTH:9.15pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:14.65pt; WIDTH:11.5pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:14.65pt; WIDTH:52.55pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;149,999 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:14.65pt; WIDTH:8.45pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:14.65pt; WIDTH:9.9pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:14.65pt; WIDTH:52.65pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;1,404,846 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:13.5pt"&gt; &lt;td style="HEIGHT:13.5pt; WIDTH:363.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:10.8pt; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Research and development &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:13.5pt; BORDER-RIGHT:0px; WIDTH:11.9pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:13.5pt; BORDER-RIGHT:0px; WIDTH:56.3pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;586,403 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:13.5pt; WIDTH:9.15pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:13.5pt; BORDER-RIGHT:0px; WIDTH:11.5pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:13.5pt; BORDER-RIGHT:0px; WIDTH:52.55pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;30,158 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:13.5pt; WIDTH:8.45pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:13.5pt; BORDER-RIGHT:0px; WIDTH:9.9pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:13.5pt; BORDER-RIGHT:0px; WIDTH:52.65pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;616,561 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:13.35pt"&gt; &lt;td style="HEIGHT:13.35pt; WIDTH:363.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:21.6pt; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Total operating expense &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:13.35pt; BORDER-RIGHT:0px; WIDTH:11.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:13.35pt; BORDER-RIGHT:0px; WIDTH:56.3pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;1,841,250 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:13.35pt; WIDTH:9.15pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:13.35pt; BORDER-RIGHT:0px; WIDTH:11.5pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:13.35pt; BORDER-RIGHT:0px; WIDTH:52.55pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;180,157 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:13.35pt; WIDTH:8.45pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:13.35pt; BORDER-RIGHT:0px; WIDTH:9.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:13.35pt; BORDER-RIGHT:0px; WIDTH:52.65pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;2,021,407 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:11.25pt"&gt; &lt;td style="HEIGHT:11.25pt; WIDTH:363.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:11.25pt; WIDTH:11.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:11.25pt; WIDTH:56.3pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:11.25pt; WIDTH:9.15pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:11.25pt; WIDTH:11.5pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:11.25pt; WIDTH:52.55pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:11.25pt; WIDTH:8.45pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:11.25pt; WIDTH:9.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:11.25pt; WIDTH:52.65pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"/&gt; &lt;/tr&gt;&lt;tr style="HEIGHT:11.25pt"&gt; &lt;td style="HEIGHT:11.25pt; WIDTH:363.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Loss from operations&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:11.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:56.3pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;(1,479,754)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:11.25pt; WIDTH:9.15pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:11.5pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:52.55pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;(232,934)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:11.25pt; WIDTH:8.45pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:9.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:52.65pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;(1,712,688)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:13.5pt"&gt; &lt;td style="HEIGHT:13.5pt; WIDTH:363.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:13.5pt; BORDER-RIGHT:0px; WIDTH:11.9pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:13.5pt; BORDER-RIGHT:0px; WIDTH:56.3pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:13.5pt; WIDTH:9.15pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:13.5pt; BORDER-RIGHT:0px; WIDTH:11.5pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:13.5pt; BORDER-RIGHT:0px; WIDTH:52.55pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:13.5pt; WIDTH:8.45pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:13.5pt; BORDER-RIGHT:0px; WIDTH:9.9pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:13.5pt; BORDER-RIGHT:0px; WIDTH:52.65pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"/&gt; &lt;/tr&gt;&lt;tr style="HEIGHT:11.25pt"&gt; &lt;td style="HEIGHT:11.25pt; WIDTH:363.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&lt;span style="FONT-SIZE:10pt"&gt;Loss before income taxes&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:11.25pt; WIDTH:11.9pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:11.25pt; WIDTH:56.3pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;(1,471,771)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:11.25pt; WIDTH:9.15pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:11.25pt; WIDTH:11.5pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:11.25pt; WIDTH:52.55pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;(232,934)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:11.25pt; WIDTH:8.45pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:11.25pt; WIDTH:9.9pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:11.25pt; WIDTH:52.65pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;(1,704,705)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:13.5pt"&gt; &lt;td style="HEIGHT:13.5pt; WIDTH:363.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:13.5pt; WIDTH:11.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:13.5pt; WIDTH:56.3pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:13.5pt; WIDTH:9.15pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:13.5pt; WIDTH:11.5pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:13.5pt; WIDTH:52.55pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:13.5pt; WIDTH:8.45pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:13.5pt; WIDTH:9.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:13.5pt; WIDTH:52.65pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"/&gt; &lt;/tr&gt;&lt;tr style="HEIGHT:11.25pt"&gt; &lt;td style="HEIGHT:11.25pt; WIDTH:363.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Net loss &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:11.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1.5pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$ &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:56.3pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1.5pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;(1,485,164)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:11.25pt; WIDTH:9.15pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:11.5pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1.5pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:52.55pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1.5pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;(232,934)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:11.25pt; WIDTH:8.45pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:9.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1.5pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$ &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:52.65pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1.5pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;(1,718,098)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:12pt"&gt; &lt;td style="HEIGHT:12pt; WIDTH:363.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:12pt; BORDER-RIGHT:0px; WIDTH:11.9pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:12pt; BORDER-RIGHT:0px; WIDTH:56.3pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:12pt; WIDTH:9.15pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:12pt; BORDER-RIGHT:0px; WIDTH:11.5pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:12pt; BORDER-RIGHT:0px; WIDTH:52.55pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:12pt; WIDTH:8.45pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:12pt; BORDER-RIGHT:0px; WIDTH:9.9pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:12pt; BORDER-RIGHT:0px; WIDTH:52.65pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"/&gt; &lt;/tr&gt;&lt;tr style="HEIGHT:12pt"&gt; &lt;td style="HEIGHT:12pt; WIDTH:363.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Basic net loss per common share &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:12pt; BORDER-RIGHT:0px; WIDTH:11.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$ &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:12pt; BORDER-RIGHT:0px; WIDTH:56.3pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;(0.13)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:12pt; WIDTH:9.15pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:12pt; BORDER-RIGHT:0px; WIDTH:11.5pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$ &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:12pt; BORDER-RIGHT:0px; WIDTH:52.55pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;(0.02)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:12pt; WIDTH:8.45pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:12pt; BORDER-RIGHT:0px; WIDTH:9.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$ &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:12pt; BORDER-RIGHT:0px; WIDTH:52.65pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;(0.15)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:11.25pt"&gt; &lt;td style="HEIGHT:11.25pt; WIDTH:363.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:11.25pt; WIDTH:11.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:11.25pt; WIDTH:56.3pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:11.25pt; WIDTH:9.15pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:11.25pt; WIDTH:11.5pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:11.25pt; WIDTH:52.55pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:11.25pt; WIDTH:8.45pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:11.25pt; WIDTH:9.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:11.25pt; WIDTH:52.65pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"/&gt; &lt;/tr&gt;&lt;tr style="HEIGHT:11.25pt"&gt; &lt;td style="HEIGHT:11.25pt; WIDTH:363.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Diluted net loss per common share &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:11.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$ &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:56.3pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;(0.13)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:11.25pt; WIDTH:9.15pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:11.5pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$ &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:52.55pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;(0.02)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:11.25pt; WIDTH:8.45pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:9.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$ &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:52.65pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;(0.15)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 16.2pt 0pt 0cm"&gt;&lt;span style="FONT-SIZE:10pt; BACKGROUND:white; COLOR:black"&gt;The effect of the restatement on the consolidated statement of operations for the six months ended November 30, 2020 is as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="WIDTH:579.3pt; BORDER-COLLAPSE:collapse; margin-left: auto; margin-right: auto;" width="772"&gt; &lt;tr&gt; &lt;td style="WIDTH:363.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td colspan="2" style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:71.9pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;As Previously Reported&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="WIDTH:9.15pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td colspan="2" style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:64.05pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Adjustments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="WIDTH:8.45pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td colspan="2" style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:62.55pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;As Restated&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:14.75pt"&gt; &lt;td style="HEIGHT:14.75pt; WIDTH:363.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Cost of sales &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:14.75pt; WIDTH:11.9pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:14.75pt; WIDTH:60pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;1,971,960 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:14.75pt; WIDTH:9.15pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:14.75pt; WIDTH:11.5pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:14.75pt; WIDTH:52.55pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;117,564 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:14.75pt; WIDTH:8.45pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:14.75pt; WIDTH:9.9pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:14.75pt; WIDTH:52.65pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;2,089,524 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:14.55pt"&gt; &lt;td style="HEIGHT:14.55pt; WIDTH:363.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:10.8pt; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Gross Profit &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:14.55pt; WIDTH:11.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:14.55pt; WIDTH:60pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;544,372 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:14.55pt; WIDTH:9.15pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:14.55pt; WIDTH:11.5pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:14.55pt; WIDTH:52.55pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;(117,564)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:14.55pt; WIDTH:8.45pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:14.55pt; WIDTH:9.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:14.55pt; WIDTH:52.65pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;426,808 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:14.05pt"&gt; &lt;td style="HEIGHT:14.05pt; WIDTH:363.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:14.05pt; WIDTH:11.9pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:14.05pt; WIDTH:60pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:14.05pt; WIDTH:9.15pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:14.05pt; WIDTH:11.5pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:14.05pt; WIDTH:52.55pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:14.05pt; WIDTH:8.45pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:14.05pt; WIDTH:9.9pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:14.05pt; WIDTH:52.65pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"/&gt; &lt;/tr&gt;&lt;tr style="HEIGHT:17pt"&gt; &lt;td style="HEIGHT:17pt; WIDTH:363.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Operating Expenses: &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:17pt; WIDTH:11.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:17pt; WIDTH:60pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:17pt; WIDTH:9.15pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:17pt; WIDTH:11.5pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:17pt; WIDTH:52.55pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:17pt; WIDTH:8.45pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:17pt; WIDTH:9.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:17pt; WIDTH:52.65pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"/&gt; &lt;/tr&gt;&lt;tr style="HEIGHT:13.65pt"&gt; &lt;td style="HEIGHT:13.65pt; WIDTH:363.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:10.8pt; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Selling, general and administrative &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:13.65pt; WIDTH:11.9pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:13.65pt; WIDTH:60pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;2,419,411 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:13.65pt; WIDTH:9.15pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:13.65pt; WIDTH:11.5pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:13.65pt; WIDTH:52.55pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;291,379 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:13.65pt; WIDTH:8.45pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:13.65pt; WIDTH:9.9pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:13.65pt; WIDTH:52.65pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;2,710,790 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:14.6pt"&gt; &lt;td style="HEIGHT:14.6pt; WIDTH:363.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:10.8pt; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Research and development &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:14.6pt; BORDER-RIGHT:0px; WIDTH:11.9pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:14.6pt; BORDER-RIGHT:0px; WIDTH:60pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;1,261,096 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:14.6pt; WIDTH:9.15pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:14.6pt; BORDER-RIGHT:0px; WIDTH:11.5pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:14.6pt; BORDER-RIGHT:0px; WIDTH:52.55pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;66,970 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:14.6pt; WIDTH:8.45pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:14.6pt; BORDER-RIGHT:0px; WIDTH:9.9pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:14.6pt; BORDER-RIGHT:0px; WIDTH:52.65pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;1,328,066 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:11.25pt"&gt; &lt;td style="HEIGHT:11.25pt; WIDTH:363.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:21.6pt; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Total operating expense &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:11.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:60pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;3,680,507 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:11.25pt; WIDTH:9.15pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:11.5pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:52.55pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;358,349 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:11.25pt; WIDTH:8.45pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:9.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:52.65pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;4,038,856 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:11.25pt"&gt; &lt;td style="HEIGHT:11.25pt; WIDTH:363.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:11.25pt; WIDTH:11.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:11.25pt; WIDTH:60pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:11.25pt; WIDTH:9.15pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:11.25pt; WIDTH:11.5pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:11.25pt; WIDTH:52.55pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:11.25pt; WIDTH:8.45pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:11.25pt; WIDTH:9.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:11.25pt; WIDTH:52.65pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"/&gt; &lt;/tr&gt;&lt;tr style="HEIGHT:11.25pt"&gt; &lt;td style="HEIGHT:11.25pt; WIDTH:363.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Loss from operations&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:11.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:60pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;(3,136,135)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:11.25pt; WIDTH:9.15pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:11.5pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:52.55pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;(475,913)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:11.25pt; WIDTH:8.45pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:9.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:52.65pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;(3,612,048)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:13.5pt"&gt; &lt;td style="HEIGHT:13.5pt; WIDTH:363.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:13.5pt; BORDER-RIGHT:0px; WIDTH:11.9pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:13.5pt; BORDER-RIGHT:0px; WIDTH:60pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:13.5pt; WIDTH:9.15pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:13.5pt; BORDER-RIGHT:0px; WIDTH:11.5pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:13.5pt; BORDER-RIGHT:0px; WIDTH:52.55pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:13.5pt; WIDTH:8.45pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:13.5pt; BORDER-RIGHT:0px; WIDTH:9.9pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:13.5pt; BORDER-RIGHT:0px; WIDTH:52.65pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"/&gt; &lt;/tr&gt;&lt;tr style="HEIGHT:11.25pt"&gt; &lt;td style="HEIGHT:11.25pt; WIDTH:363.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&lt;span style="FONT-SIZE:10pt"&gt;Loss before income taxes&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:11.25pt; WIDTH:11.9pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:11.25pt; WIDTH:60pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;(3,120,061)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:11.25pt; WIDTH:9.15pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:11.25pt; WIDTH:11.5pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:11.25pt; WIDTH:52.55pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;(475,913)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:11.25pt; WIDTH:8.45pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:11.25pt; WIDTH:9.9pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:11.25pt; WIDTH:52.65pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;(3,595,974)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:13.5pt"&gt; &lt;td style="HEIGHT:13.5pt; WIDTH:363.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:13.5pt; WIDTH:11.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:13.5pt; WIDTH:60pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:13.5pt; WIDTH:9.15pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:13.5pt; WIDTH:11.5pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:13.5pt; WIDTH:52.55pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:13.5pt; WIDTH:8.45pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:13.5pt; WIDTH:9.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:13.5pt; WIDTH:52.65pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"/&gt; &lt;/tr&gt;&lt;tr style="HEIGHT:11.25pt"&gt; &lt;td style="HEIGHT:11.25pt; WIDTH:363.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Net loss &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:11.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$ &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:60pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;(3,134,579)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:11.25pt; WIDTH:9.15pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:11.5pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:52.55pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;(475,913)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:11.25pt; WIDTH:8.45pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:9.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$ &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:52.65pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;(3,610,492)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:12pt"&gt; &lt;td style="HEIGHT:12pt; WIDTH:363.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:12pt; WIDTH:11.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:12pt; WIDTH:60pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:12pt; WIDTH:9.15pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:12pt; WIDTH:11.5pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:12pt; WIDTH:52.55pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:12pt; WIDTH:8.45pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:12pt; WIDTH:9.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:12pt; WIDTH:52.65pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:12pt"&gt; &lt;td style="HEIGHT:12pt; WIDTH:363.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Basic net loss per common share &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:12pt; BORDER-RIGHT:0px; WIDTH:11.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$ &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:12pt; BORDER-RIGHT:0px; WIDTH:60pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;(0.27)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:12pt; WIDTH:9.15pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:12pt; BORDER-RIGHT:0px; WIDTH:11.5pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$ &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:12pt; BORDER-RIGHT:0px; WIDTH:52.55pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;(0.04)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:12pt; WIDTH:8.45pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:12pt; BORDER-RIGHT:0px; WIDTH:9.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$ &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:12pt; BORDER-RIGHT:0px; WIDTH:52.65pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;(0.31)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:11.25pt"&gt; &lt;td style="HEIGHT:11.25pt; WIDTH:363.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:11.25pt; WIDTH:11.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:11.25pt; WIDTH:60pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:11.25pt; WIDTH:9.15pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:11.25pt; WIDTH:11.5pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:11.25pt; WIDTH:52.55pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:11.25pt; WIDTH:8.45pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:11.25pt; WIDTH:9.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:11.25pt; WIDTH:52.65pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"/&gt; &lt;/tr&gt;&lt;tr style="HEIGHT:11.25pt"&gt; &lt;td style="HEIGHT:11.25pt; WIDTH:363.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Diluted net loss per common share &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:11.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$ &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:60pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;(0.27)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:11.25pt; WIDTH:9.15pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:11.5pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$ &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:52.55pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;(0.04)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:11.25pt; WIDTH:8.45pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:9.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$ &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:52.65pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;(0.31)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:11.25pt"&gt; &lt;td style="HEIGHT:11.25pt; WIDTH:363.2pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:11.25pt; WIDTH:11.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:11.25pt; WIDTH:60pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:11.25pt; WIDTH:9.15pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:11.25pt; WIDTH:11.5pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:11.25pt; WIDTH:52.55pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;&lt;td style="HEIGHT:11.25pt; WIDTH:8.45pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:11.25pt; WIDTH:9.9pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:11.25pt; WIDTH:52.65pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"/&gt; &lt;/tr&gt;&lt;tr style="HEIGHT:11.25pt"&gt; &lt;td style="HEIGHT:11.25pt; WIDTH:363.2pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Comprehensive loss &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:11.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$ &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:60pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;(3,137,829)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:11.25pt; WIDTH:9.15pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:11.5pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$ &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:52.55pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;(475,913)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:11.25pt; WIDTH:8.45pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:9.9pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:11.25pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$ &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:52.65pt; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0cm 0cm 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;(3,613,742)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0cm 0cm 0pt"&gt;&lt;span style="FONT-SIZE:10pt; BACKGROUND:white; COLOR:black"&gt;The effect of the restatement on the consolidated statement of cash flows for the period ended November 30, 2020 is as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0cm 2.7pt 0pt 0cm"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 573.3pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" width="764"&gt;

&lt;tr style="height: 22.65pt;"&gt;
&lt;td style="height: 22.65pt; width: 372.5pt; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td colspan="2" style="border-top: 0px; height: 22.65pt; border-right: 0px; width: 66pt; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0cm 0cm 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;As Previously Reported&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 22.65pt; width: 9.7pt; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td colspan="2" style="border-top: 0px; height: 22.65pt; border-right: 0px; width: 56.75pt; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0cm 0cm 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Adjustments&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 22.65pt; width: 9.75pt; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td colspan="2" style="border-top: 0px; height: 22.65pt; border-right: 0px; width: 58.6pt; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0cm 0cm 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;As Restated&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 372.5pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&lt;strong&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Cash flows from operating activities:&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 9.7pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 56.3pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 9.7pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 10.25pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 46.5pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 9.75pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 9.75pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 48.85pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 372.5pt; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 9.7pt; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 56.3pt; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 9.7pt; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 10.25pt; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 46.5pt; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 9.75pt; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 9.75pt; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 48.85pt; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 372.5pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Net loss&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 9.7pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 56.3pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;(3,134,579)&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 9.7pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 10.25pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 46.5pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;(475,913)&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 9.75pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 9.75pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 48.85pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;(3,610,492)&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 372.5pt; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&lt;strong&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Adjustments to reconcile net loss to net cash used in operating activities: &lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 9.7pt; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 56.3pt; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 9.7pt; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 10.25pt; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 46.5pt; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 9.75pt; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 9.75pt; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 48.85pt; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 372.5pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Stock option expense&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 9.7pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 56.3pt; background: #b8cce4; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;24,227 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 9.7pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 10.25pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 46.5pt; background: #b8cce4; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;475,913 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 9.75pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 9.75pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 48.85pt; background: #b8cce4; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;500,140 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 372.5pt; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Net cash used in operating activities &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 9.7pt; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 56.3pt; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;(2,880,218)&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 9.7pt; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 10.25pt; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 46.5pt; text-align: right; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-12"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;-&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;&lt;/td&gt;
&lt;td style="height: 15pt; width: 9.75pt; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 9.75pt; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 48.85pt; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;(2,880,218)&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 372.5pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 9.7pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 56.3pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 9.7pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 10.25pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 46.5pt; background: #b8cce4; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 9.75pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 9.75pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 48.85pt; background: #b8cce4; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 372.5pt; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Cash and cash equivalents at end of period&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 9.7pt; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 56.3pt; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;5,683,787 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 9.7pt; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 10.25pt; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 46.5pt; text-align: right; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-13"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;-&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;&lt;/td&gt;
&lt;td style="height: 15pt; width: 9.75pt; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 9.75pt; white-space: nowrap; padding: 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0cm 0cm 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 48.85pt; white-space: nowrap; padding: 0cm 2.9pt 0cm 0cm;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0cm 0cm 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;5,683,787 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;

&lt;/table&gt;</us-gaap:ErrorCorrectionTextBlock>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c111" decimals="INF" unitRef="usd">1011030</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c112" decimals="INF" unitRef="usd">52777</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c113" decimals="INF" unitRef="usd">1063807</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit contextRef="c111" decimals="INF" unitRef="usd">361496</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c112" decimals="INF" unitRef="usd">-52777</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c113" decimals="INF" unitRef="usd">308719</us-gaap:GrossProfit>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c111" decimals="INF" unitRef="usd">1254847</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c112" decimals="INF" unitRef="usd">149999</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c113" decimals="INF" unitRef="usd">1404846</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c111" decimals="INF" unitRef="usd">586403</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c112" decimals="INF" unitRef="usd">30158</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c113" decimals="INF" unitRef="usd">616561</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:OperatingExpenses contextRef="c111" decimals="INF" unitRef="usd">1841250</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c112" decimals="INF" unitRef="usd">180157</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c113" decimals="INF" unitRef="usd">2021407</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="c111" decimals="INF" unitRef="usd">-1479754</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c112" decimals="INF" unitRef="usd">-232934</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c113" decimals="INF" unitRef="usd">-1712688</us-gaap:OperatingIncomeLoss>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c111" decimals="INF" unitRef="usd">-1471771</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c112" decimals="INF" unitRef="usd">-232934</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c113" decimals="INF" unitRef="usd">-1704705</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:NetIncomeLoss contextRef="c111" decimals="INF" unitRef="usd">-1485164</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c112" decimals="INF" unitRef="usd">-232934</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c113" decimals="INF" unitRef="usd">-1718098</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic contextRef="c111" decimals="INF" unitRef="usdPershares">-0.13</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="c112" decimals="INF" unitRef="usdPershares">-0.02</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="c113" decimals="INF" unitRef="usdPershares">-0.15</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted contextRef="c111" decimals="INF" unitRef="usdPershares">-0.13</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted contextRef="c112" decimals="INF" unitRef="usdPershares">-0.02</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted contextRef="c113" decimals="INF" unitRef="usdPershares">-0.15</us-gaap:EarningsPerShareDiluted>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c114" decimals="INF" unitRef="usd">1971960</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c115" decimals="INF" unitRef="usd">117564</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c116" decimals="INF" unitRef="usd">2089524</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit contextRef="c114" decimals="INF" unitRef="usd">544372</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c115" decimals="INF" unitRef="usd">-117564</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c116" decimals="INF" unitRef="usd">426808</us-gaap:GrossProfit>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c114" decimals="INF" unitRef="usd">2419411</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c115" decimals="INF" unitRef="usd">291379</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c116" decimals="INF" unitRef="usd">2710790</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c114" decimals="INF" unitRef="usd">1261096</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c115" decimals="INF" unitRef="usd">66970</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c116" decimals="INF" unitRef="usd">1328066</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:OperatingExpenses contextRef="c114" decimals="INF" unitRef="usd">3680507</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c115" decimals="INF" unitRef="usd">358349</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c116" decimals="INF" unitRef="usd">4038856</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="c114" decimals="INF" unitRef="usd">-3136135</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c115" decimals="INF" unitRef="usd">-475913</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c116" decimals="INF" unitRef="usd">-3612048</us-gaap:OperatingIncomeLoss>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c114" decimals="INF" unitRef="usd">-3120061</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c115" decimals="INF" unitRef="usd">-475913</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c116" decimals="INF" unitRef="usd">-3595974</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:NetIncomeLoss contextRef="c114" decimals="INF" unitRef="usd">-3134579</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c115" decimals="INF" unitRef="usd">-475913</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c116" decimals="INF" unitRef="usd">-3610492</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic contextRef="c114" decimals="INF" unitRef="usdPershares">-0.27</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="c115" decimals="INF" unitRef="usdPershares">-0.04</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="c116" decimals="INF" unitRef="usdPershares">-0.31</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted contextRef="c114" decimals="INF" unitRef="usdPershares">-0.27</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted contextRef="c115" decimals="INF" unitRef="usdPershares">-0.04</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted contextRef="c116" decimals="INF" unitRef="usdPershares">-0.31</us-gaap:EarningsPerShareDiluted>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c114" decimals="INF" unitRef="usd">-3137829</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c115" decimals="INF" unitRef="usd">-475913</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c116" decimals="INF" unitRef="usd">-3613742</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:NetIncomeLoss contextRef="c117" decimals="INF" unitRef="usd">-3134579</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c118" decimals="INF" unitRef="usd">-475913</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c119" decimals="INF" unitRef="usd">-3610492</us-gaap:NetIncomeLoss>
    <us-gaap:StockOptionPlanExpense contextRef="c117" decimals="INF" unitRef="usd">24227</us-gaap:StockOptionPlanExpense>
    <us-gaap:StockOptionPlanExpense contextRef="c118" decimals="INF" unitRef="usd">475913</us-gaap:StockOptionPlanExpense>
    <us-gaap:StockOptionPlanExpense contextRef="c119" decimals="INF" unitRef="usd">500140</us-gaap:StockOptionPlanExpense>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c117" decimals="INF" unitRef="usd">-2880218</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c119" decimals="INF" unitRef="usd">-2880218</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c120" decimals="INF" unitRef="usd">5683787</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c122" decimals="INF" unitRef="usd">5683787</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <dei:EntityCurrentReportingStatus contextRef="c0" id="hidden-fact-0">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="c0" id="hidden-fact-1">Yes</dei:EntityInteractiveDataCurrent>
    <us-gaap:ContractWithCustomerLiability
      contextRef="c3"
      id="hidden-fact-2"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="c2"
      id="hidden-fact-3"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="c3"
      id="hidden-fact-4"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="c4"
      id="hidden-fact-5"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="c5"
      id="hidden-fact-6"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="c2"
      id="hidden-fact-7"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="c3"
      id="hidden-fact-8"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="c8"
      id="hidden-fact-9"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="c8"
      id="hidden-fact-10"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="c6"
      id="hidden-fact-11"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="c118"
      id="hidden-fact-12"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="c121"
      id="hidden-fact-13"
      unitRef="usd"
      xsi:nil="true"/>
    <dei:AmendmentFlag contextRef="c0">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="c0">--05-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalPeriodFocus contextRef="c0">Q2</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentFiscalYearFocus contextRef="c0">2022</dei:DocumentFiscalYearFocus>
    <dei:EntityCentralIndexKey contextRef="c0">0000073290</dei:EntityCentralIndexKey>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>42
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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M CA6@A^F@@,,.@.,2)T.&"[AWZ2K*U8R0R4.!X&-V6:48I584.>" )?OY]B
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M%HMO:W"W0@S'8H\%\5'(/X _P,MZ#NY^^S#2A62A<NE^/N-C-J-Y8<8E/3X
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M)T.J?!6\QDV[."Z9+P3?XUYQE7NN<I#KQ)26F,=^OCMS>3#NGT(%DGG,(8P
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M^029@+G8)K9GZ',P)EQ/XRBLD8=?Y^%WYG$-^V$L<UOSSGQ+X5R">4 U:2<
M&^*"6EQP\KB]EB\P%G#[6 C,<<N):XQ;$V8;MX'9WO"3= C5QZT)['.& WW<
M6F#4]0AV/*;5TD020KCO'<SE1BT)WN]&^$T#]VAE*UYMXGJ6B6M!=HU<<K#7
MD3<9+['J)68K^!Q.63OD"M=0Z_O,];AV*%,+LL^]0#??F0T'3LE=QK0^O+!
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MLW2)V+=*-IC34[0JI8D4'Q,J8HJY")>OT/7,UN8'UT::L$O&K\GLGVHL88U
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M/AM!,H$L9^3[U'9$2-O0F ,[^"^.G/ !22X%\IQB(\OA?+9^[H6B, V>4YI
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MEF"WRU+_V+4WSLQ,.PK\4O6CD_X96P]\/KT8\N??BO(S2$W@*7\E$3X_%B]
MQN98EK^E:(E]AY>)BU-9<]87<_3 +O*E&D27%P.[Q3 :V.>G(AXNOMK7I?0L
M*%-A0*<A1U%!0VOD@3HTVDE<EEM0@94V;-ZESU2:37GA+488H#!F>\!+.+J_
MRDC1(4PG\?#/6/T6=NFHLM_2GU]>MI:^'UE*[]KZN\6.%[-0H^< SRZ$&R@B
MNVX)TG"7@*3%4TZY!A10%4VIKN]^G=P<]2_98LR+E*A!M+4QKL_8Q/0X&!23
M+"Q<__C]]50]&I0?\+P-/0GD$E4L?(,(XNY^/'WX!T<.2*WN/Y+K$*]QC[&2
MTO:<$1_9;@ BH)H/$4MSH:?&0>E34F9;LG&1^>^0OS6'U^+FI%'-)5%H?H]$
ME=RFC^29V^SIK.THM34%:5M($OAMGZ:G?EMIUJ>#>%.8#$;6G#-!\N [GU!D
MLD(%?QS9CH%PBBTADZ[3QR&?G1AKB$J8Q;(FD1?OQQJUYE3"]IEU,-7 C3:N
M-M&#MJTD-7)7Y@!ZEDPR",*IJQP7A.#T10X0$(7(0"ZEIVY"W!CQ7>38Y$/=
M.8T =JWN-I5&\)F9Q[8!ZTCARN(4@RRYC ^L3[%W_UAM=8P81:(%+G749<R3
M"AC#LFZ_ISX@"ULA77DF#Q;/$"_D+=JWAO=@N?"M9YE$L$$C@A?W T\O?(LL
MUGW9&8U]\K//6 S.6DMA/R\<!EQG^NY2#R/4!7YZT@(_'7: _ZDJ4M=N36X?
M1K?O)JA4C&:S\8,-$2=Y#:;"9-OY(C^I4\8(4LK/:+?;2(0G4-!F1UA49,5R
M:[^23DM<MR-%S-A._<?[Y6# ;X;T,B[)OE]3N.?BR(A0O%;#T^, O8H[(/W^
M&_6N*%).,+'-'109CEL\1ZF7!(W[X#O'XI\Y)34YMT@,CYL$0@^,43]MQ7'>
MB/FHI0_!99"8K4(N.>U"S!L9,$D>2^(.K5]P[R*OT?:F?/)12NNLM#Q_@3C+
ME&15D%US5S9'K,N!AG5_(M5K$-?%DX9-W7.& <.YYL#$8_YU;6SU+-"GB \/
M?_X%_3O5OQ#5YD,&_3:Q3.TPAY,)9PI<KY=+CFDH*N@6N=4BIN$3(CSDV4/U
MA.O<48\@'?L7-&^?XO4#Q>L/_EV*%R9AX!C;?;&N"?C@VAYBM9!C/^,PUZ4D
M+P,+GE;:9],=8Q9:Q+;!9K-/YKGA\C3\+ "Q&<7$Z-QCPP,:TF5I9]::'$.)
M3I4;GIAK9R"Z1VPX]T62E7'?]E';4[OI29]AAN<@@,SJ?!OH4X^H'*J79#IB
ME..JK8$^JY,HRQ)BGG3CD1G/'CYR\?BM:R$>U<61+WSN3.T@O).M*@G5S2,+
MR=%*9VG;$M[IP+B351T6+0A_EWYS#W_[#?#:I:=LKC!^P/GX'+<! )' [43A
MM%VNP=\XI?]CMNW/VAR?"5A$D<=*,ZF54Q3E)YT:J]3;4ZG$;B7QM/C:KJT;
M"(P1>J[1\,=4\GRW3HQ9L:(,)P#"V;^V"6?'^]JI5<8,Q49*/5#%;Z-S,MG:
M*P$=ED2GW+ZB)]43BM)'B+Z[Z4O+**F3"D4D*W3<*C5/D.>=),5O XFL0_:"
M[#&/L7-_L=([QM/-7/N)41(%LK6&S)'.E_%2DO+V$:++6J<RZAJ6"U+]*&WL
MEGXRY-@.XDDQHM,KEX$97_!-8L[CN[-[0;9<28< ;>RNX-O</7-][YI)C/JJ
M$-ES9.T:Y[8_'DQPVGD;'ML,1%/OBCK1B+)FI$-6JCH:UL6+-M]U'VU7S#)E
M'SLB%_>["CPG=YFQAILS ^M)D<])..-]17M4-^ZQ\U#4T?]N'BZ9E2W92+8@
M(XSL-KHE$S=&0.D#CW\[AB(=:$'"-OCB:D_-WH^FXZ.KT6Q\0QGC1Q20V[L,
M?IB+:QURVF5C4G$@BS"AZ9209)3^6V&=.N]?1&J&J8<CT07L1^&W*U.Q$OB2
MO(U/VOE04QZ)#,C#+0=:EY($ 'ULSXDIXL42"8Q-/&3J0K8DPY056PWA3VGK
M1-I/KGXK+%K2L]R3EJ&- R.J&(;A03,>,R];@T!"ULC&/X0SZ-4KD=C ]* #
M$6-H2H;4XR>B8W<6WI:VW,0_8Q9$?%=9G'P^FB6K@CL4 H;L2L+6HTAU)KHF
MGCH8#)>JZD9\_F.!G@PBDZC]DAMU*,<$W^U,T0>_@"G!_0)3?3Y:($3C(554
M-K!^W]Q,K;B4[G<+?(%MX?AA!]F,VZ Q6[>U&[.3.$5J%-T3&1OL>R_TQ(5+
M*!6\R;)E;^"#6GI\%^\#;OE<.Z2+ V+%0*APB*:=JF;H%_TRGO/0I4%E+]T!
MYK:S6WE)-I@5*[GET@J/'3.K*.RBZ-!X-7,#9J(P4+.FMKNVF]C2E*6BMT^-
M/RVL'N^$U9NL<?94YLP]D Z[=R<-N'L+7LG@'Z*.D@)6*6HCONV0M)6Z9X0$
MX$^]&:U#2[2AN&1K.+IKN+*>VWE/URCA\2NO;L[8VW(U??_0J1';"YO*1@M5
MR&Q;$8<UJCT[H#<8HZODXP:1+68,B:&9O392-+5OQWY_8O*CNA,3,!/+-;;;
MJ'NBL%:_.=D?6:[=!;N$E51%&=%%/QJ>G:'4W#N]5.^L( TD;SKI#4X]]%3]
M,.A'I\?'KU2_=W:BKOD@F12O[/%HR4ET?DI+AKW!26?CY^D5[7YZ&?7[LOO9
M0-VT\<FWB1!YVL-2V.14"8:!2>^H,!=^/%,@!C"B\,)A&>QEOS?@J>67P*IG
M"_.=05A_:\3&>H#[<G@2G5Q0:O(GCQ$"6G;IO^^$G0/Q'*'73K^&3X73OP0'
M>VHZ_G5\^VF,V9:[=[>39\$!;+2?[_!71#A@\4,",GS17D>SBZ03L'4IA[U<
MQG1T)28[8KG3'PI4, A(H<[<E&=5X;TE=GY[=]5VZS>%P32E#[$Y(&)PN-NX
M<-U/--D8Y651P.4@P$KL10 [*R,@&![A4F<8/$!<=F 0K]YNG,N"66"=+34J
M_A4763:U\U6<KLG0DALQQTPM&FD\""DNM)0QA-;WM6,^^<X\B=V&"V.N)K\[
MM'68>W*917#SC?E68%PQP);\DY6A[ ,V3_H\;G /+I-BGAWJN#YL:JM3,>;@
M?>TCN')T**GOUDZ?33W*M4/46MKIT19AKAM26KJD ^6=>5(9JNWZ(S'N.P>0
MFSQ^U#R+YT%^1+$H41"M8!N+AY-<X713)],M*FZ(V-M, 63,QW,W,O)I'_Q)
M7$*2@WG4]N>*PK["W>D@N[:.$]W4MK7MJQ9W#]=!_F@;)#;VS;@!F);-$F:C
M=)<_C^R<MP[$)+B#*>TY?[R>NN>.NB$-LP&2'=K:LR\,EE_=+3 RI>QL^-.*
MS(3TCVJ])++\TQ=%?*KF)XBV&QU<?ZK\1H@0>^3T9/(KR([;+!@#&KF;AHY;
M:9 Y+AG5.<CC "*H<&.J>+DL]=(7Z*S5^W$G7D C7\TI$/G,*7/G[FUX."G$
M,KW%&G7R<T=20$?,$[Y6H.M-9N1K#O\J'A=ETO:39^A_58Z5:#D/3R]=A]LV
M*_#MF>][#T_[_.DZ5)BS$RFO7EP.;>?[=.!ZX"?G?!E(W9&?.J+3'4GAL52G
M0_%S@_.!;87+PR>G4A*^=HSJ%C#ZMI1[*F#[I_+G8#CL--)/HK.3<]^K'YZ[
MLYQ&E\?NA(/HU)YKIG%AB +*DT[;D\?$VY*&="/XAJTP$\*4Z-S>1ZJ0C4_N
M[W%1'GW8]_2_#_CC[=A>F&^;X-R3J;KW&OV<Q0+7,>:&PRM<"_,*:G*.1.PP
MQW0\&X^FUS)4>T->_L,=MWUY7(!MBBTE^1M@;1/6S5MU^ZX=P^Y7[ RP]X.V
MNAM?8/G^ZJ;!)?-_O;!/L>-%V-L?6FE+_TSP]976VO7=Q[%Z&/U]AVTKGHVS
M/=>XO2T=.&OZ SZ?HPQ;N:GC+Z[P_WQ@\"PZ.1L$_4&23MNU^.Z!B"[R;^^F
MX\F[6W7]:3H=WU[_0SU,1[>S#VU-*'B;!(_@2$E27B7A;G:$=<LVEW3OH]CH
MJNA]!9:\WF+[=6"<J:5D+^/2#33ERJS;B2(>4&(7'KZR0D(XOFKH0>'%&3TN
M5[7EO?WO5O!QB4?<U0YXD\SVI &8 CJNM,NK!)ZGCT%\(6&%Q"^=-RRTZO8,
MO(O:=[;IIJ%^-JS)I%?G&R;L, Z]0((G SA-%?V.*<;A]W3HUAG:$7T_""%U
M??Q<ZA5>#_"HN4C)*)3:-E-W,4#\:I;N)0[)5JY ^S=%[-Z4[%X&:5\$PL4,
M/PG2[?_QY:[OUV6RBI-W[Q^.[MX>?9JYUC@;R _C$7WQ83*ZFGS8O25\J#Z*
MMO4%^3:9=JB>E31YK$&NSOGLAC"MI+&L_25EU[.3=TSM'=][_C((7.Q\]H*(
M;S0L&(J[R4<*Q571C,OMTH%VQ)5704B!YMGK*8S>W:=[\8U?F"*/^'E74J7*
M)]'!N$9(9D<4B3;X#3Y63S9HU%'BD>LP/G1OPK#"@0XG0]@SGYW9LA6WNWG>
MH5H597W$)W1/?0PX$[[ Q-94F8L8U'0E3E<L:.=GZ%=<('*O;JAV+O2WKS8H
M,LFK, 2$UUG<M<F\W,;HWO&++3DY'+8]N%9O F;9>)AAN,L>[0FZUP&"UTJX
MDPCE+ G2@C.MYY3HUAP\!JD?J1$P;G@*G6TWP1/:I,,30J[F9QM8ONK8'K3'
MTRP?[F8S=3^>2I<#UU%X3IELS :CTBLV,I4K7]JQ1[GC;ZO-?H_=FG!XW\46
M56S9:$]5SIGC&Y/Q/CLH4"*?:=M/4YL"K#&<'V9-VPJ3-YBP_Q(EZ6YK</$;
ME'1);*>M$+7UQ78.G02%SE+S9$%[D3EPC+4KA HL-[H%WLF5C-;)8I[P2!#&
M&QC"O4,A:46R2P'WKAH.A@Y=Z.-P#IW^MO;']\>BX>5E='XVW UE<!EKYR5>
MT[M;^GP]EM;_5"/X)BO]2>C7<ONM[S#O[6)=%6C"\ "?L_;=YX.KU%@U=EZ:
M]'Q-*W%,]X:IV?C:OV J-2FHQ1=XW?B1+60PZ,Y[IR*9!XC;*6H;81RX6>WL
M,<%V,QO?>AM43^U[E]OKX%5YE%8L^86 E;S[1-Z:Y[_U[QP<R:OVVN7RPL*/
M<;E$3S/3"WKTN'=^^D)\D/NC+C;\XKUY45,.PQ\QUZU++*#?%P6IB_T#&_@W
M,?[R?U!+ P04    " "M@2Q4@9>% 5X#   Q!P  &    'AL+W=O<FMS:&5E
M=',O<VAE970Y+GAM;)5586_;-A#]*P<MV#K LV3)=HS,-F G+M)B2;,XW3 ,
M_4!+)XD(1:HD%=O_?D=*4;TAR= O-H^\>^_=G7B<[Y5^-"6BA4,EI%D$I;7U
M11B:M,2*F:&J4=))KG3%+)FZ"$VMD64^J!)A'$73L&)<!LNYW[O3R[EJK. 2
M[S28IJJ8/JY1J/TB& 7/&_>\**W;")?SFA6X1?NYOM-DA3U*QBN4ABL)&O-%
ML!I=K,?.WSO\P7%O3M;@,MDI]>B,#]DBB)P@%)A:A\#H[PDO40@'1#*^=IA!
M3^D"3]?/Z.]][I3+CAF\5.)/GMER$<P"R#!GC;#W:G^-73X3AY<J8?PO[%O?
M211 VABKJBZ8%%1<MO_LT-7A)&#V6D#<!<1>=TOD55XQRY9SK?:@G3>AN85/
MU4>3."Y=4[96TRFG.+O<7J_N-]>??KO:W&]_@LWOGS\\_#4/+2&[\S#M4-8M
M2OP*RA1NE+2E@8W,,/MW?$B*>EGQLZQU_";@K7H:0A(-(([BT1MX29]FXO&2
MU]*T*GTLE<A0&TKS:\/M$6Z51?A[M3-6T\?QY0V:<4\S]C3C[Z:YXB85RC2:
M&!_P8&$MR/7+2Z5^F^+VT\,&D@LX;=R//\SBT?FO7?O JP!5^\\>#W1_#4+6
M:"X+L"6"X0>HVGZAZQ<I?,)JA[JO.#"9N44$>V: U;56!TY7 ,41SJ;)>!!%
MD?<YFT21-]Z1GT9CR2<;@$%LTYZ!58Z3!+SGDLF4,T'ZR(LNMC4_#UQ0C?YJ
MBN,0KKY'Y<#[7:JJ9O((ALH.R3093,\C,"4C8% Y<&L@514A@?%U819JS5,Z
MU4P6CBW7JH*S\3"*G=JSR7":0$.4V@=_9+*A<05QW-6&BN$E-X9&65T+GXJO
MAI.S>KB!5:&QW7W75R+^GTK ON1IZ<I!\X2RY1(*(C*.+D7,?#+_Z<1H<#X9
M];V0:+\YMV1]<5Z*G<ZZ/N:64J4*-]0&*H>K%C=NZAJ@J0_(2)=A CV+P(*)
M 4W35#72^[M=160:<G151>$^@F<%.1?.B00XRTU2V/Z2#%^Z;.')&*M0%WY8
MN^X143O1^MW^/5BU8_";>_N8W#!-K36D-J?0:'@^"4"W [HUK*K]4-PI2R/6
M+TMZTU [!SK/%36M,QQ!_THN_P%02P,$%     @ K8$L5*J5Z>." P  ! @
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M8PMLTP$3(PS]O.$0^K_$X,_L'$4'.3>/VCI%/U_VFL=?"+T=>M^[%_5W;J+
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M4+L-M)XK*D0S< [:SX[9?U!+ P04    " "M@2Q4?7^%N 4'  !1$0  &0
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MIU&>D-U.< \^933U<W+=A8**7/2;QR%VZ!K'P8*2!6_PM.[I@WU9V//*7G6
M$\01S:*4^%%.\SS'2N39E<1ZS)E" UN]$FRHY<JE+LX2"(4V(7Z<D<1/:)SX
MY%XZ$FX\&3K"AS6+XQ$_LQHI":@],B)$]\D&-U=R.2[&+IZE.4WC:(_L!F%
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M&XHU=CFE6?"VRR%-H^"_[@UWZLXMQ;^[$?Y@7TS>[HO)J"\FH[Z8G(_P1E0
MA=P;)\YS4'HR%&ZR,QD5SLZ&+'1/AL*-X>S]#Q=.B1MOS5_*@54[=O&VNCMB
MWP9W]YK^[C00>Q)$- C220\_B3ULWY'G'/U+DY/=@&9HB\#/]B;[KV8N';;O
MNML/+ER/V##<+=_8"M@2=?5 P#&:"U7/4HSWQW/RUMO6;/2:N^1JX5[F<:.1
M;6.Z-][-ZN;_@M/N-?E%O/NSX3-3"X%FK?D<JMY!&D^)ZE[@NXF1*_?2C'LW
M7L'=L.(,EULK@.=S*<TPL0";?U%._@-02P,$%     @ K8$L5&H-^A'<'P
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MH-EWA@!0I.]1,84K[V_8L9B;8AG 2=\F:3>'C/M![EH$3A55($X]WB#-6PF
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M+AG3P&0?V.L^!).\X#V/N0 &=P$#L37 L8N9HX;;[:087;=05REZY*TJ5]S
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MYKDE1ODPOJK[EM99C&C>A3+L>/)PN#MB;KL44 QGDA<93AECE7PJ.S<H@2B
MA^#QB)8R00L6_-\]7>#E9FU-*^"+L277J,P5G'];E]:F<E@L+:?VD!9.I:#@
MS4<)Q-3GTI!5V^BZX3'=ZJPSTW#.U%:=MCN&]^^>G%H5VES+3RW8-D]DBEKA
M,J8H#]@L]5C;-0[33K[9%G=LOT1D$I<!3I*YM)AWMGA?OJ=9'7C2<B\7)" -
M5Y^_J GFE#*%_PM:4-HXD2''4IIV4XS0U@+DR*X[K)4$,R\.)9^9.(B6#1/S
M^#VM?I]G(Z.0%5SR,\>6O9%QPHR[!EHNO(::!CDDV3L,4?]<D'N:V5.1A+\K
M4NZJ-"TH+CLTOA]X<;HI 1H?/>%"?917"\!;;J^I.#(GI;0G)MYM$5)&=\MK
MJSON?(E)PXPC9]I7=\P+8'5/-W//S"ESNNIQ23 A%=)2+X@M_W+))Q<2NU[*
MS5I[YYP+-Q$\V3899^F!];(0=;8!K5^I/4\4U-(@':W2M+AWC[T1P87KN @6
MBUPO7.[6H-Y/6WX-&F[4C!RFKYR::-P2XB]N92Y$H(^"1HT\B&4I1H=OYM_%
MU+1Z4[*)^W\5SP 9]/J3V]#_*>Q6HC6D=WII.U%,.0[?GKG^E-YIAS\-?(4Y
M.Y',^\5ESW2HG'9MK\K).1^G56.RIT>TNB/)2>?JM"?VN'O>-2TK\O+)J50+
M!G:CFHFBCLGRG\JPG5/YL]OK-1I>3EIG)^>NIZ9W;M=RVKH\MBOLMD[-NJ8:
M1V[)\3UI%/;YC%*=.I)"%=\%8LQVZ)_,^DZ_1'W:J_.]XU[26_61#1=D<DJ6
M'!OT7"_A!TYX33^-[NYP&1%Z)#[1?V[PQX>AN92H;K/A0F/1O'K!=7+-<11S
M%K,#BR/A#EKBE'T]TRYVB$WU093.X9,H$XN<H.#:.RD^E'S&BQ/^/W B93*<
M#ON3@9Q*N29'ZV;,O26J09Q_C+WN]+#-M,WFCH9M=4]L'6#K>!U(MM.+(>;@
MI-Z-1/]^V8W"C N_#:IG%#YZB9_^(_7[;GV<IGOX.,U(,I3WP;>7BL+A@??5
M?@;CST-UW__[ELHLN5?;]*($]6U GHM'?\!39-_4Y%7+X)NM)#YMN#]KG9QU
MO;X)PC13!GUVN]OS^5WWXG</]^)_R-#9F:H!I^G!9?\R-Y# 7R2FI^F%6_(#
M'?L?QI/AZ..M&GR93(:W@W^H^TG_=GI3YW&]F^NX;53*(')MG3TG[-=*ZOR/
MO?MNK8NL?6 LN4IO<W@PSJY$Y#L$N6W"356\JKM@N:F6W5F?HQ+.\,45;BA<
MTM?F%'-=4MA](YKST1WA-M]7FEUR"2\*;KBZ)Q> /4WY>+ZVN-CBRS?N1:MQ
M[\GP-M+>FJ:9.G+]S%4B+0VNKLS.T[YKW[@/C%-+ K0!^?M\NYZN'4-S5M*U
MO4DM$3_G>HE+O1XT%T:8A%R;GI-M"N9&^D,K_7SOC[O?;?O>C>:IW/KZ/DY
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M;"]W;W)K<VAE971S+W-H965T,3<N>&UL?57;;N(P$/V54;0/NQ)J+@0"")"
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M>)H=Q7X:.3C/G1Z4-R@GUMX&KT&H^OI%-FQ'WU-?7SVT*+ C>ZMC'OEUDNS
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MKO0(L<NM'O)8&( ^7W.N/@,S1]J_C>0?4$L#!!0    ( *V!+%3;5&NX7 ,
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MC:8,D.55:=X1=*GKM'LJ9-6GFPM9R0-3$^3S&:5BVU$+E/\->G\ 4$L#!!0
M   ( *V!+%2/(0RHD0,  ,\-   9    >&PO=V]R:W-H965T<R]S:&5E=#(R
M+GAM;+57WV_:.AC]5ZSH/FS2VL3Y!52 U :ZB]125-:[AZO[8(*36$MB9AO8
M_OO93@CI8A"Z:U_ =LXYG[_O.+$]W%/VC6<8"_"CR$L^LC(A-C>VS>,,%XA?
MTPTNY9.$L@()V66IS3<,H[4F%;GM.DYH%XB4UGBHQQ9L/*1;D9,2+QC@VZ)
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M+LP40#Y/*!6'C@K0W.'&OP!02P,$%     @ K8$L5-W5!02- P  ?PP  !D
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M.@J3H,]7G*M=8 2:_XGX#U!+ P04    " "M@2Q4G6^2!Z\#  !%#P  &0
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MO9"[:B'HS$)<,&>YW HPRQ.2&/C3?G[0P[=54IK,H-?,W*%>@X_L< -<YQ-
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M3"JERL>MZG,)+P#J_9HQ^3HH'#2=\^@_4$L#!!0    ( *V!+%1[A. IT@,
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M-PMZZ5"[!32?*V7W'4?0O)W)'U!+ P04    " "M@2Q4] <[') "  !4!P
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M*6[4_5^R#DB4_J8JT=7_Z+ZVQ0,T7>E"I?5@0)#&V>9O]+U.1&, ^+$/H/4
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MJLV70BVKUXIN55&HM/JXD-%,YJ4!_#Y7JGCX4DZP?97M]']02P,$%     @
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M^+/N)]KL$U!+ 0(4 Q0    ( *V!+%0'04UB@0   +$    0
M  "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ K8$L5+^BCP#M
M    *P(  !$              ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L!
M A0#%     @ K8$L5)E<G",0!@  G"<  !,              ( !RP$  'AL
M+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    " "M@2Q4CF=^!S@%  !P%0
M&               @($,"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L!
M A0#%     @ K8$L5/A]R"<L!P  NAX  !@              ("!>@T  'AL
M+W=O<FMS:&5E=',O<VAE970R+GAM;%!+ 0(4 Q0    ( *V!+%2R=)<P!@0
M (D/   8              " @=P4  !X;"]W;W)K<VAE971S+W-H965T,RYX
M;6Q02P$"% ,4    " "M@2Q4L5;:(%4&   X&0  &               @($8
M&0  >&PO=V]R:W-H965T<R]S:&5E=#0N>&UL4$L! A0#%     @ K8$L5"<,
M,A)7!0  :Q4  !@              ("!HQ\  'AL+W=O<FMS:&5E=',O<VAE
M970U+GAM;%!+ 0(4 Q0    ( *V!+%043@J.E08  "T9   8
M  " @3 E  !X;"]W;W)K<VAE971S+W-H965T-BYX;6Q02P$"% ,4    " "M
M@2Q4L7<W0.,)  !C%P  &               @('[*P  >&PO=V]R:W-H965T
M<R]S:&5E=#<N>&UL4$L! A0#%     @ K8$L5. ;7P; '0  E5$  !@
M         ("!%#8  'AL+W=O<FMS:&5E=',O<VAE970X+GAM;%!+ 0(4 Q0
M   ( *V!+%2!EX4!7@,  #$'   8              " @0I4  !X;"]W;W)K
M<VAE971S+W-H965T.2YX;6Q02P$"% ,4    " "M@2Q4JI7IXX(#   $"
M&0              @(&>5P  >&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+
M 0(4 Q0    ( *V!+%1*/M=D\P<  )P2   9              " @5=;  !X
M;"]W;W)K<VAE971S+W-H965T,3$N>&UL4$L! A0#%     @ K8$L5 ;OM2[9
M!0  ] P  !D              ("!@6,  'AL+W=O<FMS:&5E=',O<VAE970Q
M,BYX;6Q02P$"% ,4    " "M@2Q43L_=2/@#  """   &0
M@(&1:0  >&PO=V]R:W-H965T<R]S:&5E=#$S+GAM;%!+ 0(4 Q0    ( *V!
M+%1]?X6X!0<  %$1   9              " @<!M  !X;"]W;W)K<VAE971S
M+W-H965T,30N>&UL4$L! A0#%     @ K8$L5&H-^A'<'P  $6   !D
M         ("!_'0  'AL+W=O<FMS:&5E=',O<VAE970Q-2YX;6Q02P$"% ,4
M    " "M@2Q4"%]CH^,#  #F"   &0              @($/E0  >&PO=V]R
M:W-H965T<R]S:&5E=#$V+GAM;%!+ 0(4 Q0    ( *V!+%3>\WT!XP(  #0&
M   9              " @2F9  !X;"]W;W)K<VAE971S+W-H965T,3<N>&UL
M4$L! A0#%     @ K8$L5/JO%JTJ P  $P<  !D              ("!0YP
M 'AL+W=O<FMS:&5E=',O<VAE970Q."YX;6Q02P$"% ,4    " "M@2Q4,"J[
M"<8(  "U+0  &0              @(&DGP  >&PO=V]R:W-H965T<R]S:&5E
M=#$Y+GAM;%!+ 0(4 Q0    ( *V!+%0ALUFD=@(  $(&   9
M  " @:&H  !X;"]W;W)K<VAE971S+W-H965T,C N>&UL4$L! A0#%     @
MK8$L5-M4:[A< P  )PP  !D              ("!3JL  'AL+W=O<FMS:&5E
M=',O<VAE970R,2YX;6Q02P$"% ,4    " "M@2Q4CR$,J)$#  #/#0  &0
M            @('AK@  >&PO=V]R:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4
M Q0    ( *V!+%3=U04$C0,  '\,   9              " @:FR  !X;"]W
M;W)K<VAE971S+W-H965T,C,N>&UL4$L! A0#%     @ K8$L5-=.;>B% @
M,P8  !D              ("!;;8  'AL+W=O<FMS:&5E=',O<VAE970R-"YX
M;6Q02P$"% ,4    " "M@2Q4G6^2!Z\#  !%#P  &0              @($I
MN0  >&PO=V]R:W-H965T<R]S:&5E=#(U+GAM;%!+ 0(4 Q0    ( *V!+%1[
MA. IT@,  .$/   9              " @0^]  !X;"]W;W)K<VAE971S+W-H
M965T,C8N>&UL4$L! A0#%     @ K8$L5'[ZZ_3# @  1P<  !D
M     ("!&,$  'AL+W=O<FMS:&5E=',O<VAE970R-RYX;6Q02P$"% ,4
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M  "'$   #0              @ $%T@  >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0
M   ( *V!+%27BKL<P    !,"   +              "  3O5  !?<F5L<R\N
M<F5L<U!+ 0(4 Q0    ( *V!+%1(R4[#/ ,  *P4   /              "
M 236  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " "M@2Q49(35>E<!  "1
M$@  &@              @ &-V0  >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E
M;'-02P$"% ,4    " "M@2Q4.6DC=8(!  !,$P  $P              @ $<
LVP  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     )@ F $$*  #/W      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>123</ContextCount>
  <ElementCount>296</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>39</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="bmra-20211130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biomerica.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="bmra-20211130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>001 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biomerica.com/role/ConsolidatedBalanceSheet</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="bmra-20211130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biomerica.com/role/ConsolidatedBalanceSheet_Parentheticals</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Parentheticals)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="bmra-20211130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>003 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biomerica.com/role/ConsolidatedIncomeStatement</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="bmra-20211130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biomerica.com/role/ShareholdersEquityType2or3</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="bmra-20211130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biomerica.com/role/ConsolidatedCashFlow</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="bmra-20211130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>006 - Disclosure - BASIS OF PRESENTATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biomerica.com/role/BASISOFPRESENTATION</Role>
      <ShortName>BASIS OF PRESENTATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="bmra-20211130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>007 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIES</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="bmra-20211130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>008 - Disclosure - SHAREHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biomerica.com/role/SHAREHOLDERSEQUITY</Role>
      <ShortName>SHAREHOLDERS' EQUITY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="bmra-20211130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>009 - Disclosure - GEOGRAPHIC INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biomerica.com/role/GEOGRAPHICINFORMATION</Role>
      <ShortName>GEOGRAPHIC INFORMATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="bmra-20211130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>010 - Disclosure - LEASES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biomerica.com/role/LEASES</Role>
      <ShortName>LEASES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="bmra-20211130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>011 - Disclosure - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biomerica.com/role/COMMITMENTSANDCONTINGENCIES</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="bmra-20211130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>012 - Disclosure - SUBSEQUENT EVENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biomerica.com/role/SUBSEQUENTEVENTS</Role>
      <ShortName>SUBSEQUENT EVENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="bmra-20211130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>013 - Disclosure - RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biomerica.com/role/RESTATEMENTOFPREVIOUSLYISSUEDFINANCIALSTATEMENTS</Role>
      <ShortName>RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="bmra-20211130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>014 - Disclosure - Accounting Policies, by Policy (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biomerica.com/role/AccountingPoliciesByPolicy</Role>
      <ShortName>Accounting Policies, by Policy (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="bmra-20211130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>015 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIES</ParentRole>
      <Position>16</Position>
    </Report>
    <Report instance="bmra-20211130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>016 - Disclosure - GEOGRAPHIC INFORMATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biomerica.com/role/GEOGRAPHICINFORMATIONTables</Role>
      <ShortName>GEOGRAPHIC INFORMATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.biomerica.com/role/GEOGRAPHICINFORMATION</ParentRole>
      <Position>17</Position>
    </Report>
    <Report instance="bmra-20211130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>017 - Disclosure - LEASES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biomerica.com/role/LEASESTables</Role>
      <ShortName>LEASES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.biomerica.com/role/LEASES</ParentRole>
      <Position>18</Position>
    </Report>
    <Report instance="bmra-20211130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>018 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="bmra-20211130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>019 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details) - Inventories</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biomerica.com/role/InventoriesTable</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Details) - Inventories</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="bmra-20211130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>020 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details) - Options Activity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biomerica.com/role/OptionsActivityTable</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Details) - Options Activity</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="bmra-20211130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>021 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details) - Revenue from contracts with customers</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biomerica.com/role/RevenuefromcontractswithcustomersTable</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Details) - Revenue from contracts with customers</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="bmra-20211130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>022 - Disclosure - SHAREHOLDERS' EQUITY (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biomerica.com/role/SHAREHOLDERSEQUITYDetails</Role>
      <ShortName>SHAREHOLDERS' EQUITY (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.biomerica.com/role/SHAREHOLDERSEQUITY</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="bmra-20211130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>023 - Disclosure - GEOGRAPHIC INFORMATION (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biomerica.com/role/GEOGRAPHICINFORMATIONDetails</Role>
      <ShortName>GEOGRAPHIC INFORMATION (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.biomerica.com/role/GEOGRAPHICINFORMATIONTables</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="bmra-20211130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>024 - Disclosure - GEOGRAPHIC INFORMATION (Details) - Geographic information regarding net sales</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biomerica.com/role/GeographicinformationregardingnetsalesTable</Role>
      <ShortName>GEOGRAPHIC INFORMATION (Details) - Geographic information regarding net sales</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.biomerica.com/role/GEOGRAPHICINFORMATIONTables</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="bmra-20211130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>025 - Disclosure - LEASES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biomerica.com/role/LEASESDetails</Role>
      <ShortName>LEASES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.biomerica.com/role/LEASESTables</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="bmra-20211130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>026 - Disclosure - LEASES (Details) - Supplemental cash flow information related to leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biomerica.com/role/SupplementalcashflowinformationrelatedtoleasesTable</Role>
      <ShortName>LEASES (Details) - Supplemental cash flow information related to leases</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.biomerica.com/role/LEASESTables</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="bmra-20211130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>027 - Disclosure - LEASES (Details) - The maturity of lease liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biomerica.com/role/ThematurityofleaseliabilitiesTable</Role>
      <ShortName>LEASES (Details) - The maturity of lease liabilities</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.biomerica.com/role/LEASESTables</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="bmra-20211130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>028 - Disclosure - SUBSEQUENT EVENTS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biomerica.com/role/SUBSEQUENTEVENTSDetails</Role>
      <ShortName>SUBSEQUENT EVENTS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.biomerica.com/role/SUBSEQUENTEVENTS</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="bmra-20211130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>029 - Disclosure - RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Details) - Restatement on the consolidated statement of operations and the consolidated statement of cash flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biomerica.com/role/RestatementontheconsolidatedstatementofoperationsandtheconsolidatedstatementofcashflowsTable</Role>
      <ShortName>RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Details) - Restatement on the consolidated statement of operations and the consolidated statement of cash flows</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.biomerica.com/role/RESTATEMENTOFPREVIOUSLYISSUEDFINANCIALSTATEMENTS</ParentRole>
      <Position>30</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="bmra-20211130.htm">bmra-20211130.htm</File>
    <File>bmra-20211130.xsd</File>
    <File>bmra-20211130_cal.xml</File>
    <File>bmra-20211130_def.xml</File>
    <File>bmra-20211130_lab.xml</File>
    <File>bmra-20211130_pre.xml</File>
    <File>exhibit31_1.htm</File>
    <File>exhibit31_2.htm</File>
    <File>exhibit32_1.htm</File>
    <File>exhibit32_2.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/srt/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/country/2021</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>47
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "bmra-20211130.htm": {
   "axisCustom": 1,
   "axisStandard": 14,
   "contextCount": 123,
   "dts": {
    "calculationLink": {
     "local": [
      "bmra-20211130_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "bmra-20211130_def.xml"
     ]
    },
    "inline": {
     "local": [
      "bmra-20211130.htm"
     ]
    },
    "labelLink": {
     "local": [
      "bmra-20211130_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "bmra-20211130_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "bmra-20211130.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "https://xbrl.sec.gov/sic/2021/sic-2021.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 329,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2021-01-31": 12,
    "http://xbrl.sec.gov/dei/2021": 7,
    "total": 19
   },
   "keyCustom": 11,
   "keyStandard": 285,
   "memberCustom": 11,
   "memberStandard": 26,
   "nsprefix": "bmra",
   "nsuri": "http://www.biomerica.com/20211130",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20211130.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000 - Document - Document And Entity Information",
     "role": "http://www.biomerica.com/role/DocumentAndEntityInformation",
     "shortName": "Document And Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20211130.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20211130.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "bmra:GeographicInformationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "009 - Disclosure - GEOGRAPHIC INFORMATION",
     "role": "http://www.biomerica.com/role/GEOGRAPHICINFORMATION",
     "shortName": "GEOGRAPHIC INFORMATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20211130.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "bmra:GeographicInformationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20211130.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "010 - Disclosure - LEASES",
     "role": "http://www.biomerica.com/role/LEASES",
     "shortName": "LEASES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20211130.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20211130.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "011 - Disclosure - COMMITMENTS AND CONTINGENCIES",
     "role": "http://www.biomerica.com/role/COMMITMENTSANDCONTINGENCIES",
     "shortName": "COMMITMENTS AND CONTINGENCIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20211130.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20211130.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "012 - Disclosure - SUBSEQUENT EVENTS",
     "role": "http://www.biomerica.com/role/SUBSEQUENTEVENTS",
     "shortName": "SUBSEQUENT EVENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20211130.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20211130.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ErrorCorrectionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "013 - Disclosure - RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS",
     "role": "http://www.biomerica.com/role/RESTATEMENTOFPREVIOUSLYISSUEDFINANCIALSTATEMENTS",
     "shortName": "RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20211130.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ErrorCorrectionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20211130.htm",
      "contextRef": "c6",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "014 - Disclosure - Accounting Policies, by Policy (Policies)",
     "role": "http://www.biomerica.com/role/AccountingPoliciesByPolicy",
     "shortName": "Accounting Policies, by Policy (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20211130.htm",
      "contextRef": "c6",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20211130.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "015 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "role": "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20211130.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20211130.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "016 - Disclosure - GEOGRAPHIC INFORMATION (Tables)",
     "role": "http://www.biomerica.com/role/GEOGRAPHICINFORMATIONTables",
     "shortName": "GEOGRAPHIC INFORMATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20211130.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20211130.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "bmra:ScheduleOfCashFlowSupplementalDisclosuresRelatedToLeaseTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "017 - Disclosure - LEASES (Tables)",
     "role": "http://www.biomerica.com/role/LEASESTables",
     "shortName": "LEASES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20211130.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "bmra:ScheduleOfCashFlowSupplementalDisclosuresRelatedToLeaseTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20211130.htm",
      "contextRef": "c2",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:RetainedEarningsAccumulatedDeficit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "018 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details)",
     "role": "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20211130.htm",
      "contextRef": "c37",
      "decimals": "0",
      "lang": null,
      "name": "bmra:ShelfRegistrationStatementMaximumAuthorizedCommonStockIssuanceValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20211130.htm",
      "contextRef": "c2",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "001 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS",
     "role": "http://www.biomerica.com/role/ConsolidatedBalanceSheet",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20211130.htm",
      "contextRef": "c2",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20211130.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "019 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details) - Inventories",
     "role": "http://www.biomerica.com/role/InventoriesTable",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Details) - Inventories",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20211130.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20211130.htm",
      "contextRef": "c55",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "020 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details) - Options Activity",
     "role": "http://www.biomerica.com/role/OptionsActivityTable",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Details) - Options Activity",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20211130.htm",
      "contextRef": "c56",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPershares",
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20211130.htm",
      "contextRef": "c6",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "021 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details) - Revenue from contracts with customers",
     "role": "http://www.biomerica.com/role/RevenuefromcontractswithcustomersTable",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Details) - Revenue from contracts with customers",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20211130.htm",
      "contextRef": "c6",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20211130.htm",
      "contextRef": "c0",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProceedsFromIssuanceOfCommonStock",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "022 - Disclosure - SHAREHOLDERS' EQUITY (Details)",
     "role": "http://www.biomerica.com/role/SHAREHOLDERSEQUITYDetails",
     "shortName": "SHAREHOLDERS' EQUITY (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20211130.htm",
      "contextRef": "c51",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20211130.htm",
      "contextRef": "c77",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "023 - Disclosure - GEOGRAPHIC INFORMATION (Details)",
     "role": "http://www.biomerica.com/role/GEOGRAPHICINFORMATIONDetails",
     "shortName": "GEOGRAPHIC INFORMATION (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20211130.htm",
      "contextRef": "c77",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "pure",
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20211130.htm",
      "contextRef": "c6",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "024 - Disclosure - GEOGRAPHIC INFORMATION (Details) - Geographic information regarding net sales",
     "role": "http://www.biomerica.com/role/GeographicinformationregardingnetsalesTable",
     "shortName": "GEOGRAPHIC INFORMATION (Details) - Geographic information regarding net sales",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20211130.htm",
      "contextRef": "c80",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20211130.htm",
      "contextRef": "c0",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:PaymentsForRent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "025 - Disclosure - LEASES (Details)",
     "role": "http://www.biomerica.com/role/LEASESDetails",
     "shortName": "LEASES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20211130.htm",
      "contextRef": "c0",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:PaymentsForRent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "bmra:ScheduleOfCashFlowSupplementalDisclosuresRelatedToLeaseTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20211130.htm",
      "contextRef": "c6",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "026 - Disclosure - LEASES (Details) - Supplemental cash flow information related to leases",
     "role": "http://www.biomerica.com/role/SupplementalcashflowinformationrelatedtoleasesTable",
     "shortName": "LEASES (Details) - Supplemental cash flow information related to leases",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "bmra:ScheduleOfCashFlowSupplementalDisclosuresRelatedToLeaseTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20211130.htm",
      "contextRef": "c6",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20211130.htm",
      "contextRef": "c2",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "027 - Disclosure - LEASES (Details) - The maturity of lease liabilities",
     "role": "http://www.biomerica.com/role/ThematurityofleaseliabilitiesTable",
     "shortName": "LEASES (Details) - The maturity of lease liabilities",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20211130.htm",
      "contextRef": "c2",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20211130.htm",
      "contextRef": "c108",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "028 - Disclosure - SUBSEQUENT EVENTS (Details)",
     "role": "http://www.biomerica.com/role/SUBSEQUENTEVENTSDetails",
     "shortName": "SUBSEQUENT EVENTS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20211130.htm",
      "contextRef": "c108",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20211130.htm",
      "contextRef": "c2",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parentheticals)",
     "role": "http://www.biomerica.com/role/ConsolidatedBalanceSheet_Parentheticals",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Parentheticals)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20211130.htm",
      "contextRef": "c2",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20211130.htm",
      "contextRef": "c111",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "029 - Disclosure - RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Details) - Restatement on the consolidated statement of operations and the consolidated statement of cash flows",
     "role": "http://www.biomerica.com/role/RestatementontheconsolidatedstatementofoperationsandtheconsolidatedstatementofcashflowsTable",
     "shortName": "RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Details) - Restatement on the consolidated statement of operations and the consolidated statement of cash flows",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20211130.htm",
      "contextRef": "c111",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20211130.htm",
      "contextRef": "c6",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "003 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED)",
     "role": "http://www.biomerica.com/role/ConsolidatedIncomeStatement",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20211130.htm",
      "contextRef": "c6",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:CostOfRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20211130.htm",
      "contextRef": "c9",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (Unaudited)",
     "role": "http://www.biomerica.com/role/ShareholdersEquityType2or3",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20211130.htm",
      "contextRef": "c9",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20211130.htm",
      "contextRef": "c0",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)",
     "role": "http://www.biomerica.com/role/ConsolidatedCashFlow",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20211130.htm",
      "contextRef": "c0",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:DepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20211130.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccounting",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "006 - Disclosure - BASIS OF PRESENTATION",
     "role": "http://www.biomerica.com/role/BASISOFPRESENTATION",
     "shortName": "BASIS OF PRESENTATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20211130.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccounting",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20211130.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "007 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES",
     "role": "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIES",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20211130.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20211130.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "008 - Disclosure - SHAREHOLDERS' EQUITY",
     "role": "http://www.biomerica.com/role/SHAREHOLDERSEQUITY",
     "shortName": "SHAREHOLDERS' EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20211130.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 39,
   "tag": {
    "bmra_A5ConvertiblePreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "A5ConvertiblePreferredStockMember",
        "terseLabel": "5% Convertible Preferred Stock [Member]"
       }
      }
     },
     "localname": "A5ConvertiblePreferredStockMember",
     "nsuri": "http://www.biomerica.com/20211130",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet",
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.biomerica.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "domainItemType"
    },
    "bmra_AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract",
        "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract",
     "nsuri": "http://www.biomerica.com/20211130",
     "presentation": [
      "http://www.biomerica.com/role/RestatementontheconsolidatedstatementofoperationsandtheconsolidatedstatementofcashflowsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "bmra_BuildingInIrvineCaliforniaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "BuildingInIrvineCaliforniaMember",
        "terseLabel": "Building In Irvine California [Member]"
       }
      }
     },
     "localname": "BuildingInIrvineCaliforniaMember",
     "nsuri": "http://www.biomerica.com/20211130",
     "presentation": [
      "http://www.biomerica.com/role/LEASESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmra_CashPaidDuringThePeriodForAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CashPaidDuringThePeriodForAbstract",
        "terseLabel": "Cash paid during the period for:"
       }
      }
     },
     "localname": "CashPaidDuringThePeriodForAbstract",
     "nsuri": "http://www.biomerica.com/20211130",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "bmra_ClinicalLabMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ClinicalLabMember",
        "terseLabel": "Clinical Lab [Member]"
       }
      }
     },
     "localname": "ClinicalLabMember",
     "nsuri": "http://www.biomerica.com/20211130",
     "presentation": [
      "http://www.biomerica.com/role/RevenuefromcontractswithcustomersTable"
     ],
     "xbrltype": "domainItemType"
    },
    "bmra_ContractManufacturingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ContractManufacturingMember",
        "terseLabel": "Contract Manufacturing [Member]"
       }
      }
     },
     "localname": "ContractManufacturingMember",
     "nsuri": "http://www.biomerica.com/20211130",
     "presentation": [
      "http://www.biomerica.com/role/RevenuefromcontractswithcustomersTable"
     ],
     "xbrltype": "domainItemType"
    },
    "bmra_DocumentAndEntityInformationAbstract": {
     "auth_ref": [],
     "localname": "DocumentAndEntityInformationAbstract",
     "nsuri": "http://www.biomerica.com/20211130",
     "xbrltype": "stringItemType"
    },
    "bmra_FirstAmendmentToLeaseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "FirstAmendmentToLeaseMember",
        "terseLabel": "First Amendment To Lease [Member]"
       }
      }
     },
     "localname": "FirstAmendmentToLeaseMember",
     "nsuri": "http://www.biomerica.com/20211130",
     "presentation": [
      "http://www.biomerica.com/role/LEASESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmra_GEOGRAPHICINFORMATIONDetailsGeographicinformationregardingnetsalesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "GEOGRAPHIC INFORMATION (Details) - Geographic information regarding net sales [Line Items]"
       }
      }
     },
     "localname": "GEOGRAPHICINFORMATIONDetailsGeographicinformationregardingnetsalesLineItems",
     "nsuri": "http://www.biomerica.com/20211130",
     "presentation": [
      "http://www.biomerica.com/role/GeographicinformationregardingnetsalesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "bmra_GEOGRAPHICINFORMATIONDetailsGeographicinformationregardingnetsalesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "GEOGRAPHIC INFORMATION (Details) - Geographic information regarding net sales [Table]"
       }
      }
     },
     "localname": "GEOGRAPHICINFORMATIONDetailsGeographicinformationregardingnetsalesTable",
     "nsuri": "http://www.biomerica.com/20211130",
     "presentation": [
      "http://www.biomerica.com/role/GeographicinformationregardingnetsalesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "bmra_GEOGRAPHICINFORMATIONDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "GEOGRAPHIC INFORMATION (Details) [Line Items]"
       }
      }
     },
     "localname": "GEOGRAPHICINFORMATIONDetailsLineItems",
     "nsuri": "http://www.biomerica.com/20211130",
     "presentation": [
      "http://www.biomerica.com/role/GEOGRAPHICINFORMATIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bmra_GEOGRAPHICINFORMATIONDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "GEOGRAPHIC INFORMATION (Details) [Table]"
       }
      }
     },
     "localname": "GEOGRAPHICINFORMATIONDetailsTable",
     "nsuri": "http://www.biomerica.com/20211130",
     "presentation": [
      "http://www.biomerica.com/role/GEOGRAPHICINFORMATIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bmra_GeographicInformationDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographic Information Disclosure [Abstract]"
       }
      }
     },
     "localname": "GeographicInformationDisclosureAbstract",
     "nsuri": "http://www.biomerica.com/20211130",
     "xbrltype": "stringItemType"
    },
    "bmra_GeographicInformationDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments according to the geographic areas.",
        "label": "GeographicInformationDisclosureTextBlock",
        "terseLabel": "Geographic Information Disclosure [Text Block]"
       }
      }
     },
     "localname": "GeographicInformationDisclosureTextBlock",
     "nsuri": "http://www.biomerica.com/20211130",
     "presentation": [
      "http://www.biomerica.com/role/GEOGRAPHICINFORMATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bmra_GeographicInformationRegardingNetSalesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographic information regarding net sales [Abstract]"
       }
      }
     },
     "localname": "GeographicInformationRegardingNetSalesAbstract",
     "nsuri": "http://www.biomerica.com/20211130",
     "xbrltype": "stringItemType"
    },
    "bmra_IncreaseDecreaseInLeaseLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedCashFlow": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in LeaseLiability",
        "label": "Reduction in lease liability"
       }
      }
     },
     "localname": "IncreaseDecreaseInLeaseLiability",
     "nsuri": "http://www.biomerica.com/20211130",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmra_InventoriesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventories [Abstract]"
       }
      }
     },
     "localname": "InventoriesAbstract",
     "nsuri": "http://www.biomerica.com/20211130",
     "xbrltype": "stringItemType"
    },
    "bmra_LEASESDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "LEASES (Details) [Line Items]"
       }
      }
     },
     "localname": "LEASESDetailsLineItems",
     "nsuri": "http://www.biomerica.com/20211130",
     "presentation": [
      "http://www.biomerica.com/role/LEASESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bmra_LEASESDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "LEASES (Details) [Table]"
       }
      }
     },
     "localname": "LEASESDetailsTable",
     "nsuri": "http://www.biomerica.com/20211130",
     "presentation": [
      "http://www.biomerica.com/role/LEASESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bmra_LeaseAmendmentAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "LeaseAmendmentAxis",
        "terseLabel": "Lease Amendment [Axis]"
       }
      }
     },
     "localname": "LeaseAmendmentAxis",
     "nsuri": "http://www.biomerica.com/20211130",
     "presentation": [
      "http://www.biomerica.com/role/LEASESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bmra_LeaseAmendmentDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "LeaseAmendment [Domain]"
       }
      }
     },
     "localname": "LeaseAmendmentDomain",
     "nsuri": "http://www.biomerica.com/20211130",
     "presentation": [
      "http://www.biomerica.com/role/LEASESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmra_LiquidityPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for liquidity position during the period.",
        "label": "LiquidityPolicyTextBlock",
        "terseLabel": "Liquidity [Policy Text Block]"
       }
      }
     },
     "localname": "LiquidityPolicyTextBlock",
     "nsuri": "http://www.biomerica.com/20211130",
     "presentation": [
      "http://www.biomerica.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bmra_MarketsAndMethodsOfDistributionPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for Markets And Methods Of Distribution during the period.",
        "label": "MarketsAndMethodsOfDistributionPolicyTextBlock",
        "terseLabel": "Markets And Methods Of Distribution [Policy Text Block]"
       }
      }
     },
     "localname": "MarketsAndMethodsOfDistributionPolicyTextBlock",
     "nsuri": "http://www.biomerica.com/20211130",
     "presentation": [
      "http://www.biomerica.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bmra_OperatingLeaseInitiationDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date the operating lease was initiated, in CCYY-MM-DD format.",
        "label": "OperatingLeaseInitiationDate",
        "terseLabel": "Operating Lease Initiation Date"
       }
      }
     },
     "localname": "OperatingLeaseInitiationDate",
     "nsuri": "http://www.biomerica.com/20211130",
     "presentation": [
      "http://www.biomerica.com/role/LEASESDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "bmra_OperatingLeaseRightOfUseAssetAccumulatedAmortization": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated amortization of right-of-use asset from operating lease",
        "label": "Accumulated amortization, Right of Use Assets (in Dollars)"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetAccumulatedAmortization",
     "nsuri": "http://www.biomerica.com/20211130",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet_Parentheticals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmra_OptionsActivityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options Activity [Abstract]"
       }
      }
     },
     "localname": "OptionsActivityAbstract",
     "nsuri": "http://www.biomerica.com/20211130",
     "xbrltype": "stringItemType"
    },
    "bmra_OverthecounterMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "OverthecounterMember",
        "terseLabel": "Over-the-counter [Member]"
       }
      }
     },
     "localname": "OverthecounterMember",
     "nsuri": "http://www.biomerica.com/20211130",
     "presentation": [
      "http://www.biomerica.com/role/RevenuefromcontractswithcustomersTable"
     ],
     "xbrltype": "domainItemType"
    },
    "bmra_PhysiciansOfficeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "PhysiciansOfficeMember",
        "terseLabel": "Physicians Office [Member]"
       }
      }
     },
     "localname": "PhysiciansOfficeMember",
     "nsuri": "http://www.biomerica.com/20211130",
     "presentation": [
      "http://www.biomerica.com/role/RevenuefromcontractswithcustomersTable"
     ],
     "xbrltype": "domainItemType"
    },
    "bmra_PreferredStockUndesignatedShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of preferred shares undesignated during the period.",
        "label": "Preferred Stock, undesignated shares"
       }
      }
     },
     "localname": "PreferredStockUndesignatedShares",
     "nsuri": "http://www.biomerica.com/20211130",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet_Parentheticals"
     ],
     "xbrltype": "sharesItemType"
    },
    "bmra_PrepaidsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for prepaids.",
        "label": "PrepaidsPolicyPolicyTextBlock",
        "terseLabel": "Prepaids Policy [Policy Text Block]"
       }
      }
     },
     "localname": "PrepaidsPolicyPolicyTextBlock",
     "nsuri": "http://www.biomerica.com/20211130",
     "presentation": [
      "http://www.biomerica.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bmra_PropertySubjectToOrAvailableForOperatingLease_Domain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "PropertySubjectToOrAvailableForOperatingLease_ [Domain]"
       }
      }
     },
     "localname": "PropertySubjectToOrAvailableForOperatingLease_Domain",
     "nsuri": "http://www.biomerica.com/20211130",
     "presentation": [
      "http://www.biomerica.com/role/LEASESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmra_PurchasedTechnologyRightsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "PurchasedTechnologyRightsMember",
        "terseLabel": "Purchased Technology Rights [Member]"
       }
      }
     },
     "localname": "PurchasedTechnologyRightsMember",
     "nsuri": "http://www.biomerica.com/20211130",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmra_RentPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rent percentage.",
        "label": "RentPercentage",
        "terseLabel": "Rent Percentage"
       }
      }
     },
     "localname": "RentPercentage",
     "nsuri": "http://www.biomerica.com/20211130",
     "presentation": [
      "http://www.biomerica.com/role/LEASESDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "bmra_RestatementOfCompanysFinancialStatementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "RestatementOfCompanysFinancialStatementsMember",
        "terseLabel": "Restatement Of Companys Financial Statements [Member]"
       }
      }
     },
     "localname": "RestatementOfCompanysFinancialStatementsMember",
     "nsuri": "http://www.biomerica.com/20211130",
     "presentation": [
      "http://www.biomerica.com/role/RestatementontheconsolidatedstatementofoperationsandtheconsolidatedstatementofcashflowsTable"
     ],
     "xbrltype": "domainItemType"
    },
    "bmra_RestatementOnTheConsolidatedStatementOfOperationsAndTheConsolidatedStatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement on the consolidated statement of operations and the consolidated statement of cash flows [Abstract]"
       }
      }
     },
     "localname": "RestatementOnTheConsolidatedStatementOfOperationsAndTheConsolidatedStatementOfCashFlowsAbstract",
     "nsuri": "http://www.biomerica.com/20211130",
     "xbrltype": "stringItemType"
    },
    "bmra_RevenueFromContractsWithCustomersAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from contracts with customers [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractsWithCustomersAbstract",
     "nsuri": "http://www.biomerica.com/20211130",
     "xbrltype": "stringItemType"
    },
    "bmra_RevenuesFromSalesToUnaffiliatedCustomersAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "RevenuesFromSalesToUnaffiliatedCustomersAbstract",
        "terseLabel": "Revenues from sales to unaffiliated customers:"
       }
      }
     },
     "localname": "RevenuesFromSalesToUnaffiliatedCustomersAbstract",
     "nsuri": "http://www.biomerica.com/20211130",
     "presentation": [
      "http://www.biomerica.com/role/GeographicinformationregardingnetsalesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "bmra_RightOfUseAssetsObtainedInExchangeForAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "RightOfUseAssetsObtainedInExchangeForAbstract",
        "terseLabel": "Right-of-use assets obtained in exchange for"
       }
      }
     },
     "localname": "RightOfUseAssetsObtainedInExchangeForAbstract",
     "nsuri": "http://www.biomerica.com/20211130",
     "presentation": [
      "http://www.biomerica.com/role/SupplementalcashflowinformationrelatedtoleasesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "bmra_SHAREHOLDERSEQUITYDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SHAREHOLDERS' EQUITY (Details) [Line Items]"
       }
      }
     },
     "localname": "SHAREHOLDERSEQUITYDetailsLineItems",
     "nsuri": "http://www.biomerica.com/20211130",
     "presentation": [
      "http://www.biomerica.com/role/SHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bmra_SHAREHOLDERSEQUITYDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SHAREHOLDERS' EQUITY (Details) [Table]"
       }
      }
     },
     "localname": "SHAREHOLDERSEQUITYDetailsTable",
     "nsuri": "http://www.biomerica.com/20211130",
     "presentation": [
      "http://www.biomerica.com/role/SHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]"
       }
      }
     },
     "localname": "SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems",
     "nsuri": "http://www.biomerica.com/20211130",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SIGNIFICANT ACCOUNTING POLICIES (Details) - Options Activity [Line Items]"
       }
      }
     },
     "localname": "SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityLineItems",
     "nsuri": "http://www.biomerica.com/20211130",
     "presentation": [
      "http://www.biomerica.com/role/OptionsActivityTable"
     ],
     "xbrltype": "stringItemType"
    },
    "bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SIGNIFICANT ACCOUNTING POLICIES (Details) - Options Activity [Table]"
       }
      }
     },
     "localname": "SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityTable",
     "nsuri": "http://www.biomerica.com/20211130",
     "presentation": [
      "http://www.biomerica.com/role/OptionsActivityTable"
     ],
     "xbrltype": "stringItemType"
    },
    "bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SIGNIFICANT ACCOUNTING POLICIES (Details) [Table]"
       }
      }
     },
     "localname": "SIGNIFICANTACCOUNTINGPOLICIESDetailsTable",
     "nsuri": "http://www.biomerica.com/20211130",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bmra_SUBSEQUENTEVENTSDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SUBSEQUENT EVENTS (Details) [Line Items]"
       }
      }
     },
     "localname": "SUBSEQUENTEVENTSDetailsLineItems",
     "nsuri": "http://www.biomerica.com/20211130",
     "presentation": [
      "http://www.biomerica.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bmra_SUBSEQUENTEVENTSDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SUBSEQUENT EVENTS (Details) [Table]"
       }
      }
     },
     "localname": "SUBSEQUENTEVENTSDetailsTable",
     "nsuri": "http://www.biomerica.com/20211130",
     "presentation": [
      "http://www.biomerica.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bmra_ScheduleOfCashFlowSupplementalDisclosuresRelatedToLeaseTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of supplemental cash flow information related to lease for the periods.",
        "label": "ScheduleOfCashFlowSupplementalDisclosuresRelatedToLeaseTableTextBlock",
        "terseLabel": "Schedule Of Cash Flow Supplemental Disclosures Related To Lease [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfCashFlowSupplementalDisclosuresRelatedToLeaseTableTextBlock",
     "nsuri": "http://www.biomerica.com/20211130",
     "presentation": [
      "http://www.biomerica.com/role/LEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bmra_ShelfRegistrationStatementMaximumAuthorizedCommonStockIssuanceValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount related with Maximum Authorized Common Stock Issuance of Shelf Registration Statement.",
        "label": "ShelfRegistrationStatementMaximumAuthorizedCommonStockIssuanceValue",
        "terseLabel": "Shelf Registration Statement, Maximum Authorized Common Stock Issuance, Value"
       }
      }
     },
     "localname": "ShelfRegistrationStatementMaximumAuthorizedCommonStockIssuanceValue",
     "nsuri": "http://www.biomerica.com/20211130",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmra_SupplementalCashFlowInformationRelatedToLeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental cash flow information related to leases [Abstract]"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationRelatedToLeasesAbstract",
     "nsuri": "http://www.biomerica.com/20211130",
     "xbrltype": "stringItemType"
    },
    "bmra_TheMaturityOfLeaseLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "The maturity of lease liabilities [Abstract]"
       }
      }
     },
     "localname": "TheMaturityOfLeaseLiabilitiesAbstract",
     "nsuri": "http://www.biomerica.com/20211130",
     "xbrltype": "stringItemType"
    },
    "bmra_TwoDistributorsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "TwoDistributorsMember",
        "terseLabel": "Two Distributors [Member]"
       }
      }
     },
     "localname": "TwoDistributorsMember",
     "nsuri": "http://www.biomerica.com/20211130",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmra_TwoVendorsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "TwoVendorsMember",
        "terseLabel": "Two Vendors [Member]"
       }
      }
     },
     "localname": "TwoVendorsMember",
     "nsuri": "http://www.biomerica.com/20211130",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_MX": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "MEXICO",
        "terseLabel": "MEXICO"
       }
      }
     },
     "localname": "MX",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.biomerica.com/role/GEOGRAPHICINFORMATIONDetails",
      "http://www.biomerica.com/role/LEASESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "localname": "DocumentInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "localname": "DocumentInformationTable",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r436"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r436"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r436"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r438"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r436"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r436"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r436"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r436"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_AsiaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asia [Member]",
        "terseLabel": "Asia [Member]"
       }
      }
     },
     "localname": "AsiaMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/GeographicinformationregardingnetsalesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EuropeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Europe [Member]",
        "terseLabel": "Europe [Member]"
       }
      }
     },
     "localname": "EuropeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/GeographicinformationregardingnetsalesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r228",
      "r231",
      "r261",
      "r262",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r401",
      "r403",
      "r429",
      "r430"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum [Member]"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SHAREHOLDERSEQUITYDetails",
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r228",
      "r231",
      "r261",
      "r262",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r401",
      "r403",
      "r429",
      "r430"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum [Member]"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SHAREHOLDERSEQUITYDetails",
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NorthAmericaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "North America [Member]",
        "terseLabel": "North America [Member]"
       }
      }
     },
     "localname": "NorthAmericaMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/GeographicinformationregardingnetsalesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r228",
      "r231",
      "r259",
      "r261",
      "r262",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r401",
      "r403",
      "r429",
      "r430"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SHAREHOLDERSEQUITYDetails",
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r228",
      "r231",
      "r259",
      "r261",
      "r262",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r401",
      "r403",
      "r429",
      "r430"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SHAREHOLDERSEQUITYDetails",
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember": {
     "auth_ref": [
      "r103",
      "r104",
      "r105",
      "r108",
      "r109",
      "r111",
      "r112"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period, Error Correction, Adjustment [Member]",
        "terseLabel": "Revision of Prior Period, Error Correction, Adjustment [Member]"
       }
      }
     },
     "localname": "RevisionOfPriorPeriodErrorCorrectionAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/RestatementontheconsolidatedstatementofoperationsandtheconsolidatedstatementofcashflowsTable"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioPreviouslyReportedMember": {
     "auth_ref": [
      "r1",
      "r98",
      "r100",
      "r101",
      "r102",
      "r103",
      "r104",
      "r105",
      "r106",
      "r108",
      "r109",
      "r111",
      "r112",
      "r124",
      "r185",
      "r186",
      "r284",
      "r296",
      "r307",
      "r308",
      "r309",
      "r310",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r439",
      "r440"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Previously Reported [Member]",
        "terseLabel": "Previously Reported [Member]"
       }
      }
     },
     "localname": "ScenarioPreviouslyReportedMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/RestatementontheconsolidatedstatementofoperationsandtheconsolidatedstatementofcashflowsTable"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r167",
      "r168",
      "r249",
      "r252",
      "r402",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/GeographicinformationregardingnetsalesTable",
      "http://www.biomerica.com/role/LEASESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SouthAmericaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "South America [Member]",
        "terseLabel": "South America [Member]"
       }
      }
     },
     "localname": "SouthAmericaMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/GeographicinformationregardingnetsalesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r167",
      "r168",
      "r249",
      "r252",
      "r402",
      "r415",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/GEOGRAPHICINFORMATIONDetails",
      "http://www.biomerica.com/role/GeographicinformationregardingnetsalesTable",
      "http://www.biomerica.com/role/LEASESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r37"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Accounts Payable and Accrued Liabilities, Current",
        "terseLabel": "Accounts payable and accrued expenses"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableMember": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Obligations incurred and payable to vendors for goods and services received.",
        "label": "Accounts Payable [Member]",
        "terseLabel": "Accounts Payable [Member]"
       }
      }
     },
     "localname": "AccountsPayableMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsReceivableMember": {
     "auth_ref": [
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold.",
        "label": "Accounts Receivable [Member]",
        "terseLabel": "Accounts Receivable [Member]"
       }
      }
     },
     "localname": "AccountsReceivableMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r6",
      "r17",
      "r171",
      "r172"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts receivable, less allowance for doubtful accounts of $27,777 and $837,415 as of November 30, 2021 and May 31, 2021, respectively"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r35",
      "r207"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated depreciation and amortization (in Dollars)"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet_Parentheticals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r20",
      "r53",
      "r54",
      "r55",
      "r388",
      "r409",
      "r413"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r52",
      "r55",
      "r62",
      "r63",
      "r64",
      "r98",
      "r99",
      "r100",
      "r304",
      "r404",
      "r405",
      "r440"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "AOCI Attributable to Parent [Member]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r18",
      "r284",
      "r347"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional paid-in-capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r98",
      "r99",
      "r100",
      "r281",
      "r282",
      "r283",
      "r308"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital [Member]"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement.",
        "label": "Compensation expense in connection with options granted"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net loss to net cash provided by (used in) operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r264",
      "r278",
      "r285"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "terseLabel": "Share-based Payment Arrangement, Expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r24",
      "r177",
      "r187"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Allowance for doubtful accounts (in Dollars)"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet_Parentheticals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on receivable, classified as other and current.",
        "label": "Allowance for Credit Loss, Receivable, Other, Current",
        "terseLabel": "Allowance for Credit Loss, Receivable, Other, Current"
       }
      }
     },
     "localname": "AllowanceForDoubtfulOtherReceivablesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r83",
      "r197",
      "r204"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization of Intangible Assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r122"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r95",
      "r153",
      "r158",
      "r164",
      "r183",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r301",
      "r305",
      "r313",
      "r345",
      "r347",
      "r377",
      "r387"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total Assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r7",
      "r8",
      "r50",
      "r95",
      "r183",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r301",
      "r305",
      "r313",
      "r345",
      "r347"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current Assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r265",
      "r279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/OptionsActivityTable",
      "http://www.biomerica.com/role/SHAREHOLDERSEQUITYDetails",
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccounting": {
     "auth_ref": [
      "r97"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting [Text Block]",
        "terseLabel": "Basis of Accounting [Text Block]"
       }
      }
     },
     "localname": "BasisOfAccounting",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/BASISOFPRESENTATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r4",
      "r33",
      "r85"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and cash equivalents",
        "periodEndLabel": "Cash and cash equivalents at end of period",
        "periodStartLabel": "Cash and cash equivalents at beginning of period",
        "terseLabel": "Cash and cash equivalents at end of period"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet",
      "http://www.biomerica.com/role/ConsolidatedCashFlow",
      "http://www.biomerica.com/role/RestatementontheconsolidatedstatementofoperationsandtheconsolidatedstatementofcashflowsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r11",
      "r86"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalents, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r78",
      "r316"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedCashFlow": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase (decrease) in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashUninsuredAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash as of the balance sheet date that is not insured by the Federal Deposit Insurance Corporation.",
        "label": "Cash, Uninsured Amount",
        "terseLabel": "Cash, Uninsured Amount"
       }
      }
     },
     "localname": "CashUninsuredAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r93",
      "r95",
      "r115",
      "r116",
      "r117",
      "r119",
      "r121",
      "r128",
      "r129",
      "r130",
      "r183",
      "r217",
      "r221",
      "r222",
      "r223",
      "r226",
      "r227",
      "r229",
      "r230",
      "r233",
      "r237",
      "r313",
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet",
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet_Parentheticals"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r41",
      "r215",
      "r379",
      "r392"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and contingencies (Notes 1 and 6)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r212",
      "r213",
      "r214",
      "r216",
      "r417"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies Disclosure [Text Block]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/COMMITMENTSANDCONTINGENCIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r98",
      "r99",
      "r308"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SHAREHOLDERSEQUITYDetails",
      "http://www.biomerica.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common stock par value (in Dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet_Parentheticals"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common stock, shares authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet_Parentheticals"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common stock, shares issued"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet_Parentheticals"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r16",
      "r243"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common stock, shares outstanding"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet_Parentheticals"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r16",
      "r347"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common stock, $0.08 par value, 25,000,000 shares authorized, 12,692,327 and 12,307,157 issued and outstanding at November 30, 2021 and May 31, 2021, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r57",
      "r59",
      "r60",
      "r68",
      "r382",
      "r395"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedIncomeStatement": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive loss",
        "totalLabel": "Comprehensive loss"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedIncomeStatement",
      "http://www.biomerica.com/role/RestatementontheconsolidatedstatementofoperationsandtheconsolidatedstatementofcashflowsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r137",
      "r138",
      "r170",
      "r311",
      "r312",
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r137",
      "r138",
      "r170",
      "r311",
      "r312",
      "r414",
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r137",
      "r138",
      "r170",
      "r311",
      "r312",
      "r414",
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r133",
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "terseLabel": "Concentration Risk, Credit Risk, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r137",
      "r138",
      "r170",
      "r311",
      "r312"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Concentration Risk, Percentage"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r137",
      "r138",
      "r170",
      "r311",
      "r312",
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r89",
      "r303"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Consolidation, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerLiability": {
     "auth_ref": [
      "r246",
      "r247",
      "r250"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Contract with Customer, Liability",
        "terseLabel": "Advance from customers"
       }
      }
     },
     "localname": "ContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r72",
      "r361"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of sales"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/RestatementontheconsolidatedstatementofoperationsandtheconsolidatedstatementofcashflowsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfGoodsProductLineMember": {
     "auth_ref": [
      "r137"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost of product sold and service rendered from specified product or service, when it serves as benchmark in concentration of risk calculation.",
        "label": "Cost of Goods and Service, Product and Service Benchmark [Member]",
        "terseLabel": "Cost of Goods and Service, Product and Service Benchmark [Member]"
       }
      }
     },
     "localname": "CostOfGoodsProductLineMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfRevenue": {
     "auth_ref": [
      "r73",
      "r95",
      "r183",
      "r217",
      "r218",
      "r219",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r313"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedIncomeStatement": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.",
        "label": "Cost of Revenue",
        "negatedLabel": "Cost of sales"
       }
      }
     },
     "localname": "CostOfRevenue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesPolicyTextBlock": {
     "auth_ref": [
      "r258"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cost of product sold and service rendered.",
        "label": "Cost of Goods and Service [Policy Text Block]",
        "terseLabel": "Cost of Goods and Service [Policy Text Block]"
       }
      }
     },
     "localname": "CostOfSalesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "auth_ref": [
      "r136",
      "r170"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.",
        "label": "Customer Concentration Risk [Member]",
        "terseLabel": "Customer Concentration Risk [Member]"
       }
      }
     },
     "localname": "CustomerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r292"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "terseLabel": "Deferred Tax Assets, Valuation Allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationAndAmortization": {
     "auth_ref": [
      "r83",
      "r206"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedCashFlow": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.",
        "label": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r83",
      "r148"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation, Depletion and Amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/RevenuefromcontractswithcustomersTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r249",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/RevenuefromcontractswithcustomersTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r249"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregation of Revenue [Table Text Block]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureTextBlockAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Text Block [Abstract]"
       }
      }
     },
     "localname": "DisclosureTextBlockAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DistributionRightsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Legal rights, generally of a limited duration, to distribute a product or products, often within specific geographic areas or supply channels.",
        "label": "Distribution Rights [Member]",
        "terseLabel": "Distribution Rights [Member]"
       }
      }
     },
     "localname": "DistributionRightsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r69",
      "r103",
      "r104",
      "r106",
      "r107",
      "r108",
      "r113",
      "r115",
      "r119",
      "r120",
      "r121",
      "r124",
      "r125",
      "r309",
      "r310",
      "r383",
      "r396"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Basic net loss per common share (in Dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedIncomeStatement",
      "http://www.biomerica.com/role/RestatementontheconsolidatedstatementofoperationsandtheconsolidatedstatementofcashflowsTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r69",
      "r103",
      "r104",
      "r106",
      "r107",
      "r108",
      "r115",
      "r119",
      "r120",
      "r121",
      "r124",
      "r125",
      "r309",
      "r310",
      "r383",
      "r396"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Diluted net loss per common share (in Dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedIncomeStatement",
      "http://www.biomerica.com/role/RestatementontheconsolidatedstatementofoperationsandtheconsolidatedstatementofcashflowsTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r122",
      "r123"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Earnings Per Share, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents": {
     "auth_ref": [
      "r316"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedCashFlow": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.",
        "label": "Effect of exchange rate changes in cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashAndCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Accrued compensation"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r277"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Share-based Payment Arrangement, Option [Member]"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/OptionsActivityTable",
      "http://www.biomerica.com/role/SHAREHOLDERSEQUITYDetails",
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r62",
      "r63",
      "r64",
      "r98",
      "r99",
      "r100",
      "r102",
      "r109",
      "r112",
      "r127",
      "r184",
      "r243",
      "r244",
      "r281",
      "r282",
      "r283",
      "r295",
      "r296",
      "r308",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r404",
      "r405",
      "r406",
      "r440"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityInterestIssuedOrIssuableByTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of equity interests that are issued or issuable in a business combination.",
        "label": "Equity Interest Type [Axis]"
       }
      }
     },
     "localname": "EquityInterestIssuedOrIssuableByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet",
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.biomerica.com/role/SHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityInterestIssuedOrIssuableTypeDomain": {
     "auth_ref": [
      "r300"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of equity interest issued or issuable to acquire an entity in a business combination.",
        "label": "Equity Interest Issued or Issuable, Type [Domain]"
       }
      }
     },
     "localname": "EquityInterestIssuedOrIssuableTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet",
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.biomerica.com/role/SHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "auth_ref": [
      "r181"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.",
        "label": "Equity Method Investment, Ownership Percentage",
        "terseLabel": "Equity Method Investment, Ownership Percentage"
       }
      }
     },
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ErrorCorrectionTextBlock": {
     "auth_ref": [
      "r110"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting error correction.",
        "label": "Error Correction [Text Block]",
        "terseLabel": "Error Correction [Text Block]"
       }
      }
     },
     "localname": "ErrorCorrectionTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/RESTATEMENTOFPREVIOUSLYISSUEDFINANCIALSTATEMENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis": {
     "auth_ref": [
      "r103",
      "r104",
      "r105",
      "r108",
      "r109",
      "r111",
      "r112"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of error correction.",
        "label": "Error Correction, Type [Axis]"
       }
      }
     },
     "localname": "ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/RestatementontheconsolidatedstatementofoperationsandtheconsolidatedstatementofcashflowsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Error Corrections and Prior Period Adjustments Restatement [Line Items]"
       }
      }
     },
     "localname": "ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/RestatementontheconsolidatedstatementofoperationsandtheconsolidatedstatementofcashflowsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Finite-Lived Intangible Asset, Useful Life"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r203"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Accumulated amortization, Intangible Assets (in Dollars)"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet_Parentheticals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r198",
      "r199",
      "r203",
      "r205",
      "r362",
      "r363"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r198",
      "r202"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r325"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "terseLabel": "Foreign Currency Transactions and Translations Policy [Policy Text Block]"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": {
     "auth_ref": [
      "r195",
      "r200"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]",
        "terseLabel": "Goodwill and Intangible Assets, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r71",
      "r95",
      "r153",
      "r157",
      "r160",
      "r163",
      "r165",
      "r183",
      "r217",
      "r218",
      "r219",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r313"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedIncomeStatement": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedIncomeStatement",
      "http://www.biomerica.com/role/RestatementontheconsolidatedstatementofoperationsandtheconsolidatedstatementofcashflowsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r66",
      "r153",
      "r157",
      "r160",
      "r163",
      "r165",
      "r376",
      "r380",
      "r384",
      "r398"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedIncomeStatement": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Loss before income taxes",
        "totalLabel": "Loss before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedIncomeStatement",
      "http://www.biomerica.com/role/RestatementontheconsolidatedstatementofoperationsandtheconsolidatedstatementofcashflowsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r96",
      "r111",
      "r112",
      "r151",
      "r289",
      "r297",
      "r298",
      "r399"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedIncomeStatement": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedLabel": "Provision for income taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r61",
      "r287",
      "r288",
      "r290",
      "r291",
      "r293",
      "r294"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Tax, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxesPaid": {
     "auth_ref": [
      "r79",
      "r87"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.",
        "label": "Income taxes"
       }
      }
     },
     "localname": "IncomeTaxesPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedCashFlow": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Accounts payable and accrued expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedCashFlow": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "auth_ref": [
      "r82",
      "r358"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedCashFlow": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Advance from customers"
       }
      }
     },
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedCashFlow": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Accrued compensation"
       }
      }
     },
     "localname": "IncreaseDecreaseInEmployeeRelatedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedCashFlow": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedCashFlow": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets",
        "negatedLabel": "Other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedCashFlow": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses and other"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r196",
      "r201"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible assets, net of accumulated amortization of $91,030 and $126,769 as of November 30, 2021 and May 31, 2021, respectively"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r25",
      "r193"
     ],
     "calculation": {
      "http://www.biomerica.com/role/InventoriesTable": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Finished products"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/InventoriesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryGross": {
     "auth_ref": [
      "r43"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross amount, as of the balance sheet date, of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Inventory, Gross",
        "terseLabel": "Inventory, Gross"
       }
      }
     },
     "localname": "InventoryGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/GEOGRAPHICINFORMATIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryLIFOReserve": {
     "auth_ref": [
      "r45"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which inventory stated at last-in first-out (LIFO) is less than (in excess of) inventory stated at other inventory cost methods.",
        "label": "Inventory, LIFO Reserve",
        "terseLabel": "Inventory, LIFO Reserve"
       }
      }
     },
     "localname": "InventoryLIFOReserve",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryLIFOReservePeriodCharge": {
     "auth_ref": [
      "r46",
      "r47",
      "r48",
      "r191"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedCashFlow": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The change in the inventory reserve representing the cumulative difference in cost between the first in, first out and the last in, first out inventory valuation methods, which change has been reflected in the statement of income during the period.",
        "label": "Inventory reserve"
       }
      }
     },
     "localname": "InventoryLIFOReservePeriodCharge",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r5",
      "r43",
      "r347"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.biomerica.com/role/InventoriesTable": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventories, net",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet",
      "http://www.biomerica.com/role/InventoriesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r9",
      "r44",
      "r90",
      "r126",
      "r189",
      "r190",
      "r194",
      "r359"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory, Policy [Policy Text Block]",
        "terseLabel": "Inventory, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "auth_ref": [
      "r27",
      "r193"
     ],
     "calculation": {
      "http://www.biomerica.com/role/InventoriesTable": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.",
        "label": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterialsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/InventoriesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryValuationReserves": {
     "auth_ref": [
      "r43",
      "r192"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of valuation reserve for inventory.",
        "label": "Inventory Valuation Reserves",
        "terseLabel": "Inventory Valuation Reserves"
       }
      }
     },
     "localname": "InventoryValuationReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r26",
      "r193"
     ],
     "calculation": {
      "http://www.biomerica.com/role/InventoriesTable": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Work in progress"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/InventoriesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInterestAndDividend": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedIncomeStatement": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income and dividend income on nonoperating securities.",
        "label": "Dividend and interest income"
       }
      }
     },
     "localname": "InvestmentIncomeInterestAndDividend",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentPolicyTextBlock": {
     "auth_ref": [
      "r182",
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment in financial asset.",
        "label": "Investment, Policy [Policy Text Block]",
        "terseLabel": "Investment, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "InvestmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Investments": {
     "auth_ref": [
      "r393"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all investments.",
        "label": "Investments"
       }
      }
     },
     "localname": "Investments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseAndRentalExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "Operating Leases, Rent Expense",
        "terseLabel": "Operating Leases, Rent Expense"
       }
      }
     },
     "localname": "LeaseAndRentalExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/LEASESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseExpirationDate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date which lease or group of leases is set to expire, in YYYY-MM-DD format.",
        "label": "Lease Expiration Date",
        "terseLabel": "Lease Expiration Date"
       }
      }
     },
     "localname": "LeaseExpirationDate1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/LEASESDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r334"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee, Leases [Policy Text Block]",
        "terseLabel": "Lessee, Leases [Policy Text Block]"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r339"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/LEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r339"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ThematurityofleaseliabilitiesTable": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total undiscounted lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ThematurityofleaseliabilitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r339"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ThematurityofleaseliabilitiesTable": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "1 to 2 years"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ThematurityofleaseliabilitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r339"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ThematurityofleaseliabilitiesTable": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "4 to 5 years"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ThematurityofleaseliabilitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r339"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ThematurityofleaseliabilitiesTable": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "3 to 4 years"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ThematurityofleaseliabilitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r339"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ThematurityofleaseliabilitiesTable": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2 to 3 years"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ThematurityofleaseliabilitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [
      "r339"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ThematurityofleaseliabilitiesTable": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.",
        "label": "Less than 1 year"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ThematurityofleaseliabilitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r339"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Less imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ThematurityofleaseliabilitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Lessee, Operating Leases [Text Block]"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/LEASES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r38",
      "r95",
      "r159",
      "r183",
      "r217",
      "r218",
      "r219",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r302",
      "r305",
      "r306",
      "r313",
      "r345",
      "r346"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total Liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r23",
      "r95",
      "r183",
      "r313",
      "r347",
      "r378",
      "r390"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total Liabilities and Shareholders' Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r40",
      "r95",
      "r183",
      "r217",
      "r218",
      "r219",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r302",
      "r305",
      "r306",
      "r313",
      "r345",
      "r346",
      "r347"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current Liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MiddleEastMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region of Middle East.",
        "label": "Middle East [Member]",
        "terseLabel": "Middle East [Member]"
       }
      }
     },
     "localname": "MiddleEastMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/GeographicinformationregardingnetsalesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r78"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedCashFlow": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r78"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedCashFlow": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r78",
      "r81",
      "r84"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedCashFlow": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net cash used in operating activities",
        "totalLabel": "Net cash provided by (used in) operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedCashFlow",
      "http://www.biomerica.com/role/RestatementontheconsolidatedstatementofoperationsandtheconsolidatedstatementofcashflowsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedCashFlow",
      "http://www.biomerica.com/role/RestatementontheconsolidatedstatementofoperationsandtheconsolidatedstatementofcashflowsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r3",
      "r56",
      "r58",
      "r64",
      "r67",
      "r84",
      "r95",
      "r101",
      "r103",
      "r104",
      "r106",
      "r107",
      "r111",
      "r112",
      "r118",
      "r153",
      "r157",
      "r160",
      "r163",
      "r165",
      "r183",
      "r217",
      "r218",
      "r219",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r310",
      "r313",
      "r381",
      "r394"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedCashFlow": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.biomerica.com/role/ConsolidatedIncomeStatement": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net loss",
        "totalLabel": "Net loss"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedCashFlow",
      "http://www.biomerica.com/role/ConsolidatedIncomeStatement",
      "http://www.biomerica.com/role/RestatementontheconsolidatedstatementofoperationsandtheconsolidatedstatementofcashflowsTable",
      "http://www.biomerica.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "New Accounting Pronouncements, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r143"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of Reportable Segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/GEOGRAPHICINFORMATIONDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedIncomeStatement": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Total operating expense",
        "totalLabel": "Total operating expense"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedIncomeStatement",
      "http://www.biomerica.com/role/RestatementontheconsolidatedstatementofoperationsandtheconsolidatedstatementofcashflowsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:",
        "verboseLabel": "Operating Expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedIncomeStatement",
      "http://www.biomerica.com/role/RestatementontheconsolidatedstatementofoperationsandtheconsolidatedstatementofcashflowsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r153",
      "r157",
      "r160",
      "r163",
      "r165"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedIncomeStatement": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Loss from operations",
        "totalLabel": "Loss from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedIncomeStatement",
      "http://www.biomerica.com/role/RestatementontheconsolidatedstatementofoperationsandtheconsolidatedstatementofcashflowsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseExpense": {
     "auth_ref": [
      "r332"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating lease expense. Excludes sublease income.",
        "label": "Operating Lease, Expense",
        "terseLabel": "Operating Lease, Expense"
       }
      }
     },
     "localname": "OperatingLeaseExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/LEASESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r331"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Total operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ThematurityofleaseliabilitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r331"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Lease liability, current portion"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r331"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Lease liability, net of current portion"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r333",
      "r335"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating cash flows from operating leases"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SupplementalcashflowinformationrelatedtoleasesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r330"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Right of use assets, net of accumulated amortization of $595,116 and $469,077 as of November 30, 2021 and May 31, 2021, respectively"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedCashFlow": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense for right-of-use asset from operating lease.",
        "label": "Amortization of right-of-use asset"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r338",
      "r340"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Weighted average discount rate"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SupplementalcashflowinformationrelatedtoleasesTable"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r337",
      "r340"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Weighted average remaining lease term (in years)"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SupplementalcashflowinformationrelatedtoleasesTable"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLeasesRentExpenseMinimumRentals": {
     "auth_ref": [
      "r326",
      "r327",
      "r328"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the payments that the lessee is obligated to make or can be required to make in connection with a property under the terms of an agreement classified as an operating lease, excluding contingent rentals and a guarantee by the lessee of the lessor's debt and the lessee's obligation to pay (apart from the rental payments) executory costs such as insurance, maintenance, and taxes.",
        "label": "Operating Leases, Rent Expense, Minimum Rentals",
        "terseLabel": "Operating Leases, Rent Expense, Minimum Rentals"
       }
      }
     },
     "localname": "OperatingLeasesRentExpenseMinimumRentals",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/LEASESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r36"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r51",
      "r53",
      "r314",
      "r315",
      "r317"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedIncomeStatement": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Foreign currency translation"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedIncomeStatement",
      "http://www.biomerica.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive loss, net of tax:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherIncomeAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Income and Expenses [Abstract]",
        "terseLabel": "Other income:"
       }
      }
     },
     "localname": "OtherIncomeAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r286"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other research and development expense.",
        "label": "Other Research and Development Expense",
        "terseLabel": "Other Research and Development Expense"
       }
      }
     },
     "localname": "OtherResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PatentsMember": {
     "auth_ref": [
      "r299"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law.",
        "label": "Patents [Member]",
        "terseLabel": "Patents [Member]"
       }
      }
     },
     "localname": "PatentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentsForRent": {
     "auth_ref": [
      "r80"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash payments to lessor's for use of assets under operating leases.",
        "label": "Payments for Rent",
        "terseLabel": "Payments for Rent"
       }
      }
     },
     "localname": "PaymentsForRent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/LEASESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireIntangibleAssets": {
     "auth_ref": [
      "r76"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedCashFlow": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.",
        "label": "Payments to Acquire Intangible Assets",
        "negatedLabel": "Increase in intangibles"
       }
      }
     },
     "localname": "PaymentsToAcquireIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r76"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedCashFlow": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredStockNoParValue": {
     "auth_ref": [
      "r15",
      "r229"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount per share of no-par value preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, No Par Value (in Dollars per share)"
       }
      }
     },
     "localname": "PreferredStockNoParValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet_Parentheticals"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r15",
      "r229"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par Value (in Dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet_Parentheticals"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, shares authorized"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet_Parentheticals"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r15",
      "r229"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, shares issued"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet_Parentheticals"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, shares outstanding"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet_Parentheticals"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r15",
      "r347"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred stock, Series A 5% convertible, $0.08 par value, 571,429 shares authorized, none issued and outstanding as of November 30, 2021 and May 31, 2021",
        "terseLabel": "Preferred stock, undesignated, no par value, 4,428,571 shares authorized, none issued and outstanding as of November 30, 2021 and May 31, 2021"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets.",
        "label": "Prepaid Expense and Other Assets",
        "terseLabel": "Prepaid Expense and Other Assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r7",
      "r31",
      "r32"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid expenses and other"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PriorPeriodAdjustmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prior Period Adjustment [Abstract]"
       }
      }
     },
     "localname": "PriorPeriodAdjustmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedCashFlow": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from sale of common stock, net",
        "terseLabel": "Proceeds from Issuance of Common Stock"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedCashFlow",
      "http://www.biomerica.com/role/SHAREHOLDERSEQUITYDetails",
      "http://www.biomerica.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r77",
      "r280"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedCashFlow": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from exercise of stock options",
        "terseLabel": "Proceeds from Stock Options Exercised"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedCashFlow",
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyAvailableForOperatingLeaseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Property available for operating lease.",
        "label": "Property Available for Operating Lease [Member]",
        "terseLabel": "Property Available for Operating Lease [Member]"
       }
      }
     },
     "localname": "PropertyAvailableForOperatingLeaseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/LEASESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r12",
      "r13",
      "r208",
      "r347",
      "r385",
      "r391"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property and equipment, net of accumulated depreciation and amortization of $2,026,764 and $1,972,357 as of November 30, 2021 and May 31, 2021, respectively",
        "terseLabel": "Property, Plant and Equipment, Net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet",
      "http://www.biomerica.com/role/GEOGRAPHICINFORMATIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r34",
      "r208",
      "r418",
      "r419"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property, Plant and Equipment, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Property, Plant and Equipment, Useful Life"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis": {
     "auth_ref": [
      "r329"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by property that could be leased or is available for lease.",
        "label": "Property Subject to or Available for Operating Lease [Axis]"
       }
      }
     },
     "localname": "PropertySubjectToOrAvailableForOperatingLeaseAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/LEASESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "auth_ref": [
      "r70",
      "r188"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedCashFlow": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.",
        "label": "Change in allowance on accounts receivable"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r260",
      "r342",
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r260",
      "r342",
      "r344",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r286",
      "r360",
      "r431"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedIncomeStatement": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedIncomeStatement",
      "http://www.biomerica.com/role/RestatementontheconsolidatedstatementofoperationsandtheconsolidatedstatementofcashflowsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "auth_ref": [
      "r286"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.",
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "terseLabel": "Research and Development Expense, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r19",
      "r244",
      "r284",
      "r347",
      "r389",
      "r408",
      "r413"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet": {
       "order": 6.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Accumulated deficit",
        "terseLabel": "Retained Earnings (Accumulated Deficit)"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet",
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r98",
      "r99",
      "r100",
      "r102",
      "r109",
      "r112",
      "r184",
      "r281",
      "r282",
      "r283",
      "r295",
      "r296",
      "r308",
      "r404",
      "r406"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings [Member]"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r144",
      "r145",
      "r156",
      "r161",
      "r162",
      "r166",
      "r167",
      "r170",
      "r248",
      "r249",
      "r361"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue From Customers"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/RevenuefromcontractswithcustomersTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock": {
     "auth_ref": [
      "r169"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.",
        "label": "Revenue from External Customers by Geographic Areas [Table Text Block]",
        "terseLabel": "Revenue from External Customers by Geographic Areas [Table Text Block]"
       }
      }
     },
     "localname": "RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/GEOGRAPHICINFORMATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "auth_ref": [
      "r91",
      "r92"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.",
        "label": "Revenue [Policy Text Block]",
        "terseLabel": "Revenue [Policy Text Block]"
       }
      }
     },
     "localname": "RevenueRecognitionPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r65",
      "r95",
      "r144",
      "r145",
      "r156",
      "r161",
      "r162",
      "r166",
      "r167",
      "r170",
      "r183",
      "r217",
      "r218",
      "r219",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r313",
      "r384"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedIncomeStatement": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Net sales",
        "terseLabel": "Net Sales"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedIncomeStatement",
      "http://www.biomerica.com/role/GeographicinformationregardingnetsalesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r336",
      "r340"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-use assets obtained in exchange for new operating lease liabilities"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SupplementalcashflowinformationrelatedtoleasesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received on stock transaction after deduction of issuance costs.",
        "label": "Sale of Stock, Consideration Received on Transaction",
        "terseLabel": "Sale of Stock, Consideration Received on Transaction"
       }
      }
     },
     "localname": "SaleOfStockConsiderationReceivedOnTransaction",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.",
        "label": "Sale of Stock, Number of Shares Issued in Transaction",
        "terseLabel": "Sale of Stock, Number of Shares Issued in Transaction (in Shares)"
       }
      }
     },
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.",
        "label": "Sale of Stock, Price Per Share",
        "terseLabel": "Sale of Stock, Price Per Share (in Dollars per share)"
       }
      }
     },
     "localname": "SaleOfStockPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SalesRevenueNetMember": {
     "auth_ref": [
      "r137",
      "r170"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue Benchmark [Member]",
        "terseLabel": "Revenue Benchmark [Member]"
       }
      }
     },
     "localname": "SalesRevenueNetMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable": {
     "auth_ref": [
      "r103",
      "r104",
      "r105",
      "r108",
      "r109",
      "r111",
      "r112",
      "r124"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of prior period adjustments to correct an error in previously issued financial statements. The disclosure may include, but is not limited to: (1) the effect of the correction on each financial statement line item and any per-share amounts affected for each prior period presented (2) the cumulative effect of the change on retained earnings or other appropriate components of equity or net assets in the statement of financial position, as of the beginning of the earliest period presented, and (3) the effect of the prior period adjustment (both gross and net of applicable income tax) on the net income of each prior period presented in the entity's annual report for the year in which the adjustments are made. This table can be used to disclose the amounts as previously reported and the effect of the correction or other adjustment on per line item or per share amount basis. This table uses as its line items financial statement line items that are affected by prior period adjustments.",
        "label": "Schedule of Error Corrections and Prior Period Adjustment Restatement [Table]"
       }
      }
     },
     "localname": "ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/RestatementontheconsolidatedstatementofoperationsandtheconsolidatedstatementofcashflowsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r9",
      "r28",
      "r29",
      "r30"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Schedule of Inventory, Current [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r269",
      "r275",
      "r276"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Share-based Payment Arrangement, Option, Activity [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SecurityDeposit": {
     "auth_ref": [
      "r49"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease.",
        "label": "Security Deposit",
        "terseLabel": "Security Deposit"
       }
      }
     },
     "localname": "SecurityDeposit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/LEASESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r142",
      "r144",
      "r145",
      "r146",
      "r147",
      "r148",
      "r149",
      "r150",
      "r151",
      "r152",
      "r153",
      "r154",
      "r155",
      "r156",
      "r157",
      "r158",
      "r159",
      "r160",
      "r161",
      "r162",
      "r163",
      "r164",
      "r165",
      "r170",
      "r210",
      "r211",
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/RevenuefromcontractswithcustomersTable"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r74"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedIncomeStatement": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedIncomeStatement",
      "http://www.biomerica.com/role/RestatementontheconsolidatedstatementofoperationsandtheconsolidatedstatementofcashflowsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeriesAPreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Outstanding nonredeemable series A preferred stock or outstanding series A preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Series A Preferred Stock [Member]",
        "terseLabel": "Series A Preferred Stock [Member]"
       }
      }
     },
     "localname": "SeriesAPreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet",
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet_Parentheticals"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": {
     "auth_ref": [
      "r274"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period",
        "negatedLabel": "Option Cancelled or expired, Shares | shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/OptionsActivityTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r274"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price of options that were either forfeited or expired.",
        "label": "Option Cancelled or expired, Exercise Price Weighted Average | $ / shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/OptionsActivityTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Option Granted, Shares | shares",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in Shares)",
        "verboseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/OptionsActivityTable",
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails",
      "http://www.biomerica.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r271",
      "r279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Options Outstanding, Shares | shares",
        "periodStartLabel": "Options Outstanding, Shares | shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/OptionsActivityTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r270"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Option Outstanding, Exercise Price Weighted Average | $ / shares",
        "periodStartLabel": "Option Outstanding, Exercise Price Weighted Average | $ / shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/OptionsActivityTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r263",
      "r267"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SHAREHOLDERSEQUITYDetails",
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Option Exercised, Exercise Price Weighted Average | $ / shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/OptionsActivityTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Option Granted, Exercise Price Weighted Average | $ / shares",
        "terseLabel": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in Dollars per share)",
        "verboseLabel": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/OptionsActivityTable",
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails",
      "http://www.biomerica.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r265",
      "r268"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Share-based Payment Arrangement [Policy Text Block]"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks of a company.",
        "label": "Share Price",
        "terseLabel": "Share Price"
       }
      }
     },
     "localname": "SharePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r266"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1": {
     "auth_ref": [
      "r272"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price (in Dollars per share)"
       }
      }
     },
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharesIssued": {
     "auth_ref": [
      "r243"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.",
        "label": "Shares, Issued",
        "periodEndLabel": "Balances (in Shares)",
        "periodStartLabel": "Balances (in Shares)"
       }
      }
     },
     "localname": "SharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r88",
      "r97"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Significant Accounting Policies [Text Block]"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r2",
      "r142",
      "r144",
      "r145",
      "r146",
      "r147",
      "r148",
      "r149",
      "r150",
      "r151",
      "r152",
      "r153",
      "r154",
      "r155",
      "r156",
      "r157",
      "r158",
      "r159",
      "r160",
      "r161",
      "r162",
      "r163",
      "r164",
      "r165",
      "r170",
      "r195",
      "r209",
      "r210",
      "r211",
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/RevenuefromcontractswithcustomersTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r14",
      "r15",
      "r16",
      "r93",
      "r95",
      "r115",
      "r116",
      "r117",
      "r119",
      "r121",
      "r128",
      "r129",
      "r130",
      "r183",
      "r217",
      "r221",
      "r222",
      "r223",
      "r226",
      "r227",
      "r229",
      "r230",
      "r233",
      "r237",
      "r243",
      "r313",
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet",
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet_Parentheticals"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r42",
      "r62",
      "r63",
      "r64",
      "r98",
      "r99",
      "r100",
      "r102",
      "r109",
      "r112",
      "r127",
      "r184",
      "r243",
      "r244",
      "r281",
      "r282",
      "r283",
      "r295",
      "r296",
      "r308",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r404",
      "r405",
      "r406",
      "r440"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet",
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.biomerica.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r98",
      "r99",
      "r100",
      "r127",
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet",
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.biomerica.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r15",
      "r16",
      "r243",
      "r244"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Net proceeds from ATM (in Shares)",
        "verboseLabel": "Stock Issued During Period, Shares, New Issues"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SUBSEQUENTEVENTSDetails",
      "http://www.biomerica.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r15",
      "r16",
      "r243",
      "r244",
      "r273"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Option Exercised, Shares | shares",
        "terseLabel": "Exercise of stock options (in Shares)",
        "verboseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period (in Shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/OptionsActivityTable",
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails",
      "http://www.biomerica.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r15",
      "r16",
      "r243",
      "r244"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Net proceeds from ATM"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r42",
      "r243",
      "r244"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Exercise of stock options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockOptionPlanExpense": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedCashFlow": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for option under share-based payment arrangement.",
        "label": "Stock option expense"
       }
      }
     },
     "localname": "StockOptionPlanExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedCashFlow",
      "http://www.biomerica.com/role/RestatementontheconsolidatedstatementofoperationsandtheconsolidatedstatementofcashflowsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r16",
      "r21",
      "r22",
      "r95",
      "r179",
      "r183",
      "r313",
      "r347"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Balances",
        "periodStartLabel": "Balances",
        "totalLabel": "Total Shareholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet",
      "http://www.biomerica.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Shareholders' Equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Note [Abstract]"
       }
      }
     },
     "localname": "StockholdersEquityNoteAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r94",
      "r230",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r244",
      "r245"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Stockholders' Equity Note Disclosure [Text Block]"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SHAREHOLDERSEQUITY"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r324",
      "r349"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event [Member]"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r324",
      "r349"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r348",
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "Subsequent Events [Text Block]"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SUBSEQUENTEVENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplierConcentrationRiskMember": {
     "auth_ref": [
      "r136"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that purchases in the period from one or more significant suppliers is to cost of goods or services, as defined by the entity, such as total cost of sales or services, product line cost of sales or services, segment cost of sales or services. Risk is the materially adverse effects of loss of a material supplier or a supplier of critically needed goods or services.",
        "label": "Supplier Concentration Risk [Member]",
        "terseLabel": "Supplier Concentration Risk [Member]"
       }
      }
     },
     "localname": "SupplierConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ThresholdPeriodPastDueForWriteoffOfTradeAccountsReceivable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Threshold period past due for trade accounts receivable to write off as uncollectible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Threshold Period Past Due for Write-off of Trade Accounts Receivable",
        "terseLabel": "Threshold Period Past Due for Write-off of Trade Accounts Receivable"
       }
      }
     },
     "localname": "ThresholdPeriodPastDueForWriteoffOfTradeAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_TradeAndOtherAccountsReceivablePolicy": {
     "auth_ref": [
      "r173",
      "r174",
      "r175",
      "r176",
      "r178",
      "r180"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for accounts receivable.",
        "label": "Accounts Receivable [Policy Text Block]",
        "terseLabel": "Accounts Receivable [Policy Text Block]"
       }
      }
     },
     "localname": "TradeAndOtherAccountsReceivablePolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r131",
      "r132",
      "r134",
      "r135",
      "r139",
      "r140",
      "r141"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r114",
      "r121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Diluted (in Shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Weighted average number of common and common equivalent shares:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r113",
      "r121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Basic (in Shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 4
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(19)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=SL124452830-107794"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2626-109256"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=124437754&loc=d3e543-108305"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8672-108599"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "a",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e4975-111524"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=SL6953423-111524"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5212-111524"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5093-111524"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.L)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e99989-122729"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "http://asc.fasb.org/topic&trid=2126998"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130531-203044"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130532-203044"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "705",
   "URI": "http://asc.fasb.org/topic&trid=2122478"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)-(4)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(4)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=120253306&loc=d3e28129-110885"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123602790&loc=d3e30304-110892"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32022-110900"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "830",
   "URI": "http://asc.fasb.org/topic&trid=2175825"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=123403832&loc=d3e34039-112682"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(Note 3)",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=123403562&loc=d3e38371-112697"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=123406913&loc=d3e41499-112717"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=123405975&loc=d3e41551-112718"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918666-209980"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888251"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "http://asc.fasb.org/topic&trid=2122774"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=123371682&loc=d3e55415-109406"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "330",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123345438&loc=d3e61044-112788"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.1(h))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(b))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=123364037&loc=d3e3115-115594"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r432": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r433": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r434": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r435": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r436": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r437": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r438": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8,17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a-c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(5))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(a),(b))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>48
<FILENAME>0001513162-22-000008-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001513162-22-000008-xbrl.zip
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MS47C O1VJ5B+>:+G(1^WG>X]^:*_79J6V?:X6>/CV)O;I4]?<RK8-0P(O^;
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MLN"4.8>[L.,"1MB?0[]H^DOX]+Q#U;S^EA_HFD;A(?Y?X%'5S<M)9N;\+(O
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MC:CI4.<2K<.SF=H>UF'BYY;A9<OPU) C<6K)FAIR)$XM65-++T<>,]B1FB2
M'C4,&+1 GJE)62=H=CZ(H@UU4W=<9IR_T"0D.Z7"$\QJS'*O[?& P;[Y[%4W
MM?H,<S5]QV]5-JQ<E87:@BR\W7<2D#&SP9A[;1_OSYA%L2A4BW&69"-C9H,Q
M]]I>W9<Q94&N%8528?XD#V3,<V?,O;8?]V?,BB0*E07'@A]X;S+CB;Q=ZE#%
M5@?<=M?H"S6L$3N]Y5QCZ7M71F3@T/!3E$L<DVQ9!>@]VWWY0 #0?#.%@;6X
M7):J0DG>K$D! @@"" )(@@%DST9D.P)(62B5Y_L&(( @@"" I Q ]FQ=MA.
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M6VA@KT8DVT0&JD)-E(3BIEDGFZ6@J9;!?OHU)\,\5D.P*/[] .FR_FTW8Z)
MI-C$5O846#FI1,THB<=)] >4**IJ#>$'8]U\AM&[\%S%AH]-H@/K/]N*04:*
M[1+KB;@#ZE"XL>)2?A+)Q<(F$/"/ E@$?S7]Y?!HH,)(J+T>#H+KHKIV\=C$
M+<:VWTCF%VH7:H 1%ED'\@6H?MI9O1_ ;I,B7P;VI]GI/-2_-?/7W6;]E_QU
M\[;3;5X2Q7A5QDYNPFS\SRK.VXX.FXG7;CP,T&79E^1'42R759413B$#F^F
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M7K(?QK#< ;710D4S[N!*)V"_&_I$;9MJ0;RR;FH=QH(\GKD"!2IR62B6-\.
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ML5Q6548XA0QLAK _]CL-D$8F,SR$R^"=RY=R-;/2AYE?]N3CNM6Y;W9;C;I
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MQ/"7V"<SY(CZ)YM<S\DWL Q&UB!>P9M(@0?C[[.MOT7$!7KOKOGBT@:B#9E
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MU,!SC@/Z3N%))/4O:+G6J[\/!U?LI]KOOX(BH.$A6D)+E3NJ73*BADY?^-!
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MKV$"4)V[ZE*>"Z=+QG1G@*1'&,,E7A\-7E_/Z1V\[NF5&B_T"\L!W(#6Z^Z
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M<4_6]B7AY+ZZ__+EYNG+X.YI2/IWUP#==T^@5@_NKF[VW*IUR\7K)+U:4W*
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MZL5[=#8\]J^$Z^'VYFIP-[RY^T3ZGQX' ^Z3.(2UFKX:W%[VN;/;/J_K-E4
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M?=VTJ8M%H"*YX@I:PA(+S, M38IW:# ]=(%X-XX#6W$]MP&-'IAS;CA1;.H
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MPI3H50QKDK$]Y_H-?;';M5*S%W&?++F<G'H )"LY\0Q%2:<M>.(9>J=!J$/
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M"KNM;AN -Z+?5QSM, 2J,H23'1B>>]&6/,$P_YHY$@UW-II3HF&C6JJUNAF
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M5"L%1*+\/,<@MI *> A8[OK34VG!&, +C ?)LX+:*,@&A2^"FN*S70G  2<
M<[)MG5<9'UG *<1Y,S4XZX%#<'86O@3D8&PHTRDR_9L_!.-..*C#[*AC/7,N
MF.H$%&&0V-"W=<,P47D(:$)@8E-GQK1!YE2WIE/++ F%1\Q3TU#E("\4AC
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M3XBE1#<B3[E>,33_ -^] P'V##D9N($WGY5?^%DYP+/RW<C^[7T<!U50BPD
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M7*V7+\QOSWC-\IJ$NC3>@?*G4-J&;NJJ8DB&,DC/_=G+S!<8$CRN+53*V2#
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MVYI(*NS&FA#;7VH\:RK8!*Q-)2!D00T7I*NM@\MS3$![SD[44X*=L#2O->0
M>ZW)Q9<)0,[)Q=)^2& -2C&.>>5R:(#_5('!@5P $L.A QM"Q""\#=W<!=-U
M1M=KL1NN+(>FHSIF.6OK)@]? T!,%5T+DPU?CO87>?\;DV. )(16VI-6HC+%
MIW5G4:;LDD&#O+&HOJ(TUZEGJV.:TPE\" ^!!'-GE/W1ZF3)N=1TE8O-\*6
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M31H=>/  <3 Y;(R!S/10X=^*T#%A1LSM'M"\0[Q1QXI[-&Y.\@R6<!=F\<'
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MN251KZ5-:R+[H1O^AN?J.BW4C89]7@*<J;J0JP'T?3!)#BWS$P2+Q^ 5R\\
M.P'6218P U_]!>:6U+454\^MO-9K=^YR >C]4DD.O4Q$P <66H0 5C,Y0L^8
M&/2H?&,7V"P,J<&+M%M!\!7 QB^CCY4#, O SZF?3\U:)JZPCN(<83@1Q>P_
M,8#)P)@CQ/\@\H-L=C[<Q3!<"C**8OB@Y1N1P6A</0 T0'Y4#8.19Y0H1'1[
M'E8.@Z>)B681ORFJGV/&2%L+"@VP*M?(T<XR2[-Y*/M.F9T:I 'U0T9?J#]
MJ=1_*+3L X%"Z5G!E"6PX!1GYY'BY(JC1K"$D>>QSTZ3)GGZ/UU+XXFR%1S0
ML2X 2WK^?-ON]!Y:W=N';J=?.*63Y2ZU EI!/69*]GYJRER-5O]$"8)#=[X"
M"US0<Q96TJ-F^]S[0:9A3II97E#O1%7 -*&2*SC,87KB4HF ,"-U97).E#>X
M^![F/RE!-O,]O"=U<U(7'8H@,MY'94<^)%=P)/<^SI8AT+:O>(@CL[14IHU
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MLUN/BFY@D/"59=_!EXJKFZ-KHC@DEJERX>DP@3GJFEW[43=)6S'TH66;+X8
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MT#/]^1Q6;7FV2ASVYY@H&@UP@4=A,?#AP-)F\&/L3HR/_P]02P,$%     @
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M/SRF-E+:>3*P-2,?[#S;,$M.5@(0N4OR36R&C^B2_!:Y/FE6#=F9\9ZV>P?
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MA&68:S?R6FCSHIJA/$):I*HO*.,W7JAQN4\K\2(7^0S* J<OL%-<*]$ZCVC
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MQ:R[GQUC^B9PL*7']0&9T+1>$WM'X,%'Q$S?V7,8WD3DMIE&(5RK"UO62G-
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MJ5(D5.4@+E$:CX]4T*3^,*A$)&#4NUB2!J]#V)!PJ($Z-]J)X[T,-D1/[$]
M:Y*8:%UW?R4V&;)@BB1PU2_ !OS<2_HUEO8PDP(&*&A[OCI_+$GB%^<K[UNH
M+UUX?NOK%(8(Y/->W&H:#=?#/#_OU?)Q"/"B%R^,7W]XYM[@S$^FQ\,^[,]!
M(_7A!I\2[=IFW]10(G!NT6RXM>>9(=/7M?INP&I%SCV\8DI+QUPM9/^>-)AJ
MIR3<6IB,0YJ(1B/Y89^$4]FP= BVI,6"Z.OQ:C8?D14E@HYR/A)-QV&I-M%
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M]Y&/T^ ^@L@NB*\NYZ^(E'^_(-*>7M*?G* /34VJ)KPK+UDE=,_S*>@KG-P
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M+5R<&6&\Y>=CA'&P4QEAQ<D=%%,%)_=\#FZ)!F@<W"(6F>>+TO=!T+4"GEV
MZ[7:'-/2R31Q9YHM5+FJW<Q1.3+BEA&UIU70RQOVRZ+J-$Q<0$%JI\%L;?&V
MLD<U&#)^TS[58S@MO'AF?E-2Q53Z*H%)B\[^)Q74D"=4]07LE:E1K^IH=^A3
M>Z:I<UA=3LFQTFF7F]!CB-O=H5<EF::D6*)M/K<J+^/R6F<Z,0W9&P3VR5D0
MD6W(F7W+6WX^]BT'NSY!QDTQ?>ZA18D2:)BX(BX9FKBGFPU>9ZO-Z?.:/OBY
M)@[T*H*%B:L'_P%W[Y&8;U,]D>J%@-5;Q3Z8B1X-4Q!PKN$<"$H(%,1^IH67
M0(_=JJF)"C2ZK_3ETY#JY 1<"^0U\?B28)UA/U^R^8O:2/86IWO5M [W/FT5
M7N'/:)I$X2V3,$6-0F41=:LD2@Z)H(@:?^[G<+XHOCD:LJ,_X&IMIP:G&]UN
ME".W+[=AS9AIJU"H#C550D%C#>NMO1O+BR]&.*V)W60!\"3";<-9H\A4 ?*4
M*ZB/$H?!FIA!DU::D"QGLX^@& UY6AZME)//F$FM>K4 &Y7AY(3W]]3R1.CR
MX0=?>X29[-UY-M1 M+CZB0ZWKHB#3'4AOVO)Z7SRAKSPRM]E7WM/'\CQDP1>
MF-(^&_DC[:GR)97+6LZ25.$C>O7@/:%M,<'Q&:,K2>Z[?#GA@](?\Q5^B)-?
MX#E.O,:I3163K&O=:E&B)% SF #6^2Z)[PE6CI/%M07*U30%\>96;P[_+(B"
M] '[[^/8MZEGDG5=Z9D8)5%3NGP"*!H\YYK)EJ86*5?3%.3WU31Z!.?1\#S"
M*.@7)3"-1',MJ8<,!]'CJOPZHQCNN@2;C@A*:TE&JG$O&6Z%Y5J%^7<OU9 \
M7X@6E\^1J?4/9?U%)]F3QL=R; N^3\^H,0E1Z'EMO+@OA+MV25,H7J?GTNCL
MGJKCF$Y7K+&)$7<4T56>_]&=7NP>4G)U/(Q:K:&+N_"K)%A/4W?'%NZ3M*NS
MN:W+J)-N]LW/M>SX1">B BK*P9+O^-_1JW^V@T!'JR?ZQ)5B&SW\8_O,4%$H
MZ4TU@F;^CV).)K8!A>4'HOD>6N"DYQ&[3GR?Q.E$Y>@GP--FQ?'QT9>?).]9
M:R*9Q_ I?I 2=1OSXQ.QVWXFZ$24<-MUC-BLCBU;=:J#WY"E9]6P[I-6Q<,)
M7%B=AC#34#-U[T2!.OZ/"@X3VH1F1]H+I_GYPB/B;[F2MSW*-"V8?QYO8WRE
M[O69CRPYZ_WC[-)G:B*EYH=21[5;J@_6TTD<AEZ2HAU.F,X[;OK]+Z7SAZ-?
M.HUA<XU+HZDM-IW>.VWM^"^EWT?374*K$"W;FW^Z-ET_$BPGX-BE3F[:E>\V
M_Y6,.R,%'W4OZ"]!5RDI9W&RP4&V)T*'$C;/NR"A$$K,9QEC5F/MI(;2Y&3)
M/_9CJ.00AN2;CA.H+!PD\K#T'+_ML=1US*B,GEA,^Y=-C=S\3O=)*9K;83\E
ML2;;P;].KL,H7X;5?60R*X%B<4L&3M;$O+F"Q?O>QL*BMWXP!L&@;F]R)ZK-
ME4?C55^'JMYU+VD6]#5^Q-$>0SF7HFYT6B\<W>]UGSXT"PK0#R-AWQHZ/R\;
M7D! 3P1$547<\;M0,T&6B?#]6&1<7K7L<_YNGP813M,;?$]=I<FV'/F*5E\0
M2E$1]6;-AW"V)">-637$Q^UK+R1Y0/(N1V?K*GOZG-=.@+K Y/_\6^]Y$A4S
MP</FJW<#_!0;(8!"QYS^"0YT<H 6U#75E$D#[MRA<MI#'/J$A5 ()'NYC#,\
M:1D&Q9*VO2(I-K)FU?FDWWF[./T#8G,13)Y)<08]T78:6<MY8?06\3V.[Q-O
M]Q"LSZ--G&RI*W$2I.LP3HF+T<NPTX5EK92#)D("3:IFH]IT5,WG%WVP_YBQ
MIPQ+FZX/>PPK@'"7N,;WQ"^!1SHXN_'"GL5!>H*TY4/T0TNM<D%-Y9("#-1T
MIM6>9^%-F E7KGYRCO7V*](DJVS,:D$OU/4G"(#:\4G^U3XZY2O8R063XJ!4
M-2]T',_0$A*HC9I.<VNKVO=N\7/VC@S^95)32[:>W0Q""28"W:D=@3 %T3F"
MT]"!=:4ARKIII:*_YY4,W=MN]KM=2-74"Z&0WUD8/S5V.=HA\#:FC8'[G7^&
MH*T976;XB:SY&C!63G)#P+4.1PH093%K&2VHQ67]=!RF N4I.8"=YIMAV:&+
M0BUZUDRR#PJ6LKL%\I$07HP5?=I*A<SKMU<=W)@F.MX'Y5*L;X$2^@TOI*_A
M#FJU^9BRKENKN\P+(BBP710J/8N3YJK3=B\=@H_5(/  1$5!.8!X$&\.]BG.
MFYRC. <+69UE[6RRJ1 'XZFMQBBL&MFZOO(:0:T:0;V!S!X0G&Z";=W97N,M
M0:3XXRU.MD<6-E\-)"Q>R?;%353VKDA-\/+4A*28FFMW1B;33/T7["6U9X[.
M-VQ]G1!OY9IL,[ZODZX&AC54E86:U%>8J,9$31%[(S$7+>;@IJO%?CZ5-CQP
M>\%BJ@/:6BMBDUDRP^T#_N!E^X3LX:M-8T_O6Z98#Y(5ZT$?'X&"D;E0A)9.
MAH8:G9-_'A6.>PFO]*'T&3/@0+^ :S\LL!8*DYIMP#Y.5ILSHM5>^",Y=";9
M% >@8W%[-,=2H,< $&7$=D-']$!W[((-5XKZ+CF06\:GO-:Z)WM\B9^SVR<<
M/N(/<90]3!,P,$;&9DJ%*9("K3Z"Z-9K9J&Z/>R'JD)O=18QR3RXI;LL?#>W
M3[%3)2YPL!L.ZXF=0&E?@]*^Z2CMG+6V)7(39:WSQ#!VUFLIHI;3/,#HCX75
M.%EO] 1:^@:T]*N6ELY=1>M"-U;2DBE3&[WY@F=$_LXUE2(Q-P.WAIM 2[\"
M+?VZNY?.75/K,C=5U)(MD]NO3K7322M!7>1$40. C_91$8W"?AXXV.53/PUC
M=8B&#GI1)5WD8XVMI\_0Z62YA7_9UU(A)G/92$4(RH($P7:WS^@-6(8)LMF<
M3525*F@KKI11(]T"3'N1*[FD=1/35UV_LCU2YT[5>>Q>>E>JO <U:C@<;[=!
MQE[\1#X\K" +X @:$*J2T,?J%]P+ \LO('HA)]"_&@S:E+<!19'-[J)-KXE&
M-+KL]N:9<=64_5V*?]V3E4X?Z7*3/LT1+6;WB:( "V'Z7C$<L?&NFS_IBJ[Q
M]$9&\P#?^2H)XH0]V5_Z/^]3JK.3ZI!\1:N*)$5%H$UT3EZ$#E6SG-],]A)H
M7;/43#!0K_RY=EKDR:^BVP=,ML$T#@,?<D7+#/K5)C_3H<-9Y(N'%7FG?=_Y
M3XN#G9BX#5*$KVG+55$<H>P!0W&!$B*J_753&)C01 I.>?G@6N*JZX_'IKK6
MJAE,+T_#X/]QG!*0M-TD6?0&)X\!<=-NXG":&FJ2Y6S>EXK1$%JU*=5D^AC.
ML>NN%EG3/I62:GZO>9HD<7(<)PE>%SK+/6#2FO:_>ZG](Q\8^2PF,%G)C4D0
MM6J]3$&!0-'I4JA::R&H0.1 [Z=4N/H7,QFW#:PK'P?_.(G7>P +@I!\("E>
M?WD?/[XB4]BW07Z@GP3]&#J ;)5G;R\L>N.7#Z'JYB(@(.(T: :7AMY!J#J4
MO^R]A+ L)&JSBQ.9^Z4OUC9,>]V()%BHQ%T.1VR\H[-50S9M1> 1.O +ORH:
M_IV0G604G6A"'-^%T5*)!A(JA<C];3(:G=1SS1TI U<D;57H$MC3&F]L,(D7
MI0%[;#G:WM !.L7MK]81T$)$>1R4X]L;A*NS02">SCG!([1OZ!< GD99D+V<
M!2%6ME]7ZT,'F.4MH;V^R JEPQ",0VR@JRP4F00*D7.),M@!&)QK?!^ 7Q]E
ME]YVV"G !3BVGZTA[R8&<IE78Q$,=N-RJ*31E#R'O/YN=07N/%K'"=DR:"B(
MQGV.P8U(7HYC?PQ]D,-WH!Y2A.3:TIBZ0'0RH@XL!8  @D.3LH= FRJE9LD0
M#;OUGL]]<D8%FV!-5QCM9!%!MFUN2+&1JQ29A)JS.D>0$RU2"*VI/S+*S8V0
MI>\GD,/#_G,11%CV3EQ79WA0'>Q"'#3DBI*/7!0_()B#5I'S,TLBIJ:6B$@>
MLK?DP([A\6-R&S]%XVE(#:;=V(8 "TWU.*9O7!,$4QSO(4+A</6B1:EA<*,!
MDAYEJ^0JB1^#2-K*HZ=NM $[5) 6*II:4IHNQ;QYJ(I 8%Q]X1$^AM)<Q6GF
MA7\+=B,9P%RP3AQA'B::^L+F(#*I;>2Z5!>NJ+C*TJ79P&.&'6J98&^P8C0
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M'#R"PS")T@U Q[9*FJ,J;,6; \S3&1" 1"=[YI12J <$+&0]4,!%%Q.H'U:
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MTX[3)(F3XYA8.?0+KRYY564Y&"SXT"@TQ, M$ 6(*H@+5,'D>( 6A6K*@[J
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M2/[/>U: );V-"2Z$!4$(5S[LR=Y%G)+?CU26J+86. #E:@A>I^;/'#^'%;^
M/X]2P,A)B&L"EG(C99.)SJ*5U/2?^K4RZ597=1[8D;W7$5-JN\E[[IS>QLLU
M.;H3K/N>L&S_2C[/?*KD3:$+XU-%&=?JU&.'W>!HT?3AUGMF2'SOA7M6P#\,
MXR=/TL^]F$J?C!?1_W(Z*N>[%)0&>3Q1:7/%<E+5=ANPC9A8QE"ZG7SEF.S&
M..V1KEN#0CV%!AQEMJZCLZX?Z?SLK?[,L[U?BMQ2<IQN]N%%L!%^BPHGG@%
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M+KP^>H7#+"U^<P"_.3@\.GAS].5SZO^;8 G+KZ#K:P.KN#'6?%"N.$ZW;+Y
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M@1< @D(P\/T0.&-,_TLE7$?1U\X3U,,*M_##TFN8K]R RC+#CV.&LPO2E07
M&#C#F)5252,](^KDAQI;1:I@#ZTMZ!F@.B/<--6B X+?"+(()T;P6GS@=KXG
M2^ 6X "2)B>I_<P"9'^Y ^L'@+G\D^I6VL@#!S;RHX\HXH/A80C66^ZZKN7[
MXT6DF[;YM5R::7:K)U0&4@F';QN?0;.J:)PK"\2<A;-29K-9VHH@RD]VLB,'
MT&!IIWK&4S5V&/*RO3AW0IBXJ9H-S4-1/8]D-AA)M]^E!BECCQW?!X'?#3%5
M4>M6L5C286]H$O:375L6^A*(,M-!S258:@ZW_%7'B_(VJ(NQM5RBG-\)NA;&
M.^@M/UINJ&?+S"?9\-S"-.O<1,^'HSS9A[5::GC&Q[W^%-B *$<FAQ$(DF[I
M&:4L@2:G2&Y&V9 9V[:F1Z6[$=##7$Y 6X9?'A45'K$,-\2KV%C0Z3]M@.<#
M,AV,@Q7 N4YHH8Q'KNDM#C>57"!F7!;YX:? T]'OX;1DLBRDYV\2/@T*++>F
M3S/!]# VV$U<*SZ/(0ORAKIGNJ9,IL"SX:]XL+&@4N&M2'(XCH_3O>609AA,
MX7(5C!?W9#Z@/=)"(EMBQAC/D<<*N!1X*[*^BA]0<](3T,NV;W0#6,E/#@EC
M ;L!0<5;TFAPK# 9Y/TGVPUI6M4M0LXC=%U-1'$(/G<&>;!3XI=(S9<')VF$
M/%NC=U(LZ;S)*T%'WDVIR5:LBD;G\8SXJ'8;]T1\7]=?E.%B>,A>;")\R1#7
M@A@F"RQU9XEU(EP3:T=C-<27)7_!(='@1&6M 2\>^2:W!-7F7A0$XT+5;"2[
MO]ZX: ? -,ZE;HCV:JGM(9L#0;-CO)O<:?@$@U4WN=*0:KG3<TC!E&AV4RA&
M;@5V\GL2)8D@^?WK7B^=([="I.EXJ1B[5?@9C)<V-!&W>N9E3+6&8J@E!J5[
M;UDI];PX%1B*!?M.$W'53!]T#T.S^QGI 6AV-]I%ZS6, X4TG0!%5[2!9^OB
MBR7/\.%O@:GF'1H&4J;R+*)TLER]%LW79DK%M2"8P )+G3\J>9"?20_4EP-5
M),?LIJ+:@(_.ZD]Q4K.Z*:+MC]?-$M=FZBA6:E-@Q=<^Y&D><B="#$^4(IR=
M J3@*%$JV.HXT>4\RYU8T!EX76L#B>>C)[!:(LMLGK4(;:5H&3LM[-AVN ZC
M*%]T-$8K3F*P IX/MR"NAS=$/CWC'"_FUI.N@+F0#L9O&0A1+@JPBJ-(&4N8
MTGOT'G#Z%O:(_^QG%.^!!;2A'L>50VR;_" >%.5WE77=HM.^-+09:=$<7811
MPMC?S43@,MM?LK]MB,-*H:V:A:LA3"C^H3;%M+K'U7%YCZ:K?AQ7W'TI O)2
M!.2E",A+$9"7(B O14!>BH#LZ7LI O)2!.2E",A+$9"7(B"B8^>E",A+$1!6
M6-EUT2/=C=X@W$/A0[ (W=-K]%JSL(4T.)L9_V2CEXLEBZ%JL,3$(>9)!)/]
M&X62_.R""%//Z:P1\4.^1G\OO7FJ^["AGG+G,LVQ+489%4HV9D+FQ+S)FNE8
MM@-<[KU4PZ8/(5ALRR%EZ,3X!GHP $.XI>]MY6]2<I&J:!Z04*,=BX0,OBJ.
MG^NGZ4PL/,91)YTHJ6$"</3J60-Y.Z6BS\)]8_+-BZ&2*ZXJ:([T\3MAL$(8
M?CV<=VBD]T1D.X9R%6XJ#I)5\1G'H!KC,A'7@MQ6%ECRY\HU8S5%2HW#@#ZX
M2LL8-$9C5F9+N<S!)G^*K)30$2+K0%/)RAEAY^PD5R.5D/=C0PYQ7I%[SP$^
M7'ITY8X-BVLO4]G(.5-2C4!"R?N&]RB9]-I&G5(>N>UP7;@03&,*]2X(U"2X
M$7>4):\5@20F8"F/-8-#:IC4Z(B6R3K_36(I2BEU34>!3A32[7TR!;:0P"*W
M\TV= (ZQO,4X"7X/PROI0]"CAK1F*);)DAP.R7.M>A(=]HV;-/,*<O(Y]"D8
M!J_'=Y$?C!>)*IIFI*R$EG!S!(O$J=#[F" /+*/20K4"4;<8^?X$HX6FRRG9
M]HV&)PJM,<M+#HD:Y;=4%@Q)"G?[6B?B<FFF-TH"HXH!F;+K[W)I1:Y+JYH"
MC^CGTL-B9PT]2'4+X!8DVFK*,.(2;7+:K#3T?*81'Y2FDC:F!#[2=?IT28],
M,RZ*SOUU,LR6:#9N)41M!73&4MI/.M',!&PZH,%ER<S95^4*6I.ZPPUAO>1E
MY)@=>3*K9A8D^52&^B6;H@O>L3(T>:H1]X<MLDT^4 5X-:K@U7>$#E7[8PW3
MFQ=TCH%;Z !/3\211ZYICOFLOO@-! ::YHH''::3&]+1N)Y82*:99+Y!GG\-
M%@@GU1OFUA/P^T^DLT1CZ%EX%P7Q:)4_6F@516Y?VD.-L2@]^AK=]0K,'EHY
M4U4&L(XY$I63H75-MA"Z AYELEH2G2J%2B+11F6<:@0"S8Y<7D)+Z#J"15D)
M!LF!EM9L20^HKRT?VEK8*I;4EKFV!"<%Z3-J>.M!-PPT'0&7R6K)B"N%2D&B
MC>RP^P3HA07@=+9DJ5Z"44AOWXT7)\><6O=1PDJTA'!Q<&LDY=0O_,BKKKZI
M64P#TWLOV;$C8R+Y:;[Q '6)FLD,UDP2B:@.AB.A&JVC'/;F+PH6NI.:ROV>
M^-GM<-E.H%&3LB<=)*VH@DG<$XAH8A"F%QI[(/ZO_D!J/;7:XK^K8*!&WJ":
M9X)*^G"#,)FPO/@.O+V;8\OSB<+Q5>?H-S=BY=:"'NUO!T.?3%N]$)/_CSNM
MM=9M$WH;/CI5-KYY;%8IW^9"S@4]TVJ&+'F&G1:A9#0&:C5R8@O#2<TEQT9.
M5:X\*2WG]1;A=Z]J%Y),ZN$T^3 )CV0%-<->JGF6BSF+_'8>T^,OYUF/@5@Z
MG3^0!^B[0=J+S!5*/)/+>=7EH8KQ4K'5JWEY1&.-LU,IYW)3BV6])9=&CFJ:
M*7B95XRZ;Z4P)S='C5;C5/BRB\8!QY9X)G,E[]BK@,]H6C?'FR0Z:>:6?AX5
M(;@9YT>U1I*BBN#)\2,E&LDN$=6VE;0,,65)B;)'WWG]M9<H/Y;4KA%:@E8F
MO>LL-DHRU5K?UJG6^JT^"R3W-&D=)WH311R)9!S4.B?77NK@I,K6.8QS-E&%
M=0W44"0?G"+&$ZN4C3A'95"B?QMOHMS4_A/ -O1U<2FLQ9GXVM4#4PQ;0Q5/
M2S2-#=:X&;#4.)O=M(PE,/%5YH&KGA9&X#'Z%UWA2![)[9CO^4!44_94^; W
M0O.QZ)9X7QP8UKBAH60?]I*.<*[I"'QVUF1Z09UJKW*!W#_#^+:=/T<E8<DT
MCQ\X% 2"0-2K[-HY!63SX\, S #>0AO$G9L"&RT]J*U*>U.ZG_],V!B+2DK8
MOER34L-Z\0VI>E=L5,6(-&78ECTU?.9,%>,C?ZTF#D/T/4=9G$@77^VJA'F,
M2(WK+H44F:FAV+7\U8V+'E_538P9+]*F]-:M8 J4-'8R6=*V)AC1&@+.]>[>
MI]4E]V5".L1QV\9O@.OLFH0:9Q-G8=!_M"P)(ZTL\^3%LV"3*3\,JCV/YM^2
MR[J]U$_U;.B"G')S= ZC7HNB9^+X<,X*>KA2^PJGF/5EW\P[>BI/BQ&QY!D.
MRNH<B%DC8D)NL!YPU"V?:%'P]J866V *-+F^-&4);,05Y![+%@+SR#_OAH.;
M,:TTB+=)$*5+-A9+/1<0*H5^(W-#-?A*'C^O$2")PVST^52MM7&+17TC5E &
MM(I'+&6/?Y@/L&:6,)U6(:S$M["(B#.CX,!8LLI;[C)LIJ=)=%_W>Q:\XL\E
M.X!S5R("K+*L?.E*?T>JGK[NWA#[!8)-ES<0'!YL&R@"5F)W458D4!7_J<<#
M-26*L"4:+V^BE/(<EH8?+CG5;H+!QH).+U$E68[(#CA*38C?[V[(!+A4>5ZV
MP8>^Q/*@PFA.U8V<F2&T'J![DJQ?<G6RLI$V$EJ-C,%-04&7J#$='-@FQW2A
M:,,U#)6.X&)L)9SYDA&KUI^;6#OJ<]  IVWCD,A)3+:YA9Y+E39."G71E\\E
MU3!E]-<;%^T F(+H8FGS9L)0X'D9!PMI!9F;ZDR"%K>GW?H$@U4W] .:&%+B
M"VBS"K8.YBM(*;6,"L"5)$SJS7<QG.?2;H,0@5D^05/%2Q$EFL;/K1A/@&*I
M\4P2H)A(&[UR1ER>-'?<_BN$]"&4P/*6M/B,QGU(M=0S3)3B&"ZY8^IJ9(T'
M%D]T)'TFTU>PHP=H]-DEFK$</9/7C!F4BS>\4F@R"0;<"@.1FM<,PVO%\S -
M$;AKG$;5?LJP1,\;Z%F>;=R58*GQ3%P))M)&WT(DFMH .-%#:_0>!5$3D+X>
M:@WJ2H>KD'J&K@3'<#G*>*M"UE0>=E:UYDI65$M]7J2SBU4T7F>5OX.&)_\S
M]0T$+4$$;I.^07^Q #99WOI/]HKL=,"4+'ACCZI.7%OZ'^K>;BT7Z$J-%E+
M;)1:C66((:[DS%.J+C/1Y$B;*7%K,;23*XI$V_P?,I\L?A."_.Z&3O0V^Z'K
M,1Q:3*OA+IAV5M689].\UW!_CU]VD#7STW'7(4ABO",J1R6(M%EGM>1GL1AR
M@BQ_6%M8YT^;.6BZ?,]M$-^"-62N\TN<U)[>YA>RAJB3-(4L*OTS7R474VX0
M+@Z0E*1I<31S'C5W*Z(;/'"H*]HE>;">O@1/%=5U<)Z386JYYS?.PM?44X34
M7;]LKDK&=6<VF(UO)M/^K#^:=^:#\>B59!VM.'N(%O9"+K2U7R@O%R>[4M$7
M7/WQXM"R%L5/I9B^F%9)7-;J"T!26;JBP6?$!K>CP<V@VR%FW^V.[T?SP>AV
M,AX.NH/^[)L= S.X]."" .4%IZW/"<[7KJX0-J=HH]?RA(8*+Y;J'AUJ=@!]
MZ$S['\;#7G\ZZ_]Z/YA_?J6R?MH(!7J?M*T0J;08'&VY!WW;17Z(@>9QQ"W=
ML*O,PSB[AEPIK(K?\6IN4-WVQ[?3SN0#685&-^/I7>J1B1GB+4!+;&U6T!YX
M"X37D7X'H(2V7+QMB:XX%>V6C!$Y)?,F;\#H!0FA5L^/3SO]KV&_,XL<+;DY
MM@ )K:L%2YY\K'0(?!^ _"U\S6Y6A4C3(7<.7K-K0A6 JL9&LZ4KQW=W@_D=
MV9#/.J->=QQM3?JC9&,B&Y9'ZS6,2TK04"&*O%'@45^T:F50%8T5TJ"&_\4E
M2.\H$U3!J"<F91G'#ZF*X-U:[VQV?TVW.F1@]C_2T2G_X'CXX(._0J)<?QO!
MIG6C4R9,_D6THQ8U;VA*I9E>K*IHS.U>RC%K:0!@VI_-._,^7:>B"/+'P?A^
M-OP\F,WN^[V;P:A#5JS.</^968WPP 1#A..H_*$TDM9!PY8H/7+Z&"/<183@
MZ)D,O0.G5)C9I!\N,G/Y/:6@M7/K<QH-O-Y%/^VD%Y3V1YX/]=IIY;H(#=TN
M&D-@>Z+,;-R4+BW"G-[[8+SH^P%<6X&F+-@C$69G-C'FCM%1]Z"]$%EW%OX"
M(L_]#@0KY/CC!?': PP?PLJA6!*.$VSR_ >;*$;J*N6),#F$?X70@<%.AK/2
M+QO=F_+14]YQ5;>*)5<T&]#:"!2O*?2_=(EL&-"?="UHI?):E6/ !,[HY:[B
M1+M&O!4NR>VBF0],97EP,H3/L>4<"MV=5,5,O'8=A/-);A7AG&#*)ZG6(#PI
M<9B8G\P"RFZA!:MH!03RA7SJ+Z7[TO9-3+6EPMJTN2A'K$81'A55G$N+/31!
M+;=PTY%E,;+Y,95_<5'-2]"W"#F/T'6)DL>%8)K@7T!\JU96$5AK/.FHYF(!
MK>71U( OE]:N$<Y +>73R!-@Q6\JQW?T(V.D&SFX!71F\C5ZRS)ZM, EJP5S
M:ACUHU REC$%Q $)0>;Q[";&>[74\P\V"B"84ER_:I[LH8T?C!<SLG-O)@A2
M+JY%@YD%6DJHF? 6?32,])I&97K$^%P4.9%)N7^-LS>/W':MUUQ(IF37#FW5
MNN#9C!M6(JQ=6^HRQ%(BZX>L).?A&X0!7'K=D,CUB&J8N %6E"Q!SZRB7]T(
MV$:F:7EM6K7IJ@%Z:C"U@VEUTL[C9.DF#((EKU64,X%+254069-*+;.P1[I!
M*\9$VX4FB*V2V2*OK!*^E-[ZL3.Y8G./F?Y@Y)$?[:C4!,^1A;*2<X)*M&>S
M)8YOFN.A(HW]?&Z^S^E)G/]*TDK;GX8XLU? "5TP7NQ/4.(%/HB0T9SISBN\
M79LA?DP5WPRIP7YQQ"U;@30IS;1KU"ZDU6K12JR"!%6YE))74ZWE$M/Z\S1(
MNTCB> W8"9_D5GG<G& J2[@T?]O_L (_OTO_1Z%M6M2Y3W##GN6F3T?YU[N#
M] ZM=MG P*FCCYD0ED1% 27@*URA#90;D!U;F=FHQ54'#@MK6IQP%FXV;K3+
ML=R#+#]YY&^.HD@':_R5S!]J)!GU63@+$2C"5.5%-B55*/8O^-U908B;<7-E
M]&B#C=3"6=FMH$:GV\QK\E&'A"\V9AH0\ER*OB?_#'VR6YU:CX0>TD7+]4<@
MH%ZH#_!6VRNSE6+-^!P,3@I33QFPJ:F56HO43PA_H4_;(YL,RP999<@U%=81
M)98%G8K76.I2>P,]Z)-UF:9%-DDM0VY;J&5!)[_)5D<M44DOAU2 H0B)*%<1
M%C5N..9?>VC4/R@*WXD>.ARU(>0FE'U7PD29QRD]$%C0]0N[R[61DFU<,'8I
M(8?8 1@$8.WKZLA!@*'Q6&%@T?9/FOS,.BGOS'0>+>S,R0<[3U#/VI:70*WJ
MYW^_O+SXWT]W'[__O__]S=Z$3Y^][]\[7W_8+C_OO/M>^'C[ W[_P[_>_GD_
MW_GN#UO[ZVOWG\%_O_GXU[NOJ]6]N^B!R=7TU_NO][_#56_\HS,,?L5WO]^-
MP-^"OV\Z<#MY;3TMG)O?-_[0F=K=OW_\[\6=M>TMG1_L&V\S&GWX^]7[X6]?
MKA]F]H^W/X:=]ZOP_NL3FEF##X]?_[;]^-G]_*6W>^SV.^!3^->O]]]_^?//
MJ_=P\=YU)FYO_:_'JZO-[[-K=SY];?\3_#A%RT=K&B#KPY_++7[]QEHXP=77
MWX?3W_[YU/,&3V/[_6C\%OWR?Q?=V?3RTL1^L^X4DUT]CDS&H+O67V]<M ,@
M<YYS!]8/ &LQY')IQ@]3BP9Q+C6E'"C%<:.6V72]52OCSBJ]_=+!F#[)12.
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M0FJ8Y!;(.A2H*8&J8*H_2AV> AIZ3/]Q#O#Z30.+ (<21LH@:%H;>#!74MU
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MWH5_W6XU&_4?CRB+9X/AA3>LG0]N;KJW(Z\=JCCFJ1'+9-5NO$N_72N65S
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M!;^HW6O\ZE2<J"#16XG2 7>,BF3 4^NL9V0@N99T")GW&%L'8U*5&:KZ-E_
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MR.W.:_MLW&F#82C/9O7BX7=02P,$%     @ K8$L5)2_!U>"!   U!    \
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MBK>)Z3:/A7-*2\=M]/>$5%@;EUX0>-<=HYEL/BNN7YQA,.Z<O56FY?+ FZJ
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M!U!+ 0(4 Q0    ( *V!+%04+0?Y\@ ! /PL$0 1              "  0
M  !B;7)A+3(P,C$Q,3,P+FAT;5!+ 0(4 Q0    ( *V!+%15U-.[G T   )X
M   1              "  2$! 0!B;7)A+3(P,C$Q,3,P+GAS9%!+ 0(4 Q0
M   ( *V!+%3O2&$U,@L   V    5              "  >P. 0!B;7)A+3(P
M,C$Q,3,P7V-A;"YX;6Q02P$"% ,4    " "M@2Q4+/.S%E,P  "(X0( %0
M            @ %1&@$ 8FUR82TR,#(Q,3$S,%]D968N>&UL4$L! A0#%
M  @ K8$L5-;5/)1E8   /;L$ !4              ( !UTH! &)M<F$M,C R
M,3$Q,S!?;&%B+GAM;%!+ 0(4 Q0    ( *V!+%1-:DQ'P#   'O\ @ 5
M          "  6^K 0!B;7)A+3(P,C$Q,3,P7W!R92YX;6Q02P$"% ,4
M" "M@2Q462'.3/ '  #>'P  #P              @ %BW $ 97AH:6)I=#,Q
M7S$N:'1M4$L! A0#%     @ K8$L5$ZNLOS<!P  T2(   \
M ( !?^0! &5X:&EB:70S,5\R+FAT;5!+ 0(4 Q0    ( *V!+%3!82(5> 0
M ($0   /              "  8CL 0!E>&AI8FET,S)?,2YH=&U02P$"% ,4
M    " "M@2Q4E+\'5X($  #4$   #P              @ $M\0$ 97AH:6)I
?=#,R7S(N:'1M4$L%!@     *  H ?@(  -SU 0    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
